10-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-K

þ Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the fiscal year ended December 31, 2015

o Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from ______ to ______ 

Commission File Number 001-31792

CNO Financial Group, Inc.

Delaware	75-3108137
State of Incorporation	IRS Employer Identification No.
11825 N. Pennsylvania Street
Carmel, Indiana  46032	(317) 817-6100
Address of principal executive offices	Telephone

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Name of Each Exchange on which Registered
Common Stock, par value $0.01 per share	New York Stock Exchange
Rights to purchase Series C Junior Participating Preferred Stock	New York Stock Exchange

Securities registered pursuant to Section 12(g) of the Act:

None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes [ X ] No [ ]

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes [ ] No [ X ]

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days: Yes [ X ] No [ ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes [ X ] No [ ]

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of Registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. [ X ]

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act. Large accelerated filer [ X ] Accelerated filer [ ] Non-accelerated filer [ ] Smaller reporting company [ ]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act): Yes [ ] No [ X ]

At June 30, 2015, the last business day of the Registrant's most recently completed second fiscal quarter, the aggregate market value of the Registrant's common equity held by nonaffiliates was approximately $3.5 billion.

Shares of common stock outstanding as of February 9, 2016:  179,593,602

DOCUMENTS INCORPORATED BY REFERENCE: Portions of the Registrant's definitive proxy statement for the 2016 annual meeting of shareholders are incorporated by reference into Part III of this report.

TABLE OF CONTENTS

PART I		Page
Item 1.	Business of CNO	3
Item 1A.	Risk Factors	22
Item 1B.	Unresolved Staff Comments	40
Item 2.	Properties	40
Item 3.	Legal Proceedings	40
Item 4.	Mine Safety Disclosures	40
	Executive Officers of the Registrant	41
PART II
Item 5.	Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities	42
Item 6.	Selected Consolidated Financial Data	45
Item 7.	Management's Discussion and Analysis of Consolidated Financial Condition and Results of Operations	46
Item 7A.	Quantitative and Qualitative Disclosures About Market Risk	115
Item 8.	Consolidated Financial Statements and Supplementary Data	116
Item 9.	Changes in and Disagreements with Accountants on Accounting and Financial Disclosure	199
Item 9A.	Controls and Procedures	199
Item 9B.	Other Information	199
PART III
Item 10.	Directors, Executive Officers and Corporate Governance	200
Item 11.	Executive Compensation	200
Item 12.	Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters	200
Item 13.	Certain Relationships and Related Transactions, and Director Independence	200
Item 14.	Principal Accountant Fees and Services	200
PART IV
Item 15.	Exhibits and Financial Statement Schedules	201

2

PART I

ITEM 1. BUSINESS OF CNO.

CNO Financial Group, Inc., a Delaware corporation ("CNO"), is a holding company for a group of insurance companies operating throughout the United States that develop, market and administer health insurance, annuity, individual life insurance and other insurance products. The terms "CNO Financial Group, Inc.", "CNO", the "Company", "we", "us", and "our" as used in this report refer to CNO and its subsidiaries. Such terms, when used to describe insurance business and products, refer to the insurance business and products of CNO's insurance subsidiaries.

We focus on serving middle-income pre-retiree and retired Americans, which we believe are attractive, underserved, high growth markets. We sell our products through three distribution channels: career agents, independent producers (some of whom sell one or more of our product lines exclusively) and direct marketing. As of December 31, 2015, we had shareholders' equity of $4.1 billion and assets of $31.1 billion. For the year ended December 31, 2015, we had revenues of $3.8 billion and net income of $270.7 million. See our consolidated financial statements and accompanying footnotes for additional financial information about the Company and its segments.

The Company manages its business through the following operating segments: Bankers Life, Washington National and Colonial Penn, which are defined on the basis of product distribution; and corporate operations, comprised of holding company activities and certain noninsurance company businesses. The Company’s insurance segments are described below:

• Bankers Life,which markets and distributes Medicare supplement insurance, interest-sensitive life insurance, traditional life insurance, fixed annuities and long-term care insurance products to the middle-income senior market through a dedicated field force of career agents, financial and investment advisors, and sales managers supported by a network of community-based sales offices.  The Bankers Life segment includes primarily the business of Bankers Life and Casualty Company ("Bankers Life").  Bankers Life also has various distribution and marketing agreements with other insurance companies to use Bankers Life's career agents to distribute Medicare Advantage and prescription drug plans ("PDP") products in exchange for a fee.

• Washington National, which markets and distributes supplemental health (including specified disease, accident and hospital indemnity insurance products) and life insurance to middle-income consumers at home and at the worksite.  These products are marketed through Performance Matters Associates of Texas, Inc. ("PMA", a wholly owned subsidiary) and through independent marketing organizations and insurance agencies including worksite marketing.  The products being marketed are underwritten by Washington National Insurance Company ("Washington National"). This segment's business also includes certain closed blocks of annuities and Medicare supplement policies which are no longer being actively marketed by this segment and were primarily issued or acquired by Washington National.

• Colonial Penn, which markets primarily graded benefit and simplified issue life insurance directly to customers in the senior middle-income market through television advertising, direct mail, the internet and telemarketing.  The Colonial Penn segment includes primarily the business of Colonial Penn Life Insurance Company ("Colonial Penn").

As further described in the note to the consolidated financial statements entitled "Sale of Subsidiary", we sold Conseco Life Insurance Company ("CLIC") on July 1, 2014. The business of CLIC primarily related to traditional and interest-sensitive life products. In periods prior to 2014, we had an Other CNO Business segment comprised of the long-term care business that was ceded effective December 31, 2013 and the overhead expense of CLIC that was expected to continue after the completion of the sale. Beginning on January 1, 2014: (i) the overhead expense of CLIC that was expected to continue after the completion of the sale was reallocated primarily to the Bankers Life and Washington National segments; and (ii) there was no longer an Other CNO Business segment.

3

OUR STRATEGIC DIRECTION

Our mission is to be the recognized market leader in providing financial security for the protection and retirement needs of middle-income American working families and retirees. Our strategic plans are focused on continuing to grow and deliver long-term value for all our stakeholders. Specifically, we will focus on the following priorities:

Growth

•Focus on initiatives that drive sales including lead programs, new products, agent recruitment and retention

• Expand offering middle-market consumers a range of investment and planning solutions

• Exploring non-organic growth opportunities that are focused on the middle market, fill product gaps, expand our distribution and geographic footprint and/or enhance agent recruiting

Increase profitability and return on equity

•Maintain our strong capital position and favorable financial metrics

•Continue to increase our return on equity

Effectively manage risk and deploy capital

•Active enterprise risk management process

•Continue to cost effectively repurchase our common stock

•Maintain a competitive dividend payout ratio

Further enhance the customer experience and agent productivity

•Completion and implementation of new tools to be used by our distribution force

• Further development of capabilities for generating and acting on prospect/customer data insights making it easier to sell and deliver service

Reduce long-term care exposure by approximately one-half over the next three to six years

•Drive growth of other lines of business

•Evaluate reinsurance and/or other potential solutions

Continue to invest in talent

•Expanded leadership development programs

•Emphasis on skills and experiences that are aligned with our priorities

OTHER INFORMATION

Our executive offices are located at 11825 N. Pennsylvania Street, Carmel, Indiana 46032, and our telephone number is (317) 817-6100. Our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act are available free of charge on our website at www.CNOinc.com as soon as reasonably practicable after they are electronically filed with, or furnished to, the Securities and Exchange Commission (the "SEC"). These filings are also available on the SEC's website at www.sec.gov. In addition, the public may read and copy any document we file at the SEC's Public Reference Room located at 100 F Street, NE, Room 1580, Washington, D.C. 20549. The public may obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330. Copies of these filings are also available, without charge, from CNO Investor Relations, 11825 N. Pennsylvania Street, Carmel, IN 46032.

Our website also includes the charters of our Audit and Enterprise Risk Committee, Executive Committee, Governance and Nominating Committee, Human Resources and Compensation Committee and Investment Committee, as well as our Corporate Governance Operating Principles and our Code of Business Conduct and Ethics that applies to all officers, directors and employees. Copies of these documents are available free of charge on our website at www.CNOinc.com or from CNO Investor Relations at the address shown above. Within the time period specified by the SEC and the New York Stock Exchange, we will post on our website any amendment to our Code of Business Conduct and Ethics and any waiver applicable to our principal executive officer, principal financial officer or principal accounting officer.

In May 2015, we filed with the New York Stock Exchange the Annual CEO Certification regarding the Company's compliance with their Corporate Governance listing standards as required by Section 303A.12(a) of the New York Stock Exchange Listed Company Manual. In addition, we have filed as exhibits to this 2015 Form 10-K the applicable certifications

4

of the Company's Chief Executive Officer and Chief Financial Officer required under Section 302 of the Sarbanes-Oxley Act of 2002 regarding the Company's public disclosures.

CNO became the successor to Conseco, Inc., an Indiana corporation (our "Predecessor"), in connection with a bankruptcy reorganization which became effective on September 10, 2003 (the "Effective Date"). Our Predecessor was organized in 1979 and commenced operations in 1982.

Data in Item 1 are provided as of or for the year ended December 31, 2015 (as the context implies), unless otherwise indicated.

MARKETING AND DISTRIBUTION

Insurance

Our insurance subsidiaries develop, market and administer health insurance, annuity, individual life insurance and other insurance products. We sell these products through three primary distribution channels: career agents, independent producers (some of whom sell one or more of our product lines exclusively) and direct marketing. We had premium collections, excluding premium collections related to CLIC prior to being sold, of $3.4 billion, $3.4 billion and $3.3 billion in 2015, 2014 and 2013, respectively.

Our insurance subsidiaries collectively hold licenses to market our insurance products in all fifty states, the District of Columbia, and certain protectorates of the United States. Sales to residents of the following states accounted for at least five percent of our 2015 collected premiums: Florida (9 percent), Pennsylvania (7 percent), California (6 percent) and Texas (6 percent).

We believe that most purchases of life insurance, accident and health insurance and annuity products occur only after individuals are contacted and solicited by an insurance agent. Accordingly, the success of our distribution system is largely dependent on our ability to attract and retain experienced and highly motivated agents. A description of our primary distribution channels is as follows:

Career Agents. The products of the Bankers Life segment are sold through a career agency force of over 4,500 producing agents working from over 300 Bankers Life branch offices and satellites. These agents establish one-on-one contact with potential policyholders and promote strong personal relationships with existing policyholders. The career agents sell primarily Medicare supplement and long-term care insurance policies, life insurance and annuities. In 2015, this distribution channel accounted for $2.5 billion, or 73 percent, of our total collected premiums. These agents sell Bankers Life policies, as well as Medicare Advantage plans primarily through distribution arrangements with Humana, Inc. ("Humana") and United HealthCare, and typically visit the prospective policyholder's home to conduct personalized "kitchen-table" sales presentations. After the sale of an insurance policy, the agent serves as a contact person for policyholder questions, claims assistance and additional insurance needs.

Independent Producers. The products of the Washington National segment are primarily sold through our wholly-owned marketing organization, PMA. In addition, Washington National's products are sold through a diverse network of independent agents, insurance brokers and marketing organizations. The general agency and insurance brokerage distribution system is comprised of independent licensed agents doing business in all fifty states, the District of Columbia, and certain protectorates of the United States. In 2015, this distribution channel accounted for $649.7 million, or 19 percent, of our total collected premiums.

Marketing organizations typically recruit agents by advertising our products and commission structure through direct mail advertising or through seminars for agents and brokers. These organizations bear most of the costs incurred in marketing our products. We compensate the marketing organizations by paying them a percentage of the commissions earned on new sales generated by agents recruited by such organizations. Certain of these marketing organizations are specialty organizations that have a marketing expertise or a distribution system related to a particular product or market, such as worksite and individual health products.

Direct Marketing. This distribution channel is engaged primarily in the sale of graded benefit life insurance policies through Colonial Penn. In 2015, this channel accounted for $262.9 million, or 8 percent, of our total collected premiums.

5

Products

The following table summarizes premium collections by major category and segment for the years ended December 31, 2015, 2014 and 2013 (dollars in millions):

Total premium collections

	2015		2014		2013
Health:
Bankers Life	$	1,242.3	$	1,275.1	$	1,317.8
Washington National	619.6		603.0		596.3
Colonial Penn	3.0		3.4		4.1
Other CNO Business	—		—		23.6
Total health	1,864.9		1,881.5		1,941.8
Annuities:
Bankers Life	803.0		782.3		744.1
Washington National	2.4		2.6		4.3
Total annuities	805.4		784.9		748.4
Life:
Bankers Life	446.0		424.9		368.3
Washington National	27.7		25.9		26.5
Colonial Penn	259.9		241.7		227.6
Total life	733.6		692.5		622.4
Total premium collections from business segments excluding the business of CLIC prior to being sold	3,403.9		3,358.9		3,312.6
Premium collections related to business of CLIC prior to being sold (primarily life products)	—		71.2		142.3
Total premium collections	$	3,403.9	$	3,430.1	$	3,454.9

6

Our collected premiums by product and segment were as follows:

Health

Health premium collections (dollars in millions)

	2015		2014		2013
Medicare supplement:
Bankers Life	$	739.4	$	743.3	$	745.3
Washington National	72.6		85.2		101.9
Colonial Penn	2.7		3.2		3.7
Total	814.7		831.7		850.9
Long-term care:
Bankers Life	476.6		500.6		534.0
Other CNO Business	—		—		23.6
Total	476.6		500.6		557.6
Prescription Drug Plan products included in Bankers Life	—		6.8		18.2
Supplemental health:
Bankers Life	19.2		16.3		9.9
Washington National	544.8		515.4		491.3
Total	564.0		531.7		501.2
Other:
Bankers Life	7.1		8.1		10.4
Washington National	2.2		2.4		3.1
Colonial Penn	.3		.2		.4
Total	9.6		10.7		13.9
Total health premium collections	$	1,864.9	$	1,881.5	$	1,941.8

The following describes our major health products:

Medicare Supplement. Medicare supplement collected premiums were $814.7 million during 2015, or 24 percent, of our total collected premiums. Medicare is a federal health insurance program for disabled persons and seniors (age 65 and older). Part A of the program provides protection against the costs of hospitalization and related hospital and skilled nursing facility care, subject to an initial deductible, related coinsurance amounts and specified maximum benefit levels. The deductible and coinsurance amounts are subject to change each year by the federal government. Part B of Medicare covers doctor's bills and a number of other medical costs not covered by Part A, subject to deductible and coinsurance amounts for charges approved by Medicare. The deductible amount is subject to change each year by the federal government.

Medicare supplement policies provide coverage for many of the hospital and medical expenses which the Medicare program does not cover, such as deductibles, coinsurance costs (in which the insured and Medicare share the costs of medical expenses) and specified losses which exceed the federal program's maximum benefits. Our Medicare supplement plans automatically adjust coverage to reflect changes in Medicare benefits. In marketing these products, we currently concentrate on individuals who have recently become eligible for Medicare by reaching the age of 65. Approximately 57 percent of new sales of Medicare supplement policies in 2015 were to individuals who had recently reached the age of 65.

Bankers Life sells Medicare supplement insurance. Washington National discontinued new sales of Medicare supplement policies in the fourth quarter of 2012 to focus on the sale of supplemental health products.

Long-Term Care. Long-term care collected premiums were $476.6 million during 2015, or 14 percent of our total collected premiums. Long-term care products provide coverage, within prescribed limits, for nursing homes, home healthcare, or a combination of both. We sell long-term care plans primarily to retirees and, to a lesser degree, to older self-employed individuals in the middle-income market.

7

Current nursing home care policies cover incurred charges up to a daily fixed-dollar limit with an elimination period (which, similar to a deductible, requires the insured to pay for a certain number of days of nursing home care before the insurance coverage begins), subject to a maximum benefit. Home healthcare policies cover incurred charges after a deductible or elimination period and are subject to a weekly or monthly maximum dollar amount, and an overall benefit maximum. Comprehensive policies cover both nursing home care and home healthcare. We monitor the loss experience on our long-term care products and, when necessary, apply for rate increases in the jurisdictions in which we sell such products. Regulatory filings are made before we increase our premiums on these products.

A small portion of our long-term care business was included in the former Other CNO Business segment. This business was sold through independent producers and was largely underwritten by certain of our subsidiaries prior to their acquisitions by our Predecessor in 1996 and 1997. The performance of these blocks of business did not meet the expectations we had when the blocks were acquired. As a result, we ceased selling new long-term care policies through independent distribution in 2003. In December 2013, we ceded the long-term care business in our former Other CNO Business segment to an unaffiliated reinsurer. We remain primarily liable to the insured policyholders in the event the reinsurer does not meet its contractual obligations (see the note to the consolidated financial statements entitled "Summary of Significant Accounting Policies - Reinsurance").

Our long-term care insurance block is not expected to generate significant future profits and has low margins to offset any future deterioration in experience. We continue to sell long-term care insurance through the Bankers Life career agent distribution channel. However, the business currently being sold is underwritten using stricter underwriting and pricing standards and generally has shorter benefit periods than the older long-term care business in Bankers Life.

Prescription Drug Plan and Medicare Advantage. Prior to its termination in 2013, we had a quota-share reinsurance agreement with Coventry. Such agreement had provided CNO with a specified percentage of net premiums and related profits subject to a risk corridor for CNO enrollees. The $6.8 million of premiums collected in 2014 represented adjustments to premiums on such business related to periods prior to the termination of the agreement. We continue to receive distribution income from Coventry for PDP business sold through our Bankers Life segment.

Bankers Life primarily partners with Humana and United HealthCare to offer Medicare Advantage plans to its policyholders and consumers nationwide through its career agency force and receives marketing fees based on sales.

Supplemental Health Products. Supplemental health collected premiums were $564.0 million during 2015, or 17 percent of our total collected premiums. These policies generally provide fixed or limited benefits. Cancer insurance and heart/stroke products are guaranteed renewable individual accident and health insurance policies. Payments under cancer insurance policies are generally made directly to, or at the direction of, the policyholder following diagnosis of, or treatment for, a covered type of cancer. Heart/stroke policies provide for payments directly to the policyholder for treatment of a covered heart disease, heart attack or stroke. Accident products combine insurance for accidental death with limited benefit disability income insurance. Hospital indemnity products provide a fixed dollar amount per day of confinement in a hospital. The benefits provided under the supplemental health policies do not necessarily reflect the actual cost incurred by the insured as a result of the illness, or accident, and benefits are not reduced by any other medical insurance payments made to or on behalf of the insured.

Approximately 72 percent of the total number of our supplemental health policies inforce was sold with return of premium or cash value riders. The return of premium rider generally provides that, after a policy has been inforce for a specified number of years or upon the policyholder reaching a specified age, we will pay to the policyholder, or in some cases, a beneficiary under the policy, the aggregate amount of all premiums paid under the policy, without interest, less the aggregate amount of all claims incurred under the policy. For some policies, the return of premium rider does not have any claim offset. The cash value rider is similar to the return of premium rider, but also provides for payment of a graded portion of the return of premium benefit if the policy terminates before the return of premium benefit is earned.

Premiums collected on supplemental health products in the Bankers Life segment primarily relate to a new critical illness product that was introduced in 2012. This critical illness insurance product pays a lump sum cash benefit directly to the insured when the insured is diagnosed with a specified critical illness. The product is designed to provide additional financial protection associated with treatment and recovery as well as cover non-medical expenses such as: (i) loss of income; (ii) at home recovery or treatment; (iii) experimental and/or alternative medicine; (iv) co-pays, deductibles and out-of-network expenses; and (v) child care and transportation costs.

8

Other Health Products. Collected premiums on other health products were $9.6 million during 2015. This category includes various other health products such as disability income products which are sold in small amounts and other products such as major medical health insurance which are no longer actively marketed.

Annuities

Annuity premium collections (dollars in millions)

	2015		2014		2013
Fixed index annuity:
Bankers Life	$	706.6	$	646.2	$	566.8
Washington National	1.9		2.0		3.8
Total fixed index annuity premium collections	708.5		648.2		570.6
Other fixed interest annuity:
Bankers Life	96.4		136.1		177.3
Washington National	.5		.6		.5
Total fixed interest annuity premium collections	96.9		136.7		177.8
Total annuity premium collections from business segments excluding the business of CLIC prior to being sold	805.4		784.9		748.4
Premium collections related to business of CLIC prior to being sold	—		.2		.3
Total annuity premium collections	$	805.4	$	785.1	$	748.7

During 2015, we collected annuity premiums of $805.4 million, or 24 percent, of our total premiums collected. Annuity products include fixed index annuity, traditional fixed rate annuity and single premium immediate annuity products sold through Bankers Life. Washington National no longer actively sells annuity products. Annuities offer a tax-deferred means of accumulating savings for retirement needs, and provide a tax-efficient source of income in the payout period. Our major source of income from fixed rate annuities is the spread between the investment income earned on the underlying general account assets and the interest credited to contractholders' accounts. For fixed index annuities, our major source of income is the spread between the investment income earned on the underlying general account assets and the cost of the index options purchased to provide index-based credits to the contractholders' accounts.

The change in mix of premium collections between Bankers Life's fixed index products and fixed interest annuity products has fluctuated due to volatility in the financial markets in recent periods. In addition, premium collections from Bankers Life's fixed rate annuity products decreased in 2015 and 2014 as low market interest rates negatively impacted the attractiveness to the consumer of these products.

The following describes the major annuity products:

Fixed Index Annuities. These products accounted for $708.5 million, or 21 percent, of our total premium collections during 2015. The account value (or "accumulation value") of these annuities is credited in an amount that is based on changes in a particular index during a specified period of time. Within each contract issued, each fixed index annuity specifies:

• The index to be used.

• The time period during which the change in the index is measured. At the end of the time period, the change in the index is applied to the account value. The time period of the contract ranges from 1 to 4 years.

• The method used to measure the change in the index.

• The measured change in the index is multiplied by a "participation rate" (percentage of change in the index) before the credit is applied. Some policies guarantee the initial participation rate for the life of the contract, and some vary the rate for each period.

9

• The measured change in the index may also be limited by a "cap" before the credit is applied. Some policies guarantee the initial cap for the life of the contract, and some vary the cap for each period.

• The measured change in the index may also be limited to the excess in the measured change over a "margin" before the credit is applied. Some policies guarantee the initial margin for the life of the contract, and some vary the margin for each period.

These products have guaranteed minimum cash surrender values, regardless of actual index performance and the resulting indexed-based interest credits applied.

We have generally been successful at hedging increases to policyholder benefits resulting from increases in the indices to which the product's return is linked.

Other Fixed Interest Annuities. These products include fixed rate single-premium deferred annuities ("SPDAs"), flexible premium deferred annuities ("FPDAs") and single-premium immediate annuities ("SPIAs"). These products accounted for $96.9 million, or 3 percent, of our total premium collections during 2015, of which SPDAs and FPDAs comprised $87.6 million. Our fixed rate SPDAs and FPDAs typically have an interest rate (the "crediting rate") that is guaranteed by the Company for the first policy year, after which we have the discretionary ability to change the crediting rate to any rate not below a guaranteed minimum rate. The guaranteed rates on annuities written recently are 1.0 percent, and the guaranteed rates on all policies inforce range from 1.0 percent to 5.5 percent. The initial crediting rate is largely a function of:

•the interest rate we can earn on invested assets acquired with the new annuity fund deposits;

•the costs related to marketing and maintaining the annuity products; and

•the rates offered on similar products by our competitors.

For subsequent adjustments to crediting rates, we take into account current and prospective yields on investments, annuity surrender assumptions, competitive industry pricing and the crediting rate history for particular groups of annuity policies with similar characteristics.

In 2015, a significant portion of our new annuity sales were "bonus interest" products. The initial credited rate on these products generally specifies a bonus crediting rate of 0.5 percent for the first policy year only. After the first year, the bonus interest portion of the initial crediting rate is automatically discontinued, and the renewal crediting rate is established. As of December 31, 2015, the average crediting rate, excluding bonuses, on our outstanding traditional annuities was 3.0 percent.

Withdrawals from fixed interest annuities we are currently selling are generally subject to a surrender charge of 8 percent to 10 percent in the first year, declining to zero over a 5 to 12 year period, depending on issue age and product. Surrender charges are set at levels intended to protect the Company from loss on early terminations and to reduce the likelihood that policyholders will terminate their policies during periods of increasing interest rates. This practice is intended to lengthen the duration of policy liabilities and to enable us to maintain profitability on such policies.

Penalty-free withdrawals from fixed interest annuities of up to 10 percent of either premiums or account value are available in most fixed interest annuities after the first year of the annuity's term.

Some fixed interest annuity products apply a market value adjustment during the surrender charge period. This adjustment is determined by a formula specified in the annuity contract, and may increase or decrease the cash surrender value depending on changes in the amount and direction of market interest rates or credited interest rates at the time of withdrawal. The resulting cash surrender values will be at least equal to the guaranteed minimum values.

SPIAs accounted for $9.3 million of our total premiums collected in 2015. SPIAs are designed to provide a series of periodic payments for a fixed period of time or for life, according to the policyholder's choice at the time of issuance. Once the payments begin, the amount, frequency and length of time over which they are payable are fixed. SPIAs often are purchased by persons at or near retirement age who desire a steady stream of payments over a future period of years. The single premium is often the payout from a fixed rate contract. The implicit interest rate on SPIAs is based on market conditions when the policy is issued. The implicit interest rate on our outstanding SPIAs averaged 6.7 percent at December 31, 2015.

10

Life Insurance

Life insurance premium collections (dollars in millions)

	2015		2014		2013
Interest-sensitive life products:
Bankers Life	$	169.1	$	169.8	$	125.8
Washington National	15.6		13.0		13.1
Colonial Penn	.2		.4		.3
Total interest-sensitive life premium collections	184.9		183.2		139.2
Traditional life:
Bankers Life	276.9		255.1		242.5
Washington National	12.1		12.9		13.4
Colonial Penn	259.7		241.3		227.3
Total traditional life premium collections	548.7		509.3		483.2
Total life premium collections from business segments excluding the business of CLIC prior to being sold	733.6		692.5		622.4
Premium collections related to business of CLIC prior to being sold:
Interest-sensitive life	—		61.3		120.4
Traditional life	—		9.7		21.6
Total premium collections related to business of CLIC prior to being sold	—		71.0		142.0
Total life insurance premium collections	$	733.6	$	763.5	$	764.4

Life products include traditional and interest-sensitive life insurance products. These products are currently sold through the Bankers Life, Washington National and Colonial Penn segments. During 2015, we collected life insurance premiums of $733.6 million, or 21 percent, of our total collected premiums.

Interest-Sensitive Life Products. These products include universal life and other interest-sensitive life products that provide life insurance with adjustable rates of return related to current interest rates. They accounted for $184.9 million, or 5 percent, of our total collected premiums in 2015. These products are marketed by independent producers and career agents (including independent producers and career agents specializing in worksite sales). The principal differences between universal life products and other interest-sensitive life products are policy provisions affecting the amount and timing of premium payments. Universal life policyholders may vary the frequency and size of their premium payments, and policy benefits may also fluctuate according to such payments. Premium payments under other interest-sensitive policies may not be varied by the policyholders. Universal life products include fixed index universal life products. The account value of these policies is credited with interest at a guaranteed rate, plus additional interest credits based on changes in a particular index during a specified time period.

Traditional Life. These products accounted for $548.7 million, or 16 percent, of our total collected premiums in 2015. Traditional life policies, including whole life, graded benefit life, term life and single premium whole life products, are marketed through independent producers, career agents and direct response marketing. Under whole life policies, the policyholder generally pays a level premium over an agreed period or the policyholder's lifetime. The annual premium in a whole life policy is generally higher than the premium for comparable term insurance coverage in the early years of the policy's life, but is generally lower than the premium for comparable term insurance coverage in the later years of the policy's life. These policies combine insurance protection with a savings component that gradually increases in amount over the life of the policy. The policyholder may borrow against the savings component generally at a rate of interest lower than that available from other lending sources. The policyholder may also choose to surrender the policy and receive the accumulated cash value rather than continuing the insurance protection. Term life products offer pure insurance protection for life with a guaranteed level premium for a specified period of time-typically 5, 10, 15 or 20 years. In some instances, these products offer an option to return the premium at the end of the guaranteed period.

11

Traditional life products also include graded benefit life insurance products. Graded benefit life products accounted for $257.6 million, or 8 percent, of our total collected premiums in 2015. Graded benefit life insurance products are offered on an individual basis primarily to persons age 50 to 85, principally in face amounts of $400 to $25,000, without medical examination or evidence of insurability. Premiums are paid as frequently as monthly. Benefits paid are less than the face amount of the policy during the first two years, except in cases of accidental death. Our Colonial Penn segment markets graded benefit life policies under its own brand name using direct response marketing techniques. New policyholder leads are generated primarily from television, print advertisements, direct response mailings and the internet.

Traditional life products also include single premium whole life insurance. This product requires one initial lump sum payment in return for providing life insurance protection for the insured's entire lifetime. Single premium whole life products accounted for $37.5 million of our total collected premiums in 2015.

INVESTMENTS

40|86 Advisors, Inc. ("40|86 Advisors", a registered investment advisor and wholly owned subsidiary of CNO) manages the investment portfolios of our insurance subsidiaries. 40|86 Advisors had approximately $24.4 billion of assets (at fair value) under management at December 31, 2015, of which $24.1 billion were our assets and $.3 billion were assets managed for third parties. Our general account investment strategies are to:

• provide largely stable investment income from a diversified high quality fixed income portfolio;

• maximize and maintain a stable spread between our investment income and the yields we pay on insurance products;

• sustain adequate liquidity levels to meet operating cash requirements, including a margin for potential adverse development;

• continually monitor and manage the relationship between our investment portfolio and the financial characteristics of our insurance reserves such as durations and cash flows; and

• maximize total return through active investment management.

Investment activities are an important and integral part of our business because investment income is a significant component of our revenues. The profitability of many of our insurance products is significantly affected by spreads between interest yields on investments and rates credited on insurance liabilities. Also, certain insurance products are priced based on long term assumptions including investment returns. Although substantially all credited rates on SPDAs, FPDAs and interest sensitive life products may be changed annually (subject to minimum guaranteed rates), changes in crediting rates may not be sufficient to maintain targeted investment spreads in all economic and market environments. In addition, competition, minimum guaranteed rates and other factors, including the impact of surrenders and withdrawals, may limit our ability to adjust or to maintain crediting rates at levels necessary to avoid narrowing of spreads under certain market conditions. As of December 31, 2015, the average yield, computed on the cost basis of our fixed maturity portfolio, was 5.5 percent, and the average interest rate credited or accruing to our total insurance liabilities was 4.5 percent.

We manage the equity-based risk component of our fixed index annuity products by:

• purchasing options on equity indices with similar payoff characteristics; and

• adjusting the participation rate to reflect the change in the cost of such options (such cost varies based on market conditions).

The prices of the options we purchase to manage the equity-based risk component of our fixed index annuities vary based on market conditions. All other factors held constant, the prices of the options generally increase with increases in the volatility of the applicable indices, which may either reduce the profitability of the fixed index products or cause us to lower participation rates. Accordingly, volatility of the indices is one factor in the uncertainty regarding the profitability of our fixed index products.

Our invested assets are predominately fixed rate in nature and their value fluctuates with changes in market rates, among other factors (such as changes in the credit quality of the issuer). We seek to manage the interest rate risk inherent in our business by managing the durations and cash flows of our fixed maturity investments along with those of the related insurance

12

liabilities. For example, one management measure we use is asset and liability duration. Duration measures expected change in fair value for a given change in interest rates. If interest rates increase by 1 percent, the fair value of a fixed maturity security with a duration of 5 years is typically expected to decrease in value by approximately 5 percent. When the estimated durations of assets and liabilities are similar, absent other factors, a change in the value of assets related to changes in interest rates should be largely offset by a change in the value of liabilities. We calculate asset and liability durations using our estimates of future asset and liability cash flows. At December 31, 2015, the estimated duration of our fixed income securities (as modified to reflect prepayments and potential calls) and the estimated duration of our insurance liabilities were both approximately 8.2 years.

COMPETITION

The markets in which we operate are competitive. Compared to CNO, many companies in the financial services industry are larger, have greater capital, technological and marketing resources, have greater access to capital and other sources of liquidity at a lower cost, offer broader and more diversified product lines, have greater brand recognition, have larger staffs and higher ratings. Banks, securities brokerage firms and other financial intermediaries also market insurance products or offer competing products, such as mutual fund products, traditional bank investments and other investment and retirement funding alternatives. We also compete with many of these companies and others in providing services for fees. In most areas, competition is based on a number of factors including pricing, service provided to distributors and policyholders and ratings. CNO's subsidiaries must also compete to attract and retain the allegiance of agents, insurance brokers and marketing companies.

In the individual health insurance business, companies compete primarily on the bases of marketing, service and price. Pursuant to federal regulations, the Medicare supplement products offered by all companies have standardized policy features. This increases the comparability of such policies and intensifies competition based on other factors. See "Insurance Underwriting" and "Governmental Regulation" for additional information. In addition to competing with the products of other insurance companies, commercial banks, mutual funds and broker dealers, our insurance products compete with health maintenance organizations, preferred provider organizations and other health care-related institutions which provide medical benefits based on contractual agreements.

Our principal competitors vary by product line. Our main competitors for agent-sold long-term care insurance products include Genworth, Northwestern Mutual and John Hancock Financial Services. Our main competitors for agent-sold Medicare supplement insurance products include Blue Cross and Blue Shield Plans, Mutual of Omaha and United HealthCare. Our main competitors for life insurance sold through direct marketing channels include Gerber Life, MetLife, Mutual of Omaha, New York Life, Massachusetts Mutual Life Insurance Company and subsidiaries of Torchmark Corporation ("Torchmark"). Our main competitors for supplemental health products sold through our Washington National segment include AFLAC, subsidiaries of Allstate, Colonial Life and Accident Company and subsidiaries of Torchmark.

In some of our product lines, such as life insurance and fixed annuities, we have a relatively small market share. Even in some of the lines in which we are one of the top writers, our market share is relatively small. For example, while, based on an Individual Long-Term Care Insurance Survey, our Bankers Life segment ranked seventh in annualized premiums of individual long-term care insurance in 2014 with a market share of approximately 4 percent, the top six writers of individual long-term care insurance had annualized premiums with a combined market share of approximately 76 percent during the period. In addition, while, based on a 2014 Medicare Supplement Loss Ratios report, we ranked fifth in direct premiums earned for Medicare supplement insurance in 2014 with a market share of 3.3 percent, the top writer of Medicare supplement insurance had direct premiums with a market share of 35 percent during the period.

Most of our major competitors have higher financial strength ratings than we do. Many of our competitors are larger companies that have greater capital, technological and marketing resources and have access to capital at a lower cost. Recent industry consolidation, including business combinations among insurance and other financial services companies, has resulted in larger competitors with even greater financial resources. Furthermore, changes in federal law have narrowed the historical separation between banks and insurance companies, enabling traditional banking institutions to enter the insurance and annuity markets and further increase competition. This increased competition may harm our ability to maintain or improve our profitability.

In addition, because the actual cost of products is unknown when they are sold, we are subject to competitors who may sell a product at a price that does not cover its actual cost. Accordingly, if we do not also lower our prices for similar products, we may lose market share to these competitors. If we lower our prices to maintain market share, our profitability will decline.

The Colonial Penn segment has faced increased competition from other insurance companies who also distribute products through direct marketing. In addition, the demand and cost of television advertising appropriate for Colonial Penn's campaigns fluctuates from period to period and will impact the average cost to generate a TV lead.

13

We must attract and retain sales representatives to sell our insurance and annuity products. Strong competition exists among insurance and financial services companies for sales representatives. We compete for sales representatives primarily on the basis of our financial position, financial strength ratings, support services, compensation, products and product features. Our competitiveness for such agents also depends upon the relationships we develop with these agents.

An important competitive factor for life insurance companies is the ratings they receive from nationally recognized rating organizations. Agents, insurance brokers and marketing companies who market our products and prospective purchasers of our products use the ratings of our insurance subsidiaries as one factor in determining which insurer's products to market or purchase. Ratings have the most impact on our sales in the worksite market and sales of our annuity, interest-sensitive life insurance and long-term care products. Financial strength ratings provided by A.M. Best Company ("A.M. Best"), Standard & Poor's Corporation ("S&P"), Fitch Ratings ("Fitch") and Moody's Investor Services, Inc. ("Moody's") and are the rating agency's opinions of the ability of our insurance subsidiaries to pay policyholder claims and obligations when due. They are not directed toward the protection of investors, and such ratings are not recommendations to buy, sell or hold securities. The most recent ratings actions are described below.

On August 26, 2015, A.M. Best upgraded the financial strength ratings of our primary insurance subsidiaries to "A-" from "B++" and the outlook for these ratings is stable. The "A-" rating is assigned to companies that have an excellent ability, in A.M. Best's opinion, to meet their ongoing obligations to policyholders.  A.M. Best ratings for the industry currently range from "A++ (Superior)" to "F (In Liquidation)" and some companies are not rated.  An "A++" rating indicates a superior ability to meet ongoing obligations to policyholders.  A.M. Best has sixteen possible ratings.  There are three ratings above the "A-" rating of our primary insurance subsidiaries and twelve ratings that are below that rating.

On June 18, 2015, S&P affirmed the financial strength ratings of "BBB+" of our primary insurance subsidiaries and revised the outlook for these ratings to positive from stable. On July 2, 2014, S&P upgraded the financial strength ratings of our primary insurance subsidiaries to "BBB+" from "BBB". S&P financial strength ratings range from "AAA" to "R" and some companies are not rated.  An insurer rated "BBB" or higher is regarded as having financial security characteristics that outweigh any vulnerabilities, and is highly likely to have the ability to meet financial commitments. An insurer rated "BBB", in S&P's opinion, has good financial security characteristics, but is more likely to be affected by adverse business conditions than are higher-rated insurers.  Pluses and minuses show the relative standing within a category.  S&P has twenty-one possible ratings.  There are seven ratings above the "BBB+" rating of our primary insurance subsidiaries and thirteen ratings that are below that rating.

On May 11, 2015, Fitch upgraded the financial strength ratings of our primary insurance subsidiaries to "BBB+" from "BBB" and the outlook for these ratings is positive. A "BBB" rating, in Fitch's opinion, indicates that there is currently a low expectation of ceased or interrupted payments. The capacity to meet policyholder and contract obligations on a timely basis is considered adequate, but adverse changes in circumstances and economic conditions are more likely to impact this capacity. Fitch ratings for the industry range from "AAA Exceptionally Strong" to "C Distressed" and some companies are not rated. Pluses and minuses show the relative standing within a category. Fitch has nineteen possible ratings. There are seven ratings above the "BBB+" rating of our primary insurance subsidiaries and eleven ratings that are below that rating.

On May 11, 2015, Moody's upgraded the financial strength ratings of our primary insurance subsidiaries to "Baa1" from "Baa2" and the outlook for these ratings is stable. On March 27, 2014, Moody's upgraded the financial strength ratings of our primary insurance subsidiaries to "Baa2" from "Baa3". Moody’s financial strength ratings range from "Aaa" to "C".  These ratings may be supplemented with numbers "1", "2", or "3" to show relative standing within a category.  In Moody's view, an insurer rated "Baa" offers adequate financial security, however, certain protective elements may be lacking or may be characteristically unreliable over any great length of time. Moody's has twenty-one possible ratings.  There are seven ratings above the "Baa1" rating of our primary insurance subsidiaries and thirteen ratings that are below the rating.

14

Rating agencies have increased the frequency and scope of their credit reviews and requested additional information from the companies that they rate, including us.  They may also adjust upward the capital and other requirements employed in the rating agency models for maintenance of certain ratings levels.  We cannot predict what actions rating agencies may take, or what actions we may take in response.  Accordingly, downgrades and outlook revisions related to us or the life insurance industry may occur in the future at any time and without notice by any rating agency.  These could increase policy surrenders and withdrawals, adversely affect relationships with our distribution channels, reduce new sales, reduce our ability to borrow and increase our future borrowing costs.

INSURANCE UNDERWRITING

Under regulations developed by the National Association of Insurance Commissioners (the "NAIC") (an association of state regulators and their staffs) and adopted by the states, we are prohibited from underwriting our Medicare supplement policies for certain first-time purchasers. If a person applies for insurance within six months after becoming eligible by reason of age, or disability in certain limited circumstances, the application may not be rejected due to medical conditions. Some states prohibit underwriting of all Medicare supplement policies. For other prospective Medicare supplement policyholders, such as senior citizens who are transferring to our products, the underwriting procedures are relatively limited, except for policies providing prescription drug coverage.

Before issuing long-term care products, we generally apply detailed underwriting procedures to assess and quantify the insurance risks. We require medical examinations of applicants (including blood and urine tests, where permitted) for certain health insurance products and for life insurance products which exceed prescribed policy amounts. These requirements vary according to the applicant's age and may vary by type of policy or product. We also rely on medical records and the potential policyholder's written application. In recent years, there have been significant regulatory changes with respect to underwriting certain types of health insurance. An increasing number of states prohibit underwriting and/or charging higher premiums for substandard risks. We monitor changes in state regulation that affect our products, and consider these regulatory developments in determining the products we market and where we market them.

Our supplemental health policies are individually underwritten using a simplified issue application. Based on an applicant's responses on the application, the underwriter either: (i) approves the policy as applied for; (ii) approves the policy with reduced benefits; or (iii) rejects the application.

Our life insurance products include policies that are underwritten individually and low face-amount life insurance products that utilize standardized underwriting procedures. After initial processing, insurance underwriters obtain the information needed to make an underwriting decision (such as medical examinations, doctors' statements and special medical tests). After collecting and reviewing the information, the underwriter either: (i) approves the policy as applied for; (ii) approves the policy with an extra premium charge because of unfavorable factors; or (iii) rejects the application.

We underwrite group insurance policies based on the characteristics of the group and its past claim experience. Graded benefit life insurance policies are issued without medical examination or evidence of insurability. There is minimal underwriting on annuities.

LIABILITIES FOR INSURANCE PRODUCTS

At December 31, 2015, the total balance of our liabilities for insurance products was $22.1 billion. These liabilities are generally payable over an extended period of time. The profitability of our insurance products depends on pricing and other factors. Differences between our expectations when we sold these products and our actual experience could result in future losses.

Liabilities for insurance products are calculated using management's best judgments, based on our past experience and standard actuarial tables, of mortality, morbidity, lapse rates, investment experience and expense levels with due consideration of provision for adverse development where prescribed by accounting principles generally accepted in the United States of America ("GAAP"). For all of our insurance products, we establish an active life reserve, a liability for due and unpaid claims, claims in the course of settlement and incurred but not reported claims. In addition, for our health insurance business, we establish a reserve for the present value of amounts not yet due on incurred claims. Many factors can affect these reserves and liabilities, such as economic and social conditions, inflation, hospital and pharmaceutical costs, changes in doctrines of legal liability and extra-contractual damage awards. Therefore, our reserves and liabilities are necessarily based on extensive estimates, assumptions and historical experience. Establishing reserves is an uncertain process, and it is possible that actual

15

claims will materially exceed our reserves and have a material adverse effect on our results of operations and financial condition. Our financial results depend significantly upon the extent to which our actual claims experience is consistent with the assumptions we used in determining our reserves and pricing our products. If our assumptions are incorrect with respect to future claims, future policyholder premiums and policy charges or the investment income on assets supporting liabilities, or our reserves are insufficient to cover our actual losses and expenses, we would be required to increase our liabilities, which would negatively affect our operating results.

REINSURANCE

Consistent with the general practice of the life insurance industry, our subsidiaries enter into both facultative and treaty agreements of indemnity reinsurance with other insurance companies in order to reinsure portions of the coverage provided by our insurance products. Indemnity reinsurance agreements are intended to limit a life insurer's maximum loss on a large or unusually hazardous risk or to diversify its risk. Indemnity reinsurance does not discharge the original insurer's primary liability to the insured. Our reinsured business is ceded to numerous reinsurers. Based on our periodic review of their financial statements, insurance industry reports and reports filed with state insurance departments, we believe the assuming companies are able to honor all contractual commitments.

As of December 31, 2015, the policy risk retention limit of our insurance subsidiaries was generally $.8 million or less. Reinsurance ceded by CNO represented 15 percent of gross combined life insurance inforce and reinsurance assumed represented .6 percent of net combined life insurance inforce. Our principal reinsurers at December 31, 2015 were as follows (dollars in millions):

Name of Reinsurer	Reinsurance receivables		Ceded life insurance inforce		A.M. Best rating
Jackson National Life Insurance Company ("Jackson") (a)	$	1,577.8	$	814.5	A+
Beechwood Re Ltd. ("BRe") (b)	502.9		—		Not rated
Wilton Reassurance Company ("Wilton Re")	331.4		1,412.9		A
RGA Reinsurance Company (c)	173.1		92.8		A+
Munich American Reassurance Company	3.4		457.0		A+
Swiss Re Life and Health America Inc.	3.0		619.4		A+
SCOR Global Life USA Reinsurance Company	1.9		103.5		A
All others (d)	265.8		280.7
	$	2,859.3	$	3,780.8

________________

(a) In addition to the life insurance business, Jackson has assumed certain annuity business from our insurance subsidiaries through a coinsurance agreement. Such business had total insurance policy liabilities of $1.2 billion at December 31, 2015.

(b) BRe has assumed long-term care business as summarized in the paragraph below.

(c) RGA Reinsurance Company has assumed a portion of the long-term care business of Bankers Life on a coinsurance basis.

(d) No other single reinsurer represents more than 2 percent of the reinsurance receivables balance or has assumed greater than 2 percent of the total ceded life insurance business inforce.

In December 2013, two of our insurance subsidiaries with long-term care business in the former Other CNO Business segment entered into 100% coinsurance agreements ceding $495 million of long-term care reserves to BRe, a reinsurer domiciled in the Cayman Islands. BRe was formed in 2012 and is focused on specialized insurance including long-term care. BRe is a reinsurer that is not licensed or accredited by the states of domicile of the insurance subsidiaries ceding the long-term care business and BRe is not rated by A.M. Best. As a result of its non-accredited status, BRe is required to provide collateral which meets the regulatory requirements of the states of domicile (New York and Indiana) in order for our insurance subsidiaries to obtain full credit in their statutory financial statements for the reinsurance receivables due from BRe. Such collateral is held in market value trusts subject to 7% over collateralization, investment guidelines and periodic true-up provisions. Future payments into the trusts to maintain collateral requirements are subject to the ability and willingness of the reinsurer to honor its obligations. In the event of default by BRe, we could be exposed to credit risk if the collateral held in the trusts cannot be realized or is liquidated at prices that are not sufficient to recover the full amount of the reinsurance receivables. We remain primarily liable to the insured policyholders in the event BRe does not meet its contractual obligations.

16

EMPLOYEES

At December 31, 2015, we had approximately 3,500 full time employees, including 1,350 employees supporting our Bankers Life segment, 300 employees supporting our Colonial Penn segment and 1,850 employees supporting our shared services and our Washington National and corporate segments. None of our employees are covered by a collective bargaining agreement. We believe that we have good relations with our employees.

GOVERNMENTAL REGULATION

Insurance Regulation and Oversight

Our insurance businesses are subject to extensive regulation and supervision by the insurance regulatory agencies of the jurisdictions in which they operate. This regulation and supervision is primarily for the benefit and protection of customers, and not for the benefit of investors or creditors. State laws generally establish supervisory agencies that have broad regulatory authority, including the power to:

• grant and revoke business licenses;

• regulate and supervise sales practices and market conduct;

• establish guaranty associations;

• license agents;

• approve policy forms;

• approve premium rates and premium rate increases for some lines of business such as long-term care and Medicare supplement;

• establish reserve requirements;

• prescribe the form and content of required financial statements and reports;

• determine the reasonableness and adequacy of statutory capital and surplus;

• perform financial, market conduct and other examinations;

• define acceptable accounting principles; and

• regulate the types and amounts of permitted investments.

In addition, the NAIC develops model laws and regulations, many of which have been adopted by state legislators and/or insurance regulators, relating to:

• reserve requirements;

• risk-based capital ("RBC") standards;

• codification of insurance accounting principles;

• investment restrictions;

• restrictions on an insurance company's ability to pay dividends;

• credit for reinsurance; and

• product illustrations.

17

The Company's insurance subsidiaries are required to file detailed annual reports, in accordance with prescribed statutory accounting rules, with regulatory authorities in each of the jurisdictions in which they do business. As part of their routine oversight process, state insurance departments conduct periodic detailed examinations, generally once every three to five years, of the books, records and accounts of insurers domiciled in their states. These examinations are generally conducted in cooperation with the departments of two or three other states under guidelines promulgated by the NAIC.

State regulatory authorities and industry groups have developed several initiatives regarding market conduct, including the form and content of disclosures to consumers, advertising, sales practices and complaint handling. Various state insurance departments periodically examine the market conduct activities of domestic and non-domestic insurance companies doing business in their states, including our insurance subsidiaries. The purpose of these market conduct examinations is to determine if operations are consistent with the laws and regulations of the state conducting the examination. In addition, market conduct has become one of the criteria used by rating agencies to establish the ratings of an insurance company. For example, A.M. Best's ratings analysis now includes a review of the insurer's compliance program.

Most states mandate minimum benefit standards and benefit ratios for accident and health insurance policies. We are generally required to maintain, with respect to our individual long-term care policies, minimum anticipated benefit ratios over the entire period of coverage of not less than 60 percent. With respect to our Medicare supplement policies, we are generally required to attain and maintain an actual benefit ratio, after three years, of not less than 65 percent. We provide to the insurance departments of all states in which we conduct business annual calculations that demonstrate compliance with required minimum benefit ratios for both long-term care and Medicare supplement insurance. These calculations are prepared utilizing statutory lapse and interest rate assumptions. In the event that we fail to maintain minimum mandated benefit ratios, our insurance subsidiaries could be required to provide retrospective refunds and/or prospective rate reductions. We believe that our insurance subsidiaries currently comply with all applicable mandated minimum benefit ratios.

Our insurance subsidiaries are required, under guaranty fund laws of most states, to pay assessments up to prescribed limits to fund policyholder losses or liabilities of insolvent insurance companies. Typically, assessments are levied on member insurers on a basis which is related to the member insurer's proportionate share of the business written by all member insurers. Assessments can be partially recovered through a reduction in future premium taxes in some states.

Insurance Holding Company Regulations

Most states have enacted laws or regulations regarding the activities of insurance holding company systems, including acquisitions, the terms of surplus debentures, the terms of transactions between or involving insurance companies and their affiliates and other related matters. Various reporting and approval requirements apply to transactions between or involving insurance companies and their affiliates within an insurance holding company system, depending on the size and nature of the transactions. Currently, the Company and its insurance subsidiaries are registered as a holding company system pursuant to such laws and regulations in the domiciliary states of the insurance subsidiaries. In addition, the Company's insurance subsidiaries routinely report to other jurisdictions.

Most states have also enacted legislation or adopted administrative regulations that affect the acquisition (or sale) of control of insurance companies. The nature and extent of such legislation and regulations vary from state to state. Generally, these regulations require an acquirer of control to file detailed information and the plan of acquisition, and to obtain administrative approval prior to the acquisition of control. "Control" is generally defined as the direct or indirect power to direct or cause the direction of the management and policies of a person and is rebuttably presumed to exist if a person or group of affiliated persons directly or indirectly owns or controls 10 percent or more of the voting securities of another person.

Insurance regulators may prohibit the payment of dividends or other payments by our insurance subsidiaries to parent companies if they determine that such payment could be adverse to our policyholders or contract holders. Otherwise, the ability of our insurance subsidiaries to pay dividends is subject to state insurance department regulations and is based on the financial statements of our insurance subsidiaries prepared in accordance with statutory accounting practices prescribed or permitted by regulatory authorities, which differ from financial statements prepared in accordance with GAAP. These regulations generally permit dividends to be paid by the insurance company if such dividends are not in excess of unassigned surplus and, for any 12-month period, are in amounts less than the greater of, or in a few states, the lesser of:

• statutory net gain from operations or statutory net income for the prior year; or

• 10 percent of statutory capital and surplus at the end of the preceding year.

18

Any dividends in excess of these levels require the approval of the director or commissioner of the applicable state insurance department.

In accordance with an order from the Florida Office of Insurance Regulation, Washington National may not distribute funds to any affiliate or shareholder, except pursuant to agreements with affiliates that have been approved, without prior notice to the Florida Office of Insurance Regulation. In addition, the RBC and other capital requirements described below can also limit, in certain circumstances, the ability of our insurance subsidiaries to pay dividends.

Long-Term Care Regulations

The NAIC has adopted model long-term care policy language providing nonforfeiture benefits and has proposed a rate stabilization standard for long-term care policies. Various bills are introduced from time to time in the U.S. Congress which propose the implementation of certain minimum consumer protection standards in all long-term care policies, including guaranteed renewability, protection against inflation and limitations on waiting periods for pre-existing conditions. Federal legislation permits premiums paid for qualified long-term care insurance to be tax-deductible medical expenses and for benefits received on such policies to be excluded from taxable income.

Our insurance subsidiaries that have long-term care business have made insurance regulatory filings seeking actuarially justified rate increases on our long-term care policies. Most of our long-term care business is guaranteed renewable, and, if necessary rate increases are not approved, we may be required to write off all or a portion of the deferred acquisition costs and the present value of future profits (collectively referred to as "insurance acquisition costs") and establish a premium deficiency reserve. If we are unable to raise our premium rates because we fail to obtain approval for actuarially justified rate increases in one or more states, our financial condition and results of operations could be adversely affected.

Capital Requirements

Using statutory statements filed with state regulators annually, the NAIC calculates certain financial ratios to assist state regulators in monitoring the financial condition of insurance companies. A "usual range" of results for each ratio is used as a benchmark. An insurance company may fall out of the usual range for one or more ratios because of specific transactions that are in themselves immaterial or eliminated at the consolidated level. Generally, an insurance company will become subject to regulatory scrutiny if it falls outside the usual ranges of four or more of the ratios, and regulators may then act, if the company has insufficient capital, to constrain the company's underwriting capacity. In the past, variances in certain ratios of our insurance subsidiaries have resulted in inquiries from insurance departments, to which we have responded. These inquiries have not led to any restrictions affecting our operations.

The NAIC's RBC requirements provide a tool for insurance regulators to determine the levels of statutory capital and surplus an insurer must maintain in relation to its insurance and investment risks and the need for possible regulatory attention. The basis of the system is a formula that applies prescribed factors to various risk elements in an insurer’s business to report a minimum capital requirement proportional to the amount of risk assumed by the insurer. The life and health insurer RBC formula is designed to measure annually: (i) the risk of loss from asset defaults and asset value fluctuations; (ii) the risk of loss from adverse mortality and morbidity experience; (iii) the risk of loss from mismatching of assets and liability cash flow due to changing interest rates; and (iv) business risks.

In addition, the RBC requirements currently provide for a trend test if a company's total adjusted capital is between 100 percent and 150 percent of its RBC at the end of the year. The trend test calculates the greater of the decrease in the margin of total adjusted capital over RBC:

• between the current year and the prior year; and

• for the average of the last 3 years.

It assumes that such decrease could occur again in the coming year. Any company whose trended total adjusted capital is less than 95 percent of its RBC would trigger a requirement to submit a comprehensive plan as described above for the Company Action Level. The 2015 statutory annual statements of each of our insurance subsidiaries reflect total adjusted capital in excess of the levels subjecting the subsidiaries to any regulatory action.

Although we are under no obligation to do so, we may elect to contribute additional capital or retain greater amounts of capital to strengthen the surplus of certain insurance subsidiaries. Any election to contribute or retain additional capital could impact the amounts our insurance subsidiaries pay as dividends to the holding company. The ability of our insurance

19

subsidiaries to pay dividends is also impacted by various criteria established by rating agencies to maintain or receive higher ratings and by the capital levels that we target for our insurance subsidiaries.

The NAIC currently has in place its "Solvency Modernization Initiative," which is designed to review the U.S. financial regulatory system and all aspects of financial regulation affecting insurance companies. Though broad in scope, the NAIC has stated that the Solvency Modernization Initiative will focus on: (1) capital requirements; (2) corporate governance and risk management; (3) group supervision; (4) statutory accounting and financial reporting; and (5) reinsurance. This initiative has resulted in the adoption by the NAIC of the Risk Management and Own Risk and Solvency Assessment Model Act ("ORSA"), which has been enacted by each of our insurance subsidiaries’ domiciliary states. ORSA requires that insurers maintain a risk management framework and conduct an internal own risk and solvency assessment of the insurer’s material risks in normal and stressed environments. The assessment must be documented in an annual summary report, a copy of which must be submitted to insurance regulators as required or upon request. We submitted our first ORSA summary report in 2015.

Regulation of Investments

Our insurance subsidiaries are subject to state laws and regulations that require diversification of their investment portfolios and limit the amount of investments in certain investment categories, such as below-investment grade bonds, equity real estate and common stocks. Failure to comply with these laws and regulations would cause investments exceeding regulatory limitations to be treated as non-admitted assets for purposes of measuring statutory surplus, and, in some instances, would require divestiture of such non-qualifying investments. The investments made by our insurance subsidiaries comply in all material respects with such investment regulations as of December 31, 2015.

Other Federal and State Laws and Regulations

Federal and state law and regulation require financial institutions to protect the security and confidentiality of personal information, including health-related and customer information, and to notify customers and other individuals about their policies and practices relating to their collection and disclosure of health-related and customer information and their practices relating to protecting the security and confidentiality of that information. State laws regulate use and disclosure of social security numbers and federal and state laws require notice to affected individuals, law enforcement, regulators and others if there is a breach of the security of certain personal information, including social security numbers. Federal and state laws and regulations regulate the ability of financial institutions to make telemarketing calls and to send unsolicited e-mail or fax messages to consumers and customers. Federal and state lawmakers and regulatory bodies may be expected to consider additional or more detailed regulation regarding these subjects and the privacy and security of personal information. The United States Department of Health and Human Services has issued regulations under the Health Insurance Portability and Accountability Act relating to standardized electronic transaction formats, code sets and the privacy of member health information. These regulations, and any corresponding state legislation, affect our administration of health insurance.

The USA PATRIOT Act of 2001 seeks to promote cooperation among financial institutions, regulators and law enforcement entities in identifying parties that may be involved in terrorism, money laundering or other illegal activities. To the extent required by applicable laws and regulations, CNO and its insurance subsidiaries have adopted anti-money laundering ("AML") programs that include policies, procedures and controls to detect and prevent money laundering, have designated compliance officers to oversee the programs, provide for on-going employee training and ensure periodic independent testing of the programs. CNO's and the insurance subsidiaries' AML programs, to the extent required, also establish and enforce customer identification programs and provide for the monitoring and the reporting to the Department of the Treasury of certain suspicious transactions.

In April 2015, the Department of Labor re-proposed regulations that would, if finalized in current form, substantially expand the range of activities that would be considered to be fiduciary investment advice under the Employee Retirement Income Security Act of 1974 and the Internal Revenue Code. If final regulations were to be issued with provisions similar to the proposed regulations, some of the investment-related information and support that our agents, advisors and employees provide to customers on a non-fiduciary basis could be substantially limited beyond what is allowed under current law. This could change the methods that we use to deliver services and the compensation we provide to our agents. The regulations are expected to be finalized in 2016 and such regulations and/or their implementation could result in increased costs and could impact the sales of certain of our products. The potential impacts of the final regulations are uncertain and difficult to predict.

In addition, the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 (the "Dodd-Frank Act") generally provides for enhanced federal supervision of financial institutions, including insurance companies in certain circumstances, and financial activities that represent a systemic risk to financial stability or the U.S. economy. Under the Dodd-Frank Act, a Federal Insurance Office has been established within the U.S. Treasury Department to monitor all aspects of the insurance

20

industry and its authority will likely extend to most lines of insurance that are written by the Company, although the Federal Insurance Office is not empowered with any general regulatory authority over insurers. The director of the Federal Insurance Office serves in an advisory capacity to the newly established Financial Stability Oversight Council and will have the ability to recommend that an insurance company or an insurance holding company be subject to heightened prudential standards by the Federal Reserve, if it is determined that financial distress at the company could pose a threat to financial stability in the U.S. The Dodd-Frank Act also provides for the preemption of state laws when inconsistent with certain international agreements, and would streamline the state-level regulation of reinsurance and surplus lines insurance. Under certain circumstances, the FDIC can assume the role of a state insurance regulator and initiate liquidation proceedings under state law.

The asset management activities of 40|86 Advisors and our other investment advisory subsidiary are subject to various federal and state securities laws and regulations. The SEC and the Commodity Futures Trading Commission are the principal regulators of our asset management operations.

Broker-Dealer and Securities Regulation

We have a broker-dealer subsidiary that is registered under the Securities Exchange Act of 1934 and is subject to federal and state regulation, including, but not limited to, the Financial Industry Regulatory Authority ("FINRA"). Agents and employees registered or associated with our broker-dealer subsidiary are subject to the Securities Exchange Act of 1934 and to examination requirements and regulation by the SEC, FINRA and state securities commissioners. The SEC and other governmental agencies, as well as state securities commissions in the U.S., have the power to conduct administrative proceedings that can result in censure, fines, the issuance of cease-and-desist orders or suspension and termination or limitation of the activities of the regulated entity or its employees.

FEDERAL INCOME TAXATION

Our annuity and life insurance products generally provide policyholders with an income tax advantage, as compared to other savings investments such as certificates of deposit and bonds, because taxes on the increase in value of the products are deferred until received by policyholders. With other savings investments, the increase in value is generally taxed as earned. Annuity benefits and life insurance benefits, which accrue prior to the death of the policyholder, are generally not taxable until paid. Life insurance death benefits are generally exempt from income tax. Also, benefits received on immediate annuities (other than structured settlements) are recognized as taxable income ratably, as opposed to the methods used for some other investments which tend to accelerate taxable income into earlier years. The tax advantage for annuities and life insurance is provided in the Internal Revenue Code (the "Code"), and is generally followed in all states and other United States taxing jurisdictions.

Congress has considered, from time to time, possible changes to the U.S. tax laws, including elimination of the tax deferral on the accretion of value of certain annuities and life insurance products. It is possible that further tax legislation will be enacted which would contain provisions with possible adverse effects on our annuity and life insurance products.

Our insurance company subsidiaries are taxed under the life insurance company provisions of the Code. Provisions in the Code require a portion of the expenses incurred in selling insurance products to be deducted over a period of years, as opposed to immediate deduction in the year incurred. This provision increases the tax for statutory accounting purposes, which reduces statutory earnings and surplus and, accordingly, decreases the amount of cash dividends that may be paid by the life insurance subsidiaries.

Our income tax expense includes deferred income taxes arising from temporary differences between the financial reporting and tax bases of assets and liabilities, capital loss carryforwards and net operating loss carryforwards ("NOLs"). In evaluating our deferred tax assets, we consider whether it is more likely than not that the deferred tax assets will be realized. The ultimate realization of our deferred tax assets depends upon generating future taxable income during the periods in which our temporary differences become deductible and before our NOLs expire. In addition, the use of our NOLs is dependent, in part, on whether the Internal Revenue Service ("IRS") ultimately agrees with the tax positions we have taken in previously filed tax returns and that we plan to take in future tax returns. Accordingly, with respect to our deferred tax assets, we assess the need for a valuation allowance on an ongoing basis.

As of December 31, 2015, 2014 and 2013, we have established a valuation allowance equal to the portion of the net deferred tax assets whose realization is uncertain. The determination of the amount of valuation allowance established is made by assessing the effects of limitations or issues on the value of our net deferred tax assets expected to be fully recognized in the future.

21

ITEM 1A.  RISK FACTORS.

CNO and its businesses are subject to a number of risks including general business and financial risk. Any or all of such risks could have a material adverse effect on the business, financial condition or results of operations of CNO. In addition, please refer to the "Cautionary Statement Regarding Forward-Looking Statements" included in "Item 7 - Management's Discussion and Analysis of Consolidated Financial Condition and Results of Operations".

Potential continuation of a low interest rate environment for an extended period of time may negatively impact our results of operations, financial position and cash flows.

In recent periods, interest rates have been at or near historically low levels. Some of our products, principally traditional whole life, universal life, fixed rate and fixed index annuity contracts, expose us to the risk that low or declining interest rates will reduce our spread (the difference between the amounts that we are required to pay under the contracts and the investment income we are able to earn on the investments supporting our obligations under the contracts). Our spread is a key component of our net income. Investment income is also an important component of the profitability of our health products, especially long-term care and supplemental health policies. In addition, interest rates impact the liability for the benefits we provide under our agent deferred compensation plan (as it is our policy to immediately recognize changes in assumptions used to determine this liability).

If interest rates were to decrease further or remain at low levels for an extended period of time, we may have to invest new cash flows or reinvest proceeds from investments that have matured or have been prepaid or sold at yields that have the effect of reducing our net investment income as well as the spread between interest earned on investments and interest credited to some of our products below present or planned levels. To the extent prepayment rates on fixed maturity investments or mortgage loans in our investment portfolio exceed our assumptions, this could increase the impact of this risk. We can lower crediting rates on certain products to offset the decrease in investment yield. However, our ability to lower these rates may be limited by: (i) contractually guaranteed minimum rates; or (ii) competition. In addition, a decrease in crediting rates may not match the timing or magnitude of changes in investment yields. Currently, the vast majority of our products with contractually guaranteed minimum rates, have crediting rates set at the minimum rate. As a result, further decreases in investment yields would decrease the spread we earn and such spread could potentially become a loss.

The following table summarizes the distribution of annuity and universal life account values, net of amounts ceded, by guaranteed interest crediting rates as of December 31, 2015 (dollars in millions):

Guaranteed	Fixed rate and fixed			Universal
rate	index annuities			life			Total
> 5.0% to 6.0%	$	.2		$	13.7		$	13.9
> 4.0% to 5.0%	38.7			296.7			335.4
> 3.0% to 4.0%	1,129.5			54.5			1,184.0
> 2.0% to 3.0%	2,729.4			184.6			2,914.0
> 1.0% to 2.0%	984.8			5.7			990.5
1.0% and under	3,142.1			248.3			3,390.4
	$	8,024.7		$	803.5		$	8,828.2
Weighted average	2.03		%	3.06		%	2.12		%

In addition, during periods of declining or low interest rates, life and annuity products may be relatively more attractive to consumers, resulting in increased premium payments on products with flexible premium features, repayment of policy loans and increased persistency (a higher percentage of insurance policies remaining in force from year-to-year).

Our expectation of future investment income is an important consideration in determining the amortization of insurance acquisition costs and analyzing the recovery of these assets as well as determining the adequacy of our liabilities for insurance products. Expectations of lower future investment earnings may cause us to accelerate amortization, write down the balance of insurance acquisition costs or establish additional liabilities for insurance products, thereby reducing net income in the future periods.

In the fourth quarter of 2015, we completed a comprehensive review of interest rate assumptions on all of our products. The new money rate is the rate of return we receive on cash flows invested at a current date. If new money rates are lower than

22

the overall weighted average return we earn from our investment portfolio, and the lower rates persist, our overall earned rates will decrease. Specifically, our current projections assume new money rates ranging from 4.74 percent to 5.51 percent for one year (previously ranged from 4.36 percent to 5.13 percent) and then grade over 5 years from these levels to an ultimate new money rate ranging from 5.73 percent to 6.50 percent (previously ranged from 5.85 percent to 6.50 percent), depending on the specific product. While subject to many uncertainties, we believe our assumptions for future new money rates are reasonable.

We have established a deficiency reserve for the life contingent payout annuities in the Washington National segment. Accordingly, these annuities are not expected to generate future profits and future unfavorable changes to our assumptions will reduce earnings in the period such changes occur.

The following hypothetical scenarios illustrate the sensitivity of changes in interest rates to our products:

• The first hypothetical scenario assumes immediate and permanent reductions to current interest rates. We estimate that a pre-tax charge of approximately $30 million would occur if assumed spreads related to our interest-sensitive life and annuity products immediately and permanently decreased by 10 basis points.

With respect to products other than interest-sensitive life and annuity products, no charge would occur if investment earnings rates immediately and permanently decreased by 20 basis points or less (a decrease of 50 basis points would result in a pre-tax charge of approximately $85 million).

• The second hypothetical scenario assumes current new money rates increase such that our current portfolio yield remains level.  We estimate that this scenario would result in an after tax charge of approximately $5 million primarily related to an increase in deficiency reserves related to life contingent payout annuities.  Under this scenario, insurance liabilities under statutory accounting principles may also increase modestly, but by less than $10 million, with a reduction in our consolidated RBC ratio of approximately 2 percentage points.

While we expect the long-term care business to generate future net profits, the margins are relatively small and are vulnerable to a variety of factors including lower interest rates, higher morbidity and higher persistency. In addition, our projections of estimated future profits (losses) indicates that profits will be recognized in earlier periods, followed by losses in later periods, which has required us to establish a future loss reserve for this business. Our 2015 comprehensive actuarial review of the long-term care business indicated margins have increased by $80 million in 2015 to approximately $180 million, or approximately 4 percent of related insurance liabilities net of insurance intangibles. Given the concentration of exposure to interest rates in our long-term care block, we modeled the following additional hypothetical scenarios to illustrate the sensitivity of additional changes in interest rates on long-term care products:

• One scenario assumes that the new money rates available to invest cash flows from our long-term care block decrease slightly for the next 12 months and then return to the current level of 5.5 percent indefinitely. This scenario would reduce margins by approximately $90 million but would not result in a charge because margins would continue to be positive.

• An additional scenario assumes that current new money rates available to invest cash flows from our long-term care block immediately decrease to approximately 3.5 percent and remain at that level indefinitely. This scenario would reduce margins by approximately $400 million and would result in a charge of approximately $220 million.

Although the hypothetical revisions described in the scenarios summarized above are not currently required or anticipated, we believe similar changes could occur based on past variances in experience and our expectations of the ranges of future experience that could reasonably occur. We have assumed that revisions to assumptions resulting in such adjustments would occur equally among policy types, ages and durations within each product classification. Any actual adjustment would be dependent on the specific policies affected and, therefore, may differ from such estimates. In addition, the impact of actual adjustments would reflect the net effect of all changes in assumptions during the period.

Sustained periods of low or declining interest rates may adversely affect our results of operations, financial position and cash flows.

23

There are risks to our business associated with broad economic conditions.

From 2008 to 2010, the U.S. economy experienced unusually severe credit and liquidity contraction and underwent a recession. Following several years of rapid credit expansion, a contraction in mortgage lending coupled with substantial declines in home prices and rising mortgage defaults, resulted in significant write-downs of asset values by financial institutions, including government-sponsored entities and major commercial and investment banks. These write-downs, initially of mortgage-backed securities but spreading to many sectors of the related credit markets, and to related credit default swaps and other derivative securities, caused many financial institutions to seek additional capital, to merge with larger and stronger institutions, to be subsidized by the U.S. government or, in some cases, to fail. These factors, combined with declining business and consumer confidence and increased unemployment, precipitated an economic slowdown.

General factors such as the availability of credit, consumer spending, business investment, capital market conditions and inflation affect our business. For example, in an economic downturn, higher unemployment, lower family income, lower corporate earnings, lower business investment and lower consumer spending may depress the demand for life insurance, annuities and other insurance products. In addition, this type of economic environment may result in higher lapses or surrenders of policies.

Our business is exposed to the performance of the debt and equity markets. Adverse market conditions can affect the liquidity and value of our investments. The manner in which debt and equity market performance and changes in interest rates have affected, and will continue to affect, our business, financial condition, growth and profitability include, but are not limited to, the following:

• The value of our investment portfolio has been materially affected in the past by changes in market conditions which resulted in substantial changes in realized and/or unrealized losses. Future adverse capital market conditions could result in additional realized and/or unrealized losses.

• Changes in interest rates also affect our investment portfolio. In periods of increasing interest rates, life insurance policy loans, surrenders and withdrawals could increase as policyholders seek higher returns. This could require us to sell invested assets at a time when their prices may be depressed by the increase in interest rates, which could cause us to realize investment losses. Conversely, during periods of declining interest rates, we could experience increased premium payments on products with flexible premium features, repayment of policy loans and increased percentages of policies remaining inforce. We could obtain lower returns on investments made with these cash flows. In addition, prepayment rates on investments may increase so that we might have to reinvest those proceeds in lower-yielding investments. As a consequence of these factors, we could experience a decrease in the spread between the returns on our investment portfolio and amounts to be credited to policyholders and contractholders, which could adversely affect our profitability.

• The attractiveness of certain of our insurance products may decrease because they are linked to the equity markets and assessments of our financial strength, resulting in lower profits. Increasing consumer concerns about the returns and features of our insurance products or our financial strength may cause existing customers to surrender policies or withdraw assets, and diminish our ability to sell policies and attract assets from new and existing customers, which would result in lower sales and fee revenues.

Claims experience on our long-term care products could negatively impact our operations if actual experience diverges from historical patterns and our expectations.

In setting premium rates, we consider historical claims information and other factors, but we cannot predict future claims with certainty. This is particularly applicable to our long-term care insurance products, for which historical claims experience may not be indicative of future experience. Long-term care products tend to have fewer claims than other health products such as Medicare supplement products, but when claims are incurred, they tend to be much higher in dollar amount and longer in duration. Also, long-term care claims are incurred much later in the life of the policy than most other supplemental health products. As a result of these traits, it is difficult to appropriately price this product. For our long-term care insurance, actual persistency in later policy durations that is higher than our persistency assumptions could have a negative impact on profitability. If these policies remain inforce longer than we assumed, then we could be required to make greater benefit payments than anticipated when the products were priced. Mortality is a critical factor influencing the length of time a claimant receives long-term care benefits. Mortality continues to improve for the general population. Improvements in actual mortality compared to our pricing assumptions have adversely affected the profitability of long-term care products and if such trends continue, further losses may be realized.

24

Our Bankers Life segment has offered long-term care insurance since 1985. In recent years, the claims experience and persistency on some of Bankers Life long-term care blocks has generally been higher than our pricing expectations which has resulted in higher benefit ratios and adversely affected our profitability. While we have received regulatory approvals for numerous premium rate increases in recent years pertaining to these blocks, there can be no assurance that future requests will be approved. Even with the rate increases that have been approved, this block experienced benefit ratios of 139.2 percent in 2015, 129.7 percent in 2014 and 129.3 percent in 2013.

The results of operations of our insurance business will decline if our premium rates are not adequate or if we are unable to increase rates.

We set the premium rates on our health insurance policies based on facts and circumstances known at the time we issue the policies and on assumptions about numerous variables, including the actuarial probability of a policyholder incurring a claim, the probable size of the claim, maintenance costs to administer the policies and the interest rate earned on our investment of premiums. In setting premium rates, we consider historical claims information, industry statistics, the rates of our competitors and other factors, but we cannot predict with certainty the future actual claims on our products. If our actual claims experience proves to be less favorable than we assumed and we are unable to raise our premium rates to the extent necessary to offset the unfavorable claims experience, our financial results will be adversely affected.

We review the adequacy of our premium rates regularly and file proposed rate increases on our health insurance products when we believe existing premium rates are too low. It is possible that we will not be able to obtain approval for premium rate increases from currently pending or future requests. If we are unable to raise our premium rates because we fail to obtain approval in one or more states, our financial results will be adversely affected. Moreover, in some instances, our ability to exit unprofitable lines of business is limited by the guaranteed renewal feature of most of our insurance policies. Due to this feature, we cannot exit such lines of business without regulatory approval, and accordingly, we may be required to continue to service those products at a loss for an extended period of time.

If we are successful in obtaining regulatory approval to raise premium rates, the increased premium rates may reduce the volume of our new sales and cause existing policyholders to allow their policies to lapse. This could result in a significantly higher ratio of claim costs to premiums if healthier policyholders allow their policies to lapse, while policies of less healthy policyholders continue inforce. This would reduce our premium income and profitability in future periods.

Our Medicare supplement health policies allow us to increase premium rates when warranted by our actual claims experience. These rate increases must be approved by the applicable state insurance departments, and we are required to submit actuarial claims data to support the need for such rate increases. The re-rate application and approval process on Medicare supplement health products is a normal recurring part of our business operations and reasonable rate increases are typically approved by the state departments as long as they are supported by actual claims experience and are not unusually large in either dollar amount or percentage increase. For policy types on which rate increases are a normal recurring event, our estimates of insurance liabilities assume we will be able to raise rates if experience on the blocks warrants such increases in the future.

As a result of higher persistency and resultant higher claims in our long-term care block in the Bankers Life segment than assumed in the original pricing, our premium rates were too low. Accordingly, we have been seeking approval from regulatory authorities for rate increases on portions of this business. Many of the rate increases have been approved by regulators and implemented, but it has become increasingly difficult to receive regulatory approval for the premium rate increases we have sought. If we are unable to obtain pending or future rate increases, the profitability of these policies and the performance of this block of business will be adversely affected. Most of our long-term care business is guaranteed renewable, and, if necessary rate increases are not approved, we would be required to recognize a loss and establish a premium deficiency reserve.

In some cases, we offer long-term care policyholders the opportunity to reduce their coverage amounts or accept non-forfeiture benefits as alternatives to increasing their premium rates. The financial impact of these alternatives could also result in policyholder anti-selection, meaning that policyholders who are less likely to incur claims may reduce their benefits, while policyholders who are more likely to incur claims may maintain full coverage and accept their rate increase.

25

Our reserves for future insurance policy benefits and claims may prove to be inadequate, requiring us to increase liabilities which results in reduced net income and shareholders' equity.

Liabilities for insurance products are calculated using management's best judgments, based on our past experience and standard actuarial tables of mortality, morbidity, lapse rates, investment experience and expense levels. For our health insurance business, we establish an active life reserve, a liability for due and unpaid claims, claims in the course of settlement, incurred but not reported claims, and a reserve for the present value of amounts on incurred claims not yet due. We establish reserves based on assumptions and estimates of factors either established at the Effective Date for business inforce or considered when we set premium rates for business written after that date.

Many factors can affect these reserves and liabilities, such as economic and social conditions, inflation, hospital and pharmaceutical costs, changes in life expectancy, regulatory actions, changes in doctrines of legal liability and extra-contractual damage awards. Therefore, the reserves and liabilities we establish are necessarily based on estimates, assumptions, industry data and prior years' statistics. It is possible that actual claims will materially exceed our reserves and have a material adverse effect on our results of operations and financial condition. We have incurred significant losses beyond our estimates as a result of actual claim costs and persistency of our long-term care business included in our Bankers Life segment. The insurance policy benefits incurred for our long-term care products in our Bankers Life segment were $669.0 million, $656.0 million and $689.2 million in 2015, 2014 and 2013, respectively. The benefit ratios for our long-term care products in our Bankers Life segment were 139.2 percent, 129.7 percent and 129.3 percent in 2015, 2014 and 2013, respectively. Our financial performance depends significantly upon the extent to which our actual claims experience and future expenses are consistent with the assumptions we used in setting our reserves. If our assumptions with respect to future claims are incorrect, and our reserves prove to be insufficient to cover our actual losses and expenses, we would be required to increase our liabilities, and our financial results could be adversely affected.

We may be required to accelerate the amortization of deferred acquisition costs or the present value of future profits or establish premium deficiency reserves.

Deferred acquisition costs represent incremental direct costs related to the successful acquisition of new or renewal insurance contracts. The present value of future profits represents the value assigned to the right to receive future cash flows from contracts existing at the Effective Date. The balances of these accounts are amortized over the expected lives of the underlying insurance contracts. On an ongoing basis, we test these accounts recorded on our balance sheet to determine if these amounts are recoverable under current assumptions. In addition, we regularly review the estimates and assumptions underlying these accounts for those products for which we amortize deferred acquisition costs or the present value of future profits in proportion to gross profits or gross margins. If facts and circumstances change, these tests and reviews could lead to reduction in the balance of those accounts, and the establishment of a premium deficiency reserve. Such results could have an adverse effect on the results of our operations and our financial condition. See "Item 7 Management's Discussion and Analysis of Consolidated Finance Condition and Results of Operations, Critical Accounting Policies, Present Value of Future Profits and Deferred Acquisition Costs."

Our operating results may suffer if policyholder surrender levels differ significantly from our assumptions.

Surrenders of our annuities and life insurance products can result in losses and decreased revenues if surrender levels differ significantly from assumed levels. At December 31, 2015, approximately 23 percent of our total insurance liabilities, or approximately $5.1 billion, could be surrendered by the policyholder without penalty. The surrender charges that are imposed on our fixed rate annuities typically decline during a penalty period, which ranges from five to twelve years after the date the policy is issued. Surrender charges are eliminated after the penalty period. Surrenders and redemptions could require us to dispose of assets earlier than we had planned, possibly at a loss. Moreover, surrenders and redemptions require faster amortization of either the acquisition costs or the commissions associated with the original sale of a product, thus reducing our net income. We believe policyholders are generally more likely to surrender their policies if they believe the issuer is having financial difficulties, or if they are able to reinvest the policy's value at a higher rate of return in an alternative insurance or investment product.

Changing interest rates may adversely affect our results of operations.

Our profitability is affected by fluctuating interest rates. While we monitor the interest rate environment and employ asset/liability and hedging strategies to mitigate such impact, our financial results could be adversely affected by changes in interest rates. Our spread-based insurance and annuity business is subject to several inherent risks arising from movements in interest rates. First, interest rate changes can cause compression of our net spread between interest earned on investments and

26

interest credited to customer deposits. Our ability to adjust for such a compression is limited by the guaranteed minimum rates that we must credit to policyholders on certain products, as well as the terms on most of our other products that limit reductions in the crediting rates to pre-established intervals. As of December 31, 2015, the vast majority of our products with contractual guaranteed minimum rates, had crediting rates set at the minimum. In addition, approximately 24 percent of our insurance liabilities were subject to interest rates that may be reset annually; 51 percent had a fixed explicit interest rate for the duration of the contract; 23 percent had credited rates that approximate the income we earn; and the remainder had no explicit interest rates. Second, if interest rate changes produce an unanticipated increase in surrenders of our spread-based products, we may be forced to sell invested assets at a loss in order to fund such surrenders. Third, the profits from many non-spread-based insurance products, such as long-term care policies, can be adversely affected when interest rates decline because we may be unable to reinvest the cash from premiums received at the interest rates anticipated when we sold the policies. Finally, changes in interest rates can have significant effects on the fair value and performance of our investments in general such as the timing of cash flows on many structured securities due to changes in the prepayment rate of the loans underlying such securities.

We employ asset/liability strategies that are designed to mitigate the effects of interest rate changes on our profitability but do not currently extensively employ derivative instruments for this purpose. We may not be successful in implementing these strategies and achieving adequate investment spreads.

We simulate our cash flows expected from existing business under various interest rate scenarios. With such estimates, we actively manage the relationship between the duration of our assets and the expected duration of our liabilities. When the estimated durations of assets and liabilities are similar, exposure to interest rate risk is minimized because a change in the value of assets should be largely offset by a change in the value of liabilities. At December 31, 2015, the estimated durations of our fixed income securities (as modified to reflect prepayments and potential calls) and insurance liabilities were both approximately 8.2 years. We estimate that our fixed maturity securities and short-term investments, net of corresponding changes in insurance acquisition costs, would decline in fair value by approximately $320 million if interest rates were to increase by 10 percent from rates as of December 31, 2015. Our simulations incorporate numerous assumptions, require significant estimates and assume an immediate change in interest rates without any management reaction to such change. Consequently, potential changes in the values of our financial instruments indicated by the simulations will likely be different from the actual changes experienced under given interest rate scenarios, and the differences may be material. Because we actively manage our investments and liabilities, our net exposure to interest rates can vary over time.

General market conditions affect investments and investment income.

The performance of our investment portfolio depends in part upon the level of and changes in interest rates, risk spreads, real estate values, market volatility, the performance of the economy in general, the performance of the specific obligors included in our portfolio and other factors that are beyond our control. Changes in these factors can affect our net investment income in any period, and such changes can be substantial.

Financial market conditions can also affect our realized and unrealized investment gains (losses). During periods of rising interest rates, the fair values of our investments will typically decline. Conversely, during periods of falling interest rates, the fair values of our investments will typically rise.

In addition, our investment borrowings from the Federal Home Loan Bank ("FHLB") are secured by collateral, the fair value of which can be significantly impacted by general market conditions. If the fair value of pledged collateral falls below specific levels, we would be required to pledge additional collateral or repay all or a portion of the investment borrowings.

We face risk with respect to our reinsurance agreements.

We transfer exposure to certain risks to others through reinsurance arrangements. Under these arrangements, other insurers assume a portion of our losses and expenses associated with reported and unreported claims in exchange for a portion of policy premiums. The availability, amount and cost of reinsurance depend on general market conditions and may vary significantly. As of December 31, 2015, our reinsurance receivables and ceded life insurance in-force totaled $2.9 billion and $3.8 billion, respectively. Our six largest reinsurers accounted for 93 percent of our ceded life insurance in-force. We face credit risk with respect to reinsurance. When we obtain reinsurance, we are still liable for those transferred risks even if the reinsurer defaults on its obligations. The failure, insolvency, inability or unwillingness of one or more of the Company's reinsurers to perform in accordance with the terms of its reinsurance agreement could negatively impact our earnings or financial position.

27

In December 2013, two of our insurance subsidiaries with long-term care business in the former Other CNO Business segment entered into 100% coinsurance agreements ceding $495 million of long-term care reserves to BRe, a reinsurer domiciled in the Cayman Islands. BRe was formed in 2012 and is focused on specialized insurance including long-term care. BRe is a reinsurer that is not licensed or accredited by the states of domicile of the insurance subsidiaries ceding the long-term care business and BRe is not rated by A.M. Best. As a result of its non-accredited status, BRe is required to provide collateral which meets the regulatory requirements of the states of domicile (New York and Indiana) in order for our insurance subsidiaries to obtain full credit in their statutory financial statements for the reinsurance receivables due from BRe. Such collateral is held in market value trusts subject to 7% over collateralization, investment guidelines and periodic true-up provisions. Future payments into the trusts to maintain collateral requirements are subject to the ability and willingness of the reinsurer to honor its obligations. In the event of default by BRe, we could be exposed to credit risk if the collateral held in the trusts cannot be realized or is liquidated at prices that are not sufficient to recover the full amount of the reinsurance receivables.

Our investment portfolio is subject to several risks that may diminish the value of our invested assets and negatively impact our profitability, our financial condition and our liquidity.

The value of our investment portfolio is subject to numerous factors, which may be difficult to predict, and are often beyond our control. These factors include, but are not limited to, the following:

• changes in interest rates and credit spreads, which can reduce the value of our investments as further discussed in the risk factor entitled "Changing interest rates may adversely affect our results of operations";

• changes in patterns of relative liquidity in the capital markets for various asset classes;

• changes in the perceived or actual ability of issuers to make timely repayments, which can reduce the value of our investments. This risk is significantly greater with respect to below-investment grade securities, which comprised 12 percent of the cost basis of our available for sale fixed maturity investments as of December 31, 2015; and

• changes in the estimated timing of receipt of cash flows. For example, our structured securities, which comprised 24 percent of our available for sale fixed maturity investments at December 31, 2015, are subject to variable prepayment on the assets underlying such securities, such as mortgage loans. When asset-backed securities, collateralized debt obligations, commercial mortgage-backed securities, mortgage pass-through securities and collateralized mortgage obligations (collectively referred to as "structured securities") prepay faster than expected, investment income may be adversely affected due to the acceleration of the amortization of purchase premiums or the inability to reinvest at comparable yields in lower interest rate environments.

We have recorded writedowns of fixed maturity investments, equity securities and other invested assets as a result of conditions which caused us to conclude a decline in the fair value of the investment was other than temporary as follows: $39.9 million in 2015 ($42.9 million, prior to the $3.0 million of impairment losses recognized through accumulated other comprehensive income); $27.3 million in 2014; and $11.6 million in 2013. Our investment portfolio is subject to the risks of further declines in realizable value. However, we attempt to mitigate this risk through the diversification and active management of our portfolio.

In the event of substantial product surrenders or policy claims, we may be required to sell assets at a loss, thereby eroding the performance of our portfolio.

Because a substantial portion of our operating results are derived from returns on our investment portfolio, significant losses in the portfolio may have a direct and materially adverse impact on our results of operations. In addition, losses on our investment portfolio could reduce the investment returns that we are able to credit to our customers of certain products, thereby impacting our sales and eroding our financial performance. Investment losses may also reduce the capital of our insurance subsidiaries, which may cause us to make additional capital contributions to those subsidiaries or may limit the ability of the insurance subsidiaries to make dividend payments to CNO.

28

Deteriorating financial performance of securities collateralized by mortgage loans and commercial mortgage loans may lead to writedowns, which could have a material adverse effect on our results of operations and financial condition.

Changes in mortgage delinquency or recovery rates, declining real estate prices, challenges to the validity of foreclosures and the quality of service provided by service providers on securities in our portfolios could lead us to determine that writedowns are appropriate in the future.

The determination of the amount of realized investment losses recorded as impairments of our investments is highly subjective and could have a material adverse effect on our operating results and financial condition.

The determination of realized investment losses recorded as impairments is based upon our ongoing evaluation and assessment of known risks. We consider a wide range of factors about the issuer and use our best judgment in evaluating the cause of a decline in estimated fair value and in assessing prospects for recovery. Inherent in our evaluation are assumptions and estimates about the operations of the issuer and its future earnings potential. Such evaluations and assessments are revised as conditions change and new information becomes available. We update our evaluations regularly and reflect losses from impairments in operating results as such evaluations are revised. Our assessment of whether unrealized losses are other-than-temporary impairments requires significant judgment and future events may occur, or additional information may become available, which may necessitate changes in our ongoing assessments which may impact the level of future impairments of securities in our portfolio. Historical trends may not be indicative of future other-than- temporary impairments.

The determination of fair value of our fixed maturity securities results in unrealized investment gains and losses and is, in some cases, highly subjective and could materially impact our operating results and financial condition.

In determining fair value, we generally utilize market transaction data for the same or similar instruments. The degree of management judgment involved in determining fair values is inversely related to the availability of market observable information. Since significant observable market inputs are not available for certain securities, it may be difficult to value them. The fair value of financial assets and financial liabilities may differ from the amount actually received to sell an asset or the amount paid to transfer a liability in an orderly transaction between market participants at the measurement date. Moreover, the use of different valuation assumptions may have a material effect on the fair values of the financial assets and financial liabilities. As of December 31, 2015 and 2014, our total unrealized net investment gains before adjustments for insurance intangibles and deferred income taxes were $0.9 billion and $2.2 billion, respectively.

Concentration of our investment portfolio in any particular sector of the economy or type of asset may have an adverse effect on our financial position or results of operations.

The concentration of our investment portfolio in any particular industry, group of related industries, asset classes (such as residential mortgage-backed securities and other asset-backed securities), or geographic area could have an adverse effect on our results of operations and financial position. While we seek to mitigate this risk by having a broadly diversified portfolio, events or developments that have a negative impact on any particular industry, group of related industries or geographic area may have an adverse effect on the investment portfolio.

Our business is subject to extensive regulation, which limits our operating flexibility and could result in our insurance subsidiaries being placed under regulatory control or otherwise negatively impact our financial results.

Our insurance business is subject to extensive regulation and supervision in the jurisdictions in which we operate. See "Business of CNO - Governmental Regulation." Our insurance subsidiaries are subject to state insurance laws that establish supervisory agencies. The regulations issued by state insurance agencies can be complex and subject to differing interpretations. If a state insurance regulatory agency determines that one of our insurance company subsidiaries is not in compliance with applicable regulations, the subsidiary is subject to various potential administrative remedies including, without limitation, monetary penalties, restrictions on the subsidiary's ability to do business in that state and a return of a portion of policyholder premiums. In addition, regulatory action or investigations could cause us to suffer significant reputational harm, which could have an adverse effect on our business, financial condition and results of operations.

Our insurance subsidiaries are also subject to RBC requirements. These requirements were designed to evaluate the adequacy of statutory capital and surplus in relation to investment and insurance risks associated with asset quality, mortality and morbidity, asset and liability matching and other business factors. The requirements are used by states as an early warning tool to discover companies that may be weakly-capitalized for the purpose of initiating regulatory action. Generally, if an

29

insurer's RBC ratio falls below specified levels, the insurer is subject to different degrees of regulatory action depending upon the magnitude of the deficiency. The 2015 statutory annual statements of each of our insurance subsidiaries reflect RBC ratios in excess of the levels subjecting the insurance subsidiaries to any regulatory action.

In addition to the RBC requirements, certain states have established minimum capital requirements for insurance companies licensed to do business in their state. These regulators have the discretionary authority, in connection with the continual licensing of the Company's insurance subsidiaries, to limit or prohibit writing new business within its jurisdiction when, in the state's judgment, the insurance subsidiary is not maintaining adequate statutory surplus or capital or that the insurance subsidiary's further transaction of business would be hazardous to policyholders. The state insurance department rules provide several standards for the regulators to use in identifying companies which may be deemed to be in hazardous financial condition. One of the standards defines hazardous conditions as existing if an insurer's operating loss in the last twelve months or any shorter period of time, (including, but not limited to: (A) net capital gain or loss; (B) change in nonadmitted assets; and (C) cash dividends paid to shareholders), is greater than fifty percent of the insurer's remaining surplus. All of our insurance subsidiaries currently exceed these standards.

Our broker-dealer and investment advisor subsidiaries are subject to regulation and supervision by the SEC, FINRA and certain state regulatory bodies. The SEC, FINRA and other governmental agencies, as well as state securities commissions, may examine or investigate the activities of broker-dealers and investment advisors. These examinations or investigations often focus on the activities of the registered representatives and registered investment advisors doing business through such entities and the entities' supervision of those persons. It is possible that any examination or investigation could lead to enforcement action by the regulator and/or may result in payments of fines and penalties, payments to customers, or both, as well as changes in systems or procedures of such entities, any of which could have a material adverse effect on the Company's financial condition or results of operations.

Furthermore, the SEC is reviewing the standard of conduct applicable to brokers, dealers and investment advisors when those entities provide personalized investment advice about securities to retail customers. FINRA has also issued a report addressing how its member firms might identify and address conflicts of interest including conflicts related to the introduction of new products and services and the compensation of the member firms' associated persons. These regulatory initiatives could have an impact on Company operations and the manner in which broker-dealers and investment advisors distribute the Company's products.

Volatility in the securities markets, and other economic factors, may adversely affect our business, particularly our sales of certain life insurance products and annuities.

Fluctuations in the securities markets and other economic factors may adversely affect sales and/or policy surrenders of our annuities and life insurance policies. For example, volatility in the equity markets may deter potential purchasers from investing in fixed index annuities and may cause current policyholders to surrender their policies for the cash value or to reduce their investments. In addition, significant or unusual volatility in the general level of interest rates could negatively impact sales and/or lapse rates on certain types of insurance products.

Litigation and regulatory investigations are inherent in our business, may harm our financial condition and reputation, and may negatively impact our financial results.

Insurance companies historically have been subject to substantial litigation. In addition to the traditional policy claims associated with their businesses, insurance companies like ours face class action suits and derivative suits from policyholders and/or shareholders. We also face significant risks related to regulatory investigations and proceedings. The litigation and regulatory matters we are, have been, or may become, subject to include matters related to the classification of our career agents as independent contractors, sales, marketing and underwriting practices, payment of contingent or other sales commissions, claim payments and procedures, product design, product disclosure, administration, additional premium charges for premiums paid on a periodic basis, calculation of cost of insurance charges, changes to certain non-guaranteed policy features, denial or delay of benefits, charging excessive or impermissible fees on products, procedures related to canceling policies and recommending unsuitable products to customers. Certain of our insurance policies allow or require us to make changes based on experience to certain non-guaranteed elements ("NGEs") such as cost of insurance charges, expense loads, credited interest rates and policyholder bonuses. We intend to make changes to certain NGEs in the future. In some instances in the past, such action has resulted in litigation and similar litigation may arise in the future. Our exposure (including the potential adverse financial consequences of delays or decisions not to pursue changes to certain NGEs), if any, arising from any such action cannot presently be determined. Our pending legal and regulatory proceedings include matters that are specific to us, as well as matters faced by other insurance companies. State insurance departments have focused and continue to focus on sales,

30

marketing and claims payment practices and product issues in their market conduct examinations. Negotiated settlements of class action and other lawsuits have had a material adverse effect on the business, financial condition and results of operations of our insurance subsidiaries.

We are, in the ordinary course of our business, a plaintiff or defendant in actions arising out of our insurance business, including class actions and reinsurance disputes, and, from time to time, we are also involved in various governmental and administrative proceedings and investigations and inquiries such as information requests, subpoenas and books and record examinations, from state, federal and other authorities. Recently, we and other insurance companies have been the subject of regulatory examinations regarding compliance with state unclaimed property laws. Such examinations have included inquiries related to the use of data available on the U.S. Social Security Administration's Death Master File to identify instances where benefits under life insurance policies, annuities and retained asset accounts are payable. It is possible that such examination or other regulatory inquiries may result in payments to beneficiaries, escheatment of funds deemed abandoned under state laws and changes to procedures for the identification and escheatment of abandoned property. See the note to the consolidated financial statements entitled "Litigation and Other Legal Proceedings." The ultimate outcome of these lawsuits, regulatory proceedings and investigations cannot be predicted with certainty. In the event of an unfavorable outcome in one or more of these matters, the ultimate liability may be in excess of liabilities we have established and could have a material adverse effect on our business, financial condition, results of operations or cash flows. We could also suffer significant reputational harm as a result of such litigation, regulatory proceedings or investigations, including harm flowing from actual or threatened revocation of licenses to do business, regulator actions to assert supervision or control over our business, and other sanctions which could have a material adverse effect on our business, financial condition, results of operations or cash flows.

Managing operational risks may not be effective in mitigating risk and loss to us.

We are subject to operational risks including, among other things, fraud, errors, failure to document transactions properly or to obtain proper internal authorization, failure to comply with regulatory requirements or obligations under our agreements, information technology failures including cyber security attacks and failure of our service providers (such as investment custodians and information technology and policyholder service providers) to comply with our services agreements. The associates and agents who conduct our business, including executive officers and other members of management, sales managers, investment professionals, product managers, sales agents and other associates, do so in part by making decisions and choices that involve exposing us to risk. These include decisions involving numerous business activities such as setting underwriting guidelines, product design and pricing, investment purchases and sales, reserve setting, claim processing, policy administration and servicing, financial and tax reporting and other activities, many of which are very complex.

We seek to monitor and control our exposure to risks arising out of these activities through a risk control framework encompassing a variety of reporting systems, internal controls, management review processes and other mechanisms. However, these processes and procedures may not effectively control all known risks or effectively identify unforeseen risks. Management of operational risks can fail for a number of reasons including design failure, systems failure, cyber security attacks, human error or unlawful activities. If our controls are not effective or properly implemented, we could suffer financial or other loss, disruption of our business, regulatory sanctions or damage to our reputation. Losses resulting from these failures may have a material adverse effect on our financial position or results of operations.

The occurrence of natural or man-made disasters or a pandemic could adversely affect our financial condition and results of operations.

We are exposed to various risks arising out of natural disasters, including earthquakes, hurricanes, floods and tornadoes, and man-made disasters, including acts of terrorism and military actions and pandemics. For example, a natural or man-made disaster or a pandemic could lead to unexpected changes in persistency rates as policyholders and contractholders who are affected by the disaster may be unable to meet their contractual obligations, such as payment of premiums on our insurance policies and deposits into our investment products. In addition, such a disaster or pandemic could also significantly increase our mortality and morbidity experience above the assumptions we used in pricing our products. The continued threat of terrorism and ongoing military actions may cause significant volatility in global financial markets, and a natural or man-made disaster or a pandemic could trigger an economic downturn in the areas directly or indirectly affected by the disaster or pandemic. These consequences could, among other things, result in a decline in business and increased claims from those areas. Disasters or a pandemic also could disrupt public and private infrastructure, including communications and financial services, which could disrupt our normal business operations.

A natural or man-made disaster or a pandemic could also disrupt the operations of our counterparties or result in increased prices for the products and services they provide to us. For example, a natural or man-made disaster or a pandemic

31

could lead to increased reinsurance prices and potentially cause us to retain more risk than we otherwise would retain if we were able to obtain reinsurance at lower prices. In addition, a disaster or a pandemic could adversely affect the value of the assets in our investment portfolio if it affects companies' ability to pay principal or interest on their securities.

Interruption in telecommunication, information technology and other operational systems, or a failure to maintain the security, confidentiality or privacy of sensitive data residing on such systems, could harm our business.

We depend heavily on our telecommunication, information technology and other operational systems and on the integrity and timeliness of data we use to run our businesses and service our customers. These systems may fail to operate properly or become disabled as a result of events or circumstances which may be wholly or partly beyond our control. Further, we face the risk of operational and technology failures by others, including financial intermediaries, vendors and parties that provide services to us. If these parties do not perform as anticipated, we may experience operational difficulties, increased costs and other adverse effects on our business. Despite our implementation of a variety of security measures, our information technology and other systems could be subject to cyber attacks (including the risk of undetected attacks) and unauthorized access, such as physical or electronic break-ins, unauthorized tampering or other security breaches, resulting in a failure to maintain the security, confidentiality or privacy of sensitive data, including personal financial and health information relating to customers. There can be no assurance that any such breach will not occur or, if any does occur, that it can be sufficiently remediated. 

Interruption in telecommunication, information technology and other operational systems, or a failure to maintain the security, confidentiality or privacy of sensitive data residing on such systems, whether due to actions by us or others, could delay or disrupt our ability to do business and service our customers, harm our reputation, subject us to litigation, regulatory sanctions and other claims, require us to incur significant expenses, lead to a loss of customers and revenues and otherwise adversely affect our business. Depending on the nature of the information compromised, in the event of a data breach or other unauthorized access to our customer data, we may also have obligations to notify customers about the incident and we may need to provide some form of remedy, such as a subscription to a credit monitoring service, for the individuals affected by the incident. A growing number of legislative and regulatory bodies have adopted consumer notification requirements in the event of unauthorized access to or acquisition of certain types of personal data. Such breach notification laws continue to evolve and may be inconsistent from one jurisdiction to another. Complying with these obligations could cause us to incur substantial costs (including fines) and could increase negative publicity surrounding any incident that compromises customer data. While we maintain insurance coverage that, subject to policy terms and conditions and a self-insured retention, is designed to address certain aspects of cyber risks, such insurance coverage may be insufficient to cover all losses or all types of claims that may arise in the continually evolving area of cyber risk.

Third parties to whom we outsource certain of our functions are also subject to the risks outlined above, and failures in their systems could adversely affect our business.

Our business could be interrupted or compromised if we experience difficulties arising from outsourcing relationships.

We outsource certain information technology and policy administration operations to third-party service providers. If we fail to maintain an effective outsourcing strategy or if third-party providers do not perform as contracted, we may experience operational difficulties, increased costs and a loss of business that could have a material adverse effect on our results of operations. In the event that one or more of our third-party service providers becomes unable to continue to provide services, we may suffer financial loss and other negative consequences.

We have substantial indebtedness which may restrict our ability to take advantage of business, strategic or financing opportunities.

As of December 31, 2015, we had an aggregate principal amount of indebtedness of $925.0 million. CNO's indebtedness will require approximately $44 million in cash to service in 2016 (based on the principal amounts outstanding and applicable interest rates as of December 31, 2015). Our substantial indebtedness and the obligations under our debt agreements may restrict our ability to take advantage of business, strategic or financing opportunities.

In conjunction with the refinancing of its existing debt, the Company entered into a $150.0 million four-year unsecured revolving credit agreement (the "New Revolving Credit Agreement") on May 19, 2015, and made an initial drawing of $100.0 million, resulting in $50.0 million available for additional borrowings. The New Revolving Credit Agreement matures on May 19, 2019. On May 19, 2015, the Company also issued $325.0 million aggregate principal amount of 4.500% Senior Notes due

32

2020 (the "2020 Notes") and $500.0 million aggregate principal amount of 5.250% Senior Notes due 2025 (together with the 2020 Notes, the "Notes"). The New Revolving Credit Agreement contains various restrictive covenants and required financial ratios that we are required to meet or maintain and that will limit our operating flexibility. If we default under any of these covenants, the lenders could declare the outstanding principal amount of the loan, accrued and unpaid interest and all other amounts owing or payable thereunder to be immediately due and payable, which would have material adverse consequences to us. In such event, the holders of the Notes could elect to take similar action with respect to those debts. If that were to occur, we would not have sufficient liquidity to repay our indebtedness.

If we fail to pay interest or principal on our other indebtedness, including the Notes, we will be in default under the indenture governing such indebtedness, which could also lead to a default under agreements governing our existing and future indebtedness, including under the New Revolving Credit Agreement. If the repayment of the related indebtedness were to be accelerated after any applicable notice or grace periods, we likely would not have sufficient funds to repay our indebtedness. Absent sufficient liquidity to repay our indebtedness, our management or our independent registered public accounting firm may conclude that there is substantial doubt regarding our ability to continue as a going concern.

The New Revolving Credit Agreement and the Indenture for the Notes contain various restrictive covenants and required financial ratios that limit our operating flexibility. The violation of one or more loan covenant requirements will entitle our lenders to declare all outstanding amounts under the New Revolving Credit Agreement and the Notes to be due and payable.

Pursuant to the New Revolving Credit Agreement, CNO agreed to a number of covenants and other provisions that restrict the Company's ability to borrow money and pursue some operating activities without the prior consent of the lenders. We also agreed to meet or maintain various financial ratios and balances. Our ability to meet these financial tests may be affected by events beyond our control. There are several conditions or circumstances that could lead to an event of default under the New Revolving Credit Agreement, as described below.

The New Revolving Credit Agreement contains certain financial, affirmative and negative covenants. The negative covenants in the New Revolving Credit Agreement include restrictions that relate to, among other things and subject to customary baskets, exceptions and limitations for facilities of this type:

• subsidiary debt;

• liens;

• restrictive agreements;

• restricted payments during the continuance of an event of default;

• disposition of assets and sale and leaseback transactions;

• transactions with affiliates;

• change in business;

• fundamental changes;

• modification of certain agreements; and

• changes to fiscal year.

The New Revolving Credit Agreement requires the Company to maintain (each as calculated in accordance with the New Revolving Credit Agreement): (i) a debt to total capitalization ratio of not more than 30.0 percent (such ratio was 19.9 percent at December 31, 2015); (ii) an aggregate ratio of total adjusted capital to company action level risk-based capital for the Company's insurance subsidiaries of not less than 250 percent (such ratio was estimated to be 449 percent at December 31, 2015); and (iii) a minimum consolidated net worth of not less than the sum of (x) $2,674 million plus (y) 50.0% of the net equity proceeds received by the Company from the issuance and sale of equity interests in the Company (the Company's consolidated net worth was $3,735.7 million at December 31, 2015 compared to the minimum requirement of $2,677 million).

The New Revolving Credit Agreement provides for customary events of default (subject in certain cases to customary grace and cure periods), which include, without limitation, the following:

• non-payment;

• breach of representations, warranties or covenants;

• cross-default and cross-acceleration;

• bankruptcy and insolvency events;

• judgment defaults;

• actual or asserted invalidity of documentation with respect to the New Revolving Credit Agreement;

33

• change of control; and

• customary ERISA defaults.

If an event of default under the New Revolving Credit Agreement occurs and is continuing, the Agent may accelerate the amounts and terminate all commitments outstanding under the New Revolving Credit Agreement.

These covenants place significant restrictions on the manner in which we may operate our business and our ability to meet these financial covenants may be affected by events beyond our control. If we default under any of these covenants, the lenders could declare the outstanding principal amount of the loan, accrued and unpaid interest and all other amounts owing and payable thereunder to be immediately due and payable, which would have material adverse consequences to us. If the lenders under the New Revolving Credit Agreement elect to accelerate the amounts due, the holders of the Notes could elect to take similar action with respect to those debts. If that were to occur, we would not have sufficient liquidity to repay our indebtedness.

The Indenture contains covenants that restrict the Company’s ability, with certain exceptions, to:

• incur certain subsidiary indebtedness without also guaranteeing the Notes;

• create liens;

• enter into sale and leaseback transactions;

• issue, sell, transfer or otherwise dispose of any shares of capital stock of any Insurance Subsidiary (as defined in the Indenture); and

• consolidate or merge with or into other companies or transfer all or substantially all of the Company’s assets.

The Indenture provides for customary events of default (subject in certain cases to customary grace and cure periods), which include nonpayment, breach of covenants in the Indenture, failure to pay at maturity or acceleration of other indebtedness, a failure to pay certain judgments and certain events of bankruptcy and insolvency. Generally, if an event of default occurs, Wilmington Trust, National Association or holders of at least 25% in principal amount of the then outstanding Notes may declare the principal of and accrued but unpaid interest, including any additional interest, on all of the Notes to be due and payable.

Our current credit ratings may adversely affect our ability to access capital and the cost of such capital, which could have a material adverse effect on our financial condition and results of operations.

Our issuer credit and senior secured debt rating from each of the major rating agencies is below investment grade. If we were to require additional capital, either to refinance our existing indebtedness or for any other reason, our current senior debt ratings, as well as conditions in the credit markets generally, could restrict our access to such capital and adversely affect its cost. See "Management's Discussion and Analysis of Financial Condition and Results of Operations-Liquidity of the Holding Companies" for more information.

CNO is a holding company and its liquidity and ability to meet its obligations may be constrained by the ability of CNO's insurance subsidiaries to distribute cash to it.

CNO and CDOC, Inc. ("CDOC") are holding companies with no business operations of their own. CNO and CDOC depend on their operating subsidiaries for cash to make principal and interest payments on debt and to pay administrative expenses and income taxes. CNO and CDOC receive cash from our insurance subsidiaries, consisting of dividends and distributions, principal and interest payments on surplus debentures and tax-sharing payments, as well as cash from their non-insurance subsidiaries consisting of dividends, distributions, loans and advances. Deterioration in the financial condition, earnings or cash flow of these significant subsidiaries for any reason could hinder the ability of such subsidiaries to pay cash dividends or other disbursements to CNO and/or CDOC, which would limit our ability to meet our debt service requirements and satisfy other financial obligations. In addition, CNO may elect to contribute additional capital to certain insurance subsidiaries to strengthen their surplus for covenant compliance or regulatory purposes (including, for example, maintaining adequate RBC level) or to provide the capital necessary for growth, in which case it is less likely that its insurance subsidiaries would pay dividends to the holding company. Accordingly, this could limit CNO's ability to meet debt service requirements and satisfy other holding company financial obligations. See "Management's Discussion and Analysis of Financial Condition and Results of Operations-Liquidity of the Holding Companies" for more information.

CNO receives dividends and other payments from CDOC and from certain non-insurance subsidiaries. CDOC receives dividends and surplus debenture interest payments from our insurance subsidiaries and payments from certain of our non-insurance subsidiaries. Payments from our non-insurance subsidiaries to CNO or CDOC, and payments from CDOC to CNO,

34

do not require approval by any regulatory authority or other third party. However, the payment of dividends or surplus debenture interest by our insurance subsidiaries to CDOC is subject to state insurance department regulations and may be prohibited by insurance regulators if they determine that such dividends or other payments could be adverse to our policyholders or contract holders. Insurance regulations generally permit dividends to be paid from statutory earned surplus of the insurance company without regulatory approval for any 12-month period in amounts equal to the greater of (or in a few states, the lesser of):

• statutory net gain from operations or statutory net income for the prior year, or

• 10 percent of statutory capital and surplus as of the end of the preceding year.

This type of dividend is referred to as an "ordinary dividend". Any dividend in excess of these levels requires the approval of the director or commissioner of the applicable state insurance department and is referred to as an "extraordinary dividend". In 2015, our insurance subsidiaries paid extraordinary dividends of $265.7 million to CDOC. Each of the immediate insurance subsidiaries of CDOC had negative earned surplus at December 31, 2015. As a result, any dividend payments from the insurance subsidiaries to CNO will be considered extraordinary dividends and will require the prior approval of the director or commissioner of the applicable state insurance department. CNO expects to receive regulatory approval for future dividends from our insurance subsidiaries, but there can be no assurance that such payments will be approved or that the financial condition of our insurance subsidiaries will not deteriorate, making future approvals less likely.

CDOC holds surplus debentures from Conseco Life Insurance Company of Texas ("CLTX") with an aggregate principal amount of $749.6 million.  Interest payments on those surplus debentures do not require additional approval provided the RBC ratio of CLTX exceeds 100 percent (but do require prior written notice to the Texas state insurance department).  The estimated RBC ratio of CLTX was 393 percent at December 31, 2015.  CDOC also holds a surplus debenture from Colonial Penn with a principal balance of $160.0 million. Interest payments on that surplus debenture require prior approval by the Pennsylvania state insurance department. Dividends and other payments from our non-insurance subsidiaries, including 40|86 Advisors and CNO Services, LLC ("CNO Services"), to CNO or CDOC do not require approval by any regulatory authority or other third party.  However, insurance regulators may prohibit payments by our insurance subsidiaries to parent companies if they determine that such payments could be adverse to our policyholders or contractholders.

In addition, although we are under no obligation to do so, we may elect to contribute additional capital to strengthen the surplus of certain insurance subsidiaries for covenant compliance or regulatory purposes or to provide the capital necessary for growth. Any election regarding the contribution of additional capital to our insurance subsidiaries could affect the ability of our top tier insurance subsidiaries to pay dividends. The ability of our insurance subsidiaries to pay dividends is also impacted by various criteria established by rating agencies to maintain or receive higher financial strength ratings and by the capital levels that we target for our insurance subsidiaries, as well as the RBC compliance requirements under the New Revolving Credit Agreement. CDOC made no capital contributions to its insurance subsidiaries in 2015.

In addition, Washington National may not distribute funds to any affiliate or shareholder, except pursuant to agreements with affiliates that have been approved, without prior notice to the Florida Office of Insurance Regulation, in accordance with an order from the Florida Office of Insurance Regulation.

We previously identified a material weakness in our internal control over financial reporting which has been remediated, and our business may be adversely affected if we fail to maintain effective controls over financial reporting.

We have previously identified material weaknesses in internal controls, including one identified at September 30, 2012 related to the accurate calculation of certain adjustments impacting other comprehensive income. Specifically, controls in place to ensure the accurate calculation of these adjustments did not operate effectively. We have emphasized the importance of performing and reviewing calculations consistent with the design of our internal control structure in an effort to ensure controls operate effectively. The Company has completed its testing of controls over the calculation of these adjustments and concluded that the material weakness identified at September 30, 2012 was remediated as of December 31, 2012.

We face the risk that, notwithstanding our efforts to date to identify and remedy the material weakness in our internal control over financial reporting, we may discover other material weaknesses in the future and the cost of remediating the material weakness could be high and could have a material adverse effect on our financial condition and results of operations.

35

Our ability to use our existing NOLs may be limited by certain transactions, and an impairment of existing NOLs could result in a significant writedown in the value of our deferred tax assets, which could cause us to breach the debt to total capitalization covenant of the New Revolving Credit Agreement.

As of December 31, 2015, we had approximately $2.6 billion of federal tax NOLs resulting in deferred tax assets of approximately $0.9 billion, expiring in years 2023 through 2032. Section 382 of the Code imposes limitations on a corporation's ability to use its NOLs when it undergoes a 50 percent "ownership change" over a three year period. Although we underwent an ownership change in 2003 as the result of our reorganization, the timing and manner in which we will be able to utilize our NOLs is not currently limited by Section 382.

We regularly monitor ownership changes (as calculated for purposes of Section 382) based on available information and, as of December 31, 2015, our analysis indicated that we were below the 50 percent ownership change threshold that would limit our ability to utilize our NOLs. A future transaction or transactions and the timing of such transaction or transactions could trigger an ownership change under Section 382. Such transactions may include, but are not limited to, additional repurchases or issuances of common stock, acquisitions or sales of shares of CNO's stock by certain holders of its shares, including persons who have held, currently hold or may accumulate in the future 5 percent or more of CNO's outstanding common stock for their own account. In January 2009, CNO's Board of Directors adopted a Section 382 Rights Agreement designed to protect shareholder value by preserving the value of our NOLs. The Section 382 Rights Agreement was amended and extended by the CNO Board of Directors on December 6, 2011 and on November 13, 2014. The Amended Section 382 Rights Agreement provides a strong economic disincentive for any one shareholder knowingly, and without the approval of the Board of Directors, to become an owner of more than 4.99% of the Company's outstanding common stock (or any other interest in CNO that would be treated as "stock" under applicable Section 382 regulations) and for any owner of more than 4.99% of CNO's outstanding common stock as of the date of the Amended Section 382 Rights Agreement to increase their ownership stake by more than 1 percent of the shares of CNO's common stock then outstanding, and thus limits the uncertainty with regard to the potential for future ownership changes. However, despite the strong economic disincentives of the Amended Section 382 Rights Agreement, shareholders may elect to increase their ownership, including beyond the limits set by the Amended Section 382 Rights Agreement, and thus adversely affect CNO's ownership shift calculations. To further protect against the possibility of triggering an ownership change under Section 382, CNO's shareholders approved an amendment to CNO's certificate of incorporation (the "Original Section 382 Charter Amendment") designed to prevent certain transfers of common stock which could otherwise adversely affect our ability to use our NOLs.

On May 8, 2013, our shareholders approved an amendment (the "Extended Section 382 Charter Amendment") to CNO’s certificate of incorporation to: (i) extend the term of the Original Section 382 Charter Amendment for three years until December 31, 2016, (ii) provide for a 4.99% ownership threshold relating to our stock, and (iii) amend certain other provisions of the Original Section 382 Charter Amendment, including updates to certain definitions, for consistency with the Amended Section 382 Rights Agreement. See the note to the consolidated financial statements entitled "Income Taxes" for further information regarding the Amended Section 382 Rights Agreement, the Extended Section 382 Charter Amendment and CNO's NOLs.

If an ownership change were to occur for purposes of Section 382, we would be required to calculate an annual limitation on the use of our NOLs to offset future taxable income. The annual restriction would be calculated based upon the value of CNO's equity at the time of such ownership change, multiplied by a federal long-term tax exempt rate (2.61 percent at December 31, 2015), and the annual restriction could eliminate our ability to use a substantial portion of our NOLs to offset future taxable income. Additionally, the writedown of our deferred tax assets that would occur in the event of an ownership change for purposes of Section 382 could cause us to breach the debt to total capitalization covenant in the New Revolving Credit Agreement.

The value of our deferred tax assets may be reduced to the extent our future profits are less than we have projected or the current corporate income tax rate is reduced, and such reductions in value may have a material adverse effect on our results of operations and our financial condition.

As of December 31, 2015, we had net deferred tax assets of $946.6 million. Our income tax expense includes deferred income taxes arising from temporary differences between the financial reporting and tax bases of assets and liabilities, capital loss carry-forwards and NOLs. We evaluate the realizability of our deferred tax assets and assess the need for a valuation allowance on an ongoing basis. In evaluating our deferred tax assets, we consider whether it is more likely than not that the deferred tax assets will be realized. The ultimate realization of our deferred tax assets depends upon generating sufficient future taxable income during the periods in which our temporary differences become deductible and before our capital loss carry-forwards and NOLs expire. Our assessment of the realizability of our deferred tax assets requires significant judgment. Failure

36

to achieve our projections may result in an increase in the valuation allowance in a future period. Any future increase in the valuation allowance would result in additional income tax expense which could have a material adverse effect upon our earnings in the future, and reduce shareholders' equity.

The value of our net deferred tax assets as of December 31, 2015 reflects the current corporate income tax rate of approximately 35 percent. A reduction in the corporate income tax rate would cause a writedown of our deferred tax assets, which may have a material adverse effect on our results of operations and financial condition.

From time to time we may become subject to tax audits, tax litigation or similar proceedings, and as a result we may owe additional taxes, interest and penalties, or our NOLs may be reduced, in amounts that may be material.

In determining our provisions for income taxes and our accounting for tax-related matters in general, we are required to exercise judgment. We regularly make estimates where the ultimate tax determination is uncertain. The final determination of any tax audit, appeal of the decision of a taxing authority, tax litigation or similar proceedings may be materially different from that reflected in our financial statements. The assessment of additional taxes, interest and penalties could be materially adverse to our current and future results of operations and financial condition. See the note to the consolidated financial statements entitled "Income Taxes" for further information.

Our results of operations may be negatively impacted if our initiatives to restructure our insurance operations or our efforts to become more efficient are unsuccessful.

We have implemented or are in the process of implementing several initiatives to improve operating results, including: (i) focusing sales efforts on higher margin products; (ii) reducing operating expenses by eliminating or reducing marketing costs of certain products; (iii) streamlining administrative procedures and reducing personnel; (iv) using third party service providers to improve service and reduce expenses; and (v) increasing retention rates on our more profitable blocks of inforce business. Many of our initiatives address issues resulting from the substantial number of acquisitions of our Predecessor. Between 1982 and 1997, our Predecessor completed 19 transactions involving the acquisitions of 44 separate insurance companies. These prior acquisitions have contributed to the complexity and cost of our current administrative operating environment and make it challenging, in some instances, to operate our business within the expense levels assumed in the pricing of our products. If we are unsuccessful in our efforts to become more efficient, our future earnings will be adversely affected.

In the event one or more of our third party service providers to whom we outsource certain of our functions becomes unable to continue to provide services or experiences a failure in their systems, our business could be adversely impacted.

Conversions to new systems can result in valuation differences between the prior system and the new system. We have recognized such differences in the past. Our planned conversions could result in future valuation adjustments, and these adjustments may have a material adverse effect on future earnings.

A decline in the current financial strength rating of our insurance subsidiaries could cause us to experience decreased sales, increased agent attrition and increased policyholder lapses and redemptions.

An important competitive factor for our insurance subsidiaries is the ratings they receive from nationally recognized rating organizations. Agents, insurance brokers and marketing companies who market our products and prospective purchasers of our products use the financial strength ratings of our insurance subsidiaries as an important factor in determining whether to market or purchase. Ratings have the most impact on our annuity, interest-sensitive life insurance and long-term care products.

The current financial strength ratings of our primary insurance subsidiaries from A.M. Best, S&P, Fitch and Moody's are "A-", "BBB+", "BBB+" and "Baa1", respectively.  A.M. Best has sixteen possible ratings. There are three ratings above our "A-" rating and twelve ratings that are below our rating. S&P has twenty-one possible ratings. There are seven ratings above our "BBB+" rating and thirteen ratings that are below our rating. Fitch has nineteen possible ratings. There are seven ratings above our "BBB+" rating and eleven ratings that are below our rating. Moody's has twenty-one possible ratings. There are seven ratings above our "Baa1" rating and thirteen ratings that are below our rating.

If our ratings are downgraded, we may experience declining sales of certain of our insurance products, defections of our independent and career sales force, and increased policies being redeemed or allowed to lapse. These events would adversely affect our financial results, which could then lead to ratings downgrades.

37

Competition from companies that have greater market share, higher ratings, greater financial resources and stronger brand recognition, may impair our ability to retain existing customers and sales representatives, attract new customers and sales representatives and maintain or improve our financial results.

The supplemental health insurance, annuity and individual life insurance markets are highly competitive. Competitors include other life and accident and health insurers, commercial banks, thrifts, mutual funds and broker-dealers.

Our principal competitors vary by product line. Our main competitors for agent-sold long-term care insurance products include Genworth, Northwestern Mutual and John Hancock. Our main competitors for agent-sold Medicare supplement insurance products include Blue Cross and Blue Shield Plans, Mutual of Omaha and United HealthCare. Our main competitors for life insurance sold through direct marketing channels include Gerber Life, MetLife, Mutual of Omaha, New York Life, Massachusetts Mutual Life Insurance Company and subsidiaries of Torchmark. Our main competitors for supplemental health products sold through our Washington National segment include AFLAC, subsidiaries of Allstate, Colonial Life and Accident Company and subsidiaries of Torchmark.

In some of our product lines, such as life insurance and fixed annuities, we have a relatively small market share. Even in some of the lines in which we are one of the top writers, our market share is relatively small. For example, while, based on an Individual Long-Term Care Insurance Survey, our Bankers Life segment ranked seventh in annualized premiums of individual long-term care insurance in 2014 with a market share of approximately 4 percent, the top six writers of individual long-term care insurance had annualized premiums with a combined market share of approximately 76 percent during the period. In addition, while, based on a 2014 Medicare Supplement Loss Ratios report, we ranked fifth in direct premiums earned for Medicare supplement insurance in 2014 with a market share of 3.3 percent, the top writer of Medicare supplement insurance had direct premiums with a market share of 35 percent during the period.

Most of our major competitors have higher financial strength ratings than we do. Many of our competitors are larger companies that have greater capital, technological and marketing resources and have access to capital at a lower cost. Recent industry consolidation, including business combinations among insurance and other financial services companies, has resulted in larger competitors with even greater financial resources. Furthermore, changes in federal law have narrowed the historical separation between banks and insurance companies, enabling traditional banking institutions to enter the insurance and annuity markets and further increase competition. This increased competition may harm our ability to maintain or improve our profitability.

In addition, because the actual cost of products is unknown when they are sold, we are subject to competitors who may sell a product at a price that does not cover its actual cost. Accordingly, if we do not also lower our prices for similar products, we may lose market share to these competitors. If we lower our prices to maintain market share, our profitability will decline.

The Colonial Penn segment has faced increased competition from other insurance companies who also distribute products through direct marketing. In addition, the demand and cost of television advertising appropriate for Colonial Penn's campaigns fluctuates from period to period and this will impact the average cost to generate a TV lead.

We must attract and retain sales representatives to sell our insurance and annuity products. Strong competition exists among insurance and financial services companies for sales representatives. We compete for sales representatives primarily on the basis of our financial position, financial strength ratings, support services, compensation, products and product features. Our competitiveness for such agents also depends upon the relationships we develop with these agents. Our Predecessor's bankruptcy continues to be an adverse factor in developing relationships with certain agents. If we are unable to attract and retain sufficient numbers of sales representatives to sell our products, our ability to compete and our revenues and profitability would suffer.

If we are unable to attract and retain agents and marketing organizations, sales of our products may be reduced.

Our products are marketed and distributed primarily through a dedicated field force of career agents and sales managers (in our Bankers Life segment) and through PMA and independent marketing organizations (in our Washington National segment). We must attract and retain agents, sales managers and independent marketing organizations to sell our products through those distribution channels. We compete with other insurance companies and financial services companies for agents and sales managers and for business through marketing organizations. If we are unable to attract and retain these agents, sales managers and marketing organizations, our ability to grow our business and generate revenues from new sales would suffer.

38

Federal and state legislation could adversely affect the financial performance of our insurance operations.

During recent years, the health insurance industry has experienced substantial changes, including those caused by healthcare legislation. Recent federal and state legislation and pending legislative proposals concerning healthcare reform contain features that could severely limit, or eliminate, our ability to vary pricing terms or apply medical underwriting standards to individuals, thereby potentially increasing our benefit ratios and adversely impacting our financial results. In particular, Medicare reform could affect our ability to price or sell our products or profitably maintain our blocks inforce. For example, the Medicare Advantage program provides incentives for health plans to offer managed care plans to seniors. The growth of managed care plans under this program could decrease sales of the traditional Medicare supplement products we sell. Some current proposals contain government provided long-term care insurance which could affect the sales of our long-term care products.

Proposals currently pending in Congress and some state legislatures may also affect our financial results. These proposals include the implementation of minimum consumer protection standards in all long-term care policies, including: guaranteed premium rates; protection against inflation; limitations on waiting periods for pre-existing conditions; setting standards for sales practices for long-term care insurance; and guaranteed consumer access to information about insurers, including information regarding lapse and replacement rates for policies and the percentage of claims denied. Enactment of any proposal that would limit the amount we can charge for our products, such as guaranteed premium rates, or that would increase the benefits we must pay, such as limitations on waiting periods, or that would otherwise increase the costs of our business, could adversely affect our financial results.

In April 2015, the Department of Labor re-proposed regulations that would, if finalized in current form, substantially expand the range of activities that would be considered to be fiduciary investment advice under the Employee Retirement Income Security Act of 1974 and the Internal Revenue Code. If final regulations were to be issued with provisions similar to the proposed regulations, some of the investment-related information and support that our agents, advisors and employees provide to customers on a non-fiduciary basis could be substantially limited beyond what is allowed under current law. This could change the methods that we use to deliver services and the compensation we provide to our agents. The regulations are expected to be finalized in 2016 and such regulations and/or their implementation could result in increased costs and could impact the sales of certain of our products. Although the potential impacts of the final regulations are uncertain and difficult to predict, they could negatively impact our sales, business, results of operations and financial condition.

On July 21, 2010, the Dodd-Frank Act was enacted and signed into law. The Dodd-Frank Act made extensive changes to the laws regulating financial services firms and requires various federal agencies to adopt a broad range of new rules and regulations. Among other provisions, the Dodd-Frank Act provides for a new framework of regulation of over-the-counter derivatives markets. This will require us to clear certain types of transactions currently traded in the over-the-counter derivative markets and may limit our ability to customize derivative transactions for our needs. In addition, we will likely experience additional collateral requirements and costs associated with derivative transactions.

The Dodd-Frank Act also establishes a Financial Stability Oversight Council, which is authorized to subject nonbank financial companies deemed systemically significant to stricter prudential standards and other requirements and to subject such a company to a special orderly liquidation process outside the federal bankruptcy code, administered by the Federal Deposit Insurance Corporation (although insurance company subsidiaries would remain subject to liquidation and rehabilitation proceedings under state law). In addition, the Dodd-Frank Act establishes a Federal Insurance Office within the Department of the Treasury. While not having a general supervisory or regulatory authority over the business of insurance, the director of this office will perform various functions with respect to insurance, including serving as a non-voting member of the Financial Stability Oversight Council and making recommendations to the Council regarding insurers to be designated for more stringent regulation. The director is also required to conduct a study on how to modernize and improve the system of insurance regulation in the United States, including by increased national uniformity through either a federal charter or effective action by the states.

Federal agencies have been given significant discretion in drafting the rules and regulations that will implement the Dodd-Frank Act. Consequently, many of the details and much of the impact of the Dodd-Frank Act may not be known for some time. In addition, this legislation mandated multiple studies and reports for Congress, which could result in additional legislative or regulatory action.

We cannot predict the requirements of the regulations ultimately adopted under the Dodd-Frank Act, the effect such regulations will have on financial markets generally, or on our businesses specifically, the additional costs associated with

39

compliance with such regulations, or any changes to our operations that may be necessary to comply with the Dodd-Frank Act, any of which could have a material adverse affect on our business, results of operations, cash flows or financial condition.

Reinsurance may not be available, affordable or adequate to protect us against losses.

As part of our overall risk and capital management strategy, we have historically purchased reinsurance from external reinsurers as well as provided internal reinsurance support for certain risks underwritten by our business segments. The availability and cost of reinsurance protection are impacted by our operating and financial performance as well as conditions beyond our control. For example, volatility in the equity markets and the related impacts on asset values required to fund liabilities may reduce the availability of certain types of reinsurance and make it more costly when it is available, as reinsurers are less willing to take on credit risk in a volatile market. Accordingly, we may be forced to incur additional expenses for reinsurance or may not be able to obtain sufficient new reinsurance on acceptable terms, which could adversely affect our ability to write future business or obtain statutory capital credit for new reinsurance.

Our insurance subsidiaries may be required to pay assessments to fund other companies' policyholder losses or liabilities and this may negatively impact our financial results.

The solvency or guaranty laws of most states in which an insurance company does business may require that company to pay assessments up to certain prescribed limits to fund policyholder losses or liabilities of other insurance companies that become insolvent. Insolvencies of insurance companies increase the possibility that these assessments may be required. These assessments may be deferred or forgiven under most guaranty laws if they would threaten an insurer's financial strength and, in certain instances, may be offset against future premium taxes. We cannot estimate the likelihood and amount of future assessments. Although past assessments have not been material, if there were a number of large insolvencies, future assessments could be material and could have a material adverse effect on our operating results and financial position.

ITEM 1B.UNRESOLVED STAFF COMMENTS.

None.

ITEM 2.PROPERTIES.

Our headquarters and the administrative operations of our Washington National segment and certain administrative operations of our subsidiaries are located on a Company-owned corporate campus in Carmel, Indiana, immediately north of Indianapolis. We currently occupy four buildings on the campus with approximately 422,000 square feet of space.

Our Bankers Life segment is primarily administered from downtown Chicago, Illinois. In 2012, Bankers Life relocated from one downtown location to another. The new location has approximately 135,000 square feet leased under an agreement which expires in 2023. Bankers Life has subleased its prior location of 222,000 square feet through the remaining term of the lease which expires in 2018. We also lease 321 sales offices in various states totaling approximately 950,000 square feet. These leases generally are short-term in length, with remaining lease terms expiring between 2016 and 2021.

Our Colonial Penn segment is administered from a Company-owned office building in Philadelphia, Pennsylvania, with approximately 127,000 square feet. We occupy approximately 45 percent of this space, with unused space leased to tenants.

Management believes that this office space is adequate for our needs.

ITEM 3.LEGAL PROCEEDINGS.

Information required for Item 3 is incorporated by reference to the discussion under the heading "Legal Proceedings" in the note to the consolidated financial statements entitled "Litigation and Other Legal Proceedings" included in Item 8 of this Form 10-K.

ITEM 4.MINE SAFETY DISCLOSURES.

Not applicable.

40

Executive Officers of the Registrant

Officer		Positions with CNO, Principal
Name and Age (a)	Since	Occupation and Business Experience (b)
Bruce Baude, 51	2012	Since July 2012, executive vice president, chief operations and technology officer. From 2008 to 2012, Mr. Baude was chief operating officer at Univita Health.
Edward J. Bonach, 61	2007	Since October 2011, chief executive officer. From May 2007 to January 2012, chief financial officer of CNO.
Eric R. Johnson, 55	1997	Since September 2003, chief investment officer of CNO and president and chief executive officer of 40|86 Advisors, CNO's wholly-owned registered investment advisor. Mr. Johnson has held various investment management positions since joining CNO in 1997.
John R. Kline, 58	1990	Since July 2002, senior vice president and chief accounting officer. Mr. Kline has served in various accounting and finance capacities with CNO since 1990.
Susan L. Menzel, 50	2005	Since May 2005, executive vice president, human resources.
Christopher J. Nickele, 59	2005	Since August 2014, executive vice president and chief actuary. From October 2005 until August 2014, executive vice president, product management and from May 2010 until March 2014, president, Other CNO Business.
Scott R. Perry, 53	2001	Since July 2011, chief business officer of CNO. From 2006 until September 2013, president of Bankers Life and from 2001 to 2006, employed in various capacities for Bankers Life.
Matthew J. Zimpfer, 48	1998	Since June 2008, executive vice president and general counsel. Mr. Zimpfer has held various legal positions since joining CNO in 1998.

___________________________

(a) The executive officers serve as such at the discretion of the Board of Directors and are elected annually.

(b) Business experience is given for at least the last five years.

41

PART II

ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES.

MARKET INFORMATION AND DIVIDENDS

The following table sets forth the dividends declared and paid per share and the ranges of high and low sales prices per share for our common stock on the New York Stock Exchange for the quarterly periods beginning January 1, 2014.

Period	Market price				Dividends
	High		Low		declared and paid
2014:
First Quarter	$	19.33	$	16.09	$	0.06
Second Quarter	19.00		15.55		0.06
Third Quarter	18.23		15.90		0.06
Fourth Quarter	18.47		15.46		0.06
2015:
First Quarter	$	17.53	$	14.89	$	0.06
Second Quarter	19.49		16.88		0.07
Third Quarter	19.28		16.06		0.07
Fourth Quarter	20.88		17.93		0.07

As of February 9, 2016, there were approximately 30,000 holders of the outstanding shares of common stock, including individual participants in securities position listings.

We commenced the payment of a dividend on our common stock in the second quarter of 2012. The dividend on our common stock is declared each quarter by our Board of Directors. In determining dividends, our Board of Directors takes into consideration our financial condition, including current and expected earnings and projected cash flows.

PERFORMANCE GRAPH

The performance graph below compares CNO's cumulative total shareholder return on its common stock for the period from December 31, 2010 through December 31, 2015 with the cumulative total return of the Standard & Poor's 500 Composite Stock Price Index (the "S&P 500 Index"), the Standard & Poor's Life and Health Insurance Index (the "S&P Life and Health Insurance Index") and the Standard & Poor's MidCap 400 Index (the "S&P MidCap 400 Index"). The comparison for each of the periods assumes that $100 was invested on December 31, 2010 in each of CNO common stock, the stocks included in the S&P 500 Index, the stocks included in the S&P Life and Health Insurance Index and the stocks included in the S&P MidCap 400 Index and that all dividends were reinvested. The stock performance shown in this graph represents past performance and should not be considered an indication of future performance of CNO's common stock.

42

*$100 invested on 12/31/10 in stock or index, including reinvestment of dividends.

	12/10		12/11		12/12		12/13		12/14		12/15
CNO Financial Group, Inc.	$	100.00	$	93.07	$	138.60	$	264.92	$	261.44	$	294.18
S&P 500 Index	100.00		102.11		118.45		156.82		178.28		180.75
S&P Life & Health Insurance Index	100.00		79.29		90.86		148.53		151.42		141.87
S&P MidCap 400 Index	100.00		98.27		115.84		154.64		169.75		166.06

43

ISSUER PURCHASES OF EQUITY SECURITIES

Period (in 2015)	Total number of shares (or units)	Average price paid per share (or unit)		Total number of shares (or units) purchased as part of publicly announced plans or programs	Maximum number (or approximate dollar value) of shares (or units) that may yet be purchased under the plans or programs(a)
					(dollars in millions)
October 1 through October 31	864,984	$	19.08	864,984	$	93.2
November 1 through November 30	362,156	19.90		362,156	486.0
December 1 through December 31	1,590,445	19.07		1,589,407	455.7
Total	2,817,585	19.18		2,816,547	455.7

_________________

(a) In May 2011, the Company announced a securities repurchase program of up to $100.0 million. In February 2012, June 2012, December 2012, December 2013, November 2014 and November 2015, the Company's Board of Directors approved, in aggregate, an additional $1,600.0 million to repurchase the Company's outstanding securities.

EQUITY COMPENSATION PLAN INFORMATION

The following table summarizes information, as of December 31, 2015, relating to our common stock that may be issued under the CNO Financial Group, Inc. Amended and Restated Long-Term Incentive Plan.

	Number of securities to be issued upon exercise of outstanding options, warrants and rights	Weighted-average exercise price of outstanding options, warrants and rights		Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in first column)
Equity compensation plans approved by security holders	5,198,765	$	13.32	6,881,705
Equity compensation plans not approved by security holders	—	—		—
Total	5,198,765	$	13.32	6,881,705

44

ITEM 6. SELECTED CONSOLIDATED FINANCIAL DATA.

	Years ended December 31,
	2015			2014		2013			2012			2011
	(Amounts in millions, except per share data)
STATEMENT OF OPERATIONS DATA
Insurance policy income	$	2,556.0		$	2,629.7	$	2,744.7		$	2,755.4		$	2,690.5
Net investment income	1,233.6			1,427.4		1,664.0			1,486.4			1,354.1
Net realized investment gains	(36.6		)	36.7		33.4			81.1			61.8
Total revenues	3,811.9			4,144.7		4,476.1			4,342.7			4,124.6
Interest expense	94.9			92.8		105.3			114.6			114.1
Total benefits and expenses	3,444.2			3,969.6		4,171.3			4,187.0			3,818.4
Income before income taxes	367.7			175.1		304.8			155.7			306.2
Income tax expense (benefit)	97.0			123.7		(173.2		)	(65.3		)	(29.5		)
Net income	270.7			51.4		478.0			221.0			335.7
PER SHARE DATA
Net income, basic	$	1.40		$	.24	$	2.16		$	.95		$	1.35
Net income, diluted	1.39			.24		2.06			.83			1.15
Dividends declared per common share	.27			.24		.11			.06			—
Book value per common share outstanding	22.49			23.06		22.49			22.80			19.12
Weighted average shares outstanding for basic earnings	193.1			212.9		221.6			233.7			248.0
Weighted average shares outstanding for diluted earnings	195.2			217.7		232.7			281.4			304.1
Shares outstanding at period-end	184.0			203.3		220.3			221.5			241.3
BALANCE SHEET DATA - AT PERIOD END (a)
Total investments	$	24,487.1		$	24,908.3	$	27,151.7		$	27,959.3		$	26,364.3
Total assets	31,125.1			31,155.9		34,750.2			34,103.7			32,901.4
Corporate notes payable	911.1			780.3		838.0			986.1			845.1
Total liabilities	26,986.6			26,467.7		29,795.0			29,054.4			28,287.6
Shareholders' equity	4,138.5			4,688.2		4,955.2			5,049.3			4,613.8
STATUTORY DATA - AT PERIOD END (b)
Statutory capital and surplus	$	1,739.2		$	1,654.4	$	1,711.9		$	1,560.4		$	1,578.1
Asset valuation reserve ("AVR")	196.9			203.1		233.9			222.2			168.4
Total statutory capital and surplus and AVR	1,936.1			1,857.5		1,945.8			1,782.6			1,746.5

____________________

(a) Selected amounts have been restated to reflect the retrospective application of the adoption of authoritative guidance that requires debt issuance costs in financial statements to be presented as a direct deduction from the carrying value of the associated debt liability rather than as an asset on the balance sheet.

(b) We have derived the statutory data from statements filed by our insurance subsidiaries with regulatory authorities which are prepared in accordance with statutory accounting principles, which vary in certain respects from GAAP.

45

ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF CONSOLIDATED FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

In this section, we review the consolidated financial condition of CNO and its consolidated results of operations for the years ended December 31, 2015, 2014 and 2013 and, where appropriate, factors that may affect future financial performance. Please read this discussion in conjunction with the consolidated financial statements and notes included in this Form 10-K.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

Our statements, trend analyses and other information contained in this report and elsewhere (such as in filings by CNO with the SEC, press releases, presentations by CNO or its management or oral statements) relative to markets for CNO's products and trends in CNO's operations or financial results, as well as other statements, contain forward-looking statements within the meaning of the federal securities laws and the Private Securities Litigation Reform Act of 1995.  Forward-looking statements typically are identified by the use of terms such as "anticipate," "believe," "plan," "estimate," "expect," "project," "intend," "may," "will," "would," "contemplate," "possible," "attempt," "seek," "should," "could," "goal," "target," "on track," "comfortable with," "optimistic," "guidance," "outlook" and similar words, although some forward-looking statements are expressed differently.  You should consider statements that contain these words carefully because they describe our expectations, plans, strategies and goals and our beliefs concerning future business conditions, our results of operations, financial position, and our business outlook or they state other "forward-looking" information based on currently available information.  The "Risk Factors" in Item 1A provide examples of risks, uncertainties and events that could cause our actual results to differ materially from the expectations expressed in our forward-looking statements.  Assumptions and other important factors that could cause our actual results to differ materially from those anticipated in our forward-looking statements include, among other things:

• changes in or sustained low interest rates causing reductions in investment income, the margins of our fixed annuity and life insurance businesses, and sales of, and demand for, our products;

• expectations of lower future investment earnings may cause us to accelerate amortization, write down the balance of insurance acquisition costs or establish additional liabilities for insurance products;

• general economic, market and political conditions, including the performance of the financial markets which may affect the value of our investments as well as our ability to raise capital or refinance existing indebtedness and the cost of doing so;

• the ultimate outcome of lawsuits filed against us and other legal and regulatory proceedings to which we are subject;

• our ability to make anticipated changes to certain non-guaranteed elements of our life insurance products;

• our ability to obtain adequate and timely rate increases on our health products, including our long-term care business;

• the receipt of any required regulatory approvals for dividend and surplus debenture interest payments from our insurance subsidiaries;

• mortality, morbidity, the increased cost and usage of health care services, persistency, the adequacy of our previous reserve estimates and other factors which may affect the profitability of our insurance products;

• changes in our assumptions related to deferred acquisition costs or the present value of future profits;

• the recoverability of our deferred tax assets and the effect of potential ownership changes and tax rate changes on their value;

• our assumption that the positions we take on our tax return filings will not be successfully challenged by the IRS;

• changes in accounting principles and the interpretation thereof;

• our ability to continue to satisfy the financial ratio and balance requirements and other covenants of our debt agreements;

46

• our ability to achieve anticipated expense reductions and levels of operational efficiencies including improvements in claims adjudication and continued automation and rationalization of operating systems;

• performance and valuation of our investments, including the impact of realized losses (including other-than-temporary impairment charges);

• our ability to identify products and markets in which we can compete effectively against competitors with greater market share, higher ratings, greater financial resources and stronger brand recognition;

• our ability to generate sufficient liquidity to meet our debt service obligations and other cash needs;

• our ability to maintain effective controls over financial reporting;

• our ability to continue to recruit and retain productive agents and distribution partners;

• customer response to new products, distribution channels and marketing initiatives;

• our ability to achieve additional upgrades of the financial strength ratings of CNO and our insurance company subsidiaries as well as the impact of our ratings on our business, our ability to access capital, and the cost of capital;

• regulatory changes or actions, including those relating to regulation of the financial affairs of our insurance companies, such as the payment of dividends and surplus debenture interest to us, regulation of the sale, underwriting and pricing of products, and health care regulation affecting health insurance products;

• changes in the Federal income tax laws and regulations which may affect or eliminate the relative tax advantages of some of our products or affect the value of our deferred tax assets;

• availability and effectiveness of reinsurance arrangements, as well as any defaults or failure of reinsurers to perform;

• the performance of third party service providers and potential difficulties arising from outsourcing arrangements;

• the growth rate of sales, collected premiums, annuity deposits and assets;

• interruption in telecommunication, information technology or other operational systems or failure to maintain the security, confidentiality or privacy of sensitive data on such systems;

• events of terrorism, cyber attacks, natural disasters or other catastrophic events, including losses from a disease pandemic;

• ineffectiveness of risk management policies and procedures in identifying, monitoring and managing risks; and

• the risk factors or uncertainties listed from time to time in our filings with the SEC.

Other factors and assumptions not identified above are also relevant to the forward-looking statements, and if they prove incorrect, could also cause actual results to differ materially from those projected.

All written or oral forward-looking statements attributable to us are expressly qualified in their entirety by the foregoing cautionary statement.  Our forward-looking statements speak only as of the date made.  We assume no obligation to update or to publicly announce the results of any revisions to any of the forward-looking statements to reflect actual results, future events or developments, changes in assumptions or changes in other factors affecting the forward-looking statements.

The reporting of RBC measures is not intended for the purpose of ranking any insurance company or for use in connection with any marketing, advertising or promotional activities.

OVERVIEW

We are a holding company for a group of insurance companies operating throughout the United States that develop, market and administer health insurance, annuity, individual life insurance and other insurance products.  We focus on serving the senior and middle-income markets, which we believe are attractive, underserved, high growth markets.  We sell our

47

products through three distribution channels: career agents, independent producers (some of whom sell one or more of our product lines exclusively) and direct marketing. In periods prior to 2014, we had an Other CNO Business segment comprised of the long-term care business that was ceded effective December 31, 2013 and the overhead expense of CLIC that was expected to continue after the completion of the sale. Beginning on January 1, 2014: (i) the overhead expense of CLIC that was expected to continue after the completion of the sale was reallocated primarily to the Bankers Life and Washington National segments; and (ii) there was no longer an Other CNO Business segment.

We measure segment performance by excluding the net loss on the sale of CLIC and gain (loss) on reinsurance transactions, the earnings of CLIC prior to being sold on July 1, 2014, net realized investment gains (losses), fair value changes in embedded derivative liabilities (net of related amortization), fair value changes in the agent deferred compensation plan, loss on extinguishment or modification of debt, income taxes and other non-operating items consisting primarily of equity in earnings of certain non-strategic investments and earnings attributable to variable interest entities ("VIEs") ("pre-tax operating earnings") because we believe that this performance measure is a better indicator of the ongoing business and trends in our business.  Our primary investment focus is on investment income to support our liabilities for insurance products as opposed to the generation of net realized investment gains (losses), and a long-term focus is necessary to maintain profitability over the life of the business.

The net loss on the sale of CLIC, gain (loss) on reinsurance transactions, the earnings of CLIC prior to being sold, net realized investment gains (losses), fair value changes in embedded derivative liabilities (net of related amortization), fair value changes in the agent deferred compensation plan, loss on extinguishment or modification of debt and other non-operating items consisting primarily of equity in earnings of certain non-strategic investments and earnings attributable to VIEs depend on market conditions or represent unusual items that do not necessarily relate to the underlying business of our segments.  Net realized investment gains (losses) and fair value changes in embedded derivative liabilities (net of related amortization) may affect future earnings levels since our underlying business is long-term in nature and changes in our investment portfolio may impact our ability to earn the assumed interest rates needed to maintain the profitability of our business.

The Company’s insurance segments are described below:

• Bankers Life,which markets and distributes Medicare supplement insurance, interest-sensitive life insurance, traditional life insurance, fixed annuities and long-term care insurance products to the middle-income senior market through a dedicated field force of career agents, financial and investment advisors, and sales managers supported by a network of community-based sales offices.  The Bankers Life segment includes primarily the business of Bankers Life and Casualty Company.  Bankers Life also has various distribution and marketing agreements with other insurance companies to use Bankers Life's career agents to distribute Medicare Advantage and PDP products in exchange for a fee.

• Washington National, which markets and distributes supplemental health (including specified disease, accident and hospital indemnity insurance products) and life insurance to middle-income consumers at home and at the worksite.  These products are marketed through PMA and through independent marketing organizations and insurance agencies including worksite marketing.  The products being marketed are underwritten by Washington National. This segment's business also includes certain closed blocks of annuities and Medicare supplement policies which are no longer being actively marketed by this segment and were primarily issued or acquired by Washington National.

• Colonial Penn, which markets primarily graded benefit and simplified issue life insurance directly to customers in the senior middle-income market through television advertising, direct mail, the internet and telemarketing.  The Colonial Penn segment includes primarily the business of Colonial Penn.

48

The following summarizes our earnings for the three years ending December 31, 2015 (dollars in millions, except per share data):

	2015			2014			2013
EBIT (a non-GAAP financial measure) (a)
Bankers Life	$	369.6		$	386.9		$	310.5
Washington National	111.5			111.2			140.6
Colonial Penn	5.6			.8			(12.5		)
Other CNO Business:
Losses from the long-term care business reinsured effective December 31, 2013	—			—			(8.0		)
Overhead expense of CLIC allocated to other segments effective January 1, 2014	—			—			(19.6		)
EBIT from business segments continuing after the CLIC sale	486.7			498.9			411.0
Corporate operations, excluding corporate interest expense	(18.9		)	(27.6		)	2.8
EBIT from operations continuing after the CLIC sale	467.8			471.3			413.8
Corporate interest expense	(45.0		)	(43.9		)	(51.3		)
Operating earnings before taxes	422.8			427.4			362.5
Tax expense on operating income	148.1			150.5			124.3
Net operating income (a)	274.7			276.9			238.2
Earnings of CLIC prior to being sold (net of taxes)	—			15.2			25.5
Net loss on sale of CLIC and gain (loss) on reinsurance transactions (including impact of taxes) (b)	—			(269.7		)	(63.3		)
Net realized investment gains (losses) (net of related amortization and taxes)	(30.8		)	21.4			16.8
Fair value changes in embedded derivative liabilities (net of related amortization and taxes)	7.7			(23.4		)	23.0
Fair value changes related to agent deferred compensation plan (net of taxes)	9.8			(17.4		)	10.2
Loss on extinguishment or modification of debt (net of taxes)	(21.3		)	(.4		)	(64.0		)
Valuation allowance for deferred tax assets and other tax items (b)	32.5			54.9			301.5
Other	(1.9		)	(6.1		)	(9.9		)
Net income	$	270.7		$	51.4		$	478.0
Per diluted share:
Net operating income	$	1.41		$	1.27		$	1.03
Earnings of CLIC prior to being sold (net of taxes)	—			.07			.11
Net loss on sale of CLIC and gain (loss) on reinsurance transactions (including impact of taxes) (b)	—			(1.24		)	(.27		)
Net realized investment gains (losses) (net of related amortization and taxes)	(.16		)	.10			.08
Fair value changes in embedded derivative liabilities (net of related amortization and taxes)	.04			(.11		)	.10
Fair value changes related to agent deferred compensation plan (net of taxes)	.05			(.08		)	.04
Loss on extinguishment or modification of debt (net of taxes)	(.11		)	—			(.28		)
Valuation allowance for deferred tax assets and other tax items (b)	.17			.25			1.29
Other	(.01		)	(.02		)	(.04		)
Net income	$	1.39		$	.24		$	2.06

49

____________

(a) Management believes that an analysis of net operating income provides a clearer comparison of the operating results of the Company from period to period because it excludes:  (i) the net loss on the sale of CLIC and gain (loss) on reinsurance transactions, including impact of taxes; (ii) the earnings of CLIC prior to being sold on July 1, 2014, net of taxes; (iii) net realized investment gains or losses, net of related amortization and taxes; (iv) fair value changes due to fluctuations in the interest rates used to discount embedded derivative liabilities related to our fixed index annuities, net of related amortization and taxes; (v) fair value changes related to the agent deferred compensation plan, net of taxes; (vi) loss on extinguishment or modification of debt, net of taxes; (vii) changes in the valuation allowance for deferred tax assets; and (viii) other non-operating items consisting primarily of equity in earnings of certain non-strategic investments and earnings attributable to variable interest entities. Net realized investment gains or losses include: (i) gains or losses on the sales of investments; (ii) other-than-temporary impairments recognized through net income; and (iii) changes in fair value of certain fixed maturity investments with embedded derivatives.  EBIT is presented as net operating income excluding corporate interest expense and income tax expense. The table above reconciles the non-GAAP measure to the corresponding GAAP measure.

In addition, management uses these non-GAAP financial measures in its budgeting process, financial analysis of segment performance and in assessing the allocation of resources. We believe these non-GAAP financial measures enhance an investor’s understanding of our financial performance and allows them to make more informed judgments about the Company as a whole. These measures also highlight operating trends that might not otherwise be transparent. However, EBIT and net operating income are not measurements of financial performance under GAAP and should not be considered as alternatives to cash flow from operating activities, as measures of liquidity, or as alternatives to net income as measures of our operating performance or any other measures of performance derived in accordance with GAAP. In addition, EBIT and net operating income should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items. EBIT and net operating income have limitations as analytical tools, and you should not consider such measures either in isolation or as substitutes for analyzing our results as reported under GAAP. Our definitions and calculation of EBIT and net operating income are not necessarily comparable to other similarly titled measures used by other companies due to different methods of calculation.

(b) Increase in valuation allowance of $19.4 million in 2014, related to the expected change in future taxable income following the sale of CLIC, is included in the "net loss on sale of CLIC and gain (loss) on reinsurance transactions (including impact of taxes)".

Our mission is to be the recognized market leader in providing financial security for the protection and retirement needs of middle-income American working families and retirees. Our strategic plans are focused on continuing to grow and deliver long-term value for all our stakeholders. Specifically, we will focus on the following priorities:

Growth

•Focus on initiatives that drive sales including lead programs, new products, agent recruitment and retention

• Expand offering middle-market consumers a range of investment and planning solutions

• Exploring non-organic growth opportunities that are focused on the middle market, fill product gaps, expand our distribution and geographic footprint and/or enhance agent recruiting

Increase profitability and return on equity

•Maintain our strong capital position and favorable financial metrics

•Continue to increase our return on equity

Effectively manage risk and deploy capital

•Active enterprise risk management process

•Continue to cost effectively repurchase our common stock

•Maintain a competitive dividend payout ratio

Further enhance the customer experience and agent productivity

•Completion and implementation of new tools to be used by our distribution force

• Further development of capabilities for generating and acting on prospect/customer data insights making it easier to sell and deliver service

50

Reduce long-term care exposure by approximately one-half over the next three to six years

•Drive growth of other lines of business

•Evaluate reinsurance and/or other potential solutions

Continue to invest in talent

•Expanded leadership development programs

•Emphasis on skills and experiences that are aligned with our priorities

CRITICAL ACCOUNTING POLICIES

The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management has made estimates in the past that we believed to be appropriate but were subsequently revised to reflect actual experience. If our future experience differs materially from these estimates and assumptions, our results of operations and financial condition could be materially affected.

We base our estimates on historical experience and other assumptions that we believe are reasonable under the circumstances. We continually evaluate the information used to make these estimates as our business and the economic environment change. The use of estimates is pervasive throughout our financial statements. The accounting policies and estimates we consider most critical are summarized below. Additional information on our accounting policies is included in the note to our consolidated financial statements entitled "Summary of Significant Accounting Policies".

Investments

At December 31, 2015, the carrying value of our investment portfolio was $24.5 billion.

Interest income on fixed maturity securities is recognized when earned using a constant effective yield method giving effect to amortization of premiums and accretion of discounts. Prepayment fees are recognized when earned. Dividends on equity securities are recognized when declared.

Our evaluation of investments for impairment requires significant judgments, including: (i) the identification of potentially impaired securities; (ii) the determination of their estimated fair value; and (iii) the assessment of whether any decline in estimated fair value is other than temporary.

We regularly evaluate all of our investments with unrealized losses for possible impairment.  Our assessment of whether unrealized losses are "other than temporary" requires significant judgment.  Factors considered include:  (i) the extent to which fair value is less than the cost basis; (ii) the length of time that the fair value has been less than cost; (iii) whether the unrealized loss is event driven, credit-driven or a result of changes in market interest rates or risk premium; (iv) the near-term prospects for specific events, developments or circumstances likely to affect the value of the investment; (v) the investment's rating and whether the investment is investment-grade and/or has been downgraded since its purchase; (vi) whether the issuer is current on all payments in accordance with the contractual terms of the investment and is expected to meet all of its obligations under the terms of the investment; (vii) whether we intend to sell the investment or it is more likely than not that circumstances will require us to sell the investment before recovery occurs; (viii) the underlying current and prospective asset and enterprise values of the issuer and the extent to which the recoverability of the carrying value of our investment may be affected by changes in such values; (ix) projections of, and unfavorable changes in, cash flows on structured securities including mortgage-backed and asset-backed securities; (x) our best estimate of the value of any collateral; and (xi) other objective and subjective factors.

Future events may occur, or additional information may become available, which may necessitate future realized losses in our portfolio.  Significant losses could have a material adverse effect on our consolidated financial statements in future periods.

Impairment losses on equity securities are recognized in net income.  The manner in which impairment losses on fixed maturity securities, available for sale, are recognized in the financial statements is dependent on the facts and circumstances related to the specific security.  If we intend to sell a security or it is more likely than not that we would be required to sell a security before the recovery of its amortized cost, the security is other-than-temporarily impaired and the full amount of the impairment is recognized as a loss through earnings.  If we do not expect to recover the amortized cost basis, we do not plan to sell the security, and if it is not more likely than not that we would be required to sell a security before the recovery of its

51

amortized cost, less any current period credit loss, the recognition of the other-than-temporary impairment is bifurcated.  We recognize the credit loss portion in net income and the noncredit loss portion in accumulated other comprehensive income.

We estimate the amount of the credit loss component of a fixed maturity security impairment as the difference between amortized cost and the present value of the expected cash flows of the security.  The present value is determined using the best estimate of future cash flows discounted at the effective interest rate implicit to the security at the date of purchase or the current yield to accrete an asset-backed or floating rate security.  The methodology and assumptions for establishing the best estimate of future cash flows vary depending on the type of security.

For most structured securities, cash flow estimates are based on bond specific facts and circumstances that may include collateral characteristics, expectations of delinquency and default rates, loss severity, prepayment speeds and structural support, including excess spread, subordination and guarantees.  For corporate bonds, cash flow estimates are derived from scenario-based outcomes of expected corporate restructurings or the disposition of assets using bond specific facts and circumstances. The previous amortized cost basis less the impairment recognized in net income becomes the security's new cost basis.  We accrete the new cost basis to the estimated future cash flows over the expected remaining life of the security, except when the security is in default or considered nonperforming.

The remaining noncredit impairment, which is recorded in accumulated other comprehensive income, is the difference between the security's estimated fair value and our best estimate of future cash flows discounted at the effective interest rate prior to impairment.  The remaining noncredit impairment typically represents changes in the market interest rates, current market liquidity and risk premiums.  As of December 31, 2015, other-than-temporary impairments included in accumulated other comprehensive income totaled $4.9 million (before taxes and related amortization).

Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date and, therefore, represents an exit price, not an entry price.  We carry certain assets and liabilities at fair value on a recurring basis, including fixed maturities, equity securities, trading securities, investments held by VIEs, derivatives, cash and cash equivalents, separate account assets and embedded derivatives.  We carry our Company-owned life insurance policy ("COLI"), which is invested in a series of mutual funds, at its cash surrender value which approximates fair value. In addition, we disclose fair value for certain financial instruments, including mortgage loans and policy loans, insurance liabilities for interest-sensitive products, investment borrowings, notes payable and borrowings related to VIEs.

The degree of judgment utilized in measuring the fair value of financial instruments is largely dependent on the level to which pricing is based on observable inputs.  Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our view of market assumptions in the absence of observable market information.  Financial instruments with readily available active quoted prices would be considered to have fair values based on the highest level of observable inputs, and little judgment would be utilized in measuring fair value.  Financial instruments that rarely trade would often have fair value based on a lower level of observable inputs, and more judgment would be utilized in measuring fair value.

Valuation Hierarchy

There is a three-level hierarchy for valuing assets or liabilities at fair value based on whether inputs are observable or unobservable.

• Level 1 – includes assets and liabilities valued using inputs that are unadjusted quoted prices in active markets for identical assets or liabilities.  Our Level 1 assets primarily include cash and exchange traded securities.

• Level 2 – includes assets and liabilities valued using inputs that are quoted prices for similar assets in an active market, quoted prices for identical or similar assets in a market that is not active, observable inputs, or observable inputs that can be corroborated by market data.  Level 2 assets and liabilities include those financial instruments that are valued by independent pricing services using models or other valuation methodologies.  These models consider various inputs such as credit rating, maturity, corporate credit spreads, reported trades and other inputs that are observable or derived from observable information in the marketplace or are supported by transactions executed in the marketplace.  Financial assets in this category primarily include:  certain publicly registered and privately placed corporate fixed maturity securities; certain government or agency securities; certain mortgage and asset-backed securities; certain equity securities; most investments held by our consolidated VIEs; certain mutual fund and hedge fund investments; most short-term investments; and non-exchange-traded derivatives such as call options. Financial liabilities in this category include investment borrowings, notes payable and borrowings related to VIEs.

52

• Level 3 – includes assets and liabilities valued using unobservable inputs that are used in model-based valuations that contain management assumptions.  Level 3 assets and liabilities include those financial instruments whose fair value is estimated based on broker/dealer quotes, pricing services or internally developed models or methodologies utilizing significant inputs not based on, or corroborated by, readily available market information.  Financial assets in this category include certain corporate securities (primarily certain below-investment grade privately placed securities), certain structured securities, mortgage loans, and other less liquid securities.  Financial liabilities in this category include our insurance liabilities for interest-sensitive products, which includes embedded derivatives (including embedded derivatives related to our fixed index annuity products and to a modified coinsurance arrangement) since their values include significant unobservable inputs including actuarial assumptions.

At each reporting date, we classify assets and liabilities into the three input levels based on the lowest level of input that is significant to the measurement of fair value for each asset and liability reported at fair value.  This classification is impacted by a number of factors, including the type of financial instrument, whether the financial instrument is new to the market and not yet established, the characteristics specific to the transaction and overall market conditions.  Our assessment of the significance of a particular input to the fair value measurement and the ultimate classification of each asset and liability requires judgment and is subject to change from period to period based on the observability of the valuation inputs.

Below-investment grade corporate debt securities typically have different characteristics than investment grade corporate debt securities.  Based on historical performance, probability of default by the borrower is significantly greater for below-investment grade corporate debt securities and in many cases severity of loss is relatively greater as such securities are generally unsecured and often subordinated to other indebtedness of the issuer.  Also, issuers of below-investment grade corporate debt securities frequently have higher levels of debt relative to investment-grade issuers, hence, all other things being equal, are generally more sensitive to adverse economic conditions.  The Company attempts to reduce the overall risk related to its investment in below-investment grade securities, as in all investments, through careful credit analysis, strict investment policy guidelines, and diversification by issuer and/or guarantor and by industry.

Our fixed maturity investments are generally purchased in the context of long-term strategies, including funding insurance liabilities, so we do not generally seek to generate short-term realized gains through the purchase and sale of such securities.  In certain circumstances, including those in which securities are selling at prices which exceed our view of their underlying economic value, or when it is possible to reinvest the proceeds to better meet our long-term asset-liability objectives, we may sell certain securities. During 2015, we sold $724.4 million of fixed maturity investments which resulted in gross investment losses (before income taxes) of $88.4 million.

We actively manage the relationship between the duration and cash flows of our invested assets and the estimated duration and cash flows of benefit payments arising from contract liabilities. These efforts may cause us to sell investments before their maturity date and could result in the realization of net realized investment gains (losses). When the estimated durations of assets and liabilities are similar, exposure to interest rate risk is minimized because a change in the value of assets should be largely offset by a change in the value of liabilities. In certain circumstances, a mismatch of the durations or related cash flows of invested assets and insurance liabilities could have a significant impact on our results of operations and financial position.

For more information on our investment portfolio and our critical accounting policies related to investments, see the note to our consolidated financial statements entitled "Investments".

Present Value of Future Profits and Deferred Acquisition Costs

In conjunction with the implementation of fresh start accounting, we eliminated the historical balances of our Predecessor's deferred acquisition costs and the present value of future profits and replaced them with the present value of future profits as calculated on the Effective Date.

The value assigned to the right to receive future cash flows from contracts existing at the Effective Date is referred to as the present value of future profits. The balance of this account is amortized, evaluated for recovery, and adjusted for the impact of unrealized gains (losses) in the same manner as the deferred acquisition costs described below. We expect to amortize the balance of the present value of future profits as of December 31, 2015 as follows: 11 percent in 2016, 10 percent in 2017, 9 percent in 2018, 8 percent in 2019 and 7 percent in 2020.

53

Deferred acquisition costs represent incremental direct costs related to the successful acquisition of new or renewal insurance contracts. For interest-sensitive life or annuity products, we amortize these costs in relation to the estimated gross profits using the interest rate credited to the underlying policies. For other products, we generally amortize these costs in relation to future anticipated premium revenue using the projected investment earnings rate.

Insurance acquisition costs are amortized to expense over the lives of the underlying policies in relation to future anticipated premiums or gross profits. The insurance acquisition costs for policies other than interest-sensitive life and annuity products are amortized with interest (using the projected investment earnings rate) over the estimated premium-paying period of the policies, in a manner which recognizes amortization expense in proportion to each year's premium income. The insurance acquisition costs for interest-sensitive life and annuity products are amortized with interest (using the interest rate credited to the underlying policy) in proportion to estimated gross profits. The interest, mortality, morbidity and persistency assumptions used to amortize insurance acquisition costs are consistent with those assumptions used to estimate liabilities for insurance products. For interest-sensitive life and annuity products, these assumptions are reviewed on a regular basis. When actual profits or our current best estimates of future profits are different from previous estimates, we adjust cumulative amortization of insurance acquisition costs to maintain amortization expense as a constant percentage of gross profits over the entire life of the policies.

When we realize a gain or loss on investments backing our interest-sensitive life or annuity products, we adjust the amortization of insurance acquisition costs to reflect the change in estimated gross profits from the products due to the gain or loss realized and the effect on future investment yields. We increased (decreased) amortization expense for such changes by $(.5) million, $1.0 million and $1.6 million during the years ended December 31, 2015, 2014 and 2013, respectively. We also adjust insurance acquisition costs for the change in amortization that would have been recorded if fixed maturity securities, available for sale, had been sold at their stated aggregate fair value and the proceeds reinvested at current yields. Such adjustments are commonly referred to as "shadow adjustments" and may include adjustments to: (i) deferred acquisition costs; (ii) the present value of future profits; (iii) loss recognition reserves; and (iv) income taxes. We include the impact of this adjustment in accumulated other comprehensive income (loss) within shareholders' equity. The total pre-tax impact of such adjustments on accumulated other comprehensive income was a decrease of $269.1 million at December 31, 2015 (including $157.1 million for premium deficiencies that would exist on certain blocks of business (primarily long-term care products) if unrealized gains on the assets backing such products had been realized and the proceeds from our sales of such assets were invested at then current yields.) The total pre-tax impact of such adjustments on accumulated other comprehensive income at December 31, 2014 was a decrease of $921.8 million (including $652.4 million for premium deficiencies that would exist on certain blocks of business (primarily long-term care products) if unrealized gains on the assets backing such products had been realized and the proceeds from our sales of such assets were invested at then current yields.)

At December 31, 2015, the balance of insurance acquisition costs was $1.8 billion prior to shadow adjustments. The recoverability of this amount is dependent on the future profitability of the related business. Each year, we evaluate the recoverability of the unamortized balance of insurance acquisition costs. These evaluations are performed to determine whether estimates of the present value of future cash flows, in combination with the related liability for insurance products, will support the unamortized balance. These future cash flows are based on our best estimate of future premium income, less benefits and expenses. The present value of these cash flows, plus the related balance of liabilities for insurance products, is then compared with the unamortized balance of insurance acquisition costs. In the event of a deficiency, such amount would be charged to amortization expense. If the deficiency exceeds the balance of insurance acquisition costs, a premium deficiency reserve is established for the excess. The determination of future cash flows involves significant judgment. Revisions to the assumptions which determine such cash flows could have a significant adverse effect on our results of operations and financial position. While we expect the long-term care business in the Bankers Life segment to generate future profits, the margins are relatively thin and are vulnerable to changes in assumptions. In 2014, we were required to establish a $9 million deficiency reserve for the life contingent payout annuities in the Washington National segment. Accordingly, these annuities are not expected to generate future profits and future unfavorable changes to our assumptions will reduce earnings in the period such changes occur.

The table presented below summarizes our estimates of cumulative adjustments to insurance acquisition costs or premium deficiency reserves (when the deficiency exceeds the balance of insurance acquisition costs) resulting from hypothetical revisions to certain assumptions. Although such hypothetical revisions are not currently required or anticipated, we believe they could occur based on past variances in experience and our expectations of the ranges of future experience that could reasonably occur. We have assumed that revisions to assumptions resulting in the adjustments summarized below would occur equally among policy types, ages and durations within each product classification. Any actual adjustment would be dependent on the specific policies affected and, therefore, may differ from the estimates summarized below. In addition, the impact of actual adjustments would reflect the net effect of all changes in assumptions during the period.

54

Change in assumptions	Estimated adjustment to income before income taxes based on revisions to certain assumptions
	(dollars in millions)
Interest-sensitive life products:
5% increase to assumed mortality	$	(15	)
5% decrease to assumed mortality	15
15% increase to assumed expenses	(5		)
15% decrease to assumed expenses	5
10 basis point decrease to assumed spread	(5		)
10 basis point increase to assumed spread	5
10% increase to assumed lapses	(1		)
10% decrease to assumed lapses	1
Fixed index and fixed interest annuity products:
20% increase to assumed surrenders	(55		)
20% decrease to assumed surrenders	70
15% increase to assumed expenses	(5		)
15% decrease to assumed expenses	5
10 basis point decrease to assumed spread	(30		)
10 basis point increase to assumed spread	30
Other than interest-sensitive life and annuity products (a):
5% increase to assumed morbidity	(125		)
50 basis point decrease to investment earnings rate	(85		)
5% decrease to assumed mortality	(5		)

__________________

(a) We have excluded the effect of reasonably likely changes in lapse, surrender and expense assumptions for policies other than interest-sensitive life and annuity products.

The following summarizes the persistency of our major blocks of insurance business summarized by segment and line of business:

	Years ended December 31,
	2015		2014		2013
Bankers Life:
Medicare supplement (1)	86.3	%	82.8	%	82.3	%
Long-term care (1)	90.4	%	91.1	%	90.9	%
Fixed index annuities (2)	91.2	%	90.8	%	90.8	%
Other annuities (2)	85.1	%	85.2	%	86.6	%
Life (1)	87.3	%	87.3	%	87.2	%
Washington National:
Medicare supplement (1)	83.7	%	84.2	%	82.4	%
Supplemental health (1)	89.0	%	88.4	%	87.2	%
Life (1)	91.8	%	92.5	%	90.9	%
Colonial Penn:
Life (1)	82.6	%	83.2	%	83.8	%

_____________________

(1) Based on number of inforce policies.

(2) Based on the percentage of the inforce block persisting.

55

Liabilities for Insurance Products - reserves for the future payment of long-term care policy claims

We calculate and maintain reserves for the future payment of claims to our policyholders based on actuarial assumptions.  For all our insurance products, we establish an active life reserve, a liability for due and unpaid claims, claims in the course of settlement and incurred but not reported claims.  In addition, for our health insurance business, we establish a reserve for the present value of amounts not yet due on claims.  Many factors can affect these reserves and liabilities, such as economic and social conditions, inflation, hospital and pharmaceutical costs, changes in doctrines of legal liability and extra-contractual damage awards.  Therefore, our reserves and liabilities are necessarily based on numerous estimates and assumptions as well as historical experience.  Establishing reserves is an uncertain process, and it is possible that actual claims will materially exceed our reserves and have a material adverse effect on our results of operations and financial condition.  For example, our long-term care policy claims may be paid over a long period of time and, therefore, loss estimates have a higher degree of uncertainty.  

The following summarizes the components of the reserves related to our long-term care business in our Bankers Life segment as well as the long-term care reserves ceded to BRe as of December 31, 2015 and 2014 (dollars in millions):

	2015		2014
Amounts classified as future policy benefits:
Active life reserves	$	3,707.8	$	3,634.5
Reserves for the present value of amounts not yet due on claims	1,306.1		1,279.7
Future loss reserves	158.3		120.1
Premium deficiency reserves assuming net unrealized gains had been realized	—		350.9
Amounts classified as liability for policy and contract claims:
Liability for due and unpaid claims, claims in the course of settlement and incurred but not reported claims	194.1		185.1
Total	5,366.3		5,570.3
Reinsurance receivables	491.0		490.1
Long-term care reserves, net of reinsurance receivables	$	4,875.3	$	5,080.2

The significant assumptions used to calculate the active life reserves include morbidity, persistency and investment yields. These assumptions are determined at the issuance date and do not change over the life of the policy.

The significant assumptions used to calculate the reserves for the present value of amounts not yet due on claims include future benefit payments, interest rates and claim continuance patterns. Interest rates are used to determine the present value of the future benefit payments and are based on the investment yield of assets supporting the reserves. Claim continuance assumptions are estimates of the expected period of time that claim payments will continue before termination due to recovery, death or attainment of policy maximum benefits. These estimates are based on historical claim experience for similar policy and coverage types. Our estimates of benefit payments, interest rates and claim continuance are reviewed regularly and updated to consider current portfolio investment yields and recent claims experience.

In December 2013, two of our insurance subsidiaries with long-term care business in our former Other CNO Business segment entered into 100% coinsurance agreements ceding $495 million of long-term care reserves to BRe. Pursuant to the agreements, the Company paid an additional premium of $96.9 million to BRe and an amount equal to the related net liabilities. We recognized a premium deficiency reserve of $96.9 million at December 31, 2013. Such deficiency reserve was no longer required when the additional premium was paid to BRe in conjunction with its assumption of the liabilities related to this block.

With respect to the long-term care block in our Bankers Life segment, the aggregate liability is not deficient, but our projections of estimated future profits (losses) indicate that profits will be recognized in earlier periods, followed by losses in later periods. In this situation, we are required to recognize future loss reserves. Such reserves are calculated based on our current estimate of the amount necessary to offset the losses in future periods and are established during the period the block is profitable. We estimate the future losses based on our current best estimates of morbidity, persistency, premium rates, maintenance expense and investment yields, which estimates are generally updated annually. During 2015, we increased the future loss reserves related to our long-term care blocks of business by $38.2 million based on these calculations.

56

The significant assumptions used to calculate the liability for due and unpaid claims, claims in the course of settlement and incurred but not reported claims are based on historical claim payment patterns and include assumptions related to the number of claims and the size and timing of claim payments. These assumptions are updated quarterly to reflect the most current information regarding claim payment patterns. In order to determine the accuracy of our prior estimates, we calculate the total redundancy (deficiency) of our prior claim reserve estimates. The 2014 claim reserve redundancy for long-term care claim reserves in our Bankers Life segment, as measured at December 31, 2015, was $16.2 million.

Estimates of unpaid losses related to long-term care business have a higher degree of uncertainty than estimates for our other products due to the range of ultimate duration of these claims and the resulting variability in their cost (in addition to the variations in the lag time in reporting claims).  As an example, an increase in the loss ratio of 5 percentage points for claims incurred in 2015 related to our long-term care business in our Bankers Life segment would have resulted in an immediate decrease in our earnings of approximately $25 million.Our financial results depend significantly upon the extent to which our actual claims experience is consistent with the assumptions we used in determining our reserves and pricing our products.  If our assumptions with respect to future claims are incorrect, and our reserves are insufficient to cover our actual losses and expenses, we would be required to increase our liabilities, which would negatively affect our operating results.

Accounting for certain marketing agreements

Bankers Life has entered into various distribution and marketing agreements with other insurance companies to use Bankers Life's career agents to distribute prescription drug and Medicare Advantage plans. These agreements allow Bankers Life to offer these products to current and potential future policyholders without investment in management and infrastructure. We receive fee income related to the plans sold through our distribution channels.

We account for these distribution agreements as follows:

• We recognize fee income based on either: (i) a fixed fee per contract sold; or (ii) a percentage of premiums collected. This fee income is recognized over the calendar year term of the contract.

• We also pay commissions to our agents who sell the plans. These payments are deferred and amortized over the term of the contract.

The following summarizes the fee revenue, net of distribution expenses, earned through these marketing agreements (dollars in millions):

	2015		2014		2013
Fee revenue:
Medicare Advantage contracts	$	23.1	$	22.4	$	16.1
PDP contracts	3.2		3.0		2.3
Total revenue	26.3		25.4		18.4
Distribution expenses	9.4		10.4		7.1
Fee revenue, net of distribution expenses	$	16.9	$	15.0	$	11.3

Income Taxes

Our income tax expense includes deferred income taxes arising from temporary differences between the financial reporting and tax bases of assets and liabilities, capital loss carryforwards and NOLs. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply in the years in which temporary differences are expected to be recovered or paid.  The effect of a change in tax rates on deferred tax assets and liabilities is recognized in earnings in the period when the changes are enacted.

A reduction of the net carrying amount of deferred tax assets by establishing a valuation allowance is required if, based on the available evidence, it is more likely than not that such assets will not be realized. In assessing the need for a valuation allowance, all available evidence, both positive and negative, shall be considered to determine whether, based on the weight of that evidence, a valuation allowance for deferred tax assets is needed. This assessment requires significant judgment and considers, among other matters, the nature, frequency and severity of current and cumulative losses, forecasts of future profitability, the duration of carryforward periods, our experience with operating loss and tax credit carryforwards expiring

57

unused, and tax planning strategies. We evaluate the need to establish a valuation allowance for our deferred tax assets on an ongoing basis. The realization of our deferred tax assets depends upon generating sufficient future taxable income of the appropriate type during the periods in which our temporary differences become deductible and before our capital loss carryforwards and life and non-life NOLs expire.

Based on our assessment, it appears more likely than not that $946.6 million of our total deferred tax assets of $1,160.1 million will be realized through future taxable earnings. Accordingly, we have established a deferred tax valuation allowance of $213.5 million at December 31, 2015. We will continue to assess the need for a valuation allowance in the future. If future results are less than projected, an increase to the valuation allowance may be required to reduce the deferred tax asset, which could have a material impact on our results of operations in the period in which it is recorded.

We use a deferred tax valuation model to assess the need for a valuation allowance. Our model is adjusted to reflect changes in our projections of future taxable income including changes resulting from investment trading strategies, reinsurance transactions and the impact of the sale of CLIC. Our estimates of future taxable income are based on evidence we consider to be objective and verifiable.

At December 31, 2015, our projection of future taxable income for purposes of determining the valuation allowance is based on our adjusted average annual taxable income which is assumed to remain flat for two years and then increase by 3 percent for the next five years, and level taxable income is assumed thereafter. In the projections used for our analysis, our adjusted average taxable income is based on the level of recent normalized taxable income, which was approximately $345 million ($75 million of which relates to non-life taxable income and $270 million relates to life taxable income).

Based on our assessment, we recognized a reduction to the allowance for deferred tax assets of $32.5 million in 2015. We have evaluated the recovery of our deferred tax assets and assessed the effect of limitations and/or interpretations on their value and have concluded that it is more likely than not that the value recognized will be fully realized in the future.

Changes in our valuation allowance are summarized as follows (dollars in millions):

Balance, December 31, 2012	$	766.9
Decrease in 2013	(472.1		)	(a)
Balance, December 31, 2013	294.8
Decrease in 2014	(48.8		)	(b)
Balance, December 31, 2014	246.0
Decrease in 2015	(32.5		)	(c)
Balance, December 31, 2015	$	213.5

___________________

(a) The 2013 reduction to the deferred tax valuation allowance primarily resulted from the impact of higher levels of income on projected future taxable income, the expiration of capital loss carryforwards, a settlement with the IRS related to the classification of a portion of the cancellation of indebtedness income and the execution of certain investment trading strategies.

(b) The 2014 reduction to the deferred tax valuation allowance primarily resulted from tax examination adjustments and the tax gain on the sale of CLIC.

(c) The 2015 reduction to the deferred tax valuation allowance primarily resulted from higher actual and projected non-life income.

Recovery of our deferred tax asset is dependent on achieving the level of future taxable income projected in our deferred tax valuation model and failure to do so could result in an increase in the valuation allowance in a future period.  Any future increase in the valuation allowance may result in additional income tax expense and reduce shareholders' equity, and such an increase could have a significant impact upon our earnings in the future.

The Code limits the extent to which losses realized by a non-life entity (or entities) may offset income from a life insurance company (or companies) to the lesser of:  (i) 35 percent of the income of the life insurance company; or (ii) 35 percent of the total loss of the non-life entities (including NOLs of the non-life entities).  There is no similar limitation on the extent to which losses realized by a life insurance entity (or entities) may offset income from a non-life entity (or entities). This limitation is the primary reason a valuation allowance for NOL carryforwards is required.

58

Section 382 of the Code imposes limitations on a corporation's ability to use its NOLs when the company undergoes an ownership change.  Future transactions and the timing of such transactions could cause an ownership change for Section 382 income tax purposes.  Such transactions may include, but are not limited to, additional repurchases under our securities repurchase program, issuances of common stock and acquisitions or sales of shares of CNO stock by certain holders of our shares, including persons who have held, currently hold or may accumulate in the future five percent or more of our outstanding common stock for their own account.  Many of these transactions are beyond our control.  If an additional ownership change were to occur for purposes of Section 382, we would be required to calculate an annual restriction on the use of our NOLs to offset future taxable income.  The annual restriction would be calculated based upon the value of CNO's equity at the time of such ownership change, multiplied by a federal long-term tax exempt rate (2.61 percent at December 31, 2015), and the annual restriction could limit our ability to use a substantial portion of our NOLs to offset future taxable income.  We regularly monitor ownership change (as calculated for purposes of Section 382) and, as of December 31, 2015, we were below the 50 percent ownership change level that would trigger further impairment of our ability to utilize our NOLs.

As of December 31, 2015, we had $2.6 billion of federal NOLs. The following table summarizes the expiration dates of our loss carryforwards assuming the IRS ultimately agrees with the position we have taken with respect to the loss on our investment in Conseco Senior Health Insurance Company ("CSHI") and other uncertain tax positions (dollars in millions):

Year of expiration	Net operating loss carryforwards						Total loss
	Life			Non-life			carryforwards
2023	$	538.3		$	1,922.0		$	2,460.3
2025	—			91.5			91.5
2026	—			207.4			207.4
2027	—			4.9			4.9
2028	—			203.7			203.7
2029	—			146.6			146.6
2032	—			44.0			44.0
Subtotal	538.3			2,620.1			3,158.4
Less:
Unrecognized tax benefits	(342.9		)	(197.4		)	(540.3		)
Total	$	195.4		$	2,422.7		$	2,618.1

In addition, at December 31, 2015, we had $39.4 million of capital loss carryforwards that expire in 2020.

We had deferred tax assets related to NOLs for state income taxes of $14.1 million and $15.2 million at December 31, 2015 and 2014, respectively.  The related state NOLs are available to offset future state taxable income in certain states through 2025.

A reconciliation of the beginning and ending amount of unrecognized tax benefits for the years ended December 31, 2015 and 2014 is as follows (dollars in millions):

	Years ended December 31,
	2015		2014
Balance at beginning of year	$	228.7	$	226.7
Increase based on tax positions taken in prior years	5.5		10.9
Decrease based on tax positions taken in prior years	—		—
Increase based on tax positions taken in the current year	—		—
Decrease in unrecognized tax benefits related to settlements with taxing authorities	—		(8.9		)
Balance at end of year	$	234.2	$	228.7

59

As of both December 31, 2015 and 2014, $155.4 million of our unrecognized tax benefits, if recognized, would affect the effective tax rate. The remaining balances relate to timing differences which, if recognized, would have no effect on the Company's tax expense. The Company recognizes interest related to unrecognized tax benefits as income tax expense in the consolidated statement of operations. Such amounts were not significant in each of the three years ended December 31, 2015. The liability for accrued interest was $3.2 million and $2.4 million at December 31, 2015 and 2014, respectively.

We recognized an $878 million ordinary loss on our investment in CSHI which was worthless when it was transferred to an independent trust in 2008. Of this loss, $742 million has been reported as a life loss and $136 million as a non-life loss. The IRS has disagreed with our ordinary loss treatment and believes that it should be treated as a capital loss, subject to a five year carryover. If the IRS position is ultimately determined to be correct, $473 million would have expired unused in 2013. Due to this uncertainty, we have not recognized a tax benefit of $166.0 million. However, if this unrecognized tax benefit would have been recognized, we would also have established a valuation allowance of $34.0 million at December 31, 2015.

The IRS has completed the examination for 2004 and 2008 through 2010 and has proposed two adjustments to which we disagree, including the adjustment to classify the loss on our investment in CSHI as a capital loss as described above. The Company is contesting these adjustments through the IRS Appeals Office. Although the resolution of the Appeals could occur in the next 12 months, there is no reasonable basis to estimate the changes in unrecognized tax benefits that may occur. The IRS has also begun an examination of 2011 and 2012. In connection with this exam, we have agreed to extend the statute of limitations to September 10, 2017. The Company’s various state income tax returns are generally open for tax years beginning in 2012, based on individual state statutes of limitation. Generally, for tax years which generate NOLs, capital losses or tax credit carryforwards, the statute remains open until the expiration of the statute of limitations for the tax year in which such carryforwards are utilized. The outcome of tax audits cannot be predicted with certainty. If the Company’s tax audits are not resolved in a manner consistent with management’s expectations, the Company may be required to adjust its provision for income taxes.

Liabilities for Insurance Products

At December 31, 2015, the total balance of our liabilities for insurance products was $22.1 billion. These liabilities are generally payable over an extended period of time and the profitability of the related products is dependent on the pricing of the products and other factors. Differences between our expectations when we sold these products and our actual experience could result in future losses.

We calculate and maintain reserves for the future payment of claims to our policyholders based on actuarial assumptions. For our insurance products, we establish an active life reserve, a liability for due and unpaid claims, claims in the course of settlement and incurred but not reported claims. In addition, for our health insurance business, we establish a reserve for the present value of amounts not yet due on claims. Many factors can affect these reserves and liabilities, such as economic and social conditions, inflation, hospital and pharmaceutical costs, changes in doctrines of legal liability and extra-contractual damage awards. We establish liabilities for annuity and interest-sensitive life products equal to the accumulated policy account values, which include an accumulation of deposit payments plus credited interest, less withdrawals and the amounts assessed against the policyholder through the end of the period. In addition, policyholder account values for certain interest-sensitive life products are impacted by our assumptions related to changes of certain NGEs that we are allowed to make under the terms of the policy, such as cost of insurance charges, expense loads, credited interest rates and policyholder bonuses. Therefore, our reserves and liabilities are necessarily based on numerous estimates and assumptions as well as historical experience. Establishing reserves is an uncertain process, and it is possible that actual claims will materially exceed our reserves and have a material adverse effect on our results of operations and financial condition. Our financial results depend significantly upon the extent to which our actual claims experience is consistent with the assumptions we used in determining our reserves and pricing our products. If our assumptions with respect to future claims are incorrect, and our reserves are insufficient to cover our actual losses and expenses, we would be required to increase our liabilities, which would negatively affect our operating results. Liabilities for insurance products are calculated using management's best judgments, based on our past experience and standard actuarial tables, of mortality, morbidity, lapse rates, investment experience and expense levels.

Accounting for Long-term Care Premium Rate Increases

Many of our long-term care policies have been subject to premium rate increases. In some cases, these premium rate increases were materially consistent with the assumptions we used to value the particular block of business at the Effective Date. With respect to certain premium rate increases, some of our policyholders were provided an option to cease paying their premiums and receive a non-forfeiture option in the form of a paid-up policy with limited benefits. In addition, our

60

policyholders could choose to reduce their coverage amounts and premiums in the same proportion, when permitted by our contracts or as required by regulators. The following describes how we account for these policyholder options:

• Premium rate increases - If premium rate increases reflect a change in our previous rate increase assumptions, the new assumptions are not reflected prospectively in our reserves. Instead, the additional premium revenue resulting from the rate increase is recognized as earned and original assumptions continue to be used to determine changes to liabilities for insurance products unless a premium deficiency exists.

• Benefit reductions - If there is a premium rate increase on one of our long-term care policies, a policyholder may choose reduced coverage with a proportionate reduction in premium, when permitted by our contracts. This option does not require additional underwriting. Benefit reductions are treated as a partial lapse of coverage, and the balance of our reserves and deferred insurance acquisition costs is reduced in proportion to the reduced coverage.

• Non-forfeiture benefits offered in conjunction with a rate increase - In some cases, non-forfeiture benefits are offered to policyholders who wish to lapse their policies at the time of a significant rate increase. In these cases, exercise of this option is treated as an extinguishment of the original contract and issuance of a new contract. The balance of our reserves and deferred insurance acquisition costs are released, and a reserve for the new contract is established.

Some of our policyholders may receive a non-forfeiture benefit if they cease paying their premiums pursuant to their original contract (or pursuant to changes made to their original contract as a result of a litigation settlement made prior to the Effective Date or an order issued by the Florida Office of Insurance Regulation). In these cases, exercise of this option is treated as the exercise of a policy benefit, and the reserve for premium paying benefits is reduced, and the reserve for the non-forfeiture benefit is adjusted to reflect the election of this benefit.

Liabilities for Loss Contingencies Related to Lawsuits

The Company and its subsidiaries are involved in various legal actions in the normal course of business, in which claims for compensatory and punitive damages are asserted, some for substantial amounts. We recognize an estimated loss from these loss contingencies when we believe it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. Some of the pending matters have been filed as purported class actions and some actions have been filed in certain jurisdictions that permit punitive damage awards that are disproportionate to the actual damages incurred. The amounts sought in certain of these actions are often large or indeterminate and the ultimate outcome of certain actions is difficult to predict. In the event of an adverse outcome in one or more of these matters, there is a possibility that the ultimate liability may be in excess of the liabilities we have established and could have a material adverse effect on our business, financial condition, results of operations and cash flows. In addition, the resolution of pending or future litigation may involve modifications to the terms of outstanding insurance policies or could impact the timing and amount of rate increases, which could adversely affect the future profitability of the related insurance policies. Based upon information presently available, and in light of legal, factual and other defenses available to the Company and its subsidiaries, the Company does not believe that it is probable that the ultimate liability from either pending or threatened legal actions, after consideration of existing loss provisions, will have a material adverse effect on the Company's consolidated financial condition, operating results or cash flows. However, given the inherent difficulty in predicting the outcome of legal proceedings, there exists the possibility such legal actions could have a material adverse effect on the Company's consolidated financial condition, operating results or cash flows.

In addition to the inherent difficulty of predicting litigation outcomes, particularly those that will be decided by a jury, some matters purport to seek substantial or an unspecified amount of damages for unsubstantiated conduct spanning several years based on complex legal theories and damages models. The alleged damages typically are indeterminate or not factually supported in the complaint, and, in any event, the Company's experience indicates that monetary demands for damages often bear little relation to the ultimate loss. In some cases, plaintiffs are seeking to certify classes in the litigation and class certification either has been denied or is pending and we have filed oppositions to class certification or sought to decertify a prior class certification. In addition, for many of these cases: (i) there is uncertainty as to the outcome of pending appeals or motions; (ii) there are significant factual issues to be resolved; and/or (iii) there are novel legal issues presented. Accordingly, the Company cannot reasonably estimate the possible loss or range of loss in excess of amounts accrued, if any, or predict the timing of the eventual resolution of these matters. The Company reviews these matters on an ongoing basis. When assessing reasonably possible and probable outcomes, the Company bases its assessment on the expected ultimate outcome following all appeals.

61

RESULTS OF OPERATIONS

The following tables and narratives summarize the operating results of our segments (dollars in millions):

	2015			2014			2013
Pre-tax operating earnings (a non-GAAP measure) (a):
Bankers Life	$	369.6		$	386.9		$	310.5
Washington National	111.5			111.2			140.6
Colonial Penn	5.6			.8			(12.5		)
Corporate operations	(63.9		)	(71.5		)	(48.5		)
Other CNO Business	—			—			(27.6		)
	422.8			427.4			362.5
Gain (loss) on reinsurance transactions:
Bankers Life	—			26.1			—
Washington National	—			3.8			—
Other CNO Business	—			—			(98.4		)
	—			29.9			(98.4		)
Net realized investment gains (losses), net of related amortization:
Bankers Life	(16.7		)	7.8			15.1
Washington National	(9.6		)	33.9			11.8
Colonial Penn	1.2			1.1			.4
Corporate operations	(22.3		)	(9.9		)	(1.5		)
	(47.4		)	32.9			25.8
Fair value changes in embedded derivative liabilities, net of related amortization:
Bankers Life	11.7			(35.6		)	34.8
Washington National	.2			(.4		)	.6
	11.9			(36.0		)	35.4
Equity in earnings of certain non-strategic investments and earnings attributable to VIEs:
Corporate operations	4.6			(8.0		)	(10.2		)
Net revenue pursuant to transition and support services agreements, net of taxes:
Corporate operations	2.5			2.6			—
Fair value changes related to agent deferred compensation plan:
Corporate operations	15.1			(26.8		)	15.8
Transition expenses:
Corporate operations	(9.0		)	—			—
Loss on extinguishment or modification of debt:
Corporate operations	(32.8		)	(.6		)	(65.4		)
Amounts related to CLIC prior to being sold:
Earnings of CLIC prior to being sold	—			23.4			39.3
Loss on sale of CLIC	—			(269.7		)	—
	—			(246.3		)	39.3
Income (loss) before income taxes:
Bankers Life	364.6			385.2			360.4
Washington National	102.1			148.5			153.0
Colonial Penn	6.8			1.9			(12.1		)
Corporate operations	(105.8		)	(114.2		)	(109.8		)
Other CNO Business	—			—			(126.0		)
Amount related to CLIC prior to being sold	—			(246.3		)	39.3
Income before income taxes	$	367.7		$	175.1		$	304.8

62

____________________

(a) These non-GAAP measures as presented in the above table and in the following segment financial data and discussions of segment results exclude the net loss on the sale of CLIC and gain (loss) on reinsurance transactions, the earnings of CLIC prior to being sold, net realized investment gains (losses), fair value changes in embedded derivative liabilities, net of related amortization, fair value changes related to the agent deferred compensation plan, equity in earnings of certain non-strategic investments and earnings attributable to VIEs, net revenue (expense) pursuant to transition and support services agreements, loss on extinguishment or modification of debt and before income taxes.  These are considered non-GAAP financial measures.  A non-GAAP measure is a numerical measure of a company's performance, financial position, or cash flows that excludes or includes amounts that are normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP.

These non-GAAP financial measures of "pre-tax operating earnings" differ from "income (loss) before income taxes" as presented in our consolidated statement of operations prepared in accordance with GAAP due to the exclusion of the net loss on the sale of CLIC and gain (loss) on reinsurance transactions, the earnings of CLIC prior to being sold, realized investment gains (losses), fair value changes in embedded derivative liabilities, net of related amortization, fair value changes related to the agent deferred compensation plan, equity in earnings of certain non-strategic investments and earnings attributable to VIEs, net revenue pursuant to transition and support services agreements and loss on extinguishment or modification of debt.  We measure segment performance excluding these items because we believe that this performance measure is a better indicator of the ongoing businesses and trends in our business. Our primary investment focus is on investment income to support our liabilities for insurance products as opposed to the generation of realized investment gains (losses), and a long-term focus is necessary to maintain profitability over the life of the business. Realized investment gains (losses), fair value changes in embedded derivative liabilities, fair value changes related to the agent deferred compensation plan and equity in earnings of certain non-strategic investments and earnings attributable to VIEs depend on market conditions and do not necessarily relate to decisions regarding the underlying business of our segments.  However, "pre-tax operating earnings" does not replace "income (loss) before income taxes" as a measure of overall profitability.

We may experience realized investment gains (losses), which will affect future earnings levels since our underlying business is long-term in nature and we need to earn the assumed interest rates on the investments backing our liabilities for insurance products to maintain the profitability of our business.  In addition, management uses this non-GAAP financial measure in its budgeting process, financial analysis of segment performance and in assessing the allocation of resources. We believe these non-GAAP financial measures enhance an investor's understanding of our financial performance and allows them to make more informed judgments about the Company as a whole.  These measures also highlight operating trends that might not otherwise be transparent.  The table above reconciles the non-GAAP measure to the corresponding GAAP measure.

General: CNO is the top tier holding company for a group of insurance companies operating throughout the United States that develop, market and administer health insurance, annuity, individual life insurance and other insurance products. We distribute these products through our Bankers Life segment, which utilizes a career agency force, through our Washington National segment, which utilizes independent producers and through our Colonial Penn segment, which utilizes direct response marketing.

63

Bankers Life (dollars in millions)

	2015			2014			2013
Premium collections:
Annuities	$	803.0		$	782.3		$	744.1
Medicare supplement and other supplemental health	1,242.3			1,275.1			1,317.8
Life	446.0			424.9			368.3
Total collections	$	2,491.3		$	2,482.3		$	2,430.2
Average liabilities for insurance products:
Fixed index annuities	$	4,075.5		$	3,636.7		$	3,185.8
Fixed interest annuities	3,487.8			3,845.0			4,137.2
SPIAs and supplemental contracts:
Mortality based	189.5			202.8			221.5
Deposit based	153.8			149.1			156.5
Health:
Long-term care	4,916.2			4,735.4			4,632.2
Medicare supplement	331.0			331.0			332.4
Other health	47.7			47.5			45.4
Life:
Interest sensitive	643.0			564.7			490.4
Non-interest sensitive	941.5			782.1			610.6
Total average liabilities for insurance products, net of reinsurance ceded	$	14,786.0		$	14,294.3		$	13,812.0
Revenues:
Insurance policy income	$	1,648.7		$	1,651.7		$	1,648.7
Net investment income:
General account invested assets	918.7			895.4			854.0
Fixed index products	(34.0		)	61.9			151.7
Fee revenue and other income	27.7			29.3			19.0
Total revenues	2,561.1			2,638.3			2,673.4
Expenses:
Insurance policy benefits	1,442.5			1,427.7			1,447.5
Amounts added to policyholder account balances:
Cost of interest credited to policyholders	118.5			127.2			141.9
Cost of options to fund index credits, net of forfeitures	60.3			49.2			47.4
Market value changes credited to policyholders	(32.9		)	63.5			151.9
Amortization related to operations	187.1			174.7			187.5
Interest expense on investment borrowings	8.8			7.9			6.7
Other operating costs and expenses	407.2			401.2			380.0
Total benefits and expenses	2,191.5			2,251.4			2,362.9
Income before gain on reinsurance transaction, net realized investment gains (losses), net of related amortization, and fair value changes in embedded derivative liabilities, net of related amortization, and income taxes	369.6			386.9			310.5
Gain on reinsurance transaction	—			26.1			—
Net realized investment gains (losses)	(17.2		)	8.3			16.3
Amortization related to net realized investment gains (losses)	.5			(.5		)	(1.2		)
Net realized investment gains (losses), net of related amortization	(16.7		)	7.8			15.1
Insurance policy benefits - fair value changes in embedded derivative liabilities	14.9			(47.0		)	51.7
Amortization related to fair value changes in embedded derivative liabilities	(3.2		)	11.4			(16.9		)
Fair value changes in embedded derivative liabilities, net of related amortization	11.7			(35.6		)	34.8
Income before income taxes	$	364.6		$	385.2		$	360.4

64

	2015			2014			2013
Health benefit ratios:
All health lines:
Insurance policy benefits	$	1,205.1		$	1,190.6		$	1,214.0
Benefit ratio (a)	96.3		%	92.5		%	92.6		%
Medicare supplement:
Insurance policy benefits	$	536.1		$	529.3		$	509.0
Benefit ratio (a)	69.6		%	68.4		%	67.1		%
Long-term care:
Insurance policy benefits	$	669.0		$	656.0		$	689.2
Benefit ratio (a)	139.2		%	129.7		%	129.3		%
Interest-adjusted benefit ratio (b)	82.8		%	77.2		%	80.6		%
PDP:
Insurance policy benefits	—		%	$	5.3		$	15.9
Benefit ratio (a)	—		%	77.9		%	80.5		%

______________

(a) We calculate benefit ratios by dividing the related product's insurance policy benefits by insurance policy income.

(b) We calculate the interest-adjusted benefit ratio (a non-GAAP measure) for Bankers Life's long-term care products by dividing such product's insurance policy benefits less the imputed interest income on the accumulated assets backing the insurance liabilities by policy income. These are considered non-GAAP financial measures. A non-GAAP measure is a numerical measure of a company's performance, financial position, or cash flows that excludes or includes amounts that are normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP.

These non-GAAP financial measures of "interest-adjusted benefit ratios" differ from "benefit ratios" due to the deduction of imputed interest income on the accumulated assets backing the insurance liabilities from the product's insurance policy benefits used to determine the ratio. Interest income is an important factor in measuring the performance of health products that are expected to be inforce for a longer duration of time, are not subject to unilateral changes in provisions (such as non-cancelable or guaranteed renewable contracts) and require the performance of various functions and services (including insurance protection) for an extended period of time. The net cash flows from long-term care products generally cause an accumulation of amounts in the early years of a policy (accounted for as reserve increases) that will be paid out as benefits in later policy years (accounted for as reserve decreases). Accordingly, as the policies age, the benefit ratio will typically increase, but the increase in benefits will be partially offset by the imputed interest income earned on the accumulated assets. The interest-adjusted benefit ratio reflects the effects of such interest income offset (which is equal to the tabular interest on the related insurance liabilities). Since interest income is an important factor in measuring the performance of this product, management believes a benefit ratio that includes the effect of interest income is useful in analyzing product performance. We utilize the interest-adjusted benefit ratio in measuring segment performance because we believe that this performance measure is a better indicator of the ongoing businesses and trends in the business. However, the "interest-adjusted benefit ratio" does not replace the "benefit ratio" as a measure of current period benefits to current period insurance policy income. Accordingly, management reviews both "benefit ratios" and "interest-adjusted benefit ratios" when analyzing the financial results attributable to these products. The imputed investment income earned on the accumulated assets backing Bankers Life's long-term care reserves was $271.2 million, $265.5 million and $259.5 million in 2015, 2014 and 2013, respectively.

The Bankers Life segment included approximately $5.5 million of additional pre-tax earnings in the last six months of 2014 from the recapture of a block of life insurance business previously ceded to Wilton Re.

Total premium collections were $2,491.3 million in 2015, up .4 percent from 2014, and $2,482.3 million in 2014, up 2.1 percent from 2013. See "Premium Collections" for further analysis of Bankers Life's premium collections.

65

Average liabilities for insurance products, net of reinsurance ceded were $14.8 billion in 2015, up 3.4 percent from 2014 and $14.3 billion in 2014, up 3.5 percent from 2013. Such average insurance liabilities for certain long-term care products were increased by $196 million, $126 million and $159 million in 2015, 2014 and 2013, respectively, to reflect the premium deficiencies that would exist if unrealized gains on the assets backing such products had been realized and the proceeds from the sales of such assets were invested at then current yields. Such increase is reflected as a reduction of accumulated other comprehensive income. In addition, the increase in the non-interest sensitive life reserves in 2014 reflects approximately $155 million of reserves related to the recapture in July 2014 of a block of life insurance business previously ceded to Wilton Re. Excluding the impact of the aforementioned items, the increase in average liabilities for insurance products was primarily due to new sales and the amounts added to policyholder account balances on interest-sensitive products.

Insurance policy income is comprised of premiums earned on policies which provide mortality or morbidity coverage and fees and other charges assessed on other policies. Insurance policy income included premium revenue of $6.8 million and $19.7 million in 2014 and 2013, respectively, related to our PDP quota-share reinsurance agreement with Coventry. In August 2013, we received a notice of Coventry's intent to terminate our PDP quota-share reinsurance agreement, as further described in the note to the consolidated financial statements entitled "Summary of Significant Accounting Policies - Reinsurance". The PDP premiums collected in 2014 represent adjustments to premiums on such business related to periods prior to the termination of the agreement.

Net investment income on general account invested assets (which excludes income on policyholder accounts) increased 2.6 percent, to $918.7 million, in 2015 and 4.8 percent, to $895.4 million, in 2014. The increase in net investment income is due to higher general account invested assets resulting from sales and increased persistency of our annuity and health products in recent periods and prepayment income. Prepayment income was $26.6 million, $16.9 million and $13.4 million in 2015, 2014 and 2013, respectively.

Net investment income related to fixed index products represents the change in the estimated fair value of options which are purchased in an effort to offset or hedge certain potential benefits accruing to the policyholders of our fixed index products. Our fixed index products are designed so that investment income spread is expected to be more than adequate to cover the cost of the options and other costs related to these policies.  Net investment income (loss) related to fixed index products was $(34.0) million, $61.9 million and $151.7 million in 2015, 2014 and 2013, respectively. Such amounts were mostly offset by the corresponding charge (credit) to amounts added to policyholder account balances - market value changes credited to policyholders.Such income and related charges fluctuate based on the value of options embedded in the segment's fixed index annuity policyholder account balances subject to this benefit and to the performance of the index to which the returns on such products are linked.

Fee revenue and other income was $27.7 million, $29.3 million and $19.0 million in 2015, 2014 and 2013, respectively. We recognized fee income of $26.3 million, $25.4 million and $18.4 million in 2015, 2014 and 2013, respectively, pursuant to distribution and marketing agreements to sell Medicare Advantage and PDP products of other insurance companies. The increase reflects higher sales of third party products by Bankers agents. In 2014, we also received a $3 million settlement from Coventry related to the termination of our PDP quota-share agreement.

Insurance policy benefits fluctuated as a result of the factors summarized below.  Benefit ratios are calculated by dividing the related insurance product’s insurance policy benefits by insurance policy income.

In the fourth quarter of 2015, we completed our comprehensive review of actuarial assumptions. Such review resulted in a decrease in reserves of $21.9 million and a decrease in amortization of $3.9 million primarily reflecting the net impact from changes in assumptions related to mortality, long-term interest rates and the spread earned on fixed index annuities. In the fourth quarter of 2014, our comprehensive review resulted in a decrease to amortization expense of $11 million due to changes in mortality, spread and surrender rate assumptions related to certain annuity and interest-sensitive life products. Such amount was partially offset by $5 million of additional reserves on such products due to the changes in assumptions and refinements to reserving methodologies.

The Medicare supplement business consists of both individual and group policies.  Government regulations generally require us to attain and maintain a ratio of total benefits incurred to total premiums earned (excluding changes in policy benefit reserves), after three years from the original issuance of the policy and over the lifetime of the policy, of not less than 65 percent on individual products and not less than 75 percent on group products, as determined in accordance with statutory accounting principles.  Since the insurance product liabilities we establish for Medicare supplement business are subject to significant estimates, the ultimate claim liability we incur for a particular period is likely to be different than our initial estimate.

66

Our benefit ratios were 69.6 percent, 68.4 percent and 67.1 percent in 2015, 2014 and 2013, respectively. Our insurance policy benefits in 2015 reflected $1.1 million of unfavorable reserve developments while the benefit ratios in 2014 and 2013 were impacted by the favorable development of prior period claim reserves of approximately $2.3 million and $10.3 million in 2014 and 2013, respectively.  Excluding the effects of prior period claim reserve redundancies and deficiencies, our benefit ratios would have been 69.4 percent, 68.7 percent and 68.5 percent in 2015, 2014 and 2013, respectively. We currently expect the benefit ratio on this Medicare supplement business to be in range of 70 percent to 73 percent during 2016.

The net cash flows from our long-term care products generally cause an accumulation of amounts in the early years of a policy (accounted for as reserve increases) which will be paid out as benefits in later policy years (accounted for as reserve decreases). Accordingly, as the policies age, the benefit ratio typically increases, but the increase in reserves is partially offset by investment income earned on the accumulated assets.  The benefit ratio on our long-term care business in the Bankers Life segment was 139.2 percent, 129.7 percent and 129.3 percent in 2015, 2014 and 2013, respectively.  The interest-adjusted benefit ratio on this business was 82.8 percent, 77.2 percent and 80.6 percent in 2015, 2014 and 2013, respectively.  The increase in the interest-adjusted benefit ratio in 2015 reflects the impacts of refinements initiated in the first quarter of 2015 used to determine the increase in our future loss reserves. The refinements were not a result of any adjustment to our total expectations of projected profits and losses on the long-term care block, and only impact the timing of the future loss reserve increases. The refinements had no impact on insurance liabilities determined in accordance with statutory accounting principles. The benefit ratio in 2014 reflects $2.8 million of reserve releases related to the use of a new process to identify changes in the status of our insureds in a more timely manner. The benefit ratio in 2013 reflected an out-of-period adjustment of $6.7 million in the first quarter of 2013 and certain refinements to reserving methodologies of $3.5 million in the second quarter of 2013, both of which increased insurance policy benefits. We currently expect the interest-adjusted benefit ratio on this long-term care business to be in the range of 81 percent to 86 percent during 2016, excluding the impacts of rate increase actions. We expect that the impacts of rate increases will favorably impact the interest-adjusted benefit ratio in 2016. Since the insurance product liabilities we establish for the long-term care business are subject to significant estimates, the ultimate claim liability we incur for a particular period is likely to be different than our initial estimate.  Our insurance policy benefits reflected reserve redundancies from prior years of $16.2 million, $21.2 million and $17.9 million in 2015, 2014 and 2013, respectively. Excluding the effects of prior year claim reserve redundancies, our benefit ratios would have been 142.5 percent, 133.8 percent and 132.7 percent in 2015, 2014 and 2013, respectively. When policies lapse, active life reserves for such lapsed policies are released, resulting in decreased insurance policy benefits (although such decrease is somewhat offset by additional amortization expense).

In 2015, earnings on our long-term care business were favorably impacted by $6.3 million of one-time reserve releases (net of the reduction in insurance intangibles) related to policyholder decisions to surrender or reduce coverage following rate increases. In 2014, the impact of rate increases was not material. In 2013, this segment's earnings were favorably impacted by approximately $4 million (net of the reduction in insurance intangibles) due to rate increase actions.

The insurance policy benefits on our PDP business resulted from our quota-share reinsurance agreement with Coventry.  Insurance margins (insurance policy income less insurance policy benefits) on the PDP business were $1.5 million and $3.8 million in 2014 and 2013, respectively. In August 2013, we received a notice of Coventry's intent to terminate our PDP quota-share reinsurance agreement, as further described in the note to the consolidated financial statements entitled "Summary of Significant Accounting Policies - Reinsurance". As a result, there was no PDP business recognized in the third and fourth quarters of 2013. The PDP results in 2014 represent adjustments to earnings on such business related to periods prior to the termination of the agreement.

Amounts added to policyholder account balances - cost of interest credited to policyholders were $118.5 million, $127.2 million and $141.9 million in 2015, 2014 and 2013, respectively. The weighted average crediting rates for these products was 2.8 percent, 2.8 percent and 3.0 percent in 2015, 2014 and 2013, respectively. The average liabilities of the fixed interest annuity block was $3.5 billion, $3.8 billion and $4.1 billion in 2015, 2014 and 2013, respectively. The decrease in the liabilities related to these annuities reflects consumer preference for fixed index products.

Amounts added to policyholder account balances for fixed index products represent a guaranteed minimum rate of return and a higher potential return that is based on a percentage (the "participation rate") of the amount of increase in the value of a particular index, such as the S&P 500 Index, over a specified period. Such amounts include our cost to fund the annual index credits, net of policies that are canceled prior to their anniversary date (classified as cost of options to fund index credits, net of forfeitures). Market value changes in the underlying indices during a specified period of time are classified as market value changes credited to policyholders. Such market value changes are generally offset by the net investment income related to fixed index products discussed above.

67

Amortization related to operations includes amortization of deferred acquisition costs and the present value of future profits. Deferred acquisition costs and the present value of future profits are collectively referred to as "insurance acquisition costs". Insurance acquisition costs are generally amortized either:  (i) in relation to the estimated gross profits for interest-sensitive life and annuity products; or (ii) in relation to actual and expected premium revenue for other products.  In addition, for interest-sensitive life and annuity products, we are required to adjust the total amortization recorded to date through the statement of operations if actual experience or other evidence suggests that earlier estimates of future gross profits should be revised. Accordingly, amortization for interest-sensitive life and annuity products is dependent on the profits realized during the period and on our expectation of future profits.  For other products, we amortize insurance acquisition costs in relation to actual and expected premium revenue, and amortization is only adjusted if expected premium revenue changes or if we determine the balance of these costs is not recoverable from future profits.  Amortization was impacted in 2015 and 2014 by our comprehensive review of actuarial assumptions discussed above under insurance policy benefits.

Interest expense on investment borrowings represents interest expense on collateralized borrowings as further described in the note to the consolidated financial statements entitled "Summary of Significant Accounting Policies - Investment Borrowings".

Other operating costs and expenses in our Bankers Life segment were $407.2 million in 2015 up 1.5 percent from 2014, and were $401.2 million in 2014, up 5.6 percent from 2013. The increase in commission and agent manager benefits in 2015 reflects the larger in-force block and increased costs associated with the agent deferred compensation plan due to changes in underlying actuarial assumptions. Expenses in 2014 included approximately $9 million of overhead expenses that were allocated to the Other CNO Business segment prior to 2014 and were expected to continue after the completion of the sale of CLIC. The increase in operating costs in 2014 from 2013 also reflected additional investments in our business, partially offset by lower legal and regulatory costs. Other operating costs and expenses include the following (dollars in millions):

	2015		2014		2013
Commission expense and agent manager benefits	$	64.4	$	57.2	$	60.0
Other operating expenses	342.8		344.0		320.0
Total	$	407.2	$	401.2	$	380.0

Gain on reinsurance transactionin 2014 resulted from the recapture of life insurance business written by Bankers Life that was reinsured by Wilton Re.

Net realized investment gains (losses) fluctuate each period. During 2015, we recognized $5.5 million of net losses from the sales of investments (primarily fixed maturities) and $11.7 million of writedowns of investments for other than temporary declines in fair value recognized through net income ($14.0 million, prior to the $2.3 million of impairment losses recognized in accumulated other comprehensive income (loss)). During 2014, net realized investment gains in this segment included $13.1 million of net gains from the sales of investments (primarily fixed maturities) and $4.8 million of writedowns of investments for other than temporary declines in fair value recognized through net income. During 2013, net realized investment gains in this segment included $22.3 million of net gains from the sales of investments (primarily fixed maturities) and $6.0 million of writedowns of investments for other than temporary declines in fair value recognized through net income.

Amortization related to net realized investment gains (losses) is the increase or decrease in the amortization of insurance acquisition costs which results from realized investment gains or losses. When we sell securities which back our interest-sensitive life and annuity products at a gain (loss) and reinvest the proceeds at a different yield, we increase (reduce) the amortization of insurance acquisition costs in order to reflect the change in estimated gross profits due to the gains (losses) realized and the resulting effect on estimated future yields. Sales of fixed maturity investments resulted in an increase (decrease) in the amortization of insurance acquisition costs of $(.5) million, $.5 million and $1.2 million in 2015, 2014 and 2013, respectively.

Insurance policy benefits - fair value changes in embedded derivative liabilities represents fair value changes due to fluctuations in the interest rates used to discount embedded derivative liabilities related to our fixed index annuities.

Amortization related to fair value changes in embedded derivative liabilities is the increase or decrease in the amortization of insurance acquisition costs which results from changes in interest rates used to discount embedded derivative liabilities related to our fixed index annuities.

68

Washington National (dollars in millions)

	2015			2014			2013
Premium collections:
Supplemental health and other health	$	547.0		$	517.8		$	494.4
Medicare supplement	72.6			85.2			101.9
Life	27.7			25.9			26.5
Annuity	2.4			2.6			4.3
Total collections	$	649.7		$	631.5		$	627.1
Average liabilities for insurance products:
Fixed index annuities	$	386.0		$	421.5		$	457.4
Fixed interest annuities	119.1			130.2			147.1
SPIAs and supplemental contracts:
Mortality based	258.4			245.4			248.9
Deposit based	260.5			252.6			245.9
Separate Accounts	5.2			8.5			14.1
Health:
Supplemental health	2,494.0			2,387.9			2,231.0
Medicare supplement	30.9			35.2			38.7
Other health	15.0			14.9			12.3
Life:
Interest sensitive life	151.9			159.4			166.2
Non-interest sensitive life	185.9			192.0			198.8
Total average liabilities for insurance products, net of reinsurance ceded	$	3,906.9		$	3,847.6		$	3,760.4
Revenues:
Insurance policy income	$	643.8		$	626.0		$	621.5
Net investment income:
General account invested assets	256.0			266.5			275.0
Fixed index products	(2.2		)	6.3			17.9
Trading account income related to reinsurer accounts	—			1.4			(3.7		)
Change in value of embedded derivative related to modified coinsurance agreement	—			(1.4		)	3.7
Trading account income related to policyholder accounts	(.2		)	3.3			4.0
Fee revenue and other income	1.3			1.1			.9
Total revenues	898.7			903.2			919.3
Expenses:
Insurance policy benefits	528.4			505.7			497.8
Amounts added to policyholder account balances:
Cost of interest credited to policyholders	14.6			14.9			14.7
Cost of options to fund index credits, net of forfeitures	6.3			5.6			6.1
Market value changes credited to policyholders	(2.7		)	10.0			22.8
Amortization related to operations	55.2			64.6			64.9
Interest expense on investment borrowings	2.0			1.7			1.9
Other operating costs and expenses	183.4			189.5			170.5
Total benefits and expenses	787.2			792.0			778.7
Income before gain on reinsurance transaction, net realized investment gains and fair value changes in embedded derivative liabilities, net of related amortization, and income taxes	111.5			111.2			140.6
Gain on reinsurance transaction	—			3.8			—
Net realized investment gains (losses)	(9.6		)	34.4			12.2
Amortization related to net realized investment gains (losses)	—			(.5		)	(.4		)
Net realized investment gains (losses), net of related amortization	(9.6		)	33.9			11.8
Insurance policy benefits - fair value changes in embedded derivative liabilities	.8			(1.5		)	2.7
Amortization related to fair value changes in embedded derivative liabilities	(.6		)	1.1			(2.1		)
Fair value changes in embedded derivative liabilities, net of related amortization	.2			(.4		)	.6
Income before income taxes	$	102.1		$	148.5		$	153.0

69

	2015			2014			2013
Health benefit ratios:
Supplemental health:
Insurance policy benefits	$	455.3		$	408.7		$	378.1
Benefit ratio (a)	84.0		%	80.1		%	78.5		%
Interest-adjusted benefit ratio (b)	59.6		%	54.6		%	52.3		%
Medicare supplement:
Insurance policy benefits	$	47.9		$	55.2		$	66.1
Benefit ratio (a)	65.0		%	63.3		%	64.6		%

_________________

(a) We calculate benefit ratios by dividing the related product’s insurance policy benefits by insurance policy income.

(b) We calculate the interest-adjusted benefit ratio (a non-GAAP measure) for Washington National's supplemental health products by dividing such product’s insurance policy benefits less the imputed interest income on the accumulated assets backing the insurance liabilities by policy income.  These are considered non-GAAP financial measures.  A non-GAAP measure is a numerical measure of a company's performance, financial position, or cash flows that excludes or includes amounts that are normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP.

These non-GAAP financial measures of "interest-adjusted benefit ratios" differ from "benefit ratios" due to the deduction of imputed interest income on the accumulated assets backing the insurance liabilities from the product’s insurance policy benefits used to determine the ratio.  Interest income is an important factor in measuring the performance of health products that are expected to be inforce for a longer duration of time, are not subject to unilateral changes in provisions (such as non-cancelable or guaranteed renewable contracts) and require the performance of various functions and services (including insurance protection) for an extended period of time.  The net cash flows from supplemental health products generally cause an accumulation of amounts in the early years of a policy (accounted for as reserve increases) that will be paid out as benefits in later policy years (accounted for as reserve decreases).  Accordingly, as the policies age, the benefit ratio will typically increase, but the increase in benefits will be partially offset by the imputed interest income earned on the accumulated assets.  The interest-adjusted benefit ratio reflects the effects of such interest income offset (which is equal to the tabular interest on the related insurance liabilities). Since interest income is an important factor in measuring the performance of these products, management believes a benefit ratio that includes the effect of interest income is useful in analyzing product performance.  We utilize the interest-adjusted benefit ratio in measuring segment performance because we believe that this performance measure is a better indicator of the ongoing businesses and trends in the business.  However, the "interest-adjusted benefit ratio" does not replace the "benefit ratio" as a measure of current period benefits to current period insurance policy income. Accordingly, management reviews both "benefit ratios" and "interest-adjusted benefit ratios" when analyzing the financial results attributable to these products.  The imputed investment income earned on the accumulated assets backing the supplemental health reserves was $132.6 million, $130.2 million and $126.4 million in 2015, 2014 and 2013, respectively.

Total premium collections were $649.7 million in 2015, up 2.9 percent from 2014, and $631.5 million in 2014, up .7 percent from 2013, driven by sales and higher persistency of the segment's supplemental health block. This segment no longer markets Medicare supplement products and no longer actively pursues sales of annuity products. See "Premium Collections" for further analysis of fluctuations in premiums collected by product.

Average liabilities for insurance products, net of reinsurance ceded were $3,906.9 million in 2015, up 1.5 percent from 2014, and $3,847.6 million in 2014, up 2.3 percent from 2013, reflecting an increase in the supplemental health block; partially offset by the run-off of the annuity blocks.

Insurance policy income is comprised of premiums earned on traditional insurance policies which provide mortality or morbidity coverage and fees and other charges assessed on other policies. Such income increased in recent periods as supplemental health premiums have increased consistent with sales; partially offset by the decrease in Medicare supplement premiums.

Net investment income on general account invested assets (which excludes income on policyholder and reinsurer accounts) decreased 3.9 percent, to $256.0 million in 2015 and 3.1 percent, to $266.5 million in 2014. As a result of the sale of CLIC, investment income decreased by approximately $3.5 million and $5.2 million in 2015 and 2014, respectively,

70

representing the investment income earned on the invested assets backing a block of health business issued by CLIC and included in the Washington National segment. Subsequent to the sale of CLIC, such business was ceded to Washington National through a modified coinsurance agreement pursuant to which all invested assets related to the insurance block were held by CLIC.

Net investment income related to fixed index products represents the change in the estimated fair value of options which are purchased in an effort to offset or hedge certain potential benefits accruing to the policyholders of our fixed index products. Our fixed index products are designed so that investment income spread is expected to be more than adequate to cover the cost of the options and other costs related to these policies. Net investment income (loss) related to fixed index products was $(2.2) million, $6.3 million and $17.9 million in 2015, 2014 and 2013, respectively. Such amounts were substantially offset by the corresponding charge to amounts added to policyholder account balances - market value changes credited to policyholders.  Such income and related charges fluctuate based on the value of options embedded in the segment's fixed index annuity policyholder account balances subject to this benefit and to the performance of the index to which the returns on such products are linked.

Trading account income related to reinsurer accounts represents the income on trading securities which were held to act as hedges for embedded derivatives related to a modified coinsurance agreement. The income on such trading account securities was designed to substantially offset the change in value of embedded derivatives related to a modified coinsurance agreement. Such trading securities were sold in the second quarter of 2014 in conjunction with the recapture of a modified coinsurance agreement.

Change in value of embedded derivative related to modified coinsurance agreement is described in the note to our consolidated financial statements entitled "Summary of Significant Accounting Policies - Accounting for Derivatives." We transferred a specific block of investments related to this agreement to our trading securities account, which we carried at estimated fair value with changes in such value recognized as trading account income. The change in the value of the embedded derivatives was largely offset by the change in value of the trading securities. In the second quarter of 2014, we recaptured this modified coinsurance agreement and the embedded derivative was eliminated.

Trading account income related to policyholder accounts represents the income on investments backing the market strategies of certain annuity products which provide for different rates of cash value growth based on the experience of a particular market strategy. The income on our trading account securities is designed to substantially offset certain amounts included in insurance policy benefits related to the aforementioned annuity products.

Insurance policy benefits fluctuated as a result of the factors summarized below. Benefit ratios are calculated by dividing the related insurance product's insurance policy benefits by insurance policy income.

In the fourth quarter of 2015, we completed our comprehensive annual review of actuarial assumptions. Such review resulted in a $1 million decrease in reserves. In the fourth quarter of 2014, our review of actuarial assumptions resulted in a $10 million increase in reserves primarily related to a closed block of payout annuities due to changes in our interest rate and mortality assumptions for this block.

Washington National's supplemental health products (including specified disease, accident and hospital indemnity products) generally provide fixed or limited benefits. For example, payments under cancer insurance policies are generally made directly to, or at the direction of, the policyholder following diagnosis of, or treatment for, a covered type of cancer. Approximately three-fourths of our supplemental health policies inforce (based on policy count) were sold with return of premium or cash value riders. The return of premium rider generally provides that after a policy has been inforce for a specified number of years or upon the policyholder reaching a specified age, we will pay to the policyholder, or a beneficiary under the policy, the aggregate amount of all premiums paid under the policy, without interest, less the aggregate amount of all claims incurred under the policy. The cash value rider is similar to the return of premium rider, but also provides for payment of a graded portion of the return of premium benefit if the policy terminates before the return of premium benefit is earned. Accordingly, the net cash flows from these products generally result in the accumulation of amounts in the early years of a policy (reflected in our earnings as reserve increases) which will be paid out as benefits in later policy years (reflected in our earnings as reserve decreases which offset the recording of benefit payments). As the policies age, the benefit ratio will typically increase, but the increase in benefits will be partially offset by investment income earned on the accumulated assets. The benefit ratio will fluctuate depending on the claim experience during the year.

Insurance margins (insurance policy income less insurance policy benefits) on supplemental health products were $86.4 million, $101.8 million and $103.4 million in 2015, 2014 and 2013, respectively. The benefit ratio on these products was 84.0

71

percent, 80.1 percent and 78.5 percent in 2015, 2014 and 2013, respectively. The interest-adjusted benefit ratio on this supplemental health business was 59.6 percent, 54.6 percent and 52.3 percent in 2015, 2014 and 2013, respectively. In 2015, the insurance margin on these products was reduced by approximately $12 million due to the unfavorable development of prior period incurred claim estimates as further discussed below. After adjusting for this item, the interest-adjusted benefit ratio was 57.3 percent in 2015. We currently expect the interest-adjusted benefit ratio on this supplemental health business to be in the range of 56 percent to 59 percent during 2016.

The unfavorable reserve developments recognized in 2015 were primarily based on the completion of an in-depth review of recent claim trends in the block, including the impact of newer cancer treatments on claims. In recent quarters, we have observed and disclosed increases in insurance policy benefits for our supplemental health products. As these developments emerged, we initiated an in-depth claim review. The review revealed some recent claim trends on certain blocks of supplemental health business that warranted additional analysis. The additional analysis revealed longer and higher treatment patterns for cancer claims than previously recognized in our claim reserving process. An example of changes in cancer treatment we noticed is an increase in the use of expensive oral drugs rather than intravenous chemotherapy. We have also observed an increase in the length of time claimants remain on a treatment regimen. Claim reserves for supplemental health business are developed using data that extends over a time period that is sufficient in an effort to produce credible averages and avoid over-reacting to normal ranges of claim volatility. We believe this approach fully recognizes the new emerging treatment patterns.

In addition, the insurance margin on supplemental health products was reduced by $2.5 million in 2014 related to premium refunds due to the use of a new process to identify changes in the status of insureds in a more timely manner. The benefit ratios on this business can be impacted by changes in the extent to which policyholders convert their current policies to policies with additional benefits, as well as persistency in certain blocks. The benefit ratios reflect a decision we made in 2013 to reduce the commission we pay on certain conversion activity. While we believe this change will improve the longer-term profitability of the block, lower conversions of policies with return-of-premium features that are approaching maturity, results in lower reserve releases. Accordingly, the benefit ratio on this block has increased.

Washington National's Medicare supplement business primarily consists of individual policies. The insurance product liabilities we establish for our Medicare supplement business are subject to significant estimates and the ultimate claim liability we incur for a particular period is likely to be different than our initial estimate.  Governmental regulations generally require us to attain and maintain a ratio of total benefits incurred to total premiums earned (excluding changes in policy benefit reserves), after three years from the original issuance of the policy and over the lifetime of the policy, of not less than 65 percent on these products, as determined in accordance with statutory accounting principles. Insurance margins (insurance policy income less insurance policy benefits) on these products were $25.7 million, $31.9 million and $36.2 million in 2015, 2014 and 2013, respectively. Such decrease reflects the run-off of this business as we discontinued new sales of Medicare supplement business in this segment in the fourth quarter of 2012.

Amounts added to policyholder account balances - cost of interest credited to policyholders were $14.6 million, $14.9 million and $14.7 million in 2015, 2014 and 2013, respectively.

Amounts added to policyholder account balances for fixed index products represent a guaranteed minimum rate of return and a higher potential return that is based on a percentage (the "participation rate") of the amount of increase in the value of a particular index, such as the S&P 500 Index, over a specified period. Such amounts include our cost to fund the annual index credits, net of policies that are canceled prior to their anniversary date (classified as cost of options to fund index credits, net of forfeitures). Market value changes in the underlying indices during a specified period of time are classified as market value changes credited to policyholders. Such market value changes are generally offset by the net investment income related to fixed index products discussed above.

Amortization related to operations includes amortization of insurance acquisition costs. Insurance acquisition costs are generally amortized in relation to actual and expected premium revenue, and amortization is only adjusted if expected premium revenue changes or if we determine the balance of these costs is not recoverable from future profits. Such amounts were generally consistent with the related premium revenue. A revision to our current assumptions could result in increases or decreases to amortization expense in future periods.

Interest expense on investment borrowings represents $2.0 million, $1.7 million and $1.9 million of interest expense on collateralized borrowings in 2015, 2014 and 2013, respectively, as further described in the note to the consolidated financial statements entitled "Summary of Significant Accounting Policies - Investment Borrowings".

72

Other operating costs and expenses were $183.4 million, $189.5 million and $170.5 million in 2015, 2014 and 2013, respectively. Other operating costs and expenses include commission expense of $68.3 million, $64.6 million and $63.1 million in 2015, 2014 and 2013, respectively. The increase in commission expense is consistent with the growth in the supplemental health block. Excluding commission expenses, expenses were down 7.8 percent in 2015 as compared to 2014. Expenses in 2014 included approximately $7 million of overhead expenses that were allocated to the Other CNO Business segment prior to 2014 and were expected to continue after the completion of the sale of CLIC.

Gain on reinsurance transactionof $3.8 million related to the recapture of a modified coinsurance agreement in the second quarter of 2014.

Net realized investment gains (losses) fluctuate each period. During 2015, we recognized $.7 million of net gains from the sales of investments; the decrease in fair value of embedded derivatives related to a modified coinsurance agreement of $7.0 million; and $3.3 million of writedowns of investments for other than temporary declines in fair value recognized through net income ($3.7 million, prior to the $.4 million of impairment losses recognized in accumulated other comprehensive income (loss)). During 2014, net realized investment gains in this segment included $35.8 million of net gains from the sales of investments (primarily fixed maturities); the increase in fair value of embedded derivatives related to a modified coinsurance agreement of $2.0 million; and $3.4 million of writedowns of investments for other than temporary declines in fair value recognized through net income. During 2013, net realized investment gains in this segment included $15.9 million of net gains from the sales of investments (primarily fixed maturities) and $3.7 million of writedowns of investments for other than temporary declines in fair value recognized through net income.

Amortization related to net realized investment gains (losses) is the increase or decrease in the amortization of insurance acquisition costs which results from realized investment gains or losses. When we sell securities which back our interest-sensitive life and annuity products at a gain (loss) and reinvest the proceeds at a different yield (or when we have the intent to sell the impaired investments before an anticipated recovery in value occurs), we increase (reduce) the amortization of insurance acquisition costs in order to reflect the change in estimated gross profits due to the gains (losses) realized and the resulting effect on estimated future yields. Sales of fixed maturity investments resulted in an increase in the amortization of insurance acquisition costs of nil, $.5 million and $.4 million in 2015, 2014 and 2013, respectively.

Insurance policy benefits - fair value changes in embedded derivative liabilities represents fair value changes due to fluctuations in the interest rates used to discount embedded derivative liabilities related to our fixed index annuities.

Amortization related to fair value changes in embedded derivative liabilities is the increase or decrease in the amortization of insurance acquisition costs which results from changes in interest rates used to discount embedded derivative liabilities related to our fixed index annuities.

73

Colonial Penn (dollars in millions)

	2015		2014		2013
Premium collections:
Life	$	259.9	$	241.7	$	227.6
Supplemental health	3.0		3.4		4.1
Total collections	$	262.9	$	245.1	$	231.7
Average liabilities for insurance products:
SPIAs - mortality based	$	73.1	$	69.6	$	73.5
Health:
Medicare supplement	7.7		8.3		9.2
Other health	4.4		4.5		4.7
Life:
Interest sensitive	16.5		17.0		17.5
Non-interest sensitive	670.1		649.8		629.4
Total average liabilities for insurance products, net of reinsurance ceded	$	771.8	$	749.2	$	734.3
Revenues:
Insurance policy income	$	263.5	$	246.0	$	232.1
Net investment income on general account invested assets	43.0		41.7		40.0
Fee revenue and other income	1.0		1.0		.8
Total revenues	307.5		288.7		272.9
Expenses:
Insurance policy benefits	188.3		172.5		165.0
Amounts added to annuity and interest-sensitive life product account balances	.7		.7		.7
Amortization related to operations	14.4		15.3		14.5
Interest expense on investment borrowings	.1		—		—
Other operating costs and expenses	98.4		99.4		105.2
Total benefits and expenses	301.9		287.9		285.4
Income (loss) before net realized investment gains and income taxes	5.6		.8		(12.5		)
Net realized investment gains (losses)	1.2		1.1		.4
Income (loss) before income taxes	$	6.8	$	1.9	$	(12.1	)

This segment's results are significantly impacted by the accounting standard related to deferred acquisition costs. We are not able to defer most of Colonial Penn's direct response advertising costs although such costs generate predictable sales and future inforce profits. We plan to continue to invest in this segment's business, including the development of new products and markets. The amount of our investment in new business during a particular period will have a significant impact on this segment's results. We expect this segment to report earnings (before net realized investment gains (losses) and income taxes) in 2016 in the range of breakeven to $6 million, but because of the seasonality of the advertising spend, we expect a loss in the $8 million to $10 million range in the first quarter of 2016. The range of earnings we expect to report in 2016 reflects uncertainty related to how the U.S. presidential election will impact the cost of television advertising.

Total premium collections increased 7.3 percent, to $262.9 million, in 2015 and 5.8 percent, to $245.1 million, in 2014. The increases have been driven by increased sales and steady persistency. See "Premium Collections" for further analysis of Colonial Penn's premium collections.

Average liabilities for insurance products, net of reinsurance ceded have increased as a result of growth in the core graded benefit and simplified issue life insurance block in this segment.

74

Insurance policy income is comprised of premiums earned on policies which provide mortality or morbidity coverage and fees and other charges assessed on other policies. The increase in such income reflects the growth in the block of graded benefit and simplified issue life insurance business.

Net investment income on general account invested assets increased in 2015 and 2014 primarily due to the increase in invested assets as a result of growth in this segment.

Insurance policy benefits fluctuated as a result of the growth in this segment.

Amortization related to operations includes amortization of insurance acquisition costs. Insurance acquisition costs in the Colonial Penn segment are amortized in relation to actual and expected premium revenue, and amortization is only adjusted if expected premium revenue changes or if we determine the balance of these costs is not recoverable from future profits. Such amounts were generally consistent with the related premium revenue and gross profits for such periods and the assumptions we made when we established the present value of future profits. A revision to our current assumptions could result in increases or decreases to amortization expense in future periods.

Other operating costs and expenses in our Colonial Penn segment fluctuate primarily due to changes in the marketing expenses incurred to generate new business. Although marketing expenses increased by approximately $6 million in 2015, our mix of marketing activities has resulted in a similar increase in the deferral of such acquisition costs. We continue to face increased competition from other insurance companies who also distribute products through direct marketing. In addition, the demand and cost of television advertising appropriate for Colonial Penn's campaigns has fluctuated widely in certain periods. In some periods, increased advertising costs have resulted in decisions to lower our planned spending. These factors may reoccur in the future.

Net realized investment gains (losses) fluctuated each period. During 2015, we recognized $1.8 million of net gains from the sales of investments (primarily fixed maturities) and $.6 million of writedowns of investments for other than temporary declines in fair value recognized through net income ($.9 million, prior to the $.3 million of impairment losses recognized in accumulated other comprehensive income (loss)). During 2014, we recognized $1.1 million of net gains from the sales of investments (primarily fixed maturities). During 2013, net realized investment gains in this segment included $.6 million of net gains from the sales of investments (primarily fixed maturities) and $.2 million of writedowns of investments for other than temporary declines in fair value recognized through net income.

75

Corporate Operations (dollars in millions)

	2015			2014			2013
Corporate operations:
Interest expense on corporate debt	$	(45.0	)	$	(43.9	)	$	(51.3	)
Net investment income (loss):
General investment portfolio	6.9			8.5			5.4
Other special-purpose portfolios:
COLI	(6.4		)	(1.3		)	15.7
Investments held in a rabbi trust	(.1		)	.4			1.3
Investments in certain hedge funds	—			(2.8		)	4.9
Other trading account activities	10.9			10.1			12.5
Fee revenue and other income	8.6			6.7			6.2
Interest expense on investment borrowings	(.2		)	(.1		)	(.1		)
Other operating costs and expenses	(38.6		)	(49.1		)	(43.1		)
Loss before net realized investment gains (losses), equity in earnings of certain non-strategic investments and earnings attributable to non-controlling interests, net revenue pursuant to transition and support services agreements, fair value changes related to agent deferred compensation plan, transition expenses, loss on extinguishment or modification of debt and income taxes	(63.9		)	(71.5		)	(48.5		)
Net realized investment gains (losses)	(22.3		)	(9.9		)	(1.5		)
Equity in earnings of certain non-strategic investments and earnings attributable to non-controlling interests	4.6			(8.0		)	(10.2		)
Net revenue pursuant to transition and support services agreements	2.5			2.6			—
Fair value changes related to agent deferred compensation plan	15.1			(26.8		)	15.8
Transition expenses	(9.0		)	—			—
Loss on extinguishment or modification of debt	(32.8		)	(.6		)	(65.4		)
Loss before income taxes	$	(105.8	)	$	(114.2	)	$	(109.8	)

Interest expense on corporate debt has been impacted by: (i) the timing and amount of debt repayments in 2015 and 2014, including the debt refinancing transactions, along with the mix of interest rates on the related outstanding borrowings; (ii) the amendment to our credit agreement dated as of September 28, 2012 (as amended by the First Amendment to Credit Agreement dated May 20, 2013, as further amended by the Second Amendment to Credit Agreement dated May 30, 2014, the "Previous Senior Secured Credit Agreement") in May 2013 which reduced the interest rate payable; and (iii) the completion of the cash tender offer (the "Offer") in March 2013 for $59.3 million aggregate principal amount of our 7.0% Senior Debentures due 2016 (the "7.0% Debentures"). Such transactions are further discussed in the note to the consolidated financial statements entitled "Notes Payable - Direct Corporate Obligations". Our average corporate debt outstanding was $888.6 million, $838.2 million and $926.9 million in 2015, 2014 and 2013, respectively. The average interest rate on our debt was 4.7 percent, 4.5 percent and 4.8 percent in 2015, 2014 and 2013, respectively.

Net investment income on general investment portfolio fluctuates based on the amount and type of invested assets in the corporate operations segment.

Net investment income on other special-purpose portfolios includes the income (loss) from:  (i) investments related to deferred compensation plans held in a rabbi trust (which is offset by amounts included in other operating costs and expenses as the investment results are allocated to participants' account balances); (ii) trading account activities; (iii) income (loss) from COLI equal to the difference between the return on these investments (representing the change in value of the underlying investments) and our overall portfolio yield; and (iv) other investments including certain hedge funds and other alternative strategies.  COLI is utilized as an investment vehicle to fund Bankers Life's agent deferred compensation plan.  For segment reporting, the Bankers Life segment is allocated a return on these investments equivalent to the yield on the Company’s overall portfolio, with any difference in the actual COLI return allocated to the Corporate operations segment. We recognized death

76

benefits, net of cash surrender value, of $1.1 million, $1.7 million and $2.9 million related to the COLI in 2015, 2014 and 2013, respectively. The corporate segment sold all of its investments in hedge funds in the fourth quarter of 2014.

Fee revenue and other income includes the fees our wholly-owned investment advisor earns for managing portfolios of commercial bank loans for investment trusts. These trusts are consolidated as VIEs in our consolidated financial statements, but the fees are reflected as revenues and the fee expense is reflected in the earnings attributable to non-controlling interests. This fee revenue fluctuates consistent with the size of the loan portfolios.

Other operating costs and expenses include general corporate expenses, net of amounts charged to subsidiaries for services provided by the corporate operations. These amounts fluctuate as a result of expenses such as consulting and legal costs which often vary from period to period. Such amounts in the first three months of 2014 included higher expenses of $3 million primarily related to accrual adjustments for incentive compensation.

Net realized investment gains (losses) often fluctuate each period. During 2015, net realized investment losses in this segment included: (i) $2.0 million of net gains from the sales of investments (including $1.3 million of losses recognized by the VIEs and $3.3 million of net gains on other sales of investments); (ii) a $7.9 million writedown of a legacy investment in a private company that was liquidated; and (iii) $16.4 million of writedowns of investments held by VIEs due to other-than-temporary declines in value. We no longer have any investment exposure to legacy private company investments. During 2014, net realized investment losses in this segment included $9.2 million of net gains from the sales of investments (of which $2.2 million were losses recognized by VIEs) and $19.1 million of writedowns of investments (none of which were recognized by VIEs) due to other-than-temporary declines in value.  During 2013, net realized investment losses in this segment included $.4 million of net losses from the sales of investments (of which $.5 million were losses recognized by VIEs) and $1.1 million of writedowns of investments (all of which were recognized by VIEs) due to other-than-temporary declines in value.

Equity in earnings of certain non-strategic investments and earnings attributable to non-controlling interests include the earnings attributable to non-controlling interests in certain VIEs that we are required to consolidate and certain private companies that were acquired in the commutation of an investment made by our Predecessor, net of affiliated amounts. This amount included an $11.3 million gain in 2015 on the dissolution of a VIE. Such earnings are not indicative and are unrelated to the Company's underlying fundamentals.

Net revenue pursuant to transition and support services agreements represents the difference between the fees we receive from Wilton Re and the overhead costs incurred to provide such services under the agreements subsequent to the sale of CLIC.

Fair value changes related to agent deferred compensation plan related to changes in the underlying actuarial assumptions used to value liabilities for our agent deferred compensation plan.

Transition expenses include one-time expenses associated with our comprehensive agreement with Cognizant for our application development, maintenance and testing functions as well as select information technology infrastructure operations.

Loss on extinguishment or modification of debt in 2015 of $32.8 million consisted of: (i) $15.0 million related to the write-off of unamortized discount and issuance costs due to the repayment of our Previous Senior Secured Credit Agreement and the 6.375% Senior Secured Notes due October 2020 (the "6.375% Notes"); and (ii) a make-whole redemption premium of $17.8 million due to the repayment of the 6.375% Notes. The loss on extinguishment of debt of $.6 million in 2014 resulted from: (i) expenses related to the amendment of the Previous Senior Secured Credit Agreement in May 2014; and (ii) the repurchase of the remaining $3.5 million principal amount of the 7.0% Debentures for a purchase price of $3.7 million. The loss on extinguishment of debt of $65.4 million in 2013 resulted from: (i) the Offer and repurchase of 7.0% Debentures, the write-off of unamortized discount and issuance costs associated with the 7.0% Debentures that were repurchased and other transaction costs; and (ii) expenses related to the amendment of our Previous Senior Secured Credit Agreement and the write-off of unamortized discount and issuance costs associated with prepayments on the Previous Senior Secured Credit Agreement. These transactions are further discussed in the note to the consolidated financial statements entitled "Notes Payable - Direct Corporate Obligations".

77

Other CNO Business (dollars in millions)

The Other CNO Business segment included the long-term care business that was ceded to BRe effective December 31, 2013, as further described below. This segment also included the overhead expense of CLIC that was expected to continue after the completion of the CLIC sale. The Other CNO Business segment no longer exists, effective January 1, 2014. Beginning on January 1, 2014 the overhead of CLIC that was expected to continue after the completion of the sale was reallocated primarily to the Bankers Life and Washington National segments.

	2013
Premium collections:
Long-term care (all renewal)	$	23.6
Average liabilities for insurance products:
Average liabilities for long-term care products, net of reinsurance ceded	$	467.4
Revenues:
Insurance policy income	$	24.1
Net investment income on general account invested assets	33.3
Total revenues	57.4
Expenses:
Insurance policy benefits	59.2
Other operating costs and expenses:
Related to the long-term care business reinsured in 4Q13	6.2
Overhead expense of CLIC expected to continue after the completion of the sale	19.6
Total benefits and expenses	85.0
Loss before loss related to reinsurance transaction and income taxes	(27.6		)
Loss related to reinsurance transaction	(98.4		)
Loss before income taxes	$	(126.0	)

	2013
Health benefit ratios:
Long-term care:
Insurance policy benefits	$	59.2
Benefit ratio (a)	245.7		%
Interest-adjusted benefit ratio (b)	131.2		%

_______________

(a) We calculate benefit ratios by dividing the related product's insurance policy benefits by insurance policy income.

(b) We calculate the interest-adjusted benefit ratio (a non-GAAP measure) for long-term care products in our Other CNO Business segment by dividing such product's insurance policy benefits less the imputed interest income on the accumulated assets backing the insurance liabilities by policy income. These are considered non-GAAP financial measures. A non-GAAP measure is a numerical measure of a company's performance, financial position, or cash flows that excludes or includes amounts that are normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP.

These non-GAAP financial measures of "interest-adjusted benefit ratios" differ from "benefit ratios" due to the deduction of imputed interest income on the accumulated assets backing the insurance liabilities from the product's insurance policy benefits used to determine the ratio. Interest income is an important factor in measuring the performance of health products that are expected to be inforce for a longer duration of time, are not subject to unilateral changes in provisions (such as non-cancelable or guaranteed renewable contracts) and require the performance of various functions and services (including insurance protection) for an extended period of time. The net cash flows from long-term care

78

products generally cause an accumulation of amounts in the early years of a policy (accounted for as reserve increases) that will be paid out as benefits in later policy years (accounted for as reserve decreases). Accordingly, as the policies age, the benefit ratio will typically increase, but the increase in benefits will be partially offset by the imputed interest income earned on the accumulated assets. The interest-adjusted benefit ratio reflects the effects of such interest income offset (which is equal to the tabular interest on the related insurance liabilities). Since interest income is an important factor in measuring the performance of these products, management believes a benefit ratio that includes the effect of interest income is useful in analyzing product performance. We utilize the interest-adjusted benefit ratio in measuring segment performance because we believe that this performance measure is a better indicator of the ongoing businesses and trends in the business. However, the "interest-adjusted benefit ratio" does not replace the "benefit ratio" as a measure of current period benefits to current period insurance policy income. Accordingly, management reviews both "benefit ratios" and "interest-adjusted benefit ratios" when analyzing the financial results attributable to these products. The imputed investment income earned on the accumulated assets backing the long-term care reserves was $27.6 million in 2013.

Loss related to reinsurance transaction resulted from the long-term care business in this segment being ceded under 100% coinsurance agreements effective December 31, 2013. As a result, the long-term care reserves in this segment were ceded to BRe. Pursuant to the agreements, we paid an additional premium of $96.9 million to BRe plus an amount equal to the related net statutory liabilities. The reinsurance receivables related to the agreements are secured by assets in market-value trusts subject to a 7% over-collateralization, investment guidelines and periodic true-up provisions. Future payments into the trusts to maintain collateral requirements are the responsibility of BRe. We evaluate this block separately to determine whether aggregate liabilities are deficient. We recognized a pre-tax loss of $98.4 million in 2013 to reflect: (i) the known loss (or premium deficiency) on the business, as we will not be recognizing additional income in future periods to recover the unamortized additional premium which will be paid to BRe; and (ii) other transaction costs related to the reinsurance agreements.

79

Amounts related to CLIC prior to being sold (dollars in millions)

	2014			2013
Premium collections:
Annuities	$	.2		$	.3
Life	71.0			142.0
Total collections	$	71.2		$	142.3
Average liabilities for insurance products:
Fixed index annuities	$	—		$	.6
Fixed interest annuities	—			148.4
SPIAs and supplemental contracts:
Mortality based	—			39.2
Deposit based	—			106.7
Health:
Supplemental health	—			146.9
Medicare supplement	—			2.2
Other health	—			6.7
Life:
Interest sensitive	—			2,317.8
Non-interest sensitive	—			432.1
Total average liabilities for insurance products, net of reinsurance ceded	$	—		$	3,200.6
Revenues:
Insurance policy income	$	106.0		$	218.3
Net investment income:
General account invested assets	100.7			210.2
Fixed index products	1.3			7.9
Fee revenue and other income	—			5.1
Total revenues	208.0			441.5
Expenses:
Insurance policy benefits	115.8			239.6
Amounts added to policyholder account balances:
Cost of interest credited to policyholders	43.2			90.2
Cost of options to fund index credits, net of forfeitures	.8			1.4
Market value changes credited to policyholders	.9			7.9
Amortization related to operations	4.3			8.8
Interest expense on investment borrowings	9.1			19.3
Other operating costs and expenses	13.3			41.0
Total benefits and expenses	187.4			408.2
Income (loss) before net realized investment gains (losses), loss on sale of CLIC and income taxes	20.6			33.3
Net realized investment gains (losses)	2.8			6.0
Amortization related to net realized investment gains (losses)	—			—
Net realized investment gains (losses), net of related amortization	2.8			6.0
Earnings of CLIC prior to being sold	23.4			39.3
Loss on sale of CLIC	(269.7		)	—
Income (loss) before income taxes	$	(246.3	)	$	39.3

The information summarized above represents the pre-tax earnings related to the operations of CLIC prior to being sold (which occurred on July 1, 2014) as well as the loss on the sale of CLIC. Operating expenses exclude overhead expense that was expected to continue after the sale of CLIC. Refer to the note to the consolidated financial statements entitled "Sale of Subsidiary" for additional information.

80

EBIT FROM BUSINESS SEGMENTS CONTINUING AFTER THE CLIC SALE SUMMARIZED BY IN-FORCE AND NEW BUSINESS

Management believes that an analysis of EBIT from our business segments continuing after the CLIC sale, separated between in-force and new business, provides increased clarity around the value drivers of our business, particularly since the new business results are significantly impacted by the rate of sales, mix of business and the distribution channel through which new sales are made. EBIT from new business includes pre-tax revenues and expenses associated with new sales of our insurance products during the first year after the sale is completed. EBIT from in-force business includes all pre-tax revenues and expenses associated with sales of insurance products that were completed more than one year before the end of the reporting period. The allocation of certain revenues and expenses between new and in-force business is based on estimates, which we believe are reasonable.

The following summarizes our earnings, separated between in-force and new business on a consolidated basis and for each of our operating segments for the three years ended December 31, 2015:

Business segments - total (dollars in millions)

	2015			2014			2013
EBIT from In-Force Business
Revenues:
Insurance policy income	$	2,206.3		$	2,163.4		$	2,147.1
Net investment income and other	1,184.0			1,263.2			1,348.8
Total revenues	3,390.3			3,426.6			3,495.9
Benefits and expenses:
Insurance policy benefits	2,111.1			2,136.4			2,287.9
Amortization	230.8			228.2			236.3
Other expenses	360.4			357.5			358.6
Total benefits and expenses	2,702.3			2,722.1			2,882.8
EBIT from In-Force Business	$	688.0		$	704.5		$	613.1
EBIT from New Business
Revenues:
Insurance policy income	$	349.7		$	360.3		$	379.3
Net investment income and other	27.3			43.3			47.8
Total revenues	377.0			403.6			427.1
Benefits and expenses:
Insurance policy benefits	212.9			240.6			267.1
Amortization	25.9			26.4			30.6
Other expenses	339.5			342.2			331.5
Total benefits and expenses	578.3			609.2			629.2
EBIT from New Business	$	(201.3	)	$	(205.6	)	$	(202.1	)
EBIT from In-Force and New Business
Revenues:
Insurance policy income	$	2,556.0		$	2,523.7		$	2,526.4
Net investment income and other	1,211.3			1,306.5			1,396.6
Total revenues	3,767.3			3,830.2			3,923.0
Benefits and expenses:
Insurance policy benefits	2,324.0			2,377.0			2,555.0
Amortization	256.7			254.6			266.9
Other expenses	699.9			699.7			690.1
Total benefits and expenses	3,280.6			3,331.3			3,512.0
EBIT from In-Force and New Business	$	486.7		$	498.9		$	411.0

81

Bankers Life (dollars in millions)

	2015			2014			2013
EBIT from In-Force Business
Revenues:
Insurance policy income	$	1,429.8		$	1,411.0		$	1,378.0
Net investment income and other	885.1			943.3			976.9
Total revenues	2,314.9			2,354.3			2,354.9
Benefits and expenses:
Insurance policy benefits	1,438.5			1,484.3			1,574.7
Amortization	167.0			153.3			160.9
Other expenses	195.7			184.7			176.7
Total benefits and expenses	1,801.2			1,822.3			1,912.3
EBIT from In-Force Business	$	513.7		$	532.0		$	442.6
EBIT from New Business
Revenues:
Insurance policy income	$	218.9		$	240.7		$	270.7
Net investment income and other	27.3			43.3			47.8
Total revenues	246.2			284.0			318.5
Benefits and expenses:
Insurance policy benefits	149.9			183.3			214.0
Amortization	20.1			21.4			26.6
Other expenses	220.3			224.4			210.0
Total benefits and expenses	390.3			429.1			450.6
EBIT from New Business	$	(144.1	)	$	(145.1	)	$	(132.1	)
EBIT from In-Force and New Business
Revenues:
Insurance policy income	$	1,648.7		$	1,651.7		$	1,648.7
Net investment income and other	912.4			986.6			1,024.7
Total revenues	2,561.1			2,638.3			2,673.4
Benefits and expenses:
Insurance policy benefits	1,588.4			1,667.6			1,788.7
Amortization	187.1			174.7			187.5
Other expenses	416.0			409.1			386.7
Total benefits and expenses	2,191.5			2,251.4			2,362.9
EBIT from In-Force and New Business	$	369.6		$	386.9		$	310.5

82

Washington National (dollars in millions)

	2015			2014			2013
EBIT from In-Force Business
Revenues:
Insurance policy income	$	564.5		$	552.1		$	558.0
Net investment income and other	254.9			277.2			297.8
Total revenues	819.4			829.3			855.8
Benefits and expenses:
Insurance policy benefits	513.2			505.2			514.2
Amortization	50.1			60.0			61.3
Other expenses	135.4			141.2			128.4
Total benefits and expenses	698.7			706.4			703.9
EBIT from In-Force Business	$	120.7		$	122.9		$	151.9
EBIT from New Business
Revenues:
Insurance policy income	$	79.3		$	73.9		$	63.5
Net investment income and other	—			—			—
Total revenues	79.3			73.9			63.5
Benefits and expenses:
Insurance policy benefits	33.4			31.0			27.2
Amortization	5.1			4.6			3.6
Other expenses	50.0			50.0			44.0
Total benefits and expenses	88.5			85.6			74.8
EBIT from New Business	$	(9.2	)	$	(11.7	)	$	(11.3	)
EBIT from In-Force and New Business
Revenues:
Insurance policy income	$	643.8		$	626.0		$	621.5
Net investment income and other	254.9			277.2			297.8
Total revenues	898.7			903.2			919.3
Benefits and expenses:
Insurance policy benefits	546.6			536.2			541.4
Amortization	55.2			64.6			64.9
Other expenses	185.4			191.2			172.4
Total benefits and expenses	787.2			792.0			778.7
EBIT from In-Force and New Business	$	111.5		$	111.2		$	140.6

83

Colonial Penn (dollars in millions)

	2015			2014			2013
EBIT from In-Force Business
Revenues:
Insurance policy income	$	212.0		$	200.3		$	187.0
Net investment income and other	44.0			42.7			40.8
Total revenues	256.0			243.0			227.8
Benefits and expenses:
Insurance policy benefits	159.4			146.9			139.8
Amortization	13.7			14.9			14.1
Other expenses	29.3			31.6			27.7
Total benefits and expenses	202.4			193.4			181.6
EBIT from In-Force Business	$	53.6		$	49.6		$	46.2
EBIT from New Business
Revenues:
Insurance policy income	$	51.5		$	45.7		$	45.1
Net investment income and other	—			—			—
Total revenues	51.5			45.7			45.1
Benefits and expenses:
Insurance policy benefits	29.6			26.3			25.9
Amortization	.7			.4			.4
Other expenses	69.2			67.8			77.5
Total benefits and expenses	99.5			94.5			103.8
EBIT from New Business	$	(48.0	)	$	(48.8	)	$	(58.7	)
EBIT from In-Force and New Business
Revenues:
Insurance policy income	$	263.5		$	246.0		$	232.1
Net investment income and other	44.0			42.7			40.8
Total revenues	307.5			288.7			272.9
Benefits and expenses:
Insurance policy benefits	189.0			173.2			165.7
Amortization	14.4			15.3			14.5
Other expenses	98.5			99.4			105.2
Total benefits and expenses	301.9			287.9			285.4
EBIT from In-Force and New Business	$	5.6		$	.8		$	(12.5	)

84

Other CNO Business (dollars in millions)

	2013
EBIT from In-Force Business (a)
Revenues:
Insurance policy income	$	24.1
Net investment income and other	33.3
Total revenues	57.4
Benefits and expenses:
Insurance policy benefits	59.2
Amortization	—
Other expenses	25.8
Total benefits and expenses	85.0
EBIT from In-Force Business	$	(27.6	)

_________________________

(a) All activity in the Other CNO Business segment related to in-force business.

The above analysis of EBIT, separated between in-force and new business, illustrates how our segments are impacted by the rate of sales, mix of business and distribution channel through which new sales are made. In addition, when the impacts from new business are separated, the value drivers of our in-force business are more apparent.

The EBIT from in-force business in the Bankers Life segment (as summarized on page 82) decreased in 2015, consistent with the explanations in the segment's results of operations section, including the impacts of: (i) favorable claim developments in 2014 which did not reoccur in 2015; (ii) higher expenses reflecting investments being made to support future sales growth and expense reductions; partially offset by: (iii) the favorable impacts from our comprehensive annual actuarial review compared to 2014; and (iv) higher prepayment income. The EBIT from in-force business in the Bankers Life segment grew in 2014 primarily due to the growth in the size of the block. The EBIT from new business in the Bankers Life segment reflects new sales.

The EBIT from in-force business in the Washington National segment (as summarized on page 83) fluctuated consistent with the explanations in the segment's results of operations section.

The EBIT from in-force business in the Colonial Penn segment (as summarized on page 84) reflects the growth in the block. The EBIT from new business in the Colonial Penn segment in 2015 and 2014 reflects a modest increase in the deferral of acquisition costs due to a slight shift to deferrable marketing activities. The vast majority of the costs to generate new business in this segment are not deferrable and EBIT will fluctuate based on management's decisions on how much marketing costs to incur in each period.

PREMIUM COLLECTIONS

In accordance with GAAP, insurance policy income in our consolidated statement of operations consists of premiums earned for traditional insurance policies that have life contingencies or morbidity features.  For annuity and interest-sensitive life contracts, premiums collected are not reported as revenues, but as deposits to insurance liabilities.  We recognize revenues for these products over time in the form of investment income and surrender or other charges.

Our insurance segments sell products through three primary distribution channels - career agents (our Bankers Life segment), direct marketing (our Colonial Penn segment) and independent producers (our Washington National segment).  Our career agency force in the Bankers Life segment sells primarily Medicare supplement and long-term care insurance policies, life insurance and annuities.  These agents visit the customer's home, which permits one-on-one contact with potential policyholders and promotes strong personal relationships with existing policyholders.  Our direct marketing distribution channel in the Colonial Penn segment is engaged primarily in the sale of graded benefit life and simplified issue life insurance policies which are sold directly to the policyholder.  Our Washington National segment sells primarily supplemental health and life insurance.  These products are marketed through PMA, a wholly-owned subsidiary that specializes in marketing and distributing health products, and through independent marketing organizations and insurance agencies, including worksite marketing.

85

Agents, insurance brokers and marketing companies who market our products and prospective purchasers of our products use the financial strength ratings of our insurance subsidiaries as an important factor in determining whether to market or purchase.  Ratings have the most impact on our sales of supplemental health and life products to consumers at the worksite.  The current financial strength ratings of our primary insurance subsidiaries from A.M. Best, S&P, Fitch and Moody's are "A-", "BBB+", "BBB+" and "Baa1", respectively.    For a description of these ratings and additional information on our ratings, see "Consolidated Financial Condition - Financial Strength Ratings of our Insurance Subsidiaries."

We set premium rates on our health insurance policies based on facts and circumstances known at the time we issue the policies using assumptions about numerous variables, including the actuarial probability of a policyholder incurring a claim, the probable size of the claim, and the interest rate earned on our investment of premiums.  We also consider historical claims information, industry statistics, the rates of our competitors and other factors.  If our actual claims experience is less favorable than we anticipated and we are unable to raise our premium rates, our financial results may be adversely affected.  We generally cannot raise our health insurance premiums in any state until we obtain the approval of the state insurance regulator.  We review the adequacy of our premium rates regularly and file for rate increases on our products when we believe such rates are too low.  It is likely that we will not be able to obtain approval for all requested premium rate increases.  If such requests are denied in one or more states, our net income may decrease.  If such requests are approved, increased premium rates may reduce the volume of our new sales and may cause existing policyholders to lapse their policies.  If the healthier policyholders allow their policies to lapse, this would reduce our premium income and profitability in the future.

86

Total premium collections by segment were as follows:

Bankers Life (dollars in millions)

	2015		2014		2013
Premiums collected by product:
Annuities:
Fixed index (first-year)	$	706.6	$	646.2	$	566.8
Other fixed interest (first-year)	89.6		129.1		170.6
Other fixed interest (renewal)	6.8		7.0		6.7
Subtotal - other fixed interest annuities	96.4		136.1		177.3
Total annuities	803.0		782.3		744.1
Health:
Medicare supplement (first-year)	80.3		88.6		92.1
Medicare supplement (renewal)	659.1		654.7		653.2
Subtotal - Medicare supplement	739.4		743.3		745.3
Long-term care (first-year)	16.7		16.8		21.2
Long-term care (renewal)	459.9		483.8		512.8
Subtotal - long-term care	476.6		500.6		534.0
PDP (first year)	—		—		.1
PDP (renewal)	—		6.8		18.1
Subtotal – PDP	—		6.8		18.2
Supplemental health (first-year)	6.1		7.6		8.3
Supplemental health (renewal)	13.1		8.7		1.6
Subtotal – supplemental health	19.2		16.3		9.9
Other health (first-year)	.1		.7		1.3
Other health (renewal)	7.0		7.4		9.1
Subtotal - other health	7.1		8.1		10.4
Total health	1,242.3		1,275.1		1,317.8
Life insurance:
Traditional (fist-year)	83.0		91.6		117.5
Traditional (renewal)	193.9		163.5		125.0
Subtotal - traditional	276.9		255.1		242.5
Interest-sensitive (first-year)	83.3		100.2		65.9
Interest-sensitive (renewal)	85.8		69.6		59.9
Subtotal - interest-sensitive	169.1		169.8		125.8
Total life insurance	446.0		424.9		368.3
Collections on insurance products:
Total first-year premium collections on insurance products	1,065.7		1,080.8		1,043.8
Total renewal premium collections on insurance products	1,425.6		1,401.5		1,386.4
Total collections on insurance products	$	2,491.3	$	2,482.3	$	2,430.2

Annuities in this segment include fixed index and other fixed interest annuities sold to the senior market. Annuity collections in this segment increased 2.6 percent, to $803.0 million in 2015 and 5.1 percent, to $782.3 million, in 2014. Premium collections from our fixed index products were favorably impacted in 2015 and 2014 by the general stock market performance which made these products attractive to certain customers. Premium collections from Bankers Life's other fixed interest annuity products have decreased in recent periods as low new money rates negatively impacted our sales and the overall sales in the fixed rate annuity market.

87

Health products include Medicare supplement, long-term care and other insurance products. Our profits on health policies depend on the overall level of sales, the length of time the business remains inforce, investment yields, claims experience and expense management.

Collected premiums on Medicare supplement policies in the Bankers Life segment decreased .5 percent, to $739.4 million, in 2015 and .3 percent, to $743.3 million, in 2014. In recent periods, we experienced a slight shift in the sale of Medicare supplement policies to the sale of Medicare Advantage policies. Medicare Advantage policies are sold through Bankers Life's agency force for other providers in exchange for marketing fees.

Premiums collected on Bankers Life's long-term care policies decreased 4.8 percent, to $476.6 million in 2015 and 6.3 percent, to $500.6 million in 2014, reflecting the run-off of this business and a continuing shift in the mix of new business to shorter duration long-term care sales, which have lower premiums per policy.

Premiums collected on PDP business related to our quota-share reinsurance agreement with Coventry. In August 2013, we received a notice of Coventry's intent to terminate our PDP quota-share reinsurance agreement as further described in the note to the consolidated financial statements entitled "Summary of Significant Accounting Policies - Reinsurance". The premiums collected in 2014 represent adjustments to premiums on such business related to periods prior to the termination of the agreement.

Premiums collected on supplemental health products relate to a new critical illness product that was introduced in 2012.

Life products in this segment include traditional and interest-sensitive life products. Life premiums collected in this segment increased 5.0 percent, to $446.0 million, in 2015 and 15 percent, to $424.9 million, in 2014. Collected premiums in 2015 reflect higher persistency; partially offset by lower first-year premiums including reduced sales of single premium life products.

88

Washington National (dollars in millions)

	2015		2014		2013
Premiums collected by product:
Health:
Medicare supplement (first-year)	$	—	$	—	$	.3
Medicare supplement (renewal)	72.6		85.2		101.6
Subtotal - Medicare supplement	72.6		85.2		101.9
Supplemental health (first-year)	74.9		72.8		64.7
Supplemental health (renewal)	469.9		442.6		426.6
Subtotal – supplemental health	544.8		515.4		491.3
Other health (first-year)	.2		.2		.2
Other health (renewal)	2.0		2.2		2.9
Subtotal – other health	2.2		2.4		3.1
Total health	619.6		603.0		596.3
Life insurance:
Traditional (fist-year)	.7		.6		.7
Traditional (renewal)	11.4		12.3		12.7
Subtotal - traditional	12.1		12.9		13.4
Interest-sensitive (first-year)	4.3		3.8		3.9
Interest-sensitive (renewal)	11.3		9.2		9.2
Subtotal - interest-sensitive	15.6		13.0		13.1
Total life insurance	27.7		25.9		26.5
Annuities:
Fixed index (first-year)	.1		.2		.4
Fixed index (renewal)	1.8		1.8		3.4
Subtotal - fixed index annuities	1.9		2.0		3.8
Other fixed interest (renewal)	.5		.6		.5
Total annuities	2.4		2.6		4.3
Collections on insurance products:
Total first-year premium collections on insurance products	80.2		77.6		70.2
Total renewal premium collections on insurance products	569.5		553.9		556.9
Total collections on insurance products	$	649.7	$	631.5	$	627.1

Health products in the Washington National segment include Medicare supplement, supplemental health and other insurance products. Our profits on health policies depend on the overall level of sales, the length of time the business remains inforce, investment yields, claim experience and expense management.

Collected premiums on Medicare supplement policies in the Washington National segment decreased 15 percent, to $72.6 million, in 2015 and 16 percent, to $85.2 million, in 2014 due to the run-off of this block of business. We discontinued new sales of Medicare supplement policies in this segment in the fourth quarter of 2012.

Premiums collected on supplemental health products (including specified disease, accident and hospital indemnity insurance products) increased 5.7 percent, to $544.8 million, in 2015 and 4.9 percent, to $515.4 million, in 2014. Such increases are due to new sales in recent periods and steady persistency.

Overall, excluding premiums from the Washington National Medicare supplement and annuity blocks which are in run-off, collected premiums were up 5.7 percent in 2015 compared to 2014, driven by strong sales and persistency.

Life premiums collected in the Washington National segment increased 6.9 percent, to $27.7 million, in 2015 and decreased 2.3 percent, to $25.9 million, in 2014.

89

Annuities in this segment include fixed index and other fixed interest annuities. We are no longer actively pursuing sales of annuity products in this segment.

Colonial Penn (dollars in millions)

	2015		2014		2013
Premiums collected by product:
Life insurance:
Traditional (fist-year)	$	51.5	$	45.7	$	45.2
Traditional (renewal)	208.2		195.6		182.1
Subtotal - traditional	259.7		241.3		227.3
Interest-sensitive (all renewal)	.2		.4		.3
Total life insurance	259.9		241.7		227.6
Health (all renewal):
Medicare supplement	2.7		3.2		3.7
Other health	.3		.2		.4
Total health	3.0		3.4		4.1
Collections on insurance products:
Total first-year premium collections on insurance products	51.5		45.7		45.2
Total renewal premium collections on insurance products	211.4		199.4		186.5
Total collections on insurance products	$	262.9	$	245.1	$	231.7

Life products in this segment are sold primarily to the senior market. Life premiums collected in this segment increased 7.5 percent, to $259.9 million, in 2015 and 6.2 percent, to $241.7 million, in 2014. Graded benefit life products sold through our direct response marketing channel accounted for $257.6 million, $239.5 million and $225.2 million of collected premiums in 2015, 2014 and 2013, respectively. Premiums collected reflect strong sales in 2015 due to the positive impact from marketing and telesales productivity initiatives, increased lead generation investments and recovery from a weak first quarter of 2014.

Health products include Medicare supplement and other insurance products. Our profits on health policies depend on the overall level of sales, the length of time the business remains inforce, investment yields, claims experience and expense management. Premiums collected on these products have decreased as we do not currently market these products through this segment.

Other CNO Business (dollars in millions)

	2013
Premiums collected by product:
Health:
Long-term care (all renewal)	$	23.6

The Other CNO Business segment reflected the long-term care premiums collected prior to the reinsurance agreement with BRe effective December 31, 2013. Refer to the note to the consolidated financial statements entitled "Summary of Significant Accounting Policies - Reinsurance" for additional information.

90

INVESTMENTS

Our investment strategy is to: (i) provide largely stable investment income from a diversified high quality fixed income portfolio; (ii) mitigate the effect of changing interest rates through active asset/liability management; (iii) provide liquidity to meet our cash obligations to policyholders and others; and (iv) maximize total return through active investment management. Consistent with this strategy, investments in fixed maturity securities, mortgage loans and policy loans made up 89 percent of our $24.5 billion investment portfolio at December 31, 2015. The remainder of the invested assets was trading securities, investments held by variable interest entities, equity securities and other invested assets.

The following table summarizes the composition of our investment portfolio as of December 31, 2015 (dollars in millions):

	Carrying value		Percent of total investments
Fixed maturities, available for sale	$	19,882.9	81	%
Equity securities	463.0		2
Mortgage loans	1,721.0		7
Policy loans	109.4		—
Trading securities	262.1		1
Investments held by variable interest entities	1,633.6		7
Company-owned life insurance	158.1		1
Other invested assets	257.0		1
Total investments	$	24,487.1	100	%

Insurance statutes regulate the types of investments that our insurance subsidiaries are permitted to make and limit the amount of funds that may be used for any one type of investment. In addition, we have internal management compliance limits on various exposures and activities which are typically more restrictive than insurance statutes. In light of these statutes and regulations and our business and investment strategy, we generally seek to invest in United States government and government-agency securities and corporate securities rated investment grade by established nationally recognized rating organizations or in securities of comparable investment quality, if not rated.

91

The following table summarizes the carrying values and gross unrealized losses of our fixed maturity securities, available for sale, by category as of December 31, 2015 (dollars in millions):

	Carrying value		Percent of fixed maturities		Gross unrealized losses		Percent of gross unrealized losses
States and political subdivisions	$	2,104.2	10.6	%	$	7.6	2.0	%
Asset-backed securities	1,852.2		9.3		13.4		3.5
Utilities	1,625.5		8.2		3.3		.9
Commercial mortgage-backed securities	1,605.3		8.1		17.6		4.5
Energy	1,514.1		7.6		160.9		41.4
Insurance	1,403.8		7.1		13.6		3.5
Healthcare/pharmaceuticals	1,270.1		6.4		18.4		4.7
Collateralized mortgage obligations	1,047.4		5.3		1.6		.4
Food/beverage	848.1		4.3		7.1		1.8
Banks	792.8		4.0		5.7		1.5
Cable/media	682.4		3.4		27.4		7.0
Real estate/REITs	627.1		3.2		1.1		.3
Capital goods	464.0		2.3		10.4		2.7
Transportation	423.4		2.1		5.5		1.4
Chemicals	409.8		2.1		13.7		3.5
Telecom	362.6		1.8		7.6		1.9
Aerospace/defense	302.4		1.5		2.1		.5
Building materials	279.7		1.4		2.0		.5
Business services	261.7		1.3		8.1		2.1
Brokerage	243.9		1.2		1.7		.4
Paper	237.1		1.1		2.6		.7
Autos	218.4		1.1		3.6		.9
Metals and mining	213.3		1.1		37.1		9.6
U.S. Treasury and Obligations	194.5		1.0		.3		.1
Other	899.1		4.5		16.1		4.2
Total fixed maturities, available for sale	$	19,882.9	100.0	%	$	388.5	100.0	%

At December 31, 2015, the carrying value of the Company's fixed maturity securities in the energy sector was $1.5 billion, with gross unrealized gains of $59.4 million and gross unrealized losses of $160.9 million. Although these securities are of high quality (90 percent are rated investment grade) and diversified (81 issuers), we could be exposed to future downgrades and declines in market values if oil prices remain at low levels for an extended period of time.

92

The following table summarizes the gross unrealized losses of our fixed maturity securities, available for sale, by category and ratings category as of December 31, 2015 (dollars in millions):

	Investment grade				Below-investment grade
	AAA/AA/A		BBB		BB		B+ and below		Total gross unrealized losses
Energy	$	1.0	$	117.9	$	26.8	$	15.2	$	160.9
Metals and mining	2.0		27.3		7.8		—		37.1
Cable/media	—		23.5		3.7		.2		27.4
Healthcare/pharmaceuticals	2.9		14.6		.2		.7		18.4
Commercial mortgage-backed securities	13.3		3.0		1.3		—		17.6
Chemicals	—		12.7		1		—		13.7
Insurance	3.3		10.3		—		—		13.6
Asset-backed securities	3.8		3.4		.6		5.6		13.4
Capital goods	—		8.5		.6		1.3		10.4
Business services	—		1.8		6.3		—		8.1
States and political subdivisions	3.0		.7		—		3.9		7.6
Telecom	—		3.3		.5		3.8		7.6
Food/beverage	.7		6.3		.1		—		7.1
Retail	—		.9		—		5.4		6.3
Banks	1.4		4.3		—		—		5.7
Transportation	—		4.3		—		1.2		5.5
Technology	—		4.6		—		.2		4.8
Autos	—		3.6		.1		—		3.7
Utilities	.1		2.6		—		.6		3.3
Paper	—		2.3		—		.3		2.6
Collateralized debt obligations	1.6		.6		—		—		2.2
Aerospace/defense	.1		—		.1		1.9		2.1
Building materials	—		—		1.7		.3		2.0
Brokerage	.3		1.2		.1		.1		1.7
Collateralized mortgage obligations	.3		.3		.1		.9		1.6
Real estate/REITs	.1		.8		.2		—		1.1
Gaming	—		—		.7		—		.7
Debt securities issued by foreign governments	.1		.5		—		—		.6
United States Treasury securities and obligations of United States government corporations and agencies	.3		—		—		—		.3
Other	.1		.1		1.2		—		1.4
Total fixed maturities, available for sale	$	34.4	$	259.4	$	53.1	$	41.6	$	388.5

Our investment strategy is to maximize, over a sustained period and within acceptable parameters of quality and risk, investment income and total investment return through active investment management.  Accordingly, we may sell securities at a gain or a loss to enhance the projected total return of the portfolio as market opportunities change, to reflect changing perceptions of risk, or to better match certain characteristics of our investment portfolio with the corresponding characteristics of our insurance liabilities.

93

Our fixed maturity securities consist predominantly of publicly traded securities. We classify securities issued in the Rule 144A market as publicly traded. Securities not publicly traded comprise approximately 10 percent of our total fixed maturity securities portfolio.

Fair Value of Investments

Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date and, therefore, represents an exit price, not an entry price.  We carry certain assets and liabilities at fair value on a recurring basis, including fixed maturities, equity securities, trading securities, investments held by VIEs, derivatives, cash and cash equivalents, separate account assets and embedded derivatives.  We carry our COLI, which is backed by a series of mutual funds, at its cash surrender value which approximates fair value. In addition, we disclose fair value for certain financial instruments, including mortgage loans and policy loans, insurance liabilities for interest-sensitive products, investment borrowings, notes payable and borrowings related to VIEs.

The degree of judgment utilized in measuring the fair value of financial instruments is largely dependent on the level to which pricing is based on observable inputs.  Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our view of market assumptions in the absence of observable market information.  Financial instruments with readily available active quoted prices would be considered to have fair values based on the highest level of observable inputs, and little judgment would be utilized in measuring fair value.  Financial instruments that rarely trade would often have fair value based on a lower level of observable inputs, and more judgment would be utilized in measuring fair value.

Valuation Hierarchy

There is a three-level hierarchy for valuing assets or liabilities at fair value based on whether inputs are observable or unobservable.

• Level 1 – includes assets and liabilities valued using inputs that are unadjusted quoted prices in active markets for identical assets or liabilities.  Our Level 1 assets primarily include cash and exchange traded securities.

• Level 2 – includes assets and liabilities valued using inputs that are quoted prices for similar assets in an active market, quoted prices for identical or similar assets in a market that is not active, observable inputs, or observable inputs that can be corroborated by market data.  Level 2 assets and liabilities include those financial instruments that are valued by independent pricing services using models or other valuation methodologies.  These models consider various inputs such as credit rating, maturity, corporate credit spreads, reported trades and other inputs that are observable or derived from observable information in the marketplace or are supported by transactions executed in the marketplace.  Financial assets in this category primarily include:  certain publicly registered and privately placed corporate fixed maturity securities; certain government or agency securities; certain mortgage and asset-backed securities; certain equity securities; most investments held by our consolidated VIEs; certain mutual fund investments; most short-term investments; and non-exchange-traded derivatives such as call options. Financial liabilities in this category include investment borrowings, notes payable and borrowings related to VIEs.

• Level 3 – includes assets and liabilities valued using unobservable inputs that are used in model-based valuations that contain management assumptions.  Level 3 assets and liabilities include those financial instruments whose fair value is estimated based on broker/dealer quotes, pricing services or internally developed models or methodologies utilizing significant inputs not based on, or corroborated by, readily available market information.  Financial assets in this category include certain corporate securities (primarily certain below-investment grade privately placed securities), certain structured securities, mortgage loans, and other less liquid securities.  Financial liabilities in this category include our insurance liabilities for interest-sensitive products, which includes embedded derivatives (including embedded derivatives related to our fixed index annuity products and to a modified coinsurance arrangement) since their values include significant unobservable inputs including actuarial assumptions.

At each reporting date, we classify assets and liabilities into the three input levels based on the lowest level of input that is significant to the measurement of fair value for each asset and liability reported at fair value.  This classification is impacted by a number of factors, including the type of financial instrument, whether the financial instrument is new to the market and not yet established, the characteristics specific to the transaction and overall market conditions.  Our assessment of the significance of a particular input to the fair value measurement and the ultimate classification of each asset and liability requires judgment and is subject to change from period to period based on the observability of the valuation inputs. Any transfers between levels

94

are reported as having occurred at the beginning of the period. There were no transfers between Level 1 and Level 2 in both 2015 and 2014.

The vast majority of our fixed maturity and equity securities, including those held in trading portfolios and those held by consolidated VIEs, short-term and separate account assets use Level 2 inputs for the determination of fair value.  These fair values are obtained primarily from independent pricing services, which use Level 2 inputs for the determination of fair value.  Our Level 2 assets are valued as follows:

•Fixed maturities available for sale, equity securities and trading securities

Corporate securities are generally priced using market and income approaches. Inputs generally consist of trades of identical or similar securities, quoted prices in inactive markets, issuer rating, benchmark yields, maturity, and credit spreads.

U.S. Treasuries and obligations of U.S. Government corporations and agencies are generally priced using the market approach. Inputs generally consist of trades of identical or similar securities, quoted prices in inactive markets and maturity.

States and political subdivisions are generally priced using the market approach. Inputs generally consist of trades of identical or similar securities, quoted prices in inactive markets, new issuances and credit spreads.

Asset-backed securities, collateralized debt obligations, commercial mortgage-backed securities, mortgage pass-through securities and collateralized mortgage obligations are generally priced using market and income approaches. Inputs generally consist of quoted prices in inactive markets, spreads on actively traded securities, expected prepayments, expected credit default rates, delinquencies, and issue specific information including, but not limited to, collateral type, seniority and vintage.

Equity securities (primarily comprised of non-redeemable preferred stock) are generally priced using the market approach. Inputs generally consist of trades of identical or similar securities, quoted prices in inactive markets, issuer rating, benchmark yields, maturity, and credit spreads.

• Investments held by VIEs

Corporate securities are generally priced using market and income approaches using pricing vendors. Inputs generally consist of issuer rating, benchmark yields, maturity, and credit spreads.

• Other invested assets - derivatives

The fair value measurements for derivative instruments, including embedded derivatives requiring bifurcation, are determined based on the consideration of several inputs including closing exchange or over-the-counter market price quotes; time value and volatility factors underlying options; market interest rates; and non-performance risk.

Third party pricing services normally derive security prices through recently reported trades for identical or similar securities making adjustments through the reporting date based upon available market observable information.  If there are no recently reported trades, the third party pricing services may use matrix or model processes to develop a security price where future cash flow expectations are discounted at an estimated risk-adjusted market rate.  The number of prices obtained for a given security is dependent on the Company's analysis of such prices as further described below.

As the Company is responsible for the determination of fair value, we have control processes designed to ensure that the fair values received from third-party pricing sources are reasonable and the valuation techniques and assumptions used appear reasonable and consistent with prevailing market conditions. Additionally, when inputs are provided by third-party pricing sources, we have controls in place to review those inputs for reasonableness. As part of these controls, we perform monthly quantitative and qualitative analysis on the prices received from third parties to determine whether the prices are reasonable estimates of fair value.  The Company's analysis includes:  (i) a review of the methodology used by third party pricing services; (ii) where available, a comparison of multiple pricing services' valuations for the same security; (iii) a review of month to month price fluctuations; (iv) a review to ensure valuations are not unreasonably dated; and (v) back testing to compare actual purchase and sale transactions with valuations received from third parties.  As a result of such procedures, the Company may

95

conclude the prices received from third parties are not reflective of current market conditions.  In those instances, we may request additional pricing quotes or apply internally developed valuations.  However, the number of such instances is insignificant and the aggregate change in value of such investments is not materially different from the original prices received.

The categorization of the fair value measurements of our investments priced by independent pricing services was based upon the Company's judgment of the inputs or methodologies used by the independent pricing services to value different asset classes.  Such inputs typically include:  benchmark yields, reported trades, broker dealer quotes, issuer spreads, benchmark securities, bids, offers and reference data.  The Company categorizes such fair value measurements based upon asset classes and the underlying observable or unobservable inputs used to value such investments.

For securities that are not priced by pricing services and may not be reliably priced using pricing models, we obtain broker quotes.  These broker quotes are non-binding andrepresent an exit price, but assumptions used to establish the fair value may not be observable and therefore represent Level 3 inputs.  Approximately 45 percent of our Level 3 fixed maturity securities were valued using unadjusted broker quotes or broker-provided valuation inputs.  The remaining Level 3 fixed maturity investments do not have readily determinable market prices and/or observable inputs.  For these securities, we use internally developed valuations.  Key assumptions used to determine fair value for these securities may include risk premiums, projected performance of underlying collateral and other factors involving significant assumptions which may not be reflective of an active market.  For certain investments, we use a matrix or model process to develop a security price where future cash flow expectations are discounted at an estimated market rate.  The pricing matrix incorporates term interest rates as well as a spread level based on the issuer's credit rating, other factors relating to the issuer, and the security's maturity.  In some instances issuer-specific spread adjustments, which can be positive or negative, are made based upon internal analysis of security specifics such as liquidity, deal size, and time to maturity.

For certain embedded derivatives, we use actuarial assumptions in the determination of fair value which we consider to be Level 3 inputs.

96

The categorization of fair value measurements, by input level, for our financial instruments carried at fair value on a recurring basis at December 31, 2015 is as follows (dollars in millions):

	Quoted prices in active markets for identical assets or liabilities (Level 1)		Significant other observable inputs (Level 2)		Significant unobservable inputs  (Level 3)		Total
Assets:
Fixed maturities, available for sale:
Corporate securities	$	—	$	12,698.1	$	170.4	$	12,868.5
United States Treasury securities and obligations of United States government corporations and agencies	—		194.5		—		194.5
States and political subdivisions	—		2,104.2		—		2,104.2
Debt securities issued by foreign governments	—		20.7		—		20.7
Asset-backed securities	—		1,816.3		35.9		1,852.2
Collateralized debt obligations	—		186.7		—		186.7
Commercial mortgage-backed securities	—		1,604.2		1.1		1,605.3
Mortgage pass-through securities	—		3.3		.1		3.4
Collateralized mortgage obligations	—		1,047.4		—		1,047.4
Total fixed maturities, available for sale	—		19,675.4		207.5		19,882.9
Equity securities - corporate securities	254.9		176.1		32.0		463.0
Trading securities:
Corporate securities	—		21.5		—		21.5
United States Treasury securities and obligations of United States government corporations and agencies	—		1.9		—		1.9
Asset-backed securities	—		35.5		—		35.5
Collateralized debt obligations	—		2.1		—		2.1
Commercial mortgage-backed securities	—		118.1		39.9		158.0
Collateralized mortgage obligations	—		38.2		—		38.2
Equity securities	4.9		—		—		4.9
Total trading securities	4.9		217.3		39.9		262.1
Investments held by variable interest entities - corporate securities	—		1,633.6		—		1,633.6
Other invested assets - derivatives	1.6		41.0		—		42.6
Assets held in separate accounts	—		4.7		—		4.7
Total assets carried at fair value by category	$	261.4	$	21,748.1	$	279.4	$	22,288.9
Liabilities:
Future policy benefits - embedded derivatives associated with fixed index annuity products	$	—	$	—	$	1,057.1	$	1,057.1

97

The following table presents additional information about assets and liabilities measured at fair value on a recurring basis and for which we have utilized significant unobservable (Level 3) inputs to determine fair value for the year ended December 31, 2015 (dollars in millions):

	December 31, 2015
	Beginning balance as of December 31, 2014			Purchases, sales, issuances and settlements, net (b)			Total realized and unrealized gains (losses) included in net income			Total realized and unrealized gains (losses) included in accumulated other comprehensive income (loss)			Transfers into Level 3 (a)		Transfers out of Level 3 (a)			Ending balance as of December 31, 2015			Amount of total gains (losses) for the year ended December 31, 2015 included in our net income relating to assets and liabilities still held as of the reporting date
Assets:
Fixed maturities, available for sale:
Corporate securities	$	365.9		$	31.0		$	(2.2	)	$	(19.5	)	$	37.4	$	(242.2	)	$	170.4		$	—
States and political subdivisions	35.5			(35.5		)	—			—			—		—			—			—
Asset-backed securities	59.2			6.7			—			(1.4		)	—		(28.6		)	35.9			—
Collateralized debt obligations	—			—			—			—			—		—			—			—
Commercial mortgage-backed securities	1.2			(.1		)	—			—			—		—			1.1			—
Mortgage pass-through securities	.4			(.3		)	—			—			—		—			.1			—
Total fixed maturities, available for sale	462.2			1.8			(2.2		)	(20.9		)	37.4		(270.8		)	207.5			—
Equity securities - corporate securities	28.0			4.0			—			—			—		—			32.0			—
Trading securities - commercial mortgage-backed securities	28.6			9.5			—			1.8			—		—			39.9			1.8
Liabilities:
Future policy benefits - embedded derivatives associated with fixed index annuity products	(1,081.5		)	(11.9		)	36.3			—			—		—			(1,057.1		)	36.3

98

_________

(a) Transfers into Level 3 are the result of unobservable inputs utilized within valuation methodologies for assets that were previously valued using observable inputs. Transfers out of Level 3 are due to the use of observable inputs in valuation methodologies as well as the utilization of pricing service information for certain assets that the Company is able to validate.

(b) Purchases, sales, issuances and settlements, net, represent the activity that occurred during the period that results in a change of the asset or liability but does not represent changes in fair value for the instruments held at the beginning of the period.  Such activity primarily consists of purchases and sales of fixed maturity and equity securities and changes to embedded derivative instruments related to insurance products resulting from the issuance of new contracts, or changes to existing contracts.  The following summarizes such activity for the year ended December 31, 2015 (dollars in millions):

	Purchases			Sales			Issuances			Settlements		Purchases, sales, issuances and settlements, net
Assets:
Fixed maturities, available for sale:
Corporate securities	$	62.2		$	(31.2	)	$	—		$	—	$	31.0
States and political subdivisions	—			(35.5		)	—			—		(35.5		)
Asset-backed securities	13.7			(7.0		)	—			—		6.7
Commercial mortgage-backed securities	—			(.1		)	—			—		(.1		)
Mortgage pass-through securities	—			(.3		)	—			—		(.3		)
Total fixed maturities, available for sale	75.9			(74.1		)	—			—		1.8
Equity securities - corporate securities	4.0			—			—			—		4.0
Trading securities - commercial mortgage-backed securities	9.5			—			—			—		9.5
Liabilities:
Future policy benefits - embedded derivatives associated with fixed index annuity products	(137.8		)	64.4			(4.0		)	65.5		(11.9		)

At December 31, 2015, 45 percent of our Level 3 fixed maturities, available for sale, were investment grade and 82 percent of our Level 3 fixed maturities, available for sale, consisted of corporate securities.

Realized and unrealized investment gains and losses presented in the preceding tables represent gains and losses during the time the applicable financial instruments were classified as Level 3.

Realized and unrealized gains (losses) on Level 3 assets are primarily reported in either net investment income for policyholder and reinsurer accounts and other special-purpose portfolios, net realized investment gains (losses) or insurance policy benefits within the consolidated statement of operations or accumulated other comprehensive income within shareholders' equity based on the appropriate accounting treatment for the instrument.

The amount presented for gains (losses) included in our net loss for assets and liabilities still held as of the reporting date primarily represents impairments for fixed maturities, available for sale, changes in fair value of trading securities and certain derivatives and changes in fair value of embedded derivative instruments included in liabilities for insurance products that exist as of the reporting date.

99

Investment ratings are assigned the second lowest rating by Nationally Recognized Statistical Rating Organizations (Moody's, S&P or Fitch), or if not rated by such firms, the rating assigned by the NAIC.  NAIC designations of "1" or "2" include fixed maturities generally rated investment grade (rated "Baa3" or higher by Moody's or rated "BBB-" or higher by S&P and Fitch).  NAIC designations of "3" through "6" are referred to as below-investment grade (which generally are rated "Ba1" or lower by Moody's or rated "BB+" or lower by S&P and Fitch).  References to investment grade or below-investment grade throughout our consolidated financial statements are determined as described above. The following table sets forth fixed maturity investments at December 31, 2015, classified by ratings (dollars in millions):

			Estimated fair value
Investment rating	Amortized cost		Amount		Percent of fixed maturities
AAA	$	996.1	$	1,046.0	5	%
AA	1,700.2		1,873.4		10
A	5,215.3		5,687.8		29
BBB+	2,495.9		2,654.9		13
BBB	3,410.7		3,464.1		17
BBB-	2,894.3		2,933.9		15
Investment grade	16,712.5		17,660.1		89
BB+	238.0		233.2		1
BB	312.4		283.6		1
BB-	298.0		292.8		2
B+ and below	1,386.1		1,413.2		7
Below-investment grade	2,234.5		2,222.8		11
Total fixed maturity securities	$	18,947.0	$	19,882.9	100	%

The following table summarizes investment yields earned over the past three years on the general account invested assets of our insurance subsidiaries. General account investments exclude the value of options (dollars in millions).

	2015			2014			2013
Weighted average general account invested assets at amortized cost	$	21,624.6		$	22,939.9		$	24,693.2
Net investment income on general account invested assets	1,217.7			1,304.3			1,412.5
Yield earned	5.63		%	5.69		%	5.72		%

Although investment income is a significant component of total revenues, the profitability of certain of our insurance products is evaluated primarily by the spreads between the interest rates we earn and the rates we credit or accrue to our insurance liabilities. At December 31, 2015 and 2014, the average yield, computed on the cost basis of our fixed maturity portfolio, was 5.5 percent and 5.6 percent, respectively, and the average interest rate credited or accruing to our total insurance liabilities (excluding interest rate bonuses for the first policy year only and excluding the effect of credited rates attributable to variable or fixed index products) was 4.5 percent.

Fixed Maturities, Available for Sale

Our fixed maturity portfolio at December 31, 2015, included primarily debt securities of the United States government, various corporations, and structured securities. Asset-backed securities, collateralized debt obligations, commercial mortgage-backed securities, mortgage pass-through securities and collateralized mortgage obligations are collectively referred to as "structured securities".

At December 31, 2015, our fixed maturity portfolio had $1,324.4 million of unrealized gains and $388.5 million of unrealized losses, for a net unrealized gain of $935.9 million. Estimated fair values of fixed maturity investments were determined based on estimates from: (i) nationally recognized pricing services (90 percent of the portfolio); (ii) broker-dealer market makers (1 percent of the portfolio); and (iii) internally developed methods (9 percent of the portfolio).

At December 31, 2015, approximately 9 percent of our invested assets (11 percent of fixed maturity investments) were fixed maturities rated below-investment grade. Our level of investments in below-investment grade fixed maturities could

100

change based on market conditions or changes in our management policies. Below-investment grade corporate debt securities typically have different characteristics than investment grade corporate debt securities. Based on historical performance, probability of default by the borrower is significantly greater for below-investment grade securities and in many cases severity of loss is relatively greater as such securities are generally unsecured and often subordinated to other indebtedness of the issuer. Also, issuers of below-investment grade corporate debt securities frequently have higher levels of debt relative to investment-grade issuers, hence, all other things being equal, are more sensitive to adverse economic conditions. The Company attempts to reduce the overall risk related to its investment in below-investment grade securities, as in all investments, through careful credit analysis, strict investment policy guidelines, and diversification by issuer and/or guarantor and by industry. At December 31, 2015, our below-investment grade fixed maturity investments had an amortized cost of $2,234.5 million and an estimated fair value of $2,222.8 million.

We continually evaluate the creditworthiness of each issuer whose securities we hold. We pay special attention to large investments, investments which have significant risk characteristics and to those securities whose fair values have declined materially for reasons other than changes in general market conditions. We evaluate the realizable value of the investment, the specific condition of the issuer and the issuer's ability to comply with the material terms of the security. We review the recent operational results and financial position of the issuer, information about its industry, information about factors affecting the issuer's performance and other information. 40|86 Advisors employs experienced securities analysts in a broad variety of specialty areas who compile and review such data. If evidence does not exist to support a realizable value equal to or greater than the amortized cost of the investment, and such decline in fair value is determined to be other than temporary, we reduce the amortized cost to its fair value, which becomes the new cost basis. We report the amount of the reduction as a realized loss. We recognize any recovery of such reductions as investment income over the remaining life of the investment (but only to the extent our current valuations indicate such amounts will ultimately be collected), or upon the repayment of the investment. During 2015, we recognized net realized investment losses of $36.6 million, which were comprised of: (i) $1.0 million of net losses from the sales of investments; (ii) an $11.3 million gain on the dissolution of a VIE; (iii) the decrease in fair value of embedded derivatives related to a modified coinsurance agreement of $7.0 million; and (iv) $39.9 million of writedowns of investments for other than temporary declines in fair value recognized through net income ($42.9 million, prior to the $3.0 million of impairment losses recognized through accumulated other comprehensive income). Our investment portfolio is subject to the risk of declines in realizable value. However, we attempt to mitigate this risk through the diversification and active management of our portfolio.

Our investment strategy is to maximize, over a sustained period and within acceptable parameters of quality and risk, investment income and total investment return through active investment management.  Accordingly, we may sell securities at a gain or a loss to enhance the projected total return of the portfolio as market opportunities change, to reflect changing perceptions of risk, or to better match certain characteristics of our investment portfolio with the corresponding characteristics of our insurance liabilities.

As of December 31, 2015, we had no investments in substantive default (i.e., in default due to nonpayment of interest or principal). There were no other fixed maturity investments about which we had serious doubts as to the recoverability of the carrying value of the investment.

When a security defaults or securities (other than structured securities) are other-than-temporarily impaired, our policy is to discontinue the accrual of interest and eliminate all previous interest accruals, if we determine that such amounts will not be ultimately realized in full. Investment income forgone on nonperforming investments was less than $.1 million for the years ended December 31, 2015 and 2014 and $.5 million for the year ended December 31, 2013.

At December 31, 2015, fixed maturity investments included structured securities with an estimated fair value of $4.7 billion (or 24 percent of all fixed maturity securities).  The yield characteristics of structured securities generally differ in some respects from those of traditional corporate fixed-income securities or government securities.  For example, interest and principal payments on structured securities may occur more frequently, often monthly.  In many instances, we are subject to variability in the amount and timing of principal and interest payments.  For example, in many cases, partial prepayments may occur at the option of the issuer and prepayment rates are influenced by a number of factors that cannot be predicted with certainty, including:  the relative sensitivity of prepayments on the underlying assets backing the security to changes in interest rates and asset values; the availability of alternative financing; a variety of economic, geographic and other factors; the timing, pace and proceeds of liquidations of defaulted collateral; and various security-specific structural considerations (for example, the repayment priority of a given security in a securitization structure).  In addition, the total amount of payments for non-agency structured securities may be affected by changes to cumulative default rates or loss severities of the related collateral.

101

Historically, the rate of prepayments on structured securities has tended to increase when prevailing interest rates have declined significantly in absolute terms and also relative to the interest rates on the underlying collateral. The yields recognized on structured securities purchased at a discount to par will generally increase (relative to the stated rate) when the underlying collateral prepays faster than expected. The yields recognized on structured securities purchased at a premium will decrease (relative to the stated rate) when the underlying collateral prepays faster than expected. When interest rates decline, the proceeds from prepayments may be reinvested at lower rates than we were earning on the prepaid securities. When interest rates increase, prepayments may decrease below expected levels. When this occurs, the average maturity and duration of structured securities increases, decreasing the yield on structured securities purchased at discounts and increasing the yield on those purchased at a premium because of a decrease in the annual amortization of premium.

For structured securities included in fixed maturities, available for sale, that were purchased at a discount or premium, we recognize investment income using an effective yield based on anticipated future prepayments and the estimated final maturity of the securities. Actual prepayment experience is periodically reviewed and effective yields are recalculated when differences arise between the prepayments originally anticipated and the actual prepayments received and currently anticipated. For credit sensitive mortgage-backed and asset-backed securities, and for securities that can be prepaid or settled in a way that we would not recover substantially all of our investment, the effective yield is recalculated on a prospective basis. Under this method, the amortized cost basis in the security is not immediately adjusted and a new yield is applied prospectively. For all other structured and asset-backed securities, the effective yield is recalculated when changes in assumptions are made, and reflected in our income on a retrospective basis. Under this method, the amortized cost basis of the investment in the securities is adjusted to the amount that would have existed had the new effective yield been applied since the acquisition of the securities. Such adjustments were not significant in 2015.

The following table sets forth the par value, amortized cost and estimated fair value of structured securities, summarized by interest rates on the underlying collateral, at December 31, 2015 (dollars in millions):

	Par value		Amortized cost		Estimated fair value
Below 4 percent	$	1,387.4	$	978.3	$	982.3
4 percent – 5 percent	1,363.8		1,289.7		1,300.0
5 percent – 6 percent	1,868.3		1,747.4		1,822.2
6 percent – 7 percent	454.6		419.4		445.2
7 percent – 8 percent	75.0		75.7		82.5
8 percent and above	64.0		63.5		62.8
Total structured securities	$	5,213.1	$	4,574.0	$	4,695.0

The amortized cost and estimated fair value of structured securities at December 31, 2015, summarized by type of security, were as follows (dollars in millions):

			Estimated fair value
Type	Amortized cost		Amount		Percent of fixed maturities
Pass-throughs, sequential and equivalent securities	$	750.0	$	799.8	4.0	%
Planned amortization classes, target amortization classes and accretion-directed bonds	187.7		202.4		1.0
Commercial mortgage-backed securities	1,581.6		1,605.3		8.1
Asset-backed securities	1,817.8		1,852.2		9.3
Collateralized debt obligations	188.5		186.7		.9
Other	48.4		48.6		.3
Total structured securities	$	4,574.0	$	4,695.0	23.6	%

Pass-throughs, sequentials and equivalent securities have unique prepayment variability characteristics.  Pass-through securities typically return principal to the holders based on cash payments from the underlying mortgage obligations.

102

Sequential securities return principal to tranche holders in a detailed hierarchy.  Planned amortization classes, targeted amortization classes and accretion-directed bonds adhere to fixed schedules of principal payments as long as the underlying mortgage loans experience prepayments within certain estimated ranges.  In most circumstances, changes in prepayment rates are first absorbed by support or companion classes insulating the timing of receipt of cash flows from the consequences of both faster prepayments (average life shortening) and slower prepayments (average life extension).

Commercial mortgage-backed securities are secured by commercial real estate mortgages, generally income producing properties that are managed for profit.  Property types include multi-family dwellings including apartments, retail centers, hotels, restaurants, hospitals, nursing homes, warehouses, and office buildings.  While most commercial mortgage-backed securities have call protection features whereby underlying borrowers may not prepay their mortgages for stated periods of time without incurring prepayment penalties, recoveries on defaulted collateral may result in involuntary prepayments.

During 2015, we sold $724.4 million of fixed maturity investments which resulted in gross investment losses (before income taxes) of $88.4 million. Securities are generally sold at a loss following unforeseen issue-specific events or conditions or shifts in perceived risks.  These reasons include but are not limited to:  (i) changes in the investment environment; (ii) expectation that the market value could deteriorate further; (iii) desire to reduce our exposure to an asset class, an issuer or an industry; (iv) prospective or actual changes in credit quality; or (v) changes in expected cash flows.

Other Investments

At December 31, 2015, we held commercial mortgage loan investments with a carrying value of $1,721.0 million (or 7.0 percent of total invested assets) and a fair value of $1,772.4 million. We had no mortgage loans that were in the process of foreclosure at December 31, 2015. During 2015, 2014 and 2013, we recognized nil, $6.8 million and $.8 million, respectively, of impairments on commercial mortgage loans. Our commercial mortgage loan portfolio is comprised of large commercial mortgage loans. We do not hold groups of smaller-balance homogeneous loans. Our loans have risk characteristics that are individually unique. Accordingly, we measure potential losses on a loan-by-loan basis rather than establishing an allowance for losses on mortgage loans. Approximately 13 percent, 9 percent, 8 percent and 5 percent of the mortgage loan balance were on properties located in California, Texas, Maryland and Florida, respectively. No other state comprised greater than five percent of the mortgage loan balance.

The following table shows the distribution of our commercial mortgage loan portfolio by property type as of December 31, 2015 (dollars in millions):

	Number of loans	Carrying value
Retail	123	$	474.8
Office building	41	365.3
Multi-family	35	486.5
Industrial	28	242.9
Other	19	151.5
Total commercial mortgage loans	246	$	1,721.0

The following table shows our commercial mortgage loan portfolio by loan size as of December 31, 2015 (dollars in millions):

	Number of loans	Carrying value
Under $5 million	126	$	216.3
$5 million but less than $10 million	59	408.8
$10 million but less than $20 million	36	491.5
Over $20 million	25	604.4
Total commercial mortgage loans	246	$	1,721.0

103

The following table summarizes the distribution of maturities of our commercial mortgage loans as of December 31, 2015 (dollars in millions):

	Number of loans	Carrying value
2016	10	$	12.3
2017	19	105.4
2018	29	138.1
2019	23	45.0
2020	10	37.8
after 2020	155	1,382.4
Total commercial mortgage loans	246	$	1,721.0

The following table provides the carrying value and estimated fair value of our outstanding mortgage loans and the underlying collateral as of December 31, 2015 (dollars in millions):

			Estimated fair value
Loan-to-value ratio (a)	Carrying value		Mortgage loans		Collateral
Less than 60%	$	796.2	$	828.0	$	1,925.0
60% to 70%	503.8		509.6		771.8
Greater than 70% to 80%	326.8		336.9		440.0
Greater than 80% to 90%	89.9		93.0		108.6
Greater than 90%	4.3		4.9		4.3
Total	$	1,721.0	$	1,772.4	$	3,249.7

________________

(a) Loan-to-value ratios are calculated as the ratio of:  (i) the carrying value of the commercial mortgage loans; to (ii) the estimated fair value of the underlying collateral.

At December 31, 2015, we held $262.1 million of trading securities. We carry trading securities at estimated fair value; changes in fair value are reflected in the statement of operations. Our trading securities include: (i) investments purchased with the intent of selling in the near term to generate income; (ii) investments supporting certain insurance liabilities (including investments backing the market strategies of our multibucket annuity products) and certain reinsurance agreements; and (iii) certain fixed maturity securities containing embedded derivatives for which we have elected the fair value option. Investment income from trading securities backing certain insurance liabilities and certain reinsurance agreements is substantially offset by the change in insurance policy benefits related to certain products and agreements.

Other invested assets also include options backing our fixed index products, COLI, credit default swaps and certain nontraditional investments, including investments in limited partnerships, promissory notes, hedge funds and real estate investments held for sale.

At December 31, 2015, we held investments with an amortized cost of $1,679.3 million and an estimated fair value of $1,633.6 million related to variable interest entities that we are required to consolidate. The investment portfolio held by the variable interest entities is primarily comprised of commercial bank loans, the borrowers for which are almost entirely rated below-investment grade. Refer to the note to the consolidated financial statements entitled "Investments in Variable Interest Entities" for additional information on these investments.

104

CONSOLIDATED FINANCIAL CONDITION

Changes in the Consolidated Balance Sheet

Changes in our consolidated balance sheet between December 31, 2015 and December 31, 2014, primarily reflect: (i) our net income for 2015; (ii) changes in the fair value of our fixed maturity securities, available for sale; and (iii) payments to repurchase common stock of $365.2 million.

In accordance with GAAP, we record our fixed maturity securities, available for sale, equity securities and certain other invested assets at estimated fair value with any unrealized gain or loss (excluding impairment losses, which are recognized through earnings), net of tax and related adjustments, recorded as a component of shareholders' equity. At December 31, 2015, we increased the carrying value of such investments by $.9 billion as a result of this fair value adjustment.

Our capital structure as of December 31, 2015 and December 31, 2014 was as follows (dollars in millions):

	December 31, 2015		December 31, 2014
Total capital:
Corporate notes payable	$	911.1	$	780.3
Shareholders’ equity:
Common stock	1.8		2.0
Additional paid-in capital	3,386.8		3,732.4
Accumulated other comprehensive income	402.8		825.3
Retained earnings	347.1		128.5
Total shareholders’ equity	4,138.5		4,688.2
Total capital	$	5,049.6	$	5,468.5

The following table summarizes certain financial ratios as of and for the years ended December 31, 2015 and December 31, 2014:

	December 31, 2015			December 31, 2014
Book value per common share	$	22.49		$	23.06
Book value per common share, excluding accumulated other comprehensive income (a)	20.30			19.00
Ratio of earnings to fixed charges	2.59X			1.62X
Debt to total capital ratios:
Corporate debt to total capital	18.0		%	14.3		%
Corporate debt to total capital, excluding accumulated other comprehensive income (a)	19.6		%	16.8		%

_____________________

(a) This non-GAAP measure differs from the corresponding GAAP measure presented immediately above, because accumulated other comprehensive income has been excluded from the value of capital used to determine this measure.  Management believes this non-GAAP measure is useful because it removes the volatility that arises from changes in accumulated other comprehensive income.  Such volatility is often caused by changes in the estimated fair value of our investment portfolio resulting from changes in general market interest rates rather than the business decisions made by management.  However, this measure does not replace the corresponding GAAP measure.

105

Contractual Obligations

The Company's significant contractual obligations as of December 31, 2015, were as follows (dollars in millions):

			Payment due in
	Total		2016		2017-2018		2019-2020		Thereafter
Insurance liabilities (a)	$	54,967.6	$	3,522.0	$	7,261.6	$	6,628.4	$	37,555.6
Notes payable (b)	1,251.6		43.6		87.0		500.6		620.4
Investment borrowings (c)	1,630.8		19.5		806.2		730.9		74.2
Borrowings related to variable interest entities (d)	2,115.0		43.6		87.0		87.1		1,897.3
Postretirement plans (e)	277.0		6.6		14.2		15.9		240.3
Operating leases and certain other contractual commitments (f)	229.3		136.5		61.5		22.4		8.9
Total	$	60,471.3	$	3,771.8	$	8,317.5	$	7,985.3	$	40,396.7

________________

(a) These cash flows represent our estimates of the payments we expect to make to our policyholders, without consideration of future premiums or reinsurance recoveries. These estimates are based on numerous assumptions (depending on the product type) related to mortality, morbidity, lapses, withdrawals, future premiums, future deposits, interest rates on investments, credited rates, expenses and other factors which affect our future payments. The cash flows presented are undiscounted for interest. As a result, total outflows for all years exceed the corresponding liabilities of $22.1 billion included in our consolidated balance sheet as of December 31, 2015. As such payments are based on numerous assumptions, the actual payments may vary significantly from the amounts shown.

In estimating the payments we expect to make to our policyholders, we considered the following:

• For products such as immediate annuities and structured settlement annuities without life contingencies, the payment obligation is fixed and determinable based on the terms of the policy.

• For products such as universal life, ordinary life, long-term care, supplemental health and fixed rate annuities, the future payments are not due until the occurrence of an insurable event (such as death or disability) or a triggering event (such as a surrender or partial withdrawal). We estimated these payments using actuarial models based on historical experience and our expectation of the future payment patterns.

• For short-term insurance products such as Medicare supplement insurance, the future payments relate only to amounts necessary to settle all outstanding claims, including those that have been incurred but not reported as of the balance sheet date. We estimated these payments based on our historical experience and our expectation of future payment patterns.

• The average interest rate we assumed would be credited to our total insurance liabilities (excluding interest rate bonuses for the first policy year only and excluding the effect of credited rates attributable to variable or fixed index products) over the term of the contracts was 4.5 percent.

(b) Includes projected interest payments based on interest rates, as applicable, as of December 31, 2015. Refer to the note to the consolidated financial statements entitled "Notes Payable - Direct Corporate Obligations" for additional information on notes payable.

(c) These borrowings primarily represent collateralized borrowings from the FHLB.

(d) These borrowings represent the securities issued by VIEs and include projected interest payments based on interest rates, as applicable, as of December 31, 2015.

(e) Includes benefits expected to be paid pursuant to our deferred compensation plan and postretirement plans based on numerous actuarial assumptions and interest credited at 4.50 percent.

106

(f) Includes amounts related to noncancellable operating leases, sponsorship agreements and commitments to purchase investments.

It is possible that the ultimate outcomes of various uncertainties could affect our liquidity in future periods. For example, the following events could have a material adverse effect on our cash flows:

• An adverse decision in pending or future litigation.

• An inability to obtain rate increases on certain of our insurance products.

• Worse than anticipated claims experience.

• Lower than expected dividends and/or surplus debenture interest payments from our insurance subsidiaries (resulting from inadequate earnings or capital or regulatory requirements).

• An inability to meet and/or maintain the covenants in our New Revolving Credit Agreement.

• A significant increase in policy surrender levels.

• A significant increase in investment defaults.

• An inability of our reinsurers to meet their financial obligations.

While we actively manage the relationship between the duration and cash flows of our invested assets and the estimated duration and cash flows of benefit payments arising from contract liabilities, there could be significant variations in the timing of such cash flows. Although we believe our current estimates properly project future claim experience, if these estimates prove to be wrong, and our experience worsens (as it did in some prior periods), our future liquidity could be adversely affected.

Liquidity for Insurance Operations

Our insurance companies generally receive adequate cash flows from premium collections and investment income to meet their obligations.  Life insurance, long-term care insurance and annuity liabilities are generally long-term in nature.  Life and annuity policyholders may, however, withdraw funds or surrender their policies, subject to any applicable penalty provisions; there are generally no withdrawal or surrender benefits for long-term care insurance.  We actively manage the relationship between the duration of our invested assets and the estimated duration of benefit payments arising from contract liabilities.

107

Three of the Company's insurance subsidiaries (Washington National, Bankers Life and Colonial Penn) are members of the FHLB.  As members of the FHLB, our insurance subsidiaries have the ability to borrow on a collateralized basis from the FHLB.  We are required to hold certain minimum amounts of FHLB common stock as a condition of membership in the FHLB, and additional amounts based on the amount of the borrowings.  At December 31, 2015, the carrying value of the FHLB common stock was $74.2 million.  As of December 31, 2015, collateralized borrowings from the FHLB totaled $1.5 billion and the proceeds were used to purchase fixed maturity securities.  The borrowings are classified as investment borrowings in the accompanying consolidated balance sheet.  The borrowings are collateralized by investments with an estimated fair value of $1.8 billion at December 31, 2015, which are maintained in custodial accounts for the benefit of the FHLB.  

The following summarizes the terms of the borrowings from the FHLB by Washington National, Bankers Life and Colonial Penn (dollars in millions):

Amount		Maturity	Interest rate at
borrowed		date	December 31, 2015
$	57.7	June 2017	Variable rate – 0.699%
50.0		August 2017	Variable rate – 0.562%
75.0		August 2017	Variable rate – 0.543%
100.0		October 2017	Variable rate – 0.751%
50.0		November 2017	Variable rate – 0.917%
50.0		January 2018	Variable rate – 0.670%
50.0		January 2018	Variable rate – 0.656%
50.0		February 2018	Variable rate – 0.654%
50.0		February 2018	Variable rate – 0.452%
22.0		February 2018	Variable rate – 0.742%
100.0		May 2018	Variable rate – 0.872%
50.0		July 2018	Variable rate – 0.793%
50.0		August 2018	Variable rate – 0.482%
10.0		December 2018	Variable rate – 0.807%
50.0		January 2019	Variable rate – 0.737%
50.0		February 2019	Variable rate – 0.452%
100.0		March 2019	Variable rate – 0.831%
21.8		July 2019	Variable rate – 0.892%
15.0		October 2019	Variable rate – 0.837%
50.0		May 2020	Variable rate – 0.851%
21.8		June 2020	Fixed rate – 1.960%
25.0		September 2020	Variable rate – 0.951%
100.0		September 2020	Variable rate – 1.082%
50.0		September 2020	Variable rate – 1.082%
75.0		September 2020	Variable rate – 0.723%
100.0		October 2020	Variable rate – 0.723%
50.0		December 2020	Variable rate – 0.951%
28.2		August 2021	Fixed rate – 2.550%
26.1		March 2023	Fixed rate – 2.160%
20.5		June 2025	Fixed rate – 2.940%
$	1,548.1

State laws generally give state insurance regulatory agencies broad authority to protect policyholders in their jurisdictions. Regulators have used this authority in the past to restrict the ability of our insurance subsidiaries to pay any

108

dividends or other amounts without prior approval. We cannot be assured that the regulators will not seek to assert greater supervision and control over our insurance subsidiaries' businesses and financial affairs.

Our estimated consolidated statutory RBC ratio of 449 percent at December 31, 2015, reflects estimated consolidated statutory operating earnings of $350 million and dividends to the holding company of $265.7 million during 2015.

During 2015, the financial statements of three of our insurance subsidiaries prepared in accordance with statutory accounting practices prescribed or permitted by regulatory authorities reflected asset adequacy or premium deficiency reserves. Total asset adequacy and premium deficiency reserves for Washington National, Bankers Conseco Life Insurance Company and Bankers Life were $8.0 million, $11.5 million and $113.7 million, respectively, at December 31, 2015. Due to differences between statutory and GAAP insurance liabilities, we were not required to recognize a similar asset adequacy or premium deficiency reserve in our consolidated financial statements prepared in accordance with GAAP. The determination of the need for and amount of asset adequacy or premium deficiency reserves is subject to numerous actuarial assumptions, including the Company's ability to change NGEs related to certain products consistent with contract provisions.

Financial Strength Ratings of our Insurance Subsidiaries

Financial strength ratings provided by A.M. Best, S&P, Fitch and Moody's are the rating agency's opinions of the ability of our insurance subsidiaries to pay policyholder claims and obligations when due.

On August 26, 2015, A.M. Best upgraded the financial strength ratings of our primary insurance subsidiaries to "A-" from "B++" and the outlook for these ratings is stable. The "A-" rating is assigned to companies that have an excellent ability, in A.M. Best's opinion, to meet their ongoing obligations to policyholders.  A.M. Best ratings for the industry currently range from "A++ (Superior)" to "F (In Liquidation)" and some companies are not rated.  An "A++" rating indicates a superior ability to meet ongoing obligations to policyholders.  A.M. Best has sixteen possible ratings.  There are three ratings above the "A-" rating of our primary insurance subsidiaries and twelve ratings that are below that rating.

On June 18, 2015, S&P affirmed the financial strength ratings of "BBB+" of our primary insurance subsidiaries and revised the outlook for these ratings to positive from stable. On July 2, 2014, S&P upgraded the financial strength ratings of our primary insurance subsidiaries to "BBB+" from "BBB". S&P financial strength ratings range from "AAA" to "R" and some companies are not rated.  An insurer rated "BBB" or higher is regarded as having financial security characteristics that outweigh any vulnerabilities, and is highly likely to have the ability to meet financial commitments. An insurer rated "BBB", in S&P's opinion, has good financial security characteristics, but is more likely to be affected by adverse business conditions than are higher-rated insurers.  Pluses and minuses show the relative standing within a category.  S&P has twenty-one possible ratings.  There are seven ratings above the "BBB+" rating of our primary insurance subsidiaries and thirteen ratings that are below that rating.

On May 11, 2015, Fitch upgraded the financial strength ratings of our primary insurance subsidiaries to "BBB+" from "BBB" and the outlook for these ratings is positive. A "BBB" rating, in Fitch's opinion, indicates that there is currently a low expectation of ceased or interrupted payments. The capacity to meet policyholder and contract obligations on a timely basis is considered adequate, but adverse changes in circumstances and economic conditions are more likely to impact this capacity. Fitch ratings for the industry range from "AAA Exceptionally Strong" to "C Distressed" and some companies are not rated. Pluses and minuses show the relative standing within a category. Fitch has nineteen possible ratings. There are seven ratings above the "BBB+" rating of our primary insurance subsidiaries and eleven ratings that are below that rating.

On May 11, 2015, Moody's upgraded the financial strength ratings of our primary insurance subsidiaries to "Baa1" from "Baa2" and the outlook for these ratings is stable. On March 27, 2014, Moody's upgraded the financial strength ratings of our primary insurance subsidiaries to "Baa2" from "Baa3". Moody’s financial strength ratings range from "Aaa" to "C".  These ratings may be supplemented with numbers "1", "2", or "3" to show relative standing within a category.  In Moody's view, an insurer rated "Baa" offers adequate financial security, however, certain protective elements may be lacking or may be characteristically unreliable over any great length of time. Moody's has twenty-one possible ratings.  There are seven ratings above the "Baa1" rating of our primary insurance subsidiaries and thirteen ratings that are below the rating.

Rating agencies have increased the frequency and scope of their credit reviews and requested additional information from the companies that they rate, including us.  They may also adjust upward the capital and other requirements employed in the rating agency models for maintenance of certain ratings levels.  We cannot predict what actions rating agencies may take, or what actions we may take in response.  Accordingly, downgrades and outlook revisions related to us or the life insurance industry may occur in the future at any time and without notice by any rating agency.  These could increase policy surrenders

109

and withdrawals, adversely affect relationships with our distribution channels, reduce new sales, reduce our ability to borrow and increase our future borrowing costs.

Liquidity of the Holding Companies

Availability and Sources and Uses of Holding Company Liquidity; Limitations on Ability of Insurance Subsidiaries to Make Dividend and Surplus Debenture Interest Payments to the Holding Companies; Limitations on Holding Company Activities

At December 31, 2015, CNO, CDOC and our other non-insurance subsidiaries held: (i) unrestricted cash and cash equivalents of $130.1 million; (ii) fixed income investments of $127.2 million; and (iii) equity securities of $124.9 million.  CNO and CDOC are holding companies with no business operations of their own; they depend on their operating subsidiaries for cash to make principal and interest payments on debt, and to pay administrative expenses and income taxes.  CNO and CDOC receive cash from insurance subsidiaries, consisting of dividends and distributions, interest payments on surplus debentures and tax-sharing payments, as well as cash from non-insurance subsidiaries consisting of dividends, distributions, loans and advances.  The principal non-insurance subsidiaries that provide cash to CNO and CDOC are 40|86 Advisors, which receives fees from the insurance subsidiaries for investment services, and CNO Services which receives fees from the insurance subsidiaries for providing administrative services.  The agreements between our insurance subsidiaries and CNO Services and 40|86 Advisors, respectively, were previously approved by the domestic insurance regulator for each insurance company, and any payments thereunder do not require further regulatory approval.

The following table sets forth the aggregate amount of dividends (net of capital contributions) and other distributions that our insurance subsidiaries paid to our non-insurance subsidiaries in each of the last three fiscal years (dollars in millions):

	Years ended December 31,
	2015		2014		2013
Dividends from insurance subsidiaries, net of contributions	$	265.7	$	174.0	$	236.8
Surplus debenture interest	60.6		63.3		63.7
Fees for services provided pursuant to service agreements	70.1		92.5		72.9
Total dividends and other distributions paid by insurance subsidiaries	$	396.4	$	329.8	$	373.4

The following summarizes the current ownership structure of CNO’s primary subsidiaries:

The ability of our insurance subsidiaries to pay dividends is subject to state insurance department regulations and is based on the financial statements of our insurance subsidiaries prepared in accordance with statutory accounting practices prescribed or permitted by regulatory authorities, which differ from GAAP.  These regulations generally permit dividends to be paid from statutory earned surplus of the insurance company for any 12-month period in amounts equal to the greater of (or in a few states, the lesser of):  (i) statutory net gain from operations or net income for the prior year; or (ii) 10 percent of statutory capital and surplus as of the end of the preceding year. This type of dividend is referred to as an "ordinary dividend". Any dividend in excess of these levels or from an insurance company that has negative earned surplus requires the approval of the director or commissioner of the applicable state insurance department and is referred to as an "extraordinary dividend".  Each of

110

the direct insurance subsidiaries of CDOC has significant negative earned surplus and any dividend payments from the subsidiaries of CDOC would be considered extraordinary dividends and, therefore, require the approval of the director or commissioner of the applicable state insurance department.  In 2015, our insurance subsidiaries paid extraordinary dividends to CDOC totaling $265.7 million.  We expect to receive regulatory approval for future dividends from our subsidiaries, but there can be no assurance that such payments will be approved or that the financial condition of our insurance subsidiaries will not change, making future approvals less likely. 

CDOC holds surplus debentures from CLTX with an aggregate principal amount of $749.6 million.  Interest payments on those surplus debentures do not require additional approval provided the RBC ratio of CLTX exceeds 100 percent (but do require prior written notice to the Texas state insurance department).  The estimated RBC ratio of CLTX was 393 percent at December 31, 2015.  CDOC also holds a surplus debenture from Colonial Penn with a principal balance of $160.0 million. Interest payments on that surplus debenture require prior approval by the Pennsylvania state insurance department. Dividends and other payments from our non-insurance subsidiaries, including 40|86 Advisors and CNO Services, to CNO or CDOC do not require approval by any regulatory authority or other third party.  However, insurance regulators may prohibit payments by our insurance subsidiaries to parent companies if they determine that such payments could be adverse to our policyholders or contractholders.

The insurance subsidiaries of CDOC receive funds to pay dividends primarily from:  (i) the earnings of their direct businesses; (ii) tax sharing payments received from subsidiaries (if applicable); and (iii) with respect to CLTX, dividends received from subsidiaries.  At December 31, 2015, the subsidiaries of CLTX had earned surplus (deficit) as summarized below (dollars in millions):

Subsidiary of CDOC	Earned surplus (deficit)			Additional information
Bankers Life	$	480.0		(a)
Colonial Penn	(297.6		)	(b)

____________________

(a) Bankers Life paid ordinary dividends of $155.0 million to CLTX in 2015.

(b) The deficit is primarily due to transactions which occurred several years ago, including a tax planning transaction and the fee paid to recapture a block of business previously ceded to an unaffiliated insurer.

A significant deterioration in the financial condition, earnings or cash flow of the material subsidiaries of CNO or CDOC for any reason could hinder such subsidiaries' ability to pay cash dividends or other disbursements to CNO and/or CDOC, which, in turn, could limit CNO's ability to meet debt service requirements and satisfy other financial obligations.  In addition, we may choose to retain capital in our insurance subsidiaries or to contribute additional capital to our insurance subsidiaries to strengthen their surplus, and these decisions could limit the amount available at our top tier insurance subsidiaries to pay dividends to the holding companies. CDOC made no capital contributions to its insurance subsidiaries in 2015.

111

In the second quarter of 2015, as further discussed in the note to the consolidated financial statements entitled "Notes Payable - Direct Corporate Obligations", we completed our debt refinancing transactions. The following table sets forth the sources and uses of cash from such transactions (dollars in millions):

Sources:
	Notes	$	825.0
	New Revolving Credit Agreement	100.0
	Total sources	$	925.0
Uses:
	Repayment of Previous Senior Secured Credit Agreement	$	502.3
	Repayment of 6.375% Notes, including redemption premium	292.8
	Accrued interest	4.3
	Debt issuance costs	16.0
	General corporate purposes	109.6
	Total uses	$	925.0

On May 19, 2015, the Company made an initial drawing of $100.0 million under the New Revolving Credit Agreement, resulting in $50.0 million available for additional borrowings. The New Revolving Credit Agreement includes an uncommitted subfacility for swingline loans of up to $5.0 million, and up to $5.0 million of the New Revolving Credit Agreement is available for the issuance of letters of credit. The Company may incur additional incremental loans under the New Revolving Credit Agreement in an aggregate principal amount of up to $50.0 million, provided that there are no events of default and subject to certain other terms and conditions including the delivery of certain documentation.

The New Revolving Credit Agreement requires the Company to maintain (each as calculated in accordance with the New Revolving Credit Agreement): (i) a debt to total capitalization ratio of not more than 30.0 percent (such ratio was 19.9 percent at December 31, 2015); (ii) an aggregate ratio of total adjusted capital to company action level risk-based capital for the Company's insurance subsidiaries of not less than 250 percent (such ratio was estimated to be 449 percent at December 31, 2015); and (iii) a minimum consolidated net worth of not less than the sum of (x) $2,674 million plus (y) 50.0% of the net equity proceeds received by the Company from the issuance and sale of equity interests in the Company (the Company's consolidated net worth was $3,735.7 million at December 31, 2015 compared to the minimum requirement of $2,677 million).

In 2015, we also made $19.8 million of scheduled quarterly principal payments due under the Previous Senior Secured Credit Agreement.

The scheduled principal and interest payments on our direct corporate obligations are as follows (dollars in millions):

	Principal		Interest (a)
2016	$	—	$	43.6
2017	—		43.5
2018	—		43.5
2019	100.0		42.0
2020	325.0		33.6
2021	500.0		120.4
	$	925.0	$	326.6

_________________________

(a) Based on interest rates as of December 31, 2015.

In May 2011, the Company announced a common share repurchase program of up to $100.0 million. In February 2012, June 2012, December 2012, December 2013, November 2014 and November 2015, the Company's Board of Directors approved, in aggregate, an additional $1,600.0 million to repurchase the Company's outstanding securities. In 2015, we

112

repurchased 20.6 million shares of common stock for $365.2 million (including $3.7 million of repurchases settled in the first quarter of 2016) under our securities repurchase program. The Company had remaining repurchase authority of $455.7 million as of December 31, 2015. We currently anticipate repurchasing a total of approximately $275 million to $375 million of our common stock during 2016, absent compelling alternatives including, but not limited to, investment in our business, dividends on common stock, acquisition transactions or ceding commissions related to reinsurance transactions. The amount and timing of the securities repurchases (if any) will be based on business and market conditions and other factors.

In 2015, 2014 and 2013, dividends declared and paid on common stock totaled $52.0 million ($0.27 per common share), $51.0 million ($0.24 per common share) and $24.4 million ($0.11 per common share), respectively. In May 2015, the Company increased its quarterly common stock dividend to $0.07 per share from $0.06 per share.

On May 30, 2014, the Company completed an amendment to the Previous Senior Secured Credit Agreement to waive the requirement that the net proceeds in excess of $125 million received from the sale of CLIC be used to prepay amounts outstanding under the Previous Senior Secured Credit Agreement.

On August 26, 2015, A.M. Best upgraded our issuer credit and senior secured debt ratings to "bbb-" from "bb+" and the outlook for these ratings is stable. In A.M. Best's view, a company rated "bbb-" has an adequate ability to meet the terms of its obligations; however, the issuer is more susceptible to changes in economic or other conditions. Pluses and minuses show the relative standing within a category. A.M. Best has a total of 22 possible ratings ranging from "aaa (Exceptional)" to "d (In default)". There are nine ratings above CNO's "bbb-" rating and twelve ratings that are below its rating.

On June 18, 2015, S&P affirmed our issuer credit and senior secured debt ratings of "BB+" and revised the outlook for these ratings to positive from stable. In S&P's view, an obligation rated "BB" is less vulnerable to nonpayment than other speculative issues. However, it faces major ongoing uncertainties or exposure to adverse business, financial or economic conditions which could lead to the obligor's inadequate capacity to meet its financial commitment on the obligation. Pluses and minuses show the relative standing within a category. S&P has a total of 22 possible ratings ranging from "AAA (Extremely Strong)" to "D (Payment Default)". There are ten ratings above CNO's "BB+" rating and eleven ratings that are below its rating.

On May 11, 2015, Moody's upgraded our issuer credit and senior secured debt ratings to "Ba1" from "Ba2" and the outlook for these ratings is stable. On March 27, 2014, Moody's upgraded our issuer credit and senior secured debt ratings to "Ba2" from "Ba3". In Moody's view, obligations rated "Ba" are judged to have speculative elements and are subject to substantial credit risk. A rating is supplemented with numerical modifiers "1", "2" or "3" to show the relative standing within a category. Moody's has a total of 21 possible ratings ranging from "Aaa" to "C". There are ten ratings above CNO's "Ba1" rating and ten ratings that are below its rating.

On May 5, 2014, Fitch upgraded our issuer credit and senior secured debt ratings to "BB+" from "BB" and the outlook for these ratings is positive. The rating outlook indicates the direction a rating is likely to move over a one to two year period. In Fitch's view, an obligation rated "BB" indicates an elevated vulnerability to default risk, particularly in the event of adverse changes in business or economic conditions over time; however, business or financial flexibility exists which supports the servicing of financial commitments. Pluses and minuses show the relative standing within a category. Fitch has a total of 21 possible ratings ranging from "AAA" to "D". There are ten ratings above CNO's "BB+" rating and ten ratings that are below its rating.

As part of our investment strategy, we may enter into repurchase agreements to increase our investment return. Pursuant to such agreements, the Company sells securities subject to an obligation to repurchase the same securities. Under these arrangements, the Company may transfer legal control over the assets but still retain effective control through an agreement that both entitles and obligates the Company to repurchase the assets. As a result, these repurchase agreements are accounted for as collateralized financing arrangements (i.e., secured borrowings) and not as a sale and subsequent repurchase of securities. There were no such borrowings outstanding at December 31, 2015.

113

Outlook

We believe that the existing cash available to the holding company, the cash flows to be generated from operations and other transactions will be sufficient to allow us to meet our debt service obligations, pay corporate expenses and satisfy other financial obligations. However, our cash flow is affected by a variety of factors, many of which are outside of our control, including insurance regulatory issues, competition, financial markets and other general business conditions. We cannot provide assurance that we will possess sufficient income and liquidity to meet all of our debt service requirements and other holding company obligations. For additional discussion regarding the liquidity and other risks that we face, see "Risk Factors".

MARKET-SENSITIVE INSTRUMENTS AND RISK MANAGEMENT

Our spread-based insurance business is subject to several inherent risks arising from movements in interest rates, especially if we fail to anticipate or respond to such movements. First, interest rate changes can cause compression of our net spread between interest earned on investments and interest credited on customer deposits, thereby adversely affecting our results. Second, if interest rate changes produce an unanticipated increase in surrenders of our spread-based products, we may be forced to sell invested assets at a loss in order to fund such surrenders. Many of our products include surrender charges, market interest rate adjustments or other features to encourage persistency; however at December 31, 2015, approximately 23 percent of our total insurance liabilities, or approximately $5.1 billion, could be surrendered by the policyholder without penalty. Finally, changes in interest rates can have significant effects on the performance of our investment portfolio as a result of changes in the prepayment rate of various securities. We use asset/liability strategies that are designed to mitigate the effect of interest rate changes on our profitability. However, there can be no assurance that management will be successful in implementing such strategies and achieving adequate investment spreads.

We seek to invest our available funds in a manner that will fund future obligations to policyholders, subject to appropriate risk considerations. We seek to meet this objective through investments that: (i) have similar cash flow characteristics with the liabilities they support; (ii) are diversified (including by types of obligors); and (iii) are predominantly investment-grade in quality.

Our investment strategy is to maximize, over a sustained period and within acceptable parameters of risk, investment income and total investment return through active investment management. Accordingly, our portfolio of fixed maturity securities is available to be sold in response to: (i) changes in market interest rates; (ii) changes in relative values of individual securities and asset sectors; (iii) changes in prepayment risks; (iv) changes in credit quality outlook for certain securities; (v) liquidity needs; and (vi) other factors. From time to time, we invest in securities for trading purposes, although such investments are a relatively small portion of our total portfolio.

The profitability of many of our products depends on the spread between the interest earned on investments and the rates credited on our insurance liabilities. In addition, changes in competition and other factors, including the level of surrenders and withdrawals, may limit our ability to adjust or to maintain crediting rates at levels necessary to avoid narrowing of spreads under certain market conditions. As of December 31, 2015, approximately 24 percent of our insurance liabilities had interest rates that may be reset annually; 51 percent had a fixed explicit interest rate for the duration of the contract; 23 percent had credited rates which approximate the income earned by the Company; and the remainder had no explicit interest rates. At December 31, 2015, the average yield, computed on the cost basis of our fixed maturity portfolio, was 5.5 percent, and the average interest rate credited or accruing to our total insurance liabilities (excluding interest rate bonuses for the first policy year only and excluding the effect of credited rates attributable to variable or fixed index products) was 4.5 percent.

We simulate the cash flows expected from our existing insurance business under various interest rate scenarios. These simulations help us to measure the potential gain or loss in fair value of our interest rate-sensitive investments and to manage the relationship between the interest sensitivity of our assets and liabilities. When the estimated durations of assets and liabilities are similar, absent other factors, a change in the value of assets related to changes in interest rates should be largely offset by a change in the value of liabilities. At December 31, 2015, the estimated duration of our fixed income securities (as modified to reflect payments and potential calls) and the estimated duration of our insurance liabilities were both approximately 8.2 years. We estimate that our fixed maturity securities and short-term investments (net of corresponding changes in insurance acquisition costs) would decline in fair value by approximately $320 million if interest rates were to increase by 10 percent from their levels at December 31, 2015. Our simulations incorporate numerous assumptions, require significant estimates and assume an immediate change in interest rates without any management of the investment portfolio in reaction to such change. Consequently, potential changes in value of our financial instruments indicated by the simulations will likely be different from the actual changes experienced under given interest rate scenarios, and the differences may be material. Because we actively manage our investments and liabilities, our net exposure to interest rates can vary over time.

114

We are subject to the risk that our investments will decline in value. This has occurred in the past and may occur again, particularly if interest rates rise from their current low levels. During 2015, we recognized net realized investment losses of $36.6 million, which were comprised of: (i) $1.0 million of net losses from the sales of investments; (ii) an $11.3 million gain on the dissolution of a VIE; (iii) the decrease in fair value of embedded derivatives related to a modified coinsurance agreement of $7.0 million; and (iv) $39.9 million of writedowns of investments for other than temporary declines in fair value recognized through net income ($42.9 million, prior to the $3.0 million of impairment losses recognized through accumulated other comprehensive income). During 2014, we recognized net realized investment gains of $36.7 million, which were comprised of: (i) $54.4 million of net gains from the sales of investments (primarily fixed maturities); (ii) the increase in fair value of certain fixed maturity investments with embedded derivatives of $7.6 million; (iii) the increase in fair value of embedded derivatives related to a modified coinsurance agreement of $2.0 million; and (iv) $27.3 million of writedowns of investments for other than temporary declines in fair value recognized through net income. During 2013, we recognized net realized investment gains of $33.4 million, which were comprised of: (i) $51.8 million of net gains from the sales of investments (primarily fixed maturities); (ii) the decrease in fair value of certain fixed maturity investments with embedded derivatives of $6.8 million; and (iii) $11.6 million of writedowns of investments for other than temporary declines in fair value recognized through net income.

The Company is subject to risk resulting from fluctuations in market prices of our equity securities. In general, these investments have more year-to-year price variability than our fixed maturity investments. However, returns over longer time frames have been consistently higher. We manage this risk by limiting our equity securities to a relatively small portion of our total investments.

Our investment in options backing our equity-linked products is closely matched with our obligation to fixed index annuity holders. Fair value changes associated with that investment are substantially offset by an increase or decrease in the amounts added to policyholder account balances for fixed index products.

Inflation

Inflation rates may impact the financial statements and operating results in several areas. Inflation influences interest rates, which in turn impact the fair value of the investment portfolio and yields on new investments. Inflation also impacts a portion of our insurance policy benefits affected by increased medical coverage costs. Operating expenses, including payrolls, are impacted to a certain degree by the inflation rate.

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

The information included under the caption "Market-Sensitive Instruments and Risk Management" in Item 7. "Management's Discussion and Analysis of Consolidated Financial Condition and Results of Operations" is incorporated herein by reference.

115

ITEM 8. CONSOLIDATED FINANCIAL STATEMENTS.

Index to Consolidated Financial Statements
	Page
Report of Independent Registered Public Accounting Firm	117
Consolidated Balance Sheet at December 31, 2015 and 2014	118
Consolidated Statement of Operations for the years ended December 31, 2015, 2014 and 2013	120
Consolidated Statement of Comprehensive Income for the years ended December 31, 2015, 2014 and 2013	121
Consolidated Statement of Shareholders' Equity for the years ended December 31, 2015, 2014 and 2013	122
Consolidated Statement of Cash Flows for the years ended December 31, 2015, 2014 and 2013	123
Notes to Consolidated Financial Statements	124

116

Report of Independent Registered Public Accounting Firm

To the Shareholders and Board of Directors of CNO Financial Group, Inc.:

In our opinion, the accompanying consolidated balance sheets and the related consolidated statements of operations, comprehensive income, shareholders' equity and cash flows present fairly, in all material respects, the financial position of CNO Financial Group, Inc. and its subsidiaries at December 31, 2015 and 2014, and the results of their operations and their cash flows for each of the three years in the period ended December 31, 2015 in conformity with accounting principles generally accepted in the United States of America. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2015, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). The Company's management is responsible for these financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in Management's Report on Internal Control over Financial Reporting appearing under Item 9A. Our responsibility is to express opinions on these financial statements and on the Company's internal control over financial reporting based on our integrated audits. We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement and whether effective internal control over financial reporting was maintained in all material respects. Our audits of the financial statements included examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, and evaluating the overall financial statement presentation. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

/s/PricewaterhouseCoopers LLP

Indianapolis, Indiana

February 19, 2016

117

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEET

December 31, 2015 and 2014

(Dollars in millions)

ASSETS

	2015		2014
Investments:
Fixed maturities, available for sale, at fair value (amortized cost: 2015 - $18,947.0; 2014 - $18,408.1)	$	19,882.9	$	20,634.9
Equity securities at fair value (cost: 2015 - $447.4; 2014 - $400.5)	463.0		419.0
Mortgage loans	1,721.0		1,691.9
Policy loans	109.4		106.9
Trading securities	262.1		244.9
Investments held by variable interest entities	1,633.6		1,367.1
Other invested assets	415.1		443.6
Total investments	24,487.1		24,908.3
Cash and cash equivalents - unrestricted	432.3		611.6
Cash and cash equivalents held by variable interest entities	364.4		68.3
Accrued investment income	237.0		242.9
Present value of future profits	449.0		489.4
Deferred acquisition costs	1,083.3		770.6
Reinsurance receivables	2,859.3		2,991.1
Income tax assets, net	898.8		758.7
Assets held in separate accounts	4.7		5.6
Other assets	309.2		309.4
Total assets	$	31,125.1	$	31,155.9

(continued on next page)

The accompanying notes are an integral part

of the consolidated financial statements.

118

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEET, continued

December 31, 2015 and 2014

(Dollars in millions)

LIABILITIES AND SHAREHOLDERS' EQUITY

	2015		2014
Liabilities:
Liabilities for insurance products:
Policyholder account balances	$	10,762.3	$	10,707.2
Future policy benefits	10,602.1		10,835.4
Liability for policy and contract claims	487.8		468.7
Unearned and advanced premiums	286.3		291.8
Liabilities related to separate accounts	4.7		5.6
Other liabilities	707.8		587.6
Investment borrowings	1,548.1		1,519.2
Borrowings related to variable interest entities	1,676.4		1,271.9
Notes payable – direct corporate obligations	911.1		780.3
Total liabilities	26,986.6		26,467.7
Commitments and Contingencies
Shareholders' equity:
Common stock ($0.01 par value, 8,000,000,000 shares authorized, shares issued and outstanding: 2015 - 184,028,511; 2014 - 203,324,458)	1.8		2.0
Additional paid-in capital	3,386.8		3,732.4
Accumulated other comprehensive income	402.8		825.3
Retained earnings	347.1		128.5
Total shareholders' equity	4,138.5		4,688.2
Total liabilities and shareholders' equity	$	31,125.1	$	31,155.9

The accompanying notes are an integral part

of the consolidated financial statements.

119

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENT OF OPERATIONS

for the years ended December 31, 2015, 2014 and 2013

(Dollars in millions, except per share data)

	2015			2014			2013
Revenues:
Insurance policy income	$	2,556.0		$	2,629.7		$	2,744.7
Net investment income (loss):
General account assets	1,203.6			1,301.0			1,405.8
Policyholder and reinsurer accounts and other special-purpose portfolios	30.0			126.4			258.2
Realized investment gains (losses):
Net realized investment gains (losses), excluding impairment losses	(8.0		)	64.0			45.0
Other-than-temporary impairments:
Total other-than-temporary impairment losses	(42.9		)	(27.3		)	(11.6		)
Portion of other-than-temporary impairment losses recognized in accumulated other comprehensive income	3.0			—			—
Net impairment losses recognized	(39.9		)	(27.3		)	(11.6		)
Gain on dissolution of a variable interest entity	11.3			—			—
Total realized gains (losses)	(36.6		)	36.7			33.4
Fee revenue and other income	58.9			50.9			34.0
Total revenues	3,811.9			4,144.7			4,476.1
Benefits and expenses:
Insurance policy benefits	2,308.3			2,586.2			2,839.7
Loss on sale of subsidiary, (gain) loss on reinsurance transactions and transition expenses	9.0			239.8			98.4
Interest expense	94.9			92.8			105.3
Amortization	260.0			247.4			296.3
Loss on extinguishment or modification of debt	32.8			.6			65.4
Other operating costs and expenses	739.2			802.8			766.2
Total benefits and expenses	3,444.2			3,969.6			4,171.3
Income before income taxes	367.7			175.1			304.8
Income tax expense (benefit):
Tax expense on period income	129.5			159.2			128.3
Valuation allowance for deferred tax assets and other tax items	(32.5		)	(35.5		)	(301.5		)
Net income	$	270.7		$	51.4		$	478.0
Earnings per common share:
Basic:
Weighted average shares outstanding	193,054,000			212,917,000			221,628,000
Net income	$	1.40		$	.24		$	2.16
Diluted:
Weighted average shares outstanding	195,166,000			217,655,000			232,702,000
Net income	$	1.39		$	.24		$	2.06

The accompanying notes are an integral part

of the consolidated financial statements.

120

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

for the years ended December 31, 2015, 2014 and 2013

(Dollars in millions)

	2015			2014			2013
Net income	$	270.7		$	51.4		$	478.0
Other comprehensive income, before tax:
Unrealized gains (losses) for the period	(1,337.6		)	942.9			(1,627.4		)
Amortization of present value of future profits and deferred acquisition costs	157.9			(113.5		)	175.2
Amount related to premium deficiencies assuming the net unrealized gains (losses) had been realized	495.3			(624.6		)	774.2
Reclassification adjustments:
For net realized investment (gains) losses included in net income	29.6			(59.0		)	(39.8		)
For amortization of the present value of future profits and deferred acquisition costs related to net realized investment gains (losses) included in net income	(.5		)	1.0			1.6
Unrealized gains (losses) on investments	(655.3		)	146.8			(716.2		)
Change related to deferred compensation plan	(.1		)	(1.4		)	.8
Other comprehensive income (loss) before tax	(655.4		)	145.4			(715.4		)
Income tax (expense) benefit related to items of accumulated other comprehensive income	232.9			(51.9		)	249.8
Other comprehensive income (loss), net of tax	(422.5		)	93.5			(465.6		)
Comprehensive income	$	(151.8	)	$	144.9		$	12.4

The accompanying notes are an integral part

of the consolidated financial statements.

121

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY

(Dollars in millions)

	Common stock and additional paid-in capital			Accumulated other  comprehensive income			Retained earnings (accumulated deficit)			Total
Balance, December 31, 2012	$	4,176.9		$	1,197.4		$	(325.0	)	$	5,049.3
Net income	—			—			478.0			478.0
Change in unrealized appreciation (depreciation) of investments (net of applicable income tax benefit of $248.7)	—			(463.7		)	—			(463.7		)
Change in noncredit component of impairment losses on fixed maturities, available for sale (net of applicable income tax benefit of $1.1)	—			(1.9		)	—			(1.9		)
Extinguishment of beneficial conversion feature related to the repurchase of convertible debentures	(12.6		)	—			—			(12.6		)
Cost of common stock repurchased	(118.4		)	—			—			(118.4		)
Dividends on common stock	—			—			(24.6		)	(24.6		)
Conversion of convertible debentures	24.9			—			—			24.9
Stock options, restricted stock and performance units	24.2			—			—			24.2
Balance, December 31, 2013	4,095.0			731.8			128.4			4,955.2
Net income	—			—			51.4			51.4
Change in unrealized appreciation (depreciation) of investments (net of applicable income tax expense of $52.3)	—			94.2			—			94.2
Change in noncredit component of impairment losses on fixed maturities, available for sale (net of applicable income tax benefit of $.4)	—			(.7		)	—			(.7		)
Cost of common stock and warrants repurchased	(376.5		)	—			—			(376.5		)
Dividends on common stock	—			—			(51.3		)	(51.3		)
Stock options, restricted stock and performance units	15.9			—			—			15.9
Balance, December 31, 2014	3,734.4			825.3			128.5			4,688.2
Net income	—			—			270.7			270.7
Change in unrealized appreciation (depreciation) of investments (net of applicable income tax benefit of $231.7)	—			(420.4		)	—			(420.4		)
Change in noncredit component of impairment losses on fixed maturities, available for sale (net of applicable income tax benefit of $1.2)	—			(2.1		)	—			(2.1		)
Cost of common stock repurchased	(365.2		)	—			—			(365.2		)
Dividends on common stock	—			—			(52.1		)	(52.1		)
Stock options, restricted stock and performance units	19.4			—			—			19.4
Balance, December 31, 2015	$	3,388.6		$	402.8		$	347.1		$	4,138.5

The accompanying notes are an integral part

of the consolidated financial statements.

122

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENT OF CASH FLOWS

for the years ended December 31, 2015, 2014 and 2013

(Dollars in millions)

	2015			2014				2013
Cash flows from operating activities:
Insurance policy income	$	2,423.4		$	2,407.9			$	2,464.9
Net investment income	1,205.9			1,279.0				1,387.7
Fee revenue and other income	58.9			50.9				34.0
Insurance policy benefits	(1,879.4		)	(1,968.4		)		(2,093.8		)
Payment to reinsurer pursuant to long-term care business reinsured	—			(590.3		)		—
Interest expense	(90.0		)	(81.7		)		(95.9		)
Deferrable policy acquisition costs	(246.4		)	(242.8		)		(222.8		)
Other operating costs	(724.4		)	(728.8		)		(745.7		)
Taxes	(4.1		)	(4.0		)		(8.0		)
Net cash from operating activities	743.9			121.8			(a)	720.4
Cash flows from investing activities:
Sales of investments	2,177.6			2,090.0				2,315.8
Maturities and redemptions of investments	1,853.4			1,618.2				2,491.9
Purchases of investments	(4,767.2		)	(3,731.6		)		(5,367.1		)
Net sales (purchases) of trading securities	(12.3		)	4.9				30.0
Change in cash and cash equivalents held by variable interest entities	(296.1		)	36.0				(50.1		)
Cash and cash equivalents held by subsidiary prior to being sold	—			(164.7		)		—
Proceeds from sale of subsidiary	—			231.0				—
Other	(25.0		)	(27.5		)		(23.0		)
Net cash provided (used) by investing activities	(1,069.6		)	56.3				(602.5		)
Cash flows from financing activities:
Issuance of notes payable, net	910.0			—				—
Payments on notes payable	(797.1		)	(62.9		)		(126.9		)
Expenses related to extinguishment or modification of debt	(17.8		)	(.6		)		(61.6		)
Amount paid to extinguish the beneficial conversion feature associated with repurchase of convertible debentures	—			—				(12.6		)
Issuance of common stock	6.3			5.0				15.1
Payments to repurchase common stock and warrants	(361.5		)	(376.5		)		(118.4		)
Common stock dividends paid	(52.0		)	(51.0		)		(24.4		)
Amounts received for deposit products	1,241.9			1,295.4				1,298.1
Withdrawals from deposit products	(1,225.0		)	(1,347.3		)		(1,464.4		)
Issuance of investment borrowings:
Federal Home Loan Bank	475.0			350.0				500.0
Related to variable interest entities	544.7			358.5				376.3
Payments on investment borrowings:
Federal Home Loan Bank	(425.7		)	(367.7		)		(250.5		)
Related to variable interest entities and other	(132.0		)	(88.8		)		(132.1		)
Investment borrowings - repurchase agreements, net	(20.4		)	20.4				—
Net cash provided (used) by financing activities	146.4			(265.5		)		(1.4		)
Net increase (decrease) in cash and cash equivalents	(179.3		)	(87.4		)		116.5
Cash and cash equivalents, beginning of year	611.6			699.0				582.5
Cash and cash equivalents, end of year	$	432.3		$	611.6			$	699.0

______________________

(a) Cash flows from operating activities reflect outflows in 2014 due to the payment to reinsurer to transfer certain long-term care business.

The accompanying notes are an integral part

of the consolidated financial statements.

123

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

1. BUSINESS AND BASIS OF PRESENTATION

CNO Financial Group, Inc., a Delaware corporation ("CNO"), is a holding company for a group of insurance companies operating throughout the United States that develop, market and administer health insurance, annuity, individual life insurance and other insurance products.  The terms "CNO Financial Group, Inc.", "CNO", the "Company", "we", "us", and "our" as used in these financial statements refer to CNO and its subsidiaries.  Such terms, when used to describe insurance business and products, refer to the insurance business and products of CNO's insurance subsidiaries.

We focus on serving middle-income pre-retiree and retired Americans, which we believe are attractive, underserved, high growth markets.  We sell our products through three distribution channels: career agents, independent producers (some of whom sell one or more of our product lines exclusively) and direct marketing.

The Company manages its business through the following operating segments: Bankers Life, Washington National and Colonial Penn, which are defined on the basis of product distribution; and corporate operations, comprised of holding company activities and certain noninsurance company businesses. The Company’s insurance segments are described below:

• Bankers Life,which markets and distributes Medicare supplement insurance, interest-sensitive life insurance, traditional life insurance, fixed annuities and long-term care insurance products to the middle-income senior market through a dedicated field force of career agents, financial and investment advisors, and sales managers supported by a network of community-based sales offices.  The Bankers Life segment includes primarily the business of Bankers Life and Casualty Company ("Bankers Life").  Bankers Life also has various distribution and marketing agreements with other insurance companies to use Bankers Life's career agents to distribute Medicare Advantage and prescription drug plan ("PDP") products in exchange for a fee.

• Washington National, which markets and distributes supplemental health (including specified disease, accident and hospital indemnity insurance products) and life insurance to middle-income consumers at home and at the worksite.  These products are marketed through Performance Matters Associates of Texas, Inc. and through independent marketing organizations and insurance agencies including worksite marketing.  The products being marketed are underwritten by Washington National Insurance Company ("Washington National"). This segment's business also includes certain closed blocks of annuities and Medicare supplement policies which are no longer being actively marketed by this segment and were primarily issued or acquired by Washington National.

• Colonial Penn, which markets primarily graded benefit and simplified issue life insurance directly to customers in the senior middle-income market through television advertising, direct mail, the internet and telemarketing.  The Colonial Penn segment includes primarily the business of Colonial Penn Life Insurance Company ("Colonial Penn").

As further described in the note to the consolidated financial statements entitled "Sale of Subsidiary", we sold Conseco Life Insurance Company ("CLIC") on July 1, 2014. The business of CLIC primarily related to traditional and interest-sensitive life products. In periods prior to 2014, we had an Other CNO Business segment comprised of the long-term care business that was ceded effective December 31, 2013 and the overhead expense of CLIC that was expected to continue after the completion of the sale. Beginning on January 1, 2014: (i) the overhead expense of CLIC that was expected to continue after the completion of the sale was reallocated primarily to the Bankers Life and Washington National segments; and (ii) there was no longer an Other CNO Business segment.

We prepare our financial statements in accordance with accounting principles generally accepted in the United States of America ("GAAP"). We have reclassified certain amounts from the prior periods to conform to the 2015 presentation. These reclassifications have no effect on net income or shareholders' equity.

The accompanying financial statements include the accounts of the Company and its subsidiaries. Our consolidated financial statements exclude transactions between us and our consolidated affiliates, or among our consolidated affiliates.

When we prepare financial statements in conformity with GAAP, we are required to make estimates and assumptions that significantly affect reported amounts of various assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reporting periods.  For example, we use significant

124

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

estimates and assumptions to calculate values for deferred acquisition costs, the present value of future profits, fair value measurements of certain investments (including derivatives), other-than-temporary impairments of investments, assets and liabilities related to income taxes, liabilities for insurance products, liabilities related to litigation and guaranty fund assessment accruals.  If our future experience differs from these estimates and assumptions, our financial statements would be materially affected.

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Investments

Fixed maturity securities include available for sale bonds and redeemable preferred stocks. We carry these investments at estimated fair value. We record any unrealized gain or loss, net of tax and related adjustments, as a component of shareholders’ equity.

Equity securities include available for sale investments in common stock and non-redeemable preferred stock. We carry these investments at estimated fair value. We record any unrealized gain or loss, net of tax and related adjustments, as a component of shareholders' equity.

Mortgage loans held in our investment portfolio are carried at amortized unpaid balances, net of provisions for estimated losses. Interest income is accrued on the principal amount of the loan based on the loan's contractual interest rate. Payment terms specified for mortgage loans may include a prepayment penalty for unscheduled payoff of the investment. Prepayment penalties are recognized as investment income when received.

Policy loans are stated at current unpaid principal balances. Policy loans are collateralized by the cash surrender value of the life insurance policy. Interest income is recorded as earned using the contractual interest rate.

Trading securities include: (i) investments purchased with the intent of selling in the near team to generate income; (ii) investments supporting certain insurance liabilities (including investments backing the market strategies of our multibucket annuity products) and certain reinsurance agreements; and (iii) certain fixed maturity securities containing embedded derivatives for which we have elected the fair value option. The change in fair value of the income generating investments and investments supporting insurance liabilities and reinsurance agreements is recognized in income from policyholder and reinsurer accounts and other special-purpose portfolios (a component of net investment income). The change in fair value of securities with embedded derivatives is recognized in realized investment gains (losses). Investment income related to investments supporting certain insurance liabilities and certain reinsurance agreements is substantially offset by the change in insurance policy benefits related to certain products and agreements.

Other invested assets include: (i) call options purchased in an effort to offset or hedge the effects of certain policyholder benefits related to our fixed index annuity and life insurance products; (ii) Company-owned life insurance ("COLI"); and (iii) certain non-traditional investments. We carry the call options at estimated fair value as further described in the section of this note entitled "Accounting for Derivatives". We carry COLI at its cash surrender value which approximates its net realizable value. Non-traditional investments include investments in certain limited partnerships and hedge funds which are accounted for using the equity method; and promissory notes, which are accounted for using the cost method. In accounting for limited partnerships and hedge funds, we consistently use the most recently available financial information provided by the general partner or manager of each of these investments, which is one to three months prior to the end of our reporting period.

Interest income on fixed maturity securities is recognized when earned using a constant effective yield method giving effect to amortization of premiums and accretion of discounts. Prepayment fees are recognized when earned. Dividends on equity securities are recognized when declared.

When we sell a security (other than trading securities), we report the difference between the sale proceeds and amortized cost (determined based on specific identification) as a realized investment gain or loss.

We regularly evaluate our investments for possible impairment as further described in the note to the consolidated financial statements entitled "Investments".

125

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

When a security defaults (including mortgage loans) or securities are other-than-temporarily impaired, our policy is to discontinue the accrual of interest and eliminate all previous interest accruals, if we determine that such amounts will not be ultimately realized in full.

Cash and Cash Equivalents

Cash and cash equivalents include commercial paper, invested cash and other investments purchased with original maturities of less than three months. We carry them at amortized cost, which approximates estimated fair value.

Deferred Acquisition Costs

Deferred acquisition costs represent incremental direct costs related to the successful acquisition of new or renewal insurance contracts. For interest-sensitive life or annuity products, we amortize these costs in relation to the estimated gross profits using the interest rate credited to the underlying policies. For other products, we amortize these costs in relation to future anticipated premium revenue using the projected investment earnings rate.

When we realize a gain or loss on investments backing our interest-sensitive life or annuity products, we adjust the amortization to reflect the change in estimated gross profits from the products due to the gain or loss realized and the effect on future investment yields. We also adjust deferred acquisition costs for the change in amortization that would have been recorded if our fixed maturity securities, available for sale, had been sold at their stated aggregate fair value and the proceeds reinvested at current yields. We limit the total adjustment related to the impact of unrealized losses to the total of costs capitalized plus interest related to insurance policies issued in a particular year. We include the impact of this adjustment in accumulated other comprehensive income (loss) within shareholders' equity.

We regularly evaluate the recoverability of the unamortized balance of the deferred acquisition costs. We consider estimated future gross profits or future premiums, expected mortality or morbidity, interest earned and credited rates, persistency and expenses in determining whether the balance is recoverable. If we determine a portion of the unamortized balance is not recoverable, it is charged to amortization expense. In certain cases, the unamortized balance of the deferred acquisition costs may not be deficient in the aggregate, but our estimates of future earnings indicate that profits would be recognized in early periods and losses in later periods. In this case, we increase the amortization of the deferred acquisition costs over the period of profits, by an amount necessary to offset losses that are expected to be recognized in the later years.

Present Value of Future Profits

The present value of future profits is the value assigned to the right to receive future cash flows from policyholder insurance contracts existing at September 10, 2003 (the "Effective Date", the effective date of the bankruptcy reorganization of Conseco, Inc., an Indiana corporation (our "Predecessor")). The discount rate we used to determine the present value of future profits was 12 percent. The balance of this account is amortized and evaluated for recovery in the same manner as described above for deferred acquisition costs.  We also adjust the present value of future profits for the change in amortization that would have been recorded if the fixed maturity securities, available for sale, had been sold at their stated aggregate fair value and the proceeds reinvested at current yields, similar to the manner described above for deferred acquisition costs.  We limit the total adjustment related to the impact of unrealized losses to the total present value of future profits plus interest.

Assets Held in Separate Accounts

Separate accounts are funds on which investment income and gains or losses accrue directly to certain policyholders. The assets of these accounts are legally segregated. They are not subject to the claims that may arise out of any other business of CNO. We report separate account assets at fair value; the underlying investment risks are assumed by the contractholders. We record the related liabilities at amounts equal to the separate account assets. We record the fees earned for administrative and contractholder services performed for the separate accounts in insurance policy income.

Recognition of Insurance Policy Income and Related Benefits and Expenses on Insurance Contracts

For interest-sensitive life and annuity contracts that do not involve significant mortality or morbidity risk, the amounts collected from policyholders are considered deposits and are not included in revenue. Revenues for these contracts consist of

126

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

charges for policy administration, cost of insurance charges and surrender charges assessed against policyholders' account balances. Such revenues are recognized when the service or coverage is provided, or when the policy is surrendered.

We establish liabilities for annuity and interest-sensitive life products equal to the accumulated policy account values, which include an accumulation of deposit payments plus credited interest, less withdrawals and the amounts assessed against the policyholder through the end of the period. In addition, policyholder account values for certain interest-sensitive life products are impacted by our assumptions related to changes of certain non-guaranteed elements that we are allowed to make under the terms of the policy, such as cost of insurance charges, expense loads, credited interest rates and policyholder bonuses. Sales inducements provided to the policyholders of these products are recognized as liabilities over the period that the contract must remain in force to qualify for the inducement. The options attributed to the policyholder related to our fixed index annuity products are accounted for as embedded derivatives as described in the section of this note entitled "Accounting for Derivatives".

Premiums from individual life products (other than interest-sensitive life contracts) and health products are recognized when due. When premiums are due over a significantly shorter period than the period over which benefits are provided, any gross premium in excess of the net premium (i.e., the portion of the gross premium required to provide for all expected future benefits and expenses) is deferred and recognized into revenue in a constant relationship to insurance in force. Benefits are recorded as an expense when they are incurred.

We establish liabilities for traditional life, accident and health insurance, and life contingent payment annuity products using mortality tables in general use in the United States, which are modified to reflect the Company's actual experience when appropriate. We establish liabilities for accident and health insurance products using morbidity tables based on the Company's actual or expected experience. These reserves are computed at amounts that, with additions from estimated future premiums received and with interest on such reserves at estimated future rates, are expected to be sufficient to meet our obligations under the terms of the policy. Liabilities for future policy benefits are computed on a net-level premium method based upon assumptions as to future claim costs, investment yields, mortality, morbidity, withdrawals, policy dividends and maintenance expenses determined when the policies were issued (or with respect to policies inforce at August 31, 2003, the Company's best estimate of such assumptions on the Effective Date). We make an additional provision to allow for potential adverse deviation for some of our assumptions. Once established, assumptions on these products are generally not changed unless a premium deficiency exists. In that case, a premium deficiency reserve is recognized and the future pattern of reserve changes is modified to reflect the relationship of premiums to benefits based on the current best estimate of future claim costs, investment yields, mortality, morbidity, withdrawals, policy dividends and maintenance expenses, determined without an additional provision for potential adverse deviation.

We establish claim reserves based on our estimate of the loss to be incurred on reported claims plus estimates of incurred but unreported claims based on our past experience.

Accounting for Long-term Care Premium Rate Increases

Many of our long-term care policies have been subject to premium rate increases. In some cases, these premium rate increases were materially consistent with the assumptions we used to value the particular block of business at the Effective Date. With respect to certain premium rate increases, some of our policyholders were provided an option to cease paying their premiums and receive a non-forfeiture option in the form of a paid-up policy with limited benefits. In addition, our policyholders could choose to reduce their coverage amounts and premiums in the same proportion, when permitted by our contracts or as required by regulators. The following describes how we account for these policyholder options:

• Premium rate increases - If premium rate increases reflect a change in our previous rate increase assumptions, the new assumptions are not reflected prospectively in our reserves. Instead, the additional premium revenue resulting from the rate increase is recognized as earned and original assumptions continue to be used to determine changes to liabilities for insurance products unless a premium deficiency exists.

• Benefit reductions - A policyholder may choose reduced coverage with a proportionate reduction in premium, when permitted by our contracts. This option does not require additional underwriting. Benefit reductions are treated as a partial lapse of coverage, and the balance of our reserves and deferred insurance acquisition costs is reduced in proportion to the reduced coverage.

127

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

• Non-forfeiture benefits offered in conjunction with a rate increase - In some cases, non-forfeiture benefits are offered to policyholders who wish to lapse their policies at the time of a significant rate increase. In these cases, exercise of this option is treated as an extinguishment of the original contract and issuance of a new contract. The balance of our reserves and deferred insurance acquisition costs are released, and a reserve for the new contract is established.

Some of our policyholders may receive a non-forfeiture benefit if they cease paying their premiums pursuant to their original contract (or pursuant to changes made to their original contract as a result of a litigation settlement made prior to the Effective Date or an order issued by the Florida Office of Insurance Regulation). In these cases, exercise of this option is treated as the exercise of a policy benefit, and the reserve for premium paying benefits is reduced, and the reserve for the non-forfeiture benefit is adjusted to reflect the election of this benefit.

Accounting for Certain Marketing and Reinsurance Agreements

Bankers Life has entered into various distribution and marketing agreements with other insurance companies to use Bankers Life's career agents to distribute prescription drug and Medicare Advantage plans. These agreements allow Bankers Life to offer these products to current and potential future policyholders without investment in management and infrastructure. We receive fee income related to the plans sold through our distribution channels. We account for these distribution agreements as follows:

• We recognize distribution income based on either: (i) a fixed fee per contract sold; or (ii) a percentage of premiums collected. This fee income is recognized over the calendar year term of the contract.

• We also pay commissions to our agents who sell the plans. These payments are deferred and amortized over the term of the contract.

Prior to its termination in August 2013, we had a quota-share reinsurance agreement with Coventry Health Care ("Coventry") that provided Bankers Life with 50 percent of the net premiums and related policy benefits of certain PDP business sold through Bankers Life's career agency force. We accounted for the quota-share agreement as follows:

• We recognized premium revenue evenly over the period of the underlying Medicare Part D contracts.

• We recognized policyholder benefits and assumed commission expense as incurred.

• We recognized risk-share premium adjustments consistent with Coventry's risk-share agreement with the Centers for Medicare and Medicaid Services.

Reinsurance

In the normal course of business, we seek to limit our loss exposure on any single insured or to certain groups of policies by ceding reinsurance to other insurance enterprises. We currently retain no more than $.8 million of mortality risk on any one policy. We diversify the risk of reinsurance loss by using a number of reinsurers that have strong claims-paying ratings. In each case, the ceding CNO subsidiary is directly liable for claims reinsured in the event the assuming company is unable to pay.

The cost of reinsurance ceded totaled $133.6 million, $176.7 million and $212.1 million in 2015, 2014 and 2013, respectively.  We deduct this cost from insurance policy income.  Reinsurance recoveries netted against insurance policy benefits totaled $167.7 million, $195.3 million and $196.2 million in 2015, 2014 and 2013, respectively.

From time-to-time, we assume insurance from other companies.  Any costs associated with the assumption of insurance are amortized consistent with the method used to amortize deferred acquisition costs.  Reinsurance premiums assumed totaled $38.5 million, $35.0 million and $37.4 million in 2015, 2014 and 2013, respectively.  Reinsurance premiums included amounts assumed pursuant to marketing and quota-share agreements with Coventry of $6.8 million and $19.7 million, in 2014 and 2013 respectively. As further described above, we received a notice of Coventry's intent to terminate the PDP quota-share reinsurance agreement in August 2013. The premiums collected from Coventry in 2014 represented adjustments to premiums

128

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

on such business related to periods prior to the termination of the agreement. We continue to receive distribution income from Coventry for PDP business sold through our Bankers Life segment.

In December 2013, two of our insurance subsidiaries with long-term care business in the former Other CNO Business segment entered into 100% coinsurance agreements ceding $495 million of long-term care reserves to Beechwood Re Ltd. ("BRe"). Pursuant to the agreements, the insurance subsidiaries paid an additional premium of $96.9 million to BRe and an amount equal to the related net liabilities. The insurance subsidiaries' ceded reserve credits are secured by assets in market-value trusts subject to a 7% over-collateralization, investment guidelines and periodic true-up provisions. Future payments into the trusts to maintain collateral requirements are the responsibility of BRe. We recognized a pre-tax loss of $98.4 million in 2013 to reflect: (i) the known loss (or premium deficiency) on the business, as we will not be recognizing additional income in future periods to recover the unamortized additional premium which will be paid to BRe; and (ii) other transaction costs.

In the second quarter of 2014, we recaptured a block of interest-sensitive life business that was previously ceded under a modified coinsurance agreement. The recapture of this block resulted in a gain related to reinsurance transaction of $3.8 million.

As further described in the note to the financial statements entitled "Sale of Subsidiary", we recaptured a block of life insurance business in 2014 that was previously ceded under a coinsurance agreement.

Income Taxes

Our income tax expense includes deferred income taxes arising from temporary differences between the financial reporting and tax bases of assets and liabilities, capital loss carryforwards and net operating loss carryforwards ("NOLs"). Deferred tax assets and liabilities are measured using enacted tax rates expected to apply in the years in which temporary differences are expected to be recovered or paid.  The effect of a change in tax rates on deferred tax assets and liabilities is recognized in earnings in the period when the changes are enacted.

A reduction of the net carrying amount of deferred tax assets by establishing a valuation allowance is required if, based on the available evidence, it is more likely than not that such assets will not be realized. In assessing the need for a valuation allowance, all available evidence, both positive and negative, shall be considered to determine whether, based on the weight of that evidence, a valuation allowance for deferred tax assets is needed. This assessment requires significant judgment and considers, among other matters, the nature, frequency and severity of current and cumulative losses, forecasts of future profitability, the duration of carryforward periods, our experience with operating loss and tax credit carryforwards expiring unused, and tax planning strategies. We evaluate the need to establish a valuation allowance for our deferred income tax assets on an ongoing basis. The realization of our deferred tax assets depends upon generating sufficient future taxable income of the appropriate type during the periods in which our temporary differences become deductible and before our capital loss carryforwards and life and non-life NOLs expire.

At December 31, 2015, our valuation allowance for our net deferred tax assets was $213.5 million, as we have determined that it is more likely than not that a portion of our deferred tax assets will not be realized. This determination was made by evaluating each component of the deferred tax assets and assessing the effects of limitations and/or interpretations on the value of such component to be fully recognized in the future.

129

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

Investments in Variable Interest Entities

We have concluded that we are the primary beneficiary with respect to certain variable interest entities ("VIEs"), which are consolidated in our financial statements. All such VIEs are collateralized loan trusts that were established to issue securities to finance the purchase of corporate loans and other permitted investments.  The assets held by the trusts are legally isolated and not available to the Company.  The liabilities of the VIEs are expected to be satisfied from the cash flows generated by the underlying loans held by the trusts, not from the assets of the Company.  The Company has no financial obligation to the VIEs beyond its investment in each VIE.

The investment portfolios held by the VIEs are primarily comprised of commercial bank loans to corporate obligors which are almost entirely rated below-investment grade.  Refer to the note to the consolidated financial statements entitled "Investments in Variable Interest Entities" for additional information about VIEs.

In addition, the Company, in the normal course of business, makes passive investments in structured securities issued by VIEs for which the Company is not the investment manager.  These structured securities include asset-backed securities, collateralized debt obligations, commercial mortgage-backed securities, residential mortgage-backed securities and collateralized mortgage obligations.  Our maximum exposure to loss on these securities is limited to our cost basis in the investment.  We have determined that we are not the primary beneficiary of these structured securities due to the relative size of our investment in comparison to the total principal amount of the individual structured securities and the level of credit subordination which reduces our obligation to absorb gains or losses.

At December 31, 2015, we held investments in various limited partnerships, in which we are not the primary beneficiary, totaling $76.9 million (classified as other invested assets).  At December 31, 2015, we had unfunded commitments to these partnerships of $82.2 million.  Our maximum exposure to loss on these investments is limited to the amount of our investment.

Investment borrowings

Three of the Company's insurance subsidiaries (Washington National, Bankers Life and Colonial Penn) are members of the Federal Home Loan Bank ("FHLB").  As members of the FHLB, our insurance subsidiaries have the ability to borrow on a collateralized basis from the FHLB.  We are required to hold certain minimum amounts of FHLB common stock as a condition of membership in the FHLB, and additional amounts based on the amount of the borrowings.  At December 31, 2015, the carrying value of the FHLB common stock was $74.2 million.  As of December 31, 2015, collateralized borrowings from the FHLB totaled $1.5 billion and the proceeds were used to purchase fixed maturity securities.  The borrowings are classified as investment borrowings in the accompanying consolidated balance sheet.  The borrowings are collateralized by investments with an estimated fair value of $1.8 billion at December 31, 2015, which are maintained in a custodial account for the benefit of the FHLB.  Substantially all of such investments are classified as fixed maturities, available for sale, in our consolidated balance sheet.

130

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

The following summarizes the terms of the borrowings from the FHLB by Washington National, Bankers Life and Colonial Penn (dollars in millions):

Amount		Maturity	Interest rate at
borrowed		date	December 31, 2015
$	57.7	June 2017	Variable rate – 0.699%
50.0		August 2017	Variable rate – 0.562%
75.0		August 2017	Variable rate – 0.543%
100.0		October 2017	Variable rate – 0.751%
50.0		November 2017	Variable rate – 0.917%
50.0		January 2018	Variable rate – 0.670%
50.0		January 2018	Variable rate – 0.656%
50.0		February 2018	Variable rate – 0.654%
50.0		February 2018	Variable rate – 0.452%
22.0		February 2018	Variable rate – 0.742%
100.0		May 2018	Variable rate – 0.872%
50.0		July 2018	Variable rate – 0.793%
50.0		August 2018	Variable rate – 0.482%
10.0		December 2018	Variable rate – 0.807%
50.0		January 2019	Variable rate – 0.737%
50.0		February 2019	Variable rate – 0.452%
100.0		March 2019	Variable rate – 0.831%
21.8		July 2019	Variable rate – 0.892%
15.0		October 2019	Variable rate – 0.837%
50.0		May 2020	Variable rate – 0.851%
21.8		June 2020	Fixed rate – 1.960%
25.0		September 2020	Variable rate – 0.951%
100.0		September 2020	Variable rate – 1.082%
50.0		September 2020	Variable rate – 1.082%
75.0		September 2020	Variable rate – 0.723%
100.0		October 2020	Variable rate – 0.723%
50.0		December 2020	Variable rate – 0.951%
28.2		August 2021	Fixed rate – 2.550%
26.1		March 2023	Fixed rate – 2.160%
20.5		June 2025	Fixed rate – 2.940%
$	1,548.1

The variable rate borrowings are pre-payable on each interest reset date without penalty.  The fixed rate borrowings are pre-payable subject to payment of a yield maintenance fee based on prevailing market interest rates.  At December 31, 2015, the aggregate yield maintenance fee to prepay all fixed rate borrowings was $1.7 million.

Interest expense of $10.9 million, $18.7 million and $27.9 million in 2015, 2014 and 2013, respectively, was recognized related to total borrowings from the FHLB.

In addition to our borrowings from the FHLB, we may enter into repurchase agreements to increase our investment return as part of our investment strategy as further discussed in the note to the consolidated financial statements entitled

131

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

"Derivatives". These repurchase agreements are accounted for as collateralized financing arrangements and not as a sale and subsequent repurchase of securities. There were no such borrowings outstanding at December 31, 2015. We had $20.4 million of such borrowings outstanding at December 31, 2014.

The primary risks associated with short-term collateralized borrowings are: (i) a substantial decline in the market value of the margined security; and (ii) that a counterparty may be unable to perform under the terms of the contract or be unwilling to extend such financing in future periods especially if the liquidity or value of the margined security has declined. Exposure is limited to any depreciation in value of the related securities.

Accounting for Derivatives

Our fixed index annuity products provide a guaranteed minimum rate of return and a higher potential return that is based on a percentage (the "participation rate") of the amount of increase in the value of a particular index, such as the Standard & Poor's 500 Index, over a specified period.  Typically, on each policy anniversary date, a new index period begins.  We are generally able to change the participation rate at the beginning of each index period during a policy year, subject to contractual minimums.  The Company accounts for the options attributed to the policyholder for the estimated life of the contract as embedded derivatives. These accounting requirements often create volatility in the earnings from these products. We typically buy call options (including call spreads) referenced to the applicable indices in an effort to offset or hedge potential increases to policyholder benefits resulting from increases in the particular index to which the policy's return is linked.

We utilize United States Treasury interest rate futures primarily to hedge interest rate risk related to anticipated mortgage loan transactions.

In periods prior to the second quarter of 2014, we were required to establish an embedded derivative related to a modified coinsurance agreement which ceded the risks of a block of interest sensitive life business. We recaptured this block in the second quarter of 2014 resulting in a gain of $3.8 million. Prior to the recapture of this block, we maintained the investments related to the modified coinsurance agreement in our trading securities account, which we carried at estimated fair value with changes in such value recognized as investment income.  Such trading securities were sold in the second quarter of 2014 in conjunction with the reinsurance recapture.

We purchase certain fixed maturity securities that contain embedded derivatives that are required to be held at fair value on the consolidated balance sheet. We have elected the fair value option to carry the entire security at fair value with changes in fair value reported in net income.

Multibucket Annuity Products

The Company's multibucket annuity is an annuity product that credits interest based on the experience of a particular market strategy. Policyholders allocate their annuity premium payments to several different market strategies based on different asset classes within the Company's investment portfolio. Interest is credited to this product based on the market return of the given strategy, less management fees, and funds may be moved between different strategies. The Company guarantees a minimum return of premium plus approximately 3 percent per annum over the life of the contract. The investments backing the market strategies of these products are designated by the Company as trading securities. The change in the fair value of these securities is recognized as investment income (classified as income from policyholder and reinsurer accounts and other special-purpose portfolios), which is substantially offset by the change in insurance policy benefits for these products. We hold insurance liabilities of $37.5 million and $43.4 million related to multibucket annuity products as of December 31, 2015 and 2014, respectively.

Sales Inducements

Certain of our annuity products offer sales inducements to contract holders in the form of enhanced crediting rates or bonus payments in the initial period of the contract.  Certain of our life insurance products offer persistency bonuses credited to the contract holders balance after the policy has been outstanding for a specified period of time.  These enhanced rates and persistency bonuses are considered sales inducements in accordance with GAAP.  Such amounts are deferred and amortized in the same manner as deferred acquisition costs.  Sales inducements deferred totaled $3.8 million, $5.1 million and $5.0 million during 2015, 2014 and 2013, respectively.  Amounts amortized totaled $13.8 million, $12.4 million and $22.9 million during

132

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

2015, 2014 and 2013, respectively.  The unamortized balance of deferred sales inducements was $57.4 million and $67.4 million at December 31, 2015 and 2014, respectively.  The balance of insurance liabilities for persistency bonus benefits was $.9 million and $1.5 million at December 31, 2015 and 2014, respectively.

Out-of-Period Adjustments

In 2014, we recorded the net effect of an out-of-period adjustment related to the calculation of incentive compensation accruals which increased other operating costs and expenses by $2.4 million, decreased tax expense by $.8 million and decreased our net income by $1.6 million (or 1 cent per diluted share). In 2013 we recorded the net effect of out-of-period adjustments which increased our insurance policy benefits by $4.7 million, increased amortization expense by $2.1 million, increased other operating costs and expenses by $1.5 million, decreased tax expense by $.7 million and decreased our net income by $7.6 million (or 3 cents per diluted share). We evaluated these adjustments taking into account both qualitative and quantitative factors and considered the impact of these adjustments in relation to each period, as well as the periods in which they originated. The impact of recognizing these adjustments in prior years was not significant to any individual period. Management believes these adjustments are immaterial to the consolidated financial statements and all previously issued financial statements.

Recently Issued Accounting Standards

Pending Accounting Standards

In May 2014, the Financial Accounting Standards Board (the "FASB") issued authoritative guidance for recognizing revenue from contracts with customers. Certain contracts with customers are specifically excluded from this guidance, including insurance contracts. The core principle of the new guidance is that an entity should recognize revenue when it transfers promised goods or services in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The guidance also requires additional disclosures about the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. In July 2015, the guidance was updated and will now be effective for the Company on January 1, 2018 and permits two methods of transition upon adoption; full retrospective and modified retrospective. Under the full retrospective method, prior periods would be restated under the new revenue standard, providing for comparability in all periods presented. Under the modified retrospective method, prior periods would not be restated. Instead, revenues and other disclosures for pre-2017 periods would be provided in the notes to the financial statements as previously reported under the current revenue standard. The Company is currently assessing the impact the guidance will have upon adoption.

In August 2014, the FASB issued authoritative guidance related to measuring the financial assets and the financial liabilities of a consolidated collateralized financing entity which provides a measurement alternative for an entity that consolidates collateralized financing entities. A collateralized financing entity is a VIE with no more than nominal equity that holds financial assets and issues beneficial interests in those financial assets; the beneficial interests have contractual recourse only to the related assets of the collateralized financing entity and are classified as financial liabilities. If elected, the alternative method results in the reporting entity measuring both the financial assets and the financial liabilities of the collateralized financing entity using the more observable of the two fair value measurements, which effectively removes measurement differences between the financial assets and the financial liabilities of the collateralized financing entity previously recorded as net income (loss) attributable to non-controlling and other beneficial interests and as an adjustment to appropriated retained earnings. The reporting entity continues to measure its own beneficial interests in the collateralized financing entity (other than those that represent compensation for services) at fair value. The guidance will be effective for the Company for interim and annual periods beginning in 2016. A reporting entity may apply the guidance using a modified retrospective approach by recording a cumulative-effect adjustment to equity as of the beginning of the annual period of adoption. A reporting entity may also apply the guidance retrospectively to all relevant prior periods. The adoption of this guidance is not expected to have a material impact on our consolidated financial statements.

In February 2015, the FASB issued authoritative guidance which updates the analysis that a reporting entity must perform to determine whether it should consolidate certain legal entities. Such guidance: (i) modifies the evaluation of whether limited partnerships and similar legal entities are VIEs or voting interest entities; (ii) eliminates the presumption that a general partner should consolidate a limited partnership; (iii) affects the consolidation analysis of reporting entities that are involved with VIEs, particularly those that have fee arrangements and related party relationships; and (iv) provides a scope exception

133

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

from consolidation guidance for certain investment funds. The guidance will be effective for the Company for interim and annual periods beginning in 2016. A reporting entity may apply the guidance using a modified retrospective approach by recording a cumulative-effect adjustment to equity as of the beginning of the annual period of adoption. A reporting entity may also apply the guidance retrospectively to all relevant prior periods. The adoption of this guidance is not expected to have a material impact on our consolidated financial statements.

In May 2015, the FASB issued authoritative guidance which requires additional disclosures related to short-duration contracts. The guidance will require insurance entities to disclose for annual reporting periods information about the liability for unpaid claims and claim adjustment expenses. The guidance also requires insurance entities to disclose information about significant changes in methodologies and assumptions used to calculate the liability for unpaid claims and claim adjustment expenses, including reasons for the change and the effects on the financial statements. Additionally, the guidance requires insurance entities to disclose for annual and interim reporting periods a rollforward of the liability for unpaid claims and claim adjustment expenses. For health insurance claims, the guidance requires the disclosure of the total of incurred-but-not-reported liabilities plus expected development on reported claims included in the liability for unpaid claims and claim adjustment expenses. The guidance will be effective for the Company for annual periods beginning after December 15, 2015, and the interim periods within annual periods beginning after December 15, 2016. The Company is currently assessing the impact the guidance will have on its disclosures upon adoption.

In January 2016, the FASB issued authoritative guidance related to the recognition and measurement of financial assets and financial liabilities which made targeted improvements to GAAP as follows:

(i) Require equity investments (except those accounted for under the equity method of accounting or those that result in consolidation of the investee) to be measured at fair value with changes in fair value recognized in net income. However, an entity may choose to measure equity investments that do not have readily determinable fair values at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer.

(ii) Simplify the impairment assessment of equity investments without readily determinable fair values by requiring a qualitative assessment to identify impairment. When a qualitative assessment indicates that impairment exists, an entity is required to measure the investment at fair value.

(iii) Eliminate the requirement for public business entities to disclose the method(s) and significant assumptions used to estimate the fair value that is required to be disclosed for financial instruments measured at amortized cost on the balance sheet.

(iv) Require public business entities to use the exit price notion when measuring the fair value of financial instruments for disclosure purposes.

(v) Require an entity to present separately in other comprehensive income the portion of the total change in the fair value of a liability resulting from a change in the instrument-specific credit risk when the entity has elected to measure the liability at fair value in accordance with the fair value option for financial instruments.

(vi) Require separate presentation of financial assets and financial liabilities by measurement category and form of financial asset (that is, securities or loans and receivables) on the balance sheet or the accompanying notes to the financial statements.

(vii) Clarify that an entity should evaluate the need for a valuation allowance on a deferred tax asset related to available-for-sale securities in combination with the entity’s other deferred tax assets.

The guidance will be effective for the Company for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. Early adoption of the guidance is not permitted; except that item (v) above is permitted to be adopted early as of the beginning of the fiscal year of adoption.

An entity should apply the amendments in the guidance by means of a cumulative-effect adjustment to the balance sheet as of the beginning of the fiscal year of adoption. The amendments related to equity securities without readily determinable fair

values (including disclosure requirements) should be applied prospectively to equity investments that exist as of the date of adoption of the guidance. The Company is currently assessing the impact the guidance will have upon adoption.

134

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

Adopted Accounting Standards

In April 2014, the FASB issued authoritative guidance changing the criteria for reporting discontinued operations. Under the revised guidance, only disposals of a component or a group of components, including those classified as held for sale, which represent a strategic shift that has or will have a major effect on a company's operations and financial results will be reported as discontinued operations. The guidance was effective prospectively for new disposals occurring after January 1, 2015.

In June 2014, the FASB issued authoritative guidance on the accounting and disclosure of repurchase-to-maturity transactions and repurchase financings. Under this new accounting guidance, repurchase-to-maturity transactions will be accounted for as secured borrowings rather than sales of an asset, and transfers of financial assets with a contemporaneous repurchase financing arrangement will no longer be evaluated to determine whether they should be accounted for on a combined basis as forward contracts. The new guidance also prescribes additional disclosures particularly on the nature of collateral pledged in the repurchase agreement accounted for as a secured borrowing. The new guidance was effective beginning on January 1, 2015. The adoption of this guidance did not have a material impact on our consolidated financial statements.

In April 2015, the FASB issued authoritative guidance which requires debt issuance costs in financial statements to be presented as a direct deduction from the carrying value of the associated debt liability rather than as an asset on the balance sheet. This guidance is effective beginning January 1, 2016, with early adoption permitted. The Company adopted this guidance in the fourth quarter of 2015. The adoption of this guidance resulted in a change in presentation on our balance sheet but did not have any impact on our operating results or cash flows. The impact of adoption on prior periods is as follows (dollars in millions):

	December 31, 2014
	As originally reported		Effect of adoption			As adjusted
Other assets	$	337.7	$	(28.3	)	$	309.4
Total assets	31,184.2		(28.3		)	31,155.9
Borrowings related to variable interest entities	1,286.1		(14.2		)	1,271.9
Notes payable - direct corporate obligations	794.4		(14.1		)	780.3
Total liabilities	26,496.0		(28.3		)	26,467.7

In May 2015, the FASB issued authoritative guidance that removes the requirement to categorize within the fair value hierarchy all investments for which fair value is measured using the net asset value per share practical expedient. The guidance also removes the requirement to make certain disclosures for all investments that are eligible to be measured at fair value using the net asset value per share practical expedient. The guidance is effective for fiscal years beginning after December 15, 2015, and interim periods within those fiscal years, with early adoption permitted. A reporting entity should apply the guidance retrospectively to all periods presented. The Company elected to early adopt this guidance as of December 31, 2015, and has removed certain investments that are measured using the net asset value per share practical expedient from the fair value hierarchy in all periods presented in our consolidated financial statements.

135

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

3. INVESTMENTS

At December 31, 2015, the amortized cost, gross unrealized gains and losses, estimated fair value and other-than-temporary impairments in accumulated other comprehensive income of fixed maturities, available for sale, and equity securities were as follows (dollars in millions):

	Amortized cost		Gross unrealized gains		Gross unrealized losses			Estimated fair value		Other-than-temporary impairments included in accumulated other comprehensive income
Investment grade (a):
Corporate securities	$	11,477.5	$	929.4	$	(262.9	)	$	12,144.0	$	—
United States Treasury securities and obligations of United States government corporations and agencies	172.5		22.3		(.3		)	194.5		—
States and political subdivisions	1,889.6		208.6		(3.7		)	2,094.5		—
Debt securities issued by foreign governments	18.9		—		(.6		)	18.3		—
Asset-backed securities	979.8		22.1		(7.2		)	994.7		—
Collateralized debt obligations	188.5		.4		(2.2		)	186.7		—
Commercial mortgage-backed securities	1,531.7		41.3		(16.3		)	1,556.7		—
Mortgage pass-through securities	3.1		.3		—			3.4		—
Collateralized mortgage obligations	450.9		17.0		(.6		)	467.3		—
Total investment grade fixed maturities, available for sale	16,712.5		1,241.4		(293.8		)	17,660.1		—
Below-investment grade (a):
Corporate securities	798.5		8.3		(82.3		)	724.5		—
States and political subdivisions	13.6		—		(3.9		)	9.7		(3.0		)
Debt securities issued by foreign governments	2.4		—		—			2.4		—
Asset-backed securities	838.0		25.7		(6.2		)	857.5		—
Commercial mortgage-backed securities	49.9		—		(1.3		)	48.6		—
Collateralized mortgage obligations	532.1		49.0		(1.0		)	580.1		(1.9		)
Total below-investment grade fixed maturities, available for sale	2,234.5		83.0		(94.7		)	2,222.8		(4.9		)
Total fixed maturities, available for sale	$	18,947.0	$	1,324.4	$	(388.5	)	$	19,882.9	$	(4.9	)
Equity securities	$	447.4	$	18.4	$	(2.8	)	$	463.0

_______________

(a) Investment ratings – Investment ratings are assigned the second lowest rating by Nationally Recognized Statistical Rating Organizations ("NRSROs") (Moody's Investor Services, Inc. ("Moody's"), Standard & Poor's Corporation ("S&P") or Fitch Ratings ("Fitch")), or if not rated by such firms, the rating assigned by the National Association of Insurance Commissioners (the "NAIC").  NAIC designations of "1" or "2" include fixed maturities generally rated investment grade (rated "Baa3" or higher by Moody's or rated "BBB-" or higher by S&P and Fitch).  NAIC designations of "3" through "6" are referred to as below-investment grade (which generally are rated "Ba1" or lower by Moody's or rated "BB+" or lower by S&P and Fitch).  References to investment grade or below-investment grade throughout our consolidated financial statements are determined as described above.

The NAIC evaluates the fixed maturity investments of insurers for regulatory and capital assessment purposes and assigns securities to one of six credit quality categories called NAIC designations, which are used by insurers when preparing

136

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

their annual statements based on statutory accounting principles. The NAIC designations are generally similar to the credit quality designations of the NRSROs for marketable fixed maturity securities, except for certain structured securities. However, certain structured securities rated below investment grade by the NRSROs can be assigned NAIC 1 or NAIC 2 designations dependent on the cost basis of the holding relative to estimated recoverable amounts as determined by the NAIC. The following summarizes the NAIC designations and NRSRO equivalent ratings:

NAIC Designation	NRSRO Equivalent Rating
1	AAA/AA/A
2	BBB
3	BB
4	B
5	CCC and lower
6	In or near default

A summary of our fixed maturity securities, available for sale, by NAIC designations (or for fixed maturity securities held by non-regulated entities, based on NRSRO ratings) as of December 31, 2015 is as follows (dollars in millions):

NAIC designation	Amortized cost		Estimated fair value		Percentage of total estimated fair value
1	$	9,491.4	$	10,238.7	51.5	%
2	8,609.3		8,876.1		44.6
3	591.4		547.4		2.8
4	187.4		160.0		.8
5	53.7		50.8		.3
6	13.8		9.9		—
	$	18,947.0	$	19,882.9	100.0	%

137

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

At December 31, 2014, the amortized cost, gross unrealized gains and losses, estimated fair value and other-than-temporary impairments in accumulated other comprehensive income of fixed maturities, available for sale, and equity securities were as follows (dollars in millions):

	Amortized cost		Gross unrealized gains		Gross unrealized losses			Estimated fair value		Other-than-temporary impairments included in accumulated other comprehensive income
Investment grade (a):
Corporate securities	$	11,177.1	$	1,710.5	$	(42.1	)	$	12,845.5	$	—
United States Treasury securities and obligations of United States government corporations and agencies	138.8		30.2		(.1		)	168.9		—
States and political subdivisions	1,960.6		299.3		(.7		)	2,259.2		—
Debt securities issued by foreign governments	1.8		.1		—			1.9		—
Asset-backed securities	720.7		52.0		(1.6		)	771.1		—
Collateralized debt obligations	314.9		2.4		(3.4		)	313.9		—
Commercial mortgage-backed securities	1,179.7		80.9		(.5		)	1,260.1		—
Mortgage pass-through securities	4.2		.4		—			4.6		—
Collateralized mortgage obligations	571.1		23.1		(.6		)	593.6		—
Total investment grade fixed maturities, available for sale	16,068.9		2,198.9		(49.0		)	18,218.8		—
Below-investment grade (a):
Corporate securities	1,139.3		29.2		(43.0		)	1,125.5		—
States and political subdivisions	20.6		.2		(2.3		)	18.5		—
Asset-backed securities	465.9		33.8		(1.8		)	497.9		—
Collateralized debt obligations	10.4		.2		—			10.6		—
Commercial mortgage-backed securities	15.3		.9		—			16.2		—
Collateralized mortgage obligations	687.7		60.4		(.7		)	747.4		(3.2		)
Total below-investment grade fixed maturities, available for sale	2,339.2		124.7		(47.8		)	2,416.1		(3.2		)
Total fixed maturities, available for sale	$	18,408.1	$	2,323.6	$	(96.8	)	$	20,634.9	$	(3.2	)
Equity securities	$	400.5	$	19.1	$	(.6	)	$	419.0

138

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

Accumulated other comprehensive income is primarily comprised of the net effect of unrealized appreciation (depreciation) on our investments.  These amounts, included in shareholders' equity as of December 31, 2015 and 2014, were as follows (dollars in millions):

	2015			2014
Net unrealized appreciation (depreciation) on fixed maturity securities, available for sale, on which an other-than-temporary impairment loss has been recognized	$	1.6		$	5.3
Net unrealized gains on all other investments	903.4			2,207.7
Adjustment to present value of future profits (a)	(121.2		)	(149.9		)
Adjustment to deferred acquisition costs	(133.3		)	(390.5		)
Adjustment to insurance liabilities	(14.6		)	(381.4		)
Unrecognized net loss related to deferred compensation plan	(8.6		)	(8.5		)
Deferred income tax liabilities	(224.5		)	(457.4		)
Accumulated other comprehensive income	$	402.8		$	825.3

________

(a) The present value of future profits is the value assigned to the right to receive future cash flows from contracts existing at September 10, 2003, the date our Predecessor emerged from bankruptcy.

At December 31, 2015, adjustments to the present value of future profits, deferred acquisition costs, insurance liabilities and deferred tax assets included $(109.3) million, $(33.2) million, $(14.6) million and $55.8 million, respectively, for premium deficiencies that would exist on certain blocks of business (primarily long-term care products) if unrealized gains on the assets backing such products had been realized and the proceeds from the sales of such assets were invested at then current yields.

At December 31, 2014, adjustments to the present value of future profits, deferred acquisition costs, insurance liabilities and deferred tax assets included $(128.8) million, $(142.2) million, $(381.4) million and $232.1 million, respectively, for premium deficiencies that would exist on certain blocks of business (primarily long-term care products) if unrealized gains on the assets backing such products had been realized and the proceeds from the sales of such assets were invested at then current yields.

Below-Investment Grade Securities

At December 31, 2015, the amortized cost of the Company's below-investment grade fixed maturity securities was $2,234.5 million, or 12 percent of the Company's fixed maturity portfolio. The estimated fair value of the below-investment grade portfolio was $2,222.8 million, or 99 percent of the amortized cost.

Below-investment grade corporate debt securities typically have different characteristics than investment grade corporate debt securities.  Based on historical performance, probability of default by the borrower is significantly greater for below-investment grade corporate debt securities and in many cases severity of loss is relatively greater as such securities are generally unsecured and often subordinated to other indebtedness of the issuer.  Also, issuers of below-investment grade corporate debt securities frequently have higher levels of debt relative to investment-grade issuers, hence, all other things being equal, are generally more sensitive to adverse economic conditions.  The Company attempts to reduce the overall risk related to its investment in below-investment grade securities, as in all investments, through careful credit analysis, strict investment policy guidelines, and diversification by issuer and/or guarantor and by industry.

139

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

Contractual Maturity

The following table sets forth the amortized cost and estimated fair value of fixed maturities, available for sale, at December 31, 2015, by contractual maturity.  Actual maturities will differ from contractual maturities because certain borrowers may have the right to call or prepay obligations with or without penalties.  In addition, structured securities (such as asset-backed securities, collateralized debt obligations, commercial mortgage-backed securities, mortgage pass-through securities and collateralized mortgage obligations, collectively referred to as "structured securities") frequently include provisions for periodic principal payments and permit periodic unscheduled payments.

	Amortized cost		Estimated fair value
	(Dollars in millions)
Due in one year or less	$	265.0	$	268.9
Due after one year through five years	2,246.2		2,389.1
Due after five years through ten years	1,755.7		1,824.5
Due after ten years	10,106.1		10,705.4
Subtotal	14,373.0		15,187.9
Structured securities	4,574.0		4,695.0
Total fixed maturities, available for sale	$	18,947.0	$	19,882.9

Net Investment Income

Net investment income consisted of the following (dollars in millions):

	2015			2014			2013
General account assets:
Fixed maturities	$	1,090.1		$	1,175.8		$	1,290.3
Equity securities	18.3			13.9			7.0
Mortgage loans	91.4			104.2			96.3
Policy loans	7.3			11.0			17.3
Other invested assets	17.4			17.1			14.4
Cash and cash equivalents	.8			.6			.5
Policyholder and reinsurer accounts and other special-purpose portfolios:
Trading securities (a)	10.7			14.8			12.8
Options related to fixed index products:
Option income	36.5			118.9			77.4
Change in value of options	(72.7		)	(49.4		)	100.1
Other special-purpose portfolios	55.5			42.1			67.9
Gross investment income	1,255.3			1,449.0			1,684.0
Less investment expenses	21.7			21.6			20.0
Net investment income	$	1,233.6		$	1,427.4		$	1,664.0

_________________

(a) Changes in the estimated fair value for trading securities still held as of the end of the respective years and included in net investment income were $.4 million, $3.4 million and $.4 million for the years ended December 31, 2015, 2014 and 2013, respectively.

There were no fixed maturity investments or mortgage loans not accruing investment income at both at December 31, 2015 and 2014.

140

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

Net Realized Investment Gains (Losses)

The following table sets forth the net realized investment gains (losses) for the periods indicated (dollars in millions):

	2015			2014			2013
Fixed maturity securities, available for sale:
Gross realized gains on sale	$	95.7		$	64.4		$	57.7
Gross realized losses on sale	(88.4		)	(13.0		)	(11.4		)
Impairments:
Total other-than-temporary impairment losses	(17.9		)	—			(7.1		)
Other-than-temporary impairment losses recognized in accumulated other comprehensive income	3.0			—			—
Net impairment losses recognized	(14.9		)	—			(7.1		)
Net realized investment gains (losses) from fixed maturities	(7.6		)	51.4			39.2
Equity securities	3.7			10.1			4.8
Commercial mortgage loans	(2.3		)	(.1		)	(1.1		)
Impairments of mortgage loans and other investments	(25.0		)	(27.3		)	(4.5		)
Gain on dissolution of a variable interest entity	11.3			—			—
Other (a)	(16.7		)	2.6			(5.0		)
Net realized investment gains (losses)	$	(36.6	)	$	36.7		$	33.4

_________________

(a) Changes in the estimated fair value of trading securities that we have elected the fair value option (and still held as of the end of the respective periods) were $(9.2) million, $7.8 million and $(3.0) million for the years ended December 31, 2015, 2014 and 2013, respectively.

During 2015, we recognized net realized investment losses of $36.6 million, which were comprised of: (i) $1.0 million of net losses from the sales of investments; (ii) an $11.3 million gain on the dissolution of a VIE; (iii) the decrease in fair value of embedded derivatives related to a modified coinsurance agreement of $7.0 million; and (iv) $39.9 million of writedowns of investments for other than temporary declines in fair value recognized through net income ($42.9 million, prior to the $3.0 million of impairment losses recognized through accumulated other comprehensive income).

During 2015, a VIE that was required to be consolidated was dissolved. A gain of $11.3 million was recognized representing the difference between the borrowings of such VIE and the contractual distributions required following the liquidation of the underlying assets.

During 2014, we recognized net realized investment gains of $36.7 million, which were comprised of: (i) $54.4 million of net gains from the sales of investments (primarily fixed maturities) with proceeds of $2.1 billion; (ii) the increase in fair value of certain fixed maturity investments with embedded derivatives of $7.6 million; (iii) the increase in fair value of embedded derivatives related to a modified coinsurance agreement of $2.0 million; and (iv) $27.3 million of writedowns of mortgage loans and other investments for other than temporary declines in fair value recognized through net income.

During 2013, we recognized net realized investment gains of $33.4 million, which were comprised of: (i) $51.8 million of net gains from the sales of investments (primarily fixed maturities) with proceeds of $2.3 billion; (ii) the decrease in fair value of certain fixed maturity investments with embedded derivatives of $6.8 million; and (iii) $11.6 million of writedowns of investments for other than temporary declines in fair value recognized through net income.

At December 31, 2015, there were no of fixed maturity securities in default or considered nonperforming.

During 2015, the $88.4 million of realized losses on sales of $724.4 million of fixed maturity securities, available for sale, primarily related to various corporate securities (including $59.7 million related to sales of investments in the energy

141

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

sector). Securities are generally sold at a loss following unforeseen issue-specific events or conditions or shifts in perceived risks.  These reasons include but are not limited to:  (i) changes in the investment environment; (ii) expectation that the market value could deteriorate further; (iii) desire to reduce our exposure to an asset class, an issuer or an industry; (iv) prospective or actual changes in credit quality; or (v) changes in expected cash flows.

During 2015, we recognized $39.9 million of impairment losses recorded in earnings which included: (i) $10.2 million of writedowns on fixed maturities in the energy sector; (ii) $16.4 million of writedowns on commercial bank loans held by VIEs; (iii) $5.4 million of writedowns on other investments (primarily fixed maturities); and (iv) a $7.9 million writedown of a legacy investment in a private company that was liquidated. We no longer have any exposure to legacy private companies related to investments acquired by our Predecessor. Factors considered in determining the writedowns of investments in 2015 included the subordination status of each investment, the impact of recent downgrades and issuer specific events, including the impact of the current low oil prices on issuers in the energy sector.

During 2014, the $13.0 million of realized losses on sales of $233.7 million of fixed maturity securities, available for sale, included:  (i) $.7 million of losses related to the sales of securities issued by state and political subdivisions; and (ii) $12.3 million of additional losses primarily related to various corporate securities.  

During 2014, we recognized $27.3 million of impairment losses recorded in earnings which included:  (i) a $6.8 million writedown of commercial mortgage loans as a result of our intent to sell the loans; (ii) $19.1 million of impairments related to two legacy private company investments where earnings and cash flows had not met the expectations assumed in our previous valuations; and (iii) $1.4 million of losses on other investments following unforeseen issue-specific events or conditions.

During 2013, the $11.4 million of realized losses on sales of $477.5 million of fixed maturity securities, available for sale, included: (i) $2.5 million of losses related to the sales of mortgage-backed securities and asset-backed securities; and (ii) $8.9 million of additional losses primarily related to various corporate securities.

During 2013, the $11.6 million of other-than-temporary impairments we recorded in earnings included:  (i) $5.0 million of losses on a corporate security; (ii) $2.5 million of losses on an equity security; and (iii) $4.1 million of losses primarily related to fixed maturity securities following unforeseen issue-specific events or conditions.

Our fixed maturity investments are generally purchased in the context of various long-term strategies, including funding insurance liabilities, so we do not generally seek to generate short-term realized gains through the purchase and sale of such securities.  In certain circumstances, including those in which securities are selling at prices which exceed our view of their underlying economic value, or when it is possible to reinvest the proceeds to better meet our long-term asset-liability objectives, we may sell certain securities.

142

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

The following summarizes the investments sold at a loss during 2015 which had been continuously in an unrealized loss position exceeding 20 percent of the amortized cost basis prior to the sale for the period indicated (dollars in millions):

		At date of sale
	Number of issuers	Amortized cost		Fair value
Less than 6 months prior to sale	12	$	38.7	$	24.5
Greater than or equal to 6 months and less than 12 months prior to sale	2	16.9		9.5
	14	$	55.6	$	34.0

We regularly evaluate all of our investments with unrealized losses for possible impairment.  Our assessment of whether unrealized losses are "other than temporary" requires significant judgment.  Factors considered include:  (i) the extent to which fair value is less than the cost basis; (ii) the length of time that the fair value has been less than cost; (iii) whether the unrealized loss is event driven, credit-driven or a result of changes in market interest rates or risk premium; (iv) the near-term prospects for specific events, developments or circumstances likely to affect the value of the investment; (v) the investment's rating and whether the investment is investment-grade and/or has been downgraded since its purchase; (vi) whether the issuer is current on all payments in accordance with the contractual terms of the investment and is expected to meet all of its obligations under the terms of the investment; (vii) whether we intend to sell the investment or it is more likely than not that circumstances will require us to sell the investment before recovery occurs; (viii) the underlying current and prospective asset and enterprise values of the issuer and the extent to which the recoverability of the carrying value of our investment may be affected by changes in such values; (ix) projections of, and unfavorable changes in, cash flows on structured securities including mortgage-backed and asset-backed securities; (x) our best estimate of the value of any collateral; and (xi) other objective and subjective factors.

Future events may occur, or additional information may become available, which may necessitate future realized losses in our portfolio.  Significant losses could have a material adverse effect on our consolidated financial statements in future periods.

Impairment losses on equity securities are recognized in net income.  The manner in which impairment losses on fixed maturity securities, available for sale, are recognized in the financial statements is dependent on the facts and circumstances related to the specific security.  If we intend to sell a security or it is more likely than not that we would be required to sell a security before the recovery of its amortized cost, the security is other-than-temporarily impaired and the full amount of the impairment is recognized as a loss through earnings.  If we do not expect to recover the amortized cost basis, we do not plan to sell the security, and if it is not more likely than not that we would be required to sell a security before the recovery of its amortized cost, less any current period credit loss, the recognition of the other-than-temporary impairment is bifurcated.  We recognize the credit loss portion in net income and the noncredit loss portion in accumulated other comprehensive income.

We estimate the amount of the credit loss component of a fixed maturity security impairment as the difference between amortized cost and the present value of the expected cash flows of the security.  The present value is determined using the best estimate of future cash flows discounted at the effective interest rate implicit to the security at the date of purchase or the current yield to accrete an asset-backed or floating rate security.  The methodology and assumptions for establishing the best estimate of future cash flows vary depending on the type of security.

For most structured securities, cash flow estimates are based on bond specific facts and circumstances that may include collateral characteristics, expectations of delinquency and default rates, loss severity, prepayment speeds and structural support, including excess spread, subordination and guarantees.  For corporate bonds, cash flow estimates are derived from scenario-based outcomes of expected corporate restructurings or the disposition of assets using bond specific facts and circumstances. The previous amortized cost basis less the impairment recognized in net income becomes the security's new cost basis.  We accrete the new cost basis to the estimated future cash flows over the expected remaining life of the security, except when the security is in default or considered nonperforming.

The remaining noncredit impairment, which is recorded in accumulated other comprehensive income, is the difference between the security's estimated fair value and our best estimate of future cash flows discounted at the effective interest rate

143

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

prior to impairment.  The remaining noncredit impairment typically represents changes in the market interest rates, current market liquidity and risk premiums.  As of December 31, 2015, other-than-temporary impairments included in accumulated other comprehensive income totaled $4.9 million (before taxes and related amortization).

Mortgage loans are impaired when it is probable that we will not collect the contractual principal and interest on the loan. We measure impairment based upon the difference between the carrying value of the loan and the estimated fair value of the collateral securing the loan less cost to sell.

The following table summarizes the amount of credit losses recognized in earnings on fixed maturity securities, available for sale, held at the beginning of the period, for which a portion of the other-than-temporary impairment was also recognized in accumulated other comprehensive income for years ended December 31, 2015, 2014 and 2013 (dollars in millions):

	Year ended
	December 31,
	2015			2014			2013
Credit losses on fixed maturity securities, available for sale, beginning of period	$	(1.0	)	$	(1.3	)	$	(1.6	)
Add:  credit losses on other-than-temporary impairments not previously recognized	(2.0		)	—			—
Less:  credit losses on securities sold	.4			.3			.3
Less:  credit losses on securities impaired due to intent to sell (a)	—			—			—
Add:  credit losses on previously impaired securities	—			—			—
Less:  increases in cash flows expected on previously impaired securities	—			—			—
Credit losses on fixed maturity securities, available for sale, end of period	$	(2.6	)	$	(1.0	)	$	(1.3	)

__________

(a) Represents securities for which the amount previously recognized in accumulated other comprehensive income was recognized in earnings because we intend to sell the security or we more likely than not will be required to sell the security before recovery of its amortized cost basis.

144

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

Investments with Unrealized Losses

The following table sets forth the amortized cost and estimated fair value of those fixed maturities, available for sale, with unrealized losses at December 31, 2015, by contractual maturity.  Actual maturities will differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without penalties.  Structured securities frequently include provisions for periodic principal payments and permit periodic unscheduled payments.

	Amortized cost		Estimated fair value
	(Dollars in millions)
Due in one year or less	$	20.7	$	20.7
Due after one year through five years	358.7		343.8
Due after five years through ten years	464.3		426.4
Due after ten years	2,938.4		2,637.5
Subtotal	3,782.1		3,428.4
Structured securities	1,916.4		1,881.6
Total	$	5,698.5	$	5,310.0

The following summarizes the investments in our portfolio rated below-investment grade which have been continuously in an unrealized loss position exceeding 20 percent of the cost basis for the period indicated as of December 31, 2015 (dollars in millions):

	Number of issuers	Cost basis		Unrealized loss			Estimated fair value
Less than 6 months	22	$	172.8	$	(50.3	)	$	122.5
Greater than or equal to 6 months and less than 12 months	2	23.0		(9.8		)	13.2
Greater than 12 months (a)	1	18.2		(6.1		)	12.1
		$	214.0	$	(66.2	)	$	147.8

________________

(a) With respect to the security which has been in an unrealized position for greater than 12 months, we have analyzed the issuer's financial performance and determined we expect to recover the entire amortized cost.

145

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

The following table summarizes the gross unrealized losses and fair values of our investments with unrealized losses that are not deemed to be other-than-temporarily impaired, aggregated by investment category and length of time that such securities have been in a continuous unrealized loss position, at December 31, 2015 (dollars in millions):

	Less than 12 months					12 months or greater					Total
Description of securities	Fair value		Unrealized losses			Fair value		Unrealized losses			Fair value		Unrealized losses
United States Treasury securities and obligations of United States government corporations and agencies	$	43.6	$	(.3	)	$	—	$	—		$	43.6	$	(.3	)
States and political subdivisions	156.8		(4.1		)	14.8		(3.5		)	171.6		(7.6		)
Debt securities issued by foreign governments	20.7		(.6		)	—		—			20.7		(.6		)
Corporate securities	2,913.6		(255.7		)	278.9		(89.5		)	3,192.5		(345.2		)
Asset-backed securities	930.3		(11.7		)	98.4		(1.7		)	1,028.7		(13.4		)
Collateralized debt obligations	96.2		(1.8		)	36.3		(.4		)	132.5		(2.2		)
Commercial mortgage-backed securities	556.0		(16.1		)	25.7		(1.5		)	581.7		(17.6		)
Mortgage pass-through securities	—		—			.1		—			.1		—
Collateralized mortgage obligations	97.8		(1.0		)	40.8		(.6		)	138.6		(1.6		)
Total fixed maturities, available for sale	$	4,815.0	$	(291.3	)	$	495.0	$	(97.2	)	$	5,310.0	$	(388.5	)
Equity securities	$	140.1	$	(2.4	)	$	2.4	$	(.4	)	$	142.5	$	(2.8	)

The following table summarizes the gross unrealized losses and fair values of our investments with unrealized losses that are not deemed to be other-than-temporarily impaired, aggregated by investment category and length of time that such securities have been in a continuous unrealized loss position, at December 31, 2014 (dollars in millions):

	Less than 12 months					12 months or greater					Total
Description of securities	Fair value		Unrealized losses			Fair value		Unrealized losses			Fair value		Unrealized losses
United States Treasury securities and obligations of United States government corporations and agencies	$	12.1	$	(.1	)	$	4.6	$	—		$	16.7	$	(.1	)
States and political subdivisions	13.2		(.3		)	44.5		(2.7		)	57.7		(3.0		)
Corporate securities	985.0		(65.9		)	297.5		(19.2		)	1,282.5		(85.1		)
Asset-backed securities	91.2		(1.3		)	60.5		(2.1		)	151.7		(3.4		)
Collateralized debt obligations	184.2		(3.4		)	—		—			184.2		(3.4		)
Commercial mortgage-backed securities	46.7		(.5		)	—		—			46.7		(.5		)
Mortgage pass-through securities	.5		—			.1		—			.6		—
Collateralized mortgage obligations	79.0		(.8		)	32.0		(.5		)	111.0		(1.3		)
Total fixed maturities, available for sale	$	1,411.9	$	(72.3	)	$	439.2	$	(24.5	)	$	1,851.1	$	(96.8	)
Equity securities	$	13.2	$	(.6	)	$	.5	$	—		$	13.7	$	(.6	)

146

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

Based on management's current assessment of investments with unrealized losses at December 31, 2015, the Company believes the issuers of the securities will continue to meet their obligations (or with respect to equity-type securities, the investment value will recover to its cost basis).  While we do not have the intent to sell securities with unrealized losses and it is not more likely than not that we will be required to sell securities with unrealized losses prior to their anticipated recovery, our intent on an individual security may change, based upon market or other unforeseen developments.  In such instances, if a loss is recognized from a sale subsequent to a balance sheet date due to these unexpected developments, the loss is recognized in the period in which we had the intent to sell the security before its anticipated recovery.

Structured Securities

At December 31, 2015 fixed maturity investments included structured securities with an estimated fair value of $4.7 billion (or 24 percent of all fixed maturity securities).  The yield characteristics of structured securities generally differ in some respects from those of traditional corporate fixed-income securities or government securities.  For example, interest and principal payments on structured securities may occur more frequently, often monthly.  In many instances, we are subject to variability in the amount and timing of principal and interest payments.  For example, in many cases, partial prepayments may occur at the option of the issuer and prepayment rates are influenced by a number of factors that cannot be predicted with certainty, including:  the relative sensitivity of prepayments on the underlying assets backing the security to changes in interest rates and asset values; the availability of alternative financing; a variety of economic, geographic and other factors; the timing, pace and proceeds of liquidations of defaulted collateral; and various security-specific structural considerations (for example, the repayment priority of a given security in a securitization structure).  In addition, the total amount of payments for non-agency structured securities may be affected by changes to cumulative default rates or loss severities of the related collateral.

Historically, the rate of prepayments on structured securities has tended to increase when prevailing interest rates have declined significantly in absolute terms and also relative to the interest rates on the underlying collateral. The yields recognized on structured securities purchased at a discount to par will generally increase (relative to the stated rate) when the underlying collateral prepays faster than expected. The yields recognized on structured securities purchased at a premium will decrease (relative to the stated rate) when the underlying collateral prepays faster than expected. When interest rates decline, the proceeds from prepayments may be reinvested at lower rates than we were earning on the prepaid securities. When interest rates increase, prepayments may decrease below expected levels. When this occurs, the average maturity and duration of structured securities increases, decreasing the yield on structured securities purchased at discounts and increasing the yield on those purchased at a premium because of a decrease in the annual amortization of premium.

For structured securities included in fixed maturities, available for sale, that were purchased at a discount or premium, we recognize investment income using an effective yield based on anticipated future prepayments and the estimated final maturity of the securities. Actual prepayment experience is periodically reviewed and effective yields are recalculated when differences arise between the prepayments originally anticipated and the actual prepayments received and currently anticipated. For credit sensitive mortgage-backed and asset-backed securities, and for securities that can be prepaid or settled in a way that we would not recover substantially all of our investment, the effective yield is recalculated on a prospective basis. Under this method, the amortized cost basis in the security is not immediately adjusted and a new yield is applied prospectively. For all other structured and asset-backed securities, the effective yield is recalculated when changes in assumptions are made, and reflected in our income on a retrospective basis. Under this method, the amortized cost basis of the investment in the securities is adjusted to the amount that would have existed had the new effective yield been applied since the acquisition of the securities. Such adjustments were not significant in 2015.

For purchased credit impaired securities, at acquisition, the difference between the undiscounted expected future cash flows and the recorded investment in the securities represents the initial accretable yield, which is accreted into net investment income over the securities’ remaining lives on a level-yield basis. Subsequently, effective yields recognized on purchased credit impaired securities are recalculated and adjusted prospectively to reflect changes in the contractual benchmark interest rates on variable rate securities and any significant increases in undiscounted expected future cash flows arising due to reasons other than interest rate changes. Significant decreases in expected cash flows arising from credit events would result in impairment if such security's fair value is below amortized cost.

147

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

The following table sets forth the par value, amortized cost and estimated fair value of structured securities, summarized by interest rates on the underlying collateral, at December 31, 2015 (dollars in millions):

	Par value		Amortized cost		Estimated fair value
Below 4 percent	$	1,387.4	$	978.3	$	982.3
4 percent – 5 percent	1,363.8		1,289.7		1,300.0
5 percent – 6 percent	1,868.3		1,747.4		1,822.2
6 percent – 7 percent	454.6		419.4		445.2
7 percent – 8 percent	75.0		75.7		82.5
8 percent and above	64.0		63.5		62.8
Total structured securities	$	5,213.1	$	4,574.0	$	4,695.0

The amortized cost and estimated fair value of structured securities at December 31, 2015, summarized by type of security, were as follows (dollars in millions):

			Estimated fair value
Type	Amortized cost		Amount		Percent of fixed maturities
Pass-throughs, sequential and equivalent securities	$	750.0	$	799.8	4.0	%
Planned amortization classes, target amortization classes and accretion-directed bonds	187.7		202.4		1.0
Commercial mortgage-backed securities	1,581.6		1,605.3		8.1
Asset-backed securities	1,817.8		1,852.2		9.3
Collateralized debt obligations	188.5		186.7		.9
Other	48.4		48.6		.3
Total structured securities	$	4,574.0	$	4,695.0	23.6	%

Pass-throughs, sequentials and equivalent securities have unique prepayment variability characteristics.  Pass-through securities typically return principal to the holders based on cash payments from the underlying mortgage obligations. Sequential securities return principal to tranche holders in a detailed hierarchy.  Planned amortization classes, targeted amortization classes and accretion-directed bonds adhere to fixed schedules of principal payments as long as the underlying mortgage loans experience prepayments within certain estimated ranges.  In most circumstances, changes in prepayment rates are first absorbed by support or companion classes insulating the timing of receipt of cash flows from the consequences of both faster prepayments (average life shortening) and slower prepayments (average life extension).

Commercial mortgage-backed securities are secured by commercial real estate mortgages, generally income producing properties that are managed for profit.  Property types include multi-family dwellings including apartments, retail centers, hotels, restaurants, hospitals, nursing homes, warehouses, and office buildings.  While most commercial mortgage-backed securities have call protection features whereby underlying borrowers may not prepay their mortgages for stated periods of time without incurring prepayment penalties, recoveries on defaulted collateral may result in involuntary prepayments.

148

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

Commercial Mortgage Loans

At December 31, 2015, the mortgage loan balance was primarily comprised of commercial mortgage loans. Approximately 13 percent, 9 percent, 8 percent and 5 percent of the mortgage loan balance were on properties located in California, Texas, Maryland and Florida, respectively. No other state comprised greater than five percent of the mortgage loan balance. None of the commercial mortgage loan balance was noncurrent at December 31, 2015. Our commercial mortgage loan portfolio is comprised of large commercial mortgage loans. We do not hold groups of smaller-balance homogeneous loans. Our loans have risk characteristics that are individually unique. Accordingly, we measure potential losses on a loan-by-loan basis rather than establishing an allowance for losses on mortgage loans.

The following table provides the carrying value and estimated fair value of our outstanding mortgage loans and the underlying collateral as of December 31, 2015 (dollars in millions):

			Estimated fair value
Loan-to-value ratio (a)	Carrying value		Mortgage loans		Collateral
Less than 60%	$	796.2	$	828.0	$	1,925.0
60% to 70%	503.8		509.6		771.8
Greater than 70% to 80%	326.8		336.9		440.0
Greater than 80% to 90%	89.9		93.0		108.6
Greater than 90%	4.3		4.9		4.3
Total	$	1,721.0	$	1,772.4	$	3,249.7

________________

(a) Loan-to-value ratios are calculated as the ratio of:  (i) the carrying value of the commercial mortgage loans; to (ii) the estimated fair value of the underlying collateral.

Other Investment Disclosures

Life insurance companies are required to maintain certain investments on deposit with state regulatory authorities. Such assets had aggregate carrying values of $38.2 million and $42.3 million at December 31, 2015 and 2014, respectively.

CNO had no fixed maturity investments that were in excess of 10 percent of shareholders' equity at December 31, 2015 and 2014.

149

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

4. FAIR VALUE MEASUREMENTS

Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date and, therefore, represents an exit price, not an entry price.  We carry certain assets and liabilities at fair value on a recurring basis, including fixed maturities, equity securities, trading securities, investments held by VIEs, derivatives, cash and cash equivalents, separate account assets and embedded derivatives.  We carry our COLI, which is invested in a series of mutual funds, at its cash surrender value which approximates fair value. In addition, we disclose fair value for certain financial instruments, including mortgage loans and policy loans, insurance liabilities for interest-sensitive products, investment borrowings, notes payable and borrowings related to VIEs.

The degree of judgment utilized in measuring the fair value of financial instruments is largely dependent on the level to which pricing is based on observable inputs.  Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our view of market assumptions in the absence of observable market information.  Financial instruments with readily available active quoted prices would be considered to have fair values based on the highest level of observable inputs, and little judgment would be utilized in measuring fair value.  Financial instruments that rarely trade would often have fair value based on a lower level of observable inputs, and more judgment would be utilized in measuring fair value.

Valuation Hierarchy

There is a three-level hierarchy for valuing assets or liabilities at fair value based on whether inputs are observable or unobservable.

• Level 1 – includes assets and liabilities valued using inputs that are unadjusted quoted prices in active markets for identical assets or liabilities.  Our Level 1 assets primarily include cash and exchange traded securities.

• Level 2 – includes assets and liabilities valued using inputs that are quoted prices for similar assets in an active market, quoted prices for identical or similar assets in a market that is not active, observable inputs, or observable inputs that can be corroborated by market data.  Level 2 assets and liabilities include those financial instruments that are valued by independent pricing services using models or other valuation methodologies.  These models consider various inputs such as credit rating, maturity, corporate credit spreads, reported trades and other inputs that are observable or derived from observable information in the marketplace or are supported by transactions executed in the marketplace.  Financial assets in this category primarily include:  certain publicly registered and privately placed corporate fixed maturity securities; certain government or agency securities; certain mortgage and asset-backed securities; certain equity securities; most investments held by our consolidated VIEs; certain mutual fund investments; most short-term investments; and non-exchange-traded derivatives such as call options. Financial liabilities in this category include investment borrowings, notes payable and borrowings related to VIEs.

• Level 3 – includes assets and liabilities valued using unobservable inputs that are used in model-based valuations that contain management assumptions.  Level 3 assets and liabilities include those financial instruments whose fair value is estimated based on broker/dealer quotes, pricing services or internally developed models or methodologies utilizing significant inputs not based on, or corroborated by, readily available market information.  Financial assets in this category include certain corporate securities (primarily certain below-investment grade privately placed securities), certain structured securities, mortgage loans, and other less liquid securities.  Financial liabilities in this category include our insurance liabilities for interest-sensitive products, which includes embedded derivatives (including embedded derivatives related to our fixed index annuity products and to a modified coinsurance arrangement) since their values include significant unobservable inputs including actuarial assumptions.

The Company elected to early adopt authoritative guidance that removed the requirement to categorize within the fair value hierarchy certain investments for which fair value is measured using the net asset value per share practical expedient. Accordingly, certain alternative investments classified as other invested assets with a carrying value of $92.7 million and $102.8 million as of December 31, 2015 and 2014, respectively, have not been classified in the fair value hierarchy.

At each reporting date, we classify assets and liabilities into the three input levels based on the lowest level of input that is significant to the measurement of fair value for each asset and liability reported at fair value.  This classification is impacted by a number of factors, including the type of financial instrument, whether the financial instrument is new to the market and not

150

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

yet established, the characteristics specific to the transaction and overall market conditions.  Our assessment of the significance of a particular input to the fair value measurement and the ultimate classification of each asset and liability requires judgment and is subject to change from period to period based on the observability of the valuation inputs. Any transfers between levels are reported as having occurred at the beginning of the period. There were no transfers between Level 1 and Level 2 in both 2015 and 2014.

The vast majority of our fixed maturity and equity securities, including those held in trading portfolios and those held by consolidated VIEs, short-term and separate account assets use Level 2 inputs for the determination of fair value.  These fair values are obtained primarily from independent pricing services, which use Level 2 inputs for the determination of fair value.  Our Level 2 assets are valued as follows:

•Fixed maturities available for sale, equity securities and trading securities

Corporate securities are generally priced using market and income approaches. Inputs generally consist of trades of identical or similar securities, quoted prices in inactive markets, issuer rating, benchmark yields, maturity, and credit spreads.

U.S. Treasuries and obligations of U.S. Government corporations and agencies are generally priced using the market approach. Inputs generally consist of trades of identical or similar securities, quoted prices in inactive markets and maturity.

States and political subdivisions are generally priced using the market approach. Inputs generally consist of trades of identical or similar securities, quoted prices in inactive markets, new issuances and credit spreads.

Asset-backed securities, collateralized debt obligations, commercial mortgage-backed securities, mortgage pass-through securities and collateralized mortgage obligations are generally priced using market and income approaches. Inputs generally consist of quoted prices in inactive markets, spreads on actively traded securities, expected prepayments, expected credit default rates, delinquencies, and issue specific information including, but not limited to, collateral type, seniority and vintage.

Equity securities (primarily comprised of non-redeemable preferred stock) are generally priced using the market approach. Inputs generally consist of trades of identical or similar securities, quoted prices in inactive markets, issuer rating, benchmark yields, maturity, and credit spreads.

• Investments held by VIEs

Corporate securities are generally priced using market and income approaches using pricing vendors. Inputs generally consist of issuer rating, benchmark yields, maturity, and credit spreads.

• Other invested assets - derivatives

The fair value measurements for derivative instruments, including embedded derivatives requiring bifurcation, are determined based on the consideration of several inputs including closing exchange or over-the-counter market price quotes; time value and volatility factors underlying options; market interest rates; and non-performance risk.

Third party pricing services normally derive security prices through recently reported trades for identical or similar securities making adjustments through the reporting date based upon available market observable information.  If there are no recently reported trades, the third party pricing services may use matrix or model processes to develop a security price where future cash flow expectations are discounted at an estimated risk-adjusted market rate.  The number of prices obtained for a given security is dependent on the Company's analysis of such prices as further described below.

As the Company is responsible for the determination of fair value, we have control processes designed to ensure that the fair values received from third-party pricing sources are reasonable and the valuation techniques and assumptions used appear reasonable and consistent with prevailing market conditions. Additionally, when inputs are provided by third-party pricing

151

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

sources, we have controls in place to review those inputs for reasonableness. As part of these controls, we perform monthly quantitative and qualitative analysis on the prices received from third parties to determine whether the prices are reasonable estimates of fair value.  The Company's analysis includes:  (i) a review of the methodology used by third party pricing services; (ii) where available, a comparison of multiple pricing services' valuations for the same security; (iii) a review of month to month price fluctuations; (iv) a review to ensure valuations are not unreasonably dated; and (v) back testing to compare actual purchase and sale transactions with valuations received from third parties.  As a result of such procedures, the Company may conclude the prices received from third parties are not reflective of current market conditions.  In those instances, we may request additional pricing quotes or apply internally developed valuations.  However, the number of such instances is insignificant and the aggregate change in value of such investments is not materially different from the original prices received.

The categorization of the fair value measurements of our investments priced by independent pricing services was based upon the Company's judgment of the inputs or methodologies used by the independent pricing services to value different asset classes.  Such inputs include:  benchmark yields, reported trades, broker dealer quotes, issuer spreads, benchmark securities, bids, offers and reference data.  The Company categorizes such fair value measurements based upon asset classes and the underlying observable or unobservable inputs used to value such investments.

For securities that are not priced by pricing services and may not be reliably priced using pricing models, we obtain broker quotes.  These broker quotes are non-binding andrepresent an exit price, but assumptions used to establish the fair value may not be observable and therefore represent Level 3 inputs.  Approximately 45 percent of our Level 3 fixed maturity securities were valued using unadjusted broker quotes or broker-provided valuation inputs.  The remaining Level 3 fixed maturity investments do not have readily determinable market prices and/or observable inputs.  For these securities, we use internally developed valuations.  Key assumptions used to determine fair value for these securities may include risk premiums, projected performance of underlying collateral and other factors involving significant assumptions which may not be reflective of an active market.  For certain investments, we use a matrix or model process to develop a security price where future cash flow expectations are discounted at an estimated market rate.  The pricing matrix incorporates term interest rates as well as a spread level based on the issuer's credit rating, other factors relating to the issuer, and the security's maturity.  In some instances issuer-specific spread adjustments, which can be positive or negative, are made based upon internal analysis of security specifics such as liquidity, deal size, and time to maturity.

For certain embedded derivatives, we use actuarial assumptions in the determination of fair value which we consider to be Level 3 inputs.

152

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

The categorization of fair value measurements, by input level, for our financial instruments carried at fair value on a recurring basis at December 31, 2015 is as follows (dollars in millions):

	Quoted prices in active markets for identical assets or liabilities (Level 1)		Significant other observable inputs (Level 2)		Significant unobservable inputs  (Level 3)		Total
Assets:
Fixed maturities, available for sale:
Corporate securities	$	—	$	12,698.1	$	170.4	$	12,868.5
United States Treasury securities and obligations of United States government corporations and agencies	—		194.5		—		194.5
States and political subdivisions	—		2,104.2		—		2,104.2
Debt securities issued by foreign governments	—		20.7		—		20.7
Asset-backed securities	—		1,816.3		35.9		1,852.2
Collateralized debt obligations	—		186.7		—		186.7
Commercial mortgage-backed securities	—		1,604.2		1.1		1,605.3
Mortgage pass-through securities	—		3.3		.1		3.4
Collateralized mortgage obligations	—		1,047.4		—		1,047.4
Total fixed maturities, available for sale	—		19,675.4		207.5		19,882.9
Equity securities - corporate securities	254.9		176.1		32.0		463.0
Trading securities:
Corporate securities	—		21.5		—		21.5
United States Treasury securities and obligations of United States government corporations and agencies	—		1.9		—		1.9
Asset-backed securities	—		35.5		—		35.5
Collateralized debt obligations	—		2.1		—		2.1
Commercial mortgage-backed securities	—		118.1		39.9		158.0
Collateralized mortgage obligations	—		38.2		—		38.2
Equity securities	4.9		—		—		4.9
Total trading securities	4.9		217.3		39.9		262.1
Investments held by variable interest entities - corporate securities	—		1,633.6		—		1,633.6
Other invested assets - derivatives	1.6		41.0		—		42.6
Assets held in separate accounts	—		4.7		—		4.7
Total assets carried at fair value by category	$	261.4	$	21,748.1	$	279.4	$	22,288.9
Liabilities:
Future policy benefits - embedded derivatives associated with fixed index annuity products	$	—	$	—	$	1,057.1	$	1,057.1

153

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

The categorization of fair value measurements, by input level, for our financial instruments carried at fair value on a recurring basis at December 31, 2014 is as follows (dollars in millions):

	Quoted prices in active markets  for identical assets or liabilities (Level 1)		Significant other observable inputs  (Level 2)		Significant unobservable inputs  (Level 3)		Total
Assets:
Fixed maturities, available for sale:
Corporate securities	$	—	$	13,605.1	$	365.9	$	13,971.0
United States Treasury securities and obligations of United States government corporations and agencies	—		168.9		—		168.9
States and political subdivisions	—		2,242.2		35.5		2,277.7
Debt securities issued by foreign governments	—		1.9		—		1.9
Asset-backed securities	—		1,209.8		59.2		1,269.0
Collateralized debt obligations	—		324.5		—		324.5
Commercial mortgage-backed securities	—		1,275.1		1.2		1,276.3
Mortgage pass-through securities	—		4.2		.4		4.6
Collateralized mortgage obligations	—		1,341.0		—		1,341.0
Total fixed maturities, available for sale	—		20,172.7		462.2		20,634.9
Equity securities - corporate securities	216.9		174.1		28.0		419.0
Trading securities:
Corporate securities	—		24.3		—		24.3
United States Treasury securities and obligations of United States government corporations and agencies	—		3.7		—		3.7
Asset-backed securities	—		24.0		—		24.0
Commercial mortgage-backed securities	—		131.0		28.6		159.6
Mortgage pass-through securities	—		.1		—		.1
Collateralized mortgage obligations	—		29.7		—		29.7
Equity securities	3.5		—		—		3.5
Total trading securities	3.5		212.8		28.6		244.9
Investments held by variable interest entities - corporate securities	—		1,367.1		—		1,367.1
Other invested assets - derivatives	1.4		107.2		—		108.6
Assets held in separate accounts	—		5.6		—		5.6
Total assets carried at fair value by category	$	221.8	$	22,039.5	$	518.8	$	22,780.1
Liabilities:
Future policy benefits - embedded derivatives associated with fixed index annuity products	$	—	$	—	$	1,081.5	$	1,081.5

154

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

For those financial instruments disclosed at fair value, we use the following methods and assumptions to determine the estimated fair values:

Mortgage loans and policy loans.  We discount future expected cash flows based on interest rates currently being offered for similar loans with similar risk characteristics.  We aggregate loans with similar characteristics in our calculations.  The fair value of policy loans approximates their carrying value.

Company-owned life insurance is backed by a series of mutual funds and is carried at cash surrender value which approximates estimated fair value.

Cash and cash equivalents include commercial paper, invested cash and other investments purchased with original maturities of less than three months. We carry them at amortized cost, which approximates estimated fair value.

Liabilities for policyholder account balances.  The estimated fair value of insurance liabilities for policyholder account balances was approximately equal to its carrying value as interest rates credited on the vast majority of account balances approximate current rates paid on similar products and because these rates are not generally guaranteed beyond one year.

Investment borrowings, notes payable and borrowings related to variable interest entities.  For publicly traded debt, we use current fair values.  For other notes, we use discounted cash flow analyses based on our current incremental borrowing rates for similar types of borrowing arrangements.

The fair value measurements for our financial instruments disclosed at fair value on a recurring basis are as follows (dollars in millions):

	December 31, 2015
	Quoted prices in active markets for identical assets or liabilities (Level 1)		Significant other observable inputs  (Level 2)		Significant unobservable inputs  (Level 3)		Total estimated fair value		Total carrying amount
Assets:
Mortgage loans	$	—	$	—	$	1,772.4	$	1,772.4	$	1,721.0
Policy loans	—		—		109.4		109.4		109.4
Other invested assets:
Company-owned life insurance	—		158.1		—		158.1		158.1
Cash and cash equivalents:
Unrestricted	432.3		—		—		432.3		432.3
Held by variable interest entities	364.4		—		—		364.4		364.4
Liabilities:
Policyholder account balances	—		—		10,762.3		10,762.3		10,762.3
Investment borrowings	—		1,549.8		—		1,549.8		1,548.1
Borrowings related to variable interest entities	—		1,673.6		—		1,673.6		1,676.4
Notes payable – direct corporate obligations	—		937.8		—		937.8		911.1

155

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

	December 31, 2014
	Quoted prices in active markets for identical assets or liabilities (Level 1)		Significant other observable inputs  (Level 2)		Significant unobservable inputs  (Level 3)		Total estimated fair value		Total carrying amount
Assets:
Mortgage loans	$	—	$	—	$	1,768.9	$	1,768.9	$	1,691.9
Policy loans	—		—		106.9		106.9		106.9
Other invested assets:
Company-owned life insurance	—		157.6		—		157.6		157.6
Cash and cash equivalents:
Unrestricted	549.6		62.0		—		611.6		611.6
Held by variable interest entities	68.3		—		—		68.3		68.3
Liabilities:
Policyholder account balances	—		—		10,707.2		10,707.2		10,707.2
Investment borrowings	—		1,520.4		—		1,520.4		1,519.2
Borrowings related to variable interest entities	—		1,229.2		—		1,229.2		1,271.9
Notes payable – direct corporate obligations	—		807.4		—		807.4		780.3

156

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

The following table presents additional information about assets and liabilities measured at fair value on a recurring basis and for which we have utilized significant unobservable (Level 3) inputs to determine fair value for the year ended December 31, 2015 (dollars in millions):

	December 31, 2015
	Beginning balance as of December 31, 2014			Purchases, sales, issuances and settlements, net (b)			Total realized and unrealized gains (losses) included in net income			Total realized and unrealized gains (losses) included in accumulated other comprehensive income (loss)			Transfers into Level 3 (a)		Transfers out of Level 3 (a)			Ending balance as of December 31, 2015			Amount of total gains (losses) for the year ended December 31, 2015 included in our net income relating to assets and liabilities still held as of the reporting date
Assets:
Fixed maturities, available for sale:
Corporate securities	$	365.9		$	31.0		$	(2.2	)	$	(19.5	)	$	37.4	$	(242.2	)	$	170.4		$	—
States and political subdivisions	35.5			(35.5		)	—			—			—		—			—			—
Asset-backed securities	59.2			6.7			—			(1.4		)	—		(28.6		)	35.9			—
Commercial mortgage-backed securities	1.2			(.1		)	—			—			—		—			1.1			—
Mortgage pass-through securities	.4			(.3		)	—			—			—		—			.1			—
Total fixed maturities, available for sale	462.2			1.8			(2.2		)	(20.9		)	37.4		(270.8		)	207.5			—
Equity securities - corporate securities	28.0			4.0			—			—			—		—			32.0			—
Trading securities - commercial mortgage-backed securities	28.6			9.5			—			1.8			—		—			39.9			1.8
Liabilities:
Future policy benefits - embedded derivatives associated with fixed index annuity products	(1,081.5		)	(11.9		)	36.3			—			—		—			(1,057.1		)	36.3

157

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

_________

(a) Transfers into Level 3 are the result of unobservable inputs utilized within valuation methodologies for assets that were previously valued using observable inputs. Transfers out of Level 3 are due to the use of observable inputs in valuation methodologies as well as the utilization of pricing service information for certain assets that the Company is able to validate.

(b) Purchases, sales, issuances and settlements, net, represent the activity that occurred during the period that results in a change of the asset or liability but does not represent changes in fair value for the instruments held at the beginning of the period.  Such activity primarily consists of purchases and sales of fixed maturity and equity securities and changes to embedded derivative instruments related to insurance products resulting from the issuance of new contracts, or changes to existing contracts.  The following summarizes such activity for the year ended December 31, 2015 (dollars in millions):

	Purchases			Sales			Issuances			Settlements		Purchases, sales, issuances and settlements, net
Assets:
Fixed maturities, available for sale:
Corporate securities	$	62.2		$	(31.2	)	$	—		$	—	$	31.0
States and political subdivisions	—			(35.5		)	—			—		(35.5		)
Asset-backed securities	13.7			(7.0		)	—			—		6.7
Commercial mortgage-backed securities	—			(.1		)	—			—		(.1		)
Mortgage pass-through securities	—			(.3		)	—			—		(.3		)
Total fixed maturities, available for sale	75.9			(74.1		)	—			—		1.8
Equity securities - corporate securities	4.0			—			—			—		4.0
Trading securities - commercial mortgage-backed securities	9.5			—			—			—		9.5
Liabilities:
Future policy benefits - embedded derivatives associated with fixed index annuity products	(137.8		)	64.4			(4.0		)	65.5		(11.9		)

158

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

The following table presents additional information about assets and liabilities measured at fair value on a recurring basis and for which we have utilized significant unobservable (Level 3) inputs to determine fair value for the year ended December 31, 2014 (dollars in millions):

	December 31, 2014
	Beginning balance as of December 31, 2013			Purchases, sales, issuances and settlements, net (b)			Total realized and unrealized gains (losses) included in net income			Total realized and unrealized gains (losses) included in accumulated other comprehensive income (loss)			Transfers into Level 3 (a)		Transfers out of Level 3 (a)			Assets of CLIC sold			Ending balance as of December 31, 2014			Amount of total gains (losses) for the year ended December 31, 2014 included in our net income relating to assets and liabilities still held as of the reporting date
Assets:
Fixed maturities, available for sale:
Corporate securities	$	359.6		$	70.0		$	—		$	20.1		$	36.8	$	(69.4	)	$	(51.2	)	$	365.9		$	—
States and political subdivisions	—			(1.8		)	—			3.0			36.5		—			(2.2		)	35.5			—
Asset-backed securities	42.2			7.6			—			5.1			14.0		—			(9.7		)	59.2			—
Collateralized debt obligations	246.7			—			—			—			—		(246.7		)	—			—			—
Commercial mortgage-backed securities	—			1.1			—			.1			—		—			—			1.2			—
Mortgage pass-through securities	1.6			(1.2		)	—			—			—		—			—			.4			—
Total fixed maturities, available for sale	650.1			75.7			—			28.3			87.3		(316.1		)	(63.1		)	462.2			—
Equity securities - corporate securities	24.5			3.5			—			—			—		—			—			28.0			—
Trading securities - commercial mortgage-backed securities	—			29.0			—			(.4		)	—		—			—			28.6			(.4		)
Liabilities:
Future policy benefits - embedded derivatives associated with fixed index annuity products	(903.7		)	(104.3		)	(73.5		)	—			—		—			—			(1,081.5		)	(73.5		)
Other liabilities - embedded derivatives associated with modified coinsurance agreement	(1.8		)	1.8			—			—			—		—			—			—			—
Total liabilities	(905.5		)	(102.5		)	(73.5		)	—			—		—			—			(1,081.5		)	(73.5		)

159

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

____________

(a) Transfers into Level 3 are the result of unobservable inputs utilized within valuation methodologies for assets that were previously valued using observable inputs. Transfers out of Level 3 are due to the use of observable inputs in valuation methodologies as well as the utilization of pricing service information for certain assets that the Company is able to validate.

(b) Purchases, sales, issuances and settlements, net, represent the activity that occurred during the period that results in a change of the asset or liability but does not represent changes in fair value for the instruments held at the beginning of the period.  Such activity primarily consists of purchases and sales of fixed maturity and equity securities and changes to embedded derivative instruments related to insurance products resulting from the issuance of new contracts, or changes to existing contracts.  The following summarizes such activity for the year ended December 31, 2014 (dollars in millions):

	Purchases			Sales			Issuances			Settlements		Purchases, sales, issuances and settlements, net
Assets:
Fixed maturities, available for sale:
Corporate securities	$	71.7		$	(1.7	)	$	—		$	—	$	70.0
States and political subdivisions	—			(1.8		)	—			—		(1.8		)
Asset-backed securities	9.9			(2.3		)	—			—		7.6
Commercial mortgage-backed securities	1.1			—			—			—		1.1
Mortgage pass-through securities	1.1			(2.3		)	—			—		(1.2		)
Total fixed maturities, available for sale	83.8			(8.1		)	—			—		75.7
Equity securities - corporate securities	3.5			—			—			—		3.5
Trading securities - commercial mortgage-backed securities	29.0			—			—			—		29.0
Liabilities:
Future policy benefits - embedded derivatives associated with fixed index annuity products	(121.9		)	7.5			(45.9		)	56.0		(104.3		)
Other liabilities - embedded derivatives associated with modified coinsurance agreement	—			3.4			(1.6		)	—		1.8
Total liabilities	(121.9		)	10.9			(47.5		)	56.0		(102.5		)

At December 31, 2015, 45 percent of our Level 3 fixed maturities, available for sale, were investment grade and 82 percent of our Level 3 fixed maturities, available for sale, consisted of corporate securities.

Realized and unrealized investment gains and losses presented in the preceding tables represent gains and losses during the time the applicable financial instruments were classified as Level 3.

Realized and unrealized gains (losses) on Level 3 assets are primarily reported in either net investment income for policyholder and reinsurer accounts and other special-purpose portfolios, net realized investment gains (losses) or insurance policy benefits within the consolidated statement of operations or accumulated other comprehensive income within shareholders' equity based on the stated accounting policy for the instrument.

The amount presented for gains (losses) included in our net loss for assets and liabilities still held as of the reporting date primarily represents impairments for fixed maturities, available for sale, changes in fair value of trading securities and certain

160

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

derivatives and changes in fair value of embedded derivative instruments included in liabilities for insurance products that exist as of the reporting date.

The following table provides additional information about the significant unobservable (Level 3) inputs developed internally by the Company to determine fair value for certain assets and liabilities carried at fair value at December 31, 2015 (dollars in millions):

	Fair value at December 31, 2015		Valuation techniques	Unobservable inputs	Range (weighted average)
Assets:
Corporate securities (a)	$	76.9	Discounted cash flow analysis	Discount margins	1.65% - 9.74% (5.35%)
Asset-backed securities (b)	22.2		Discounted cash flow analysis	Discount margins	2.83% - 4.45% (3.50%)
Equity security (c)	32.0		Market approach	Projected cash flows	Not applicable
Other assets categorized as Level 3 (d)	148.3		Unadjusted third-party price source	Not applicable	Not applicable
Total	279.4
Liabilities:
Future policy benefits (e)	1,057.1		Discounted projected embedded derivatives	Projected portfolio yields	5.15% - 5.61% (5.42%)
				Discount rates	0.00 - 3.18% (1.94%)
				Surrender rates	1.67% - 46.56% (14.09%)

________________________________

(a) Corporate securities - The significant unobservable input used in the fair value measurement of our corporate securities is discount margin added to a riskless market yield. Significant increases (decreases) in discount margin in isolation would result in a significantly lower (higher) fair value measurement.

(b) Asset-backed securities - The significant unobservable input used in the fair value measurement of these asset-backed securities is discount margin added to a riskless market yield. Significant increases (decreases) in discount margin in isolation would result in a significantly lower (higher) fair value measurement.

(c) Equity security - This equity security represents an investment in a company that is constructing a manufacturing facility. The significant unobservable input is the cash flows that will be generated upon completion of the manufacturing facility. Given the nature of this investment, the best current indicator of value is the cost basis of the investment, which we believe approximates market value.

(d) Other assets categorized as Level 3 - For these assets, there were no adjustments to quoted market prices obtained from third-party pricing sources.

(e) Future policy benefits - The significant unobservable inputs used in the fair value measurement of our embedded derivatives associated with fixed index annuity products are projected portfolio yields, discount rates and surrender rates. Increases (decreases) in projected portfolio yields in isolation would lead to a higher (lower) fair value measurement. The discount rate is based on the Treasury rate adjusted by a margin. Increases (decreases) in the discount rates would lead to a lower (higher) fair value measurement. Assumed surrender rates are used to project how long the contracts remain in force. Generally, the longer the contracts are assumed to be in force the higher the fair value of the embedded derivative.

161

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

The following table provides additional information about the significant unobservable (Level 3) inputs developed internally by the Company to determine fair value for certain assets and liabilities carried at fair value at December 31, 2014 (dollars in millions):

	Fair value at December 31, 2014		Valuation techniques	Unobservable inputs	Range (weighted average)
Assets:
Corporate securities (a)	$	312.1	Discounted cash flow analysis	Discount margins	1.48% - 5.83% (2.58%)
Asset-backed securities (b)	30.6		Discounted cash flow analysis	Discount margins	1.99% - 4.15% (2.95%)
Equity security (c)	28.0		Market approach	Projected cash flows	Not applicable
Other assets categorized as Level 3 (d)	148.1		Unadjusted third-party price source	Not applicable	Not applicable
Total	518.8
Liabilities:
Future policy benefits (e)	1,081.5		Discounted projected embedded derivatives	Projected portfolio yields	5.15% - 5.61% (5.42%)
				Discount rates	0.00 - 2.74% (1.78%)
				Surrender rates	1.98% - 47.88% (14.16%)

________________________________

(a) Corporate securities - The significant unobservable input used in the fair value measurement of our corporate securities is discount margin added to a riskless market yield. Significant increases (decreases) in discount margin in isolation would result in a significantly lower (higher) fair value measurement.

(b) Asset-backed securities - The significant unobservable input used in the fair value measurement of these asset-backed securities is discount margin added to a riskless market yield. Significant increases (decreases) in discount margin in isolation would result in a significantly lower (higher) fair value measurement.

(c) Equity security - This equity security represents an investment in a company that is constructing a manufacturing facility. The significant unobservable input is the cash flows that will be generated upon completion of the manufacturing facility. Given the nature of this investment, the best current indicator of value is the cost basis of the investment, which we believe approximates market value.

(d) Other assets categorized as Level 3 - For these assets, there were no adjustments to quoted market prices obtained from third-party pricing sources.

(e) Future policy benefits - The significant unobservable inputs used in the fair value measurement of our embedded derivatives associated with fixed index annuity products are projected portfolio yields, discount rates and surrender rates. Increases (decreases) in projected portfolio yields in isolation would lead to a higher (lower) fair value measurement. The discount rate is based on the Treasury rate adjusted by a margin. Increases (decreases) in the discount rates would lead to a lower (higher) fair value measurement. Assumed surrender rates are used to project how long the contracts remain in force. Generally, the longer the contracts are assumed to be in force the higher the fair value of the embedded derivative.

162

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

5. LIABILITIES FOR INSURANCE PRODUCTS

Our future policy benefits are summarized as follows (dollars in millions):

	Withdrawal assumption	Morbidity assumption	Mortality assumption	Interest rate assumption	2015		2014
Long-term care	Company experience	Company experience	Company experience	6%	$	5,172.2	$	5,385.2
Traditional life insurance contracts	Company experience	Company experience	(a)	5%	2,248.7		2,175.8
Accident and health contracts	Company experience	Company experience	Company experience	5%	2,589.9		2,519.1
Interest-sensitive life insurance contracts	Company experience	Company experience	Company experience	4%	44.7		47.6
Annuities and supplemental contracts with life contingencies	Company experience	Company experience	(b)	4%	546.6		707.7
Total					$	10,602.1	$	10,835.4

____________________

(a) Principally, modifications of: (i) the 1965 ‑ 70 and 1975 - 80 Basic Tables; and (ii) the 1941, 1958 and 1980 Commissioners' Standard Ordinary Tables; as well as Company experience.

(b) Principally, modifications of: (i) the 1971 Individual Annuity Mortality Table; (ii) the 1983 Table "A"; and (iii) the Annuity 2000 Mortality Table; as well as Company experience.

Our policyholder account balances are summarized as follows (dollars in millions):

	2015		2014
Fixed index annuities	$	4,884.4	$	4,496.9
Other annuities	4,885.1		5,280.8
Interest-sensitive life insurance contracts	992.8		929.5
Total	$	10,762.3	$	10,707.2

The Company establishes reserves for insurance policy benefits based on assumptions as to investment yields, mortality, morbidity, withdrawals, lapses and maintenance expenses. These reserves include amounts for estimated future payment of claims based on actuarial assumptions. The balance includes provision for the Company's best estimate of the future policyholder benefits to be incurred on this business, given recent and expected future changes in experience.

163

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

Changes in the unpaid claims reserve (included in claims payable) and disabled life reserves related to accident and health insurance (included in the liability for future policy benefits) were as follows (dollars in millions):

	2015			2014			2013
Balance, beginning of year	$	1,679.5		$	1,710.1		$	1,679.3
Less reinsurance receivables	(125.0		)	(164.1		)	(27.4		)
Net balance, beginning of year	1,554.5			1,546.0			1,651.9
Incurred claims related to:
Current year	1,481.0			1,468.1			1,511.1
Prior years (a)	(13.3		)	(39.9		)	(162.3		)
Total incurred	1,467.7			1,428.2			1,348.8
Interest on claim reserves	71.0			70.5			75.2
Paid claims related to:
Current year	841.8			848.7			870.0
Prior years	649.6			641.5			659.9
Total paid	1,491.4			1,490.2			1,529.9
Net balance, end of year	1,601.8			1,554.5			1,546.0
Add reinsurance receivables	130.0			125.0			164.1
Balance, end of year	$	1,731.8		$	1,679.5		$	1,710.1

___________

(a) The reserves and liabilities we establish are necessarily based on estimates, assumptions and prior years' statistics. Such amounts will fluctuate based upon the estimation procedures used to determine the amount of unpaid losses. It is possible that actual claims will exceed our reserves and have a material adverse effect on our results of operations and financial condition.

6. INCOME TAXES

The components of income tax expense (benefit) were as follows (dollars in millions):

	2015			2014			2013
Current tax expense	$	10.7		$	15.6		$	8.2
Deferred tax expense	118.6			143.6			120.1
Tax expense on period income	129.3			159.2			128.3
Tax expense related to the sale of CLIC	—			14.2			—
Deferred taxes on expired capital loss carryforwards	—			—			159.4
Change in valuation allowance	(32.5		)	(48.8		)	(472.1		)
Other items	.2			(.9		)	11.2
Total income tax expense (benefit)	$	97.0		$	123.7		$	(173.2	)

164

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

A reconciliation of the U.S. statutory corporate tax rate to the estimated annual effective rate reflected in the consolidated statement of operations is as follows:

	2015		2014		2013
U.S. statutory corporate rate	35.0	%	35.0	%	35.0	%
Valuation allowance	(8.8	)	(27.9	)	(154.9	)
Expired capital loss carryforwards (which were fully offset by a corresponding reduction in the valuation allowance)	—		—		52.3
Non-taxable income and nondeductible benefits, net	(.2	)	(.9	)	5.0
State taxes	2.1		1.5		1.9
Impact of the sale of CLIC	—		66.3		—
Other items	(1.7	)	(3.4	)	3.9
Effective tax rate	26.4	%	70.6	%	(56.8	)%

The components of the Company's income tax assets and liabilities are summarized below (dollars in millions):

	2015			2014
Deferred tax assets:
Net federal operating loss carryforwards	$	916.3		$	1,048.4
Net state operating loss carryforwards	14.1			15.2
Tax credits	55.3			47.2
Capital loss carryforwards	13.8			—
Investments	26.5			59.7
Insurance liabilities	600.3			585.9
Other	63.0			67.3
Gross deferred tax assets	1,689.3			1,823.7
Deferred tax liabilities:
Present value of future profits and deferred acquisition costs	(305.4		)	(320.5		)
Accumulated other comprehensive income	(223.8		)	(457.4		)
Gross deferred tax liabilities	(529.2		)	(777.9		)
Net deferred tax assets before valuation allowance	1,160.1			1,045.8
Valuation allowance	(213.5		)	(246.0		)
Net deferred tax assets	946.6			799.8
Current income taxes accrued	(47.8		)	(41.1		)
Income tax assets, net	$	898.8		$	758.7

Our income tax expense includes deferred income taxes arising from temporary differences between the financial reporting and tax bases of assets and liabilities, capital loss carryforwards and NOLs. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply in the years in which temporary differences are expected to be recovered or paid.  The effect of a change in tax rates on deferred tax assets and liabilities is recognized in earnings in the period when the changes are enacted.

A reduction of the net carrying amount of deferred tax assets by establishing a valuation allowance is required if, based on the available evidence, it is more likely than not that such assets will not be realized. In assessing the need for a valuation allowance, all available evidence, both positive and negative, shall be considered to determine whether, based on the weight of that evidence, a valuation allowance for deferred tax assets is needed. This assessment requires significant judgment and considers, among other matters, the nature, frequency and severity of current and cumulative losses, forecasts of future

165

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

profitability, the duration of carryforward periods, our experience with operating loss and tax credit carryforwards expiring unused, and tax planning strategies. We evaluate the need to establish a valuation allowance for our deferred income tax assets on an ongoing basis. The realization of our deferred tax assets depends upon generating sufficient future taxable income of the appropriate type during the periods in which our temporary differences become deductible and before our capital loss carryforwards and life and non-life NOLs expire.

Based on our assessment, it appears more likely than not that $946.6 million of our total deferred tax assets of $1,160.1 million will be realized through future taxable earnings. Accordingly, we have established a deferred tax valuation allowance of $213.5 million at December 31, 2015. We will continue to assess the need for a valuation allowance in the future. If future results are less than projected, an increase to the valuation allowance may be required to reduce the deferred tax asset, which could have a material impact on our results of operations in the period in which it is recorded.

We use a deferred tax valuation model to assess the need for a valuation allowance. Our model is adjusted to reflect changes in our projections of future taxable income including changes resulting from investment trading strategies, reinsurance transactions and the impact of the sale of CLIC. Our estimates of future taxable income are based on evidence we consider to be objective and verifiable.

At December 31, 2015, our projection of future taxable income for purposes of determining the valuation allowance is based on our adjusted average annual taxable income which is assumed to remain flat for two years and then increase by 3 percent for the next five years, and level taxable income is assumed thereafter. In the projections used for our analysis, our adjusted average taxable income is based on the level of recent normalized taxable income, which was approximately $345 million ($75 million of which relates to non-life taxable income and $270 million relates to life taxable income).

Based on our assessment, we recognized a reduction to the allowance for deferred tax assets of $32.5 million in 2015. We have evaluated the recovery of our deferred tax assets and assessed the effect of limitations and/or interpretations on their value and have concluded that it is more likely than not that the value recognized will be fully realized in the future.

Changes in our valuation allowance are summarized as follows (dollars in millions):

Balance, December 31, 2012	$	766.9
Decrease in 2013	(472.1		)	(a)
Balance, December 31, 2013	294.8
Decrease in 2014	(48.8		)	(b)
Balance, December 31, 2014	246.0
Decrease in 2015	(32.5		)	(c)
Balance, December 31, 2015	$	213.5

___________________

(a) The 2013 reduction to the deferred tax valuation allowance primarily resulted from the impact of higher levels of income on projected future taxable income, the expiration of capital loss carryforwards, a settlement with the Internal Revenue Service (the "IRS") related to the classification of a portion of the cancellation of indebtedness income and the execution of certain investment trading strategies.

(b) The 2014 reduction to the deferred tax valuation allowance primarily resulted from tax examination adjustments and the tax gain on the sale of CLIC.

(c) The 2015 reduction to the deferred tax valuation allowance primarily resulted from higher actual and projected non-life income.

Recovery of our deferred tax asset is dependent on achieving the level of future taxable income projected in our deferred tax valuation model and failure to do so could result in an increase in the valuation allowance in a future period.  Any future increase in the valuation allowance may result in additional income tax expense and reduce shareholders' equity, and such an increase could have a significant impact upon our earnings in the future.

The Internal Revenue Code (the "Code") limits the extent to which losses realized by a non-life entity (or entities) may offset income from a life insurance company (or companies) to the lesser of:  (i) 35 percent of the income of the life insurance

166

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

company; or (ii) 35 percent of the total loss of the non-life entities (including NOLs of the non-life entities).  There is no similar limitation on the extent to which losses realized by a life insurance entity (or entities) may offset income from a non-life entity (or entities). This limitation is the primary reason a valuation allowance for non-life NOL carryforwards is required.

Section 382 of the Code imposes limitations on a corporation's ability to use its NOLs when the company undergoes an ownership change.  Future transactions and the timing of such transactions could cause an ownership change for Section 382 income tax purposes.  Such transactions may include, but are not limited to, additional repurchases under our securities repurchase program, issuances of common stock and acquisitions or sales of shares of CNO stock by certain holders of our shares, including persons who have held, currently hold or may accumulate in the future five percent or more of our outstanding common stock for their own account.  Many of these transactions are beyond our control.  If an additional ownership change were to occur for purposes of Section 382, we would be required to calculate an annual restriction on the use of our NOLs to offset future taxable income.  The annual restriction would be calculated based upon the value of CNO's equity at the time of such ownership change, multiplied by a federal long-term tax exempt rate (2.61 percent at December 31, 2015), and the annual restriction could limit our ability to use a substantial portion of our NOLs to offset future taxable income.  We regularly monitor ownership change (as calculated for purposes of Section 382) and, as of December 31, 2015, we were below the 50 percent ownership change level that would trigger further impairment of our ability to utilize our NOLs.

On January 20, 2009, the Company's Board of Directors adopted a Section 382 Rights Agreement designed to protect shareholder value by preserving the value of our tax assets primarily associated with tax NOLs under Section 382. The Section 382 Rights Agreement was adopted to reduce the likelihood of an ownership change occurring by deterring the acquisition of stock that would create "5 percent shareholders" as defined in Section 382. On December 6, 2011, the Company's Board of Directors amended the Section 382 Rights Agreement to, among other things, (i) extend the final expiration date of the Amended Rights Agreement to December 6, 2014, (ii) update the purchase price of the rights described below, (iii) provide for a new series of preferred stock relating to the rights that is substantially identical to the prior series of preferred stock, (iv) provide for a 4.99 percent ownership threshold relating to any Company 382 Securities (as defined below), and amend other provisions to reflect best practices for tax benefit preservation plans, including updates to certain definitions. On November 13, 2014, the Company entered into the Second Amended and Restated Section 382 Rights Agreement which (as subsequently amended) extends the final expiration date of the Amended Section 382 Rights Agreement to November 13, 2017, updates the purchase price of the Rights and provides for a new series of preferred stock relating to the Rights that is substantially identical to the prior series of preferred stock. The Second Amended Rights Agreement was approved by the Company’s stockholders at the Company’s 2015 annual meeting.

Under the Section 382 Rights Agreement, one right was distributed for each share of our common stock outstanding as of the close of business on January 30, 2009 and for each share issued after that date. Pursuant to the Amended Section 382 Rights Agreement, if any person or group (subject to certain exemptions) becomes an owner of more than 4.99 percent of the Company's outstanding common stock (or any other interest in the Company that would be treated as "stock" under applicable Section 382 regulations) without the approval of the Board of Directors, there would be a triggering event causing significant dilution in the voting power and economic ownership of that person or group. Shareholders who held more than 4.99 percent of the Company's outstanding common stock as of December 6, 2011 will trigger a dilutive event only if they acquire additional shares exceeding one percent of our outstanding shares without prior approval from the Board of Directors.

On May 11, 2010, our shareholders approved an amendment to CNO's certificate of incorporation designed to prevent certain transfers of common stock which could otherwise adversely affect our ability to use our NOLs (the "Original Section 382 Charter Amendment"). Subject to the provisions set forth in the Original Section 382 Charter Amendment, transfers of our common stock would be void and of no effect if the effect of the purported transfer would be to: (i) increase the direct or indirect ownership of our common stock by any person or public group (as such term is defined in the regulations under Section 382) from less than 5% to 5% or more of our common stock; (ii) increase the percentage of our common stock owned directly or indirectly by a person or public group owning or deemed to own 5% or more of our common stock; or (iii) create a new public group.

On May 8, 2013, our shareholders approved an amendment (the “Extended Section 382 Charter Amendment”) to CNO’s certificate of incorporation to: (i) extend the term of the Original Section 382 Charter Amendment for three years until December 31, 2016, (ii) provide for a 4.99 percent ownership threshold relating to our stock, and (iii) amend certain other provisions of the Original Section 382 Charter Amendment, including updates to certain definitions, for consistency with the Amended Section 382 Rights Agreement.

167

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

As of December 31, 2015, we had $2.6 billion of federal NOLs. The following table summarizes the expiration dates of our loss carryforwards assuming the IRS ultimately agrees with the position we have taken with respect to the loss on our investment in Conseco Senior Health Insurance Company ("CSHI") and other uncertain tax positions (dollars in millions):

Year of expiration	Net operating loss carryforwards						Total loss
	Life			Non-life			carryforwards
2023	$	538.3		$	1,922.0		$	2,460.3
2025	—			91.5			91.5
2026	—			207.4			207.4
2027	—			4.9			4.9
2028	—			203.7			203.7
2029	—			146.6			146.6
2032	—			44.0			44.0
Subtotal	538.3			2,620.1			3,158.4
Less:
Unrecognized tax benefits	(342.9		)	(197.4		)	(540.3		)
Total	$	195.4		$	2,422.7		$	2,618.1

In addition, at December 31, 2015, we had $39.4 million of capital loss carryforwards that expire in 2020.

We had deferred tax assets related to NOLs for state income taxes of $14.1 million and $15.2 million at December 31, 2015 and 2014, respectively.  The related state NOLs are available to offset future state taxable income in certain states through 2025.

A reconciliation of the beginning and ending amount of unrecognized tax benefits for the years ended December 31, 2015 and 2014 is as follows (dollars in millions):

	Years ended December 31,
	2015		2014
Balance at beginning of year	$	228.7	$	226.7
Increase based on tax positions taken in prior years	5.5		10.9
Decrease based on tax positions taken in prior years	—		—
Increase based on tax positions taken in the current year	—		—
Decrease in unrecognized tax benefits related to settlements with taxing authorities	—		(8.9		)
Balance at end of year	$	234.2	$	228.7

As of both December 31, 2015 and 2014, $155.4 million of our unrecognized tax benefits, if recognized, would affect the effective tax rate. The remaining balances relate to timing differences which, if recognized, would have no effect on the Company's tax expense. The Company recognizes interest related to unrecognized tax benefits as income tax expense in the consolidated statement of operations. Such amounts were not significant in each of the three years ended December 31, 2015. The liability for accrued interest was $3.2 million and $2.4 million at December 31, 2015 and 2014, respectively.

We recognized an $878 million ordinary loss on our investment in CSHI which was worthless when it was transferred to an independent trust in 2008. Of this loss, $742 million has been reported as a life loss and $136 million as a non-life loss. The IRS disagreed with our ordinary loss treatment and believes that it should be treated as a capital loss, subject to a five year carryover. If the IRS position is ultimately determined to be correct, $473 million would have expired unused in 2013. Due to

168

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

this uncertainty, we have not recognized a tax benefit of $166.0 million. However, if this unrecognized tax benefit would have been recognized, we would also have established a valuation allowance of $34.0 million at December 31, 2015.

The IRS has completed the examination for 2004 and 2008 through 2010 and has proposed two adjustments to which we disagree, including the adjustment to classify the loss on our investment in CSHI as a capital loss as described above. The Company is contesting these adjustments through the IRS Appeals Office. Although the resolution of the Appeals could occur in the next 12 months, there is no reasonable basis to estimate the changes in unrecognized tax benefits that may occur. The IRS has also begun an examination of 2011 and 2012. In connection with this exam, we have agreed to extend the statute of limitations to September 10, 2017. The Company’s various state income tax returns are generally open for tax years beginning in 2012, based on individual state statutes of limitation. Generally, for tax years which generate NOLs, capital losses or tax credit carryforwards, the statute remains open until the expiration of the statute of limitations for the tax year in which such carryforwards are utilized. The outcome of tax audits cannot be predicted with certainty. If the Company’s tax audits are not resolved in a manner consistent with management’s expectations, the Company may be required to adjust its provision for income taxes.

We currently expect to utilize all of our remaining life NOLs in 2016, absent a favorable outcome on the classification of the loss on our investment in CSHI. After all of the life NOLs are utilized, we will begin making cash tax payments equal to the prescribed federal tax rate applied to 65 percent of our life insurance company taxable income due to the limitations on the extent to which we can use non-life NOLs to offset life insurance company taxable income. We will continue to pay tax on only 65 percent of our life insurance company taxable income until all non-life NOLs are utilized or expire.

In accordance with GAAP, we are precluded from recognizing the tax benefits of any tax windfall upon the exercise of a stock option or the vesting of restricted stock unless such deduction resulted in actual cash savings to the Company. Because of the Company's NOLs, no cash savings have occurred. The value of NOL carryforwards of $13.9 million related to deductions for stock options and restricted stock will be reflected in additional paid-in capital if realized.

7. NOTES PAYABLE - DIRECT CORPORATE OBLIGATIONS

The following notes payable were direct corporate obligations of the Company as of December 31, 2015 and 2014 (dollars in millions):

	2015			2014
4.500% Senior Notes due May 2020	$	325.0		$	—
5.250% Senior Notes due May 2025	500.0			—
New Revolving Credit Agreement (as defined below)	100.0			—
Unamortized debt issue costs	(13.9		)	(14.1		)
Previous Senior Secured Credit Agreement (as defined below)	—			522.1
6.375% Senior Secured Notes due October 2020 (the "6.375% Notes")	—			275.0
Unamortized discount on Previous Senior Secured Credit Agreement	—			(2.7		)
Direct corporate obligations	$	911.1		$	780.3

New Notes

On May 19, 2015, the Company executed the Indenture, dated as of May 19, 2015 (the "Base Indenture") and the First Supplemental Indenture, dated as of May 19, 2015 (the "Supplemental Indenture" and, together with the Base Indenture, the "Indenture"), between the Company and Wilmington Trust, National Association, as trustee (the "Trustee") pursuant to which the Company issued $325.0 million aggregate principal amount of 4.500% Senior Notes due 2020 (the "2020 Notes") and $500.0 million aggregate principal amount of 5.250% Senior Notes due 2025 (the "2025 Notes" and, together with the 2020 Notes, the "Notes").

The Company used the proceeds of the offering of the Notes, together with borrowings under the New Revolving Credit Agreement (as defined below): (i) to repay all amounts outstanding under the Company's Previous Senior Secured Credit

169

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

Agreement (as defined below); (ii) to redeem and satisfy and discharge all of the outstanding 6.375% Notes; and (iii) to pay fees and expenses related to the offering of the Notes and the foregoing transactions. The remaining proceeds of the Notes and the borrowings under the New Revolving Credit Agreement were used for general corporate purposes, including share repurchases.

The 2020 Notes mature on May 30, 2020, and the 2025 Notes mature on May 30, 2025. Interest on the 2020 Notes is payable at 4.500% per annum. Interest on the 2025 Notes is payable at 5.250% per annum. Interest on the Notes is payable semi-annually in cash in arrears on May 30 and November 30 of each year, commencing on November 30, 2015.

The Notes are the Company's senior unsecured obligations and rank equally with the Company's other senior unsecured and unsubordinated debt from time to time outstanding, including obligations under a $150.0 millionfour-year unsecured revolving credit agreement (the "New Revolving Credit Agreement"). The Notes are effectively subordinated to all of the Company's existing and future secured indebtedness to the extent of the value of the assets securing such indebtedness. The Notes are structurally subordinated to all existing and future indebtedness and other liabilities of the Company's subsidiaries.

The Company may redeem some or all of the 2020 Notes at any time or from time to time at a "make-whole" redemption price plus accrued and unpaid interest to, but not including, the redemption date.

Prior to February 28, 2025, the Company may redeem some or all of the 2025 Notes at any time or from time to time at a "make-whole" redemption price plus accrued and unpaid interest to, but not including, the redemption date. On and after February 28, 2025, the Company may redeem some or all of the 2025 Notes at any time or from time to time at a redemption price equal to 100% of the principal amount thereof plus accrued and unpaid interest to, but not including, the redemption date.

Upon the occurrence of a Change of Control Repurchase Event (as defined in the Indenture), the Company will be required to make an offer to repurchase the Notes at a price equal to 101% of the principal amount thereof, plus accrued and unpaid interest, if any, to, but not including, the date of repurchase.

The Indenture contains covenants that restrict the Company’s ability, with certain exceptions, to:

• incur certain subsidiary indebtedness without also guaranteeing the Notes;

• create liens;

• enter into sale and leaseback transactions;

• issue, sell, transfer or otherwise dispose of any shares of capital stock of any Insurance Subsidiary (as defined in the Indenture); and

• consolidate or merge with or into other companies or transfer all or substantially all of the Company’s assets.

The Indenture provides for customary events of default (subject in certain cases to customary grace and cure periods), which include nonpayment, breach of covenants in the Indenture, failure to pay at maturity or acceleration of other indebtedness, a failure to pay certain judgments and certain events of bankruptcy and insolvency. Generally, if an event of default occurs, the Trustee or holders of at least 25% in principal amount of the then outstanding Notes may declare the principal of and accrued but unpaid interest, including any additional interest, on all of the Notes to be due and payable.

New Revolving Credit Agreement

On May 19, 2015, the Company entered into the New Revolving Credit Agreement, with KeyBank National Association, as administrative agent (the "Agent"), and the lenders from time to time party thereto. On May 19, 2015, the Company made an initial drawing of $100.0 million under the New Revolving Credit Agreement, resulting in $50.0 million available for additional borrowings. The New Revolving Credit Agreement matures on May 19, 2019.

The New Revolving Credit Agreement includes an uncommitted subfacility for swingline loans of up to $5.0 million, and up to $5.0 million of the New Revolving Credit Agreement is available for the issuance of letters of credit. The Company may incur additional incremental loans under the New Revolving Credit Agreement in an aggregate principal amount of up to $50.0 million, provided that there are no events of default and subject to certain other terms and conditions including the delivery of certain documentation.

170

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

The interest rates with respect to loans under the New Revolving Credit Agreement are based on, at the Company's option, a floating base rate (defined as a per annum rate equal to the highest of: (i) the federal funds rate plus 0.50%; (ii) the "prime rate" of the Agent; and (iii) the eurodollar rate for a one-month interest period plus an applicable margin of initially 1.00% per annum), or a eurodollar rate plus an applicable margin of initially 2.00% per annum. At December 31, 2015, the interest rate on the amounts outstanding under the New Revolving Credit Agreement was 2.42 percent. In addition, the daily average undrawn portion of the New Revolving Credit Agreement will accrue a commitment fee payable quarterly in arrears. The applicable margin for, and the commitment fee applicable to, the New Revolving Credit Agreement, will be adjusted from time-to-time pursuant to a ratings based pricing grid. In addition, a fronting fee, in an amount equal to 0.125% per annum on the aggregate face amount of the outstanding letters of credit, will be payable to the issuers of such letters of credit.

The New Revolving Credit Agreement contains certain financial, affirmative and negative covenants. The negative covenants in the New Revolving Credit Agreement include restrictions that relate to, among other things and subject to customary baskets, exceptions and limitations for facilities of this type:

• subsidiary debt;

• liens;

• restrictive agreements;

• restricted payments during the continuance of an event of default;

• disposition of assets and sale and leaseback transactions;

• transactions with affiliates;

• change in business;

• fundamental changes;

• modification of certain agreements; and

• changes to fiscal year.

The New Revolving Credit Agreement requires the Company to maintain (each as calculated in accordance with the New Revolving Credit Agreement): (i) a debt to total capitalization ratio of not more than 30.0 percent (such ratio was 19.9 percent at December 31, 2015); (ii) an aggregate ratio of total adjusted capital to company action level risk-based capital for the Company's insurance subsidiaries of not less than 250 percent (such ratio was estimated to be 449 percent at December 31, 2015); and (iii) a minimum consolidated net worth of not less than the sum of (x) $2,674 million plus (y) 50.0% of the net equity proceeds received by the Company from the issuance and sale of equity interests in the Company (the Company's consolidated net worth was $3,735.7 million at December 31, 2015 compared to the minimum requirement of $2,677 million).

The New Revolving Credit Agreement provides for customary events of default (subject in certain cases to customary grace and cure periods), which include, without limitation, the following:

• non-payment;

• breach of representations, warranties or covenants;

• cross-default and cross-acceleration;

• bankruptcy and insolvency events;

• judgment defaults;

• actual or asserted invalidity of documentation with respect to the New Revolving Credit Agreement;

• change of control; and

• customary ERISA defaults.

If an event of default under the New Revolving Credit Agreement occurs and is continuing, the Agent may accelerate the amounts and terminate all commitments outstanding under the New Revolving Credit Agreement.

Previous Senior Secured Credit Agreement

The Company used a portion of the net proceeds from its offering of the Notes, together with borrowings under the New Revolving Credit Agreement, to repay all of the outstanding borrowings under its credit agreement, dated as of September 28, 2012 (as amended by the First Amendment to Credit Agreement dated May 20, 2013, and as further amended by the Second Amendment to Credit Agreement dated May 30, 2014, the "Previous Senior Secured Credit Agreement") among the Company, the lenders from time to time party thereto, and JPMorgan Chase Bank, N.A., as agent. The Previous Senior Secured Credit

171

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

Agreement consisted of: (i) a six-year term loan facility with $389.8 million outstanding prior to repayment; (ii) a four-year term loan facility with $112.5 million outstanding prior to repayment; and (iii) a $50.0 millionthree-year revolving credit facility that had no outstanding principal balance. Upon repayment of all such outstanding borrowings on May 19, 2015, all of the commitments under the Previous Senior Secured Credit Agreement were terminated, all of the collateral securing the facilities thereunder was released, the related security, guarantee and intercreditor agreements were terminated and any remaining restrictive covenants and certain additional events of default contained in the Previous Senior Secured Credit Agreement ceased to have effect.

The six-year term loan facility amortized in quarterly installments in amounts resulting in an annual amortization of 1% and the four-year term loan facility amortized in quarterly installments resulting in an annual amortization of 20% during the first and second years and 30% during the third and fourth years.

On May 30, 2014, the Company completed an amendment to the Previous Senior Secured Credit Agreement to waive the requirement that the net proceeds in excess of $125 million received from the sale of CLIC be used to prepay amounts outstanding under the Previous Senior Secured Credit Agreement.

In May 2013, we amended our Previous Senior Secured Credit Agreement. Pursuant to the amended terms, the applicable interest rates were decreased. At December 31, 2014, the interest rates on the six-year term loan facility and the four-year term loan facility were 3.75% and 3.00%, respectively.

Other changes made in May 2013 to the Previous Senior Secured Credit Agreement included modifications of mandatory prepayments resulting from certain restricted payments made (including any common stock dividends and share repurchases) as defined in the Previous Senior Secured Credit Agreement.

In 2015, we made $19.8 million of scheduled quarterly principal payments due under the Previous Senior Secured Credit Agreement. In 2014, we made $59.4 million of scheduled quarterly principal payments due under the Previous Senior Secured Credit Agreement. In the first six months of 2013, we made mandatory prepayments of $20.4 million in an amount equal to 33.33% of our share repurchases and common stock dividend payments, as required under the terms of our Previous Senior Secured Credit Agreement. No mandatory prepayments were required in the second half of 2013 as our debt to total capitalization ratio, as defined in the Previous Senior Secured Credit Agreement, was below 20.0 percent. We also made additional payments of $42.7 million in 2013 to cover the remaining portion of the scheduled quarterly principal payments due under the Previous Senior Secured Credit Agreement.

6.375% Notes

On September 28, 2012, we issued $275.0 million in aggregate principal amount of 6.375% Notes pursuant to an Indenture, dated as of September 28, 2012 (the "6.375% Indenture"), among the Company, the subsidiary guarantors party thereto and the Trustee. On May 19, 2015, the Company deposited with the Trustee for the 6.375% Notes sufficient funds to satisfy and discharge the indenture governing the 6.375% Indenture and to fund the make-whole redemption of the outstanding 6.375% Notes and to pay accrued and unpaid interest on the redeemed notes to, but not including, the June 10, 2015 redemption date. Upon the satisfaction and discharge of the 6.375% Indenture, all of the collateral securing the 6.375% Notes was released, the related security and intercreditor agreements were terminated and any remaining restrictive covenants and certain additional events of default contained in the 6.375% Indenture ceased to have effect.

172

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

The following table sets forth the sources and uses of cash from the debt refinancing transactions discussed above (dollars in millions):

Sources:
	Notes	$	825.0
	New Revolving Credit Agreement	100.0
	Total sources	$	925.0
Uses:
	Repayment of Previous Senior Secured Credit Agreement	$	502.3
	Repayment of 6.375% Notes, including redemption premium	292.8
	Accrued interest	4.3
	Debt issuance costs	16.0
	General corporate purposes	109.6
	Total uses	$	925.0

7.0% Debentures

From November 2009 through May 2010, we issued $293.0 million aggregate principal amount of our 7.0% Senior Debentures due 2016 (the "7.0% Debentures"). The Company used the net proceeds from the issuance of the 7.0% Debentures to retire outstanding indebtedness.

The 7.0% Debentures ranked equally in right of payment with all of the Company's unsecured and unsubordinated obligations. The 7.0% Debentures were governed by an Indenture dated as of October 16, 2009 between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee. The 7.0% Debentures bore interest at a rate of 7.0% per annum, payable semi-annually on June 30 and December 30 of each year. The 7.0% Debentures would have matured on December 30, 2016. The 7.0% Debentures were not convertible prior to June 30, 2013, except under limited circumstances. Commencing on June 30, 2013, the 7.0% Debentures were convertible into shares of our common stock at the option of the holder at any time, subject to certain exceptions and subject to our right to terminate such conversion rights under certain circumstances relating to the sale price of our common stock. As further described below, we elected to terminate the conversion rights in July 2013.

In September 2012, the Company repurchased $200.0 million in aggregate principal amount of the Company's 7.0% Debentures for a cash purchase price of $355.1 million. On March 28, 2013, the Company completed the cash tender offer (the "Offer") for $59.3 million aggregate principal amount of its 7.0% Debentures for an aggregate purchase price of $124.8 million.

In May 2013, we repurchased $4.5 million principal amount of the 7.0% Debentures for an aggregate purchase price of $9.4 million.

On July 1, 2013, the Company issued a conversion right termination notice to holders of the remaining outstanding 7.0% Debentures. Holders of the 7.0% Debentures were able to exercise their conversion right at any time on or prior to the close of business on July 30, 2013. Holders exercising their conversion right received 184.3127 shares of common stock per $1,000 principal amount of 7.0% Debentures converted. Holders of $25.7 million in aggregate principal amount of the 7.0% Debentures exercised their conversion right and received 4.7 million shares of our common stock.

On May 30, 2014, we repurchased the remaining $3.5 million principal amount of the 7.0% Debentures for a purchase price of $3.7 million.

173

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

Loss on Extinguishment of Debt

In 2015, we recognized a loss on extinguishment or modification of debt totaling $32.8 million primarily related to: (i) the redemption premium related to the repayment of the 6.375% Notes; and (ii) the write-off of unamortized discount and issuance costs associated with the repayment of the Previous Senior Secured Credit Agreement and the 6.375% Notes.

In 2014, we recognized a loss on extinguishment or modification of debt totaling $.6 million consisting of: (i) $.4 million of expenses related to the amendment of the Previous Senior Secured Credit Agreement; and (ii) $.2 million related to the repurchase of the remaining principal amount of the 7.0% Debentures.

In 2013, we recognized a loss on extinguishment of debt totaling $65.4 million consisting of: (i) $2.9 million related to the amendment of the Previous Senior Secured Credit Agreement and the write-off of unamortized discount and issuance costs associated with prepayments on the Previous Senior Secured Credit Agreement; and (ii) $62.5 million as a result of the Offer and repurchase of 7.0% Debentures described above, the write-off of unamortized discount and issuance costs associated with the 7.0% Debentures that were repurchased and other transaction costs. Additional paid-in capital was also reduced by $12.6 million to extinguish the beneficial conversion feature associated with a portion of the 7.0% Debentures that were repurchased.

Scheduled Repayment of our Direct Corporate Obligations

The scheduled repayment of our direct corporate obligations was as follows at December 31, 2015 (dollars in millions):

Year ending December 31,
2016	$	—
2017	—
2018	—
2019	100.0
2020	325.0
Thereafter	500.0
	$	925.0

8. LITIGATION AND OTHER LEGAL PROCEEDINGS

Legal Proceedings

The Company and its subsidiaries are involved in various legal actions in the normal course of business, in which claims for compensatory and punitive damages are asserted, some for substantial amounts.  We recognize an estimated loss from these loss contingencies when we believe it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. Some of the pending matters have been filed as purported class actions and some actions have been filed in certain jurisdictions that permit punitive damage awards that are disproportionate to the actual damages incurred.  The amounts sought in certain of these actions are often large or indeterminate and the ultimate outcome of certain actions is difficult to predict.  In the event of an adverse outcome in one or more of these matters, there is a possibility that the ultimate liability may be in excess of the liabilities we have established and could have a material adverse effect on our business, financial condition, results of operations and cash flows.  In addition, the resolution of pending or future litigation may involve modifications to the terms of outstanding insurance policies or could impact the timing and amount of rate increases, which could adversely affect the future profitability of the related insurance policies.  Based upon information presently available, and in light of legal, factual and other defenses available to the Company and its subsidiaries, the Company does not believe that it is probable that the ultimate liability from either pending or threatened legal actions, after consideration of existing loss provisions, will have a material adverse effect on the Company's consolidated financial condition, operating results or cash flows. However, given the inherent difficulty in predicting the outcome of legal proceedings, there exists the possibility that such legal actions could have a material adverse effect on the Company's consolidated financial condition, operating results or cash flows.

In addition to the inherent difficulty of predicting litigation outcomes, particularly those that will be decided by a jury, some matters purport to seek substantial or an unspecified amount of damages for unsubstantiated conduct spanning several

174

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

years based on complex legal theories and damages models. The alleged damages typically are indeterminate or not factually supported in the complaint, and, in any event, the Company's experience indicates that monetary demands for damages often bear little relation to the ultimate loss. In some cases, plaintiffs are seeking to certify classes in the litigation and class certification either has been denied or is pending and we have filed oppositions to class certification or sought to decertify a prior class certification. In addition, for many of these cases: (i) there is uncertainty as to the outcome of pending appeals or motions; (ii) there are significant factual issues to be resolved; and/or (iii) there are novel legal issues presented. Accordingly, the Company cannot reasonably estimate the possible loss or range of loss in excess of amounts accrued, if any, or predict the timing of the eventual resolution of these matters.  The Company reviews these matters on an ongoing basis.  When assessing reasonably possible and probable outcomes, the Company bases its assessment on the expected ultimate outcome following all appeals.

Regulatory Examinations and Fines

Insurance companies face significant risks related to regulatory investigations and actions.  Regulatory investigations generally result from matters related to sales or underwriting practices, payment of contingent or other sales commissions, claim payments and procedures, product design, product disclosure, additional premium charges for premiums paid on a periodic basis, denial or delay of benefits, charging excessive or impermissible fees on products, procedures related to canceling policies, changing the way cost of insurance charges are calculated for certain life insurance products or recommending unsuitable products to customers.  We are, in the ordinary course of our business, subject to various examinations, inquiries and information requests from state, federal and other authorities.  The ultimate outcome of these regulatory actions (including the costs of complying with information requests and policy reviews) cannot be predicted with certainty.  In the event of an unfavorable outcome in one or more of these matters, the ultimate liability may be in excess of liabilities we have established and we could suffer significant reputational harm as a result of these matters, which could also have a material adverse effect on our business, financial condition, results of operations or cash flows.

In August 2011, we were notified of an examination to be done on behalf of a number of states for the purpose of determining compliance with unclaimed property laws by the Company and its subsidiaries.  Such examination has included inquiries related to the use of data available on the U.S. Social Security Administration's Death Master File to identify instances where benefits under life insurance policies, annuities and retained asset accounts are payable. We are continuing to provide information to the examiners in response to their requests. A total of 38 states and the District of Columbia are currently participating in this examination.

Guaranty Fund Assessments

The balance sheet at December 31, 2015, included: (i) accruals of $24.0 million, representing our estimate of all known assessments that will be levied against the Company's insurance subsidiaries by various state guaranty associations based on premiums written through December 31, 2015; and (ii) receivables of $26.1 million that we estimate will be recovered through a reduction in future premium taxes as a result of such assessments. At December 31, 2014, such guaranty fund assessment accruals were $23.7 million and such receivables were $23.6 million. These estimates are subject to change when the associations determine more precisely the losses that have occurred and how such losses will be allocated among the insurance companies. We recognized expense for such assessments of $1.2 million, $1.1 million and $2.7 million in 2015, 2014 and 2013, respectively.

Guarantees

In accordance with the terms of the employment agreements of two of the Company's former chief executive officers, certain wholly-owned subsidiaries of the Company are the guarantors of the former executives' nonqualified supplemental retirement benefits. The liability for such benefits was $25.8 million and $27.2 million at December 31, 2015 and 2014, respectively, and is included in the caption "Other liabilities" in the consolidated balance sheet.

175

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

Leases and Certain Other Long-Term Commitments

The Company rents office space, equipment and computer software under noncancellable operating lease agreements. In addition, the Company has entered into certain sponsorship agreements which require future payments. Total expense pursuant to these lease and sponsorship agreements was $48.8 million, $50.4 million and $44.3 million in 2015, 2014 and 2013, respectively. Future required minimum payments as of December 31, 2015, were as follows (dollars in millions):

2016	$	54.3
2017	33.2
2018	28.3
2019	17.2
2020	5.2
Thereafter	8.9
Total	$	147.1

9. AGENT DEFERRED COMPENSATION PLAN

For our agent deferred compensation plan, it is our policy to immediately recognize changes in the actuarial benefit obligation resulting from either actual experience being different than expected or from changes in actuarial assumptions.

One of our insurance subsidiaries has a noncontributory, unfunded deferred compensation plan for qualifying members of its career agency force. Benefits are based on years of service and career earnings. The actuarial measurement date of this deferred compensation plan is December 31. The liability recognized in the consolidated balance sheet for the agent deferred compensation plan was $170.8 million and $175.1 million at December 31, 2015 and 2014, respectively. Expenses incurred on this plan were $2.2 million, $36.3 million and $(2.9) million during 2015, 2014 and 2013, respectively (including the recognition of gains (losses) of $15.2 million, $(24.3) million and $17.2 million in 2015, 2014 and 2013, respectively, primarily resulting from: (i) changes in the discount rate assumption used to determine the deferred compensation plan liability to reflect current investment yields; and (ii) changes in mortality table assumptions). We purchased COLI as an investment vehicle to fund the agent deferred compensation plan. The COLI assets are not assets of the agent deferred compensation plan, and as a result, are accounted for outside the plan and are recorded in the consolidated balance sheet as other invested assets. The carrying value of the COLI assets was $158.1 million and $157.6 million at December 31, 2015 and 2014, respectively. Changes in the cash surrender value (which approximates net realizable value) of the COLI assets are recorded as net investment income and totaled $.5 million, $5.7 million and $19.7 million in 2015, 2014 and 2013, respectively.

We used the following assumptions for the deferred compensation plan to calculate:

	2015		2014
Benefit obligations:
Discount rate	4.50	%	4.15	%
Net periodic cost:
Discount rate	4.15	%	4.75	%

The discount rate is based on the yield of a hypothetical portfolio of high quality debt instruments which could effectively settle plan benefits on a present value basis as of the measurement date. At December 31, 2015, for our deferred compensation plan for qualifying members of our career agency force, we assumed a 4.0 percent annual increase in compensation until the participant's assumed retirement date (ranging from ages 60 to 65 and completion of five years of service).

176

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

The benefits expected to be paid pursuant to our agent deferred compensation plan as of December 31, 2015 were as follows (dollars in millions):

2016	$	6.6
2017	6.9
2018	7.3
2019	7.8
2020	8.1
2021 - 2025	47.2

The Company has a qualified defined contribution plan for which substantially all employees are eligible. Company contributions, which match a portion of certain voluntary employee contributions to the plan, totaled $5.0 million, $5.1 million and $4.6 million in 2015, 2014 and 2013, respectively. Employer matching contributions are discretionary.

10. DERIVATIVES

Our freestanding and embedded derivatives, which are not designated as hedging instruments, are held at fair value and are summarized as follows (dollars in millions):

	Fair value
	2015			2014
Assets:
Other invested assets:
Fixed index call options	$	41.0		$	107.2
Interest rate futures	.1			(.2		)
Reinsurance receivables	(5.0		)	2.0
Total assets	$	36.1		$	109.0
Liabilities:
Future policy benefits:
Fixed index products	$	1,057.1		$	1,081.5
Total liabilities	$	1,057.1		$	1,081.5

The activity associated with freestanding derivative instruments is measured as either the notional or the number of contracts. The activity associated with the fixed index annuity embedded derivatives are shown by the number of policies. The following table represents activity associated with derivative instruments as of the dates indicated:

	Measurement	December 31, 2014		Additions		Maturities/terminations			December 31, 2015
Interest futures	Contracts	402		2,643		(2,781		)	264
Fixed index annuities - embedded derivative	Policies	93,185		10,256		(6,781		)	96,660
Fixed index call options	Notional (a)	$	2,403.9	$	2,397.0	$	(2,421.2	)	$	2,379.7

_________________

(a) Dollars in millions.

We are required to establish an embedded derivative related to a modified coinsurance agreement pursuant to which we assume the risks of a block of health insurance business. The embedded derivative represents the mark-to-market adjustment for approximately $145 million in underlying investments held by the ceding reinsurer.

177

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

The following table provides the pre-tax gains (losses) recognized in net income for derivative instruments, which are not designated as hedges for the periods indicated (dollars in millions):

	2015			2014			2013
Net investment income from policyholder and reinsurer accounts and other special-purpose portfolios:
Fixed index call options	$	(36.2	)	$	69.5		$	177.5
Embedded derivative related to reinsurance contract	—			(1.4		)	3.7
Total	(36.2		)	68.1			181.2
Net realized gains (losses):
Interest rate futures	(2.7		)	(7.0		)	(.4		)
Embedded derivative related to modified coinsurance agreement	(7.0		)	2.0			—
Total	(9.7		)	(5.0		)	(.4		)
Insurance policy benefits:
Embedded derivative related to fixed index annuities	36.3			(73.5		)	49.3
Total	$	(9.6	)	$	(10.4	)	$	230.1

Derivative Counterparty Risk

If the counterparties to the call options fail to meet their obligations, we may recognize a loss.  We limit our exposure to such a loss by diversifying among several counterparties believed to be strong and creditworthy.  At December 31, 2015, all of our counterparties were rated "A-" or higher by S&P.

The interest rate future contracts are effected through regulated exchanges. Such positions are marked to market and margined on a daily basis. The Company has minimal exposure to credit-related losses in the event of nonperformance.

The Company and its subsidiaries are parties to master netting arrangements with its counterparties related to entering into various derivative contracts. Exchange-traded derivatives require margin accounts which we offset.

Repurchase agreements

We may enter into agreements under which we sell securities subject to an obligation to repurchase the same securities. These repurchase agreements are accounted for as collateralized financing arrangements and not as a sale and subsequent repurchase of securities. The obligation to repurchase the securities is reflected as investment borrowings in the Company's consolidated balance sheet, while the securities underlying the repurchase agreements remain in the respective investment asset accounts. There is no offsetting or netting of the investment securities assets with the repurchase agreement liabilities. In addition, as the Company does not currently have any outstanding reverse repurchase agreements, there is no such offsetting to be done with the repurchase agreements.

The right of offset for a repurchase agreement resembles a secured borrowing, whereby the collateral would be used to settle the fair value of the repurchase agreement should the Company be in default under the agreement (e.g., fails to make an interest payment to the counterparty). If the counterparty were to default (e.g., declare bankruptcy), the Company could cancel the repurchase agreement (i.e., cease payment of principal and interest), and attempt collection on the amount of collateral value in excess of the repurchase agreement fair value. The collateral is held by a third party financial institution in the counterparty's custodial account. The counterparty has the right to sell or repledge the investment securities.

178

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

The following table summarizes information related to derivatives and repurchase agreements with master netting arrangements or collateral as of December 31, 2015 and 2014 (dollars in millions):

									Gross amounts not offset in the balance sheet
		Gross amounts recognized			Gross amounts offset in the balance sheet		Net amounts of assets presented in the balance sheet		Financial instruments		Cash collateral received		Net amount
December 31, 2015:
	Fixed index call options	$	41.0		$	—	$	41.0	$	—	$	—	$	41.0
	Interest rate futures	.1			1.5		1.6		—		—		1.6
December 31, 2014:
	Fixed index call options	107.2			—		107.2		—		—		107.2
	Interest rate futures	(.2		)	1.5		1.3		—		—		1.3
	Repurchase agreements (a)	20.4			—		20.4		20.4		—		—

_________________

(a) As of December 31, 2014, these agreements were collateralized by investment securities with a fair value of $25.3 million.

11. SHAREHOLDERS' EQUITY

Changes in the number of shares of common stock outstanding were as follows (shares in thousands):

	2015		2014		2013
Balance, beginning of year	203,324		220,324		221,502
Treasury stock purchased and retired	(20,582	)	(18,489	)	(8,949	)
Conversion of 7.0% Debentures	—		—		4,739
Stock options exercised	769		916		2,087
Restricted and performance stock vested (a)	518		573		945
Balance, end of year	184,029		203,324		220,324

____________________

(a) In 2015, 2014 and 2013, such amount was reduced by 237 thousand, 257 thousand and 472 thousand shares, respectively, which were tendered to the Company for the payment of required federal and state tax withholdings owed on the vesting of restricted and performance stock.

In May 2011, the Company announced a securities repurchase program of up to $100.0 million. In February 2012, June 2012, December 2012, December 2013, November 2014 and November 2015, the Company's Board of Directors approved, in aggregate, an additional $1,600.0 million to repurchase the Company's outstanding securities. In 2015, 2014 and 2013, we repurchased 20.6 million, 18.5 million and 8.9 million shares, respectively, for $365.2 million, $319.1 million and $118.4 million, respectively, under the securities repurchase program. In addition, in September 2014, we repurchased all outstanding common stock warrants for $57.4 million under the securities repurchase program. In 2013, the Company also purchased $63.8 million aggregate principal amount of our 7.0% Debentures as further discussed in the note to the consolidated financial statements entitled "Notes Payable - Direct Corporate Obligations". Such purchases were made pursuant to our securities repurchase program. The Company had remaining repurchase authority of $455.7 million as of December 31, 2015.

In 2015, 2014 and 2013, dividends declared and paid on common stock totaled $52.0 million ($0.27 per common share), $51.0 million ($0.24 per common share) and $24.4 million ($0.11 per common share), respectively. In May 2015, the Company increased its quarterly common stock dividend to $0.07 per share from $0.06 per share.

179

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

The Company has a long-term incentive plan which permits the grant of CNO incentive or non-qualified stock options, restricted stock awards, stock appreciation rights, performance shares or units and certain other equity-based awards to certain directors, officers and employees of the Company and certain other individuals who perform services for the Company. As of December 31, 2015, 6.9 million shares remained available for issuance under the plan. Our stock option awards are generally granted with an exercise price equal to the market price of the Company's stock on the date of grant. For options granted in 2006 and prior years, our stock option awards generally vested on a graded basis over a four year service term and expire ten years from the date of grant. Our stock option awards granted in 2007 through 2009 generally vested on a graded basis over a three year service term and expired five years from the date of grant. Our stock options granted in 2010 through 2014 generally vest on a graded basis over a three year service term and expire seven years from the date of grant. Our stock options granted in 2015 generally vest on a graded basis over a three year service term and expire ten years from the date of grant. The vesting periods for our restricted stock awards range from immediate vesting to a period of three years.

A summary of the Company's stock option activity and related information for 2015 is presented below (shares in thousands; dollars in millions, except per share amounts):

	Shares		Weighted average exercise price			Weighted average remaining life (in years)	Aggregate intrinsic value
Outstanding at the beginning of the year	5,011		$	12.04
Options granted	1,361		16.45
Exercised	(769	)	(8.20		)		$	4.8
Forfeited or terminated	(404	)	(17.70		)
Outstanding at the end of the year	5,199		13.32			4.8	$	38.4
Options exercisable at the end of the year	2,399					2.5	$	15.3
Available for future grant	6,882

180

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

A summary of the Company's stock option activity and related information for 2014 is presented below (shares in thousands; dollars in millions, except per share amounts):

	Shares		Weighted average exercise price		Weighted average remaining life (in years)	Aggregate intrinsic value
Outstanding at the beginning of the year	5,579		$	10.64
Options granted	1,014		19.10
Exercised	(917	)	5.47			$	3.8
Forfeited or terminated	(665	)	20.07
Outstanding at the end of the year	5,011		12.04		4.3	$	32.1
Options exercisable at the end of the year	2,030				2.7	$	12.1
Available for future grant	8,571

A summary of the Company's stock option activity and related information for 2013 is presented below (shares in thousands; dollars in millions, except per share amounts):

	Shares		Weighted average exercise price		Weighted average remaining life (in years)	Aggregate intrinsic value
Outstanding at the beginning of the year	6,655		$	9.72
Options granted	1,447		11.01
Exercised	(2,087	)	7.27			$	6.0
Forfeited or terminated	(436	)	13.95
Outstanding at the end of the year	5,579		10.64		4.0	$	32.5
Options exercisable at the end of the year	2,529				2.1	$	13.9
Available for future grant	9,099

We recognized compensation expense related to stock options totaling $9.6 million ($6.2 million after income taxes) in 2015, $7.9 million ($5.1 million after income taxes) in 2014 and $7.2 million ($4.7 million after income taxes) in 2013. Compensation expense related to stock options reduced both basic and diluted earnings per share by three cents in 2015 and two cents in both 2014 and 2013. At December 31, 2015, the unrecognized compensation expense for non-vested stock options totaled $11.2 million which is expected to be recognized over a weighted average period of 1.9 years. Cash received by the Company from the exercise of stock options was $6.3 million, $5.0 million and $15.1 million during 2015, 2014 and 2013, respectively.

The fair value of each stock option grant is estimated on the date of grant using the Black-Scholes option valuation model with the following weighted average assumptions:

	2015			2014			2013
	Grants			Grants			Grants
Weighted average risk-free interest rates	1.7		%	1.6		%	.8		%
Weighted average dividend yields	1.5		%	1.3		%	.7		%
Volatility factors	85		%	51		%	107		%
Weighted average expected life (in years)	6.3			4.8			4.8
Weighted average fair value per share	$	10.83		$	7.65		$	8.02

181

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant. The dividend yield is based on the Company's history and expectation of dividend payouts. Volatility factors are based on the weekly historical volatility of the Company's common stock equal to the expected life of the option. The expected life is based on the average of the graded vesting period and the contractual terms of the option.

The exercise price was equal to the market price of our stock on the date of grant for all options granted in 2015, 2014 and 2013.

The following table summarizes information about stock options outstanding at December 31, 2015 (shares in thousands):

		Options outstanding			Options exercisable
Range of exercise prices	Number outstanding	Remaining life (in years)	Average exercise price		Number exercisable	Average exercise price
$6.45 - $6.77	427	1.2	$	6.45	427	$	6.45
$7.38 - $7.51	1,097	2.8	7.46		1,097	7.46
$8.29 - $12.34	1,146	4.1	10.76		551	10.61
$12.74 - $18.27	1,332	8.9	16.40		18	14.49
$19.15 - $25.45	1,197	4.0	20.18		306	23.19
	5,199				2,399

During 2015, 2014 and 2013, the Company granted .1 million, .1 million and .2 million restricted shares, respectively, of CNO common stock to certain directors, officers and employees of the Company at a weighted average fair value of $17.59 per share, $17.15 per share and $12.00 per share, respectively. The fair value of such grants totaled $1.7 million, $1.9 million and $2.1 million in 2015, 2014 and 2013, respectively. Such amounts are recognized as compensation expense over the vesting period of the restricted stock. A summary of the Company's non-vested restricted stock activity for 2015 is presented below (shares in thousands):

	Shares		Weighted average grant date fair value
Non-vested shares, beginning of year	236		$	10.95
Granted	95		17.59
Vested	(234	)	11.73
Forfeited	(2	)	11.31
Non-vested shares, end of year	95		15.66

At December 31, 2015, the unrecognized compensation expense for non-vested restricted stock totaled $.9 million which is expected to be recognized over a weighted average period of 1.6 years. At December 31, 2014, the unrecognized compensation expense for non-vested restricted stock totaled $1.4 million. We recognized compensation expense related to restricted stock awards totaling $2.2 million, $3.0 million and $4.5 million in 2015, 2014 and 2013, respectively. The fair value of restricted stock that vested during 2015, 2014 and 2013 was $2.7 million, $3.7 million and $5.6 million, respectively.

Authoritative guidance also requires us to estimate the amount of unvested stock-based awards that will be forfeited in future periods and reduce the amount of compensation expense recognized over the applicable service period to reflect this estimate. We periodically evaluate our forfeiture assumptions to more accurately reflect our actual forfeiture experience.

The Company does not currently recognize tax benefits resulting from tax deductions in excess of the compensation expense recognized because of NOLs which are available to offset future taxable income.

In 2015, 2014 and 2013 the Company granted performance units totaling 516,660, 283,630 and 424,400, respectively, pursuant to its long-term incentive plan to certain officers of the Company. The criteria for payment for such awards are based

182

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

on certain company-wide performance levels that must be achieved within a specified performance time (generally three years), each as defined in the award. The performance units granted in 2015 provide for a payout of up to 200 percent of the award if certain performance thresholds are achieved, and the performance units granted prior to 2015 provide for a payout of up to 150 percent of the award if certain performance thresholds are achieved. Unless antidilutive, the diluted weighted average shares outstanding would reflect the number of performance units expected to be issued, using the treasury stock method.

A summary of the Company's performance units is presented below (shares in thousands):

	Total shareholder return awards		Operating return on equity awards		Pre-tax operating income awards
Awards outstanding at December 31, 2012	193		—		977
Granted in 2013	212		212		—
Additional shares issued pursuant to achieving certain performance criteria (a)	—		—		223
Shares vested in 2013	—		—		(668	)
Forfeited	(23	)	(8	)	(62	)
Awards outstanding at December 31, 2013	382		204		470
Granted in 2014	142		142		—
Additional shares issued pursuant to achieving certain performance criteria (a)	—		—		142
Shares vested in 2014	—		—		(434	)
Forfeited	(5	)	(3	)	(2	)
Awards outstanding at December 31, 2014	519		343		176
Granted in 2015	258		258		—
Additional shares issued pursuant to achieving certain performance criteria (a)	85		—		85
Shares vested in 2015	(260	)	—		(260	)
Forfeited	(53	)	(52	)	(1	)
Awards outstanding at December 31, 2015	549		549		—

_________________________

(a) The performance units that vested in these years provided for a payout of up to 150 percent of the award if certain performance levels were achieved.

The grant date fair value of the performance units awarded was $9.4 million and $5.2 million in 2015 and 2014, respectively. We recognized compensation expense of $5.3 million, $4.7 million and $3.4 million in 2015, 2014 and 2013, respectively, related to the performance units.

As further discussed in the footnote to the consolidated financial statements entitled "Income Taxes", the Company's Board of Directors adopted the Section 382 Rights Agreement on January 20, 2009 and amended and extended the Section 382 Rights Agreement on December 6, 2011 and November 13, 2014. The Section 382 Rights Agreement, as amended, is designed to protect shareholder value by preserving the value of our tax assets primarily associated with NOLs. At the time the Section 382 Rights Agreement was adopted, the Company declared a dividend of one preferred share purchase right (a "Right") for each outstanding share of common stock. The dividend was payable on January 30, 2009, to the shareholders of record as of the close of business on that date and a Right is also attached to each share of CNO common stock issued after that date. Pursuant to the Section 382 Rights Agreement, as amended, each Right entitles the shareholder to purchase from the Company one one-thousandth of a share of Series C Junior Participating Preferred Stock, par value $.01 per share (the "Junior Preferred Stock") of the Company at a price of $70.00 per one one-thousandth of a share of Junior Preferred Stock. The description and terms of the Rights are set forth in the Section 382 Rights Agreement, as amended. The Rights would become exercisable in the event any person or group (subject to certain exemptions) becomes an owner of more than 4.99 percent of the outstanding stock of CNO

183

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

(a "Threshold Holder") without the approval of the Board of Directors or an existing shareholder who is currently a Threshold Holder acquires additional shares exceeding one percent of our outstanding shares without prior approval from the Board of Directors.

A reconciliation of net income and shares used to calculate basic and diluted earnings per share is as follows (dollars in millions and shares in thousands):

	2015		2014		2013
Net income for basic earnings per share	$	270.7	$	51.4	$	478.0
Add:  interest expense on 7.0% Debentures, net of income taxes	—		—		1.6
Net income for diluted earnings per share	$	270.7	$	51.4	$	479.6
Shares:
Weighted average shares outstanding for basic earnings per share	193,054		212,917		221,628
Effect of dilutive securities on weighted average shares:
7.0% Debentures	—		—		5,780
Stock options, restricted stock and performance units	2,112		2,505		2,776
Warrants (a)	—		2,233		2,518
Dilutive potential common shares	2,112		4,738		11,074
Weighted average shares outstanding for diluted earnings per share	195,166		217,655		232,702

________

(a) All outstanding warrants were repurchased in September 2014 as further discussed above. Accordingly, the warrants have no dilutive effect in periods beginning after September 30, 2014.

Basic earnings per common share is computed by dividing net income by the weighted average number of common shares outstanding for the period.  Restricted shares (including our performance units) are not included in basic earnings per share until vested.  Diluted earnings per share reflect the potential dilution that could occur if outstanding stock options and warrants were exercised and restricted stock was vested.  The dilution from options, warrants and restricted shares is calculated using the treasury stock method.  Under this method, we assume the proceeds from the exercise of the options and warrants (or the unrecognized compensation expense with respect to restricted stock and performance units) will be used to purchase shares of our common stock at the average market price during the period, reducing the dilutive effect of the exercise of the options and warrants (or the vesting of the restricted stock and performance units). Initially, the 7.0% Debentures were convertible into 182.1494 shares of our common stock for each $1,000 principal amount of 7.0% Debentures, which was equivalent to an initial conversion price of approximately $5.49 per share. The conversion rate was subject to adjustment following the occurrence of certain events (including the payment of dividends on our common stock) in accordance with the terms of an indenture dated as of October 16, 2009. On July 1, 2013, the Company issued a conversion right termination notice to holders of the 7.0% Debentures and the right to convert the 7.0% Debentures into shares of its common stock was terminated effective July 30, 2013 as further discussed in the note to the consolidated financial statements entitled "Notes Payable - Direct Corporate Obligations".

184

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

12. OTHER OPERATING STATEMENT DATA

Insurance policy income consisted of the following (dollars in millions):

	2015			2014			2013
Direct premiums collected	$	3,769.6		$	3,856.2		$	3,966.0
Reinsurance assumed	38.4			34.5			38.0
Reinsurance ceded	(142.8		)	(187.9		)	(240.5		)
Premiums collected, net of reinsurance	3,665.2			3,702.8			3,763.5
Change in unearned premiums	5.9			9.1			(16.6		)
Less premiums on interest-sensitive life and products without mortality and morbidity risk which are recorded as additions to insurance liabilities	(1,241.9		)	(1,295.4		)	(1,298.1		)
Premiums on traditional products with mortality or morbidity risk	2,429.2			2,416.5			2,448.8
Fees and surrender charges on interest-sensitive products	126.8			213.2			295.9
Insurance policy income	$	2,556.0		$	2,629.7		$	2,744.7

The four states with the largest shares of 2015 collected premiums were Florida (9 percent), Pennsylvania (7 percent), California (6 percent) and Texas (6 percent). No other state accounted for more than five percent of total collected premiums.

Other operating costs and expenses were as follows (dollars in millions):

	2015		2014		2013
Commission expense	$	103.8	$	99.4	$	103.8
Salaries and wages	205.2		242.4		234.0
Other	430.2		461.0		428.4
Total other operating costs and expenses	$	739.2	$	802.8	$	766.2

Changes in the present value of future profits were as follows (dollars in millions):

	2015			2014			2013
Balance, beginning of year	$	489.4		$	679.3		$	626.0
Amortization	(69.1		)	(76.2		)	(92.0		)
Effect of reinsurance transaction	—			5.0			—
Amounts related to CLIC prior to being sold	—			(15.5		)	—
Amounts related to changes in unrealized investment gains (losses) on fixed maturities, available for sale	28.7			(103.2		)	145.3
Balance, end of year	$	449.0		$	489.4		$	679.3

Based on current conditions and assumptions as to future events on all policies inforce, the Company expects to amortize approximately 11 percent of the December 31, 2015 balance of the present value of future profits in 2016, 10 percent in 2017, 9 percent in 2018, 8 percent in 2019 and 7 percent in 2020. The discount rate used to determine the amortization of the present value of future profits averaged approximately 5 percent in the years ended December 31, 2015, 2014 and 2013.

In accordance with authoritative guidance, we are required to amortize the present value of future profits in relation to estimated gross profits for interest-sensitive life products and annuity products. Such guidance also requires that estimates of expected gross profits used as a basis for amortization be evaluated regularly, and that the total amortization recorded to date be

185

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

adjusted by a charge or credit to the statement of operations, if actual experience or other evidence suggests that earlier estimates should be revised.

Changes in deferred acquisition costs were as follows (dollars in millions):

	2015			2014			2013
Balance, beginning of year	$	770.6		$	968.1		$	629.7
Additions	246.4			242.8			222.8
Amortization	(190.9		)	(171.2		)	(204.3		)
Effect of reinsurance transaction	—			24.0			—
Amounts related to CLIC prior to being sold	—			(37.6		)	—
Amounts related to changes in unrealized investment gains (losses) on fixed maturities, available for sale	257.2			(255.5		)	315.9
Other	—			—			4.0
Balance, end of year	$	1,083.3		$	770.6		$	968.1

13. CONSOLIDATED STATEMENT OF CASH FLOWS

The following disclosures supplement our consolidated statement of cash flows.

The following reconciles net income to net cash provided by operating activities (dollars in millions):

	2015			2014				2013
Cash flows from operating activities:
Net income	$	270.7		$	51.4			$	478.0
Adjustments to reconcile net income to net cash from operating activities:
Amortization and depreciation	283.4			274.2				324.6
Income taxes	92.9			119.7				(181.2		)
Insurance liabilities	297.4			398.2				465.8
Accrual and amortization of investment income	(27.6		)	(148.3		)		(276.3		)
Deferral of policy acquisition costs	(246.4		)	(242.8		)		(222.8		)
Net realized investment (gains) losses	36.6			(36.7		)		(33.6		)
Payment to reinsurer pursuant to long-term care business reinsured	—			(590.3		)		—
Net loss on sale of subsidiary, (gain) loss on reinsurance transactions and transition expenses	9.0			239.8				98.4
Loss on extinguishment or modification of debt	32.8			.6				65.4
Other	(4.9		)	56.0				2.1
Net cash from operating activities	$	743.9		$	121.8		(a)	$	720.4

______________________

(a) Cash flows from operating activities reflect outflows in the 2014 period due to the payment to reinsurer to transfer certain long-term care business.

186

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

On July 1, 2014, Bankers Life recaptured the life business written by Bankers Life that was reinsured by Wilton Reassurance Company ("Wilton Re") in 2009. The following summarizes the impact of the recapture (dollars in millions):

Investments	$	139.4		(a) (b)
Cash	7.7
Present value of future profits and deferred acquisition costs	29.0			(b)
Reinsurance receivables	(155.9		)	(b)
Other liabilities	5.9			(b)
Gain on reinsurance transaction (classified as "Loss on sale of subsidiary, (gain) loss on reinsurance transactions and transition expenses")	26.1
Income tax expense	9.2
Gain on reinsurance transaction (net of income taxes)	$	16.9

___________________

(a)    Such amount has been reduced by a $28.0 million recapture fee.

(b)    Such non-cash amounts have been excluded from the consolidated statement of cash flows.

Other non-cash items not reflected in the financing activities section of the consolidated statement of cash flows (dollars in millions):

	2015		2014		2013
Stock options, restricted stock and performance units	$	17.1	$	15.6	$	15.1

14. STATUTORY INFORMATION (BASED ON NON-GAAP MEASURES)

Statutory accounting practices prescribed or permitted by regulatory authorities for the Company's insurance subsidiaries differ from GAAP. The Company's insurance subsidiaries reported the following amounts to regulatory agencies, after appropriate elimination of intercompany accounts among such subsidiaries (dollars in millions):

	2015		2014
Statutory capital and surplus	$	1,739.2	$	1,654.4
Asset valuation reserve	196.9		203.1
Interest maintenance reserve	476.0		504.1
Total	$	2,412.1	$	2,361.6

Statutory capital and surplus included investments in upstream affiliates of $42.6 million at both December 31, 2015 and 2014, which were eliminated in the consolidated financial statements prepared in accordance with GAAP.

Statutory earnings build the capital required by ratings agencies and regulators. Statutory earnings, fees and interest paid by the insurance companies to the parent company create the "cash flow capacity" the parent company needs to meet its obligations, including debt service. The consolidated statutory net income (a non-GAAP measure) of our insurance subsidiaries was $332.6 million, $364.3 million and $386.5 million in 2015, 2014 and 2013, respectively. Included in such net income were net realized capital gains (losses), net of income taxes, of $(18.0) million, $(18.2) million and $19.0 million in 2015, 2014 and 2013, respectively. In addition, such net income included pre-tax amounts for fees and interest paid to CNO or its non-life subsidiaries totaling $154.2 million, $157.5 million and $159.7 million in 2015, 2014 and 2013, respectively.

Insurance regulators may prohibit the payment of dividends or other payments by our insurance subsidiaries to parent companies if they determine that such payment could be adverse to our policyholders or contract holders. Otherwise, the ability of our insurance subsidiaries to pay dividends is subject to state insurance department regulations. Insurance regulations generally permit dividends to be paid from statutory earned surplus of the insurance company without regulatory approval for any 12-month period in amounts equal to the greater of (or in a few states, the lesser of): (i) statutory net gain from operations

187

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

or statutory net income for the prior year; or (ii) 10 percent of statutory capital and surplus as of the end of the preceding year. This type of dividend is referred to as an "ordinary dividend". Any dividend in excess of these levels requires the approval of the director or commissioner of the applicable state insurance department and is referred to as an "extraordinary dividend". During 2015, our insurance subsidiaries paid extraordinary dividends of $265.7 million to CDOC, Inc. ("CDOC") (our wholly owned subsidiary and the immediate parent of Washington National and Conseco Life Insurance Company of Texas). CDOC made no capital contributions to its insurance subsidiaries in 2015.

Each of the immediate insurance subsidiaries of CDOC had negative earned surplus at December 31, 2015. Accordingly, any dividend payments from these subsidiaries require the approval of the director or commissioner of the applicable state insurance department. The payment of interest on surplus debentures requires either prior written notice or approval of the director or commissioner of the applicable state insurance department. Dividends and other payments from our non-insurance subsidiaries to CNO or CDOC do not require approval by any regulatory authority or other third party.

In accordance with an order from the Florida Office of Insurance Regulation, Washington National may not distribute funds to any affiliate or shareholder, except pursuant to agreements that have been approved, without prior notice to the Florida Office of Insurance Regulation. In addition, the risk-based capital ("RBC") and other capital requirements described below can also limit, in certain circumstances, the ability of our insurance subsidiaries to pay dividends.

RBC requirements provide a tool for insurance regulators to determine the levels of statutory capital and surplus an insurer must maintain in relation to its insurance and investment risks and the need for possible regulatory attention. The RBC requirements provide four levels of regulatory attention, varying with the ratio of the insurance company's total adjusted capital (defined as the total of its statutory capital and surplus, asset valuation reserve and certain other adjustments) to its RBC (as measured on December 31 of each year) as follows: (i) if a company's total adjusted capital is less than 100 percent but greater than or equal to 75 percent of its RBC, the company must submit a comprehensive plan to the regulatory authority proposing corrective actions aimed at improving its capital position (the "Company Action Level"); (ii) if a company's total adjusted capital is less than 75 percent but greater than or equal to 50 percent of its RBC, the regulatory authority will perform a special examination of the company and issue an order specifying the corrective actions that must be taken; (iii) if a company's total adjusted capital is less than 50 percent but greater than or equal to 35 percent of its RBC, the regulatory authority may take any action it deems necessary, including placing the company under regulatory control; and (iv) if a company's total adjusted capital is less than 35 percent of its RBC, the regulatory authority must place the company under its control. In addition, the RBC requirements provide for a trend test if a company's total adjusted capital is between 100 percent and 150 percent of its RBC at the end of the year. The trend test calculates the greater of the decrease in the margin of total adjusted capital over RBC: (i) between the current year and the prior year; and (ii) for the average of the last 3 years. It assumes that such decrease could occur again in the coming year. Any company whose trended total adjusted capital is less than 95 percent of its RBC would trigger a requirement to submit a comprehensive plan as described above for the Company Action Level. The 2015 statutory annual statements of each of our insurance subsidiaries reflect total adjusted capital in excess of the levels subjecting the subsidiaries to any regulatory action.

In addition, although we are under no obligation to do so, we may elect to contribute additional capital or retain greater amounts of capital to strengthen the surplus of certain insurance subsidiaries. Any election to contribute or retain additional capital could impact the amounts our insurance subsidiaries pay as dividends to the holding company. The ability of our insurance subsidiaries to pay dividends is also impacted by various criteria established by rating agencies to maintain or receive higher ratings and by the capital levels that we target for our insurance subsidiaries.

At December 31, 2015, the consolidated RBC ratio of our insurance subsidiaries exceeded the minimum RBC requirement included in our New Revolving Credit Agreement. See the note to the consolidated financial statements entitled "Notes Payable - Direct Corporate Obligations" for further discussion of various financial ratios and balances we are required to maintain. We calculate the consolidated RBC ratio by assuming all of the assets, liabilities, capital and surplus and other aspects of the business of our insurance subsidiaries are combined together in one insurance subsidiary, with appropriate intercompany eliminations.

188

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

15. SALE OF SUBSIDIARY

On March 2, 2014, CNO entered into a Stock Purchase Agreement (the "Stock Purchase Agreement") with Wilton Re, pursuant to which CNO agreed to sell to Wilton Re all of the issued and outstanding shares of CLIC. The transaction closed on July 1, 2014, after the receipt of insurance regulatory approvals and satisfaction of other customary closing conditions. After adjustments for transaction costs and post-closing adjustments, the transaction resulted in net cash proceeds of $224.9 million, including the impact of intercompany transactions completed in connection with the closing. In the first quarter of 2014, we recognized an estimated loss on the sale of CLIC of $298 million, net of income taxes. In the third and fourth quarters of 2014, we recognized a reduction to the loss on the sale of CLIC of $6 million and $2.9 million, respectively, to reflect the determination of the final sales price and net proceeds.

The loss on the sale of CLIC in 2014, is summarized below (dollars in millions):

Net cash proceeds	$	224.9
Net assets being sold:
Investments	3,863.8
Cash and cash equivalents	164.7
Accrued investment income	42.7
Present value of future profits	15.5
Deferred acquisition costs	37.6
Reinsurance receivables	307.4
Income tax assets, net	84.4
Other assets	2.8
Liabilities for insurance products	(3,201.3		)
Other liabilities	(199.1		)
Investment borrowings	(383.4		)
Accumulated other comprehensive income	(240.5		)
Net assets being sold	494.6
Loss before taxes	(269.7		)
Tax expense related to the sale	14.2
Valuation allowance release related to the tax on the sale	(14.2		)
Valuation allowance increase related to the decrease in projected future taxable income	19.4
Net loss	$	(289.1	)

Because the tax basis of CLIC is lower than the net cash proceeds, the transaction generated a taxable gain and estimated tax expense of $14.2 million. Fully offsetting the tax is $14.2 million of a valuation allowance release pertaining to NOLs which may now be utilized. However, the disposition of CLIC is expected to result in a net reduction to CNO's taxable income in future periods which also required us to establish a valuation allowance of $19.4 million.

In connection with the closing of the transaction, CNO Services, LLC ("CNO Services"), an indirect wholly owned subsidiary of CNO, entered into a transition services agreement and a special support services agreement with Wilton Re, pursuant to which CNO Services makes available to Wilton Re and its affiliates, for a limited period of time, certain services required for the operation of CLIC's business following the closing. Under such agreements, we will receive $30 million in the year ending June 30, 2015 and $20 million in the year ending June 30, 2016. In addition, certain services will continue to be provided in the three years ending June 30, 2019 for an annual fee of $.2 million. The costs of the services provided to Wilton Re are expected to approximate the fees received under the agreements.

The Stock Purchase Agreement also provided that, at the closing, Bankers Life recapture the life insurance business written by Bankers Life that was reinsured by Wilton Re.  The recapture agreement was conditioned on the concurrent

189

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

consummation of the closing. On July 1, 2014, Bankers Life paid $28.0 million to recapture the life insurance business from Wilton Re and recognized a gain (net of income taxes) of $16.9 million in the third quarter of 2014 as a result of the recapture. Refer to the note to the consolidated financial statements entitled "Consolidated Statement of Cash Flows" for additional information.

16. BUSINESS SEGMENTS

The Company manages its business through the following operating segments: Bankers Life, Washington National and Colonial Penn, which are defined on the basis of product distribution; and corporate operations, comprised of holding company activities and certain noninsurance company businesses. In periods prior to 2014, we had an Other CNO Business segment comprised of the long-term care business that was ceded effective December 31, 2013 and the overhead expense of CLIC that was expected to continue after the completion of the sale. Beginning on January 1, 2014: (i) the overhead expense of CLIC that was expected to continue after the completion of the sale was reallocated primarily to the Bankers Life and Washington National segments; and (ii) there was no longer an Other CNO Business segment.

We measure segment performance by excluding the net loss on the sale of CLIC and gain (loss) on reinsurance transactions, the earnings of CLIC prior to being sold on July 1, 2014, net realized investment gains (losses), fair value changes in embedded derivative liabilities (net of related amortization), fair value changes in the agent deferred compensation plan, loss on extinguishment or modification of debt, income taxes and other non-operating items consisting primarily of equity in earnings of certain non-strategic investments and earnings attributable to VIEs ("pre-tax operating earnings") because we believe that this performance measure is a better indicator of the ongoing business and trends in our business.  Our primary investment focus is on investment income to support our liabilities for insurance products as opposed to the generation of net realized investment gains (losses), and a long-term focus is necessary to maintain profitability over the life of the business.

The net loss on the sale of CLIC, gain (loss) on reinsurance transactions, the earnings of CLIC prior to being sold, net realized investment gains (losses), fair value changes in embedded derivative liabilities (net of related amortization), fair value changes in the agent deferred compensation plan, loss on extinguishment or modification of debt and other non-operating items consisting primarily of equity in earnings of certain non-strategic investments and earnings attributable to VIEs depend on market conditions or represent unusual items that do not necessarily relate to the underlying business of our segments.  Net realized investment gains (losses) and fair value changes in embedded derivative liabilities (net of related amortization) may affect future earnings levels since our underlying business is long-term in nature and changes in our investment portfolio may impact our ability to earn the assumed interest rates needed to maintain the profitability of our business.

190

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

Operating information by segment was as follows (dollars in millions):

	2015		2014		2013
Revenues:
Bankers Life:
Insurance policy income:
Annuities	$	22.4	$	26.0	$	28.9
Health	1,251.0		1,287.1		1,311.2
Life	375.3		338.6		308.6
Net investment income (a)	884.7		957.3		1,005.7
Fee revenue and other income (a)	27.7		29.3		19.0
Total Bankers Life revenues	2,561.1		2,638.3		2,673.4
Washington National:
Insurance policy income:
Annuities	3.0		4.0		11.4
Health	615.4		597.6		587.1
Life	25.4		24.4		23.0
Net investment income (a)	253.6		276.1		296.9
Fee revenue and other income (a)	1.3		1.1		.9
Total Washington National revenues	898.7		903.2		919.3
Colonial Penn:
Insurance policy income:
Health	3.0		3.6		4.3
Life	260.5		242.4		227.8
Net investment income (a)	43.0		41.7		40.0
Fee revenue and other income (a)	1.0		1.0		.8
Total Colonial Penn revenues	307.5		288.7		272.9
Other CNO Business:
Insurance policy income - health	—		—		24.1
Net investment income (a)	—		—		33.3
Total Other CNO Business revenues	—		—		57.4
Corporate operations:
Net investment income	11.3		14.9		39.8
Fee and other income	8.6		6.7		6.2
Total corporate revenues	19.9		21.6		46.0
Total revenues	3,787.2		3,851.8		3,969.0

(continued on next page)

191

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

(continued from previous page)

	2015			2014			2013
Expenses:
Bankers Life:
Insurance policy benefits	$	1,588.4		$	1,667.6		$	1,788.7
Amortization	187.1			174.7			187.5
Interest expense on investment borrowings	8.8			7.9			6.7
Other operating costs and expenses	407.2			401.2			380.0
Total Bankers Life expenses	2,191.5			2,251.4			2,362.9
Washington National:
Insurance policy benefits	546.6			536.2			541.4
Amortization	55.2			64.6			64.9
Interest expense on investment borrowings	2.0			1.7			1.9
Other operating costs and expenses	183.4			189.5			170.5
Total Washington National expenses	787.2			792.0			778.7
Colonial Penn:
Insurance policy benefits	189.0			173.2			165.7
Amortization	14.4			15.3			14.5
Interest expense on investment borrowings	.1			—			—
Other operating costs and expenses	98.4			99.4			105.2
Total Colonial Penn expenses	301.9			287.9			285.4
Other CNO Business:
Insurance policy benefits	—			—			59.2
Other operating costs and expenses	—			—			25.8
Total Other CNO Business expenses	—			—			85.0
Corporate operations:
Interest expense on corporate debt	45.0			43.9			51.3
Interest expense on borrowings of variable interest entities	—			—			.1
Interest expense on investment borrowings	.2			.1			—
Other operating costs and expenses	38.6			49.1			43.1
Total corporate expenses	83.8			93.1			94.5
Total expenses	3,364.4			3,424.4			3,606.5
Pre-tax operating earnings by segment:
Bankers Life	369.6			386.9			310.5
Washington National	111.5			111.2			140.6
Colonial Penn	5.6			.8			(12.5		)
Other CNO Business	—			—			(27.6		)
Corporate operations	(63.9		)	(71.5		)	(48.5		)
Pre-tax operating earnings	$	422.8		$	427.4		$	362.5

___________________

(a) It is not practicable to provide additional components of revenue by product or services.

192

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

A reconciliation of segment revenues and expenses to consolidated revenues and expenses and net income is as follows (dollars in millions):

	2015			2014			2013
Total segment revenues	$	3,787.2		$	3,851.8		$	3,969.0
Net realized investment gains (losses)	(47.9		)	33.9			33.4
Revenues related to certain non-strategic investments and earnings attributable to VIEs	47.6			33.2			32.2
Fee revenue related to transition and support services agreements	25.0			15.0			—
Revenues of CLIC prior to being sold	—			210.8			441.5
Consolidated revenues	3,811.9			4,144.7			4,476.1
Total segment expenses	3,364.4			3,424.4			3,606.5
Insurance policy benefits - fair value changes in embedded derivative liabilities	(15.7		)	48.5			(54.4		)
Amortization related to fair value changes in embedded derivative liabilities	3.8			(12.5		)	19.0
Amortization related to net realized investment gains	(.5		)	1.0			1.6
Expenses related to certain non-strategic investments and expenses (earnings) attributable to VIEs	43.0			41.2			42.4
Other operating costs and expenses - fair value changes related to agent deferred compensation plan	(15.1		)	26.8			(15.8		)
Loss on extinguishment or modification of debt	32.8			.6			65.4
Loss on sale of subsidiary, (gain) loss on reinsurance transactions and transition expenses	9.0			239.8			98.4
Expenses related to transition and support services agreements	22.5			12.4			—
Expenses of CLIC prior to being sold	—			187.4			408.2
Consolidated expenses	3,444.2			3,969.6			4,171.3
Income before tax	367.7			175.1			304.8
Income tax expense:
Tax expense on period income	129.5			159.2			128.3
Valuation allowance for deferred tax assets and other tax items	(32.5		)	(35.5		)	(301.5		)
Net income	$	270.7		$	51.4		$	478.0

193

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

Segment balance sheet information was as follows (dollars in millions):

	2015		2014
Assets:
Bankers Life	$	19,067.8	$	19,303.0
Washington National	7,948.5		8,207.9
Colonial Penn	985.4		945.3
Corporate operations	3,123.4		2,699.7
Total assets	$	31,125.1	$	31,155.9
Liabilities:
Bankers Life	$	16,612.0	$	16,697.5
Washington National	6,665.1		6,778.8
Colonial Penn	869.3		802.2
Corporate operations	2,840.2		2,189.2
Total liabilities	$	26,986.6	$	26,467.7

The following table presents selected financial information of our segments (dollars in millions):

Segment	Present value of future profits		Deferred acquisition costs		Insurance liabilities
2015
Bankers Life	$	114.9	$	718.2	$	15,234.1
Washington National	290.2		280.0		6,126.2
Colonial Penn	43.9		85.1		782.9
Total	$	449.0	$	1,083.3	$	22,143.2
2014
Bankers Life	$	128.4	$	456.6	$	15,308.9
Washington National	314.2		240.2		6,228.8
Colonial Penn	46.8		73.8		771.0
Total	$	489.4	$	770.6	$	22,308.7

194

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

17. QUARTERLY FINANCIAL DATA (UNAUDITED)

We compute earnings per common share for each quarter independently of earnings per share for the year. The sum of the quarterly earnings per share may not equal the earnings per share for the year because of: (i) transactions affecting the weighted average number of shares outstanding in each quarter; and (ii) the uneven distribution of earnings during the year. Quarterly financial data (unaudited) were as follows (dollars in millions, except per share data):

2015	1st Qtr.			2nd Qtr.		3rd Qtr.		4th Qtr.
Revenues	$	978.3		$	959.5	$	904.5	$	969.6
Income before income taxes	$	82.3		$	72.7	$	52.4	$	160.3
Income tax expense	29.5			25.9		18.6		23.0
Net income	$	52.8		$	46.8	$	33.8	$	137.3
Earnings per common share:
Basic:
Net income	$	.26		$	.24	$	.18	$	.74
Diluted:
Net income	$	.26		$	.24	$	.18	$	.73
2014	1st Qtr.			2nd Qtr.		3rd Qtr.		4th Qtr.
Revenues	$	1,084.7		$	1,093.0	$	967.0	$	1,000.0
Income (loss) before income taxes	$	(169.6	)	$	114.4	$	154.4	$	75.9
Income tax expense (benefit)	58.4			36.3		37.0		(8.0		)
Net income (loss)	$	(228.0	)	$	78.1	$	117.4	$	83.9
Earnings per common share:
Basic:
Net income (loss)	$	(1.03	)	$	.36	$	.56	$	.41
Diluted:
Net income (loss)	$	(1.03	)	$	.35	$	.54	$	.41

18. INVESTMENTS IN VARIABLE INTEREST ENTITIES

We have concluded that we are the primary beneficiary with respect to certain VIEs, which are consolidated in our financial statements.  In consolidating the VIEs, we consistently use the financial information most recently distributed to investors in the VIE.

All of the VIEs are collateralized loan trusts that were established to issue securities to finance the purchase of corporate loans and other permitted investments (including two new VIEs which were consolidated in 2015, two new VIEs which were consolidated in 2014 and one new VIE which was consolidated in 2013).  The assets held by the trusts are legally isolated and not available to the Company.  The liabilities of the VIEs are expected to be satisfied from the cash flows generated by the underlying loans held by the trusts, not from the assets of the Company.  During 2015, a VIE that was required to be consolidated was dissolved. A gain of $11.3 million was recognized representing the difference between the borrowings of such VIE and the contractual distributions required following the liquidation of the underlying assets. The scheduled repayment of the remaining principal balance of the borrowings related to the VIEs are as follows: $450.2 million in 2022; $381.8 million in 2024; $326.9 million in 2026; $276.3 million in 2027; and $274.8 million in 2028. The Company has no financial obligation to the VIEs beyond its investment in each VIE.

Certain of our insurance subsidiaries are noteholders of the VIEs.  Another subsidiary of the Company is the investment manager for the VIEs.  As such, it has the power to direct the most significant activities of the VIEs which materially impacts the economic performance of the VIEs.

195

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

The following table provides supplemental information about the assets and liabilities of the VIEs which have been consolidated (dollars in millions):

	December 31, 2015
	VIEs		Eliminations			Net effect on consolidated balance sheet
Assets:
Investments held by variable interest entities	$	1,633.6	$	—		$	1,633.6
Notes receivable of VIEs held by insurance subsidiaries	—		(204.3		)	(204.3		)
Cash and cash equivalents held by variable interest entities	364.4		—			364.4
Accrued investment income	3.3		—			3.3
Income tax assets, net	26.0		(1.9		)	24.1
Other assets	1.4		(1.5		)	(0.1		)
Total assets	$	2,028.7	$	(207.7	)	$	1,821.0
Liabilities:
Other liabilities	$	196.6	$	(7.2	)	$	189.4
Borrowings related to variable interest entities	1,676.4		—			1,676.4
Notes payable of VIEs held by insurance subsidiaries	204.0		(204.0		)	—
Total liabilities	$	2,077.0	$	(211.2	)	$	1,865.8

	December 31, 2014
	VIEs		Eliminations			Net effect on consolidated balance sheet
Assets:
Investments held by variable interest entities	$	1,367.1	$	—		$	1,367.1
Notes receivable of VIEs held by insurance subsidiaries	—		(153.3		)	(153.3		)
Cash and cash equivalents held by variable interest entities	68.3		—			68.3
Accrued investment income	3.2		—			3.2
Income tax assets, net	18.1		(2.9		)	15.2
Other assets	—		(1.7		)	(1.7		)
Total assets	$	1,456.7	$	(157.9	)	$	1,298.8
Liabilities:
Other liabilities	$	61.2	$	(6.1	)	$	55.1
Borrowings related to variable interest entities	1,271.9		—			1,271.9
Notes payable of VIEs held by insurance subsidiaries	157.3		(157.3		)	—
Total liabilities	$	1,490.4	$	(163.4	)	$	1,327.0

196

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

The following table provides supplemental information about the revenues and expenses of the VIEs which have been consolidated in accordance with authoritative guidance, after giving effect to the elimination of our investment in the VIEs and investment management fees earned by a subsidiary of the Company (dollars in millions):

	2015			2014			2013
Revenues:
Net investment income – policyholder and reinsurer accounts and other special-purpose portfolios	$	62.1		$	47.2		$	42.3
Fee revenue and other income	1.6			1.1			1.8
Total revenues	63.7			48.3			44.1
Expenses:
Interest expense	38.8			30.1			26.0
Other operating expenses	2.0			1.2			1.4
Total expenses	40.8			31.3			27.4
Income before net realized investment losses and income taxes	22.9			17.0			16.7
Net realized investment losses	(17.7		)	(2.2		)	(1.6		)
Income before income taxes	$	5.2		$	14.8		$	15.1

The investment portfolios held by the VIEs are primarily comprised of commercial bank loans to corporate obligors which are almost entirely rated below-investment grade.  At December 31, 2015, such loans had an amortized cost of $1,679.3 million; gross unrealized gains of $.5 million; gross unrealized losses of $46.2 million; and an estimated fair value of $1,633.6 million.

The following table sets forth the amortized cost and estimated fair value of the investments held by the VIEs at December 31, 2015, by contractual maturity.  Actual maturities will differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without penalties.

	Amortized cost		Estimated fair value
	(Dollars in millions)
Due in one year or less	$	12.5	$	12.1
Due after one year through five years	719.2		695.1
Due after five years through ten years	947.6		926.4
Total	$	1,679.3	$	1,633.6

The following table sets forth the amortized cost and estimated fair value of those investments held by the VIEs with unrealized losses at December 31, 2015, by contractual maturity.  Actual maturities will differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without penalties.

	Amortized cost		Estimated fair value
	(Dollars in millions)
Due in one year or less	$	12.5	$	12.1
Due after one year through five years	654.3		630.0
Due after five years through ten years	852.4		830.9
Total	$	1,519.2	$	1,473.0

197

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

___________________

During 2015, the VIEs recognized net realized investment losses of $17.7 million, which were comprised of $1.3 million of net losses from the sales of fixed maturities, and $16.4 million of writedowns of investments for other than temporary declines in fair value recognized through net income. During 2014, the VIEs recognized net realized investment losses of $2.2 million from the sales of fixed maturities. During 2013, the VIEs recognized net realized investment losses of $1.6 million, which were comprised of $.5 million of net losses from the sales of fixed maturities, and $1.1 million of writedowns of investments for other than temporary declines in fair value recognized through net income.

At December 31, 2015, there were no investments held by the VIEs that were in default.

During 2015, $46.1 million of investments held by the VIEs were sold which resulted in gross investment losses (before income taxes) of $1.8 million. During 2014, $38.7 million of investments held by the VIEs were sold which resulted in gross investment losses (before income taxes) of $2.4 million. During 2013, $11.1 million of investments held by the VIEs were sold which resulted in gross investment losses (before income taxes) of $.9 million.

At December 31, 2015, the VIEs held:  (i) investments with a fair value of $1,178.7 million and gross unrealized losses of $23.9 million that had been in an unrealized loss position for less than twelve months; and (ii) investments with a fair value of $294.3 million and gross unrealized losses of $22.3 million that had been in an unrealized loss position for greater than twelve months.

At December 31, 2014, the VIEs held: (i) investments with a fair value of $1,053.2 million and gross unrealized losses of $27.3 million that had been in an unrealized loss position for less than twelve months; and (ii) investments with a fair value of $167.4 million and gross unrealized losses of $4.2 million that had been in an unrealized loss position for greater than twelve months.

The investments held by the VIEs are evaluated for other-than-temporary declines in fair value in a manner that is consistent with the Company's fixed maturities, available for sale.

198

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE.

None.

ITEM 9A. CONTROLS AND PROCEDURES.

Evaluation of Disclosure Controls and Procedures.  CNO's management, under the supervision and with the participation of the Chief Executive Officer and the Chief Financial Officer, evaluated the effectiveness of CNO's disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended).  Based on its evaluation, the Chief Executive Officer and Chief Financial Officer concluded that, as of December 31, 2015, CNO's disclosure controls and procedures were effective to ensure that information required to be disclosed by CNO in reports that it files or submits under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission's (the "SEC") rules and forms.  Disclosure controls and procedures are also designed to reasonably assure that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

Limitations on the Effectiveness of Controls. Our management, including our Chief Executive Officer and Chief Financial Officer, does not expect that our disclosure controls over financial reporting will prevent all error and fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system's objectives will be met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of error or mistake. Controls can also be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls. The design of any system of controls is based in part on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

Conclusion Regarding the Effectiveness of Disclosure Controls and Procedures. Based on our controls evaluation, our Chief Executive Officer and Chief Financial Officer concluded that as of the end of the period covered by this annual report, our disclosure controls and procedures were effective to provide reasonable assurance that: (i) the information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms; and (ii) material information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

Management's Report on Internal Control Over Financial Reporting. Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934. Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on our evaluation under the framework in Internal Control - Integrated Framework (2013), our management concluded that our internal control over financial reporting was effective as of December 31, 2015.

The effectiveness of our internal control over financial reporting as of December 31, 2015 has been audited by PricewaterhouseCoopers LLP, an independent registered public accounting firm, as stated in their report which is included herein.

Changes to Internal Control Over Financial Reporting.  There were no changes in the Company’s internal control over financial reporting (as defined in Rule 13a-15(f) under the Securities Exchange Act of 1934) during the quarter ended December 31, 2015, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

ITEM 9B. OTHER INFORMATION.

None.

199

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

PART III

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE.

We will provide information that is responsive to this Item 10 in our definitive proxy statement or in an amendment to this Annual Report not later than 120 days after the end of the fiscal year covered by this Annual Report. That information is incorporated by reference into this Item 10. Additional information called for by this item is contained in Part I of this Annual Report under the caption "Executive Officers of the Registrant."

ITEM 11. EXECUTIVE COMPENSATION.

We will provide information that is responsive to this Item 11 in our definitive proxy statement or in an amendment to this Annual Report not later than 120 days after the end of the fiscal year covered by this Annual Report. That information is incorporated by reference into this Item 11.

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS.

We will provide information that is responsive to this Item 12 in our definitive proxy statement or in an amendment to this Annual Report not later than 120 days after the end of the fiscal year covered by this Annual Report. That information is incorporated by reference into this Item 12.

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE.

We will provide information that is responsive to this Item 13 in our definitive proxy statement or in an amendment to this Annual Report not later than 120 days after the end of the fiscal year covered by this Annual Report. That information is incorporated by reference into this Item 13.

ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES.

We will provide information that is responsive to this Item 14 in our definitive proxy statement or in an amendment to this Annual Report not later than 120 days after the end of the fiscal year covered by this Annual Report. That information is incorporated by reference into this Item 14.

200

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

___________________

PART IV

ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES.

(a)	1.	Financial Statements. See Index to Consolidated Financial Statements on page 116 for a list of financial statements included in this Report.
	2.	Financial Statement Schedules:
		Schedule II ‑‑ Condensed Financial Information of Registrant (Parent Company)
		Schedule IV ‑‑ Reinsurance

All other schedules are omitted, either because they are not applicable, not required, or because the information they contain is included elsewhere in the consolidated financial statements or notes.

3. Exhibits. See Exhibit Index immediately preceding the Exhibits filed with this report.

201

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

CNO FINANCIAL GROUP, INC.

Dated:  February 19, 2016

By:	/s/ Edward J. Bonach
	Edward J. Bonach
	Chief Executive Officer

202

Pursuant to the requirements of the Securities Exchange Act of 1934, this Report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated:

Signature	Title (Capacity)	Date
/s/ EDWARD J. BONACH	Director and Chief Executive Officer	February 19, 2016
Edward J. Bonach	(Principal Executive Officer and
	Principal Financial Officer)
/s/ JOHN R. KLINE	Senior Vice President	February 19, 2016
John R. Kline	and Chief Accounting Officer
	(Principal Accounting Officer)
/s/ ELLYN L. BROWN	Director	February 19, 2016
Ellyn L. Brown
/s/ ROBERT C. GREVING	Director	February 19, 2016
Robert C. Greving
/s/ MARY R. HENDERSON	Director	February 19, 2016
Mary R. Henderson
/s/ CHARLES J. JACKLIN	Director	February 19, 2016
Charles J. Jacklin
/s/ DANIEL R. MAURER	Director	February 19, 2016
Daniel R. Maurer
/s/ NEAL C. SCHNEIDER	Director	February 19, 2016
Neal C. Schneider
/s/ FREDERICK J. SIEVERT	Director	February 19, 2016
Frederick J. Sievert
/s/ MICHAEL T. TOKARZ	Director	February 19, 2016
Michael T. Tokarz

203

Report of Independent Registered Public Accounting Firm on

Financial Statement Schedules

To the Shareholders and Board of Directors of CNO Financial Group, Inc.:

Our audits of the consolidated financial statements and of the effectiveness of internal control over financial reporting of CNO Financial Group, Inc. and subsidiaries referred to in our report dated February 19, 2016 appearing under Item 8 of this Form 10-K also included an audit of the financial statement schedules at December 31, 2015 and 2014 and for the years ended December 31, 2015, 2014 and 2013 listed in Item 15(a)(2) of this Form 10-K. In our opinion, these financial statement schedules present fairly, in all material respects, the information set forth therein when read in conjunction with the related consolidated financial statements.

/s/PricewaterhouseCoopers LLP

Indianapolis, Indiana

February 19, 2016

204

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

SCHEDULE II

Condensed Financial Information of Registrant (Parent Company)

Balance Sheet

as of December 31, 2015 and 2014

(Dollars in millions)

ASSETS
	2015		2014
Fixed maturities, available for sale, at fair value (amortized cost: 2015 - $5.0; 2014 - $35.0)	$	5.0	$	34.9
Cash and cash equivalents - unrestricted	128.9		86.6
Equity securities at fair value (cost: 2015 - $247.3; 2014 - $202.7)	254.9		216.9
Trading securities	1.0		2.1
Investment in wholly-owned subsidiaries (eliminated in consolidation)	4,809.2		5,263.3
Income tax assets, net	58.5		47.9
Other invested assets - affiliated (eliminated in consolidation)	—		27.0
Receivable from subsidiaries (eliminated in consolidation)	3.8		10.8
Other assets	3.1		3.1
Total assets	$	5,264.4	$	5,692.6
LIABILITIES AND SHAREHOLDERS' EQUITY
Liabilities:
Notes payable	$	911.1	$	780.3
Payable to subsidiaries (eliminated in consolidation)	135.9		114.3
Other liabilities	78.9		109.8
Total liabilities	1,125.9		1,004.4
Commitments and Contingencies
Shareholders' equity:
Common stock and additional paid-in capital ($0.01 par value, 8,000,000,000 shares authorized, shares issued and outstanding: 2015 - 184,028,511; 2014 – 203,324,458)	3,388.6		3,734.4
Accumulated other comprehensive income	402.8		825.3
Retained earnings	347.1		128.5
Total shareholders' equity	4,138.5		4,688.2
Total liabilities and shareholders' equity	$	5,264.4	$	5,692.6

The accompanying notes are an integral part

of the condensed financial statements.

205

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

SCHEDULE II

Condensed Financial Information of Registrant (Parent Company)

Statement of Operations

for the years ended December 31, 2015, 2014 and 2013

(Dollars in millions)

	2015			2014			2013
Revenues:
Net investment income	$	16.9		$	12.7		$	21.1
Net realized investment gains	3.5			11.1			.4
Intercompany revenues (losses) (eliminated in consolidation)	(1.5		)	(1.0		)	1.6
Total revenues	18.9			22.8			23.1
Expenses:
Interest expense	45.2			44.0			51.4
Intercompany expenses (eliminated in consolidation)	.4			.3			.3
Operating costs and expenses	21.0			66.6			26.1
Loss on extinguishment of debt	32.8			.6			65.4
Total expenses	99.4			111.5			143.2
Loss before income taxes and equity in undistributed earnings of subsidiaries	(80.5		)	(88.7		)	(120.1		)
Income tax benefit on period income	(37.9		)	(34.1		)	(8.8		)
Loss before equity in undistributed earnings of subsidiaries	(42.6		)	(54.6		)	(111.3		)
Equity in undistributed earnings of subsidiaries (eliminated in consolidation)	313.3			106.0			589.3
Net income	$	270.7		$	51.4		$	478.0

The accompanying notes are an integral part

of the condensed financial statements.

206

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

SCHEDULE II

Condensed Financial Information of Registrant (Parent Company)

Statement of Cash Flows

for the years ended December 31, 2015, 2014 and 2013

(Dollars in millions)

	2015			2014			2013
Cash flows from operating activities	$	(55.1	)	$	(66.7	)	$	(65.9	)
Cash flows from investing activities:
Sales of investments	66.5			229.8			95.8
Sales of investments - affiliated*	16.0			18.3			—
Maturities and redemptions of investments - affiliated*	8.3			—			—
Purchases of investments	(68.6		)	(320.1		)	(119.3		)
Purchases of investments - affiliated*	(3.4		)	(30.7		)	(10.0		)
Net sales of trading securities	11.8			9.9			12.6
Dividends received from consolidated subsidiary, net of capital contributions of nil in 2015, $18.8 in 2014 and nil in 2013*	269.7			423.5			242.8
Net cash provided by investing activities	300.3			330.7			221.9
Cash flows from financing activities:
Issuance of notes payable, net	910.0			—			—
Payments on notes payable	(797.1		)	(62.9		)	(126.9		)
Expenses related to extinguishment or modification of debt	(17.8		)	(.6		)	(61.6		)
Issuance of common stock	6.3			5.0			15.1
Payments to repurchase common stock and warrants	(361.5		)	(376.5		)	(118.4		)
Common stock dividends paid	(52.0		)	(51.0		)	(24.4		)
Amount paid to extinguish the beneficial conversion feature associated with repurchase of convertible debentures	—			—			(12.6		)
Investment borrowings - repurchase agreements, net	(20.4		)	20.4			—
Issuance of notes payable to affiliates*	234.4			257.8			222.1
Payments on notes payable to affiliates*	(104.8		)	(100.7		)	(83.9		)
Net cash used by financing activities	(202.9		)	(308.5		)	(190.6		)
Net increase (decrease) in cash and cash equivalents	42.3			(44.5		)	(34.6		)
Cash and cash equivalents, beginning of the year	86.6			131.1			165.7
Cash and cash equivalents, end of the year	$	128.9		$	86.6		$	131.1

* Eliminated in consolidation

The accompanying notes are an integral part

of the condensed financial statements.

207

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

SCHEDULE II

Notes to Condensed Financial Information

1. Basis of Presentation

The condensed financial information should be read in conjunction with the consolidated financial statements of CNO Financial Group, Inc. The condensed financial information includes the accounts and activity of the parent company.

208

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

SCHEDULE IV

Reinsurance

for the years ended December 31, 2015, 2014 and 2013

(Dollars in millions)

	2015			2014			2013
Life insurance inforce:
Direct	$	25,807.0		$	25,029.0		$	53,304.9
Assumed	137.4			147.1			305.7
Ceded	(3,780.8		)	(3,660.1		)	(11,477.6		)
Net insurance inforce	$	22,163.6		$	21,516.0		$	42,133.0
Percentage of assumed to net	.6		%	.7		%	.7		%

	2015			2014			2013
Insurance policy income:
Direct	$	2,524.3		$	2,558.2		$	2,623.5
Assumed	38.5			35.0			37.4
Ceded	(133.6		)	(176.7		)	(212.1		)
Net premiums	$	2,429.2		$	2,416.5		$	2,448.8
Percentage of assumed to net	1.6		%	1.4		%	1.5		%

209

EXHIBIT INDEX

Exhibit

No.Description

2.1 Stock Purchase Agreement dated March 2, 2014 by and between CNO Financial Group, Inc. and Wilton Reassurance Company, incorporated by reference to Exhibit 2.1 of our Current Report on Form 8-K filed March 4, 2014.

3.1 Amended and Restated Certificate of Incorporation of CNO Financial Group, Inc., incorporated by reference to Exhibit 3.1 of our Current Report on Form 8-K filed May 8, 2013.

3.2 Amended and Restated Bylaws of CNO Financial Group, Inc. dated as of February 28, 2013, incorporated by reference to Exhibit 3.2 of our Current Report on Form 8-K filed February 28, 2013.

3.3 Certificate of Designations of Series C Junior Participating Preferred Stock of CNO Financial Group, Inc., incorporated by reference to Exhibit 3.1 of our Current Report on Form 8-K filed November 13, 2014.

4.1 Second Amended and Restated Section 382 Rights Agreement, dated as of November 13, 2014, between the Corporation and American Stock Transfer & Trust Company, LLC, as Rights Agent, which includes the Certificate of Designations for the Series C Junior Participating Preferred Stock as Exhibit A, the Form of Right Certificate as Exhibit B and the Summary of Rights to Purchase Preferred Shares as Exhibit C, incorporated by reference to Exhibit 4.1 of our Current Report on Form 8-K filed November 13, 2014, as amended by the First Amendment to Rights Agreement, dated as of April 22, 2015, between the Corporation and the Rights Agent, incorporated by reference to Exhibit 4.1 of our Quarterly Report on Form 10-Q for the quarter ended March 31, 2015.

4.2 Form of specimen stock certificate, incorporated by reference to Exhibit 4.1 of our Current Report on Form 8-K filed May 12, 2010.

4.3 Indenture, dated as of May 19, 2015, between CNO Financial Group, Inc. and Wilmington Trust, National Association, as trustee (the “Trustee”), incorporated by reference to Exhibit 4.1 of our Current Report on Form 8-K filed May 19, 2015.

4.4 First Supplemental Indenture, dated as of May 19, 2015, between the Corporation and the Trustee, relating to the 4.500% Senior Notes due 2020 and the 5.250% Senior Notes due 2025, incorporated by reference to Exhibit 4.2 of our Current Report on Form 8-K filed May 19, 2015.

4.5 Form of 4.500% Senior Notes due 2020 (included in Exhibit 4.4).

4.6 Form of 5.250% Senior Notes due 2025 (included in Exhibit 4.4).

10.1 Underwriting Agreement dated as of May 14, 2015, between CNO Financial Group, Inc. and Goldman, Sachs & Co. and RBC Capital Markets LLC, as representatives of the several underwriters named therein, incorporated by reference to Exhibit 1.1 of our Current Report on Form 8-K filed May 19, 2015.

10.2 Credit Agreement, dated as of May 19, 2015, by and among CNO Financial Group, Inc., the lenders from time to time party thereto, and KeyBank National Association, as administrative agent for the lenders, incorporated by reference to Exhibit 10.1 of our Current Report on Form 8-K dated May 19, 2015.

10.3 Letter of agreement dated as of August 3, 2007 between CNO Services, LLC (formerly Conseco Services, LLC) and John R. Kline, incorporated by reference to Exhibit 10.11 of our Quarterly Report on Form 10-Q for the quarter ended September 30, 2007.

10.4 CNO Financial Group, Inc. Amended and Restated Long-Term Incentive Plan, incorporated by reference to Exhibit 10.13 of our Quarterly Report on Form 10-Q for the quarter ended September 30, 2011.

10.5 Form of stock option agreement under Amended and Restated Long-Term Incentive Plan, incorporated by reference to Exhibit 10.1 of our Quarterly Report on Form 10-Q for the quarter ended March 31, 2014.

210

10.6 Form of restricted stock agreement under Amended and Restated Long-Term Incentive Plan, incorporated by reference to Exhibit 10.2 of our Quarterly Report on Form 10-Q for the quarter ended March 31, 2014.

10.7 Form of performance unit award agreement (TSR) under the Amended and Restated Long-Term Incentive Plan, incorporated by reference to Exhibit 10.3 of our Quarterly Report on Form 10-Q for the quarter ended March 31, 2014.

10.8 Form of performance unit award agreement (ROE) under the Amended and Restated Long-Term Incentive Plan, incorporated by reference to Exhibit 10.4 of our Quarterly Report on Form 10-Q for the quarter ended March 31, 2014.

10.9 Form of stock option agreement for 2015 under Amended and Restated Long-Term Incentive Plan, incorporated by reference to Exhibit 10.1 of our Quarterly Report on Form 10-Q for the quarter ended March 31, 2015.

10.10 Form of restricted stock agreement for 2015 under Amended and Restated Long-Term Incentive Plan, incorporated by reference to Exhibit 10.2 of our Quarterly Report on Form 10-Q for the quarter ended March 31, 2015.

10.11 Form of performance unit award agreement (TSR) for 2015 under the Amended and Restated Long-Term Incentive Plan, incorporated by reference to Exhibit 10.3 of our Quarterly Report on Form 10-Q for the quarter ended March 31, 2015.

10.12 Form of performance unit award agreement (ROE) for 2015 under the Amended and Restated Long-Term Incentive Plan, incorporated by reference to Exhibit 10.4 of our Quarterly Report on Form 10-Q for the quarter ended March 31, 2015.

10.13 Form of amendment to outstanding stock option agreements under the Amended and Restated Long-Term Incentive Plan, incorporated by reference to Exhibit 10.5 of our Quarterly Report on Form 10-Q for the quarter ended March 31, 2015.

10.14 Form of amendment to outstanding restricted stock agreements under the Amended and Restated Long-Term Incentive Plan, incorporated by reference to Exhibit 10.6 of our Quarterly Report on Form 10-Q for the quarter ended March 31, 2015.

10.15 Form of amendment to outstanding performance unit award agreements under the Amended and Restated Long-Term Incentive Plan, incorporated by reference to Exhibit 10.7 of our Quarterly Report on Form 10-Q for the quarter ended March 31, 2015.

10.16 Form of Indemnification Agreement among the Corporation, CDOC, Inc., CNO Services, LLC (formerly Conseco Services, LLC) and each director of the Corporation, incorporated by reference to Exhibit 10.16 of our Annual Report on Form 10-K for the year ended December 31, 2008.

10.17 Closing Agreement on Final Determination Covering Specific Matters, incorporated by reference to Exhibit 10.14 of our Current Report on Form 8-K filed September 14, 2004.

10.18 2015 Pay for Performance Incentive Plan, incorporated by reference to Exhibit 10.1 of our Current Report on Form 8-K filed March 12, 2015.

10.19 Closing Agreement on Final Determination Covering Specific Matters, incorporated by reference to Exhibit 10.21 of our Current Report on Form 8-K filed August 1, 2006.

10.20 Deferred Compensation Plan effective January 1, 2007, incorporated by reference to Exhibit 10.24 of our Quarterly Report on Form 10-Q for the quarter ended September 30, 2006, as amended by First Amendment of the Deferred Compensation Plan, effective January 1, 2007, incorporated by reference to Exhibit 10.24 of our Annual Report on Form 10-K for the year ended December 31, 2007.

10.21 Amended and Restated Employment Agreement dated as of December 18, 2014 between CNO Services, LLC and Susan L. Menzel, incorporated by reference to Exhibit 10.16 of our Annual Report on Form 10-K for the year ended December 31, 2014.

211

10.22 Amended and Restated Employment Agreement dated as of December 18, 2014 between CNO Services, LLC and Christopher J. Nickele, incorporated by reference to Exhibit 10.17 of our Annual Report on Form 10-K for the year ended December 31, 2014.

10.23 Amended and Restated Employment Agreement dated as of January 5, 2015 between CNO Financial Group, Inc. and Scott R. Perry, incorporated by reference to Exhibit 10.18 of our Annual Report on Form 10-K for the year ended December 31, 2014.

10.24 Amended and Restated Employment Agreement dated as of December 18, 2014 between CNO Financial Group, Inc. and Edward J. Bonach, incorporated by reference to Exhibit 10.20 of our Annual Report on Form 10-K for the year ended December 31, 2014.

10.25 Amended and Restated Employment Agreement dated as of December 17, 2014 between 40|86 Advisors, Inc. and Eric R. Johnson, incorporated by reference to Exhibit 10.21 of our Annual Report on Form 10-K for the year ended December 31, 2014.

10.26 Amended and Restated Employment Agreement dated as of January 12, 2015 between CNO Services, LLC and Matthew J. Zimpfer, incorporated by reference to Exhibit 10.22 of our Annual Report on Form 10-K for the year ended December 31, 2014.

10.27 Amended and Restated Employment Agreement dated as of January 6, 2015 between CNO Services, LLC and Bruce Baude, incorporated by reference to Exhibit 10.23 of our Annual Report on Form 10-K for the year ended December 31, 2014, as amended by Amendment dated July 30, 2015, incorporated by reference to Exhibit 10.1 of our Quarterly Report on Form 10-Q for the quarter ended June 30, 2015.

10.28 Coinsurance and Administration Agreement between Conseco Insurance Company and Reassure American Life Insurance Company, incorporated by reference to Exhibit 10.34 of our Quarterly Report on Form 10-Q for the quarter ended June 30, 2007.

12.1 Computation of Ratio of Earnings to Fixed Charges and Preferred Dividends.

21 Subsidiaries of the Registrant.

23.1 Consent of PricewaterhouseCoopers LLP.

31.1 Certification Pursuant to the Securities Exchange Act Rule 13a-14(a)/15d-14(a), as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1 Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS XBRL Instance Document.

101.SCH XBRL Taxonomy Extension Schema Document.

101.CAL XBRL Taxonomy Extension Calculation Linkbase Document.

101.DEF XBRL Taxonomy Extension Definition Linkbase Document.

101.LAB XBRL Taxonomy Extension Label Linkbase Document.

101.PRE XBRL Taxonomy Extension Presentation Linkbase Document.

212

COMPENSATION PLANS AND ARRANGEMENTS

10.3 Letter of agreement dated as of August 3, 2007 between CNO Services, LLC (formerly Conseco Services, LLC) and John R. Kline, incorporated by reference to Exhibit 10.11 of our Quarterly Report on Form 10-Q for the quarter ended September 30, 2007.

10.4 CNO Financial Group, Inc. Amended and Restated Long-Term Incentive Plan, incorporated by reference to Exhibit 10.13 of our Quarterly Report on Form 10-Q for the quarter ended September 30, 2011.

10.5 Form of stock option agreement under Amended and Restated Long-Term Incentive Plan, incorporated by reference to Exhibit 10.1 of our Quarterly Report on Form 10-Q for the quarter ended March 31, 2014.

10.6 Form of restricted stock agreement under Amended and Restated Long-Term Incentive Plan, incorporated by reference to Exhibit 10.2 of our Quarterly Report on Form 10-Q for the quarter ended March 31, 2014.

10.7 Form of performance unit award agreement (TSR) under the Amended and Restated Long-Term Incentive Plan, incorporated by reference to Exhibit 10.3 of our Quarterly Report on Form 10-Q for the quarter ended March 31, 2014.

10.8 Form of performance unit award agreement (ROE) under the Amended and Restated Long-Term Incentive Plan, incorporated by reference to Exhibit 10.4 of our Quarterly Report on Form 10-Q for the quarter ended March 31, 2014.

10.9 Form of stock option agreement for 2015 under Amended and Restated Long-Term Incentive Plan, incorporated by reference to Exhibit 10.1 of our Quarterly Report on Form 10-Q for the quarter ended March 31, 2015.

10.10 Form of restricted stock agreement for 2015 under Amended and Restated Long-Term Incentive Plan, incorporated by reference to Exhibit 10.2 of our Quarterly Report on Form 10-Q for the quarter ended March 31, 2015.

10.11 Form of performance unit award agreement (TSR) for 2015 under the Amended and Restated Long-Term Incentive Plan, incorporated by reference to Exhibit 10.3 of our Quarterly Report on Form 10-Q for the quarter ended March 31, 2015.

10.12 Form of performance unit award agreement (ROE) for 2015 under the Amended and Restated Long-Term Incentive Plan, incorporated by reference to Exhibit 10.4 of our Quarterly Report on Form 10-Q for the quarter ended March 31, 2015.

10.13 Form of amendment to outstanding stock option agreements under the Amended and Restated Long-Term Incentive Plan, incorporated by reference to Exhibit 10.5 of our Quarterly Report on Form 10-Q for the quarter ended March 31, 2015.

10.14 Form of amendment to outstanding restricted stock agreements under the Amended and Restated Long-Term Incentive Plan, incorporated by reference to Exhibit 10.6 of our Quarterly Report on Form 10-Q for the quarter ended March 31, 2015.

10.15 Form of amendment to outstanding performance unit award agreements under the Amended and Restated Long-Term Incentive Plan, incorporated by reference to Exhibit 10.7 of our Quarterly Report on Form 10-Q for the quarter ended March 31, 2015.

10.18 2015 Pay for Performance Incentive Plan, incorporated by reference to Exhibit 10.1 of our Current Report on Form 8-K filed March 12, 2015.

10.20 Deferred Compensation Plan effective January 1, 2007, incorporated by reference to Exhibit 10.24 of our Quarterly Report on Form 10-Q for the quarter ended September 30, 2006, as amended by First Amendment of the Deferred Compensation Plan, effective January 1, 2007, incorporated by reference to Exhibit 10.24 of our Annual Report on Form 10-K for the year ended December 31, 2007.

213

10.21 Amended and Restated Employment Agreement dated as of December 18, 2014 between CNO Services, LLC and Susan L. Menzel, incorporated by reference to Exhibit 10.16 of our Annual Report on Form 10-K for the year ended December 31, 2014.

10.22 Amended and Restated Employment Agreement dated as of December 18, 2014 between CNO Services, LLC and Christopher J. Nickele, incorporated by reference to Exhibit 10.17 of our Annual Report on Form 10-K for the year ended December 31, 2014.

10.23 Amended and Restated Employment Agreement dated as of January 5, 2015 between CNO Financial Group, Inc. and Scott R. Perry, incorporated by reference to Exhibit 10.18 of our Annual Report on Form 10-K for the year ended December 31, 2014.

10.24 Amended and Restated Employment Agreement dated as of December 18, 2014 between CNO Financial Group, Inc. and Edward J. Bonach, incorporated by reference to Exhibit 10.20 of our Annual Report on Form 10-K for the year ended December 31, 2014.

10.25 Amended and Restated Employment Agreement dated as of December 17, 2014 between 40|86 Advisors, Inc. and Eric R. Johnson, incorporated by reference to Exhibit 10.21 of our Annual Report on Form 10-K for the year ended December 31, 2014.

10.26 Amended and Restated Employment Agreement dated as of January 12, 2015 between CNO Services, LLC and Matthew J. Zimpfer, incorporated by reference to Exhibit 10.22 of our Annual Report on Form 10-K for the year ended December 31, 2014.

10.27 Amended and Restated Employment Agreement dated as of January 6, 2015 between CNO Services, LLC and Bruce Baude, incorporated by reference to Exhibit 10.23 of our Annual Report on Form 10-K for the year ended December 31, 2014, as amended by Amendment dated July 30, 2015, incorporated by reference to Exhibit 10.1 of our Quarterly Report on Form 10-Q for the quarter ended June 30, 2015.

214

EX-12.1

Exhibit 12.1

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

Computation of Ratio of Earnings to Fixed Charges

(Dollars in millions)

	2015		2014		2013			2012			2011
Pretax income from operations:
Net income	$	270.7	$	51.4	$	478.0		$	221.0		$	335.7
Add income tax expense (benefit)	97.0		123.7		(173.2		)	(65.3		)	(29.5		)
Pretax income from operations	367.7		175.1		304.8			155.7			306.2
Add fixed charges:
Interest expense on corporate debt	45.0		43.9		51.3			66.2			76.3
Interest expense on investment borrowings and borrowings related to variable interest entities	49.9		48.9		54.0			48.4			37.8
Interest added to policyholder account balances	122.7		173.0		232.5			260.5			282.5
Portion of rental (a)	14.1		15.1		13.3			14.6			13.1
Fixed charges	231.7		280.9		351.1			389.7			409.7
Adjusted earnings	$	599.4	$	456.0	$	655.9		$	545.4		$	715.9
Ratio of earnings to fixed charges	2.59X		1.62X		1.87X			1.40X			1.75X

____________________

(a) Interest portion of rental is estimated to be 33 percent.

EX-21

Exhibit 21

Subsidiaries of CNO Financial Group, Inc.

Name	State or Other Jurisdiction
40|86 Advisors, Inc.	Delaware
40|86 Mortgage Capital, Inc.	Delaware
American Life and Casualty Marketing Division Co.	Iowa
Association Management Corporation	Illinois
Bankers Conseco Life Insurance Company	New York
Bankers Life Advisory Services, Inc.	Indiana
Bankers Life and Casualty Company	Illinois
Bankers Life Securities General Agency, Inc.	Indiana
Bankers Life Securities, Inc.	Indiana
C.P. Real Estate Services Corp.	New Jersey
CDOC, Inc.	Delaware
CNO Management Services Company	Texas
CNO Services, LLC	Indiana
Colonial Penn Life Insurance Company	Pennsylvania
Conseco Life Insurance Company of Texas	Texas
Conseco Marketing, L.L.C.	Indiana
CreekSource LLC	Delaware
Design Benefit Plans, Inc.	Illinois
Hawthorne Advertising Agency Incorporated	Pennsylvania
K.F. Agency, Inc.	Illinois
K.F. Insurance Agency of Massachusetts, Inc.	Massachusetts
Performance Matters Associates of Texas, Inc.	Texas
Washington National Insurance Company	Indiana

EX-23.1

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (No. 333-108835 and 333-166788) and Form S-3 (No. 333-204039) of our report dated February 19, 2016 relating to the consolidated financial statements and the effectiveness of internal control over financial reporting, which appears in this Annual Report on Form 10-K. We also consent to the incorporation by reference of our report dated February 19, 2016 relating to the financial statement schedules, which appears in this Form 10-K.

/s/ PricewaterhouseCoopers LLP

PricewaterhouseCoopers LLP     

Indianapolis, Indiana

February 19, 2016

EX-31.1

Exhibit 31.1

CERTIFICATION

I, Edward J. Bonach, certify that:

1. I have reviewed this annual report on Form 10-K of CNO Financial Group, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date:  February 19, 2016

/s/ Edward J. Bonach

Edward J. Bonach

Chief Executive Officer and Chief Financial Officer

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of CNO Financial Group, Inc. (the "Company") on Form 10-K for the year ending December 31, 2015 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Edward J. Bonach, Chief Executive Officer and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my actual knowledge:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Edward J. Bonach

Edward J. Bonach

Chief Executive Officer and Chief Financial Officer

February 19, 2016

A signed original of this written statement required by Section 906 has been provided to CNO Financial Group, Inc. and will be retained by CNO Financial Group, Inc. and furnished to the Securities and Exchange Commission upon request.

XML

DOCUMENT AND ENTITY INFORMATION - USD ($) $ in Billions	12 Months Ended
	Dec. 31, 2015	Feb. 09, 2016	Jun. 30, 2015
Document and Entity Information [Abstract]
Entity Registrant Name	CNO Financial Group, Inc.
Entity Central Index Key	0001224608
Document Type	10-K
Document Period End Date	Dec. 31, 2015
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	FY
Entity Filer Category	Large Accelerated Filer
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	Yes
Entity Current Reporting Status	Yes
Amendment Flag	false
Entity Public Float			$ 3.5
Entity Common Stock, Shares Outstanding		179,593,602

XML

CONSOLIDATED BALANCE SHEET - USD ($) $ in Millions	Dec. 31, 2015	Dec. 31, 2014
Investments:
Fixed maturities, available for sale, at fair value (amortized cost: 2015 - $18,947.0; 2014 - $18,408.1)	$ 19,882.9	$ 20,634.9
Equity securities at fair value (cost: 2015 - $447.4; 2014 - $400.5)	463.0	419.0
Mortgage loans	1,721.0	1,691.9
Policy loans	109.4	106.9
Trading securities	262.1	244.9
Investments held by variable interest entities	1,633.6	1,367.1
Other invested assets	415.1	443.6
Total investments	24,487.1	24,908.3
Cash and cash equivalents - unrestricted	432.3	611.6
Cash and cash equivalents held by variable interest entities	364.4	68.3
Accrued investment income	237.0	242.9
Present value of future profits	449.0	489.4
Deferred acquisition costs	1,083.3	770.6
Reinsurance receivables	2,859.3	2,991.1
Income tax assets, net	898.8	758.7
Assets held in separate accounts	4.7	5.6
Other assets	309.2	309.4
Total assets	31,125.1	31,155.9
Liabilities for insurance products:
Policyholder account balances	10,762.3	10,707.2
Future policy benefits	10,602.1	10,835.4
Liability for policy and contract claims	487.8	468.7
Unearned and advanced premiums	286.3	291.8
Liabilities related to separate accounts	4.7	5.6
Other liabilities	707.8	587.6
Investment borrowings	1,548.1	1,519.2
Borrowings related to variable interest entities	1,676.4	1,271.9
Notes payable – direct corporate obligations	911.1	780.3
Total liabilities	$ 26,986.6	$ 26,467.7
Commitments and Contingencies
Shareholders' equity:
Common stock ($0.01 par value, 8,000,000,000 shares authorized, shares issued and outstanding: 2015 - 184,028,511; 2014 - 203,324,458)	$ 1.8	$ 2.0
Additional paid-in capital	3,386.8	3,732.4
Accumulated other comprehensive income	402.8	825.3
Retained earnings	347.1	128.5
Total shareholders' equity	4,138.5	4,688.2
Total liabilities and shareholders' equity	$ 31,125.1	$ 31,155.9

XML

CONSOLIDATED BALANCE SHEET (Parentheticals) - USD ($) $ in Millions	Dec. 31, 2015	Dec. 31, 2014
Investments:
Fixed maturities, available for sale, amortized cost	$ 18,947.0	$ 18,408.1
Equity securities cost	$ 447.4	$ 400.5
Shareholders' equity:
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	8,000,000,000	8,000,000,000
Common stock, shares issued (in shares)	184,028,511	203,324,458
Common stock, shares outstanding (in shares)	184,028,511	203,324,458

XML

CONSOLIDATED STATEMENT OF OPERATIONS - USD ($) shares in Thousands, $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Revenues:
Insurance policy income	$ 2,556.0	$ 2,629.7	$ 2,744.7
Net investment income (loss):
General account assets	1,203.6	1,301.0	1,405.8
Policyholder and reinsurer accounts and other special-purpose portfolios	30.0	126.4	258.2
Realized investment gains (losses):
Net realized investment gains (losses), excluding impairment losses	(8.0)	64.0	45.0
Other-than-temporary impairments:
Total other-than-temporary impairment losses	(42.9)	(27.3)	(11.6)
Portion of other-than-temporary impairment losses recognized in accumulated other comprehensive income	3.0	0.0	0.0
Net impairment losses recognized	(39.9)	(27.3)	(11.6)
Gain on dissolution of a variable interest entity	11.3	0.0	0.0
Total realized gains (losses)	(36.6)	36.7	33.4
Fee revenue and other income	58.9	50.9	34.0
Total revenues	3,811.9	4,144.7	4,476.1
Benefits and expenses:
Insurance policy benefits	2,308.3	2,586.2	2,839.7
Loss on sale of subsidiary, (gain) loss on reinsurance transactions and transition expenses	9.0	239.8	98.4
Interest expense	94.9	92.8	105.3
Amortization	260.0	247.4	296.3
Loss on extinguishment or modification of debt	32.8	0.6	65.4
Other operating costs and expenses	739.2	802.8	766.2
Total benefits and expenses	3,444.2	3,969.6	4,171.3
Income before income taxes	367.7	175.1	304.8
Income tax expense (benefit):
Tax expense on period income	129.5	159.2	128.3
Valuation allowance for deferred tax assets and other tax items	(32.5)	(35.5)	(301.5)
Net income	$ 270.7	$ 51.4	$ 478.0
Basic:
Weighted average shares outstanding (in shares)	193,054	212,917	221,628
Net income (in dollars per share)	$ 1.40	$ 0.24	$ 2.16
Diluted:
Weighted average shares outstanding (in shares)	195,166	217,655	232,702
Net income (in dollars per share)	$ 1.39	$ 0.24	$ 2.06

XML

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Statement of Comprehensive Income [Abstract]
Net income	$ 270.7	$ 51.4	$ 478.0
Other comprehensive income, before tax:
Unrealized gains (losses) for the period	(1,337.6)	942.9	(1,627.4)
Amortization of present value of future profits and deferred acquisition costs	157.9	(113.5)	175.2
Amount related to premium deficiencies assuming the net unrealized gains (losses) had been realized	495.3	(624.6)	774.2
Reclassification adjustments:
For net realized investment (gains) losses included in net income	29.6	(59.0)	(39.8)
For amortization of the present value of future profits and deferred acquisition costs related to net realized investment gains (losses) included in net income	(0.5)	1.0	1.6
Unrealized gains (losses) on investments	(655.3)	146.8	(716.2)
Change related to deferred compensation plan	(0.1)	(1.4)	0.8
Other comprehensive income (loss) before tax	(655.4)	145.4	(715.4)
Income tax (expense) benefit related to items of accumulated other comprehensive income	232.9	(51.9)	249.8
Other comprehensive income (loss), net of tax	(422.5)	93.5	(465.6)
Comprehensive income	$ (151.8)	$ 144.9	$ 12.4

XML

CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY - USD ($) $ in Millions	Total	Common stock and additional paid-in capital [Member]	Accumulated other comprehensive income [Member]	Retained earnings (accumulated deficit) [Member]
Balance, beginning of period at Dec. 31, 2012	$ 5,049.3	$ 4,176.9	$ 1,197.4	$ (325.0)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	478.0			478.0
Change in unrealized appreciation (depreciation) of investments (net of applicable income tax expense (benefit))	(463.7)		(463.7)
Change in noncredit component of impairment losses on fixed maturities, available for sale (net of applicable income tax expense (benefit))	(1.9)		(1.9)
Extinguishment of beneficial conversion feature related to the repurchase of convertible debentures	(12.6)	(12.6)
Cost of common stock repurchased	(118.4)	(118.4)
Dividends on common stock	(24.6)			(24.6)
Conversion of convertible debentures	24.9	24.9
Stock options, restricted stock and performance units	24.2	24.2
Balance, end of period at Dec. 31, 2013	4,955.2	4,095.0	731.8	128.4
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	51.4			51.4
Change in unrealized appreciation (depreciation) of investments (net of applicable income tax expense (benefit))	94.2		94.2
Change in noncredit component of impairment losses on fixed maturities, available for sale (net of applicable income tax expense (benefit))	(0.7)		(0.7)
Cost of common stock repurchased	(376.5)	(376.5)
Dividends on common stock	(51.3)			(51.3)
Stock options, restricted stock and performance units	15.9	15.9
Balance, end of period at Dec. 31, 2014	4,688.2	3,734.4	825.3	128.5
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	270.7			270.7
Change in unrealized appreciation (depreciation) of investments (net of applicable income tax expense (benefit))	(420.4)		(420.4)
Change in noncredit component of impairment losses on fixed maturities, available for sale (net of applicable income tax expense (benefit))	(2.1)		(2.1)
Cost of common stock repurchased	(365.2)	(365.2)
Dividends on common stock	(52.1)			(52.1)
Stock options, restricted stock and performance units	19.4	19.4
Balance, end of period at Dec. 31, 2015	$ 4,138.5	$ 3,388.6	$ 402.8	$ 347.1

XML

CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY (Parentheticals) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Statement of Stockholders' Equity [Abstract]
Change in unrealized appreciation (depreciation) of investments, applicable income tax expense (benefit)	$ (231.7)	$ 52.3	$ (248.7)
Change in noncredit component of impairment losses on fixed maturities, available for sale, applicable income tax expense (benefit)	$ (1.2)	$ (0.4)	$ (1.1)

XML

CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014		Dec. 31, 2013
Cash flows from operating activities:
Insurance policy income	$ 2,423.4	$ 2,407.9		$ 2,464.9
Net investment income	1,205.9	1,279.0		1,387.7
Fee revenue and other income	58.9	50.9		34.0
Insurance policy benefits	(1,879.4)	(1,968.4)		(2,093.8)
Payment to reinsurer pursuant to long-term care business reinsured	0.0	(590.3)		0.0
Interest expense	(90.0)	(81.7)		(95.9)
Deferrable policy acquisition costs	(246.4)	(242.8)		(222.8)
Other operating costs	(724.4)	(728.8)		(745.7)
Taxes	(4.1)	(4.0)		(8.0)
Net cash from operating activities	743.9	121.8	[1]	720.4
Cash flows from investing activities:
Sales of investments	2,177.6	2,090.0		2,315.8
Maturities and redemptions of investments	1,853.4	1,618.2		2,491.9
Purchases of investments	(4,767.2)	(3,731.6)		(5,367.1)
Net sales (purchases) of trading securities	(12.3)	4.9		30.0
Change in cash and cash equivalents held by variable interest entities	(296.1)	36.0		(50.1)
Cash and cash equivalents held by subsidiary prior to being sold	0.0	(164.7)		0.0
Proceeds from sale of subsidiary	0.0	231.0		0.0
Other	(25.0)	(27.5)		(23.0)
Net cash provided (used) by investing activities	(1,069.6)	56.3		(602.5)
Cash flows from financing activities:
Issuance of notes payable, net	910.0	0.0		0.0
Payments on notes payable	(797.1)	(62.9)		(126.9)
Expenses related to extinguishment or modification of debt	(17.8)	(0.6)		(61.6)
Amount paid to extinguish the beneficial conversion feature associated with repurchase of convertible debentures	0.0	0.0		(12.6)
Issuance of common stock	6.3	5.0		15.1
Payments to repurchase common stock and warrants	(361.5)	(376.5)		(118.4)
Common stock dividends paid	(52.0)	(51.0)		(24.4)
Amounts received for deposit products	1,241.9	1,295.4		1,298.1
Withdrawals from deposit products	(1,225.0)	(1,347.3)		(1,464.4)
Issuance of investment borrowings:
Federal Home Loan Bank	475.0	350.0		500.0
Related to variable interest entities	544.7	358.5		376.3
Payments on investment borrowings:
Federal Home Loan Bank	(425.7)	(367.7)		(250.5)
Related to variable interest entities and other	(132.0)	(88.8)		(132.1)
Investment borrowings - repurchase agreements, net	(20.4)	20.4		0.0
Net cash provided (used) by financing activities	146.4	(265.5)		(1.4)
Net increase (decrease) in cash and cash equivalents	(179.3)	(87.4)		116.5
Cash and cash equivalents, beginning of year	611.6	699.0		582.5
Cash and cash equivalents, end of year	$ 432.3	$ 611.6		$ 699.0

[1] Cash flows from operating activities reflect outflows in 2014 due to the payment to reinsurer to transfer certain long-term care business.

XML

BUSINESS AND BASIS OF PRESENTATION

12 Months Ended

Dec. 31, 2015

Organization, Consolidation and Presentation of Financial Statements [Abstract]

BUSINESS AND BASIS OF PRESENTATION

BUSINESS AND BASIS OF PRESENTATION

CNO Financial Group, Inc., a Delaware corporation ("CNO"), is a holding company for a group of insurance companies operating throughout the United States that develop, market and administer health insurance, annuity, individual life insurance and other insurance products.  The terms "CNO Financial Group, Inc.", "CNO", the "Company", "we", "us", and "our" as used in these financial statements refer to CNO and its subsidiaries.  Such terms, when used to describe insurance business and products, refer to the insurance business and products of CNO's insurance subsidiaries.

We focus on serving middle-income pre-retiree and retired Americans, which we believe are attractive, underserved, high growth markets.  We sell our products through three distribution channels: career agents, independent producers (some of whom sell one or more of our product lines exclusively) and direct marketing.

The Company manages its business through the following operating segments: Bankers Life, Washington National and Colonial Penn, which are defined on the basis of product distribution; and corporate operations, comprised of holding company activities and certain noninsurance company businesses. The Company’s insurance segments are described below:

• Bankers Life,which markets and distributes Medicare supplement insurance, interest-sensitive life insurance, traditional life insurance, fixed annuities and long-term care insurance products to the middle-income senior market through a dedicated field force of career agents, financial and investment advisors, and sales managers supported by a network of community-based sales offices.  The Bankers Life segment includes primarily the business of Bankers Life and Casualty Company ("Bankers Life").  Bankers Life also has various distribution and marketing agreements with other insurance companies to use Bankers Life's career agents to distribute Medicare Advantage and prescription drug plan ("PDP") products in exchange for a fee.

• Washington National, which markets and distributes supplemental health (including specified disease, accident and hospital indemnity insurance products) and life insurance to middle-income consumers at home and at the worksite.  These products are marketed through Performance Matters Associates of Texas, Inc. and through independent marketing organizations and insurance agencies including worksite marketing.  The products being marketed are underwritten by Washington National Insurance Company ("Washington National"). This segment's business also includes certain closed blocks of annuities and Medicare supplement policies which are no longer being actively marketed by this segment and were primarily issued or acquired by Washington National.

• Colonial Penn, which markets primarily graded benefit and simplified issue life insurance directly to customers in the senior middle-income market through television advertising, direct mail, the internet and telemarketing.  The Colonial Penn segment includes primarily the business of Colonial Penn Life Insurance Company ("Colonial Penn").

As further described in the note to the consolidated financial statements entitled "Sale of Subsidiary", we sold Conseco Life Insurance Company ("CLIC") on July 1, 2014. The business of CLIC primarily related to traditional and interest-sensitive life products. In periods prior to 2014, we had an Other CNO Business segment comprised of the long-term care business that was ceded effective December 31, 2013 and the overhead expense of CLIC that was expected to continue after the completion of the sale. Beginning on January 1, 2014: (i) the overhead expense of CLIC that was expected to continue after the completion of the sale was reallocated primarily to the Bankers Life and Washington National segments; and (ii) there was no longer an Other CNO Business segment.

We prepare our financial statements in accordance with accounting principles generally accepted in the United States of America ("GAAP"). We have reclassified certain amounts from the prior periods to conform to the 2015 presentation. These reclassifications have no effect on net income or shareholders' equity.

The accompanying financial statements include the accounts of the Company and its subsidiaries. Our consolidated financial statements exclude transactions between us and our consolidated affiliates, or among our consolidated affiliates.

When we prepare financial statements in conformity with GAAP, we are required to make estimates and assumptions that significantly affect reported amounts of various assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reporting periods.  For example, we use significant estimates and assumptions to calculate values for deferred acquisition costs, the present value of future profits, fair value measurements of certain investments (including derivatives), other-than-temporary impairments of investments, assets and liabilities related to income taxes, liabilities for insurance products, liabilities related to litigation and guaranty fund assessment accruals.  If our future experience differs from these estimates and assumptions, our financial statements would be materially affected.

XML

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

12 Months Ended

Dec. 31, 2015

Accounting Policies [Abstract]

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Investments

Fixed maturity securities include available for sale bonds and redeemable preferred stocks. We carry these investments at estimated fair value. We record any unrealized gain or loss, net of tax and related adjustments, as a component of shareholders’ equity.

Equity securities include available for sale investments in common stock and non-redeemable preferred stock. We carry these investments at estimated fair value. We record any unrealized gain or loss, net of tax and related adjustments, as a component of shareholders' equity.

Mortgage loans held in our investment portfolio are carried at amortized unpaid balances, net of provisions for estimated losses. Interest income is accrued on the principal amount of the loan based on the loan's contractual interest rate. Payment terms specified for mortgage loans may include a prepayment penalty for unscheduled payoff of the investment. Prepayment penalties are recognized as investment income when received.

Policy loans are stated at current unpaid principal balances. Policy loans are collateralized by the cash surrender value of the life insurance policy. Interest income is recorded as earned using the contractual interest rate.

Trading securities include: (i) investments purchased with the intent of selling in the near team to generate income; (ii) investments supporting certain insurance liabilities (including investments backing the market strategies of our multibucket annuity products) and certain reinsurance agreements; and (iii) certain fixed maturity securities containing embedded derivatives for which we have elected the fair value option. The change in fair value of the income generating investments and investments supporting insurance liabilities and reinsurance agreements is recognized in income from policyholder and reinsurer accounts and other special-purpose portfolios (a component of net investment income). The change in fair value of securities with embedded derivatives is recognized in realized investment gains (losses). Investment income related to investments supporting certain insurance liabilities and certain reinsurance agreements is substantially offset by the change in insurance policy benefits related to certain products and agreements.

Other invested assets include: (i) call options purchased in an effort to offset or hedge the effects of certain policyholder benefits related to our fixed index annuity and life insurance products; (ii) Company-owned life insurance ("COLI"); and (iii) certain non-traditional investments. We carry the call options at estimated fair value as further described in the section of this note entitled "Accounting for Derivatives". We carry COLI at its cash surrender value which approximates its net realizable value. Non-traditional investments include investments in certain limited partnerships and hedge funds which are accounted for using the equity method; and promissory notes, which are accounted for using the cost method. In accounting for limited partnerships and hedge funds, we consistently use the most recently available financial information provided by the general partner or manager of each of these investments, which is one to three months prior to the end of our reporting period.

Interest income on fixed maturity securities is recognized when earned using a constant effective yield method giving effect to amortization of premiums and accretion of discounts. Prepayment fees are recognized when earned. Dividends on equity securities are recognized when declared.

When we sell a security (other than trading securities), we report the difference between the sale proceeds and amortized cost (determined based on specific identification) as a realized investment gain or loss.

We regularly evaluate our investments for possible impairment as further described in the note to the consolidated financial statements entitled "Investments".

When a security defaults (including mortgage loans) or securities are other-than-temporarily impaired, our policy is to discontinue the accrual of interest and eliminate all previous interest accruals, if we determine that such amounts will not be ultimately realized in full.

Cash and Cash Equivalents

Cash and cash equivalents include commercial paper, invested cash and other investments purchased with original maturities of less than three months. We carry them at amortized cost, which approximates estimated fair value.

Deferred Acquisition Costs

Deferred acquisition costs represent incremental direct costs related to the successful acquisition of new or renewal insurance contracts. For interest-sensitive life or annuity products, we amortize these costs in relation to the estimated gross profits using the interest rate credited to the underlying policies. For other products, we amortize these costs in relation to future anticipated premium revenue using the projected investment earnings rate.

When we realize a gain or loss on investments backing our interest-sensitive life or annuity products, we adjust the amortization to reflect the change in estimated gross profits from the products due to the gain or loss realized and the effect on future investment yields. We also adjust deferred acquisition costs for the change in amortization that would have been recorded if our fixed maturity securities, available for sale, had been sold at their stated aggregate fair value and the proceeds reinvested at current yields. We limit the total adjustment related to the impact of unrealized losses to the total of costs capitalized plus interest related to insurance policies issued in a particular year. We include the impact of this adjustment in accumulated other comprehensive income (loss) within shareholders' equity.

We regularly evaluate the recoverability of the unamortized balance of the deferred acquisition costs. We consider estimated future gross profits or future premiums, expected mortality or morbidity, interest earned and credited rates, persistency and expenses in determining whether the balance is recoverable. If we determine a portion of the unamortized balance is not recoverable, it is charged to amortization expense. In certain cases, the unamortized balance of the deferred acquisition costs may not be deficient in the aggregate, but our estimates of future earnings indicate that profits would be recognized in early periods and losses in later periods. In this case, we increase the amortization of the deferred acquisition costs over the period of profits, by an amount necessary to offset losses that are expected to be recognized in the later years.

Present Value of Future Profits

The present value of future profits is the value assigned to the right to receive future cash flows from policyholder insurance contracts existing at September 10, 2003 (the "Effective Date", the effective date of the bankruptcy reorganization of Conseco, Inc., an Indiana corporation (our "Predecessor")). The discount rate we used to determine the present value of future profits was 12 percent. The balance of this account is amortized and evaluated for recovery in the same manner as described above for deferred acquisition costs.  We also adjust the present value of future profits for the change in amortization that would have been recorded if the fixed maturity securities, available for sale, had been sold at their stated aggregate fair value and the proceeds reinvested at current yields, similar to the manner described above for deferred acquisition costs.  We limit the total adjustment related to the impact of unrealized losses to the total present value of future profits plus interest.

Assets Held in Separate Accounts

Separate accounts are funds on which investment income and gains or losses accrue directly to certain policyholders. The assets of these accounts are legally segregated. They are not subject to the claims that may arise out of any other business of CNO. We report separate account assets at fair value; the underlying investment risks are assumed by the contractholders. We record the related liabilities at amounts equal to the separate account assets. We record the fees earned for administrative and contractholder services performed for the separate accounts in insurance policy income.

Recognition of Insurance Policy Income and Related Benefits and Expenses on Insurance Contracts

For interest-sensitive life and annuity contracts that do not involve significant mortality or morbidity risk, the amounts collected from policyholders are considered deposits and are not included in revenue. Revenues for these contracts consist of charges for policy administration, cost of insurance charges and surrender charges assessed against policyholders' account balances. Such revenues are recognized when the service or coverage is provided, or when the policy is surrendered.

We establish liabilities for annuity and interest-sensitive life products equal to the accumulated policy account values, which include an accumulation of deposit payments plus credited interest, less withdrawals and the amounts assessed against the policyholder through the end of the period. In addition, policyholder account values for certain interest-sensitive life products are impacted by our assumptions related to changes of certain non-guaranteed elements that we are allowed to make under the terms of the policy, such as cost of insurance charges, expense loads, credited interest rates and policyholder bonuses. Sales inducements provided to the policyholders of these products are recognized as liabilities over the period that the contract must remain in force to qualify for the inducement. The options attributed to the policyholder related to our fixed index annuity products are accounted for as embedded derivatives as described in the section of this note entitled "Accounting for Derivatives".

Premiums from individual life products (other than interest-sensitive life contracts) and health products are recognized when due. When premiums are due over a significantly shorter period than the period over which benefits are provided, any gross premium in excess of the net premium (i.e., the portion of the gross premium required to provide for all expected future benefits and expenses) is deferred and recognized into revenue in a constant relationship to insurance in force. Benefits are recorded as an expense when they are incurred.

We establish liabilities for traditional life, accident and health insurance, and life contingent payment annuity products using mortality tables in general use in the United States, which are modified to reflect the Company's actual experience when appropriate. We establish liabilities for accident and health insurance products using morbidity tables based on the Company's actual or expected experience. These reserves are computed at amounts that, with additions from estimated future premiums received and with interest on such reserves at estimated future rates, are expected to be sufficient to meet our obligations under the terms of the policy. Liabilities for future policy benefits are computed on a net-level premium method based upon assumptions as to future claim costs, investment yields, mortality, morbidity, withdrawals, policy dividends and maintenance expenses determined when the policies were issued (or with respect to policies inforce at August 31, 2003, the Company's best estimate of such assumptions on the Effective Date). We make an additional provision to allow for potential adverse deviation for some of our assumptions. Once established, assumptions on these products are generally not changed unless a premium deficiency exists. In that case, a premium deficiency reserve is recognized and the future pattern of reserve changes is modified to reflect the relationship of premiums to benefits based on the current best estimate of future claim costs, investment yields, mortality, morbidity, withdrawals, policy dividends and maintenance expenses, determined without an additional provision for potential adverse deviation.

We establish claim reserves based on our estimate of the loss to be incurred on reported claims plus estimates of incurred but unreported claims based on our past experience.

Accounting for Long-term Care Premium Rate Increases

Many of our long-term care policies have been subject to premium rate increases. In some cases, these premium rate increases were materially consistent with the assumptions we used to value the particular block of business at the Effective Date. With respect to certain premium rate increases, some of our policyholders were provided an option to cease paying their premiums and receive a non-forfeiture option in the form of a paid-up policy with limited benefits. In addition, our policyholders could choose to reduce their coverage amounts and premiums in the same proportion, when permitted by our contracts or as required by regulators. The following describes how we account for these policyholder options:

• Premium rate increases - If premium rate increases reflect a change in our previous rate increase assumptions, the new assumptions are not reflected prospectively in our reserves. Instead, the additional premium revenue resulting from the rate increase is recognized as earned and original assumptions continue to be used to determine changes to liabilities for insurance products unless a premium deficiency exists.

• Benefit reductions - A policyholder may choose reduced coverage with a proportionate reduction in premium, when permitted by our contracts. This option does not require additional underwriting. Benefit reductions are treated as a partial lapse of coverage, and the balance of our reserves and deferred insurance acquisition costs is reduced in proportion to the reduced coverage.

• Non-forfeiture benefits offered in conjunction with a rate increase - In some cases, non-forfeiture benefits are offered to policyholders who wish to lapse their policies at the time of a significant rate increase. In these cases, exercise of this option is treated as an extinguishment of the original contract and issuance of a new contract. The balance of our reserves and deferred insurance acquisition costs are released, and a reserve for the new contract is established.

Some of our policyholders may receive a non-forfeiture benefit if they cease paying their premiums pursuant to their original contract (or pursuant to changes made to their original contract as a result of a litigation settlement made prior to the Effective Date or an order issued by the Florida Office of Insurance Regulation). In these cases, exercise of this option is treated as the exercise of a policy benefit, and the reserve for premium paying benefits is reduced, and the reserve for the non-forfeiture benefit is adjusted to reflect the election of this benefit.

Accounting for Certain Marketing and Reinsurance Agreements

Bankers Life has entered into various distribution and marketing agreements with other insurance companies to use Bankers Life's career agents to distribute prescription drug and Medicare Advantage plans. These agreements allow Bankers Life to offer these products to current and potential future policyholders without investment in management and infrastructure. We receive fee income related to the plans sold through our distribution channels. We account for these distribution agreements as follows:

• We recognize distribution income based on either: (i) a fixed fee per contract sold; or (ii) a percentage of premiums collected. This fee income is recognized over the calendar year term of the contract.

• We also pay commissions to our agents who sell the plans. These payments are deferred and amortized over the term of the contract.

Prior to its termination in August 2013, we had a quota-share reinsurance agreement with Coventry Health Care ("Coventry") that provided Bankers Life with 50 percent of the net premiums and related policy benefits of certain PDP business sold through Bankers Life's career agency force. We accounted for the quota-share agreement as follows:

• We recognized premium revenue evenly over the period of the underlying Medicare Part D contracts.

• We recognized policyholder benefits and assumed commission expense as incurred.

• We recognized risk-share premium adjustments consistent with Coventry's risk-share agreement with the Centers for Medicare and Medicaid Services.

Reinsurance

In the normal course of business, we seek to limit our loss exposure on any single insured or to certain groups of policies by ceding reinsurance to other insurance enterprises. We currently retain no more than $.8 million of mortality risk on any one policy. We diversify the risk of reinsurance loss by using a number of reinsurers that have strong claims-paying ratings. In each case, the ceding CNO subsidiary is directly liable for claims reinsured in the event the assuming company is unable to pay.

The cost of reinsurance ceded totaled $133.6 million, $176.7 million and $212.1 million in 2015, 2014 and 2013, respectively.  We deduct this cost from insurance policy income.  Reinsurance recoveries netted against insurance policy benefits totaled $167.7 million, $195.3 million and $196.2 million in 2015, 2014 and 2013, respectively.

From time-to-time, we assume insurance from other companies.  Any costs associated with the assumption of insurance are amortized consistent with the method used to amortize deferred acquisition costs.  Reinsurance premiums assumed totaled $38.5 million, $35.0 million and $37.4 million in 2015, 2014 and 2013, respectively.  Reinsurance premiums included amounts assumed pursuant to marketing and quota-share agreements with Coventry of $6.8 million and $19.7 million, in 2014 and 2013 respectively. As further described above, we received a notice of Coventry's intent to terminate the PDP quota-share reinsurance agreement in August 2013. The premiums collected from Coventry in 2014 represented adjustments to premiums on such business related to periods prior to the termination of the agreement. We continue to receive distribution income from Coventry for PDP business sold through our Bankers Life segment.

In December 2013, two of our insurance subsidiaries with long-term care business in the former Other CNO Business segment entered into 100% coinsurance agreements ceding $495 million of long-term care reserves to Beechwood Re Ltd. ("BRe"). Pursuant to the agreements, the insurance subsidiaries paid an additional premium of $96.9 million to BRe and an amount equal to the related net liabilities. The insurance subsidiaries' ceded reserve credits are secured by assets in market-value trusts subject to a 7% over-collateralization, investment guidelines and periodic true-up provisions. Future payments into the trusts to maintain collateral requirements are the responsibility of BRe. We recognized a pre-tax loss of $98.4 million in 2013 to reflect: (i) the known loss (or premium deficiency) on the business, as we will not be recognizing additional income in future periods to recover the unamortized additional premium which will be paid to BRe; and (ii) other transaction costs.

In the second quarter of 2014, we recaptured a block of interest-sensitive life business that was previously ceded under a modified coinsurance agreement. The recapture of this block resulted in a gain related to reinsurance transaction of $3.8 million.

As further described in the note to the financial statements entitled "Sale of Subsidiary", we recaptured a block of life insurance business in 2014 that was previously ceded under a coinsurance agreement.

Income Taxes

Our income tax expense includes deferred income taxes arising from temporary differences between the financial reporting and tax bases of assets and liabilities, capital loss carryforwards and net operating loss carryforwards ("NOLs"). Deferred tax assets and liabilities are measured using enacted tax rates expected to apply in the years in which temporary differences are expected to be recovered or paid.  The effect of a change in tax rates on deferred tax assets and liabilities is recognized in earnings in the period when the changes are enacted.

A reduction of the net carrying amount of deferred tax assets by establishing a valuation allowance is required if, based on the available evidence, it is more likely than not that such assets will not be realized. In assessing the need for a valuation allowance, all available evidence, both positive and negative, shall be considered to determine whether, based on the weight of that evidence, a valuation allowance for deferred tax assets is needed. This assessment requires significant judgment and considers, among other matters, the nature, frequency and severity of current and cumulative losses, forecasts of future profitability, the duration of carryforward periods, our experience with operating loss and tax credit carryforwards expiring unused, and tax planning strategies. We evaluate the need to establish a valuation allowance for our deferred income tax assets on an ongoing basis. The realization of our deferred tax assets depends upon generating sufficient future taxable income of the appropriate type during the periods in which our temporary differences become deductible and before our capital loss carryforwards and life and non-life NOLs expire.

At December 31, 2015, our valuation allowance for our net deferred tax assets was $213.5 million, as we have determined that it is more likely than not that a portion of our deferred tax assets will not be realized. This determination was made by evaluating each component of the deferred tax assets and assessing the effects of limitations and/or interpretations on the value of such component to be fully recognized in the future.

Investments in Variable Interest Entities

We have concluded that we are the primary beneficiary with respect to certain variable interest entities ("VIEs"), which are consolidated in our financial statements. All such VIEs are collateralized loan trusts that were established to issue securities to finance the purchase of corporate loans and other permitted investments.  The assets held by the trusts are legally isolated and not available to the Company.  The liabilities of the VIEs are expected to be satisfied from the cash flows generated by the underlying loans held by the trusts, not from the assets of the Company.  The Company has no financial obligation to the VIEs beyond its investment in each VIE.

The investment portfolios held by the VIEs are primarily comprised of commercial bank loans to corporate obligors which are almost entirely rated below-investment grade.  Refer to the note to the consolidated financial statements entitled "Investments in Variable Interest Entities" for additional information about VIEs.

In addition, the Company, in the normal course of business, makes passive investments in structured securities issued by VIEs for which the Company is not the investment manager.  These structured securities include asset-backed securities, collateralized debt obligations, commercial mortgage-backed securities, residential mortgage-backed securities and collateralized mortgage obligations.  Our maximum exposure to loss on these securities is limited to our cost basis in the investment.  We have determined that we are not the primary beneficiary of these structured securities due to the relative size of our investment in comparison to the total principal amount of the individual structured securities and the level of credit subordination which reduces our obligation to absorb gains or losses.

At December 31, 2015, we held investments in various limited partnerships, in which we are not the primary beneficiary, totaling $76.9 million (classified as other invested assets).  At December 31, 2015, we had unfunded commitments to these partnerships of $82.2 million.  Our maximum exposure to loss on these investments is limited to the amount of our investment.

Investment borrowings

Three of the Company's insurance subsidiaries (Washington National, Bankers Life and Colonial Penn) are members of the Federal Home Loan Bank ("FHLB").  As members of the FHLB, our insurance subsidiaries have the ability to borrow on a collateralized basis from the FHLB.  We are required to hold certain minimum amounts of FHLB common stock as a condition of membership in the FHLB, and additional amounts based on the amount of the borrowings.  At December 31, 2015, the carrying value of the FHLB common stock was $74.2 million.  As of December 31, 2015, collateralized borrowings from the FHLB totaled $1.5 billion and the proceeds were used to purchase fixed maturity securities.  The borrowings are classified as investment borrowings in the accompanying consolidated balance sheet.  The borrowings are collateralized by investments with an estimated fair value of $1.8 billion at December 31, 2015, which are maintained in a custodial account for the benefit of the FHLB.  Substantially all of such investments are classified as fixed maturities, available for sale, in our consolidated balance sheet.

The following summarizes the terms of the borrowings from the FHLB by Washington National, Bankers Life and Colonial Penn (dollars in millions):

Amount		Maturity	Interest rate at
borrowed		date	December 31, 2015
$	57.7	June 2017	Variable rate – 0.699%
50.0		August 2017	Variable rate – 0.562%
75.0		August 2017	Variable rate – 0.543%
100.0		October 2017	Variable rate – 0.751%
50.0		November 2017	Variable rate – 0.917%
50.0		January 2018	Variable rate – 0.670%
50.0		January 2018	Variable rate – 0.656%
50.0		February 2018	Variable rate – 0.654%
50.0		February 2018	Variable rate – 0.452%
22.0		February 2018	Variable rate – 0.742%
100.0		May 2018	Variable rate – 0.872%
50.0		July 2018	Variable rate – 0.793%
50.0		August 2018	Variable rate – 0.482%
10.0		December 2018	Variable rate – 0.807%
50.0		January 2019	Variable rate – 0.737%
50.0		February 2019	Variable rate – 0.452%
100.0		March 2019	Variable rate – 0.831%
21.8		July 2019	Variable rate – 0.892%
15.0		October 2019	Variable rate – 0.837%
50.0		May 2020	Variable rate – 0.851%
21.8		June 2020	Fixed rate – 1.960%
25.0		September 2020	Variable rate – 0.951%
100.0		September 2020	Variable rate – 1.082%
50.0		September 2020	Variable rate – 1.082%
75.0		September 2020	Variable rate – 0.723%
100.0		October 2020	Variable rate – 0.723%
50.0		December 2020	Variable rate – 0.951%
28.2		August 2021	Fixed rate – 2.550%
26.1		March 2023	Fixed rate – 2.160%
20.5		June 2025	Fixed rate – 2.940%
$	1,548.1

The variable rate borrowings are pre-payable on each interest reset date without penalty.  The fixed rate borrowings are pre-payable subject to payment of a yield maintenance fee based on prevailing market interest rates.  At December 31, 2015, the aggregate yield maintenance fee to prepay all fixed rate borrowings was $1.7 million.

Interest expense of $10.9 million, $18.7 million and $27.9 million in 2015, 2014 and 2013, respectively, was recognized related to total borrowings from the FHLB.

In addition to our borrowings from the FHLB, we may enter into repurchase agreements to increase our investment return as part of our investment strategy as further discussed in the note to the consolidated financial statements entitled "Derivatives". These repurchase agreements are accounted for as collateralized financing arrangements and not as a sale and subsequent repurchase of securities. There were no such borrowings outstanding at December 31, 2015. We had $20.4 million of such borrowings outstanding at December 31, 2014.

The primary risks associated with short-term collateralized borrowings are: (i) a substantial decline in the market value of the margined security; and (ii) that a counterparty may be unable to perform under the terms of the contract or be unwilling to extend such financing in future periods especially if the liquidity or value of the margined security has declined. Exposure is limited to any depreciation in value of the related securities.

Accounting for Derivatives

Our fixed index annuity products provide a guaranteed minimum rate of return and a higher potential return that is based on a percentage (the "participation rate") of the amount of increase in the value of a particular index, such as the Standard & Poor's 500 Index, over a specified period.  Typically, on each policy anniversary date, a new index period begins.  We are generally able to change the participation rate at the beginning of each index period during a policy year, subject to contractual minimums.  The Company accounts for the options attributed to the policyholder for the estimated life of the contract as embedded derivatives. These accounting requirements often create volatility in the earnings from these products. We typically buy call options (including call spreads) referenced to the applicable indices in an effort to offset or hedge potential increases to policyholder benefits resulting from increases in the particular index to which the policy's return is linked.

We utilize United States Treasury interest rate futures primarily to hedge interest rate risk related to anticipated mortgage loan transactions.

In periods prior to the second quarter of 2014, we were required to establish an embedded derivative related to a modified coinsurance agreement which ceded the risks of a block of interest sensitive life business. We recaptured this block in the second quarter of 2014 resulting in a gain of $3.8 million. Prior to the recapture of this block, we maintained the investments related to the modified coinsurance agreement in our trading securities account, which we carried at estimated fair value with changes in such value recognized as investment income.  Such trading securities were sold in the second quarter of 2014 in conjunction with the reinsurance recapture.

We purchase certain fixed maturity securities that contain embedded derivatives that are required to be held at fair value on the consolidated balance sheet. We have elected the fair value option to carry the entire security at fair value with changes in fair value reported in net income.

Multibucket Annuity Products

The Company's multibucket annuity is an annuity product that credits interest based on the experience of a particular market strategy. Policyholders allocate their annuity premium payments to several different market strategies based on different asset classes within the Company's investment portfolio. Interest is credited to this product based on the market return of the given strategy, less management fees, and funds may be moved between different strategies. The Company guarantees a minimum return of premium plus approximately 3 percent per annum over the life of the contract. The investments backing the market strategies of these products are designated by the Company as trading securities. The change in the fair value of these securities is recognized as investment income (classified as income from policyholder and reinsurer accounts and other special-purpose portfolios), which is substantially offset by the change in insurance policy benefits for these products. We hold insurance liabilities of $37.5 million and $43.4 million related to multibucket annuity products as of December 31, 2015 and 2014, respectively.

Sales Inducements

Certain of our annuity products offer sales inducements to contract holders in the form of enhanced crediting rates or bonus payments in the initial period of the contract.  Certain of our life insurance products offer persistency bonuses credited to the contract holders balance after the policy has been outstanding for a specified period of time.  These enhanced rates and persistency bonuses are considered sales inducements in accordance with GAAP.  Such amounts are deferred and amortized in the same manner as deferred acquisition costs.  Sales inducements deferred totaled $3.8 million, $5.1 million and $5.0 million during 2015, 2014 and 2013, respectively.  Amounts amortized totaled $13.8 million, $12.4 million and $22.9 million during 2015, 2014 and 2013, respectively.  The unamortized balance of deferred sales inducements was $57.4 million and $67.4 million at December 31, 2015 and 2014, respectively.  The balance of insurance liabilities for persistency bonus benefits was $.9 million and $1.5 million at December 31, 2015 and 2014, respectively.

Out-of-Period Adjustments

In 2014, we recorded the net effect of an out-of-period adjustment related to the calculation of incentive compensation accruals which increased other operating costs and expenses by $2.4 million, decreased tax expense by $.8 million and decreased our net income by $1.6 million (or 1 cent per diluted share). In 2013 we recorded the net effect of out-of-period adjustments which increased our insurance policy benefits by $4.7 million, increased amortization expense by $2.1 million, increased other operating costs and expenses by $1.5 million, decreased tax expense by $.7 million and decreased our net income by $7.6 million (or 3 cents per diluted share). We evaluated these adjustments taking into account both qualitative and quantitative factors and considered the impact of these adjustments in relation to each period, as well as the periods in which they originated. The impact of recognizing these adjustments in prior years was not significant to any individual period. Management believes these adjustments are immaterial to the consolidated financial statements and all previously issued financial statements.

Recently Issued Accounting Standards

Pending Accounting Standards

In May 2014, the Financial Accounting Standards Board (the "FASB") issued authoritative guidance for recognizing revenue from contracts with customers. Certain contracts with customers are specifically excluded from this guidance, including insurance contracts. The core principle of the new guidance is that an entity should recognize revenue when it transfers promised goods or services in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The guidance also requires additional disclosures about the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. In July 2015, the guidance was updated and will now be effective for the Company on January 1, 2018 and permits two methods of transition upon adoption; full retrospective and modified retrospective. Under the full retrospective method, prior periods would be restated under the new revenue standard, providing for comparability in all periods presented. Under the modified retrospective method, prior periods would not be restated. Instead, revenues and other disclosures for pre-2017 periods would be provided in the notes to the financial statements as previously reported under the current revenue standard. The Company is currently assessing the impact the guidance will have upon adoption.

In August 2014, the FASB issued authoritative guidance related to measuring the financial assets and the financial liabilities of a consolidated collateralized financing entity which provides a measurement alternative for an entity that consolidates collateralized financing entities. A collateralized financing entity is a VIE with no more than nominal equity that holds financial assets and issues beneficial interests in those financial assets; the beneficial interests have contractual recourse only to the related assets of the collateralized financing entity and are classified as financial liabilities. If elected, the alternative method results in the reporting entity measuring both the financial assets and the financial liabilities of the collateralized financing entity using the more observable of the two fair value measurements, which effectively removes measurement differences between the financial assets and the financial liabilities of the collateralized financing entity previously recorded as net income (loss) attributable to non-controlling and other beneficial interests and as an adjustment to appropriated retained earnings. The reporting entity continues to measure its own beneficial interests in the collateralized financing entity (other than those that represent compensation for services) at fair value. The guidance will be effective for the Company for interim and annual periods beginning in 2016. A reporting entity may apply the guidance using a modified retrospective approach by recording a cumulative-effect adjustment to equity as of the beginning of the annual period of adoption. A reporting entity may also apply the guidance retrospectively to all relevant prior periods. The adoption of this guidance is not expected to have a material impact on our consolidated financial statements.

In February 2015, the FASB issued authoritative guidance which updates the analysis that a reporting entity must perform to determine whether it should consolidate certain legal entities. Such guidance: (i) modifies the evaluation of whether limited partnerships and similar legal entities are VIEs or voting interest entities; (ii) eliminates the presumption that a general partner should consolidate a limited partnership; (iii) affects the consolidation analysis of reporting entities that are involved with VIEs, particularly those that have fee arrangements and related party relationships; and (iv) provides a scope exception from consolidation guidance for certain investment funds. The guidance will be effective for the Company for interim and annual periods beginning in 2016. A reporting entity may apply the guidance using a modified retrospective approach by recording a cumulative-effect adjustment to equity as of the beginning of the annual period of adoption. A reporting entity may also apply the guidance retrospectively to all relevant prior periods. The adoption of this guidance is not expected to have a material impact on our consolidated financial statements.

In May 2015, the FASB issued authoritative guidance which requires additional disclosures related to short-duration contracts. The guidance will require insurance entities to disclose for annual reporting periods information about the liability for unpaid claims and claim adjustment expenses. The guidance also requires insurance entities to disclose information about significant changes in methodologies and assumptions used to calculate the liability for unpaid claims and claim adjustment expenses, including reasons for the change and the effects on the financial statements. Additionally, the guidance requires insurance entities to disclose for annual and interim reporting periods a rollforward of the liability for unpaid claims and claim adjustment expenses. For health insurance claims, the guidance requires the disclosure of the total of incurred-but-not-reported liabilities plus expected development on reported claims included in the liability for unpaid claims and claim adjustment expenses. The guidance will be effective for the Company for annual periods beginning after December 15, 2015, and the interim periods within annual periods beginning after December 15, 2016. The Company is currently assessing the impact the guidance will have on its disclosures upon adoption.

In January 2016, the FASB issued authoritative guidance related to the recognition and measurement of financial assets and financial liabilities which made targeted improvements to GAAP as follows:

(i) Require equity investments (except those accounted for under the equity method of accounting or those that result in consolidation of the investee) to be measured at fair value with changes in fair value recognized in net income. However, an entity may choose to measure equity investments that do not have readily determinable fair values at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer.

(ii) Simplify the impairment assessment of equity investments without readily determinable fair values by requiring a qualitative assessment to identify impairment. When a qualitative assessment indicates that impairment exists, an entity is required to measure the investment at fair value.

(iii) Eliminate the requirement for public business entities to disclose the method(s) and significant assumptions used to estimate the fair value that is required to be disclosed for financial instruments measured at amortized cost on the balance sheet.

(iv) Require public business entities to use the exit price notion when measuring the fair value of financial instruments for disclosure purposes.

(v) Require an entity to present separately in other comprehensive income the portion of the total change in the fair value of a liability resulting from a change in the instrument-specific credit risk when the entity has elected to measure the liability at fair value in accordance with the fair value option for financial instruments.

(vi) Require separate presentation of financial assets and financial liabilities by measurement category and form of financial asset (that is, securities or loans and receivables) on the balance sheet or the accompanying notes to the financial statements.

(vii) Clarify that an entity should evaluate the need for a valuation allowance on a deferred tax asset related to available-for-sale securities in combination with the entity’s other deferred tax assets.

The guidance will be effective for the Company for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. Early adoption of the guidance is not permitted; except that item (v) above is permitted to be adopted early as of the beginning of the fiscal year of adoption.

An entity should apply the amendments in the guidance by means of a cumulative-effect adjustment to the balance sheet as of the beginning of the fiscal year of adoption. The amendments related to equity securities without readily determinable fair

values (including disclosure requirements) should be applied prospectively to equity investments that exist as of the date of adoption of the guidance. The Company is currently assessing the impact the guidance will have upon adoption.

Adopted Accounting Standards

In April 2014, the FASB issued authoritative guidance changing the criteria for reporting discontinued operations. Under the revised guidance, only disposals of a component or a group of components, including those classified as held for sale, which represent a strategic shift that has or will have a major effect on a company's operations and financial results will be reported as discontinued operations. The guidance was effective prospectively for new disposals occurring after January 1, 2015.

In June 2014, the FASB issued authoritative guidance on the accounting and disclosure of repurchase-to-maturity transactions and repurchase financings. Under this new accounting guidance, repurchase-to-maturity transactions will be accounted for as secured borrowings rather than sales of an asset, and transfers of financial assets with a contemporaneous repurchase financing arrangement will no longer be evaluated to determine whether they should be accounted for on a combined basis as forward contracts. The new guidance also prescribes additional disclosures particularly on the nature of collateral pledged in the repurchase agreement accounted for as a secured borrowing. The new guidance was effective beginning on January 1, 2015. The adoption of this guidance did not have a material impact on our consolidated financial statements.

In April 2015, the FASB issued authoritative guidance which requires debt issuance costs in financial statements to be presented as a direct deduction from the carrying value of the associated debt liability rather than as an asset on the balance sheet. This guidance is effective beginning January 1, 2016, with early adoption permitted. The Company adopted this guidance in the fourth quarter of 2015. The adoption of this guidance resulted in a change in presentation on our balance sheet but did not have any impact on our operating results or cash flows. The impact of adoption on prior periods is as follows (dollars in millions):

	December 31, 2014
	As originally reported		Effect of adoption			As adjusted
Other assets	$	337.7	$	(28.3	)	$	309.4
Total assets	31,184.2		(28.3		)	31,155.9
Borrowings related to variable interest entities	1,286.1		(14.2		)	1,271.9
Notes payable - direct corporate obligations	794.4		(14.1		)	780.3
Total liabilities	26,496.0		(28.3		)	26,467.7

In May 2015, the FASB issued authoritative guidance that removes the requirement to categorize within the fair value hierarchy all investments for which fair value is measured using the net asset value per share practical expedient. The guidance also removes the requirement to make certain disclosures for all investments that are eligible to be measured at fair value using the net asset value per share practical expedient. The guidance is effective for fiscal years beginning after December 15, 2015, and interim periods within those fiscal years, with early adoption permitted. A reporting entity should apply the guidance retrospectively to all periods presented. The Company elected to early adopt this guidance as of December 31, 2015, and has removed certain investments that are measured using the net asset value per share practical expedient from the fair value hierarchy in all periods presented in our consolidated financial statements.

XML

INVESTMENTS

12 Months Ended

Dec. 31, 2015

Investments, Debt and Equity Securities [Abstract]

INVESTMENTS

INVESTMENTS

At December 31, 2015, the amortized cost, gross unrealized gains and losses, estimated fair value and other-than-temporary impairments in accumulated other comprehensive income of fixed maturities, available for sale, and equity securities were as follows (dollars in millions):

	Amortized cost		Gross unrealized gains		Gross unrealized losses			Estimated fair value		Other-than-temporary impairments included in accumulated other comprehensive income
Investment grade (a):
Corporate securities	$	11,477.5	$	929.4	$	(262.9	)	$	12,144.0	$	—
United States Treasury securities and obligations of United States government corporations and agencies	172.5		22.3		(.3		)	194.5		—
States and political subdivisions	1,889.6		208.6		(3.7		)	2,094.5		—
Debt securities issued by foreign governments	18.9		—		(.6		)	18.3		—
Asset-backed securities	979.8		22.1		(7.2		)	994.7		—
Collateralized debt obligations	188.5		.4		(2.2		)	186.7		—
Commercial mortgage-backed securities	1,531.7		41.3		(16.3		)	1,556.7		—
Mortgage pass-through securities	3.1		.3		—			3.4		—
Collateralized mortgage obligations	450.9		17.0		(.6		)	467.3		—
Total investment grade fixed maturities, available for sale	16,712.5		1,241.4		(293.8		)	17,660.1		—
Below-investment grade (a):
Corporate securities	798.5		8.3		(82.3		)	724.5		—
States and political subdivisions	13.6		—		(3.9		)	9.7		(3.0		)
Debt securities issued by foreign governments	2.4		—		—			2.4		—
Asset-backed securities	838.0		25.7		(6.2		)	857.5		—
Commercial mortgage-backed securities	49.9		—		(1.3		)	48.6		—
Collateralized mortgage obligations	532.1		49.0		(1.0		)	580.1		(1.9		)
Total below-investment grade fixed maturities, available for sale	2,234.5		83.0		(94.7		)	2,222.8		(4.9		)
Total fixed maturities, available for sale	$	18,947.0	$	1,324.4	$	(388.5	)	$	19,882.9	$	(4.9	)
Equity securities	$	447.4	$	18.4	$	(2.8	)	$	463.0

_______________

(a) Investment ratings – Investment ratings are assigned the second lowest rating by Nationally Recognized Statistical Rating Organizations ("NRSROs") (Moody's Investor Services, Inc. ("Moody's"), Standard & Poor's Corporation ("S&P") or Fitch Ratings ("Fitch")), or if not rated by such firms, the rating assigned by the National Association of Insurance Commissioners (the "NAIC").  NAIC designations of "1" or "2" include fixed maturities generally rated investment grade (rated "Baa3" or higher by Moody's or rated "BBB-" or higher by S&P and Fitch).  NAIC designations of "3" through "6" are referred to as below-investment grade (which generally are rated "Ba1" or lower by Moody's or rated "BB+" or lower by S&P and Fitch).  References to investment grade or below-investment grade throughout our consolidated financial statements are determined as described above.

The NAIC evaluates the fixed maturity investments of insurers for regulatory and capital assessment purposes and assigns securities to one of six credit quality categories called NAIC designations, which are used by insurers when preparing their annual statements based on statutory accounting principles. The NAIC designations are generally similar to the credit quality designations of the NRSROs for marketable fixed maturity securities, except for certain structured securities. However, certain structured securities rated below investment grade by the NRSROs can be assigned NAIC 1 or NAIC 2 designations dependent on the cost basis of the holding relative to estimated recoverable amounts as determined by the NAIC. The following summarizes the NAIC designations and NRSRO equivalent ratings:

NAIC Designation	NRSRO Equivalent Rating
1	AAA/AA/A
2	BBB
3	BB
4	B
5	CCC and lower
6	In or near default

A summary of our fixed maturity securities, available for sale, by NAIC designations (or for fixed maturity securities held by non-regulated entities, based on NRSRO ratings) as of December 31, 2015 is as follows (dollars in millions):

NAIC designation	Amortized cost		Estimated fair value		Percentage of total estimated fair value
1	$	9,491.4	$	10,238.7	51.5	%
2	8,609.3		8,876.1		44.6
3	591.4		547.4		2.8
4	187.4		160.0		.8
5	53.7		50.8		.3
6	13.8		9.9		—
	$	18,947.0	$	19,882.9	100.0	%

At December 31, 2014, the amortized cost, gross unrealized gains and losses, estimated fair value and other-than-temporary impairments in accumulated other comprehensive income of fixed maturities, available for sale, and equity securities were as follows (dollars in millions):

	Amortized cost		Gross unrealized gains		Gross unrealized losses			Estimated fair value		Other-than-temporary impairments included in accumulated other comprehensive income
Investment grade (a):
Corporate securities	$	11,177.1	$	1,710.5	$	(42.1	)	$	12,845.5	$	—
United States Treasury securities and obligations of United States government corporations and agencies	138.8		30.2		(.1		)	168.9		—
States and political subdivisions	1,960.6		299.3		(.7		)	2,259.2		—
Debt securities issued by foreign governments	1.8		.1		—			1.9		—
Asset-backed securities	720.7		52.0		(1.6		)	771.1		—
Collateralized debt obligations	314.9		2.4		(3.4		)	313.9		—
Commercial mortgage-backed securities	1,179.7		80.9		(.5		)	1,260.1		—
Mortgage pass-through securities	4.2		.4		—			4.6		—
Collateralized mortgage obligations	571.1		23.1		(.6		)	593.6		—
Total investment grade fixed maturities, available for sale	16,068.9		2,198.9		(49.0		)	18,218.8		—
Below-investment grade (a):
Corporate securities	1,139.3		29.2		(43.0		)	1,125.5		—
States and political subdivisions	20.6		.2		(2.3		)	18.5		—
Asset-backed securities	465.9		33.8		(1.8		)	497.9		—
Collateralized debt obligations	10.4		.2		—			10.6		—
Commercial mortgage-backed securities	15.3		.9		—			16.2		—
Collateralized mortgage obligations	687.7		60.4		(.7		)	747.4		(3.2		)
Total below-investment grade fixed maturities, available for sale	2,339.2		124.7		(47.8		)	2,416.1		(3.2		)
Total fixed maturities, available for sale	$	18,408.1	$	2,323.6	$	(96.8	)	$	20,634.9	$	(3.2	)
Equity securities	$	400.5	$	19.1	$	(.6	)	$	419.0

Accumulated other comprehensive income is primarily comprised of the net effect of unrealized appreciation (depreciation) on our investments.  These amounts, included in shareholders' equity as of December 31, 2015 and 2014, were as follows (dollars in millions):

	2015			2014
Net unrealized appreciation (depreciation) on fixed maturity securities, available for sale, on which an other-than-temporary impairment loss has been recognized	$	1.6		$	5.3
Net unrealized gains on all other investments	903.4			2,207.7
Adjustment to present value of future profits (a)	(121.2		)	(149.9		)
Adjustment to deferred acquisition costs	(133.3		)	(390.5		)
Adjustment to insurance liabilities	(14.6		)	(381.4		)
Unrecognized net loss related to deferred compensation plan	(8.6		)	(8.5		)
Deferred income tax liabilities	(224.5		)	(457.4		)
Accumulated other comprehensive income	$	402.8		$	825.3

________

(a) The present value of future profits is the value assigned to the right to receive future cash flows from contracts existing at September 10, 2003, the date our Predecessor emerged from bankruptcy.

At December 31, 2015, adjustments to the present value of future profits, deferred acquisition costs, insurance liabilities and deferred tax assets included $(109.3) million, $(33.2) million, $(14.6) million and $55.8 million, respectively, for premium deficiencies that would exist on certain blocks of business (primarily long-term care products) if unrealized gains on the assets backing such products had been realized and the proceeds from the sales of such assets were invested at then current yields.

At December 31, 2014, adjustments to the present value of future profits, deferred acquisition costs, insurance liabilities and deferred tax assets included $(128.8) million, $(142.2) million, $(381.4) million and $232.1 million, respectively, for premium deficiencies that would exist on certain blocks of business (primarily long-term care products) if unrealized gains on the assets backing such products had been realized and the proceeds from the sales of such assets were invested at then current yields.

Below-Investment Grade Securities

At December 31, 2015, the amortized cost of the Company's below-investment grade fixed maturity securities was $2,234.5 million, or 12 percent of the Company's fixed maturity portfolio. The estimated fair value of the below-investment grade portfolio was $2,222.8 million, or 99 percent of the amortized cost.

Below-investment grade corporate debt securities typically have different characteristics than investment grade corporate debt securities.  Based on historical performance, probability of default by the borrower is significantly greater for below-investment grade corporate debt securities and in many cases severity of loss is relatively greater as such securities are generally unsecured and often subordinated to other indebtedness of the issuer.  Also, issuers of below-investment grade corporate debt securities frequently have higher levels of debt relative to investment-grade issuers, hence, all other things being equal, are generally more sensitive to adverse economic conditions.  The Company attempts to reduce the overall risk related to its investment in below-investment grade securities, as in all investments, through careful credit analysis, strict investment policy guidelines, and diversification by issuer and/or guarantor and by industry.

Contractual Maturity

The following table sets forth the amortized cost and estimated fair value of fixed maturities, available for sale, at December 31, 2015, by contractual maturity.  Actual maturities will differ from contractual maturities because certain borrowers may have the right to call or prepay obligations with or without penalties.  In addition, structured securities (such as asset-backed securities, collateralized debt obligations, commercial mortgage-backed securities, mortgage pass-through securities and collateralized mortgage obligations, collectively referred to as "structured securities") frequently include provisions for periodic principal payments and permit periodic unscheduled payments.

	Amortized cost		Estimated fair value
	(Dollars in millions)
Due in one year or less	$	265.0	$	268.9
Due after one year through five years	2,246.2		2,389.1
Due after five years through ten years	1,755.7		1,824.5
Due after ten years	10,106.1		10,705.4
Subtotal	14,373.0		15,187.9
Structured securities	4,574.0		4,695.0
Total fixed maturities, available for sale	$	18,947.0	$	19,882.9

Net Investment Income

Net investment income consisted of the following (dollars in millions):

	2015			2014			2013
General account assets:
Fixed maturities	$	1,090.1		$	1,175.8		$	1,290.3
Equity securities	18.3			13.9			7.0
Mortgage loans	91.4			104.2			96.3
Policy loans	7.3			11.0			17.3
Other invested assets	17.4			17.1			14.4
Cash and cash equivalents	.8			.6			.5
Policyholder and reinsurer accounts and other special-purpose portfolios:
Trading securities (a)	10.7			14.8			12.8
Options related to fixed index products:
Option income	36.5			118.9			77.4
Change in value of options	(72.7		)	(49.4		)	100.1
Other special-purpose portfolios	55.5			42.1			67.9
Gross investment income	1,255.3			1,449.0			1,684.0
Less investment expenses	21.7			21.6			20.0
Net investment income	$	1,233.6		$	1,427.4		$	1,664.0

_________________

(a) Changes in the estimated fair value for trading securities still held as of the end of the respective years and included in net investment income were $.4 million, $3.4 million and $.4 million for the years ended December 31, 2015, 2014 and 2013, respectively.

There were no fixed maturity investments or mortgage loans not accruing investment income at both at December 31, 2015 and 2014.

Net Realized Investment Gains (Losses)

The following table sets forth the net realized investment gains (losses) for the periods indicated (dollars in millions):

	2015			2014			2013
Fixed maturity securities, available for sale:
Gross realized gains on sale	$	95.7		$	64.4		$	57.7
Gross realized losses on sale	(88.4		)	(13.0		)	(11.4		)
Impairments:
Total other-than-temporary impairment losses	(17.9		)	—			(7.1		)
Other-than-temporary impairment losses recognized in accumulated other comprehensive income	3.0			—			—
Net impairment losses recognized	(14.9		)	—			(7.1		)
Net realized investment gains (losses) from fixed maturities	(7.6		)	51.4			39.2
Equity securities	3.7			10.1			4.8
Commercial mortgage loans	(2.3		)	(.1		)	(1.1		)
Impairments of mortgage loans and other investments	(25.0		)	(27.3		)	(4.5		)
Gain on dissolution of a variable interest entity	11.3			—			—
Other (a)	(16.7		)	2.6			(5.0		)
Net realized investment gains (losses)	$	(36.6	)	$	36.7		$	33.4

_________________

(a) Changes in the estimated fair value of trading securities that we have elected the fair value option (and still held as of the end of the respective periods) were $(9.2) million, $7.8 million and $(3.0) million for the years ended December 31, 2015, 2014 and 2013, respectively.

During 2015, we recognized net realized investment losses of $36.6 million, which were comprised of: (i) $1.0 million of net losses from the sales of investments; (ii) an $11.3 million gain on the dissolution of a VIE; (iii) the decrease in fair value of embedded derivatives related to a modified coinsurance agreement of $7.0 million; and (iv) $39.9 million of writedowns of investments for other than temporary declines in fair value recognized through net income ($42.9 million, prior to the $3.0 million of impairment losses recognized through accumulated other comprehensive income).

During 2015, a VIE that was required to be consolidated was dissolved. A gain of $11.3 million was recognized representing the difference between the borrowings of such VIE and the contractual distributions required following the liquidation of the underlying assets.

During 2014, we recognized net realized investment gains of $36.7 million, which were comprised of: (i) $54.4 million of net gains from the sales of investments (primarily fixed maturities) with proceeds of $2.1 billion; (ii) the increase in fair value of certain fixed maturity investments with embedded derivatives of $7.6 million; (iii) the increase in fair value of embedded derivatives related to a modified coinsurance agreement of $2.0 million; and (iv) $27.3 million of writedowns of mortgage loans and other investments for other than temporary declines in fair value recognized through net income.

During 2013, we recognized net realized investment gains of $33.4 million, which were comprised of: (i) $51.8 million of net gains from the sales of investments (primarily fixed maturities) with proceeds of $2.3 billion; (ii) the decrease in fair value of certain fixed maturity investments with embedded derivatives of $6.8 million; and (iii) $11.6 million of writedowns of investments for other than temporary declines in fair value recognized through net income.

At December 31, 2015, there were no of fixed maturity securities in default or considered nonperforming.

During 2015, the $88.4 million of realized losses on sales of $724.4 million of fixed maturity securities, available for sale, primarily related to various corporate securities (including $59.7 million related to sales of investments in the energy sector). Securities are generally sold at a loss following unforeseen issue-specific events or conditions or shifts in perceived risks.  These reasons include but are not limited to:  (i) changes in the investment environment; (ii) expectation that the market value could deteriorate further; (iii) desire to reduce our exposure to an asset class, an issuer or an industry; (iv) prospective or actual changes in credit quality; or (v) changes in expected cash flows.

During 2015, we recognized $39.9 million of impairment losses recorded in earnings which included: (i) $10.2 million of writedowns on fixed maturities in the energy sector; (ii) $16.4 million of writedowns on commercial bank loans held by VIEs; (iii) $5.4 million of writedowns on other investments (primarily fixed maturities); and (iv) a $7.9 million writedown of a legacy investment in a private company that was liquidated. We no longer have any exposure to legacy private companies related to investments acquired by our Predecessor. Factors considered in determining the writedowns of investments in 2015 included the subordination status of each investment, the impact of recent downgrades and issuer specific events, including the impact of the current low oil prices on issuers in the energy sector.

During 2014, the $13.0 million of realized losses on sales of $233.7 million of fixed maturity securities, available for sale, included:  (i) $.7 million of losses related to the sales of securities issued by state and political subdivisions; and (ii) $12.3 million of additional losses primarily related to various corporate securities.  

During 2014, we recognized $27.3 million of impairment losses recorded in earnings which included:  (i) a $6.8 million writedown of commercial mortgage loans as a result of our intent to sell the loans; (ii) $19.1 million of impairments related to two legacy private company investments where earnings and cash flows had not met the expectations assumed in our previous valuations; and (iii) $1.4 million of losses on other investments following unforeseen issue-specific events or conditions.

During 2013, the $11.4 million of realized losses on sales of $477.5 million of fixed maturity securities, available for sale, included: (i) $2.5 million of losses related to the sales of mortgage-backed securities and asset-backed securities; and (ii) $8.9 million of additional losses primarily related to various corporate securities.

During 2013, the $11.6 million of other-than-temporary impairments we recorded in earnings included:  (i) $5.0 million of losses on a corporate security; (ii) $2.5 million of losses on an equity security; and (iii) $4.1 million of losses primarily related to fixed maturity securities following unforeseen issue-specific events or conditions.

Our fixed maturity investments are generally purchased in the context of various long-term strategies, including funding insurance liabilities, so we do not generally seek to generate short-term realized gains through the purchase and sale of such securities.  In certain circumstances, including those in which securities are selling at prices which exceed our view of their underlying economic value, or when it is possible to reinvest the proceeds to better meet our long-term asset-liability objectives, we may sell certain securities.

The following summarizes the investments sold at a loss during 2015 which had been continuously in an unrealized loss position exceeding 20 percent of the amortized cost basis prior to the sale for the period indicated (dollars in millions):

		At date of sale
	Number of issuers	Amortized cost		Fair value
Less than 6 months prior to sale	12	$	38.7	$	24.5
Greater than or equal to 6 months and less than 12 months prior to sale	2	16.9		9.5
	14	$	55.6	$	34.0

We regularly evaluate all of our investments with unrealized losses for possible impairment.  Our assessment of whether unrealized losses are "other than temporary" requires significant judgment.  Factors considered include:  (i) the extent to which fair value is less than the cost basis; (ii) the length of time that the fair value has been less than cost; (iii) whether the unrealized loss is event driven, credit-driven or a result of changes in market interest rates or risk premium; (iv) the near-term prospects for specific events, developments or circumstances likely to affect the value of the investment; (v) the investment's rating and whether the investment is investment-grade and/or has been downgraded since its purchase; (vi) whether the issuer is current on all payments in accordance with the contractual terms of the investment and is expected to meet all of its obligations under the terms of the investment; (vii) whether we intend to sell the investment or it is more likely than not that circumstances will require us to sell the investment before recovery occurs; (viii) the underlying current and prospective asset and enterprise values of the issuer and the extent to which the recoverability of the carrying value of our investment may be affected by changes in such values; (ix) projections of, and unfavorable changes in, cash flows on structured securities including mortgage-backed and asset-backed securities; (x) our best estimate of the value of any collateral; and (xi) other objective and subjective factors.

Future events may occur, or additional information may become available, which may necessitate future realized losses in our portfolio.  Significant losses could have a material adverse effect on our consolidated financial statements in future periods.

Impairment losses on equity securities are recognized in net income.  The manner in which impairment losses on fixed maturity securities, available for sale, are recognized in the financial statements is dependent on the facts and circumstances related to the specific security.  If we intend to sell a security or it is more likely than not that we would be required to sell a security before the recovery of its amortized cost, the security is other-than-temporarily impaired and the full amount of the impairment is recognized as a loss through earnings.  If we do not expect to recover the amortized cost basis, we do not plan to sell the security, and if it is not more likely than not that we would be required to sell a security before the recovery of its amortized cost, less any current period credit loss, the recognition of the other-than-temporary impairment is bifurcated.  We recognize the credit loss portion in net income and the noncredit loss portion in accumulated other comprehensive income.

We estimate the amount of the credit loss component of a fixed maturity security impairment as the difference between amortized cost and the present value of the expected cash flows of the security.  The present value is determined using the best estimate of future cash flows discounted at the effective interest rate implicit to the security at the date of purchase or the current yield to accrete an asset-backed or floating rate security.  The methodology and assumptions for establishing the best estimate of future cash flows vary depending on the type of security.

For most structured securities, cash flow estimates are based on bond specific facts and circumstances that may include collateral characteristics, expectations of delinquency and default rates, loss severity, prepayment speeds and structural support, including excess spread, subordination and guarantees.  For corporate bonds, cash flow estimates are derived from scenario-based outcomes of expected corporate restructurings or the disposition of assets using bond specific facts and circumstances. The previous amortized cost basis less the impairment recognized in net income becomes the security's new cost basis.  We accrete the new cost basis to the estimated future cash flows over the expected remaining life of the security, except when the security is in default or considered nonperforming.

The remaining noncredit impairment, which is recorded in accumulated other comprehensive income, is the difference between the security's estimated fair value and our best estimate of future cash flows discounted at the effective interest rate prior to impairment.  The remaining noncredit impairment typically represents changes in the market interest rates, current market liquidity and risk premiums.  As of December 31, 2015, other-than-temporary impairments included in accumulated other comprehensive income totaled $4.9 million (before taxes and related amortization).

Mortgage loans are impaired when it is probable that we will not collect the contractual principal and interest on the loan. We measure impairment based upon the difference between the carrying value of the loan and the estimated fair value of the collateral securing the loan less cost to sell.

The following table summarizes the amount of credit losses recognized in earnings on fixed maturity securities, available for sale, held at the beginning of the period, for which a portion of the other-than-temporary impairment was also recognized in accumulated other comprehensive income for years ended December 31, 2015, 2014 and 2013 (dollars in millions):

	Year ended
	December 31,
	2015			2014			2013
Credit losses on fixed maturity securities, available for sale, beginning of period	$	(1.0	)	$	(1.3	)	$	(1.6	)
Add:  credit losses on other-than-temporary impairments not previously recognized	(2.0		)	—			—
Less:  credit losses on securities sold	.4			.3			.3
Less:  credit losses on securities impaired due to intent to sell (a)	—			—			—
Add:  credit losses on previously impaired securities	—			—			—
Less:  increases in cash flows expected on previously impaired securities	—			—			—
Credit losses on fixed maturity securities, available for sale, end of period	$	(2.6	)	$	(1.0	)	$	(1.3	)

__________

(a) Represents securities for which the amount previously recognized in accumulated other comprehensive income was recognized in earnings because we intend to sell the security or we more likely than not will be required to sell the security before recovery of its amortized cost basis.

Investments with Unrealized Losses

The following table sets forth the amortized cost and estimated fair value of those fixed maturities, available for sale, with unrealized losses at December 31, 2015, by contractual maturity.  Actual maturities will differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without penalties.  Structured securities frequently include provisions for periodic principal payments and permit periodic unscheduled payments.

	Amortized cost		Estimated fair value
	(Dollars in millions)
Due in one year or less	$	20.7	$	20.7
Due after one year through five years	358.7		343.8
Due after five years through ten years	464.3		426.4
Due after ten years	2,938.4		2,637.5
Subtotal	3,782.1		3,428.4
Structured securities	1,916.4		1,881.6
Total	$	5,698.5	$	5,310.0

The following summarizes the investments in our portfolio rated below-investment grade which have been continuously in an unrealized loss position exceeding 20 percent of the cost basis for the period indicated as of December 31, 2015 (dollars in millions):

	Number of issuers	Cost basis		Unrealized loss			Estimated fair value
Less than 6 months	22	$	172.8	$	(50.3	)	$	122.5
Greater than or equal to 6 months and less than 12 months	2	23.0		(9.8		)	13.2
Greater than 12 months (a)	1	18.2		(6.1		)	12.1
		$	214.0	$	(66.2	)	$	147.8

________________

(a) With respect to the security which has been in an unrealized position for greater than 12 months, we have analyzed the issuer's financial performance and determined we expect to recover the entire amortized cost.

The following table summarizes the gross unrealized losses and fair values of our investments with unrealized losses that are not deemed to be other-than-temporarily impaired, aggregated by investment category and length of time that such securities have been in a continuous unrealized loss position, at December 31, 2015 (dollars in millions):

	Less than 12 months					12 months or greater					Total
Description of securities	Fair value		Unrealized losses			Fair value		Unrealized losses			Fair value		Unrealized losses
United States Treasury securities and obligations of United States government corporations and agencies	$	43.6	$	(.3	)	$	—	$	—		$	43.6	$	(.3	)
States and political subdivisions	156.8		(4.1		)	14.8		(3.5		)	171.6		(7.6		)
Debt securities issued by foreign governments	20.7		(.6		)	—		—			20.7		(.6		)
Corporate securities	2,913.6		(255.7		)	278.9		(89.5		)	3,192.5		(345.2		)
Asset-backed securities	930.3		(11.7		)	98.4		(1.7		)	1,028.7		(13.4		)
Collateralized debt obligations	96.2		(1.8		)	36.3		(.4		)	132.5		(2.2		)
Commercial mortgage-backed securities	556.0		(16.1		)	25.7		(1.5		)	581.7		(17.6		)
Mortgage pass-through securities	—		—			.1		—			.1		—
Collateralized mortgage obligations	97.8		(1.0		)	40.8		(.6		)	138.6		(1.6		)
Total fixed maturities, available for sale	$	4,815.0	$	(291.3	)	$	495.0	$	(97.2	)	$	5,310.0	$	(388.5	)
Equity securities	$	140.1	$	(2.4	)	$	2.4	$	(.4	)	$	142.5	$	(2.8	)

The following table summarizes the gross unrealized losses and fair values of our investments with unrealized losses that are not deemed to be other-than-temporarily impaired, aggregated by investment category and length of time that such securities have been in a continuous unrealized loss position, at December 31, 2014 (dollars in millions):

	Less than 12 months					12 months or greater					Total
Description of securities	Fair value		Unrealized losses			Fair value		Unrealized losses			Fair value		Unrealized losses
United States Treasury securities and obligations of United States government corporations and agencies	$	12.1	$	(.1	)	$	4.6	$	—		$	16.7	$	(.1	)
States and political subdivisions	13.2		(.3		)	44.5		(2.7		)	57.7		(3.0		)
Corporate securities	985.0		(65.9		)	297.5		(19.2		)	1,282.5		(85.1		)
Asset-backed securities	91.2		(1.3		)	60.5		(2.1		)	151.7		(3.4		)
Collateralized debt obligations	184.2		(3.4		)	—		—			184.2		(3.4		)
Commercial mortgage-backed securities	46.7		(.5		)	—		—			46.7		(.5		)
Mortgage pass-through securities	.5		—			.1		—			.6		—
Collateralized mortgage obligations	79.0		(.8		)	32.0		(.5		)	111.0		(1.3		)
Total fixed maturities, available for sale	$	1,411.9	$	(72.3	)	$	439.2	$	(24.5	)	$	1,851.1	$	(96.8	)
Equity securities	$	13.2	$	(.6	)	$	.5	$	—		$	13.7	$	(.6	)

Based on management's current assessment of investments with unrealized losses at December 31, 2015, the Company believes the issuers of the securities will continue to meet their obligations (or with respect to equity-type securities, the investment value will recover to its cost basis).  While we do not have the intent to sell securities with unrealized losses and it is not more likely than not that we will be required to sell securities with unrealized losses prior to their anticipated recovery, our intent on an individual security may change, based upon market or other unforeseen developments.  In such instances, if a loss is recognized from a sale subsequent to a balance sheet date due to these unexpected developments, the loss is recognized in the period in which we had the intent to sell the security before its anticipated recovery.

Structured Securities

At December 31, 2015 fixed maturity investments included structured securities with an estimated fair value of $4.7 billion (or 24 percent of all fixed maturity securities).  The yield characteristics of structured securities generally differ in some respects from those of traditional corporate fixed-income securities or government securities.  For example, interest and principal payments on structured securities may occur more frequently, often monthly.  In many instances, we are subject to variability in the amount and timing of principal and interest payments.  For example, in many cases, partial prepayments may occur at the option of the issuer and prepayment rates are influenced by a number of factors that cannot be predicted with certainty, including:  the relative sensitivity of prepayments on the underlying assets backing the security to changes in interest rates and asset values; the availability of alternative financing; a variety of economic, geographic and other factors; the timing, pace and proceeds of liquidations of defaulted collateral; and various security-specific structural considerations (for example, the repayment priority of a given security in a securitization structure).  In addition, the total amount of payments for non-agency structured securities may be affected by changes to cumulative default rates or loss severities of the related collateral.

Historically, the rate of prepayments on structured securities has tended to increase when prevailing interest rates have declined significantly in absolute terms and also relative to the interest rates on the underlying collateral. The yields recognized on structured securities purchased at a discount to par will generally increase (relative to the stated rate) when the underlying collateral prepays faster than expected. The yields recognized on structured securities purchased at a premium will decrease (relative to the stated rate) when the underlying collateral prepays faster than expected. When interest rates decline, the proceeds from prepayments may be reinvested at lower rates than we were earning on the prepaid securities. When interest rates increase, prepayments may decrease below expected levels. When this occurs, the average maturity and duration of structured securities increases, decreasing the yield on structured securities purchased at discounts and increasing the yield on those purchased at a premium because of a decrease in the annual amortization of premium.

For structured securities included in fixed maturities, available for sale, that were purchased at a discount or premium, we recognize investment income using an effective yield based on anticipated future prepayments and the estimated final maturity of the securities. Actual prepayment experience is periodically reviewed and effective yields are recalculated when differences arise between the prepayments originally anticipated and the actual prepayments received and currently anticipated. For credit sensitive mortgage-backed and asset-backed securities, and for securities that can be prepaid or settled in a way that we would not recover substantially all of our investment, the effective yield is recalculated on a prospective basis. Under this method, the amortized cost basis in the security is not immediately adjusted and a new yield is applied prospectively. For all other structured and asset-backed securities, the effective yield is recalculated when changes in assumptions are made, and reflected in our income on a retrospective basis. Under this method, the amortized cost basis of the investment in the securities is adjusted to the amount that would have existed had the new effective yield been applied since the acquisition of the securities. Such adjustments were not significant in 2015.

For purchased credit impaired securities, at acquisition, the difference between the undiscounted expected future cash flows and the recorded investment in the securities represents the initial accretable yield, which is accreted into net investment income over the securities’ remaining lives on a level-yield basis. Subsequently, effective yields recognized on purchased credit impaired securities are recalculated and adjusted prospectively to reflect changes in the contractual benchmark interest rates on variable rate securities and any significant increases in undiscounted expected future cash flows arising due to reasons other than interest rate changes. Significant decreases in expected cash flows arising from credit events would result in impairment if such security's fair value is below amortized cost.

The following table sets forth the par value, amortized cost and estimated fair value of structured securities, summarized by interest rates on the underlying collateral, at December 31, 2015 (dollars in millions):

	Par value		Amortized cost		Estimated fair value
Below 4 percent	$	1,387.4	$	978.3	$	982.3
4 percent – 5 percent	1,363.8		1,289.7		1,300.0
5 percent – 6 percent	1,868.3		1,747.4		1,822.2
6 percent – 7 percent	454.6		419.4		445.2
7 percent – 8 percent	75.0		75.7		82.5
8 percent and above	64.0		63.5		62.8
Total structured securities	$	5,213.1	$	4,574.0	$	4,695.0

The amortized cost and estimated fair value of structured securities at December 31, 2015, summarized by type of security, were as follows (dollars in millions):

			Estimated fair value
Type	Amortized cost		Amount		Percent of fixed maturities
Pass-throughs, sequential and equivalent securities	$	750.0	$	799.8	4.0	%
Planned amortization classes, target amortization classes and accretion-directed bonds	187.7		202.4		1.0
Commercial mortgage-backed securities	1,581.6		1,605.3		8.1
Asset-backed securities	1,817.8		1,852.2		9.3
Collateralized debt obligations	188.5		186.7		.9
Other	48.4		48.6		.3
Total structured securities	$	4,574.0	$	4,695.0	23.6	%

Pass-throughs, sequentials and equivalent securities have unique prepayment variability characteristics.  Pass-through securities typically return principal to the holders based on cash payments from the underlying mortgage obligations. Sequential securities return principal to tranche holders in a detailed hierarchy.  Planned amortization classes, targeted amortization classes and accretion-directed bonds adhere to fixed schedules of principal payments as long as the underlying mortgage loans experience prepayments within certain estimated ranges.  In most circumstances, changes in prepayment rates are first absorbed by support or companion classes insulating the timing of receipt of cash flows from the consequences of both faster prepayments (average life shortening) and slower prepayments (average life extension).

Commercial mortgage-backed securities are secured by commercial real estate mortgages, generally income producing properties that are managed for profit.  Property types include multi-family dwellings including apartments, retail centers, hotels, restaurants, hospitals, nursing homes, warehouses, and office buildings.  While most commercial mortgage-backed securities have call protection features whereby underlying borrowers may not prepay their mortgages for stated periods of time without incurring prepayment penalties, recoveries on defaulted collateral may result in involuntary prepayments.

Commercial Mortgage Loans

At December 31, 2015, the mortgage loan balance was primarily comprised of commercial mortgage loans. Approximately 13 percent, 9 percent, 8 percent and 5 percent of the mortgage loan balance were on properties located in California, Texas, Maryland and Florida, respectively. No other state comprised greater than five percent of the mortgage loan balance. None of the commercial mortgage loan balance was noncurrent at December 31, 2015. Our commercial mortgage loan portfolio is comprised of large commercial mortgage loans. We do not hold groups of smaller-balance homogeneous loans. Our loans have risk characteristics that are individually unique. Accordingly, we measure potential losses on a loan-by-loan basis rather than establishing an allowance for losses on mortgage loans.

The following table provides the carrying value and estimated fair value of our outstanding mortgage loans and the underlying collateral as of December 31, 2015 (dollars in millions):

			Estimated fair value
Loan-to-value ratio (a)	Carrying value		Mortgage loans		Collateral
Less than 60%	$	796.2	$	828.0	$	1,925.0
60% to 70%	503.8		509.6		771.8
Greater than 70% to 80%	326.8		336.9		440.0
Greater than 80% to 90%	89.9		93.0		108.6
Greater than 90%	4.3		4.9		4.3
Total	$	1,721.0	$	1,772.4	$	3,249.7

________________

(a) Loan-to-value ratios are calculated as the ratio of:  (i) the carrying value of the commercial mortgage loans; to (ii) the estimated fair value of the underlying collateral.

Other Investment Disclosures

Life insurance companies are required to maintain certain investments on deposit with state regulatory authorities. Such assets had aggregate carrying values of $38.2 million and $42.3 million at December 31, 2015 and 2014, respectively.

CNO had no fixed maturity investments that were in excess of 10 percent of shareholders' equity at December 31, 2015 and 2014.

XML

FAIR VALUE MEASUREMENTS

12 Months Ended

Dec. 31, 2015

Fair Value Disclosures [Abstract]

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS

Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date and, therefore, represents an exit price, not an entry price.  We carry certain assets and liabilities at fair value on a recurring basis, including fixed maturities, equity securities, trading securities, investments held by VIEs, derivatives, cash and cash equivalents, separate account assets and embedded derivatives.  We carry our COLI, which is invested in a series of mutual funds, at its cash surrender value which approximates fair value. In addition, we disclose fair value for certain financial instruments, including mortgage loans and policy loans, insurance liabilities for interest-sensitive products, investment borrowings, notes payable and borrowings related to VIEs.

The degree of judgment utilized in measuring the fair value of financial instruments is largely dependent on the level to which pricing is based on observable inputs.  Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our view of market assumptions in the absence of observable market information.  Financial instruments with readily available active quoted prices would be considered to have fair values based on the highest level of observable inputs, and little judgment would be utilized in measuring fair value.  Financial instruments that rarely trade would often have fair value based on a lower level of observable inputs, and more judgment would be utilized in measuring fair value.

Valuation Hierarchy

There is a three-level hierarchy for valuing assets or liabilities at fair value based on whether inputs are observable or unobservable.

• Level 1 – includes assets and liabilities valued using inputs that are unadjusted quoted prices in active markets for identical assets or liabilities.  Our Level 1 assets primarily include cash and exchange traded securities.

• Level 2 – includes assets and liabilities valued using inputs that are quoted prices for similar assets in an active market, quoted prices for identical or similar assets in a market that is not active, observable inputs, or observable inputs that can be corroborated by market data.  Level 2 assets and liabilities include those financial instruments that are valued by independent pricing services using models or other valuation methodologies.  These models consider various inputs such as credit rating, maturity, corporate credit spreads, reported trades and other inputs that are observable or derived from observable information in the marketplace or are supported by transactions executed in the marketplace.  Financial assets in this category primarily include:  certain publicly registered and privately placed corporate fixed maturity securities; certain government or agency securities; certain mortgage and asset-backed securities; certain equity securities; most investments held by our consolidated VIEs; certain mutual fund investments; most short-term investments; and non-exchange-traded derivatives such as call options. Financial liabilities in this category include investment borrowings, notes payable and borrowings related to VIEs.

• Level 3 – includes assets and liabilities valued using unobservable inputs that are used in model-based valuations that contain management assumptions.  Level 3 assets and liabilities include those financial instruments whose fair value is estimated based on broker/dealer quotes, pricing services or internally developed models or methodologies utilizing significant inputs not based on, or corroborated by, readily available market information.  Financial assets in this category include certain corporate securities (primarily certain below-investment grade privately placed securities), certain structured securities, mortgage loans, and other less liquid securities.  Financial liabilities in this category include our insurance liabilities for interest-sensitive products, which includes embedded derivatives (including embedded derivatives related to our fixed index annuity products and to a modified coinsurance arrangement) since their values include significant unobservable inputs including actuarial assumptions.

The Company elected to early adopt authoritative guidance that removed the requirement to categorize within the fair value hierarchy certain investments for which fair value is measured using the net asset value per share practical expedient. Accordingly, certain alternative investments classified as other invested assets with a carrying value of $92.7 million and $102.8 million as of December 31, 2015 and 2014, respectively, have not been classified in the fair value hierarchy.

At each reporting date, we classify assets and liabilities into the three input levels based on the lowest level of input that is significant to the measurement of fair value for each asset and liability reported at fair value.  This classification is impacted by a number of factors, including the type of financial instrument, whether the financial instrument is new to the market and not yet established, the characteristics specific to the transaction and overall market conditions.  Our assessment of the significance of a particular input to the fair value measurement and the ultimate classification of each asset and liability requires judgment and is subject to change from period to period based on the observability of the valuation inputs. Any transfers between levels are reported as having occurred at the beginning of the period. There were no transfers between Level 1 and Level 2 in both 2015 and 2014.

The vast majority of our fixed maturity and equity securities, including those held in trading portfolios and those held by consolidated VIEs, short-term and separate account assets use Level 2 inputs for the determination of fair value.  These fair values are obtained primarily from independent pricing services, which use Level 2 inputs for the determination of fair value.  Our Level 2 assets are valued as follows:

•Fixed maturities available for sale, equity securities and trading securities

Corporate securities are generally priced using market and income approaches. Inputs generally consist of trades of identical or similar securities, quoted prices in inactive markets, issuer rating, benchmark yields, maturity, and credit spreads.

U.S. Treasuries and obligations of U.S. Government corporations and agencies are generally priced using the market approach. Inputs generally consist of trades of identical or similar securities, quoted prices in inactive markets and maturity.

States and political subdivisions are generally priced using the market approach. Inputs generally consist of trades of identical or similar securities, quoted prices in inactive markets, new issuances and credit spreads.

Asset-backed securities, collateralized debt obligations, commercial mortgage-backed securities, mortgage pass-through securities and collateralized mortgage obligations are generally priced using market and income approaches. Inputs generally consist of quoted prices in inactive markets, spreads on actively traded securities, expected prepayments, expected credit default rates, delinquencies, and issue specific information including, but not limited to, collateral type, seniority and vintage.

Equity securities (primarily comprised of non-redeemable preferred stock) are generally priced using the market approach. Inputs generally consist of trades of identical or similar securities, quoted prices in inactive markets, issuer rating, benchmark yields, maturity, and credit spreads.

• Investments held by VIEs

Corporate securities are generally priced using market and income approaches using pricing vendors. Inputs generally consist of issuer rating, benchmark yields, maturity, and credit spreads.

• Other invested assets - derivatives

The fair value measurements for derivative instruments, including embedded derivatives requiring bifurcation, are determined based on the consideration of several inputs including closing exchange or over-the-counter market price quotes; time value and volatility factors underlying options; market interest rates; and non-performance risk.

Third party pricing services normally derive security prices through recently reported trades for identical or similar securities making adjustments through the reporting date based upon available market observable information.  If there are no recently reported trades, the third party pricing services may use matrix or model processes to develop a security price where future cash flow expectations are discounted at an estimated risk-adjusted market rate.  The number of prices obtained for a given security is dependent on the Company's analysis of such prices as further described below.

As the Company is responsible for the determination of fair value, we have control processes designed to ensure that the fair values received from third-party pricing sources are reasonable and the valuation techniques and assumptions used appear reasonable and consistent with prevailing market conditions. Additionally, when inputs are provided by third-party pricing sources, we have controls in place to review those inputs for reasonableness. As part of these controls, we perform monthly quantitative and qualitative analysis on the prices received from third parties to determine whether the prices are reasonable estimates of fair value.  The Company's analysis includes:  (i) a review of the methodology used by third party pricing services; (ii) where available, a comparison of multiple pricing services' valuations for the same security; (iii) a review of month to month price fluctuations; (iv) a review to ensure valuations are not unreasonably dated; and (v) back testing to compare actual purchase and sale transactions with valuations received from third parties.  As a result of such procedures, the Company may conclude the prices received from third parties are not reflective of current market conditions.  In those instances, we may request additional pricing quotes or apply internally developed valuations.  However, the number of such instances is insignificant and the aggregate change in value of such investments is not materially different from the original prices received.

The categorization of the fair value measurements of our investments priced by independent pricing services was based upon the Company's judgment of the inputs or methodologies used by the independent pricing services to value different asset classes.  Such inputs include:  benchmark yields, reported trades, broker dealer quotes, issuer spreads, benchmark securities, bids, offers and reference data.  The Company categorizes such fair value measurements based upon asset classes and the underlying observable or unobservable inputs used to value such investments.

For securities that are not priced by pricing services and may not be reliably priced using pricing models, we obtain broker quotes.  These broker quotes are non-binding andrepresent an exit price, but assumptions used to establish the fair value may not be observable and therefore represent Level 3 inputs.  Approximately 45 percent of our Level 3 fixed maturity securities were valued using unadjusted broker quotes or broker-provided valuation inputs.  The remaining Level 3 fixed maturity investments do not have readily determinable market prices and/or observable inputs.  For these securities, we use internally developed valuations.  Key assumptions used to determine fair value for these securities may include risk premiums, projected performance of underlying collateral and other factors involving significant assumptions which may not be reflective of an active market.  For certain investments, we use a matrix or model process to develop a security price where future cash flow expectations are discounted at an estimated market rate.  The pricing matrix incorporates term interest rates as well as a spread level based on the issuer's credit rating, other factors relating to the issuer, and the security's maturity.  In some instances issuer-specific spread adjustments, which can be positive or negative, are made based upon internal analysis of security specifics such as liquidity, deal size, and time to maturity.

For certain embedded derivatives, we use actuarial assumptions in the determination of fair value which we consider to be Level 3 inputs.

The categorization of fair value measurements, by input level, for our financial instruments carried at fair value on a recurring basis at December 31, 2015 is as follows (dollars in millions):

	Quoted prices in active markets for identical assets or liabilities (Level 1)		Significant other observable inputs (Level 2)		Significant unobservable inputs  (Level 3)		Total
Assets:
Fixed maturities, available for sale:
Corporate securities	$	—	$	12,698.1	$	170.4	$	12,868.5
United States Treasury securities and obligations of United States government corporations and agencies	—		194.5		—		194.5
States and political subdivisions	—		2,104.2		—		2,104.2
Debt securities issued by foreign governments	—		20.7		—		20.7
Asset-backed securities	—		1,816.3		35.9		1,852.2
Collateralized debt obligations	—		186.7		—		186.7
Commercial mortgage-backed securities	—		1,604.2		1.1		1,605.3
Mortgage pass-through securities	—		3.3		.1		3.4
Collateralized mortgage obligations	—		1,047.4		—		1,047.4
Total fixed maturities, available for sale	—		19,675.4		207.5		19,882.9
Equity securities - corporate securities	254.9		176.1		32.0		463.0
Trading securities:
Corporate securities	—		21.5		—		21.5
United States Treasury securities and obligations of United States government corporations and agencies	—		1.9		—		1.9
Asset-backed securities	—		35.5		—		35.5
Collateralized debt obligations	—		2.1		—		2.1
Commercial mortgage-backed securities	—		118.1		39.9		158.0
Collateralized mortgage obligations	—		38.2		—		38.2
Equity securities	4.9		—		—		4.9
Total trading securities	4.9		217.3		39.9		262.1
Investments held by variable interest entities - corporate securities	—		1,633.6		—		1,633.6
Other invested assets - derivatives	1.6		41.0		—		42.6
Assets held in separate accounts	—		4.7		—		4.7
Total assets carried at fair value by category	$	261.4	$	21,748.1	$	279.4	$	22,288.9
Liabilities:
Future policy benefits - embedded derivatives associated with fixed index annuity products	$	—	$	—	$	1,057.1	$	1,057.1

The categorization of fair value measurements, by input level, for our financial instruments carried at fair value on a recurring basis at December 31, 2014 is as follows (dollars in millions):

	Quoted prices in active markets  for identical assets or liabilities (Level 1)		Significant other observable inputs  (Level 2)		Significant unobservable inputs  (Level 3)		Total
Assets:
Fixed maturities, available for sale:
Corporate securities	$	—	$	13,605.1	$	365.9	$	13,971.0
United States Treasury securities and obligations of United States government corporations and agencies	—		168.9		—		168.9
States and political subdivisions	—		2,242.2		35.5		2,277.7
Debt securities issued by foreign governments	—		1.9		—		1.9
Asset-backed securities	—		1,209.8		59.2		1,269.0
Collateralized debt obligations	—		324.5		—		324.5
Commercial mortgage-backed securities	—		1,275.1		1.2		1,276.3
Mortgage pass-through securities	—		4.2		.4		4.6
Collateralized mortgage obligations	—		1,341.0		—		1,341.0
Total fixed maturities, available for sale	—		20,172.7		462.2		20,634.9
Equity securities - corporate securities	216.9		174.1		28.0		419.0
Trading securities:
Corporate securities	—		24.3		—		24.3
United States Treasury securities and obligations of United States government corporations and agencies	—		3.7		—		3.7
Asset-backed securities	—		24.0		—		24.0
Commercial mortgage-backed securities	—		131.0		28.6		159.6
Mortgage pass-through securities	—		.1		—		.1
Collateralized mortgage obligations	—		29.7		—		29.7
Equity securities	3.5		—		—		3.5
Total trading securities	3.5		212.8		28.6		244.9
Investments held by variable interest entities - corporate securities	—		1,367.1		—		1,367.1
Other invested assets - derivatives	1.4		107.2		—		108.6
Assets held in separate accounts	—		5.6		—		5.6
Total assets carried at fair value by category	$	221.8	$	22,039.5	$	518.8	$	22,780.1
Liabilities:
Future policy benefits - embedded derivatives associated with fixed index annuity products	$	—	$	—	$	1,081.5	$	1,081.5

For those financial instruments disclosed at fair value, we use the following methods and assumptions to determine the estimated fair values:

Mortgage loans and policy loans.  We discount future expected cash flows based on interest rates currently being offered for similar loans with similar risk characteristics.  We aggregate loans with similar characteristics in our calculations.  The fair value of policy loans approximates their carrying value.

Company-owned life insurance is backed by a series of mutual funds and is carried at cash surrender value which approximates estimated fair value.

Cash and cash equivalents include commercial paper, invested cash and other investments purchased with original maturities of less than three months. We carry them at amortized cost, which approximates estimated fair value.

Liabilities for policyholder account balances.  The estimated fair value of insurance liabilities for policyholder account balances was approximately equal to its carrying value as interest rates credited on the vast majority of account balances approximate current rates paid on similar products and because these rates are not generally guaranteed beyond one year.

Investment borrowings, notes payable and borrowings related to variable interest entities.  For publicly traded debt, we use current fair values.  For other notes, we use discounted cash flow analyses based on our current incremental borrowing rates for similar types of borrowing arrangements.

The fair value measurements for our financial instruments disclosed at fair value on a recurring basis are as follows (dollars in millions):

	December 31, 2015
	Quoted prices in active markets for identical assets or liabilities (Level 1)		Significant other observable inputs  (Level 2)		Significant unobservable inputs  (Level 3)		Total estimated fair value		Total carrying amount
Assets:
Mortgage loans	$	—	$	—	$	1,772.4	$	1,772.4	$	1,721.0
Policy loans	—		—		109.4		109.4		109.4
Other invested assets:
Company-owned life insurance	—		158.1		—		158.1		158.1
Cash and cash equivalents:
Unrestricted	432.3		—		—		432.3		432.3
Held by variable interest entities	364.4		—		—		364.4		364.4
Liabilities:
Policyholder account balances	—		—		10,762.3		10,762.3		10,762.3
Investment borrowings	—		1,549.8		—		1,549.8		1,548.1
Borrowings related to variable interest entities	—		1,673.6		—		1,673.6		1,676.4
Notes payable – direct corporate obligations	—		937.8		—		937.8		911.1

	December 31, 2014
	Quoted prices in active markets for identical assets or liabilities (Level 1)		Significant other observable inputs  (Level 2)		Significant unobservable inputs  (Level 3)		Total estimated fair value		Total carrying amount
Assets:
Mortgage loans	$	—	$	—	$	1,768.9	$	1,768.9	$	1,691.9
Policy loans	—		—		106.9		106.9		106.9
Other invested assets:
Company-owned life insurance	—		157.6		—		157.6		157.6
Cash and cash equivalents:
Unrestricted	549.6		62.0		—		611.6		611.6
Held by variable interest entities	68.3		—		—		68.3		68.3
Liabilities:
Policyholder account balances	—		—		10,707.2		10,707.2		10,707.2
Investment borrowings	—		1,520.4		—		1,520.4		1,519.2
Borrowings related to variable interest entities	—		1,229.2		—		1,229.2		1,271.9
Notes payable – direct corporate obligations	—		807.4		—		807.4		780.3

The following table presents additional information about assets and liabilities measured at fair value on a recurring basis and for which we have utilized significant unobservable (Level 3) inputs to determine fair value for the year ended December 31, 2015 (dollars in millions):

	December 31, 2015
	Beginning balance as of December 31, 2014			Purchases, sales, issuances and settlements, net (b)			Total realized and unrealized gains (losses) included in net income			Total realized and unrealized gains (losses) included in accumulated other comprehensive income (loss)			Transfers into Level 3 (a)		Transfers out of Level 3 (a)			Ending balance as of December 31, 2015			Amount of total gains (losses) for the year ended December 31, 2015 included in our net income relating to assets and liabilities still held as of the reporting date
Assets:
Fixed maturities, available for sale:
Corporate securities	$	365.9		$	31.0		$	(2.2	)	$	(19.5	)	$	37.4	$	(242.2	)	$	170.4		$	—
States and political subdivisions	35.5			(35.5		)	—			—			—		—			—			—
Asset-backed securities	59.2			6.7			—			(1.4		)	—		(28.6		)	35.9			—
Commercial mortgage-backed securities	1.2			(.1		)	—			—			—		—			1.1			—
Mortgage pass-through securities	.4			(.3		)	—			—			—		—			.1			—
Total fixed maturities, available for sale	462.2			1.8			(2.2		)	(20.9		)	37.4		(270.8		)	207.5			—
Equity securities - corporate securities	28.0			4.0			—			—			—		—			32.0			—
Trading securities - commercial mortgage-backed securities	28.6			9.5			—			1.8			—		—			39.9			1.8
Liabilities:
Future policy benefits - embedded derivatives associated with fixed index annuity products	(1,081.5		)	(11.9		)	36.3			—			—		—			(1,057.1		)	36.3

_________

(a) Transfers into Level 3 are the result of unobservable inputs utilized within valuation methodologies for assets that were previously valued using observable inputs. Transfers out of Level 3 are due to the use of observable inputs in valuation methodologies as well as the utilization of pricing service information for certain assets that the Company is able to validate.

(b) Purchases, sales, issuances and settlements, net, represent the activity that occurred during the period that results in a change of the asset or liability but does not represent changes in fair value for the instruments held at the beginning of the period.  Such activity primarily consists of purchases and sales of fixed maturity and equity securities and changes to embedded derivative instruments related to insurance products resulting from the issuance of new contracts, or changes to existing contracts.  The following summarizes such activity for the year ended December 31, 2015 (dollars in millions):

	Purchases			Sales			Issuances			Settlements		Purchases, sales, issuances and settlements, net
Assets:
Fixed maturities, available for sale:
Corporate securities	$	62.2		$	(31.2	)	$	—		$	—	$	31.0
States and political subdivisions	—			(35.5		)	—			—		(35.5		)
Asset-backed securities	13.7			(7.0		)	—			—		6.7
Commercial mortgage-backed securities	—			(.1		)	—			—		(.1		)
Mortgage pass-through securities	—			(.3		)	—			—		(.3		)
Total fixed maturities, available for sale	75.9			(74.1		)	—			—		1.8
Equity securities - corporate securities	4.0			—			—			—		4.0
Trading securities - commercial mortgage-backed securities	9.5			—			—			—		9.5
Liabilities:
Future policy benefits - embedded derivatives associated with fixed index annuity products	(137.8		)	64.4			(4.0		)	65.5		(11.9		)

The following table presents additional information about assets and liabilities measured at fair value on a recurring basis and for which we have utilized significant unobservable (Level 3) inputs to determine fair value for the year ended December 31, 2014 (dollars in millions):

	December 31, 2014
	Beginning balance as of December 31, 2013			Purchases, sales, issuances and settlements, net (b)			Total realized and unrealized gains (losses) included in net income			Total realized and unrealized gains (losses) included in accumulated other comprehensive income (loss)			Transfers into Level 3 (a)		Transfers out of Level 3 (a)			Assets of CLIC sold			Ending balance as of December 31, 2014			Amount of total gains (losses) for the year ended December 31, 2014 included in our net income relating to assets and liabilities still held as of the reporting date
Assets:
Fixed maturities, available for sale:
Corporate securities	$	359.6		$	70.0		$	—		$	20.1		$	36.8	$	(69.4	)	$	(51.2	)	$	365.9		$	—
States and political subdivisions	—			(1.8		)	—			3.0			36.5		—			(2.2		)	35.5			—
Asset-backed securities	42.2			7.6			—			5.1			14.0		—			(9.7		)	59.2			—
Collateralized debt obligations	246.7			—			—			—			—		(246.7		)	—			—			—
Commercial mortgage-backed securities	—			1.1			—			.1			—		—			—			1.2			—
Mortgage pass-through securities	1.6			(1.2		)	—			—			—		—			—			.4			—
Total fixed maturities, available for sale	650.1			75.7			—			28.3			87.3		(316.1		)	(63.1		)	462.2			—
Equity securities - corporate securities	24.5			3.5			—			—			—		—			—			28.0			—
Trading securities - commercial mortgage-backed securities	—			29.0			—			(.4		)	—		—			—			28.6			(.4		)
Liabilities:
Future policy benefits - embedded derivatives associated with fixed index annuity products	(903.7		)	(104.3		)	(73.5		)	—			—		—			—			(1,081.5		)	(73.5		)
Other liabilities - embedded derivatives associated with modified coinsurance agreement	(1.8		)	1.8			—			—			—		—			—			—			—
Total liabilities	(905.5		)	(102.5		)	(73.5		)	—			—		—			—			(1,081.5		)	(73.5		)

____________

(a) Transfers into Level 3 are the result of unobservable inputs utilized within valuation methodologies for assets that were previously valued using observable inputs. Transfers out of Level 3 are due to the use of observable inputs in valuation methodologies as well as the utilization of pricing service information for certain assets that the Company is able to validate.

(b) Purchases, sales, issuances and settlements, net, represent the activity that occurred during the period that results in a change of the asset or liability but does not represent changes in fair value for the instruments held at the beginning of the period.  Such activity primarily consists of purchases and sales of fixed maturity and equity securities and changes to embedded derivative instruments related to insurance products resulting from the issuance of new contracts, or changes to existing contracts.  The following summarizes such activity for the year ended December 31, 2014 (dollars in millions):

	Purchases			Sales			Issuances			Settlements		Purchases, sales, issuances and settlements, net
Assets:
Fixed maturities, available for sale:
Corporate securities	$	71.7		$	(1.7	)	$	—		$	—	$	70.0
States and political subdivisions	—			(1.8		)	—			—		(1.8		)
Asset-backed securities	9.9			(2.3		)	—			—		7.6
Commercial mortgage-backed securities	1.1			—			—			—		1.1
Mortgage pass-through securities	1.1			(2.3		)	—			—		(1.2		)
Total fixed maturities, available for sale	83.8			(8.1		)	—			—		75.7
Equity securities - corporate securities	3.5			—			—			—		3.5
Trading securities - commercial mortgage-backed securities	29.0			—			—			—		29.0
Liabilities:
Future policy benefits - embedded derivatives associated with fixed index annuity products	(121.9		)	7.5			(45.9		)	56.0		(104.3		)
Other liabilities - embedded derivatives associated with modified coinsurance agreement	—			3.4			(1.6		)	—		1.8
Total liabilities	(121.9		)	10.9			(47.5		)	56.0		(102.5		)

At December 31, 2015, 45 percent of our Level 3 fixed maturities, available for sale, were investment grade and 82 percent of our Level 3 fixed maturities, available for sale, consisted of corporate securities.

Realized and unrealized investment gains and losses presented in the preceding tables represent gains and losses during the time the applicable financial instruments were classified as Level 3.

Realized and unrealized gains (losses) on Level 3 assets are primarily reported in either net investment income for policyholder and reinsurer accounts and other special-purpose portfolios, net realized investment gains (losses) or insurance policy benefits within the consolidated statement of operations or accumulated other comprehensive income within shareholders' equity based on the stated accounting policy for the instrument.

The amount presented for gains (losses) included in our net loss for assets and liabilities still held as of the reporting date primarily represents impairments for fixed maturities, available for sale, changes in fair value of trading securities and certain derivatives and changes in fair value of embedded derivative instruments included in liabilities for insurance products that exist as of the reporting date.

The following table provides additional information about the significant unobservable (Level 3) inputs developed internally by the Company to determine fair value for certain assets and liabilities carried at fair value at December 31, 2015 (dollars in millions):

	Fair value at December 31, 2015		Valuation techniques	Unobservable inputs	Range (weighted average)
Assets:
Corporate securities (a)	$	76.9	Discounted cash flow analysis	Discount margins	1.65% - 9.74% (5.35%)
Asset-backed securities (b)	22.2		Discounted cash flow analysis	Discount margins	2.83% - 4.45% (3.50%)
Equity security (c)	32.0		Market approach	Projected cash flows	Not applicable
Other assets categorized as Level 3 (d)	148.3		Unadjusted third-party price source	Not applicable	Not applicable
Total	279.4
Liabilities:
Future policy benefits (e)	1,057.1		Discounted projected embedded derivatives	Projected portfolio yields	5.15% - 5.61% (5.42%)
				Discount rates	0.00 - 3.18% (1.94%)
				Surrender rates	1.67% - 46.56% (14.09%)

________________________________

(a) Corporate securities - The significant unobservable input used in the fair value measurement of our corporate securities is discount margin added to a riskless market yield. Significant increases (decreases) in discount margin in isolation would result in a significantly lower (higher) fair value measurement.

(b) Asset-backed securities - The significant unobservable input used in the fair value measurement of these asset-backed securities is discount margin added to a riskless market yield. Significant increases (decreases) in discount margin in isolation would result in a significantly lower (higher) fair value measurement.

(c) Equity security - This equity security represents an investment in a company that is constructing a manufacturing facility. The significant unobservable input is the cash flows that will be generated upon completion of the manufacturing facility. Given the nature of this investment, the best current indicator of value is the cost basis of the investment, which we believe approximates market value.

(d) Other assets categorized as Level 3 - For these assets, there were no adjustments to quoted market prices obtained from third-party pricing sources.

(e) Future policy benefits - The significant unobservable inputs used in the fair value measurement of our embedded derivatives associated with fixed index annuity products are projected portfolio yields, discount rates and surrender rates. Increases (decreases) in projected portfolio yields in isolation would lead to a higher (lower) fair value measurement. The discount rate is based on the Treasury rate adjusted by a margin. Increases (decreases) in the discount rates would lead to a lower (higher) fair value measurement. Assumed surrender rates are used to project how long the contracts remain in force. Generally, the longer the contracts are assumed to be in force the higher the fair value of the embedded derivative.

The following table provides additional information about the significant unobservable (Level 3) inputs developed internally by the Company to determine fair value for certain assets and liabilities carried at fair value at December 31, 2014 (dollars in millions):

	Fair value at December 31, 2014		Valuation techniques	Unobservable inputs	Range (weighted average)
Assets:
Corporate securities (a)	$	312.1	Discounted cash flow analysis	Discount margins	1.48% - 5.83% (2.58%)
Asset-backed securities (b)	30.6		Discounted cash flow analysis	Discount margins	1.99% - 4.15% (2.95%)
Equity security (c)	28.0		Market approach	Projected cash flows	Not applicable
Other assets categorized as Level 3 (d)	148.1		Unadjusted third-party price source	Not applicable	Not applicable
Total	518.8
Liabilities:
Future policy benefits (e)	1,081.5		Discounted projected embedded derivatives	Projected portfolio yields	5.15% - 5.61% (5.42%)
				Discount rates	0.00 - 2.74% (1.78%)
				Surrender rates	1.98% - 47.88% (14.16%)

________________________________

(a) Corporate securities - The significant unobservable input used in the fair value measurement of our corporate securities is discount margin added to a riskless market yield. Significant increases (decreases) in discount margin in isolation would result in a significantly lower (higher) fair value measurement.

(b) Asset-backed securities - The significant unobservable input used in the fair value measurement of these asset-backed securities is discount margin added to a riskless market yield. Significant increases (decreases) in discount margin in isolation would result in a significantly lower (higher) fair value measurement.

(c) Equity security - This equity security represents an investment in a company that is constructing a manufacturing facility. The significant unobservable input is the cash flows that will be generated upon completion of the manufacturing facility. Given the nature of this investment, the best current indicator of value is the cost basis of the investment, which we believe approximates market value.

(d) Other assets categorized as Level 3 - For these assets, there were no adjustments to quoted market prices obtained from third-party pricing sources.

(e) Future policy benefits - The significant unobservable inputs used in the fair value measurement of our embedded derivatives associated with fixed index annuity products are projected portfolio yields, discount rates and surrender rates. Increases (decreases) in projected portfolio yields in isolation would lead to a higher (lower) fair value measurement. The discount rate is based on the Treasury rate adjusted by a margin. Increases (decreases) in the discount rates would lead to a lower (higher) fair value measurement. Assumed surrender rates are used to project how long the contracts remain in force. Generally, the longer the contracts are assumed to be in force the higher the fair value of the embedded derivative.

XML

LIABILITIES FOR INSURANCE PRODUCTS

12 Months Ended

Dec. 31, 2015

Insurance [Abstract]

LIABILITIES FOR INSURANCE PRODUCTS

LIABILITIES FOR INSURANCE PRODUCTS

Our future policy benefits are summarized as follows (dollars in millions):

	Withdrawal assumption	Morbidity assumption	Mortality assumption	Interest rate assumption	2015		2014
Long-term care	Company experience	Company experience	Company experience	6%	$	5,172.2	$	5,385.2
Traditional life insurance contracts	Company experience	Company experience	(a)	5%	2,248.7		2,175.8
Accident and health contracts	Company experience	Company experience	Company experience	5%	2,589.9		2,519.1
Interest-sensitive life insurance contracts	Company experience	Company experience	Company experience	4%	44.7		47.6
Annuities and supplemental contracts with life contingencies	Company experience	Company experience	(b)	4%	546.6		707.7
Total					$	10,602.1	$	10,835.4

____________________

(a) Principally, modifications of: (i) the 1965 ‑ 70 and 1975 - 80 Basic Tables; and (ii) the 1941, 1958 and 1980 Commissioners' Standard Ordinary Tables; as well as Company experience.

(b) Principally, modifications of: (i) the 1971 Individual Annuity Mortality Table; (ii) the 1983 Table "A"; and (iii) the Annuity 2000 Mortality Table; as well as Company experience.

Our policyholder account balances are summarized as follows (dollars in millions):

	2015		2014
Fixed index annuities	$	4,884.4	$	4,496.9
Other annuities	4,885.1		5,280.8
Interest-sensitive life insurance contracts	992.8		929.5
Total	$	10,762.3	$	10,707.2

The Company establishes reserves for insurance policy benefits based on assumptions as to investment yields, mortality, morbidity, withdrawals, lapses and maintenance expenses. These reserves include amounts for estimated future payment of claims based on actuarial assumptions. The balance includes provision for the Company's best estimate of the future policyholder benefits to be incurred on this business, given recent and expected future changes in experience.

Changes in the unpaid claims reserve (included in claims payable) and disabled life reserves related to accident and health insurance (included in the liability for future policy benefits) were as follows (dollars in millions):

	2015			2014			2013
Balance, beginning of year	$	1,679.5		$	1,710.1		$	1,679.3
Less reinsurance receivables	(125.0		)	(164.1		)	(27.4		)
Net balance, beginning of year	1,554.5			1,546.0			1,651.9
Incurred claims related to:
Current year	1,481.0			1,468.1			1,511.1
Prior years (a)	(13.3		)	(39.9		)	(162.3		)
Total incurred	1,467.7			1,428.2			1,348.8
Interest on claim reserves	71.0			70.5			75.2
Paid claims related to:
Current year	841.8			848.7			870.0
Prior years	649.6			641.5			659.9
Total paid	1,491.4			1,490.2			1,529.9
Net balance, end of year	1,601.8			1,554.5			1,546.0
Add reinsurance receivables	130.0			125.0			164.1
Balance, end of year	$	1,731.8		$	1,679.5		$	1,710.1

___________

(a) The reserves and liabilities we establish are necessarily based on estimates, assumptions and prior years' statistics. Such amounts will fluctuate based upon the estimation procedures used to determine the amount of unpaid losses. It is possible that actual claims will exceed our reserves and have a material adverse effect on our results of operations and financial condition.

XML

INCOME TAXES

12 Months Ended

Dec. 31, 2015

Income Tax Disclosure [Abstract]

INCOME TAXES

INCOME TAXES

The components of income tax expense (benefit) were as follows (dollars in millions):

	2015			2014			2013
Current tax expense	$	10.7		$	15.6		$	8.2
Deferred tax expense	118.6			143.6			120.1
Tax expense on period income	129.3			159.2			128.3
Tax expense related to the sale of CLIC	—			14.2			—
Deferred taxes on expired capital loss carryforwards	—			—			159.4
Change in valuation allowance	(32.5		)	(48.8		)	(472.1		)
Other items	.2			(.9		)	11.2
Total income tax expense (benefit)	$	97.0		$	123.7		$	(173.2	)

A reconciliation of the U.S. statutory corporate tax rate to the estimated annual effective rate reflected in the consolidated statement of operations is as follows:

	2015		2014		2013
U.S. statutory corporate rate	35.0	%	35.0	%	35.0	%
Valuation allowance	(8.8	)	(27.9	)	(154.9	)
Expired capital loss carryforwards (which were fully offset by a corresponding reduction in the valuation allowance)	—		—		52.3
Non-taxable income and nondeductible benefits, net	(.2	)	(.9	)	5.0
State taxes	2.1		1.5		1.9
Impact of the sale of CLIC	—		66.3		—
Other items	(1.7	)	(3.4	)	3.9
Effective tax rate	26.4	%	70.6	%	(56.8	)%

The components of the Company's income tax assets and liabilities are summarized below (dollars in millions):

	2015			2014
Deferred tax assets:
Net federal operating loss carryforwards	$	916.3		$	1,048.4
Net state operating loss carryforwards	14.1			15.2
Tax credits	55.3			47.2
Capital loss carryforwards	13.8			—
Investments	26.5			59.7
Insurance liabilities	600.3			585.9
Other	63.0			67.3
Gross deferred tax assets	1,689.3			1,823.7
Deferred tax liabilities:
Present value of future profits and deferred acquisition costs	(305.4		)	(320.5		)
Accumulated other comprehensive income	(223.8		)	(457.4		)
Gross deferred tax liabilities	(529.2		)	(777.9		)
Net deferred tax assets before valuation allowance	1,160.1			1,045.8
Valuation allowance	(213.5		)	(246.0		)
Net deferred tax assets	946.6			799.8
Current income taxes accrued	(47.8		)	(41.1		)
Income tax assets, net	$	898.8		$	758.7

Our income tax expense includes deferred income taxes arising from temporary differences between the financial reporting and tax bases of assets and liabilities, capital loss carryforwards and NOLs. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply in the years in which temporary differences are expected to be recovered or paid.  The effect of a change in tax rates on deferred tax assets and liabilities is recognized in earnings in the period when the changes are enacted.

A reduction of the net carrying amount of deferred tax assets by establishing a valuation allowance is required if, based on the available evidence, it is more likely than not that such assets will not be realized. In assessing the need for a valuation allowance, all available evidence, both positive and negative, shall be considered to determine whether, based on the weight of that evidence, a valuation allowance for deferred tax assets is needed. This assessment requires significant judgment and considers, among other matters, the nature, frequency and severity of current and cumulative losses, forecasts of future profitability, the duration of carryforward periods, our experience with operating loss and tax credit carryforwards expiring unused, and tax planning strategies. We evaluate the need to establish a valuation allowance for our deferred income tax assets on an ongoing basis. The realization of our deferred tax assets depends upon generating sufficient future taxable income of the appropriate type during the periods in which our temporary differences become deductible and before our capital loss carryforwards and life and non-life NOLs expire.

Based on our assessment, it appears more likely than not that $946.6 million of our total deferred tax assets of $1,160.1 million will be realized through future taxable earnings. Accordingly, we have established a deferred tax valuation allowance of $213.5 million at December 31, 2015. We will continue to assess the need for a valuation allowance in the future. If future results are less than projected, an increase to the valuation allowance may be required to reduce the deferred tax asset, which could have a material impact on our results of operations in the period in which it is recorded.

We use a deferred tax valuation model to assess the need for a valuation allowance. Our model is adjusted to reflect changes in our projections of future taxable income including changes resulting from investment trading strategies, reinsurance transactions and the impact of the sale of CLIC. Our estimates of future taxable income are based on evidence we consider to be objective and verifiable.

At December 31, 2015, our projection of future taxable income for purposes of determining the valuation allowance is based on our adjusted average annual taxable income which is assumed to remain flat for two years and then increase by 3 percent for the next five years, and level taxable income is assumed thereafter. In the projections used for our analysis, our adjusted average taxable income is based on the level of recent normalized taxable income, which was approximately $345 million ($75 million of which relates to non-life taxable income and $270 million relates to life taxable income).

Based on our assessment, we recognized a reduction to the allowance for deferred tax assets of $32.5 million in 2015. We have evaluated the recovery of our deferred tax assets and assessed the effect of limitations and/or interpretations on their value and have concluded that it is more likely than not that the value recognized will be fully realized in the future.

Changes in our valuation allowance are summarized as follows (dollars in millions):

Balance, December 31, 2012	$	766.9
Decrease in 2013	(472.1		)	(a)
Balance, December 31, 2013	294.8
Decrease in 2014	(48.8		)	(b)
Balance, December 31, 2014	246.0
Decrease in 2015	(32.5		)	(c)
Balance, December 31, 2015	$	213.5

___________________

(a) The 2013 reduction to the deferred tax valuation allowance primarily resulted from the impact of higher levels of income on projected future taxable income, the expiration of capital loss carryforwards, a settlement with the Internal Revenue Service (the "IRS") related to the classification of a portion of the cancellation of indebtedness income and the execution of certain investment trading strategies.

(b) The 2014 reduction to the deferred tax valuation allowance primarily resulted from tax examination adjustments and the tax gain on the sale of CLIC.

(c) The 2015 reduction to the deferred tax valuation allowance primarily resulted from higher actual and projected non-life income.

Recovery of our deferred tax asset is dependent on achieving the level of future taxable income projected in our deferred tax valuation model and failure to do so could result in an increase in the valuation allowance in a future period.  Any future increase in the valuation allowance may result in additional income tax expense and reduce shareholders' equity, and such an increase could have a significant impact upon our earnings in the future.

The Internal Revenue Code (the "Code") limits the extent to which losses realized by a non-life entity (or entities) may offset income from a life insurance company (or companies) to the lesser of:  (i) 35 percent of the income of the life insurance company; or (ii) 35 percent of the total loss of the non-life entities (including NOLs of the non-life entities).  There is no similar limitation on the extent to which losses realized by a life insurance entity (or entities) may offset income from a non-life entity (or entities). This limitation is the primary reason a valuation allowance for non-life NOL carryforwards is required.

Section 382 of the Code imposes limitations on a corporation's ability to use its NOLs when the company undergoes an ownership change.  Future transactions and the timing of such transactions could cause an ownership change for Section 382 income tax purposes.  Such transactions may include, but are not limited to, additional repurchases under our securities repurchase program, issuances of common stock and acquisitions or sales of shares of CNO stock by certain holders of our shares, including persons who have held, currently hold or may accumulate in the future five percent or more of our outstanding common stock for their own account.  Many of these transactions are beyond our control.  If an additional ownership change were to occur for purposes of Section 382, we would be required to calculate an annual restriction on the use of our NOLs to offset future taxable income.  The annual restriction would be calculated based upon the value of CNO's equity at the time of such ownership change, multiplied by a federal long-term tax exempt rate (2.61 percent at December 31, 2015), and the annual restriction could limit our ability to use a substantial portion of our NOLs to offset future taxable income.  We regularly monitor ownership change (as calculated for purposes of Section 382) and, as of December 31, 2015, we were below the 50 percent ownership change level that would trigger further impairment of our ability to utilize our NOLs.

On January 20, 2009, the Company's Board of Directors adopted a Section 382 Rights Agreement designed to protect shareholder value by preserving the value of our tax assets primarily associated with tax NOLs under Section 382. The Section 382 Rights Agreement was adopted to reduce the likelihood of an ownership change occurring by deterring the acquisition of stock that would create "5 percent shareholders" as defined in Section 382. On December 6, 2011, the Company's Board of Directors amended the Section 382 Rights Agreement to, among other things, (i) extend the final expiration date of the Amended Rights Agreement to December 6, 2014, (ii) update the purchase price of the rights described below, (iii) provide for a new series of preferred stock relating to the rights that is substantially identical to the prior series of preferred stock, (iv) provide for a 4.99 percent ownership threshold relating to any Company 382 Securities (as defined below), and amend other provisions to reflect best practices for tax benefit preservation plans, including updates to certain definitions. On November 13, 2014, the Company entered into the Second Amended and Restated Section 382 Rights Agreement which (as subsequently amended) extends the final expiration date of the Amended Section 382 Rights Agreement to November 13, 2017, updates the purchase price of the Rights and provides for a new series of preferred stock relating to the Rights that is substantially identical to the prior series of preferred stock. The Second Amended Rights Agreement was approved by the Company’s stockholders at the Company’s 2015 annual meeting.

Under the Section 382 Rights Agreement, one right was distributed for each share of our common stock outstanding as of the close of business on January 30, 2009 and for each share issued after that date. Pursuant to the Amended Section 382 Rights Agreement, if any person or group (subject to certain exemptions) becomes an owner of more than 4.99 percent of the Company's outstanding common stock (or any other interest in the Company that would be treated as "stock" under applicable Section 382 regulations) without the approval of the Board of Directors, there would be a triggering event causing significant dilution in the voting power and economic ownership of that person or group. Shareholders who held more than 4.99 percent of the Company's outstanding common stock as of December 6, 2011 will trigger a dilutive event only if they acquire additional shares exceeding one percent of our outstanding shares without prior approval from the Board of Directors.

On May 11, 2010, our shareholders approved an amendment to CNO's certificate of incorporation designed to prevent certain transfers of common stock which could otherwise adversely affect our ability to use our NOLs (the "Original Section 382 Charter Amendment"). Subject to the provisions set forth in the Original Section 382 Charter Amendment, transfers of our common stock would be void and of no effect if the effect of the purported transfer would be to: (i) increase the direct or indirect ownership of our common stock by any person or public group (as such term is defined in the regulations under Section 382) from less than 5% to 5% or more of our common stock; (ii) increase the percentage of our common stock owned directly or indirectly by a person or public group owning or deemed to own 5% or more of our common stock; or (iii) create a new public group.

On May 8, 2013, our shareholders approved an amendment (the “Extended Section 382 Charter Amendment”) to CNO’s certificate of incorporation to: (i) extend the term of the Original Section 382 Charter Amendment for three years until December 31, 2016, (ii) provide for a 4.99 percent ownership threshold relating to our stock, and (iii) amend certain other provisions of the Original Section 382 Charter Amendment, including updates to certain definitions, for consistency with the Amended Section 382 Rights Agreement.

As of December 31, 2015, we had $2.6 billion of federal NOLs. The following table summarizes the expiration dates of our loss carryforwards assuming the IRS ultimately agrees with the position we have taken with respect to the loss on our investment in Conseco Senior Health Insurance Company ("CSHI") and other uncertain tax positions (dollars in millions):

Year of expiration	Net operating loss carryforwards						Total loss
	Life			Non-life			carryforwards
2023	$	538.3		$	1,922.0		$	2,460.3
2025	—			91.5			91.5
2026	—			207.4			207.4
2027	—			4.9			4.9
2028	—			203.7			203.7
2029	—			146.6			146.6
2032	—			44.0			44.0
Subtotal	538.3			2,620.1			3,158.4
Less:
Unrecognized tax benefits	(342.9		)	(197.4		)	(540.3		)
Total	$	195.4		$	2,422.7		$	2,618.1

In addition, at December 31, 2015, we had $39.4 million of capital loss carryforwards that expire in 2020.

We had deferred tax assets related to NOLs for state income taxes of $14.1 million and $15.2 million at December 31, 2015 and 2014, respectively.  The related state NOLs are available to offset future state taxable income in certain states through 2025.

A reconciliation of the beginning and ending amount of unrecognized tax benefits for the years ended December 31, 2015 and 2014 is as follows (dollars in millions):

	Years ended December 31,
	2015		2014
Balance at beginning of year	$	228.7	$	226.7
Increase based on tax positions taken in prior years	5.5		10.9
Decrease based on tax positions taken in prior years	—		—
Increase based on tax positions taken in the current year	—		—
Decrease in unrecognized tax benefits related to settlements with taxing authorities	—		(8.9		)
Balance at end of year	$	234.2	$	228.7

As of both December 31, 2015 and 2014, $155.4 million of our unrecognized tax benefits, if recognized, would affect the effective tax rate. The remaining balances relate to timing differences which, if recognized, would have no effect on the Company's tax expense. The Company recognizes interest related to unrecognized tax benefits as income tax expense in the consolidated statement of operations. Such amounts were not significant in each of the three years ended December 31, 2015. The liability for accrued interest was $3.2 million and $2.4 million at December 31, 2015 and 2014, respectively.

We recognized an $878 million ordinary loss on our investment in CSHI which was worthless when it was transferred to an independent trust in 2008. Of this loss, $742 million has been reported as a life loss and $136 million as a non-life loss. The IRS disagreed with our ordinary loss treatment and believes that it should be treated as a capital loss, subject to a five year carryover. If the IRS position is ultimately determined to be correct, $473 million would have expired unused in 2013. Due to this uncertainty, we have not recognized a tax benefit of $166.0 million. However, if this unrecognized tax benefit would have been recognized, we would also have established a valuation allowance of $34.0 million at December 31, 2015.

The IRS has completed the examination for 2004 and 2008 through 2010 and has proposed two adjustments to which we disagree, including the adjustment to classify the loss on our investment in CSHI as a capital loss as described above. The Company is contesting these adjustments through the IRS Appeals Office. Although the resolution of the Appeals could occur in the next 12 months, there is no reasonable basis to estimate the changes in unrecognized tax benefits that may occur. The IRS has also begun an examination of 2011 and 2012. In connection with this exam, we have agreed to extend the statute of limitations to September 10, 2017. The Company’s various state income tax returns are generally open for tax years beginning in 2012, based on individual state statutes of limitation. Generally, for tax years which generate NOLs, capital losses or tax credit carryforwards, the statute remains open until the expiration of the statute of limitations for the tax year in which such carryforwards are utilized. The outcome of tax audits cannot be predicted with certainty. If the Company’s tax audits are not resolved in a manner consistent with management’s expectations, the Company may be required to adjust its provision for income taxes.

We currently expect to utilize all of our remaining life NOLs in 2016, absent a favorable outcome on the classification of the loss on our investment in CSHI. After all of the life NOLs are utilized, we will begin making cash tax payments equal to the prescribed federal tax rate applied to 65 percent of our life insurance company taxable income due to the limitations on the extent to which we can use non-life NOLs to offset life insurance company taxable income. We will continue to pay tax on only 65 percent of our life insurance company taxable income until all non-life NOLs are utilized or expire.

In accordance with GAAP, we are precluded from recognizing the tax benefits of any tax windfall upon the exercise of a stock option or the vesting of restricted stock unless such deduction resulted in actual cash savings to the Company. Because of the Company's NOLs, no cash savings have occurred. The value of NOL carryforwards of $13.9 million related to deductions for stock options and restricted stock will be reflected in additional paid-in capital if realized.

XML

NOTES PAYABLE - DIRECT CORPORATE OBLIGATIONS

12 Months Ended

Dec. 31, 2015

Debt Disclosure [Abstract]

NOTES PAYABLE - DIRECT CORPORATE OBLIGATIONS

NOTES PAYABLE - DIRECT CORPORATE OBLIGATIONS

The following notes payable were direct corporate obligations of the Company as of December 31, 2015 and 2014 (dollars in millions):

	2015			2014
4.500% Senior Notes due May 2020	$	325.0		$	—
5.250% Senior Notes due May 2025	500.0			—
New Revolving Credit Agreement (as defined below)	100.0			—
Unamortized debt issue costs	(13.9		)	(14.1		)
Previous Senior Secured Credit Agreement (as defined below)	—			522.1
6.375% Senior Secured Notes due October 2020 (the "6.375% Notes")	—			275.0
Unamortized discount on Previous Senior Secured Credit Agreement	—			(2.7		)
Direct corporate obligations	$	911.1		$	780.3

New Notes

On May 19, 2015, the Company executed the Indenture, dated as of May 19, 2015 (the "Base Indenture") and the First Supplemental Indenture, dated as of May 19, 2015 (the "Supplemental Indenture" and, together with the Base Indenture, the "Indenture"), between the Company and Wilmington Trust, National Association, as trustee (the "Trustee") pursuant to which the Company issued $325.0 million aggregate principal amount of 4.500% Senior Notes due 2020 (the "2020 Notes") and $500.0 million aggregate principal amount of 5.250% Senior Notes due 2025 (the "2025 Notes" and, together with the 2020 Notes, the "Notes").

The Company used the proceeds of the offering of the Notes, together with borrowings under the New Revolving Credit Agreement (as defined below): (i) to repay all amounts outstanding under the Company's Previous Senior Secured Credit Agreement (as defined below); (ii) to redeem and satisfy and discharge all of the outstanding 6.375% Notes; and (iii) to pay fees and expenses related to the offering of the Notes and the foregoing transactions. The remaining proceeds of the Notes and the borrowings under the New Revolving Credit Agreement were used for general corporate purposes, including share repurchases.

The 2020 Notes mature on May 30, 2020, and the 2025 Notes mature on May 30, 2025. Interest on the 2020 Notes is payable at 4.500% per annum. Interest on the 2025 Notes is payable at 5.250% per annum. Interest on the Notes is payable semi-annually in cash in arrears on May 30 and November 30 of each year, commencing on November 30, 2015.

The Notes are the Company's senior unsecured obligations and rank equally with the Company's other senior unsecured and unsubordinated debt from time to time outstanding, including obligations under a $150.0 millionfour-year unsecured revolving credit agreement (the "New Revolving Credit Agreement"). The Notes are effectively subordinated to all of the Company's existing and future secured indebtedness to the extent of the value of the assets securing such indebtedness. The Notes are structurally subordinated to all existing and future indebtedness and other liabilities of the Company's subsidiaries.

The Company may redeem some or all of the 2020 Notes at any time or from time to time at a "make-whole" redemption price plus accrued and unpaid interest to, but not including, the redemption date.

Prior to February 28, 2025, the Company may redeem some or all of the 2025 Notes at any time or from time to time at a "make-whole" redemption price plus accrued and unpaid interest to, but not including, the redemption date. On and after February 28, 2025, the Company may redeem some or all of the 2025 Notes at any time or from time to time at a redemption price equal to 100% of the principal amount thereof plus accrued and unpaid interest to, but not including, the redemption date.

Upon the occurrence of a Change of Control Repurchase Event (as defined in the Indenture), the Company will be required to make an offer to repurchase the Notes at a price equal to 101% of the principal amount thereof, plus accrued and unpaid interest, if any, to, but not including, the date of repurchase.

The Indenture contains covenants that restrict the Company’s ability, with certain exceptions, to:

• incur certain subsidiary indebtedness without also guaranteeing the Notes;

• create liens;

• enter into sale and leaseback transactions;

• issue, sell, transfer or otherwise dispose of any shares of capital stock of any Insurance Subsidiary (as defined in the Indenture); and

• consolidate or merge with or into other companies or transfer all or substantially all of the Company’s assets.

The Indenture provides for customary events of default (subject in certain cases to customary grace and cure periods), which include nonpayment, breach of covenants in the Indenture, failure to pay at maturity or acceleration of other indebtedness, a failure to pay certain judgments and certain events of bankruptcy and insolvency. Generally, if an event of default occurs, the Trustee or holders of at least 25% in principal amount of the then outstanding Notes may declare the principal of and accrued but unpaid interest, including any additional interest, on all of the Notes to be due and payable.

New Revolving Credit Agreement

On May 19, 2015, the Company entered into the New Revolving Credit Agreement, with KeyBank National Association, as administrative agent (the "Agent"), and the lenders from time to time party thereto. On May 19, 2015, the Company made an initial drawing of $100.0 million under the New Revolving Credit Agreement, resulting in $50.0 million available for additional borrowings. The New Revolving Credit Agreement matures on May 19, 2019.

The New Revolving Credit Agreement includes an uncommitted subfacility for swingline loans of up to $5.0 million, and up to $5.0 million of the New Revolving Credit Agreement is available for the issuance of letters of credit. The Company may incur additional incremental loans under the New Revolving Credit Agreement in an aggregate principal amount of up to $50.0 million, provided that there are no events of default and subject to certain other terms and conditions including the delivery of certain documentation.

The interest rates with respect to loans under the New Revolving Credit Agreement are based on, at the Company's option, a floating base rate (defined as a per annum rate equal to the highest of: (i) the federal funds rate plus 0.50%; (ii) the "prime rate" of the Agent; and (iii) the eurodollar rate for a one-month interest period plus an applicable margin of initially 1.00% per annum), or a eurodollar rate plus an applicable margin of initially 2.00% per annum. At December 31, 2015, the interest rate on the amounts outstanding under the New Revolving Credit Agreement was 2.42 percent. In addition, the daily average undrawn portion of the New Revolving Credit Agreement will accrue a commitment fee payable quarterly in arrears. The applicable margin for, and the commitment fee applicable to, the New Revolving Credit Agreement, will be adjusted from time-to-time pursuant to a ratings based pricing grid. In addition, a fronting fee, in an amount equal to 0.125% per annum on the aggregate face amount of the outstanding letters of credit, will be payable to the issuers of such letters of credit.

The New Revolving Credit Agreement contains certain financial, affirmative and negative covenants. The negative covenants in the New Revolving Credit Agreement include restrictions that relate to, among other things and subject to customary baskets, exceptions and limitations for facilities of this type:

• subsidiary debt;

• liens;

• restrictive agreements;

• restricted payments during the continuance of an event of default;

• disposition of assets and sale and leaseback transactions;

• transactions with affiliates;

• change in business;

• fundamental changes;

• modification of certain agreements; and

• changes to fiscal year.

The New Revolving Credit Agreement requires the Company to maintain (each as calculated in accordance with the New Revolving Credit Agreement): (i) a debt to total capitalization ratio of not more than 30.0 percent (such ratio was 19.9 percent at December 31, 2015); (ii) an aggregate ratio of total adjusted capital to company action level risk-based capital for the Company's insurance subsidiaries of not less than 250 percent (such ratio was estimated to be 449 percent at December 31, 2015); and (iii) a minimum consolidated net worth of not less than the sum of (x) $2,674 million plus (y) 50.0% of the net equity proceeds received by the Company from the issuance and sale of equity interests in the Company (the Company's consolidated net worth was $3,735.7 million at December 31, 2015 compared to the minimum requirement of $2,677 million).

The New Revolving Credit Agreement provides for customary events of default (subject in certain cases to customary grace and cure periods), which include, without limitation, the following:

• non-payment;

• breach of representations, warranties or covenants;

• cross-default and cross-acceleration;

• bankruptcy and insolvency events;

• judgment defaults;

• actual or asserted invalidity of documentation with respect to the New Revolving Credit Agreement;

• change of control; and

• customary ERISA defaults.

If an event of default under the New Revolving Credit Agreement occurs and is continuing, the Agent may accelerate the amounts and terminate all commitments outstanding under the New Revolving Credit Agreement.

Previous Senior Secured Credit Agreement

The Company used a portion of the net proceeds from its offering of the Notes, together with borrowings under the New Revolving Credit Agreement, to repay all of the outstanding borrowings under its credit agreement, dated as of September 28, 2012 (as amended by the First Amendment to Credit Agreement dated May 20, 2013, and as further amended by the Second Amendment to Credit Agreement dated May 30, 2014, the "Previous Senior Secured Credit Agreement") among the Company, the lenders from time to time party thereto, and JPMorgan Chase Bank, N.A., as agent. The Previous Senior Secured Credit Agreement consisted of: (i) a six-year term loan facility with $389.8 million outstanding prior to repayment; (ii) a four-year term loan facility with $112.5 million outstanding prior to repayment; and (iii) a $50.0 millionthree-year revolving credit facility that had no outstanding principal balance. Upon repayment of all such outstanding borrowings on May 19, 2015, all of the commitments under the Previous Senior Secured Credit Agreement were terminated, all of the collateral securing the facilities thereunder was released, the related security, guarantee and intercreditor agreements were terminated and any remaining restrictive covenants and certain additional events of default contained in the Previous Senior Secured Credit Agreement ceased to have effect.

The six-year term loan facility amortized in quarterly installments in amounts resulting in an annual amortization of 1% and the four-year term loan facility amortized in quarterly installments resulting in an annual amortization of 20% during the first and second years and 30% during the third and fourth years.

On May 30, 2014, the Company completed an amendment to the Previous Senior Secured Credit Agreement to waive the requirement that the net proceeds in excess of $125 million received from the sale of CLIC be used to prepay amounts outstanding under the Previous Senior Secured Credit Agreement.

In May 2013, we amended our Previous Senior Secured Credit Agreement. Pursuant to the amended terms, the applicable interest rates were decreased. At December 31, 2014, the interest rates on the six-year term loan facility and the four-year term loan facility were 3.75% and 3.00%, respectively.

Other changes made in May 2013 to the Previous Senior Secured Credit Agreement included modifications of mandatory prepayments resulting from certain restricted payments made (including any common stock dividends and share repurchases) as defined in the Previous Senior Secured Credit Agreement.

In 2015, we made $19.8 million of scheduled quarterly principal payments due under the Previous Senior Secured Credit Agreement. In 2014, we made $59.4 million of scheduled quarterly principal payments due under the Previous Senior Secured Credit Agreement. In the first six months of 2013, we made mandatory prepayments of $20.4 million in an amount equal to 33.33% of our share repurchases and common stock dividend payments, as required under the terms of our Previous Senior Secured Credit Agreement. No mandatory prepayments were required in the second half of 2013 as our debt to total capitalization ratio, as defined in the Previous Senior Secured Credit Agreement, was below 20.0 percent. We also made additional payments of $42.7 million in 2013 to cover the remaining portion of the scheduled quarterly principal payments due under the Previous Senior Secured Credit Agreement.

6.375% Notes

On September 28, 2012, we issued $275.0 million in aggregate principal amount of 6.375% Notes pursuant to an Indenture, dated as of September 28, 2012 (the "6.375% Indenture"), among the Company, the subsidiary guarantors party thereto and the Trustee. On May 19, 2015, the Company deposited with the Trustee for the 6.375% Notes sufficient funds to satisfy and discharge the indenture governing the 6.375% Indenture and to fund the make-whole redemption of the outstanding 6.375% Notes and to pay accrued and unpaid interest on the redeemed notes to, but not including, the June 10, 2015 redemption date. Upon the satisfaction and discharge of the 6.375% Indenture, all of the collateral securing the 6.375% Notes was released, the related security and intercreditor agreements were terminated and any remaining restrictive covenants and certain additional events of default contained in the 6.375% Indenture ceased to have effect.

The following table sets forth the sources and uses of cash from the debt refinancing transactions discussed above (dollars in millions):

Sources:
	Notes	$	825.0
	New Revolving Credit Agreement	100.0
	Total sources	$	925.0
Uses:
	Repayment of Previous Senior Secured Credit Agreement	$	502.3
	Repayment of 6.375% Notes, including redemption premium	292.8
	Accrued interest	4.3
	Debt issuance costs	16.0
	General corporate purposes	109.6
	Total uses	$	925.0

7.0% Debentures

From November 2009 through May 2010, we issued $293.0 million aggregate principal amount of our 7.0% Senior Debentures due 2016 (the "7.0% Debentures"). The Company used the net proceeds from the issuance of the 7.0% Debentures to retire outstanding indebtedness.

The 7.0% Debentures ranked equally in right of payment with all of the Company's unsecured and unsubordinated obligations. The 7.0% Debentures were governed by an Indenture dated as of October 16, 2009 between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee. The 7.0% Debentures bore interest at a rate of 7.0% per annum, payable semi-annually on June 30 and December 30 of each year. The 7.0% Debentures would have matured on December 30, 2016. The 7.0% Debentures were not convertible prior to June 30, 2013, except under limited circumstances. Commencing on June 30, 2013, the 7.0% Debentures were convertible into shares of our common stock at the option of the holder at any time, subject to certain exceptions and subject to our right to terminate such conversion rights under certain circumstances relating to the sale price of our common stock. As further described below, we elected to terminate the conversion rights in July 2013.

In September 2012, the Company repurchased $200.0 million in aggregate principal amount of the Company's 7.0% Debentures for a cash purchase price of $355.1 million. On March 28, 2013, the Company completed the cash tender offer (the "Offer") for $59.3 million aggregate principal amount of its 7.0% Debentures for an aggregate purchase price of $124.8 million.

In May 2013, we repurchased $4.5 million principal amount of the 7.0% Debentures for an aggregate purchase price of $9.4 million.

On July 1, 2013, the Company issued a conversion right termination notice to holders of the remaining outstanding 7.0% Debentures. Holders of the 7.0% Debentures were able to exercise their conversion right at any time on or prior to the close of business on July 30, 2013. Holders exercising their conversion right received 184.3127 shares of common stock per $1,000 principal amount of 7.0% Debentures converted. Holders of $25.7 million in aggregate principal amount of the 7.0% Debentures exercised their conversion right and received 4.7 million shares of our common stock.

On May 30, 2014, we repurchased the remaining $3.5 million principal amount of the 7.0% Debentures for a purchase price of $3.7 million.

Loss on Extinguishment of Debt

In 2015, we recognized a loss on extinguishment or modification of debt totaling $32.8 million primarily related to: (i) the redemption premium related to the repayment of the 6.375% Notes; and (ii) the write-off of unamortized discount and issuance costs associated with the repayment of the Previous Senior Secured Credit Agreement and the 6.375% Notes.

In 2014, we recognized a loss on extinguishment or modification of debt totaling $.6 million consisting of: (i) $.4 million of expenses related to the amendment of the Previous Senior Secured Credit Agreement; and (ii) $.2 million related to the repurchase of the remaining principal amount of the 7.0% Debentures.

In 2013, we recognized a loss on extinguishment of debt totaling $65.4 million consisting of: (i) $2.9 million related to the amendment of the Previous Senior Secured Credit Agreement and the write-off of unamortized discount and issuance costs associated with prepayments on the Previous Senior Secured Credit Agreement; and (ii) $62.5 million as a result of the Offer and repurchase of 7.0% Debentures described above, the write-off of unamortized discount and issuance costs associated with the 7.0% Debentures that were repurchased and other transaction costs. Additional paid-in capital was also reduced by $12.6 million to extinguish the beneficial conversion feature associated with a portion of the 7.0% Debentures that were repurchased.

Scheduled Repayment of our Direct Corporate Obligations

The scheduled repayment of our direct corporate obligations was as follows at December 31, 2015 (dollars in millions):

Year ending December 31,
2016	$	—
2017	—
2018	—
2019	100.0
2020	325.0
Thereafter	500.0
	$	925.0

XML

LITIGATION AND OTHER LEGAL PROCEEDINGS

12 Months Ended

Dec. 31, 2015

Commitments and Contingencies Disclosure [Abstract]

LITIGATION AND OTHER LEGAL PROCEEDINGS

LITIGATION AND OTHER LEGAL PROCEEDINGS

Legal Proceedings

The Company and its subsidiaries are involved in various legal actions in the normal course of business, in which claims for compensatory and punitive damages are asserted, some for substantial amounts.  We recognize an estimated loss from these loss contingencies when we believe it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. Some of the pending matters have been filed as purported class actions and some actions have been filed in certain jurisdictions that permit punitive damage awards that are disproportionate to the actual damages incurred.  The amounts sought in certain of these actions are often large or indeterminate and the ultimate outcome of certain actions is difficult to predict.  In the event of an adverse outcome in one or more of these matters, there is a possibility that the ultimate liability may be in excess of the liabilities we have established and could have a material adverse effect on our business, financial condition, results of operations and cash flows.  In addition, the resolution of pending or future litigation may involve modifications to the terms of outstanding insurance policies or could impact the timing and amount of rate increases, which could adversely affect the future profitability of the related insurance policies.  Based upon information presently available, and in light of legal, factual and other defenses available to the Company and its subsidiaries, the Company does not believe that it is probable that the ultimate liability from either pending or threatened legal actions, after consideration of existing loss provisions, will have a material adverse effect on the Company's consolidated financial condition, operating results or cash flows. However, given the inherent difficulty in predicting the outcome of legal proceedings, there exists the possibility that such legal actions could have a material adverse effect on the Company's consolidated financial condition, operating results or cash flows.

In addition to the inherent difficulty of predicting litigation outcomes, particularly those that will be decided by a jury, some matters purport to seek substantial or an unspecified amount of damages for unsubstantiated conduct spanning several years based on complex legal theories and damages models. The alleged damages typically are indeterminate or not factually supported in the complaint, and, in any event, the Company's experience indicates that monetary demands for damages often bear little relation to the ultimate loss. In some cases, plaintiffs are seeking to certify classes in the litigation and class certification either has been denied or is pending and we have filed oppositions to class certification or sought to decertify a prior class certification. In addition, for many of these cases: (i) there is uncertainty as to the outcome of pending appeals or motions; (ii) there are significant factual issues to be resolved; and/or (iii) there are novel legal issues presented. Accordingly, the Company cannot reasonably estimate the possible loss or range of loss in excess of amounts accrued, if any, or predict the timing of the eventual resolution of these matters.  The Company reviews these matters on an ongoing basis.  When assessing reasonably possible and probable outcomes, the Company bases its assessment on the expected ultimate outcome following all appeals.

Regulatory Examinations and Fines

Insurance companies face significant risks related to regulatory investigations and actions.  Regulatory investigations generally result from matters related to sales or underwriting practices, payment of contingent or other sales commissions, claim payments and procedures, product design, product disclosure, additional premium charges for premiums paid on a periodic basis, denial or delay of benefits, charging excessive or impermissible fees on products, procedures related to canceling policies, changing the way cost of insurance charges are calculated for certain life insurance products or recommending unsuitable products to customers.  We are, in the ordinary course of our business, subject to various examinations, inquiries and information requests from state, federal and other authorities.  The ultimate outcome of these regulatory actions (including the costs of complying with information requests and policy reviews) cannot be predicted with certainty.  In the event of an unfavorable outcome in one or more of these matters, the ultimate liability may be in excess of liabilities we have established and we could suffer significant reputational harm as a result of these matters, which could also have a material adverse effect on our business, financial condition, results of operations or cash flows.

In August 2011, we were notified of an examination to be done on behalf of a number of states for the purpose of determining compliance with unclaimed property laws by the Company and its subsidiaries.  Such examination has included inquiries related to the use of data available on the U.S. Social Security Administration's Death Master File to identify instances where benefits under life insurance policies, annuities and retained asset accounts are payable. We are continuing to provide information to the examiners in response to their requests. A total of 38 states and the District of Columbia are currently participating in this examination.

Guaranty Fund Assessments

The balance sheet at December 31, 2015, included: (i) accruals of $24.0 million, representing our estimate of all known assessments that will be levied against the Company's insurance subsidiaries by various state guaranty associations based on premiums written through December 31, 2015; and (ii) receivables of $26.1 million that we estimate will be recovered through a reduction in future premium taxes as a result of such assessments. At December 31, 2014, such guaranty fund assessment accruals were $23.7 million and such receivables were $23.6 million. These estimates are subject to change when the associations determine more precisely the losses that have occurred and how such losses will be allocated among the insurance companies. We recognized expense for such assessments of $1.2 million, $1.1 million and $2.7 million in 2015, 2014 and 2013, respectively.

Guarantees

In accordance with the terms of the employment agreements of two of the Company's former chief executive officers, certain wholly-owned subsidiaries of the Company are the guarantors of the former executives' nonqualified supplemental retirement benefits. The liability for such benefits was $25.8 million and $27.2 million at December 31, 2015 and 2014, respectively, and is included in the caption "Other liabilities" in the consolidated balance sheet.

Leases and Certain Other Long-Term Commitments

The Company rents office space, equipment and computer software under noncancellable operating lease agreements. In addition, the Company has entered into certain sponsorship agreements which require future payments. Total expense pursuant to these lease and sponsorship agreements was $48.8 million, $50.4 million and $44.3 million in 2015, 2014 and 2013, respectively. Future required minimum payments as of December 31, 2015, were as follows (dollars in millions):

2016	$	54.3
2017	33.2
2018	28.3
2019	17.2
2020	5.2
Thereafter	8.9
Total	$	147.1

XML

AGENT DEFERRED COMPENSATION PLAN

12 Months Ended

Dec. 31, 2015

Compensation and Retirement Disclosure [Abstract]

AGENT DEFERRED COMPENSATION PLAN

AGENT DEFERRED COMPENSATION PLAN

For our agent deferred compensation plan, it is our policy to immediately recognize changes in the actuarial benefit obligation resulting from either actual experience being different than expected or from changes in actuarial assumptions.

One of our insurance subsidiaries has a noncontributory, unfunded deferred compensation plan for qualifying members of its career agency force. Benefits are based on years of service and career earnings. The actuarial measurement date of this deferred compensation plan is December 31. The liability recognized in the consolidated balance sheet for the agent deferred compensation plan was $170.8 million and $175.1 million at December 31, 2015 and 2014, respectively. Expenses incurred on this plan were $2.2 million, $36.3 million and $(2.9) million during 2015, 2014 and 2013, respectively (including the recognition of gains (losses) of $15.2 million, $(24.3) million and $17.2 million in 2015, 2014 and 2013, respectively, primarily resulting from: (i) changes in the discount rate assumption used to determine the deferred compensation plan liability to reflect current investment yields; and (ii) changes in mortality table assumptions). We purchased COLI as an investment vehicle to fund the agent deferred compensation plan. The COLI assets are not assets of the agent deferred compensation plan, and as a result, are accounted for outside the plan and are recorded in the consolidated balance sheet as other invested assets. The carrying value of the COLI assets was $158.1 million and $157.6 million at December 31, 2015 and 2014, respectively. Changes in the cash surrender value (which approximates net realizable value) of the COLI assets are recorded as net investment income and totaled $.5 million, $5.7 million and $19.7 million in 2015, 2014 and 2013, respectively.

We used the following assumptions for the deferred compensation plan to calculate:

	2015		2014
Benefit obligations:
Discount rate	4.50	%	4.15	%
Net periodic cost:
Discount rate	4.15	%	4.75	%

The discount rate is based on the yield of a hypothetical portfolio of high quality debt instruments which could effectively settle plan benefits on a present value basis as of the measurement date. At December 31, 2015, for our deferred compensation plan for qualifying members of our career agency force, we assumed a 4.0 percent annual increase in compensation until the participant's assumed retirement date (ranging from ages 60 to 65 and completion of five years of service).

The benefits expected to be paid pursuant to our agent deferred compensation plan as of December 31, 2015 were as follows (dollars in millions):

2016	$	6.6
2017	6.9
2018	7.3
2019	7.8
2020	8.1
2021 - 2025	47.2

The Company has a qualified defined contribution plan for which substantially all employees are eligible. Company contributions, which match a portion of certain voluntary employee contributions to the plan, totaled $5.0 million, $5.1 million and $4.6 million in 2015, 2014 and 2013, respectively. Employer matching contributions are discretionary.

XML

DERIVATIVES

12 Months Ended

Dec. 31, 2015

Derivative Instruments and Hedging Activities Disclosure [Abstract]

DERIVATIVES

DERIVATIVES

Our freestanding and embedded derivatives, which are not designated as hedging instruments, are held at fair value and are summarized as follows (dollars in millions):

	Fair value
	2015			2014
Assets:
Other invested assets:
Fixed index call options	$	41.0		$	107.2
Interest rate futures	.1			(.2		)
Reinsurance receivables	(5.0		)	2.0
Total assets	$	36.1		$	109.0
Liabilities:
Future policy benefits:
Fixed index products	$	1,057.1		$	1,081.5
Total liabilities	$	1,057.1		$	1,081.5

The activity associated with freestanding derivative instruments is measured as either the notional or the number of contracts. The activity associated with the fixed index annuity embedded derivatives are shown by the number of policies. The following table represents activity associated with derivative instruments as of the dates indicated:

	Measurement	December 31, 2014		Additions		Maturities/terminations			December 31, 2015
Interest futures	Contracts	402		2,643		(2,781		)	264
Fixed index annuities - embedded derivative	Policies	93,185		10,256		(6,781		)	96,660
Fixed index call options	Notional (a)	$	2,403.9	$	2,397.0	$	(2,421.2	)	$	2,379.7

_________________

(a) Dollars in millions.

We are required to establish an embedded derivative related to a modified coinsurance agreement pursuant to which we assume the risks of a block of health insurance business. The embedded derivative represents the mark-to-market adjustment for approximately $145 million in underlying investments held by the ceding reinsurer.

The following table provides the pre-tax gains (losses) recognized in net income for derivative instruments, which are not designated as hedges for the periods indicated (dollars in millions):

	2015			2014			2013
Net investment income from policyholder and reinsurer accounts and other special-purpose portfolios:
Fixed index call options	$	(36.2	)	$	69.5		$	177.5
Embedded derivative related to reinsurance contract	—			(1.4		)	3.7
Total	(36.2		)	68.1			181.2
Net realized gains (losses):
Interest rate futures	(2.7		)	(7.0		)	(.4		)
Embedded derivative related to modified coinsurance agreement	(7.0		)	2.0			—
Total	(9.7		)	(5.0		)	(.4		)
Insurance policy benefits:
Embedded derivative related to fixed index annuities	36.3			(73.5		)	49.3
Total	$	(9.6	)	$	(10.4	)	$	230.1

Derivative Counterparty Risk

If the counterparties to the call options fail to meet their obligations, we may recognize a loss.  We limit our exposure to such a loss by diversifying among several counterparties believed to be strong and creditworthy.  At December 31, 2015, all of our counterparties were rated "A-" or higher by S&P.

The interest rate future contracts are effected through regulated exchanges. Such positions are marked to market and margined on a daily basis. The Company has minimal exposure to credit-related losses in the event of nonperformance.

The Company and its subsidiaries are parties to master netting arrangements with its counterparties related to entering into various derivative contracts. Exchange-traded derivatives require margin accounts which we offset.

Repurchase agreements

We may enter into agreements under which we sell securities subject to an obligation to repurchase the same securities. These repurchase agreements are accounted for as collateralized financing arrangements and not as a sale and subsequent repurchase of securities. The obligation to repurchase the securities is reflected as investment borrowings in the Company's consolidated balance sheet, while the securities underlying the repurchase agreements remain in the respective investment asset accounts. There is no offsetting or netting of the investment securities assets with the repurchase agreement liabilities. In addition, as the Company does not currently have any outstanding reverse repurchase agreements, there is no such offsetting to be done with the repurchase agreements.

The right of offset for a repurchase agreement resembles a secured borrowing, whereby the collateral would be used to settle the fair value of the repurchase agreement should the Company be in default under the agreement (e.g., fails to make an interest payment to the counterparty). If the counterparty were to default (e.g., declare bankruptcy), the Company could cancel the repurchase agreement (i.e., cease payment of principal and interest), and attempt collection on the amount of collateral value in excess of the repurchase agreement fair value. The collateral is held by a third party financial institution in the counterparty's custodial account. The counterparty has the right to sell or repledge the investment securities.

The following table summarizes information related to derivatives and repurchase agreements with master netting arrangements or collateral as of December 31, 2015 and 2014 (dollars in millions):

									Gross amounts not offset in the balance sheet
		Gross amounts recognized			Gross amounts offset in the balance sheet		Net amounts of assets presented in the balance sheet		Financial instruments		Cash collateral received		Net amount
December 31, 2015:
	Fixed index call options	$	41.0		$	—	$	41.0	$	—	$	—	$	41.0
	Interest rate futures	.1			1.5		1.6		—		—		1.6
December 31, 2014:
	Fixed index call options	107.2			—		107.2		—		—		107.2
	Interest rate futures	(.2		)	1.5		1.3		—		—		1.3
	Repurchase agreements (a)	20.4			—		20.4		20.4		—		—

_________________

(a) As of December 31, 2014, these agreements were collateralized by investment securities with a fair value of $25.3 million.

XML

SHAREHOLDERS' EQUITY

12 Months Ended

Dec. 31, 2015

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

SHAREHOLDERS' EQUITY

SHAREHOLDERS' EQUITY

Changes in the number of shares of common stock outstanding were as follows (shares in thousands):

	2015		2014		2013
Balance, beginning of year	203,324		220,324		221,502
Treasury stock purchased and retired	(20,582	)	(18,489	)	(8,949	)
Conversion of 7.0% Debentures	—		—		4,739
Stock options exercised	769		916		2,087
Restricted and performance stock vested (a)	518		573		945
Balance, end of year	184,029		203,324		220,324

____________________

(a) In 2015, 2014 and 2013, such amount was reduced by 237 thousand, 257 thousand and 472 thousand shares, respectively, which were tendered to the Company for the payment of required federal and state tax withholdings owed on the vesting of restricted and performance stock.

In May 2011, the Company announced a securities repurchase program of up to $100.0 million. In February 2012, June 2012, December 2012, December 2013, November 2014 and November 2015, the Company's Board of Directors approved, in aggregate, an additional $1,600.0 million to repurchase the Company's outstanding securities. In 2015, 2014 and 2013, we repurchased 20.6 million, 18.5 million and 8.9 million shares, respectively, for $365.2 million, $319.1 million and $118.4 million, respectively, under the securities repurchase program. In addition, in September 2014, we repurchased all outstanding common stock warrants for $57.4 million under the securities repurchase program. In 2013, the Company also purchased $63.8 million aggregate principal amount of our 7.0% Debentures as further discussed in the note to the consolidated financial statements entitled "Notes Payable - Direct Corporate Obligations". Such purchases were made pursuant to our securities repurchase program. The Company had remaining repurchase authority of $455.7 million as of December 31, 2015.

In 2015, 2014 and 2013, dividends declared and paid on common stock totaled $52.0 million ($0.27 per common share), $51.0 million ($0.24 per common share) and $24.4 million ($0.11 per common share), respectively. In May 2015, the Company increased its quarterly common stock dividend to $0.07 per share from $0.06 per share.

The Company has a long-term incentive plan which permits the grant of CNO incentive or non-qualified stock options, restricted stock awards, stock appreciation rights, performance shares or units and certain other equity-based awards to certain directors, officers and employees of the Company and certain other individuals who perform services for the Company. As of December 31, 2015, 6.9 million shares remained available for issuance under the plan. Our stock option awards are generally granted with an exercise price equal to the market price of the Company's stock on the date of grant. For options granted in 2006 and prior years, our stock option awards generally vested on a graded basis over a four year service term and expire ten years from the date of grant. Our stock option awards granted in 2007 through 2009 generally vested on a graded basis over a three year service term and expired five years from the date of grant. Our stock options granted in 2010 through 2014 generally vest on a graded basis over a three year service term and expire seven years from the date of grant. Our stock options granted in 2015 generally vest on a graded basis over a three year service term and expire ten years from the date of grant. The vesting periods for our restricted stock awards range from immediate vesting to a period of three years.

A summary of the Company's stock option activity and related information for 2015 is presented below (shares in thousands; dollars in millions, except per share amounts):

	Shares		Weighted average exercise price			Weighted average remaining life (in years)	Aggregate intrinsic value
Outstanding at the beginning of the year	5,011		$	12.04
Options granted	1,361		16.45
Exercised	(769	)	(8.20		)		$	4.8
Forfeited or terminated	(404	)	(17.70		)
Outstanding at the end of the year	5,199		13.32			4.8	$	38.4
Options exercisable at the end of the year	2,399					2.5	$	15.3
Available for future grant	6,882

A summary of the Company's stock option activity and related information for 2014 is presented below (shares in thousands; dollars in millions, except per share amounts):

	Shares		Weighted average exercise price		Weighted average remaining life (in years)	Aggregate intrinsic value
Outstanding at the beginning of the year	5,579		$	10.64
Options granted	1,014		19.10
Exercised	(917	)	5.47			$	3.8
Forfeited or terminated	(665	)	20.07
Outstanding at the end of the year	5,011		12.04		4.3	$	32.1
Options exercisable at the end of the year	2,030				2.7	$	12.1
Available for future grant	8,571

A summary of the Company's stock option activity and related information for 2013 is presented below (shares in thousands; dollars in millions, except per share amounts):

	Shares		Weighted average exercise price		Weighted average remaining life (in years)	Aggregate intrinsic value
Outstanding at the beginning of the year	6,655		$	9.72
Options granted	1,447		11.01
Exercised	(2,087	)	7.27			$	6.0
Forfeited or terminated	(436	)	13.95
Outstanding at the end of the year	5,579		10.64		4.0	$	32.5
Options exercisable at the end of the year	2,529				2.1	$	13.9
Available for future grant	9,099

We recognized compensation expense related to stock options totaling $9.6 million ($6.2 million after income taxes) in 2015, $7.9 million ($5.1 million after income taxes) in 2014 and $7.2 million ($4.7 million after income taxes) in 2013. Compensation expense related to stock options reduced both basic and diluted earnings per share by three cents in 2015 and two cents in both 2014 and 2013. At December 31, 2015, the unrecognized compensation expense for non-vested stock options totaled $11.2 million which is expected to be recognized over a weighted average period of 1.9 years. Cash received by the Company from the exercise of stock options was $6.3 million, $5.0 million and $15.1 million during 2015, 2014 and 2013, respectively.

The fair value of each stock option grant is estimated on the date of grant using the Black-Scholes option valuation model with the following weighted average assumptions:

	2015			2014			2013
	Grants			Grants			Grants
Weighted average risk-free interest rates	1.7		%	1.6		%	.8		%
Weighted average dividend yields	1.5		%	1.3		%	.7		%
Volatility factors	85		%	51		%	107		%
Weighted average expected life (in years)	6.3			4.8			4.8
Weighted average fair value per share	$	10.83		$	7.65		$	8.02

The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant. The dividend yield is based on the Company's history and expectation of dividend payouts. Volatility factors are based on the weekly historical volatility of the Company's common stock equal to the expected life of the option. The expected life is based on the average of the graded vesting period and the contractual terms of the option.

The exercise price was equal to the market price of our stock on the date of grant for all options granted in 2015, 2014 and 2013.

The following table summarizes information about stock options outstanding at December 31, 2015 (shares in thousands):

		Options outstanding			Options exercisable
Range of exercise prices	Number outstanding	Remaining life (in years)	Average exercise price		Number exercisable	Average exercise price
$6.45 - $6.77	427	1.2	$	6.45	427	$	6.45
$7.38 - $7.51	1,097	2.8	7.46		1,097	7.46
$8.29 - $12.34	1,146	4.1	10.76		551	10.61
$12.74 - $18.27	1,332	8.9	16.40		18	14.49
$19.15 - $25.45	1,197	4.0	20.18		306	23.19
	5,199				2,399

During 2015, 2014 and 2013, the Company granted .1 million, .1 million and .2 million restricted shares, respectively, of CNO common stock to certain directors, officers and employees of the Company at a weighted average fair value of $17.59 per share, $17.15 per share and $12.00 per share, respectively. The fair value of such grants totaled $1.7 million, $1.9 million and $2.1 million in 2015, 2014 and 2013, respectively. Such amounts are recognized as compensation expense over the vesting period of the restricted stock. A summary of the Company's non-vested restricted stock activity for 2015 is presented below (shares in thousands):

	Shares		Weighted average grant date fair value
Non-vested shares, beginning of year	236		$	10.95
Granted	95		17.59
Vested	(234	)	11.73
Forfeited	(2	)	11.31
Non-vested shares, end of year	95		15.66

At December 31, 2015, the unrecognized compensation expense for non-vested restricted stock totaled $.9 million which is expected to be recognized over a weighted average period of 1.6 years. At December 31, 2014, the unrecognized compensation expense for non-vested restricted stock totaled $1.4 million. We recognized compensation expense related to restricted stock awards totaling $2.2 million, $3.0 million and $4.5 million in 2015, 2014 and 2013, respectively. The fair value of restricted stock that vested during 2015, 2014 and 2013 was $2.7 million, $3.7 million and $5.6 million, respectively.

Authoritative guidance also requires us to estimate the amount of unvested stock-based awards that will be forfeited in future periods and reduce the amount of compensation expense recognized over the applicable service period to reflect this estimate. We periodically evaluate our forfeiture assumptions to more accurately reflect our actual forfeiture experience.

The Company does not currently recognize tax benefits resulting from tax deductions in excess of the compensation expense recognized because of NOLs which are available to offset future taxable income.

In 2015, 2014 and 2013 the Company granted performance units totaling 516,660, 283,630 and 424,400, respectively, pursuant to its long-term incentive plan to certain officers of the Company. The criteria for payment for such awards are based on certain company-wide performance levels that must be achieved within a specified performance time (generally three years), each as defined in the award. The performance units granted in 2015 provide for a payout of up to 200 percent of the award if certain performance thresholds are achieved, and the performance units granted prior to 2015 provide for a payout of up to 150 percent of the award if certain performance thresholds are achieved. Unless antidilutive, the diluted weighted average shares outstanding would reflect the number of performance units expected to be issued, using the treasury stock method.

A summary of the Company's performance units is presented below (shares in thousands):

	Total shareholder return awards		Operating return on equity awards		Pre-tax operating income awards
Awards outstanding at December 31, 2012	193		—		977
Granted in 2013	212		212		—
Additional shares issued pursuant to achieving certain performance criteria (a)	—		—		223
Shares vested in 2013	—		—		(668	)
Forfeited	(23	)	(8	)	(62	)
Awards outstanding at December 31, 2013	382		204		470
Granted in 2014	142		142		—
Additional shares issued pursuant to achieving certain performance criteria (a)	—		—		142
Shares vested in 2014	—		—		(434	)
Forfeited	(5	)	(3	)	(2	)
Awards outstanding at December 31, 2014	519		343		176
Granted in 2015	258		258		—
Additional shares issued pursuant to achieving certain performance criteria (a)	85		—		85
Shares vested in 2015	(260	)	—		(260	)
Forfeited	(53	)	(52	)	(1	)
Awards outstanding at December 31, 2015	549		549		—

_________________________

(a) The performance units that vested in these years provided for a payout of up to 150 percent of the award if certain performance levels were achieved.

The grant date fair value of the performance units awarded was $9.4 million and $5.2 million in 2015 and 2014, respectively. We recognized compensation expense of $5.3 million, $4.7 million and $3.4 million in 2015, 2014 and 2013, respectively, related to the performance units.

As further discussed in the footnote to the consolidated financial statements entitled "Income Taxes", the Company's Board of Directors adopted the Section 382 Rights Agreement on January 20, 2009 and amended and extended the Section 382 Rights Agreement on December 6, 2011 and November 13, 2014. The Section 382 Rights Agreement, as amended, is designed to protect shareholder value by preserving the value of our tax assets primarily associated with NOLs. At the time the Section 382 Rights Agreement was adopted, the Company declared a dividend of one preferred share purchase right (a "Right") for each outstanding share of common stock. The dividend was payable on January 30, 2009, to the shareholders of record as of the close of business on that date and a Right is also attached to each share of CNO common stock issued after that date. Pursuant to the Section 382 Rights Agreement, as amended, each Right entitles the shareholder to purchase from the Company one one-thousandth of a share of Series C Junior Participating Preferred Stock, par value $.01 per share (the "Junior Preferred Stock") of the Company at a price of $70.00 per one one-thousandth of a share of Junior Preferred Stock. The description and terms of the Rights are set forth in the Section 382 Rights Agreement, as amended. The Rights would become exercisable in the event any person or group (subject to certain exemptions) becomes an owner of more than 4.99 percent of the outstanding stock of CNO (a "Threshold Holder") without the approval of the Board of Directors or an existing shareholder who is currently a Threshold Holder acquires additional shares exceeding one percent of our outstanding shares without prior approval from the Board of Directors.

A reconciliation of net income and shares used to calculate basic and diluted earnings per share is as follows (dollars in millions and shares in thousands):

	2015		2014		2013
Net income for basic earnings per share	$	270.7	$	51.4	$	478.0
Add:  interest expense on 7.0% Debentures, net of income taxes	—		—		1.6
Net income for diluted earnings per share	$	270.7	$	51.4	$	479.6
Shares:
Weighted average shares outstanding for basic earnings per share	193,054		212,917		221,628
Effect of dilutive securities on weighted average shares:
7.0% Debentures	—		—		5,780
Stock options, restricted stock and performance units	2,112		2,505		2,776
Warrants (a)	—		2,233		2,518
Dilutive potential common shares	2,112		4,738		11,074
Weighted average shares outstanding for diluted earnings per share	195,166		217,655		232,702

________

(a) All outstanding warrants were repurchased in September 2014 as further discussed above. Accordingly, the warrants have no dilutive effect in periods beginning after September 30, 2014.

Basic earnings per common share is computed by dividing net income by the weighted average number of common shares outstanding for the period.  Restricted shares (including our performance units) are not included in basic earnings per share until vested.  Diluted earnings per share reflect the potential dilution that could occur if outstanding stock options and warrants were exercised and restricted stock was vested.  The dilution from options, warrants and restricted shares is calculated using the treasury stock method.  Under this method, we assume the proceeds from the exercise of the options and warrants (or the unrecognized compensation expense with respect to restricted stock and performance units) will be used to purchase shares of our common stock at the average market price during the period, reducing the dilutive effect of the exercise of the options and warrants (or the vesting of the restricted stock and performance units). Initially, the 7.0% Debentures were convertible into 182.1494 shares of our common stock for each $1,000 principal amount of 7.0% Debentures, which was equivalent to an initial conversion price of approximately $5.49 per share. The conversion rate was subject to adjustment following the occurrence of certain events (including the payment of dividends on our common stock) in accordance with the terms of an indenture dated as of October 16, 2009. On July 1, 2013, the Company issued a conversion right termination notice to holders of the 7.0% Debentures and the right to convert the 7.0% Debentures into shares of its common stock was terminated effective July 30, 2013 as further discussed in the note to the consolidated financial statements entitled "Notes Payable - Direct Corporate Obligations".

XML

OTHER OPERATING STATEMENT DATA

12 Months Ended

Dec. 31, 2015

Insurance [Abstract]

OTHER OPERATING STATEMENT DATA

OTHER OPERATING STATEMENT DATA

Insurance policy income consisted of the following (dollars in millions):

	2015			2014			2013
Direct premiums collected	$	3,769.6		$	3,856.2		$	3,966.0
Reinsurance assumed	38.4			34.5			38.0
Reinsurance ceded	(142.8		)	(187.9		)	(240.5		)
Premiums collected, net of reinsurance	3,665.2			3,702.8			3,763.5
Change in unearned premiums	5.9			9.1			(16.6		)
Less premiums on interest-sensitive life and products without mortality and morbidity risk which are recorded as additions to insurance liabilities	(1,241.9		)	(1,295.4		)	(1,298.1		)
Premiums on traditional products with mortality or morbidity risk	2,429.2			2,416.5			2,448.8
Fees and surrender charges on interest-sensitive products	126.8			213.2			295.9
Insurance policy income	$	2,556.0		$	2,629.7		$	2,744.7

The four states with the largest shares of 2015 collected premiums were Florida (9 percent), Pennsylvania (7 percent), California (6 percent) and Texas (6 percent). No other state accounted for more than five percent of total collected premiums.

Other operating costs and expenses were as follows (dollars in millions):

	2015		2014		2013
Commission expense	$	103.8	$	99.4	$	103.8
Salaries and wages	205.2		242.4		234.0
Other	430.2		461.0		428.4
Total other operating costs and expenses	$	739.2	$	802.8	$	766.2

Changes in the present value of future profits were as follows (dollars in millions):

	2015			2014			2013
Balance, beginning of year	$	489.4		$	679.3		$	626.0
Amortization	(69.1		)	(76.2		)	(92.0		)
Effect of reinsurance transaction	—			5.0			—
Amounts related to CLIC prior to being sold	—			(15.5		)	—
Amounts related to changes in unrealized investment gains (losses) on fixed maturities, available for sale	28.7			(103.2		)	145.3
Balance, end of year	$	449.0		$	489.4		$	679.3

Based on current conditions and assumptions as to future events on all policies inforce, the Company expects to amortize approximately 11 percent of the December 31, 2015 balance of the present value of future profits in 2016, 10 percent in 2017, 9 percent in 2018, 8 percent in 2019 and 7 percent in 2020. The discount rate used to determine the amortization of the present value of future profits averaged approximately 5 percent in the years ended December 31, 2015, 2014 and 2013.

In accordance with authoritative guidance, we are required to amortize the present value of future profits in relation to estimated gross profits for interest-sensitive life products and annuity products. Such guidance also requires that estimates of expected gross profits used as a basis for amortization be evaluated regularly, and that the total amortization recorded to date be adjusted by a charge or credit to the statement of operations, if actual experience or other evidence suggests that earlier estimates should be revised.

Changes in deferred acquisition costs were as follows (dollars in millions):

	2015			2014			2013
Balance, beginning of year	$	770.6		$	968.1		$	629.7
Additions	246.4			242.8			222.8
Amortization	(190.9		)	(171.2		)	(204.3		)
Effect of reinsurance transaction	—			24.0			—
Amounts related to CLIC prior to being sold	—			(37.6		)	—
Amounts related to changes in unrealized investment gains (losses) on fixed maturities, available for sale	257.2			(255.5		)	315.9
Other	—			—			4.0
Balance, end of year	$	1,083.3		$	770.6		$	968.1

XML

CONSOLIDATED STATEMENT CASH FLOWS

12 Months Ended

Dec. 31, 2015

Supplemental Cash Flow Elements [Abstract]

CONSOLIDATED STATEMENT OF CASH FLOWS

CONSOLIDATED STATEMENT OF CASH FLOWS

The following disclosures supplement our consolidated statement of cash flows.

The following reconciles net income to net cash provided by operating activities (dollars in millions):

	2015			2014				2013
Cash flows from operating activities:
Net income	$	270.7		$	51.4			$	478.0
Adjustments to reconcile net income to net cash from operating activities:
Amortization and depreciation	283.4			274.2				324.6
Income taxes	92.9			119.7				(181.2		)
Insurance liabilities	297.4			398.2				465.8
Accrual and amortization of investment income	(27.6		)	(148.3		)		(276.3		)
Deferral of policy acquisition costs	(246.4		)	(242.8		)		(222.8		)
Net realized investment (gains) losses	36.6			(36.7		)		(33.6		)
Payment to reinsurer pursuant to long-term care business reinsured	—			(590.3		)		—
Net loss on sale of subsidiary, (gain) loss on reinsurance transactions and transition expenses	9.0			239.8				98.4
Loss on extinguishment or modification of debt	32.8			.6				65.4
Other	(4.9		)	56.0				2.1
Net cash from operating activities	$	743.9		$	121.8		(a)	$	720.4

______________________

(a) Cash flows from operating activities reflect outflows in the 2014 period due to the payment to reinsurer to transfer certain long-term care business.

On July 1, 2014, Bankers Life recaptured the life business written by Bankers Life that was reinsured by Wilton Reassurance Company ("Wilton Re") in 2009. The following summarizes the impact of the recapture (dollars in millions):

Investments	$	139.4		(a) (b)
Cash	7.7
Present value of future profits and deferred acquisition costs	29.0			(b)
Reinsurance receivables	(155.9		)	(b)
Other liabilities	5.9			(b)
Gain on reinsurance transaction (classified as "Loss on sale of subsidiary, (gain) loss on reinsurance transactions and transition expenses")	26.1
Income tax expense	9.2
Gain on reinsurance transaction (net of income taxes)	$	16.9

___________________

(a)    Such amount has been reduced by a $28.0 million recapture fee.

(b)    Such non-cash amounts have been excluded from the consolidated statement of cash flows.

Other non-cash items not reflected in the financing activities section of the consolidated statement of cash flows (dollars in millions):

	2015		2014		2013
Stock options, restricted stock and performance units	$	17.1	$	15.6	$	15.1

XML

STATUTORY INFORMATION (BASED ON NON-GAAP MEASURES)

12 Months Ended

Dec. 31, 2015

Insurance [Abstract]

STATUTORY INFORMATION (BASED ON NON-GAAP MEASURES)

STATUTORY INFORMATION (BASED ON NON-GAAP MEASURES)

Statutory accounting practices prescribed or permitted by regulatory authorities for the Company's insurance subsidiaries differ from GAAP. The Company's insurance subsidiaries reported the following amounts to regulatory agencies, after appropriate elimination of intercompany accounts among such subsidiaries (dollars in millions):

	2015		2014
Statutory capital and surplus	$	1,739.2	$	1,654.4
Asset valuation reserve	196.9		203.1
Interest maintenance reserve	476.0		504.1
Total	$	2,412.1	$	2,361.6

Statutory capital and surplus included investments in upstream affiliates of $42.6 million at both December 31, 2015 and 2014, which were eliminated in the consolidated financial statements prepared in accordance with GAAP.

Statutory earnings build the capital required by ratings agencies and regulators. Statutory earnings, fees and interest paid by the insurance companies to the parent company create the "cash flow capacity" the parent company needs to meet its obligations, including debt service. The consolidated statutory net income (a non-GAAP measure) of our insurance subsidiaries was $332.6 million, $364.3 million and $386.5 million in 2015, 2014 and 2013, respectively. Included in such net income were net realized capital gains (losses), net of income taxes, of $(18.0) million, $(18.2) million and $19.0 million in 2015, 2014 and 2013, respectively. In addition, such net income included pre-tax amounts for fees and interest paid to CNO or its non-life subsidiaries totaling $154.2 million, $157.5 million and $159.7 million in 2015, 2014 and 2013, respectively.

Insurance regulators may prohibit the payment of dividends or other payments by our insurance subsidiaries to parent companies if they determine that such payment could be adverse to our policyholders or contract holders. Otherwise, the ability of our insurance subsidiaries to pay dividends is subject to state insurance department regulations. Insurance regulations generally permit dividends to be paid from statutory earned surplus of the insurance company without regulatory approval for any 12-month period in amounts equal to the greater of (or in a few states, the lesser of): (i) statutory net gain from operations or statutory net income for the prior year; or (ii) 10 percent of statutory capital and surplus as of the end of the preceding year. This type of dividend is referred to as an "ordinary dividend". Any dividend in excess of these levels requires the approval of the director or commissioner of the applicable state insurance department and is referred to as an "extraordinary dividend". During 2015, our insurance subsidiaries paid extraordinary dividends of $265.7 million to CDOC, Inc. ("CDOC") (our wholly owned subsidiary and the immediate parent of Washington National and Conseco Life Insurance Company of Texas). CDOC made no capital contributions to its insurance subsidiaries in 2015.

Each of the immediate insurance subsidiaries of CDOC had negative earned surplus at December 31, 2015. Accordingly, any dividend payments from these subsidiaries require the approval of the director or commissioner of the applicable state insurance department. The payment of interest on surplus debentures requires either prior written notice or approval of the director or commissioner of the applicable state insurance department. Dividends and other payments from our non-insurance subsidiaries to CNO or CDOC do not require approval by any regulatory authority or other third party.

In accordance with an order from the Florida Office of Insurance Regulation, Washington National may not distribute funds to any affiliate or shareholder, except pursuant to agreements that have been approved, without prior notice to the Florida Office of Insurance Regulation. In addition, the risk-based capital ("RBC") and other capital requirements described below can also limit, in certain circumstances, the ability of our insurance subsidiaries to pay dividends.

RBC requirements provide a tool for insurance regulators to determine the levels of statutory capital and surplus an insurer must maintain in relation to its insurance and investment risks and the need for possible regulatory attention. The RBC requirements provide four levels of regulatory attention, varying with the ratio of the insurance company's total adjusted capital (defined as the total of its statutory capital and surplus, asset valuation reserve and certain other adjustments) to its RBC (as measured on December 31 of each year) as follows: (i) if a company's total adjusted capital is less than 100 percent but greater than or equal to 75 percent of its RBC, the company must submit a comprehensive plan to the regulatory authority proposing corrective actions aimed at improving its capital position (the "Company Action Level"); (ii) if a company's total adjusted capital is less than 75 percent but greater than or equal to 50 percent of its RBC, the regulatory authority will perform a special examination of the company and issue an order specifying the corrective actions that must be taken; (iii) if a company's total adjusted capital is less than 50 percent but greater than or equal to 35 percent of its RBC, the regulatory authority may take any action it deems necessary, including placing the company under regulatory control; and (iv) if a company's total adjusted capital is less than 35 percent of its RBC, the regulatory authority must place the company under its control. In addition, the RBC requirements provide for a trend test if a company's total adjusted capital is between 100 percent and 150 percent of its RBC at the end of the year. The trend test calculates the greater of the decrease in the margin of total adjusted capital over RBC: (i) between the current year and the prior year; and (ii) for the average of the last 3 years. It assumes that such decrease could occur again in the coming year. Any company whose trended total adjusted capital is less than 95 percent of its RBC would trigger a requirement to submit a comprehensive plan as described above for the Company Action Level. The 2015 statutory annual statements of each of our insurance subsidiaries reflect total adjusted capital in excess of the levels subjecting the subsidiaries to any regulatory action.

In addition, although we are under no obligation to do so, we may elect to contribute additional capital or retain greater amounts of capital to strengthen the surplus of certain insurance subsidiaries. Any election to contribute or retain additional capital could impact the amounts our insurance subsidiaries pay as dividends to the holding company. The ability of our insurance subsidiaries to pay dividends is also impacted by various criteria established by rating agencies to maintain or receive higher ratings and by the capital levels that we target for our insurance subsidiaries.

At December 31, 2015, the consolidated RBC ratio of our insurance subsidiaries exceeded the minimum RBC requirement included in our New Revolving Credit Agreement. See the note to the consolidated financial statements entitled "Notes Payable - Direct Corporate Obligations" for further discussion of various financial ratios and balances we are required to maintain. We calculate the consolidated RBC ratio by assuming all of the assets, liabilities, capital and surplus and other aspects of the business of our insurance subsidiaries are combined together in one insurance subsidiary, with appropriate intercompany eliminations.

XML

SALE OF SUBSIDIARY

12 Months Ended

Dec. 31, 2015

Discontinued Operations and Disposal Groups [Abstract]

SALE OF SUBSIDIARY

SALE OF SUBSIDIARY

On March 2, 2014, CNO entered into a Stock Purchase Agreement (the "Stock Purchase Agreement") with Wilton Re, pursuant to which CNO agreed to sell to Wilton Re all of the issued and outstanding shares of CLIC. The transaction closed on July 1, 2014, after the receipt of insurance regulatory approvals and satisfaction of other customary closing conditions. After adjustments for transaction costs and post-closing adjustments, the transaction resulted in net cash proceeds of $224.9 million, including the impact of intercompany transactions completed in connection with the closing. In the first quarter of 2014, we recognized an estimated loss on the sale of CLIC of $298 million, net of income taxes. In the third and fourth quarters of 2014, we recognized a reduction to the loss on the sale of CLIC of $6 million and $2.9 million, respectively, to reflect the determination of the final sales price and net proceeds.

The loss on the sale of CLIC in 2014, is summarized below (dollars in millions):

Net cash proceeds	$	224.9
Net assets being sold:
Investments	3,863.8
Cash and cash equivalents	164.7
Accrued investment income	42.7
Present value of future profits	15.5
Deferred acquisition costs	37.6
Reinsurance receivables	307.4
Income tax assets, net	84.4
Other assets	2.8
Liabilities for insurance products	(3,201.3		)
Other liabilities	(199.1		)
Investment borrowings	(383.4		)
Accumulated other comprehensive income	(240.5		)
Net assets being sold	494.6
Loss before taxes	(269.7		)
Tax expense related to the sale	14.2
Valuation allowance release related to the tax on the sale	(14.2		)
Valuation allowance increase related to the decrease in projected future taxable income	19.4
Net loss	$	(289.1	)

Because the tax basis of CLIC is lower than the net cash proceeds, the transaction generated a taxable gain and estimated tax expense of $14.2 million. Fully offsetting the tax is $14.2 million of a valuation allowance release pertaining to NOLs which may now be utilized. However, the disposition of CLIC is expected to result in a net reduction to CNO's taxable income in future periods which also required us to establish a valuation allowance of $19.4 million.

In connection with the closing of the transaction, CNO Services, LLC ("CNO Services"), an indirect wholly owned subsidiary of CNO, entered into a transition services agreement and a special support services agreement with Wilton Re, pursuant to which CNO Services makes available to Wilton Re and its affiliates, for a limited period of time, certain services required for the operation of CLIC's business following the closing. Under such agreements, we will receive $30 million in the year ending June 30, 2015 and $20 million in the year ending June 30, 2016. In addition, certain services will continue to be provided in the three years ending June 30, 2019 for an annual fee of $.2 million. The costs of the services provided to Wilton Re are expected to approximate the fees received under the agreements.

The Stock Purchase Agreement also provided that, at the closing, Bankers Life recapture the life insurance business written by Bankers Life that was reinsured by Wilton Re.  The recapture agreement was conditioned on the concurrent consummation of the closing. On July 1, 2014, Bankers Life paid $28.0 million to recapture the life insurance business from Wilton Re and recognized a gain (net of income taxes) of $16.9 million in the third quarter of 2014 as a result of the recapture. Refer to the note to the consolidated financial statements entitled "Consolidated Statement of Cash Flows" for additional information.

XML

BUSINESS SEGMENTS

12 Months Ended

Dec. 31, 2015

Segment Reporting [Abstract]

BUSINESS SEGMENTS

BUSINESS SEGMENTS

The Company manages its business through the following operating segments: Bankers Life, Washington National and Colonial Penn, which are defined on the basis of product distribution; and corporate operations, comprised of holding company activities and certain noninsurance company businesses. In periods prior to 2014, we had an Other CNO Business segment comprised of the long-term care business that was ceded effective December 31, 2013 and the overhead expense of CLIC that was expected to continue after the completion of the sale. Beginning on January 1, 2014: (i) the overhead expense of CLIC that was expected to continue after the completion of the sale was reallocated primarily to the Bankers Life and Washington National segments; and (ii) there was no longer an Other CNO Business segment.

We measure segment performance by excluding the net loss on the sale of CLIC and gain (loss) on reinsurance transactions, the earnings of CLIC prior to being sold on July 1, 2014, net realized investment gains (losses), fair value changes in embedded derivative liabilities (net of related amortization), fair value changes in the agent deferred compensation plan, loss on extinguishment or modification of debt, income taxes and other non-operating items consisting primarily of equity in earnings of certain non-strategic investments and earnings attributable to VIEs ("pre-tax operating earnings") because we believe that this performance measure is a better indicator of the ongoing business and trends in our business.  Our primary investment focus is on investment income to support our liabilities for insurance products as opposed to the generation of net realized investment gains (losses), and a long-term focus is necessary to maintain profitability over the life of the business.

The net loss on the sale of CLIC, gain (loss) on reinsurance transactions, the earnings of CLIC prior to being sold, net realized investment gains (losses), fair value changes in embedded derivative liabilities (net of related amortization), fair value changes in the agent deferred compensation plan, loss on extinguishment or modification of debt and other non-operating items consisting primarily of equity in earnings of certain non-strategic investments and earnings attributable to VIEs depend on market conditions or represent unusual items that do not necessarily relate to the underlying business of our segments.  Net realized investment gains (losses) and fair value changes in embedded derivative liabilities (net of related amortization) may affect future earnings levels since our underlying business is long-term in nature and changes in our investment portfolio may impact our ability to earn the assumed interest rates needed to maintain the profitability of our business.

Operating information by segment was as follows (dollars in millions):

	2015		2014		2013
Revenues:
Bankers Life:
Insurance policy income:
Annuities	$	22.4	$	26.0	$	28.9
Health	1,251.0		1,287.1		1,311.2
Life	375.3		338.6		308.6
Net investment income (a)	884.7		957.3		1,005.7
Fee revenue and other income (a)	27.7		29.3		19.0
Total Bankers Life revenues	2,561.1		2,638.3		2,673.4
Washington National:
Insurance policy income:
Annuities	3.0		4.0		11.4
Health	615.4		597.6		587.1
Life	25.4		24.4		23.0
Net investment income (a)	253.6		276.1		296.9
Fee revenue and other income (a)	1.3		1.1		.9
Total Washington National revenues	898.7		903.2		919.3
Colonial Penn:
Insurance policy income:
Health	3.0		3.6		4.3
Life	260.5		242.4		227.8
Net investment income (a)	43.0		41.7		40.0
Fee revenue and other income (a)	1.0		1.0		.8
Total Colonial Penn revenues	307.5		288.7		272.9
Other CNO Business:
Insurance policy income - health	—		—		24.1
Net investment income (a)	—		—		33.3
Total Other CNO Business revenues	—		—		57.4
Corporate operations:
Net investment income	11.3		14.9		39.8
Fee and other income	8.6		6.7		6.2
Total corporate revenues	19.9		21.6		46.0
Total revenues	3,787.2		3,851.8		3,969.0

(continued on next page)

(continued from previous page)

	2015			2014			2013
Expenses:
Bankers Life:
Insurance policy benefits	$	1,588.4		$	1,667.6		$	1,788.7
Amortization	187.1			174.7			187.5
Interest expense on investment borrowings	8.8			7.9			6.7
Other operating costs and expenses	407.2			401.2			380.0
Total Bankers Life expenses	2,191.5			2,251.4			2,362.9
Washington National:
Insurance policy benefits	546.6			536.2			541.4
Amortization	55.2			64.6			64.9
Interest expense on investment borrowings	2.0			1.7			1.9
Other operating costs and expenses	183.4			189.5			170.5
Total Washington National expenses	787.2			792.0			778.7
Colonial Penn:
Insurance policy benefits	189.0			173.2			165.7
Amortization	14.4			15.3			14.5
Interest expense on investment borrowings	.1			—			—
Other operating costs and expenses	98.4			99.4			105.2
Total Colonial Penn expenses	301.9			287.9			285.4
Other CNO Business:
Insurance policy benefits	—			—			59.2
Other operating costs and expenses	—			—			25.8
Total Other CNO Business expenses	—			—			85.0
Corporate operations:
Interest expense on corporate debt	45.0			43.9			51.3
Interest expense on borrowings of variable interest entities	—			—			.1
Interest expense on investment borrowings	.2			.1			—
Other operating costs and expenses	38.6			49.1			43.1
Total corporate expenses	83.8			93.1			94.5
Total expenses	3,364.4			3,424.4			3,606.5
Pre-tax operating earnings by segment:
Bankers Life	369.6			386.9			310.5
Washington National	111.5			111.2			140.6
Colonial Penn	5.6			.8			(12.5		)
Other CNO Business	—			—			(27.6		)
Corporate operations	(63.9		)	(71.5		)	(48.5		)
Pre-tax operating earnings	$	422.8		$	427.4		$	362.5

___________________

(a) It is not practicable to provide additional components of revenue by product or services.

A reconciliation of segment revenues and expenses to consolidated revenues and expenses and net income is as follows (dollars in millions):

	2015			2014			2013
Total segment revenues	$	3,787.2		$	3,851.8		$	3,969.0
Net realized investment gains (losses)	(47.9		)	33.9			33.4
Revenues related to certain non-strategic investments and earnings attributable to VIEs	47.6			33.2			32.2
Fee revenue related to transition and support services agreements	25.0			15.0			—
Revenues of CLIC prior to being sold	—			210.8			441.5
Consolidated revenues	3,811.9			4,144.7			4,476.1
Total segment expenses	3,364.4			3,424.4			3,606.5
Insurance policy benefits - fair value changes in embedded derivative liabilities	(15.7		)	48.5			(54.4		)
Amortization related to fair value changes in embedded derivative liabilities	3.8			(12.5		)	19.0
Amortization related to net realized investment gains	(.5		)	1.0			1.6
Expenses related to certain non-strategic investments and expenses (earnings) attributable to VIEs	43.0			41.2			42.4
Other operating costs and expenses - fair value changes related to agent deferred compensation plan	(15.1		)	26.8			(15.8		)
Loss on extinguishment or modification of debt	32.8			.6			65.4
Loss on sale of subsidiary, (gain) loss on reinsurance transactions and transition expenses	9.0			239.8			98.4
Expenses related to transition and support services agreements	22.5			12.4			—
Expenses of CLIC prior to being sold	—			187.4			408.2
Consolidated expenses	3,444.2			3,969.6			4,171.3
Income before tax	367.7			175.1			304.8
Income tax expense:
Tax expense on period income	129.5			159.2			128.3
Valuation allowance for deferred tax assets and other tax items	(32.5		)	(35.5		)	(301.5		)
Net income	$	270.7		$	51.4		$	478.0

Segment balance sheet information was as follows (dollars in millions):

	2015		2014
Assets:
Bankers Life	$	19,067.8	$	19,303.0
Washington National	7,948.5		8,207.9
Colonial Penn	985.4		945.3
Corporate operations	3,123.4		2,699.7
Total assets	$	31,125.1	$	31,155.9
Liabilities:
Bankers Life	$	16,612.0	$	16,697.5
Washington National	6,665.1		6,778.8
Colonial Penn	869.3		802.2
Corporate operations	2,840.2		2,189.2
Total liabilities	$	26,986.6	$	26,467.7

The following table presents selected financial information of our segments (dollars in millions):

Segment	Present value of future profits		Deferred acquisition costs		Insurance liabilities
2015
Bankers Life	$	114.9	$	718.2	$	15,234.1
Washington National	290.2		280.0		6,126.2
Colonial Penn	43.9		85.1		782.9
Total	$	449.0	$	1,083.3	$	22,143.2
2014
Bankers Life	$	128.4	$	456.6	$	15,308.9
Washington National	314.2		240.2		6,228.8
Colonial Penn	46.8		73.8		771.0
Total	$	489.4	$	770.6	$	22,308.7

XML

QUARTERLY FINANCIAL DATA (UNAUDITED)

12 Months Ended

Dec. 31, 2015

Quarterly Financial Data [Abstract]

QUARTERLY FINANCIAL DATA (UNAUDITED)

QUARTERLY FINANCIAL DATA (UNAUDITED)

We compute earnings per common share for each quarter independently of earnings per share for the year. The sum of the quarterly earnings per share may not equal the earnings per share for the year because of: (i) transactions affecting the weighted average number of shares outstanding in each quarter; and (ii) the uneven distribution of earnings during the year. Quarterly financial data (unaudited) were as follows (dollars in millions, except per share data):

2015	1st Qtr.			2nd Qtr.		3rd Qtr.		4th Qtr.
Revenues	$	978.3		$	959.5	$	904.5	$	969.6
Income before income taxes	$	82.3		$	72.7	$	52.4	$	160.3
Income tax expense	29.5			25.9		18.6		23.0
Net income	$	52.8		$	46.8	$	33.8	$	137.3
Earnings per common share:
Basic:
Net income	$	.26		$	.24	$	.18	$	.74
Diluted:
Net income	$	.26		$	.24	$	.18	$	.73
2014	1st Qtr.			2nd Qtr.		3rd Qtr.		4th Qtr.
Revenues	$	1,084.7		$	1,093.0	$	967.0	$	1,000.0
Income (loss) before income taxes	$	(169.6	)	$	114.4	$	154.4	$	75.9
Income tax expense (benefit)	58.4			36.3		37.0		(8.0		)
Net income (loss)	$	(228.0	)	$	78.1	$	117.4	$	83.9
Earnings per common share:
Basic:
Net income (loss)	$	(1.03	)	$	.36	$	.56	$	.41
Diluted:
Net income (loss)	$	(1.03	)	$	.35	$	.54	$	.41

XML

INVESTMENTS IN VARIABLE INTEREST ENTITIES

12 Months Ended

Dec. 31, 2015

Organization, Consolidation and Presentation of Financial Statements [Abstract]

INVESTMENTS IN VARIABLE INTEREST ENTITIES

INVESTMENTS IN VARIABLE INTEREST ENTITIES

We have concluded that we are the primary beneficiary with respect to certain VIEs, which are consolidated in our financial statements.  In consolidating the VIEs, we consistently use the financial information most recently distributed to investors in the VIE.

All of the VIEs are collateralized loan trusts that were established to issue securities to finance the purchase of corporate loans and other permitted investments (including two new VIEs which were consolidated in 2015, two new VIEs which were consolidated in 2014 and one new VIE which was consolidated in 2013).  The assets held by the trusts are legally isolated and not available to the Company.  The liabilities of the VIEs are expected to be satisfied from the cash flows generated by the underlying loans held by the trusts, not from the assets of the Company.  During 2015, a VIE that was required to be consolidated was dissolved. A gain of $11.3 million was recognized representing the difference between the borrowings of such VIE and the contractual distributions required following the liquidation of the underlying assets. The scheduled repayment of the remaining principal balance of the borrowings related to the VIEs are as follows: $450.2 million in 2022; $381.8 million in 2024; $326.9 million in 2026; $276.3 million in 2027; and $274.8 million in 2028. The Company has no financial obligation to the VIEs beyond its investment in each VIE.

Certain of our insurance subsidiaries are noteholders of the VIEs.  Another subsidiary of the Company is the investment manager for the VIEs.  As such, it has the power to direct the most significant activities of the VIEs which materially impacts the economic performance of the VIEs.

The following table provides supplemental information about the assets and liabilities of the VIEs which have been consolidated (dollars in millions):

	December 31, 2015
	VIEs		Eliminations			Net effect on consolidated balance sheet
Assets:
Investments held by variable interest entities	$	1,633.6	$	—		$	1,633.6
Notes receivable of VIEs held by insurance subsidiaries	—		(204.3		)	(204.3		)
Cash and cash equivalents held by variable interest entities	364.4		—			364.4
Accrued investment income	3.3		—			3.3
Income tax assets, net	26.0		(1.9		)	24.1
Other assets	1.4		(1.5		)	(0.1		)
Total assets	$	2,028.7	$	(207.7	)	$	1,821.0
Liabilities:
Other liabilities	$	196.6	$	(7.2	)	$	189.4
Borrowings related to variable interest entities	1,676.4		—			1,676.4
Notes payable of VIEs held by insurance subsidiaries	204.0		(204.0		)	—
Total liabilities	$	2,077.0	$	(211.2	)	$	1,865.8

	December 31, 2014
	VIEs		Eliminations			Net effect on consolidated balance sheet
Assets:
Investments held by variable interest entities	$	1,367.1	$	—		$	1,367.1
Notes receivable of VIEs held by insurance subsidiaries	—		(153.3		)	(153.3		)
Cash and cash equivalents held by variable interest entities	68.3		—			68.3
Accrued investment income	3.2		—			3.2
Income tax assets, net	18.1		(2.9		)	15.2
Other assets	—		(1.7		)	(1.7		)
Total assets	$	1,456.7	$	(157.9	)	$	1,298.8
Liabilities:
Other liabilities	$	61.2	$	(6.1	)	$	55.1
Borrowings related to variable interest entities	1,271.9		—			1,271.9
Notes payable of VIEs held by insurance subsidiaries	157.3		(157.3		)	—
Total liabilities	$	1,490.4	$	(163.4	)	$	1,327.0

The following table provides supplemental information about the revenues and expenses of the VIEs which have been consolidated in accordance with authoritative guidance, after giving effect to the elimination of our investment in the VIEs and investment management fees earned by a subsidiary of the Company (dollars in millions):

	2015			2014			2013
Revenues:
Net investment income – policyholder and reinsurer accounts and other special-purpose portfolios	$	62.1		$	47.2		$	42.3
Fee revenue and other income	1.6			1.1			1.8
Total revenues	63.7			48.3			44.1
Expenses:
Interest expense	38.8			30.1			26.0
Other operating expenses	2.0			1.2			1.4
Total expenses	40.8			31.3			27.4
Income before net realized investment losses and income taxes	22.9			17.0			16.7
Net realized investment losses	(17.7		)	(2.2		)	(1.6		)
Income before income taxes	$	5.2		$	14.8		$	15.1

The investment portfolios held by the VIEs are primarily comprised of commercial bank loans to corporate obligors which are almost entirely rated below-investment grade.  At December 31, 2015, such loans had an amortized cost of $1,679.3 million; gross unrealized gains of $.5 million; gross unrealized losses of $46.2 million; and an estimated fair value of $1,633.6 million.

The following table sets forth the amortized cost and estimated fair value of the investments held by the VIEs at December 31, 2015, by contractual maturity.  Actual maturities will differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without penalties.

	Amortized cost		Estimated fair value
	(Dollars in millions)
Due in one year or less	$	12.5	$	12.1
Due after one year through five years	719.2		695.1
Due after five years through ten years	947.6		926.4
Total	$	1,679.3	$	1,633.6

The following table sets forth the amortized cost and estimated fair value of those investments held by the VIEs with unrealized losses at December 31, 2015, by contractual maturity.  Actual maturities will differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without penalties.

	Amortized cost		Estimated fair value
	(Dollars in millions)
Due in one year or less	$	12.5	$	12.1
Due after one year through five years	654.3		630.0
Due after five years through ten years	852.4		830.9
Total	$	1,519.2	$	1,473.0

During 2015, the VIEs recognized net realized investment losses of $17.7 million, which were comprised of $1.3 million of net losses from the sales of fixed maturities, and $16.4 million of writedowns of investments for other than temporary declines in fair value recognized through net income. During 2014, the VIEs recognized net realized investment losses of $2.2 million from the sales of fixed maturities. During 2013, the VIEs recognized net realized investment losses of $1.6 million, which were comprised of $.5 million of net losses from the sales of fixed maturities, and $1.1 million of writedowns of investments for other than temporary declines in fair value recognized through net income.

At December 31, 2015, there were no investments held by the VIEs that were in default.

During 2015, $46.1 million of investments held by the VIEs were sold which resulted in gross investment losses (before income taxes) of $1.8 million. During 2014, $38.7 million of investments held by the VIEs were sold which resulted in gross investment losses (before income taxes) of $2.4 million. During 2013, $11.1 million of investments held by the VIEs were sold which resulted in gross investment losses (before income taxes) of $.9 million.

At December 31, 2015, the VIEs held:  (i) investments with a fair value of $1,178.7 million and gross unrealized losses of $23.9 million that had been in an unrealized loss position for less than twelve months; and (ii) investments with a fair value of $294.3 million and gross unrealized losses of $22.3 million that had been in an unrealized loss position for greater than twelve months.

At December 31, 2014, the VIEs held: (i) investments with a fair value of $1,053.2 million and gross unrealized losses of $27.3 million that had been in an unrealized loss position for less than twelve months; and (ii) investments with a fair value of $167.4 million and gross unrealized losses of $4.2 million that had been in an unrealized loss position for greater than twelve months.

The investments held by the VIEs are evaluated for other-than-temporary declines in fair value in a manner that is consistent with the Company's fixed maturities, available for sale.

XML

SCHEDULE II

12 Months Ended

Dec. 31, 2015

Condensed Financial Information of Parent Company Only Disclosure [Abstract]

Condensed Financial Information of Registrant (Parent Company)

SCHEDULE II

Condensed Financial Information of Registrant (Parent Company)

Balance Sheet

as of December 31, 2015 and 2014

(Dollars in millions)

ASSETS
	2015		2014
Fixed maturities, available for sale, at fair value (amortized cost: 2015 - $5.0; 2014 - $35.0)	$	5.0	$	34.9
Cash and cash equivalents - unrestricted	128.9		86.6
Equity securities at fair value (cost: 2015 - $247.3; 2014 - $202.7)	254.9		216.9
Trading securities	1.0		2.1
Investment in wholly-owned subsidiaries (eliminated in consolidation)	4,809.2		5,263.3
Income tax assets, net	58.5		47.9
Other invested assets - affiliated (eliminated in consolidation)	—		27.0
Receivable from subsidiaries (eliminated in consolidation)	3.8		10.8
Other assets	3.1		3.1
Total assets	$	5,264.4	$	5,692.6
LIABILITIES AND SHAREHOLDERS' EQUITY
Liabilities:
Notes payable	$	911.1	$	780.3
Payable to subsidiaries (eliminated in consolidation)	135.9		114.3
Other liabilities	78.9		109.8
Total liabilities	1,125.9		1,004.4
Commitments and Contingencies
Shareholders' equity:
Common stock and additional paid-in capital ($0.01 par value, 8,000,000,000 shares authorized, shares issued and outstanding: 2015 - 184,028,511; 2014 – 203,324,458)	3,388.6		3,734.4
Accumulated other comprehensive income	402.8		825.3
Retained earnings	347.1		128.5
Total shareholders' equity	4,138.5		4,688.2
Total liabilities and shareholders' equity	$	5,264.4	$	5,692.6

The accompanying notes are an integral part

of the condensed financial statements.

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

SCHEDULE II

Condensed Financial Information of Registrant (Parent Company)

Statement of Operations

for the years ended December 31, 2015, 2014 and 2013

(Dollars in millions)

	2015			2014			2013
Revenues:
Net investment income	$	16.9		$	12.7		$	21.1
Net realized investment gains	3.5			11.1			.4
Intercompany revenues (losses) (eliminated in consolidation)	(1.5		)	(1.0		)	1.6
Total revenues	18.9			22.8			23.1
Expenses:
Interest expense	45.2			44.0			51.4
Intercompany expenses (eliminated in consolidation)	.4			.3			.3
Operating costs and expenses	21.0			66.6			26.1
Loss on extinguishment of debt	32.8			.6			65.4
Total expenses	99.4			111.5			143.2
Loss before income taxes and equity in undistributed earnings of subsidiaries	(80.5		)	(88.7		)	(120.1		)
Income tax benefit on period income	(37.9		)	(34.1		)	(8.8		)
Loss before equity in undistributed earnings of subsidiaries	(42.6		)	(54.6		)	(111.3		)
Equity in undistributed earnings of subsidiaries (eliminated in consolidation)	313.3			106.0			589.3
Net income	$	270.7		$	51.4		$	478.0

The accompanying notes are an integral part

of the condensed financial statements.

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

SCHEDULE II

Condensed Financial Information of Registrant (Parent Company)

Statement of Cash Flows

for the years ended December 31, 2015, 2014 and 2013

(Dollars in millions)

	2015			2014			2013
Cash flows from operating activities	$	(55.1	)	$	(66.7	)	$	(65.9	)
Cash flows from investing activities:
Sales of investments	66.5			229.8			95.8
Sales of investments - affiliated*	16.0			18.3			—
Maturities and redemptions of investments - affiliated*	8.3			—			—
Purchases of investments	(68.6		)	(320.1		)	(119.3		)
Purchases of investments - affiliated*	(3.4		)	(30.7		)	(10.0		)
Net sales of trading securities	11.8			9.9			12.6
Dividends received from consolidated subsidiary, net of capital contributions of nil in 2015, $18.8 in 2014 and nil in 2013*	269.7			423.5			242.8
Net cash provided by investing activities	300.3			330.7			221.9
Cash flows from financing activities:
Issuance of notes payable, net	910.0			—			—
Payments on notes payable	(797.1		)	(62.9		)	(126.9		)
Expenses related to extinguishment or modification of debt	(17.8		)	(.6		)	(61.6		)
Issuance of common stock	6.3			5.0			15.1
Payments to repurchase common stock and warrants	(361.5		)	(376.5		)	(118.4		)
Common stock dividends paid	(52.0		)	(51.0		)	(24.4		)
Amount paid to extinguish the beneficial conversion feature associated with repurchase of convertible debentures	—			—			(12.6		)
Investment borrowings - repurchase agreements, net	(20.4		)	20.4			—
Issuance of notes payable to affiliates*	234.4			257.8			222.1
Payments on notes payable to affiliates*	(104.8		)	(100.7		)	(83.9		)
Net cash used by financing activities	(202.9		)	(308.5		)	(190.6		)
Net increase (decrease) in cash and cash equivalents	42.3			(44.5		)	(34.6		)
Cash and cash equivalents, beginning of the year	86.6			131.1			165.7
Cash and cash equivalents, end of the year	$	128.9		$	86.6		$	131.1

* Eliminated in consolidation

The accompanying notes are an integral part

of the condensed financial statements.

CNO FINANCIAL GROUP, INC. AND SUBSIDIARIES

SCHEDULE II

Notes to Condensed Financial Information

1. Basis of Presentation

The condensed financial information should be read in conjunction with the consolidated financial statements of CNO Financial Group, Inc. The condensed financial information includes the accounts and activity of the parent company.

XML

SCHEDULE IV

12 Months Ended

Dec. 31, 2015

Supplemental Schedule of Reinsurance Premiums for Insurance Companies [Abstract]

Reinsurance

SCHEDULE IV

Reinsurance

for the years ended December 31, 2015, 2014 and 2013

(Dollars in millions)

	2015			2014			2013
Life insurance inforce:
Direct	$	25,807.0		$	25,029.0		$	53,304.9
Assumed	137.4			147.1			305.7
Ceded	(3,780.8		)	(3,660.1		)	(11,477.6		)
Net insurance inforce	$	22,163.6		$	21,516.0		$	42,133.0
Percentage of assumed to net	.6		%	.7		%	.7		%

	2015			2014			2013
Insurance policy income:
Direct	$	2,524.3		$	2,558.2		$	2,623.5
Assumed	38.5			35.0			37.4
Ceded	(133.6		)	(176.7		)	(212.1		)
Net premiums	$	2,429.2		$	2,416.5		$	2,448.8
Percentage of assumed to net	1.6		%	1.4		%	1.5		%

XML

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)

12 Months Ended

Dec. 31, 2015

Accounting Policies [Abstract]

Segments

The Company’s insurance segments are described below:

• Bankers Life,which markets and distributes Medicare supplement insurance, interest-sensitive life insurance, traditional life insurance, fixed annuities and long-term care insurance products to the middle-income senior market through a dedicated field force of career agents, financial and investment advisors, and sales managers supported by a network of community-based sales offices.  The Bankers Life segment includes primarily the business of Bankers Life and Casualty Company ("Bankers Life").  Bankers Life also has various distribution and marketing agreements with other insurance companies to use Bankers Life's career agents to distribute Medicare Advantage and prescription drug plan ("PDP") products in exchange for a fee.

• Washington National, which markets and distributes supplemental health (including specified disease, accident and hospital indemnity insurance products) and life insurance to middle-income consumers at home and at the worksite.  These products are marketed through Performance Matters Associates of Texas, Inc. and through independent marketing organizations and insurance agencies including worksite marketing.  The products being marketed are underwritten by Washington National Insurance Company ("Washington National"). This segment's business also includes certain closed blocks of annuities and Medicare supplement policies which are no longer being actively marketed by this segment and were primarily issued or acquired by Washington National.

• Colonial Penn, which markets primarily graded benefit and simplified issue life insurance directly to customers in the senior middle-income market through television advertising, direct mail, the internet and telemarketing.  The Colonial Penn segment includes primarily the business of Colonial Penn Life Insurance Company ("Colonial Penn").

Basis of Accounting

We prepare our financial statements in accordance with accounting principles generally accepted in the United States of America ("GAAP"). We have reclassified certain amounts from the prior periods to conform to the 2015 presentation. These reclassifications have no effect on net income or shareholders' equity.

Consolidation

The accompanying financial statements include the accounts of the Company and its subsidiaries. Our consolidated financial statements exclude transactions between us and our consolidated affiliates, or among our consolidated affiliates.

Use of Estimates

When we prepare financial statements in conformity with GAAP, we are required to make estimates and assumptions that significantly affect reported amounts of various assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reporting periods.  For example, we use significant estimates and assumptions to calculate values for deferred acquisition costs, the present value of future profits, fair value measurements of certain investments (including derivatives), other-than-temporary impairments of investments, assets and liabilities related to income taxes, liabilities for insurance products, liabilities related to litigation and guaranty fund assessment accruals.  If our future experience differs from these estimates and assumptions, our financial statements would be materially affected.

Investments

Investments

Fixed maturity securities include available for sale bonds and redeemable preferred stocks. We carry these investments at estimated fair value. We record any unrealized gain or loss, net of tax and related adjustments, as a component of shareholders’ equity.

Equity securities include available for sale investments in common stock and non-redeemable preferred stock. We carry these investments at estimated fair value. We record any unrealized gain or loss, net of tax and related adjustments, as a component of shareholders' equity.

Mortgage loans held in our investment portfolio are carried at amortized unpaid balances, net of provisions for estimated losses. Interest income is accrued on the principal amount of the loan based on the loan's contractual interest rate. Payment terms specified for mortgage loans may include a prepayment penalty for unscheduled payoff of the investment. Prepayment penalties are recognized as investment income when received.

Policy loans are stated at current unpaid principal balances. Policy loans are collateralized by the cash surrender value of the life insurance policy. Interest income is recorded as earned using the contractual interest rate.

Trading securities include: (i) investments purchased with the intent of selling in the near team to generate income; (ii) investments supporting certain insurance liabilities (including investments backing the market strategies of our multibucket annuity products) and certain reinsurance agreements; and (iii) certain fixed maturity securities containing embedded derivatives for which we have elected the fair value option. The change in fair value of the income generating investments and investments supporting insurance liabilities and reinsurance agreements is recognized in income from policyholder and reinsurer accounts and other special-purpose portfolios (a component of net investment income). The change in fair value of securities with embedded derivatives is recognized in realized investment gains (losses). Investment income related to investments supporting certain insurance liabilities and certain reinsurance agreements is substantially offset by the change in insurance policy benefits related to certain products and agreements.

Other invested assets include: (i) call options purchased in an effort to offset or hedge the effects of certain policyholder benefits related to our fixed index annuity and life insurance products; (ii) Company-owned life insurance ("COLI"); and (iii) certain non-traditional investments. We carry the call options at estimated fair value as further described in the section of this note entitled "Accounting for Derivatives". We carry COLI at its cash surrender value which approximates its net realizable value. Non-traditional investments include investments in certain limited partnerships and hedge funds which are accounted for using the equity method; and promissory notes, which are accounted for using the cost method. In accounting for limited partnerships and hedge funds, we consistently use the most recently available financial information provided by the general partner or manager of each of these investments, which is one to three months prior to the end of our reporting period.

Interest income on fixed maturity securities is recognized when earned using a constant effective yield method giving effect to amortization of premiums and accretion of discounts. Prepayment fees are recognized when earned. Dividends on equity securities are recognized when declared.

When we sell a security (other than trading securities), we report the difference between the sale proceeds and amortized cost (determined based on specific identification) as a realized investment gain or loss.

We regularly evaluate our investments for possible impairment as further described in the note to the consolidated financial statements entitled "Investments".

When a security defaults (including mortgage loans) or securities are other-than-temporarily impaired, our policy is to discontinue the accrual of interest and eliminate all previous interest accruals, if we determine that such amounts will not be ultimately realized in full.

Cash and Cash Equivalents

Cash and Cash Equivalents

Cash and cash equivalents include commercial paper, invested cash and other investments purchased with original maturities of less than three months. We carry them at amortized cost, which approximates estimated fair value.

Deferred Acquisition Costs

Deferred Acquisition Costs

Deferred acquisition costs represent incremental direct costs related to the successful acquisition of new or renewal insurance contracts. For interest-sensitive life or annuity products, we amortize these costs in relation to the estimated gross profits using the interest rate credited to the underlying policies. For other products, we amortize these costs in relation to future anticipated premium revenue using the projected investment earnings rate.

When we realize a gain or loss on investments backing our interest-sensitive life or annuity products, we adjust the amortization to reflect the change in estimated gross profits from the products due to the gain or loss realized and the effect on future investment yields. We also adjust deferred acquisition costs for the change in amortization that would have been recorded if our fixed maturity securities, available for sale, had been sold at their stated aggregate fair value and the proceeds reinvested at current yields. We limit the total adjustment related to the impact of unrealized losses to the total of costs capitalized plus interest related to insurance policies issued in a particular year. We include the impact of this adjustment in accumulated other comprehensive income (loss) within shareholders' equity.

We regularly evaluate the recoverability of the unamortized balance of the deferred acquisition costs. We consider estimated future gross profits or future premiums, expected mortality or morbidity, interest earned and credited rates, persistency and expenses in determining whether the balance is recoverable. If we determine a portion of the unamortized balance is not recoverable, it is charged to amortization expense. In certain cases, the unamortized balance of the deferred acquisition costs may not be deficient in the aggregate, but our estimates of future earnings indicate that profits would be recognized in early periods and losses in later periods. In this case, we increase the amortization of the deferred acquisition costs over the period of profits, by an amount necessary to offset losses that are expected to be recognized in the later years.

Present Value of Future Profits

Present Value of Future Profits

The present value of future profits is the value assigned to the right to receive future cash flows from policyholder insurance contracts existing at September 10, 2003 (the "Effective Date", the effective date of the bankruptcy reorganization of Conseco, Inc., an Indiana corporation (our "Predecessor")). The discount rate we used to determine the present value of future profits was 12 percent. The balance of this account is amortized and evaluated for recovery in the same manner as described above for deferred acquisition costs.  We also adjust the present value of future profits for the change in amortization that would have been recorded if the fixed maturity securities, available for sale, had been sold at their stated aggregate fair value and the proceeds reinvested at current yields, similar to the manner described above for deferred acquisition costs.  We limit the total adjustment related to the impact of unrealized losses to the total present value of future profits plus interest.

Assets Held in Separate Accounts

Assets Held in Separate Accounts

Separate accounts are funds on which investment income and gains or losses accrue directly to certain policyholders. The assets of these accounts are legally segregated. They are not subject to the claims that may arise out of any other business of CNO. We report separate account assets at fair value; the underlying investment risks are assumed by the contractholders. We record the related liabilities at amounts equal to the separate account assets. We record the fees earned for administrative and contractholder services performed for the separate accounts in insurance policy income.

Recognition of Insurance Policy Income and Related Benefits and Expenses on Insurance Contracts

Recognition of Insurance Policy Income and Related Benefits and Expenses on Insurance Contracts

For interest-sensitive life and annuity contracts that do not involve significant mortality or morbidity risk, the amounts collected from policyholders are considered deposits and are not included in revenue. Revenues for these contracts consist of charges for policy administration, cost of insurance charges and surrender charges assessed against policyholders' account balances. Such revenues are recognized when the service or coverage is provided, or when the policy is surrendered.

We establish liabilities for annuity and interest-sensitive life products equal to the accumulated policy account values, which include an accumulation of deposit payments plus credited interest, less withdrawals and the amounts assessed against the policyholder through the end of the period. In addition, policyholder account values for certain interest-sensitive life products are impacted by our assumptions related to changes of certain non-guaranteed elements that we are allowed to make under the terms of the policy, such as cost of insurance charges, expense loads, credited interest rates and policyholder bonuses. Sales inducements provided to the policyholders of these products are recognized as liabilities over the period that the contract must remain in force to qualify for the inducement. The options attributed to the policyholder related to our fixed index annuity products are accounted for as embedded derivatives as described in the section of this note entitled "Accounting for Derivatives".

Premiums from individual life products (other than interest-sensitive life contracts) and health products are recognized when due. When premiums are due over a significantly shorter period than the period over which benefits are provided, any gross premium in excess of the net premium (i.e., the portion of the gross premium required to provide for all expected future benefits and expenses) is deferred and recognized into revenue in a constant relationship to insurance in force. Benefits are recorded as an expense when they are incurred.

We establish liabilities for traditional life, accident and health insurance, and life contingent payment annuity products using mortality tables in general use in the United States, which are modified to reflect the Company's actual experience when appropriate. We establish liabilities for accident and health insurance products using morbidity tables based on the Company's actual or expected experience. These reserves are computed at amounts that, with additions from estimated future premiums received and with interest on such reserves at estimated future rates, are expected to be sufficient to meet our obligations under the terms of the policy. Liabilities for future policy benefits are computed on a net-level premium method based upon assumptions as to future claim costs, investment yields, mortality, morbidity, withdrawals, policy dividends and maintenance expenses determined when the policies were issued (or with respect to policies inforce at August 31, 2003, the Company's best estimate of such assumptions on the Effective Date). We make an additional provision to allow for potential adverse deviation for some of our assumptions. Once established, assumptions on these products are generally not changed unless a premium deficiency exists. In that case, a premium deficiency reserve is recognized and the future pattern of reserve changes is modified to reflect the relationship of premiums to benefits based on the current best estimate of future claim costs, investment yields, mortality, morbidity, withdrawals, policy dividends and maintenance expenses, determined without an additional provision for potential adverse deviation.

We establish claim reserves based on our estimate of the loss to be incurred on reported claims plus estimates of incurred but unreported claims based on our past experience.

Accounting for Long-term Care Premium Rate Increases

Accounting for Long-term Care Premium Rate Increases

Many of our long-term care policies have been subject to premium rate increases. In some cases, these premium rate increases were materially consistent with the assumptions we used to value the particular block of business at the Effective Date. With respect to certain premium rate increases, some of our policyholders were provided an option to cease paying their premiums and receive a non-forfeiture option in the form of a paid-up policy with limited benefits. In addition, our policyholders could choose to reduce their coverage amounts and premiums in the same proportion, when permitted by our contracts or as required by regulators. The following describes how we account for these policyholder options:

• Premium rate increases - If premium rate increases reflect a change in our previous rate increase assumptions, the new assumptions are not reflected prospectively in our reserves. Instead, the additional premium revenue resulting from the rate increase is recognized as earned and original assumptions continue to be used to determine changes to liabilities for insurance products unless a premium deficiency exists.

• Benefit reductions - A policyholder may choose reduced coverage with a proportionate reduction in premium, when permitted by our contracts. This option does not require additional underwriting. Benefit reductions are treated as a partial lapse of coverage, and the balance of our reserves and deferred insurance acquisition costs is reduced in proportion to the reduced coverage.

• Non-forfeiture benefits offered in conjunction with a rate increase - In some cases, non-forfeiture benefits are offered to policyholders who wish to lapse their policies at the time of a significant rate increase. In these cases, exercise of this option is treated as an extinguishment of the original contract and issuance of a new contract. The balance of our reserves and deferred insurance acquisition costs are released, and a reserve for the new contract is established.

Some of our policyholders may receive a non-forfeiture benefit if they cease paying their premiums pursuant to their original contract (or pursuant to changes made to their original contract as a result of a litigation settlement made prior to the Effective Date or an order issued by the Florida Office of Insurance Regulation). In these cases, exercise of this option is treated as the exercise of a policy benefit, and the reserve for premium paying benefits is reduced, and the reserve for the non-forfeiture benefit is adjusted to reflect the election of this benefit.

Accounting for Certain Marketing and Reinsurance Agreements

Accounting for Certain Marketing and Reinsurance Agreements

Bankers Life has entered into various distribution and marketing agreements with other insurance companies to use Bankers Life's career agents to distribute prescription drug and Medicare Advantage plans. These agreements allow Bankers Life to offer these products to current and potential future policyholders without investment in management and infrastructure. We receive fee income related to the plans sold through our distribution channels. We account for these distribution agreements as follows:

• We recognize distribution income based on either: (i) a fixed fee per contract sold; or (ii) a percentage of premiums collected. This fee income is recognized over the calendar year term of the contract.

• We also pay commissions to our agents who sell the plans. These payments are deferred and amortized over the term of the contract.

Prior to its termination in August 2013, we had a quota-share reinsurance agreement with Coventry Health Care ("Coventry") that provided Bankers Life with 50 percent of the net premiums and related policy benefits of certain PDP business sold through Bankers Life's career agency force. We accounted for the quota-share agreement as follows:

• We recognized premium revenue evenly over the period of the underlying Medicare Part D contracts.

• We recognized policyholder benefits and assumed commission expense as incurred.

• We recognized risk-share premium adjustments consistent with Coventry's risk-share agreement with the Centers for Medicare and Medicaid Services.

Reinsurance

In the normal course of business, we seek to limit our loss exposure on any single insured or to certain groups of policies by ceding reinsurance to other insurance enterprises. We currently retain no more than $.8 million of mortality risk on any one policy. We diversify the risk of reinsurance loss by using a number of reinsurers that have strong claims-paying ratings. In each case, the ceding CNO subsidiary is directly liable for claims reinsured in the event the assuming company is unable to pay.

The cost of reinsurance ceded totaled $133.6 million, $176.7 million and $212.1 million in 2015, 2014 and 2013, respectively.  We deduct this cost from insurance policy income.  Reinsurance recoveries netted against insurance policy benefits totaled $167.7 million, $195.3 million and $196.2 million in 2015, 2014 and 2013, respectively.

From time-to-time, we assume insurance from other companies.  Any costs associated with the assumption of insurance are amortized consistent with the method used to amortize deferred acquisition costs.  Reinsurance premiums assumed totaled $38.5 million, $35.0 million and $37.4 million in 2015, 2014 and 2013, respectively.  Reinsurance premiums included amounts assumed pursuant to marketing and quota-share agreements with Coventry of $6.8 million and $19.7 million, in 2014 and 2013 respectively. As further described above, we received a notice of Coventry's intent to terminate the PDP quota-share reinsurance agreement in August 2013. The premiums collected from Coventry in 2014 represented adjustments to premiums on such business related to periods prior to the termination of the agreement. We continue to receive distribution income from Coventry for PDP business sold through our Bankers Life segment.

In December 2013, two of our insurance subsidiaries with long-term care business in the former Other CNO Business segment entered into 100% coinsurance agreements ceding $495 million of long-term care reserves to Beechwood Re Ltd. ("BRe"). Pursuant to the agreements, the insurance subsidiaries paid an additional premium of $96.9 million to BRe and an amount equal to the related net liabilities. The insurance subsidiaries' ceded reserve credits are secured by assets in market-value trusts subject to a 7% over-collateralization, investment guidelines and periodic true-up provisions. Future payments into the trusts to maintain collateral requirements are the responsibility of BRe. We recognized a pre-tax loss of $98.4 million in 2013 to reflect: (i) the known loss (or premium deficiency) on the business, as we will not be recognizing additional income in future periods to recover the unamortized additional premium which will be paid to BRe; and (ii) other transaction costs.

In the second quarter of 2014, we recaptured a block of interest-sensitive life business that was previously ceded under a modified coinsurance agreement. The recapture of this block resulted in a gain related to reinsurance transaction of $3.8 million.

As further described in the note to the financial statements entitled "Sale of Subsidiary", we recaptured a block of life insurance business in 2014 that was previously ceded under a coinsurance agreement.

Income Taxes

Income Taxes

Our income tax expense includes deferred income taxes arising from temporary differences between the financial reporting and tax bases of assets and liabilities, capital loss carryforwards and net operating loss carryforwards ("NOLs"). Deferred tax assets and liabilities are measured using enacted tax rates expected to apply in the years in which temporary differences are expected to be recovered or paid.  The effect of a change in tax rates on deferred tax assets and liabilities is recognized in earnings in the period when the changes are enacted.

A reduction of the net carrying amount of deferred tax assets by establishing a valuation allowance is required if, based on the available evidence, it is more likely than not that such assets will not be realized. In assessing the need for a valuation allowance, all available evidence, both positive and negative, shall be considered to determine whether, based on the weight of that evidence, a valuation allowance for deferred tax assets is needed. This assessment requires significant judgment and considers, among other matters, the nature, frequency and severity of current and cumulative losses, forecasts of future profitability, the duration of carryforward periods, our experience with operating loss and tax credit carryforwards expiring unused, and tax planning strategies. We evaluate the need to establish a valuation allowance for our deferred income tax assets on an ongoing basis. The realization of our deferred tax assets depends upon generating sufficient future taxable income of the appropriate type during the periods in which our temporary differences become deductible and before our capital loss carryforwards and life and non-life NOLs expire.

At December 31, 2015, our valuation allowance for our net deferred tax assets was $213.5 million, as we have determined that it is more likely than not that a portion of our deferred tax assets will not be realized. This determination was made by evaluating each component of the deferred tax assets and assessing the effects of limitations and/or interpretations on the value of such component to be fully recognized in the future.

Investments in Variable Interest Entities

Investments in Variable Interest Entities

We have concluded that we are the primary beneficiary with respect to certain variable interest entities ("VIEs"), which are consolidated in our financial statements. All such VIEs are collateralized loan trusts that were established to issue securities to finance the purchase of corporate loans and other permitted investments.  The assets held by the trusts are legally isolated and not available to the Company.  The liabilities of the VIEs are expected to be satisfied from the cash flows generated by the underlying loans held by the trusts, not from the assets of the Company.  The Company has no financial obligation to the VIEs beyond its investment in each VIE.

The investment portfolios held by the VIEs are primarily comprised of commercial bank loans to corporate obligors which are almost entirely rated below-investment grade.  Refer to the note to the consolidated financial statements entitled "Investments in Variable Interest Entities" for additional information about VIEs.

In addition, the Company, in the normal course of business, makes passive investments in structured securities issued by VIEs for which the Company is not the investment manager.  These structured securities include asset-backed securities, collateralized debt obligations, commercial mortgage-backed securities, residential mortgage-backed securities and collateralized mortgage obligations.  Our maximum exposure to loss on these securities is limited to our cost basis in the investment.  We have determined that we are not the primary beneficiary of these structured securities due to the relative size of our investment in comparison to the total principal amount of the individual structured securities and the level of credit subordination which reduces our obligation to absorb gains or losses.

Investment borrowings

Substantially all of such investments are classified as fixed maturities, available for sale, in our consolidated balance sheet.

Accounting for Derivatives

Accounting for Derivatives

Our fixed index annuity products provide a guaranteed minimum rate of return and a higher potential return that is based on a percentage (the "participation rate") of the amount of increase in the value of a particular index, such as the Standard & Poor's 500 Index, over a specified period.  Typically, on each policy anniversary date, a new index period begins.  We are generally able to change the participation rate at the beginning of each index period during a policy year, subject to contractual minimums.  The Company accounts for the options attributed to the policyholder for the estimated life of the contract as embedded derivatives. These accounting requirements often create volatility in the earnings from these products. We typically buy call options (including call spreads) referenced to the applicable indices in an effort to offset or hedge potential increases to policyholder benefits resulting from increases in the particular index to which the policy's return is linked.

We utilize United States Treasury interest rate futures primarily to hedge interest rate risk related to anticipated mortgage loan transactions.

In periods prior to the second quarter of 2014, we were required to establish an embedded derivative related to a modified coinsurance agreement which ceded the risks of a block of interest sensitive life business. We recaptured this block in the second quarter of 2014 resulting in a gain of $3.8 million. Prior to the recapture of this block, we maintained the investments related to the modified coinsurance agreement in our trading securities account, which we carried at estimated fair value with changes in such value recognized as investment income.  Such trading securities were sold in the second quarter of 2014 in conjunction with the reinsurance recapture.

We purchase certain fixed maturity securities that contain embedded derivatives that are required to be held at fair value on the consolidated balance sheet. We have elected the fair value option to carry the entire security at fair value with changes in fair value reported in net income.

Multibucket Annuity Products

Multibucket Annuity Products

The Company's multibucket annuity is an annuity product that credits interest based on the experience of a particular market strategy. Policyholders allocate their annuity premium payments to several different market strategies based on different asset classes within the Company's investment portfolio. Interest is credited to this product based on the market return of the given strategy, less management fees, and funds may be moved between different strategies. The Company guarantees a minimum return of premium plus approximately 3 percent per annum over the life of the contract. The investments backing the market strategies of these products are designated by the Company as trading securities. The change in the fair value of these securities is recognized as investment income (classified as income from policyholder and reinsurer accounts and other special-purpose portfolios), which is substantially offset by the change in insurance policy benefits for these products.

Sales Inducements

Sales Inducements

Certain of our annuity products offer sales inducements to contract holders in the form of enhanced crediting rates or bonus payments in the initial period of the contract.  Certain of our life insurance products offer persistency bonuses credited to the contract holders balance after the policy has been outstanding for a specified period of time.  These enhanced rates and persistency bonuses are considered sales inducements in accordance with GAAP.  Such amounts are deferred and amortized in the same manner as deferred acquisition costs.

Out-of-Period Adjustments

Out-of-Period Adjustments

In 2014, we recorded the net effect of an out-of-period adjustment related to the calculation of incentive compensation accruals which increased other operating costs and expenses by $2.4 million, decreased tax expense by $.8 million and decreased our net income by $1.6 million (or 1 cent per diluted share). In 2013 we recorded the net effect of out-of-period adjustments which increased our insurance policy benefits by $4.7 million, increased amortization expense by $2.1 million, increased other operating costs and expenses by $1.5 million, decreased tax expense by $.7 million and decreased our net income by $7.6 million (or 3 cents per diluted share). We evaluated these adjustments taking into account both qualitative and quantitative factors and considered the impact of these adjustments in relation to each period, as well as the periods in which they originated. The impact of recognizing these adjustments in prior years was not significant to any individual period. Management believes these adjustments are immaterial to the consolidated financial statements and all previously issued financial statements.

Recently Issued Accounting Standards

In May 2015, the FASB issued authoritative guidance that removes the requirement to categorize within the fair value hierarchy all investments for which fair value is measured using the net asset value per share practical expedient. The guidance also removes the requirement to make certain disclosures for all investments that are eligible to be measured at fair value using the net asset value per share practical expedient. The guidance is effective for fiscal years beginning after December 15, 2015, and interim periods within those fiscal years, with early adoption permitted. A reporting entity should apply the guidance retrospectively to all periods presented. The Company elected to early adopt this guidance as of December 31, 2015, and has removed certain investments that are measured using the net asset value per share practical expedient from the fair value hierarchy in all periods presented in our consolidated financial statements.

Recently Issued Accounting Standards

Pending Accounting Standards

In May 2014, the Financial Accounting Standards Board (the "FASB") issued authoritative guidance for recognizing revenue from contracts with customers. Certain contracts with customers are specifically excluded from this guidance, including insurance contracts. The core principle of the new guidance is that an entity should recognize revenue when it transfers promised goods or services in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The guidance also requires additional disclosures about the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. In July 2015, the guidance was updated and will now be effective for the Company on January 1, 2018 and permits two methods of transition upon adoption; full retrospective and modified retrospective. Under the full retrospective method, prior periods would be restated under the new revenue standard, providing for comparability in all periods presented. Under the modified retrospective method, prior periods would not be restated. Instead, revenues and other disclosures for pre-2017 periods would be provided in the notes to the financial statements as previously reported under the current revenue standard. The Company is currently assessing the impact the guidance will have upon adoption.

In August 2014, the FASB issued authoritative guidance related to measuring the financial assets and the financial liabilities of a consolidated collateralized financing entity which provides a measurement alternative for an entity that consolidates collateralized financing entities. A collateralized financing entity is a VIE with no more than nominal equity that holds financial assets and issues beneficial interests in those financial assets; the beneficial interests have contractual recourse only to the related assets of the collateralized financing entity and are classified as financial liabilities. If elected, the alternative method results in the reporting entity measuring both the financial assets and the financial liabilities of the collateralized financing entity using the more observable of the two fair value measurements, which effectively removes measurement differences between the financial assets and the financial liabilities of the collateralized financing entity previously recorded as net income (loss) attributable to non-controlling and other beneficial interests and as an adjustment to appropriated retained earnings. The reporting entity continues to measure its own beneficial interests in the collateralized financing entity (other than those that represent compensation for services) at fair value. The guidance will be effective for the Company for interim and annual periods beginning in 2016. A reporting entity may apply the guidance using a modified retrospective approach by recording a cumulative-effect adjustment to equity as of the beginning of the annual period of adoption. A reporting entity may also apply the guidance retrospectively to all relevant prior periods. The adoption of this guidance is not expected to have a material impact on our consolidated financial statements.

In February 2015, the FASB issued authoritative guidance which updates the analysis that a reporting entity must perform to determine whether it should consolidate certain legal entities. Such guidance: (i) modifies the evaluation of whether limited partnerships and similar legal entities are VIEs or voting interest entities; (ii) eliminates the presumption that a general partner should consolidate a limited partnership; (iii) affects the consolidation analysis of reporting entities that are involved with VIEs, particularly those that have fee arrangements and related party relationships; and (iv) provides a scope exception from consolidation guidance for certain investment funds. The guidance will be effective for the Company for interim and annual periods beginning in 2016. A reporting entity may apply the guidance using a modified retrospective approach by recording a cumulative-effect adjustment to equity as of the beginning of the annual period of adoption. A reporting entity may also apply the guidance retrospectively to all relevant prior periods. The adoption of this guidance is not expected to have a material impact on our consolidated financial statements.

In May 2015, the FASB issued authoritative guidance which requires additional disclosures related to short-duration contracts. The guidance will require insurance entities to disclose for annual reporting periods information about the liability for unpaid claims and claim adjustment expenses. The guidance also requires insurance entities to disclose information about significant changes in methodologies and assumptions used to calculate the liability for unpaid claims and claim adjustment expenses, including reasons for the change and the effects on the financial statements. Additionally, the guidance requires insurance entities to disclose for annual and interim reporting periods a rollforward of the liability for unpaid claims and claim adjustment expenses. For health insurance claims, the guidance requires the disclosure of the total of incurred-but-not-reported liabilities plus expected development on reported claims included in the liability for unpaid claims and claim adjustment expenses. The guidance will be effective for the Company for annual periods beginning after December 15, 2015, and the interim periods within annual periods beginning after December 15, 2016. The Company is currently assessing the impact the guidance will have on its disclosures upon adoption.

In January 2016, the FASB issued authoritative guidance related to the recognition and measurement of financial assets and financial liabilities which made targeted improvements to GAAP as follows:

(i) Require equity investments (except those accounted for under the equity method of accounting or those that result in consolidation of the investee) to be measured at fair value with changes in fair value recognized in net income. However, an entity may choose to measure equity investments that do not have readily determinable fair values at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer.

(ii) Simplify the impairment assessment of equity investments without readily determinable fair values by requiring a qualitative assessment to identify impairment. When a qualitative assessment indicates that impairment exists, an entity is required to measure the investment at fair value.

(iii) Eliminate the requirement for public business entities to disclose the method(s) and significant assumptions used to estimate the fair value that is required to be disclosed for financial instruments measured at amortized cost on the balance sheet.

(iv) Require public business entities to use the exit price notion when measuring the fair value of financial instruments for disclosure purposes.

(v) Require an entity to present separately in other comprehensive income the portion of the total change in the fair value of a liability resulting from a change in the instrument-specific credit risk when the entity has elected to measure the liability at fair value in accordance with the fair value option for financial instruments.

(vi) Require separate presentation of financial assets and financial liabilities by measurement category and form of financial asset (that is, securities or loans and receivables) on the balance sheet or the accompanying notes to the financial statements.

(vii) Clarify that an entity should evaluate the need for a valuation allowance on a deferred tax asset related to available-for-sale securities in combination with the entity’s other deferred tax assets.

The guidance will be effective for the Company for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. Early adoption of the guidance is not permitted; except that item (v) above is permitted to be adopted early as of the beginning of the fiscal year of adoption.

An entity should apply the amendments in the guidance by means of a cumulative-effect adjustment to the balance sheet as of the beginning of the fiscal year of adoption. The amendments related to equity securities without readily determinable fair

values (including disclosure requirements) should be applied prospectively to equity investments that exist as of the date of adoption of the guidance. The Company is currently assessing the impact the guidance will have upon adoption.

Adopted Accounting Standards

In April 2014, the FASB issued authoritative guidance changing the criteria for reporting discontinued operations. Under the revised guidance, only disposals of a component or a group of components, including those classified as held for sale, which represent a strategic shift that has or will have a major effect on a company's operations and financial results will be reported as discontinued operations. The guidance was effective prospectively for new disposals occurring after January 1, 2015.

In June 2014, the FASB issued authoritative guidance on the accounting and disclosure of repurchase-to-maturity transactions and repurchase financings. Under this new accounting guidance, repurchase-to-maturity transactions will be accounted for as secured borrowings rather than sales of an asset, and transfers of financial assets with a contemporaneous repurchase financing arrangement will no longer be evaluated to determine whether they should be accounted for on a combined basis as forward contracts. The new guidance also prescribes additional disclosures particularly on the nature of collateral pledged in the repurchase agreement accounted for as a secured borrowing. The new guidance was effective beginning on January 1, 2015. The adoption of this guidance did not have a material impact on our consolidated financial statements.

In April 2015, the FASB issued authoritative guidance which requires debt issuance costs in financial statements to be presented as a direct deduction from the carrying value of the associated debt liability rather than as an asset on the balance sheet. This guidance is effective beginning January 1, 2016, with early adoption permitted. The Company adopted this guidance in the fourth quarter of 2015. The adoption of this guidance resulted in a change in presentation on our balance sheet but did not have any impact on our operating results or cash flows.

Fair Value Measurements

Realized and unrealized gains (losses) on Level 3 assets are primarily reported in either net investment income for policyholder and reinsurer accounts and other special-purpose portfolios, net realized investment gains (losses) or insurance policy benefits within the consolidated statement of operations or accumulated other comprehensive income within shareholders' equity based on the stated accounting policy for the instrument.

The amount presented for gains (losses) included in our net loss for assets and liabilities still held as of the reporting date primarily represents impairments for fixed maturities, available for sale, changes in fair value of trading securities and certain derivatives and changes in fair value of embedded derivative instruments included in liabilities for insurance products that exist as of the reporting date.

For those financial instruments disclosed at fair value, we use the following methods and assumptions to determine the estimated fair values:

Mortgage loans and policy loans.  We discount future expected cash flows based on interest rates currently being offered for similar loans with similar risk characteristics.  We aggregate loans with similar characteristics in our calculations.  The fair value of policy loans approximates their carrying value.

Company-owned life insurance is backed by a series of mutual funds and is carried at cash surrender value which approximates estimated fair value.

Cash and cash equivalents include commercial paper, invested cash and other investments purchased with original maturities of less than three months. We carry them at amortized cost, which approximates estimated fair value.

Liabilities for policyholder account balances.  The estimated fair value of insurance liabilities for policyholder account balances was approximately equal to its carrying value as interest rates credited on the vast majority of account balances approximate current rates paid on similar products and because these rates are not generally guaranteed beyond one year.

Investment borrowings, notes payable and borrowings related to variable interest entities.  For publicly traded debt, we use current fair values.  For other notes, we use discounted cash flow analyses based on our current incremental borrowing rates for similar types of borrowing arrangements.

Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date and, therefore, represents an exit price, not an entry price.  We carry certain assets and liabilities at fair value on a recurring basis, including fixed maturities, equity securities, trading securities, investments held by VIEs, derivatives, cash and cash equivalents, separate account assets and embedded derivatives.  We carry our COLI, which is invested in a series of mutual funds, at its cash surrender value which approximates fair value. In addition, we disclose fair value for certain financial instruments, including mortgage loans and policy loans, insurance liabilities for interest-sensitive products, investment borrowings, notes payable and borrowings related to VIEs.

The degree of judgment utilized in measuring the fair value of financial instruments is largely dependent on the level to which pricing is based on observable inputs.  Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our view of market assumptions in the absence of observable market information.  Financial instruments with readily available active quoted prices would be considered to have fair values based on the highest level of observable inputs, and little judgment would be utilized in measuring fair value.  Financial instruments that rarely trade would often have fair value based on a lower level of observable inputs, and more judgment would be utilized in measuring fair value.

Valuation Hierarchy

There is a three-level hierarchy for valuing assets or liabilities at fair value based on whether inputs are observable or unobservable.

• Level 1 – includes assets and liabilities valued using inputs that are unadjusted quoted prices in active markets for identical assets or liabilities.  Our Level 1 assets primarily include cash and exchange traded securities.

• Level 2 – includes assets and liabilities valued using inputs that are quoted prices for similar assets in an active market, quoted prices for identical or similar assets in a market that is not active, observable inputs, or observable inputs that can be corroborated by market data.  Level 2 assets and liabilities include those financial instruments that are valued by independent pricing services using models or other valuation methodologies.  These models consider various inputs such as credit rating, maturity, corporate credit spreads, reported trades and other inputs that are observable or derived from observable information in the marketplace or are supported by transactions executed in the marketplace.  Financial assets in this category primarily include:  certain publicly registered and privately placed corporate fixed maturity securities; certain government or agency securities; certain mortgage and asset-backed securities; certain equity securities; most investments held by our consolidated VIEs; certain mutual fund investments; most short-term investments; and non-exchange-traded derivatives such as call options. Financial liabilities in this category include investment borrowings, notes payable and borrowings related to VIEs.

• Level 3 – includes assets and liabilities valued using unobservable inputs that are used in model-based valuations that contain management assumptions.  Level 3 assets and liabilities include those financial instruments whose fair value is estimated based on broker/dealer quotes, pricing services or internally developed models or methodologies utilizing significant inputs not based on, or corroborated by, readily available market information.  Financial assets in this category include certain corporate securities (primarily certain below-investment grade privately placed securities), certain structured securities, mortgage loans, and other less liquid securities.  Financial liabilities in this category include our insurance liabilities for interest-sensitive products, which includes embedded derivatives (including embedded derivatives related to our fixed index annuity products and to a modified coinsurance arrangement) since their values include significant unobservable inputs including actuarial assumptions.

The Company elected to early adopt authoritative guidance that removed the requirement to categorize within the fair value hierarchy certain investments for which fair value is measured using the net asset value per share practical expedient. Accordingly, certain alternative investments classified as other invested assets with a carrying value of $92.7 million and $102.8 million as of December 31, 2015 and 2014, respectively, have not been classified in the fair value hierarchy.

At each reporting date, we classify assets and liabilities into the three input levels based on the lowest level of input that is significant to the measurement of fair value for each asset and liability reported at fair value.  This classification is impacted by a number of factors, including the type of financial instrument, whether the financial instrument is new to the market and not yet established, the characteristics specific to the transaction and overall market conditions.  Our assessment of the significance of a particular input to the fair value measurement and the ultimate classification of each asset and liability requires judgment and is subject to change from period to period based on the observability of the valuation inputs. Any transfers between levels are reported as having occurred at the beginning of the period. There were no transfers between Level 1 and Level 2 in both 2015 and 2014.

The vast majority of our fixed maturity and equity securities, including those held in trading portfolios and those held by consolidated VIEs, short-term and separate account assets use Level 2 inputs for the determination of fair value.  These fair values are obtained primarily from independent pricing services, which use Level 2 inputs for the determination of fair value.  Our Level 2 assets are valued as follows:

•Fixed maturities available for sale, equity securities and trading securities

Corporate securities are generally priced using market and income approaches. Inputs generally consist of trades of identical or similar securities, quoted prices in inactive markets, issuer rating, benchmark yields, maturity, and credit spreads.

U.S. Treasuries and obligations of U.S. Government corporations and agencies are generally priced using the market approach. Inputs generally consist of trades of identical or similar securities, quoted prices in inactive markets and maturity.

States and political subdivisions are generally priced using the market approach. Inputs generally consist of trades of identical or similar securities, quoted prices in inactive markets, new issuances and credit spreads.

Asset-backed securities, collateralized debt obligations, commercial mortgage-backed securities, mortgage pass-through securities and collateralized mortgage obligations are generally priced using market and income approaches. Inputs generally consist of quoted prices in inactive markets, spreads on actively traded securities, expected prepayments, expected credit default rates, delinquencies, and issue specific information including, but not limited to, collateral type, seniority and vintage.

Equity securities (primarily comprised of non-redeemable preferred stock) are generally priced using the market approach. Inputs generally consist of trades of identical or similar securities, quoted prices in inactive markets, issuer rating, benchmark yields, maturity, and credit spreads.

• Investments held by VIEs

Corporate securities are generally priced using market and income approaches using pricing vendors. Inputs generally consist of issuer rating, benchmark yields, maturity, and credit spreads.

• Other invested assets - derivatives

The fair value measurements for derivative instruments, including embedded derivatives requiring bifurcation, are determined based on the consideration of several inputs including closing exchange or over-the-counter market price quotes; time value and volatility factors underlying options; market interest rates; and non-performance risk.

Third party pricing services normally derive security prices through recently reported trades for identical or similar securities making adjustments through the reporting date based upon available market observable information.  If there are no recently reported trades, the third party pricing services may use matrix or model processes to develop a security price where future cash flow expectations are discounted at an estimated risk-adjusted market rate.  The number of prices obtained for a given security is dependent on the Company's analysis of such prices as further described below.

As the Company is responsible for the determination of fair value, we have control processes designed to ensure that the fair values received from third-party pricing sources are reasonable and the valuation techniques and assumptions used appear reasonable and consistent with prevailing market conditions. Additionally, when inputs are provided by third-party pricing sources, we have controls in place to review those inputs for reasonableness. As part of these controls, we perform monthly quantitative and qualitative analysis on the prices received from third parties to determine whether the prices are reasonable estimates of fair value.  The Company's analysis includes:  (i) a review of the methodology used by third party pricing services; (ii) where available, a comparison of multiple pricing services' valuations for the same security; (iii) a review of month to month price fluctuations; (iv) a review to ensure valuations are not unreasonably dated; and (v) back testing to compare actual purchase and sale transactions with valuations received from third parties.  As a result of such procedures, the Company may conclude the prices received from third parties are not reflective of current market conditions.  In those instances, we may request additional pricing quotes or apply internally developed valuations.  However, the number of such instances is insignificant and the aggregate change in value of such investments is not materially different from the original prices received.

The categorization of the fair value measurements of our investments priced by independent pricing services was based upon the Company's judgment of the inputs or methodologies used by the independent pricing services to value different asset classes.  Such inputs include:  benchmark yields, reported trades, broker dealer quotes, issuer spreads, benchmark securities, bids, offers and reference data.  The Company categorizes such fair value measurements based upon asset classes and the underlying observable or unobservable inputs used to value such investments.

For securities that are not priced by pricing services and may not be reliably priced using pricing models, we obtain broker quotes.  These broker quotes are non-binding andrepresent an exit price, but assumptions used to establish the fair value may not be observable and therefore represent Level 3 inputs.  Approximately 45 percent of our Level 3 fixed maturity securities were valued using unadjusted broker quotes or broker-provided valuation inputs.  The remaining Level 3 fixed maturity investments do not have readily determinable market prices and/or observable inputs.  For these securities, we use internally developed valuations.  Key assumptions used to determine fair value for these securities may include risk premiums, projected performance of underlying collateral and other factors involving significant assumptions which may not be reflective of an active market.  For certain investments, we use a matrix or model process to develop a security price where future cash flow expectations are discounted at an estimated market rate.  The pricing matrix incorporates term interest rates as well as a spread level based on the issuer's credit rating, other factors relating to the issuer, and the security's maturity.  In some instances issuer-specific spread adjustments, which can be positive or negative, are made based upon internal analysis of security specifics such as liquidity, deal size, and time to maturity.

For certain embedded derivatives, we use actuarial assumptions in the determination of fair value which we consider to be Level 3 inputs.

XML

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

12 Months Ended

Dec. 31, 2015

Accounting Policies [Abstract]

Schedule of terms of federal home loan bank borrowing

The following summarizes the terms of the borrowings from the FHLB by Washington National, Bankers Life and Colonial Penn (dollars in millions):

Amount		Maturity	Interest rate at
borrowed		date	December 31, 2015
$	57.7	June 2017	Variable rate – 0.699%
50.0		August 2017	Variable rate – 0.562%
75.0		August 2017	Variable rate – 0.543%
100.0		October 2017	Variable rate – 0.751%
50.0		November 2017	Variable rate – 0.917%
50.0		January 2018	Variable rate – 0.670%
50.0		January 2018	Variable rate – 0.656%
50.0		February 2018	Variable rate – 0.654%
50.0		February 2018	Variable rate – 0.452%
22.0		February 2018	Variable rate – 0.742%
100.0		May 2018	Variable rate – 0.872%
50.0		July 2018	Variable rate – 0.793%
50.0		August 2018	Variable rate – 0.482%
10.0		December 2018	Variable rate – 0.807%
50.0		January 2019	Variable rate – 0.737%
50.0		February 2019	Variable rate – 0.452%
100.0		March 2019	Variable rate – 0.831%
21.8		July 2019	Variable rate – 0.892%
15.0		October 2019	Variable rate – 0.837%
50.0		May 2020	Variable rate – 0.851%
21.8		June 2020	Fixed rate – 1.960%
25.0		September 2020	Variable rate – 0.951%
100.0		September 2020	Variable rate – 1.082%
50.0		September 2020	Variable rate – 1.082%
75.0		September 2020	Variable rate – 0.723%
100.0		October 2020	Variable rate – 0.723%
50.0		December 2020	Variable rate – 0.951%
28.2		August 2021	Fixed rate – 2.550%
26.1		March 2023	Fixed rate – 2.160%
20.5		June 2025	Fixed rate – 2.940%
$	1,548.1

Effect of early adoption of new accounting standard on prior period

The impact of adoption on prior periods is as follows (dollars in millions):

	December 31, 2014
	As originally reported		Effect of adoption			As adjusted
Other assets	$	337.7	$	(28.3	)	$	309.4
Total assets	31,184.2		(28.3		)	31,155.9
Borrowings related to variable interest entities	1,286.1		(14.2		)	1,271.9
Notes payable - direct corporate obligations	794.4		(14.1		)	780.3
Total liabilities	26,496.0		(28.3		)	26,467.7

XML

INVESTMENTS (Tables)

12 Months Ended

Dec. 31, 2015

Investments, Debt and Equity Securities [Abstract]

Schedule of fixed maturities for available for sale and equity securities

At December 31, 2015, the amortized cost, gross unrealized gains and losses, estimated fair value and other-than-temporary impairments in accumulated other comprehensive income of fixed maturities, available for sale, and equity securities were as follows (dollars in millions):

	Amortized cost		Gross unrealized gains		Gross unrealized losses			Estimated fair value		Other-than-temporary impairments included in accumulated other comprehensive income
Investment grade (a):
Corporate securities	$	11,477.5	$	929.4	$	(262.9	)	$	12,144.0	$	—
United States Treasury securities and obligations of United States government corporations and agencies	172.5		22.3		(.3		)	194.5		—
States and political subdivisions	1,889.6		208.6		(3.7		)	2,094.5		—
Debt securities issued by foreign governments	18.9		—		(.6		)	18.3		—
Asset-backed securities	979.8		22.1		(7.2		)	994.7		—
Collateralized debt obligations	188.5		.4		(2.2		)	186.7		—
Commercial mortgage-backed securities	1,531.7		41.3		(16.3		)	1,556.7		—
Mortgage pass-through securities	3.1		.3		—			3.4		—
Collateralized mortgage obligations	450.9		17.0		(.6		)	467.3		—
Total investment grade fixed maturities, available for sale	16,712.5		1,241.4		(293.8		)	17,660.1		—
Below-investment grade (a):
Corporate securities	798.5		8.3		(82.3		)	724.5		—
States and political subdivisions	13.6		—		(3.9		)	9.7		(3.0		)
Debt securities issued by foreign governments	2.4		—		—			2.4		—
Asset-backed securities	838.0		25.7		(6.2		)	857.5		—
Commercial mortgage-backed securities	49.9		—		(1.3		)	48.6		—
Collateralized mortgage obligations	532.1		49.0		(1.0		)	580.1		(1.9		)
Total below-investment grade fixed maturities, available for sale	2,234.5		83.0		(94.7		)	2,222.8		(4.9		)
Total fixed maturities, available for sale	$	18,947.0	$	1,324.4	$	(388.5	)	$	19,882.9	$	(4.9	)
Equity securities	$	447.4	$	18.4	$	(2.8	)	$	463.0

_______________

(a) Investment ratings – Investment ratings are assigned the second lowest rating by Nationally Recognized Statistical Rating Organizations ("NRSROs") (Moody's Investor Services, Inc. ("Moody's"), Standard & Poor's Corporation ("S&P") or Fitch Ratings ("Fitch")), or if not rated by such firms, the rating assigned by the National Association of Insurance Commissioners (the "NAIC").  NAIC designations of "1" or "2" include fixed maturities generally rated investment grade (rated "Baa3" or higher by Moody's or rated "BBB-" or higher by S&P and Fitch).  NAIC designations of "3" through "6" are referred to as below-investment grade (which generally are rated "Ba1" or lower by Moody's or rated "BB+" or lower by S&P and Fitch).  References to investment grade or below-investment grade throughout our consolidated financial statements are determined as described above.

Schedule of NAIC designations and NRSRO equivalent ratings

The following summarizes the NAIC designations and NRSRO equivalent ratings:

NAIC Designation	NRSRO Equivalent Rating
1	AAA/AA/A
2	BBB
3	BB
4	B
5	CCC and lower
6	In or near default

Summary of fixed maturity securities available for sale

A summary of our fixed maturity securities, available for sale, by NAIC designations (or for fixed maturity securities held by non-regulated entities, based on NRSRO ratings) as of December 31, 2015 is as follows (dollars in millions):

NAIC designation	Amortized cost		Estimated fair value		Percentage of total estimated fair value
1	$	9,491.4	$	10,238.7	51.5	%
2	8,609.3		8,876.1		44.6
3	591.4		547.4		2.8
4	187.4		160.0		.8
5	53.7		50.8		.3
6	13.8		9.9		—
	$	18,947.0	$	19,882.9	100.0	%

Schedule of fixed maturities for available for sale and equity securities

At December 31, 2014, the amortized cost, gross unrealized gains and losses, estimated fair value and other-than-temporary impairments in accumulated other comprehensive income of fixed maturities, available for sale, and equity securities were as follows (dollars in millions):

	Amortized cost		Gross unrealized gains		Gross unrealized losses			Estimated fair value		Other-than-temporary impairments included in accumulated other comprehensive income
Investment grade (a):
Corporate securities	$	11,177.1	$	1,710.5	$	(42.1	)	$	12,845.5	$	—
United States Treasury securities and obligations of United States government corporations and agencies	138.8		30.2		(.1		)	168.9		—
States and political subdivisions	1,960.6		299.3		(.7		)	2,259.2		—
Debt securities issued by foreign governments	1.8		.1		—			1.9		—
Asset-backed securities	720.7		52.0		(1.6		)	771.1		—
Collateralized debt obligations	314.9		2.4		(3.4		)	313.9		—
Commercial mortgage-backed securities	1,179.7		80.9		(.5		)	1,260.1		—
Mortgage pass-through securities	4.2		.4		—			4.6		—
Collateralized mortgage obligations	571.1		23.1		(.6		)	593.6		—
Total investment grade fixed maturities, available for sale	16,068.9		2,198.9		(49.0		)	18,218.8		—
Below-investment grade (a):
Corporate securities	1,139.3		29.2		(43.0		)	1,125.5		—
States and political subdivisions	20.6		.2		(2.3		)	18.5		—
Asset-backed securities	465.9		33.8		(1.8		)	497.9		—
Collateralized debt obligations	10.4		.2		—			10.6		—
Commercial mortgage-backed securities	15.3		.9		—			16.2		—
Collateralized mortgage obligations	687.7		60.4		(.7		)	747.4		(3.2		)
Total below-investment grade fixed maturities, available for sale	2,339.2		124.7		(47.8		)	2,416.1		(3.2		)
Total fixed maturities, available for sale	$	18,408.1	$	2,323.6	$	(96.8	)	$	20,634.9	$	(3.2	)
Equity securities	$	400.5	$	19.1	$	(.6	)	$	419.0

Schedule of accumulated other comprehensive income (loss)

Accumulated other comprehensive income is primarily comprised of the net effect of unrealized appreciation (depreciation) on our investments.  These amounts, included in shareholders' equity as of December 31, 2015 and 2014, were as follows (dollars in millions):

	2015			2014
Net unrealized appreciation (depreciation) on fixed maturity securities, available for sale, on which an other-than-temporary impairment loss has been recognized	$	1.6		$	5.3
Net unrealized gains on all other investments	903.4			2,207.7
Adjustment to present value of future profits (a)	(121.2		)	(149.9		)
Adjustment to deferred acquisition costs	(133.3		)	(390.5		)
Adjustment to insurance liabilities	(14.6		)	(381.4		)
Unrecognized net loss related to deferred compensation plan	(8.6		)	(8.5		)
Deferred income tax liabilities	(224.5		)	(457.4		)
Accumulated other comprehensive income	$	402.8		$	825.3

________

(a) The present value of future profits is the value assigned to the right to receive future cash flows from contracts existing at September 10, 2003, the date our Predecessor emerged from bankruptcy.

Schedule of investments classified by contractual maturity date

The following table sets forth the amortized cost and estimated fair value of fixed maturities, available for sale, at December 31, 2015, by contractual maturity.  Actual maturities will differ from contractual maturities because certain borrowers may have the right to call or prepay obligations with or without penalties.  In addition, structured securities (such as asset-backed securities, collateralized debt obligations, commercial mortgage-backed securities, mortgage pass-through securities and collateralized mortgage obligations, collectively referred to as "structured securities") frequently include provisions for periodic principal payments and permit periodic unscheduled payments.

	Amortized cost		Estimated fair value
	(Dollars in millions)
Due in one year or less	$	265.0	$	268.9
Due after one year through five years	2,246.2		2,389.1
Due after five years through ten years	1,755.7		1,824.5
Due after ten years	10,106.1		10,705.4
Subtotal	14,373.0		15,187.9
Structured securities	4,574.0		4,695.0
Total fixed maturities, available for sale	$	18,947.0	$	19,882.9

Schedule of investment income

Net investment income consisted of the following (dollars in millions):

	2015			2014			2013
General account assets:
Fixed maturities	$	1,090.1		$	1,175.8		$	1,290.3
Equity securities	18.3			13.9			7.0
Mortgage loans	91.4			104.2			96.3
Policy loans	7.3			11.0			17.3
Other invested assets	17.4			17.1			14.4
Cash and cash equivalents	.8			.6			.5
Policyholder and reinsurer accounts and other special-purpose portfolios:
Trading securities (a)	10.7			14.8			12.8
Options related to fixed index products:
Option income	36.5			118.9			77.4
Change in value of options	(72.7		)	(49.4		)	100.1
Other special-purpose portfolios	55.5			42.1			67.9
Gross investment income	1,255.3			1,449.0			1,684.0
Less investment expenses	21.7			21.6			20.0
Net investment income	$	1,233.6		$	1,427.4		$	1,664.0

_________________

(a) Changes in the estimated fair value for trading securities still held as of the end of the respective years and included in net investment income were $.4 million, $3.4 million and $.4 million for the years ended December 31, 2015, 2014 and 2013, respectively.

Schedule of realized gain (loss) on investments

The following table sets forth the net realized investment gains (losses) for the periods indicated (dollars in millions):

	2015			2014			2013
Fixed maturity securities, available for sale:
Gross realized gains on sale	$	95.7		$	64.4		$	57.7
Gross realized losses on sale	(88.4		)	(13.0		)	(11.4		)
Impairments:
Total other-than-temporary impairment losses	(17.9		)	—			(7.1		)
Other-than-temporary impairment losses recognized in accumulated other comprehensive income	3.0			—			—
Net impairment losses recognized	(14.9		)	—			(7.1		)
Net realized investment gains (losses) from fixed maturities	(7.6		)	51.4			39.2
Equity securities	3.7			10.1			4.8
Commercial mortgage loans	(2.3		)	(.1		)	(1.1		)
Impairments of mortgage loans and other investments	(25.0		)	(27.3		)	(4.5		)
Gain on dissolution of a variable interest entity	11.3			—			—
Other (a)	(16.7		)	2.6			(5.0		)
Net realized investment gains (losses)	$	(36.6	)	$	36.7		$	33.4

_________________

(a) Changes in the estimated fair value of trading securities that we have elected the fair value option (and still held as of the end of the respective periods) were $(9.2) million, $7.8 million and $(3.0) million for the years ended December 31, 2015, 2014 and 2013, respectively.

Schedule of investments in our portfolio rated below-investment grade which have been continuously in an unrealized loss position

The following summarizes the investments in our portfolio rated below-investment grade which have been continuously in an unrealized loss position exceeding 20 percent of the cost basis for the period indicated as of December 31, 2015 (dollars in millions):

	Number of issuers	Cost basis		Unrealized loss			Estimated fair value
Less than 6 months	22	$	172.8	$	(50.3	)	$	122.5
Greater than or equal to 6 months and less than 12 months	2	23.0		(9.8		)	13.2
Greater than 12 months (a)	1	18.2		(6.1		)	12.1
		$	214.0	$	(66.2	)	$	147.8

________________

(a) With respect to the security which has been in an unrealized position for greater than 12 months, we have analyzed the issuer's financial performance and determined we expect to recover the entire amortized cost.

The following summarizes the investments sold at a loss during 2015 which had been continuously in an unrealized loss position exceeding 20 percent of the amortized cost basis prior to the sale for the period indicated (dollars in millions):

		At date of sale
	Number of issuers	Amortized cost		Fair value
Less than 6 months prior to sale	12	$	38.7	$	24.5
Greater than or equal to 6 months and less than 12 months prior to sale	2	16.9		9.5
	14	$	55.6	$	34.0

Schedule of credit losses recognized in earnings

The following table summarizes the amount of credit losses recognized in earnings on fixed maturity securities, available for sale, held at the beginning of the period, for which a portion of the other-than-temporary impairment was also recognized in accumulated other comprehensive income for years ended December 31, 2015, 2014 and 2013 (dollars in millions):

	Year ended
	December 31,
	2015			2014			2013
Credit losses on fixed maturity securities, available for sale, beginning of period	$	(1.0	)	$	(1.3	)	$	(1.6	)
Add:  credit losses on other-than-temporary impairments not previously recognized	(2.0		)	—			—
Less:  credit losses on securities sold	.4			.3			.3
Less:  credit losses on securities impaired due to intent to sell (a)	—			—			—
Add:  credit losses on previously impaired securities	—			—			—
Less:  increases in cash flows expected on previously impaired securities	—			—			—
Credit losses on fixed maturity securities, available for sale, end of period	$	(2.6	)	$	(1.0	)	$	(1.3	)

__________

(a) Represents securities for which the amount previously recognized in accumulated other comprehensive income was recognized in earnings because we intend to sell the security or we more likely than not will be required to sell the security before recovery of its amortized cost basis.

Schedule of investments with unrealized losses classified by contractual maturity date

The following table sets forth the amortized cost and estimated fair value of those fixed maturities, available for sale, with unrealized losses at December 31, 2015, by contractual maturity.  Actual maturities will differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without penalties.  Structured securities frequently include provisions for periodic principal payments and permit periodic unscheduled payments.

	Amortized cost		Estimated fair value
	(Dollars in millions)
Due in one year or less	$	20.7	$	20.7
Due after one year through five years	358.7		343.8
Due after five years through ten years	464.3		426.4
Due after ten years	2,938.4		2,637.5
Subtotal	3,782.1		3,428.4
Structured securities	1,916.4		1,881.6
Total	$	5,698.5	$	5,310.0

Schedule of unrealized loss on investments

The following table summarizes the gross unrealized losses and fair values of our investments with unrealized losses that are not deemed to be other-than-temporarily impaired, aggregated by investment category and length of time that such securities have been in a continuous unrealized loss position, at December 31, 2015 (dollars in millions):

	Less than 12 months					12 months or greater					Total
Description of securities	Fair value		Unrealized losses			Fair value		Unrealized losses			Fair value		Unrealized losses
United States Treasury securities and obligations of United States government corporations and agencies	$	43.6	$	(.3	)	$	—	$	—		$	43.6	$	(.3	)
States and political subdivisions	156.8		(4.1		)	14.8		(3.5		)	171.6		(7.6		)
Debt securities issued by foreign governments	20.7		(.6		)	—		—			20.7		(.6		)
Corporate securities	2,913.6		(255.7		)	278.9		(89.5		)	3,192.5		(345.2		)
Asset-backed securities	930.3		(11.7		)	98.4		(1.7		)	1,028.7		(13.4		)
Collateralized debt obligations	96.2		(1.8		)	36.3		(.4		)	132.5		(2.2		)
Commercial mortgage-backed securities	556.0		(16.1		)	25.7		(1.5		)	581.7		(17.6		)
Mortgage pass-through securities	—		—			.1		—			.1		—
Collateralized mortgage obligations	97.8		(1.0		)	40.8		(.6		)	138.6		(1.6		)
Total fixed maturities, available for sale	$	4,815.0	$	(291.3	)	$	495.0	$	(97.2	)	$	5,310.0	$	(388.5	)
Equity securities	$	140.1	$	(2.4	)	$	2.4	$	(.4	)	$	142.5	$	(2.8	)

The following table summarizes the gross unrealized losses and fair values of our investments with unrealized losses that are not deemed to be other-than-temporarily impaired, aggregated by investment category and length of time that such securities have been in a continuous unrealized loss position, at December 31, 2014 (dollars in millions):

	Less than 12 months					12 months or greater					Total
Description of securities	Fair value		Unrealized losses			Fair value		Unrealized losses			Fair value		Unrealized losses
United States Treasury securities and obligations of United States government corporations and agencies	$	12.1	$	(.1	)	$	4.6	$	—		$	16.7	$	(.1	)
States and political subdivisions	13.2		(.3		)	44.5		(2.7		)	57.7		(3.0		)
Corporate securities	985.0		(65.9		)	297.5		(19.2		)	1,282.5		(85.1		)
Asset-backed securities	91.2		(1.3		)	60.5		(2.1		)	151.7		(3.4		)
Collateralized debt obligations	184.2		(3.4		)	—		—			184.2		(3.4		)
Commercial mortgage-backed securities	46.7		(.5		)	—		—			46.7		(.5		)
Mortgage pass-through securities	.5		—			.1		—			.6		—
Collateralized mortgage obligations	79.0		(.8		)	32.0		(.5		)	111.0		(1.3		)
Total fixed maturities, available for sale	$	1,411.9	$	(72.3	)	$	439.2	$	(24.5	)	$	1,851.1	$	(96.8	)
Equity securities	$	13.2	$	(.6	)	$	.5	$	—		$	13.7	$	(.6	)

Schedule of structured securities

The following table sets forth the par value, amortized cost and estimated fair value of structured securities, summarized by interest rates on the underlying collateral, at December 31, 2015 (dollars in millions):

	Par value		Amortized cost		Estimated fair value
Below 4 percent	$	1,387.4	$	978.3	$	982.3
4 percent – 5 percent	1,363.8		1,289.7		1,300.0
5 percent – 6 percent	1,868.3		1,747.4		1,822.2
6 percent – 7 percent	454.6		419.4		445.2
7 percent – 8 percent	75.0		75.7		82.5
8 percent and above	64.0		63.5		62.8
Total structured securities	$	5,213.1	$	4,574.0	$	4,695.0

The amortized cost and estimated fair value of structured securities at December 31, 2015, summarized by type of security, were as follows (dollars in millions):

			Estimated fair value
Type	Amortized cost		Amount		Percent of fixed maturities
Pass-throughs, sequential and equivalent securities	$	750.0	$	799.8	4.0	%
Planned amortization classes, target amortization classes and accretion-directed bonds	187.7		202.4		1.0
Commercial mortgage-backed securities	1,581.6		1,605.3		8.1
Asset-backed securities	1,817.8		1,852.2		9.3
Collateralized debt obligations	188.5		186.7		.9
Other	48.4		48.6		.3
Total structured securities	$	4,574.0	$	4,695.0	23.6	%

Summary of weighted average loan-to-value ratio for outstanding mortgage loans

The following table provides the carrying value and estimated fair value of our outstanding mortgage loans and the underlying collateral as of December 31, 2015 (dollars in millions):

			Estimated fair value
Loan-to-value ratio (a)	Carrying value		Mortgage loans		Collateral
Less than 60%	$	796.2	$	828.0	$	1,925.0
60% to 70%	503.8		509.6		771.8
Greater than 70% to 80%	326.8		336.9		440.0
Greater than 80% to 90%	89.9		93.0		108.6
Greater than 90%	4.3		4.9		4.3
Total	$	1,721.0	$	1,772.4	$	3,249.7

________________

(a) Loan-to-value ratios are calculated as the ratio of:  (i) the carrying value of the commercial mortgage loans; to (ii) the estimated fair value of the underlying collateral.

XML

FAIR VALUE MEASUREMENTS (Tables)

12 Months Ended

Dec. 31, 2015

Fair Value Disclosures [Abstract]

Fair value measurements of financial instruments measured on a recurring basis

The fair value measurements for our financial instruments disclosed at fair value on a recurring basis are as follows (dollars in millions):

	December 31, 2015
	Quoted prices in active markets for identical assets or liabilities (Level 1)		Significant other observable inputs  (Level 2)		Significant unobservable inputs  (Level 3)		Total estimated fair value		Total carrying amount
Assets:
Mortgage loans	$	—	$	—	$	1,772.4	$	1,772.4	$	1,721.0
Policy loans	—		—		109.4		109.4		109.4
Other invested assets:
Company-owned life insurance	—		158.1		—		158.1		158.1
Cash and cash equivalents:
Unrestricted	432.3		—		—		432.3		432.3
Held by variable interest entities	364.4		—		—		364.4		364.4
Liabilities:
Policyholder account balances	—		—		10,762.3		10,762.3		10,762.3
Investment borrowings	—		1,549.8		—		1,549.8		1,548.1
Borrowings related to variable interest entities	—		1,673.6		—		1,673.6		1,676.4
Notes payable – direct corporate obligations	—		937.8		—		937.8		911.1

	December 31, 2014
	Quoted prices in active markets for identical assets or liabilities (Level 1)		Significant other observable inputs  (Level 2)		Significant unobservable inputs  (Level 3)		Total estimated fair value		Total carrying amount
Assets:
Mortgage loans	$	—	$	—	$	1,768.9	$	1,768.9	$	1,691.9
Policy loans	—		—		106.9		106.9		106.9
Other invested assets:
Company-owned life insurance	—		157.6		—		157.6		157.6
Cash and cash equivalents:
Unrestricted	549.6		62.0		—		611.6		611.6
Held by variable interest entities	68.3		—		—		68.3		68.3
Liabilities:
Policyholder account balances	—		—		10,707.2		10,707.2		10,707.2
Investment borrowings	—		1,520.4		—		1,520.4		1,519.2
Borrowings related to variable interest entities	—		1,229.2		—		1,229.2		1,271.9
Notes payable – direct corporate obligations	—		807.4		—		807.4		780.3

The categorization of fair value measurements, by input level, for our financial instruments carried at fair value on a recurring basis at December 31, 2015 is as follows (dollars in millions):

	Quoted prices in active markets for identical assets or liabilities (Level 1)		Significant other observable inputs (Level 2)		Significant unobservable inputs  (Level 3)		Total
Assets:
Fixed maturities, available for sale:
Corporate securities	$	—	$	12,698.1	$	170.4	$	12,868.5
United States Treasury securities and obligations of United States government corporations and agencies	—		194.5		—		194.5
States and political subdivisions	—		2,104.2		—		2,104.2
Debt securities issued by foreign governments	—		20.7		—		20.7
Asset-backed securities	—		1,816.3		35.9		1,852.2
Collateralized debt obligations	—		186.7		—		186.7
Commercial mortgage-backed securities	—		1,604.2		1.1		1,605.3
Mortgage pass-through securities	—		3.3		.1		3.4
Collateralized mortgage obligations	—		1,047.4		—		1,047.4
Total fixed maturities, available for sale	—		19,675.4		207.5		19,882.9
Equity securities - corporate securities	254.9		176.1		32.0		463.0
Trading securities:
Corporate securities	—		21.5		—		21.5
United States Treasury securities and obligations of United States government corporations and agencies	—		1.9		—		1.9
Asset-backed securities	—		35.5		—		35.5
Collateralized debt obligations	—		2.1		—		2.1
Commercial mortgage-backed securities	—		118.1		39.9		158.0
Collateralized mortgage obligations	—		38.2		—		38.2
Equity securities	4.9		—		—		4.9
Total trading securities	4.9		217.3		39.9		262.1
Investments held by variable interest entities - corporate securities	—		1,633.6		—		1,633.6
Other invested assets - derivatives	1.6		41.0		—		42.6
Assets held in separate accounts	—		4.7		—		4.7
Total assets carried at fair value by category	$	261.4	$	21,748.1	$	279.4	$	22,288.9
Liabilities:
Future policy benefits - embedded derivatives associated with fixed index annuity products	$	—	$	—	$	1,057.1	$	1,057.1

The categorization of fair value measurements, by input level, for our financial instruments carried at fair value on a recurring basis at December 31, 2014 is as follows (dollars in millions):

	Quoted prices in active markets  for identical assets or liabilities (Level 1)		Significant other observable inputs  (Level 2)		Significant unobservable inputs  (Level 3)		Total
Assets:
Fixed maturities, available for sale:
Corporate securities	$	—	$	13,605.1	$	365.9	$	13,971.0
United States Treasury securities and obligations of United States government corporations and agencies	—		168.9		—		168.9
States and political subdivisions	—		2,242.2		35.5		2,277.7
Debt securities issued by foreign governments	—		1.9		—		1.9
Asset-backed securities	—		1,209.8		59.2		1,269.0
Collateralized debt obligations	—		324.5		—		324.5
Commercial mortgage-backed securities	—		1,275.1		1.2		1,276.3
Mortgage pass-through securities	—		4.2		.4		4.6
Collateralized mortgage obligations	—		1,341.0		—		1,341.0
Total fixed maturities, available for sale	—		20,172.7		462.2		20,634.9
Equity securities - corporate securities	216.9		174.1		28.0		419.0
Trading securities:
Corporate securities	—		24.3		—		24.3
United States Treasury securities and obligations of United States government corporations and agencies	—		3.7		—		3.7
Asset-backed securities	—		24.0		—		24.0
Commercial mortgage-backed securities	—		131.0		28.6		159.6
Mortgage pass-through securities	—		.1		—		.1
Collateralized mortgage obligations	—		29.7		—		29.7
Equity securities	3.5		—		—		3.5
Total trading securities	3.5		212.8		28.6		244.9
Investments held by variable interest entities - corporate securities	—		1,367.1		—		1,367.1
Other invested assets - derivatives	1.4		107.2		—		108.6
Assets held in separate accounts	—		5.6		—		5.6
Total assets carried at fair value by category	$	221.8	$	22,039.5	$	518.8	$	22,780.1
Liabilities:
Future policy benefits - embedded derivatives associated with fixed index annuity products	$	—	$	—	$	1,081.5	$	1,081.5

Fair value, assets measured on recurring basis, unobservable input reconciliation

The following table presents additional information about assets and liabilities measured at fair value on a recurring basis and for which we have utilized significant unobservable (Level 3) inputs to determine fair value for the year ended December 31, 2015 (dollars in millions):

	December 31, 2015
	Beginning balance as of December 31, 2014			Purchases, sales, issuances and settlements, net (b)			Total realized and unrealized gains (losses) included in net income			Total realized and unrealized gains (losses) included in accumulated other comprehensive income (loss)			Transfers into Level 3 (a)		Transfers out of Level 3 (a)			Ending balance as of December 31, 2015			Amount of total gains (losses) for the year ended December 31, 2015 included in our net income relating to assets and liabilities still held as of the reporting date
Assets:
Fixed maturities, available for sale:
Corporate securities	$	365.9		$	31.0		$	(2.2	)	$	(19.5	)	$	37.4	$	(242.2	)	$	170.4		$	—
States and political subdivisions	35.5			(35.5		)	—			—			—		—			—			—
Asset-backed securities	59.2			6.7			—			(1.4		)	—		(28.6		)	35.9			—
Commercial mortgage-backed securities	1.2			(.1		)	—			—			—		—			1.1			—
Mortgage pass-through securities	.4			(.3		)	—			—			—		—			.1			—
Total fixed maturities, available for sale	462.2			1.8			(2.2		)	(20.9		)	37.4		(270.8		)	207.5			—
Equity securities - corporate securities	28.0			4.0			—			—			—		—			32.0			—
Trading securities - commercial mortgage-backed securities	28.6			9.5			—			1.8			—		—			39.9			1.8
Liabilities:
Future policy benefits - embedded derivatives associated with fixed index annuity products	(1,081.5		)	(11.9		)	36.3			—			—		—			(1,057.1		)	36.3

_________

(a) Transfers into Level 3 are the result of unobservable inputs utilized within valuation methodologies for assets that were previously valued using observable inputs. Transfers out of Level 3 are due to the use of observable inputs in valuation methodologies as well as the utilization of pricing service information for certain assets that the Company is able to validate.

(b) Purchases, sales, issuances and settlements, net, represent the activity that occurred during the period that results in a change of the asset or liability but does not represent changes in fair value for the instruments held at the beginning of the period.  Such activity primarily consists of purchases and sales of fixed maturity and equity securities and changes to embedded derivative instruments related to insurance products resulting from the issuance of new contracts, or changes to existing contracts.  The following summarizes such activity for the year ended December 31, 2015 (dollars in millions):

	Purchases			Sales			Issuances			Settlements		Purchases, sales, issuances and settlements, net
Assets:
Fixed maturities, available for sale:
Corporate securities	$	62.2		$	(31.2	)	$	—		$	—	$	31.0
States and political subdivisions	—			(35.5		)	—			—		(35.5		)
Asset-backed securities	13.7			(7.0		)	—			—		6.7
Commercial mortgage-backed securities	—			(.1		)	—			—		(.1		)
Mortgage pass-through securities	—			(.3		)	—			—		(.3		)
Total fixed maturities, available for sale	75.9			(74.1		)	—			—		1.8
Equity securities - corporate securities	4.0			—			—			—		4.0
Trading securities - commercial mortgage-backed securities	9.5			—			—			—		9.5
Liabilities:
Future policy benefits - embedded derivatives associated with fixed index annuity products	(137.8		)	64.4			(4.0		)	65.5		(11.9		)

The following table presents additional information about assets and liabilities measured at fair value on a recurring basis and for which we have utilized significant unobservable (Level 3) inputs to determine fair value for the year ended December 31, 2014 (dollars in millions):

	December 31, 2014
	Beginning balance as of December 31, 2013			Purchases, sales, issuances and settlements, net (b)			Total realized and unrealized gains (losses) included in net income			Total realized and unrealized gains (losses) included in accumulated other comprehensive income (loss)			Transfers into Level 3 (a)		Transfers out of Level 3 (a)			Assets of CLIC sold			Ending balance as of December 31, 2014			Amount of total gains (losses) for the year ended December 31, 2014 included in our net income relating to assets and liabilities still held as of the reporting date
Assets:
Fixed maturities, available for sale:
Corporate securities	$	359.6		$	70.0		$	—		$	20.1		$	36.8	$	(69.4	)	$	(51.2	)	$	365.9		$	—
States and political subdivisions	—			(1.8		)	—			3.0			36.5		—			(2.2		)	35.5			—
Asset-backed securities	42.2			7.6			—			5.1			14.0		—			(9.7		)	59.2			—
Collateralized debt obligations	246.7			—			—			—			—		(246.7		)	—			—			—
Commercial mortgage-backed securities	—			1.1			—			.1			—		—			—			1.2			—
Mortgage pass-through securities	1.6			(1.2		)	—			—			—		—			—			.4			—
Total fixed maturities, available for sale	650.1			75.7			—			28.3			87.3		(316.1		)	(63.1		)	462.2			—
Equity securities - corporate securities	24.5			3.5			—			—			—		—			—			28.0			—
Trading securities - commercial mortgage-backed securities	—			29.0			—			(.4		)	—		—			—			28.6			(.4		)
Liabilities:
Future policy benefits - embedded derivatives associated with fixed index annuity products	(903.7		)	(104.3		)	(73.5		)	—			—		—			—			(1,081.5		)	(73.5		)
Other liabilities - embedded derivatives associated with modified coinsurance agreement	(1.8		)	1.8			—			—			—		—			—			—			—
Total liabilities	(905.5		)	(102.5		)	(73.5		)	—			—		—			—			(1,081.5		)	(73.5		)

____________

(a) Transfers into Level 3 are the result of unobservable inputs utilized within valuation methodologies for assets that were previously valued using observable inputs. Transfers out of Level 3 are due to the use of observable inputs in valuation methodologies as well as the utilization of pricing service information for certain assets that the Company is able to validate.

(b) Purchases, sales, issuances and settlements, net, represent the activity that occurred during the period that results in a change of the asset or liability but does not represent changes in fair value for the instruments held at the beginning of the period.  Such activity primarily consists of purchases and sales of fixed maturity and equity securities and changes to embedded derivative instruments related to insurance products resulting from the issuance of new contracts, or changes to existing contracts.  The following summarizes such activity for the year ended December 31, 2014 (dollars in millions):

	Purchases			Sales			Issuances			Settlements		Purchases, sales, issuances and settlements, net
Assets:
Fixed maturities, available for sale:
Corporate securities	$	71.7		$	(1.7	)	$	—		$	—	$	70.0
States and political subdivisions	—			(1.8		)	—			—		(1.8		)
Asset-backed securities	9.9			(2.3		)	—			—		7.6
Commercial mortgage-backed securities	1.1			—			—			—		1.1
Mortgage pass-through securities	1.1			(2.3		)	—			—		(1.2		)
Total fixed maturities, available for sale	83.8			(8.1		)	—			—		75.7
Equity securities - corporate securities	3.5			—			—			—		3.5
Trading securities - commercial mortgage-backed securities	29.0			—			—			—		29.0
Liabilities:
Future policy benefits - embedded derivatives associated with fixed index annuity products	(121.9		)	7.5			(45.9		)	56.0		(104.3		)
Other liabilities - embedded derivatives associated with modified coinsurance agreement	—			3.4			(1.6		)	—		1.8
Total liabilities	(121.9		)	10.9			(47.5		)	56.0		(102.5		)

Fair value, liabilities measured on recurring basis, unobservable input reconciliation

The following table presents additional information about assets and liabilities measured at fair value on a recurring basis and for which we have utilized significant unobservable (Level 3) inputs to determine fair value for the year ended December 31, 2015 (dollars in millions):

	December 31, 2015
	Beginning balance as of December 31, 2014			Purchases, sales, issuances and settlements, net (b)			Total realized and unrealized gains (losses) included in net income			Total realized and unrealized gains (losses) included in accumulated other comprehensive income (loss)			Transfers into Level 3 (a)		Transfers out of Level 3 (a)			Ending balance as of December 31, 2015			Amount of total gains (losses) for the year ended December 31, 2015 included in our net income relating to assets and liabilities still held as of the reporting date
Assets:
Fixed maturities, available for sale:
Corporate securities	$	365.9		$	31.0		$	(2.2	)	$	(19.5	)	$	37.4	$	(242.2	)	$	170.4		$	—
States and political subdivisions	35.5			(35.5		)	—			—			—		—			—			—
Asset-backed securities	59.2			6.7			—			(1.4		)	—		(28.6		)	35.9			—
Commercial mortgage-backed securities	1.2			(.1		)	—			—			—		—			1.1			—
Mortgage pass-through securities	.4			(.3		)	—			—			—		—			.1			—
Total fixed maturities, available for sale	462.2			1.8			(2.2		)	(20.9		)	37.4		(270.8		)	207.5			—
Equity securities - corporate securities	28.0			4.0			—			—			—		—			32.0			—
Trading securities - commercial mortgage-backed securities	28.6			9.5			—			1.8			—		—			39.9			1.8
Liabilities:
Future policy benefits - embedded derivatives associated with fixed index annuity products	(1,081.5		)	(11.9		)	36.3			—			—		—			(1,057.1		)	36.3

_________

(a) Transfers into Level 3 are the result of unobservable inputs utilized within valuation methodologies for assets that were previously valued using observable inputs. Transfers out of Level 3 are due to the use of observable inputs in valuation methodologies as well as the utilization of pricing service information for certain assets that the Company is able to validate.

(b) Purchases, sales, issuances and settlements, net, represent the activity that occurred during the period that results in a change of the asset or liability but does not represent changes in fair value for the instruments held at the beginning of the period.  Such activity primarily consists of purchases and sales of fixed maturity and equity securities and changes to embedded derivative instruments related to insurance products resulting from the issuance of new contracts, or changes to existing contracts.  The following summarizes such activity for the year ended December 31, 2015 (dollars in millions):

	Purchases			Sales			Issuances			Settlements		Purchases, sales, issuances and settlements, net
Assets:
Fixed maturities, available for sale:
Corporate securities	$	62.2		$	(31.2	)	$	—		$	—	$	31.0
States and political subdivisions	—			(35.5		)	—			—		(35.5		)
Asset-backed securities	13.7			(7.0		)	—			—		6.7
Commercial mortgage-backed securities	—			(.1		)	—			—		(.1		)
Mortgage pass-through securities	—			(.3		)	—			—		(.3		)
Total fixed maturities, available for sale	75.9			(74.1		)	—			—		1.8
Equity securities - corporate securities	4.0			—			—			—		4.0
Trading securities - commercial mortgage-backed securities	9.5			—			—			—		9.5
Liabilities:
Future policy benefits - embedded derivatives associated with fixed index annuity products	(137.8		)	64.4			(4.0		)	65.5		(11.9		)

The following table presents additional information about assets and liabilities measured at fair value on a recurring basis and for which we have utilized significant unobservable (Level 3) inputs to determine fair value for the year ended December 31, 2014 (dollars in millions):

	December 31, 2014
	Beginning balance as of December 31, 2013			Purchases, sales, issuances and settlements, net (b)			Total realized and unrealized gains (losses) included in net income			Total realized and unrealized gains (losses) included in accumulated other comprehensive income (loss)			Transfers into Level 3 (a)		Transfers out of Level 3 (a)			Assets of CLIC sold			Ending balance as of December 31, 2014			Amount of total gains (losses) for the year ended December 31, 2014 included in our net income relating to assets and liabilities still held as of the reporting date
Assets:
Fixed maturities, available for sale:
Corporate securities	$	359.6		$	70.0		$	—		$	20.1		$	36.8	$	(69.4	)	$	(51.2	)	$	365.9		$	—
States and political subdivisions	—			(1.8		)	—			3.0			36.5		—			(2.2		)	35.5			—
Asset-backed securities	42.2			7.6			—			5.1			14.0		—			(9.7		)	59.2			—
Collateralized debt obligations	246.7			—			—			—			—		(246.7		)	—			—			—
Commercial mortgage-backed securities	—			1.1			—			.1			—		—			—			1.2			—
Mortgage pass-through securities	1.6			(1.2		)	—			—			—		—			—			.4			—
Total fixed maturities, available for sale	650.1			75.7			—			28.3			87.3		(316.1		)	(63.1		)	462.2			—
Equity securities - corporate securities	24.5			3.5			—			—			—		—			—			28.0			—
Trading securities - commercial mortgage-backed securities	—			29.0			—			(.4		)	—		—			—			28.6			(.4		)
Liabilities:
Future policy benefits - embedded derivatives associated with fixed index annuity products	(903.7		)	(104.3		)	(73.5		)	—			—		—			—			(1,081.5		)	(73.5		)
Other liabilities - embedded derivatives associated with modified coinsurance agreement	(1.8		)	1.8			—			—			—		—			—			—			—
Total liabilities	(905.5		)	(102.5		)	(73.5		)	—			—		—			—			(1,081.5		)	(73.5		)

____________

(a) Transfers into Level 3 are the result of unobservable inputs utilized within valuation methodologies for assets that were previously valued using observable inputs. Transfers out of Level 3 are due to the use of observable inputs in valuation methodologies as well as the utilization of pricing service information for certain assets that the Company is able to validate.

(b) Purchases, sales, issuances and settlements, net, represent the activity that occurred during the period that results in a change of the asset or liability but does not represent changes in fair value for the instruments held at the beginning of the period.  Such activity primarily consists of purchases and sales of fixed maturity and equity securities and changes to embedded derivative instruments related to insurance products resulting from the issuance of new contracts, or changes to existing contracts.  The following summarizes such activity for the year ended December 31, 2014 (dollars in millions):

	Purchases			Sales			Issuances			Settlements		Purchases, sales, issuances and settlements, net
Assets:
Fixed maturities, available for sale:
Corporate securities	$	71.7		$	(1.7	)	$	—		$	—	$	70.0
States and political subdivisions	—			(1.8		)	—			—		(1.8		)
Asset-backed securities	9.9			(2.3		)	—			—		7.6
Commercial mortgage-backed securities	1.1			—			—			—		1.1
Mortgage pass-through securities	1.1			(2.3		)	—			—		(1.2		)
Total fixed maturities, available for sale	83.8			(8.1		)	—			—		75.7
Equity securities - corporate securities	3.5			—			—			—		3.5
Trading securities - commercial mortgage-backed securities	29.0			—			—			—		29.0
Liabilities:
Future policy benefits - embedded derivatives associated with fixed index annuity products	(121.9		)	7.5			(45.9		)	56.0		(104.3		)
Other liabilities - embedded derivatives associated with modified coinsurance agreement	—			3.4			(1.6		)	—		1.8
Total liabilities	(121.9		)	10.9			(47.5		)	56.0		(102.5		)

Fair value inputs

The following table provides additional information about the significant unobservable (Level 3) inputs developed internally by the Company to determine fair value for certain assets and liabilities carried at fair value at December 31, 2015 (dollars in millions):

	Fair value at December 31, 2015		Valuation techniques	Unobservable inputs	Range (weighted average)
Assets:
Corporate securities (a)	$	76.9	Discounted cash flow analysis	Discount margins	1.65% - 9.74% (5.35%)
Asset-backed securities (b)	22.2		Discounted cash flow analysis	Discount margins	2.83% - 4.45% (3.50%)
Equity security (c)	32.0		Market approach	Projected cash flows	Not applicable
Other assets categorized as Level 3 (d)	148.3		Unadjusted third-party price source	Not applicable	Not applicable
Total	279.4
Liabilities:
Future policy benefits (e)	1,057.1		Discounted projected embedded derivatives	Projected portfolio yields	5.15% - 5.61% (5.42%)
				Discount rates	0.00 - 3.18% (1.94%)
				Surrender rates	1.67% - 46.56% (14.09%)

________________________________

(a) Corporate securities - The significant unobservable input used in the fair value measurement of our corporate securities is discount margin added to a riskless market yield. Significant increases (decreases) in discount margin in isolation would result in a significantly lower (higher) fair value measurement.

(b) Asset-backed securities - The significant unobservable input used in the fair value measurement of these asset-backed securities is discount margin added to a riskless market yield. Significant increases (decreases) in discount margin in isolation would result in a significantly lower (higher) fair value measurement.

(c) Equity security - This equity security represents an investment in a company that is constructing a manufacturing facility. The significant unobservable input is the cash flows that will be generated upon completion of the manufacturing facility. Given the nature of this investment, the best current indicator of value is the cost basis of the investment, which we believe approximates market value.

(d) Other assets categorized as Level 3 - For these assets, there were no adjustments to quoted market prices obtained from third-party pricing sources.

(e) Future policy benefits - The significant unobservable inputs used in the fair value measurement of our embedded derivatives associated with fixed index annuity products are projected portfolio yields, discount rates and surrender rates. Increases (decreases) in projected portfolio yields in isolation would lead to a higher (lower) fair value measurement. The discount rate is based on the Treasury rate adjusted by a margin. Increases (decreases) in the discount rates would lead to a lower (higher) fair value measurement. Assumed surrender rates are used to project how long the contracts remain in force. Generally, the longer the contracts are assumed to be in force the higher the fair value of the embedded derivative.

The following table provides additional information about the significant unobservable (Level 3) inputs developed internally by the Company to determine fair value for certain assets and liabilities carried at fair value at December 31, 2014 (dollars in millions):

	Fair value at December 31, 2014		Valuation techniques	Unobservable inputs	Range (weighted average)
Assets:
Corporate securities (a)	$	312.1	Discounted cash flow analysis	Discount margins	1.48% - 5.83% (2.58%)
Asset-backed securities (b)	30.6		Discounted cash flow analysis	Discount margins	1.99% - 4.15% (2.95%)
Equity security (c)	28.0		Market approach	Projected cash flows	Not applicable
Other assets categorized as Level 3 (d)	148.1		Unadjusted third-party price source	Not applicable	Not applicable
Total	518.8
Liabilities:
Future policy benefits (e)	1,081.5		Discounted projected embedded derivatives	Projected portfolio yields	5.15% - 5.61% (5.42%)
				Discount rates	0.00 - 2.74% (1.78%)
				Surrender rates	1.98% - 47.88% (14.16%)

________________________________

(a) Corporate securities - The significant unobservable input used in the fair value measurement of our corporate securities is discount margin added to a riskless market yield. Significant increases (decreases) in discount margin in isolation would result in a significantly lower (higher) fair value measurement.

(b) Asset-backed securities - The significant unobservable input used in the fair value measurement of these asset-backed securities is discount margin added to a riskless market yield. Significant increases (decreases) in discount margin in isolation would result in a significantly lower (higher) fair value measurement.

(c) Equity security - This equity security represents an investment in a company that is constructing a manufacturing facility. The significant unobservable input is the cash flows that will be generated upon completion of the manufacturing facility. Given the nature of this investment, the best current indicator of value is the cost basis of the investment, which we believe approximates market value.

(d) Other assets categorized as Level 3 - For these assets, there were no adjustments to quoted market prices obtained from third-party pricing sources.

(e) Future policy benefits - The significant unobservable inputs used in the fair value measurement of our embedded derivatives associated with fixed index annuity products are projected portfolio yields, discount rates and surrender rates. Increases (decreases) in projected portfolio yields in isolation would lead to a higher (lower) fair value measurement. The discount rate is based on the Treasury rate adjusted by a margin. Increases (decreases) in the discount rates would lead to a lower (higher) fair value measurement. Assumed surrender rates are used to project how long the contracts remain in force. Generally, the longer the contracts are assumed to be in force the higher the fair value of the embedded derivative.

XML

LIABILITIES FOR INSURANCE PRODUCTS (Tables)

12 Months Ended

Dec. 31, 2015

Insurance [Abstract]

Schedule of insurance liabilities by product segment

Our future policy benefits are summarized as follows (dollars in millions):

	Withdrawal assumption	Morbidity assumption	Mortality assumption	Interest rate assumption	2015		2014
Long-term care	Company experience	Company experience	Company experience	6%	$	5,172.2	$	5,385.2
Traditional life insurance contracts	Company experience	Company experience	(a)	5%	2,248.7		2,175.8
Accident and health contracts	Company experience	Company experience	Company experience	5%	2,589.9		2,519.1
Interest-sensitive life insurance contracts	Company experience	Company experience	Company experience	4%	44.7		47.6
Annuities and supplemental contracts with life contingencies	Company experience	Company experience	(b)	4%	546.6		707.7
Total					$	10,602.1	$	10,835.4

____________________

(a) Principally, modifications of: (i) the 1965 ‑ 70 and 1975 - 80 Basic Tables; and (ii) the 1941, 1958 and 1980 Commissioners' Standard Ordinary Tables; as well as Company experience.

(b) Principally, modifications of: (i) the 1971 Individual Annuity Mortality Table; (ii) the 1983 Table "A"; and (iii) the Annuity 2000 Mortality Table; as well as Company experience.

Our policyholder account balances are summarized as follows (dollars in millions):

	2015		2014
Fixed index annuities	$	4,884.4	$	4,496.9
Other annuities	4,885.1		5,280.8
Interest-sensitive life insurance contracts	992.8		929.5
Total	$	10,762.3	$	10,707.2

Summary of liabilities for unpaid claims adjustment expense

Changes in the unpaid claims reserve (included in claims payable) and disabled life reserves related to accident and health insurance (included in the liability for future policy benefits) were as follows (dollars in millions):

	2015			2014			2013
Balance, beginning of year	$	1,679.5		$	1,710.1		$	1,679.3
Less reinsurance receivables	(125.0		)	(164.1		)	(27.4		)
Net balance, beginning of year	1,554.5			1,546.0			1,651.9
Incurred claims related to:
Current year	1,481.0			1,468.1			1,511.1
Prior years (a)	(13.3		)	(39.9		)	(162.3		)
Total incurred	1,467.7			1,428.2			1,348.8
Interest on claim reserves	71.0			70.5			75.2
Paid claims related to:
Current year	841.8			848.7			870.0
Prior years	649.6			641.5			659.9
Total paid	1,491.4			1,490.2			1,529.9
Net balance, end of year	1,601.8			1,554.5			1,546.0
Add reinsurance receivables	130.0			125.0			164.1
Balance, end of year	$	1,731.8		$	1,679.5		$	1,710.1

___________

(a) The reserves and liabilities we establish are necessarily based on estimates, assumptions and prior years' statistics. Such amounts will fluctuate based upon the estimation procedures used to determine the amount of unpaid losses. It is possible that actual claims will exceed our reserves and have a material adverse effect on our results of operations and financial condition.

XML

INCOME TAXES (Tables)

12 Months Ended

Dec. 31, 2015

Income Tax Disclosure [Abstract]

Schedule of components of income tax expense

The components of income tax expense (benefit) were as follows (dollars in millions):

	2015			2014			2013
Current tax expense	$	10.7		$	15.6		$	8.2
Deferred tax expense	118.6			143.6			120.1
Tax expense on period income	129.3			159.2			128.3
Tax expense related to the sale of CLIC	—			14.2			—
Deferred taxes on expired capital loss carryforwards	—			—			159.4
Change in valuation allowance	(32.5		)	(48.8		)	(472.1		)
Other items	.2			(.9		)	11.2
Total income tax expense (benefit)	$	97.0		$	123.7		$	(173.2	)

Schedule of effective income tax rate reconciliation

A reconciliation of the U.S. statutory corporate tax rate to the estimated annual effective rate reflected in the consolidated statement of operations is as follows:

	2015		2014		2013
U.S. statutory corporate rate	35.0	%	35.0	%	35.0	%
Valuation allowance	(8.8	)	(27.9	)	(154.9	)
Expired capital loss carryforwards (which were fully offset by a corresponding reduction in the valuation allowance)	—		—		52.3
Non-taxable income and nondeductible benefits, net	(.2	)	(.9	)	5.0
State taxes	2.1		1.5		1.9
Impact of the sale of CLIC	—		66.3		—
Other items	(1.7	)	(3.4	)	3.9
Effective tax rate	26.4	%	70.6	%	(56.8	)%

Schedule of deferred tax assets and liabilities

The components of the Company's income tax assets and liabilities are summarized below (dollars in millions):

	2015			2014
Deferred tax assets:
Net federal operating loss carryforwards	$	916.3		$	1,048.4
Net state operating loss carryforwards	14.1			15.2
Tax credits	55.3			47.2
Capital loss carryforwards	13.8			—
Investments	26.5			59.7
Insurance liabilities	600.3			585.9
Other	63.0			67.3
Gross deferred tax assets	1,689.3			1,823.7
Deferred tax liabilities:
Present value of future profits and deferred acquisition costs	(305.4		)	(320.5		)
Accumulated other comprehensive income	(223.8		)	(457.4		)
Gross deferred tax liabilities	(529.2		)	(777.9		)
Net deferred tax assets before valuation allowance	1,160.1			1,045.8
Valuation allowance	(213.5		)	(246.0		)
Net deferred tax assets	946.6			799.8
Current income taxes accrued	(47.8		)	(41.1		)
Income tax assets, net	$	898.8		$	758.7

Summary of valuation allowance

Changes in our valuation allowance are summarized as follows (dollars in millions):

Balance, December 31, 2012	$	766.9
Decrease in 2013	(472.1		)	(a)
Balance, December 31, 2013	294.8
Decrease in 2014	(48.8		)	(b)
Balance, December 31, 2014	246.0
Decrease in 2015	(32.5		)	(c)
Balance, December 31, 2015	$	213.5

___________________

(a) The 2013 reduction to the deferred tax valuation allowance primarily resulted from the impact of higher levels of income on projected future taxable income, the expiration of capital loss carryforwards, a settlement with the Internal Revenue Service (the "IRS") related to the classification of a portion of the cancellation of indebtedness income and the execution of certain investment trading strategies.

(b) The 2014 reduction to the deferred tax valuation allowance primarily resulted from tax examination adjustments and the tax gain on the sale of CLIC.

(c) The 2015 reduction to the deferred tax valuation allowance primarily resulted from higher actual and projected non-life income.

Summary of operating loss carryforwards

As of December 31, 2015, we had $2.6 billion of federal NOLs. The following table summarizes the expiration dates of our loss carryforwards assuming the IRS ultimately agrees with the position we have taken with respect to the loss on our investment in Conseco Senior Health Insurance Company ("CSHI") and other uncertain tax positions (dollars in millions):

Year of expiration	Net operating loss carryforwards						Total loss
	Life			Non-life			carryforwards
2023	$	538.3		$	1,922.0		$	2,460.3
2025	—			91.5			91.5
2026	—			207.4			207.4
2027	—			4.9			4.9
2028	—			203.7			203.7
2029	—			146.6			146.6
2032	—			44.0			44.0
Subtotal	538.3			2,620.1			3,158.4
Less:
Unrecognized tax benefits	(342.9		)	(197.4		)	(540.3		)
Total	$	195.4		$	2,422.7		$	2,618.1

Reconciliation of unrecognized tax benefits

A reconciliation of the beginning and ending amount of unrecognized tax benefits for the years ended December 31, 2015 and 2014 is as follows (dollars in millions):

	Years ended December 31,
	2015		2014
Balance at beginning of year	$	228.7	$	226.7
Increase based on tax positions taken in prior years	5.5		10.9
Decrease based on tax positions taken in prior years	—		—
Increase based on tax positions taken in the current year	—		—
Decrease in unrecognized tax benefits related to settlements with taxing authorities	—		(8.9		)
Balance at end of year	$	234.2	$	228.7

XML

NOTES PAYABLE - DIRECT CORPORATE OBLIGATIONS (Tables)

12 Months Ended

Dec. 31, 2015

Debt Disclosure [Abstract]

Schedule of long-term debt instruments

The following notes payable were direct corporate obligations of the Company as of December 31, 2015 and 2014 (dollars in millions):

	2015			2014
4.500% Senior Notes due May 2020	$	325.0		$	—
5.250% Senior Notes due May 2025	500.0			—
New Revolving Credit Agreement (as defined below)	100.0			—
Unamortized debt issue costs	(13.9		)	(14.1		)
Previous Senior Secured Credit Agreement (as defined below)	—			522.1
6.375% Senior Secured Notes due October 2020 (the "6.375% Notes")	—			275.0
Unamortized discount on Previous Senior Secured Credit Agreement	—			(2.7		)
Direct corporate obligations	$	911.1		$	780.3

Sources and uses of recapitalization transactions

The following table sets forth the sources and uses of cash from the debt refinancing transactions discussed above (dollars in millions):

Sources:
	Notes	$	825.0
	New Revolving Credit Agreement	100.0
	Total sources	$	925.0
Uses:
	Repayment of Previous Senior Secured Credit Agreement	$	502.3
	Repayment of 6.375% Notes, including redemption premium	292.8
	Accrued interest	4.3
	Debt issuance costs	16.0
	General corporate purposes	109.6
	Total uses	$	925.0

Schedule of maturities of long-term debt

The scheduled repayment of our direct corporate obligations was as follows at December 31, 2015 (dollars in millions):

Year ending December 31,
2016	$	—
2017	—
2018	—
2019	100.0
2020	325.0
Thereafter	500.0
	$	925.0

XML

LITIGATION AND OTHER LEGAL PROCEEDINGS (Tables)

12 Months Ended

Dec. 31, 2015

Commitments and Contingencies Disclosure [Abstract]

Schedule of future minimum rental payments for operating leases

Future required minimum payments as of December 31, 2015, were as follows (dollars in millions):

2016	$	54.3
2017	33.2
2018	28.3
2019	17.2
2020	5.2
Thereafter	8.9
Total	$	147.1

XML

AGENT DEFERRED COMPENSATION PLAN (Tables)

12 Months Ended

Dec. 31, 2015

Compensation and Retirement Disclosure [Abstract]

Schedule of assumptions used

We used the following assumptions for the deferred compensation plan to calculate:

	2015		2014
Benefit obligations:
Discount rate	4.50	%	4.15	%
Net periodic cost:
Discount rate	4.15	%	4.75	%

Schedule of expected benefit payments

The benefits expected to be paid pursuant to our agent deferred compensation plan as of December 31, 2015 were as follows (dollars in millions):

2016	$	6.6
2017	6.9
2018	7.3
2019	7.8
2020	8.1
2021 - 2025	47.2

XML

DERIVATIVES (Tables)

12 Months Ended

Dec. 31, 2015

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Fair value by balance sheet location

Our freestanding and embedded derivatives, which are not designated as hedging instruments, are held at fair value and are summarized as follows (dollars in millions):

	Fair value
	2015			2014
Assets:
Other invested assets:
Fixed index call options	$	41.0		$	107.2
Interest rate futures	.1			(.2		)
Reinsurance receivables	(5.0		)	2.0
Total assets	$	36.1		$	109.0
Liabilities:
Future policy benefits:
Fixed index products	$	1,057.1		$	1,081.5
Total liabilities	$	1,057.1		$	1,081.5

Schedule of derivative instruments

The following table represents activity associated with derivative instruments as of the dates indicated:

	Measurement	December 31, 2014		Additions		Maturities/terminations			December 31, 2015
Interest futures	Contracts	402		2,643		(2,781		)	264
Fixed index annuities - embedded derivative	Policies	93,185		10,256		(6,781		)	96,660
Fixed index call options	Notional (a)	$	2,403.9	$	2,397.0	$	(2,421.2	)	$	2,379.7

_________________

(a) Dollars in millions.

Schedule pre-tax gains (losses) recognized in net income for derivative instruments

The following table provides the pre-tax gains (losses) recognized in net income for derivative instruments, which are not designated as hedges for the periods indicated (dollars in millions):

	2015			2014			2013
Net investment income from policyholder and reinsurer accounts and other special-purpose portfolios:
Fixed index call options	$	(36.2	)	$	69.5		$	177.5
Embedded derivative related to reinsurance contract	—			(1.4		)	3.7
Total	(36.2		)	68.1			181.2
Net realized gains (losses):
Interest rate futures	(2.7		)	(7.0		)	(.4		)
Embedded derivative related to modified coinsurance agreement	(7.0		)	2.0			—
Total	(9.7		)	(5.0		)	(.4		)
Insurance policy benefits:
Embedded derivative related to fixed index annuities	36.3			(73.5		)	49.3
Total	$	(9.6	)	$	(10.4	)	$	230.1

Derivatives with master netting arrangements

The following table summarizes information related to derivatives and repurchase agreements with master netting arrangements or collateral as of December 31, 2015 and 2014 (dollars in millions):

									Gross amounts not offset in the balance sheet
		Gross amounts recognized			Gross amounts offset in the balance sheet		Net amounts of assets presented in the balance sheet		Financial instruments		Cash collateral received		Net amount
December 31, 2015:
	Fixed index call options	$	41.0		$	—	$	41.0	$	—	$	—	$	41.0
	Interest rate futures	.1			1.5		1.6		—		—		1.6
December 31, 2014:
	Fixed index call options	107.2			—		107.2		—		—		107.2
	Interest rate futures	(.2		)	1.5		1.3		—		—		1.3
	Repurchase agreements (a)	20.4			—		20.4		20.4		—		—

_________________

(a) As of December 31, 2014, these agreements were collateralized by investment securities with a fair value of $25.3 million.

XML

SHAREHOLDERS' EQUITY (Tables)

12 Months Ended

Dec. 31, 2015

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of common stock outstanding

Changes in the number of shares of common stock outstanding were as follows (shares in thousands):

	2015		2014		2013
Balance, beginning of year	203,324		220,324		221,502
Treasury stock purchased and retired	(20,582	)	(18,489	)	(8,949	)
Conversion of 7.0% Debentures	—		—		4,739
Stock options exercised	769		916		2,087
Restricted and performance stock vested (a)	518		573		945
Balance, end of year	184,029		203,324		220,324

____________________

(a) In 2015, 2014 and 2013, such amount was reduced by 237 thousand, 257 thousand and 472 thousand shares, respectively, which were tendered to the Company for the payment of required federal and state tax withholdings owed on the vesting of restricted and performance stock.

Schedule of share-based compensation

A summary of the Company's stock option activity and related information for 2015 is presented below (shares in thousands; dollars in millions, except per share amounts):

	Shares		Weighted average exercise price			Weighted average remaining life (in years)	Aggregate intrinsic value
Outstanding at the beginning of the year	5,011		$	12.04
Options granted	1,361		16.45
Exercised	(769	)	(8.20		)		$	4.8
Forfeited or terminated	(404	)	(17.70		)
Outstanding at the end of the year	5,199		13.32			4.8	$	38.4
Options exercisable at the end of the year	2,399					2.5	$	15.3
Available for future grant	6,882

A summary of the Company's stock option activity and related information for 2014 is presented below (shares in thousands; dollars in millions, except per share amounts):

	Shares		Weighted average exercise price		Weighted average remaining life (in years)	Aggregate intrinsic value
Outstanding at the beginning of the year	5,579		$	10.64
Options granted	1,014		19.10
Exercised	(917	)	5.47			$	3.8
Forfeited or terminated	(665	)	20.07
Outstanding at the end of the year	5,011		12.04		4.3	$	32.1
Options exercisable at the end of the year	2,030				2.7	$	12.1
Available for future grant	8,571

A summary of the Company's stock option activity and related information for 2013 is presented below (shares in thousands; dollars in millions, except per share amounts):

	Shares		Weighted average exercise price		Weighted average remaining life (in years)	Aggregate intrinsic value
Outstanding at the beginning of the year	6,655		$	9.72
Options granted	1,447		11.01
Exercised	(2,087	)	7.27			$	6.0
Forfeited or terminated	(436	)	13.95
Outstanding at the end of the year	5,579		10.64		4.0	$	32.5
Options exercisable at the end of the year	2,529				2.1	$	13.9
Available for future grant	9,099

Schedule of valuation assumptions on payment awards

The fair value of each stock option grant is estimated on the date of grant using the Black-Scholes option valuation model with the following weighted average assumptions:

	2015			2014			2013
	Grants			Grants			Grants
Weighted average risk-free interest rates	1.7		%	1.6		%	.8		%
Weighted average dividend yields	1.5		%	1.3		%	.7		%
Volatility factors	85		%	51		%	107		%
Weighted average expected life (in years)	6.3			4.8			4.8
Weighted average fair value per share	$	10.83		$	7.65		$	8.02

Schedule of share-based compensation by exercise price range

The following table summarizes information about stock options outstanding at December 31, 2015 (shares in thousands):

		Options outstanding			Options exercisable
Range of exercise prices	Number outstanding	Remaining life (in years)	Average exercise price		Number exercisable	Average exercise price
$6.45 - $6.77	427	1.2	$	6.45	427	$	6.45
$7.38 - $7.51	1,097	2.8	7.46		1,097	7.46
$8.29 - $12.34	1,146	4.1	10.76		551	10.61
$12.74 - $18.27	1,332	8.9	16.40		18	14.49
$19.15 - $25.45	1,197	4.0	20.18		306	23.19
	5,199				2,399

Schedule of nonvested share activity

A summary of the Company's non-vested restricted stock activity for 2015 is presented below (shares in thousands):

	Shares		Weighted average grant date fair value
Non-vested shares, beginning of year	236		$	10.95
Granted	95		17.59
Vested	(234	)	11.73
Forfeited	(2	)	11.31
Non-vested shares, end of year	95		15.66

Schedule of performance share-based compensation

A summary of the Company's performance units is presented below (shares in thousands):

	Total shareholder return awards		Operating return on equity awards		Pre-tax operating income awards
Awards outstanding at December 31, 2012	193		—		977
Granted in 2013	212		212		—
Additional shares issued pursuant to achieving certain performance criteria (a)	—		—		223
Shares vested in 2013	—		—		(668	)
Forfeited	(23	)	(8	)	(62	)
Awards outstanding at December 31, 2013	382		204		470
Granted in 2014	142		142		—
Additional shares issued pursuant to achieving certain performance criteria (a)	—		—		142
Shares vested in 2014	—		—		(434	)
Forfeited	(5	)	(3	)	(2	)
Awards outstanding at December 31, 2014	519		343		176
Granted in 2015	258		258		—
Additional shares issued pursuant to achieving certain performance criteria (a)	85		—		85
Shares vested in 2015	(260	)	—		(260	)
Forfeited	(53	)	(52	)	(1	)
Awards outstanding at December 31, 2015	549		549		—

_________________________

(a) The performance units that vested in these years provided for a payout of up to 150 percent of the award if certain performance levels were achieved.

Schedule of earnings per share reconciliation

A reconciliation of net income and shares used to calculate basic and diluted earnings per share is as follows (dollars in millions and shares in thousands):

	2015		2014		2013
Net income for basic earnings per share	$	270.7	$	51.4	$	478.0
Add:  interest expense on 7.0% Debentures, net of income taxes	—		—		1.6
Net income for diluted earnings per share	$	270.7	$	51.4	$	479.6
Shares:
Weighted average shares outstanding for basic earnings per share	193,054		212,917		221,628
Effect of dilutive securities on weighted average shares:
7.0% Debentures	—		—		5,780
Stock options, restricted stock and performance units	2,112		2,505		2,776
Warrants (a)	—		2,233		2,518
Dilutive potential common shares	2,112		4,738		11,074
Weighted average shares outstanding for diluted earnings per share	195,166		217,655		232,702

________

(a) All outstanding warrants were repurchased in September 2014 as further discussed above. Accordingly, the warrants have no dilutive effect in periods beginning after September 30, 2014.

XML

OTHER OPERATING STATEMENT DATA (Tables)

12 Months Ended

Dec. 31, 2015

Insurance [Abstract]

Schedule of insurance policy income

Insurance policy income consisted of the following (dollars in millions):

	2015			2014			2013
Direct premiums collected	$	3,769.6		$	3,856.2		$	3,966.0
Reinsurance assumed	38.4			34.5			38.0
Reinsurance ceded	(142.8		)	(187.9		)	(240.5		)
Premiums collected, net of reinsurance	3,665.2			3,702.8			3,763.5
Change in unearned premiums	5.9			9.1			(16.6		)
Less premiums on interest-sensitive life and products without mortality and morbidity risk which are recorded as additions to insurance liabilities	(1,241.9		)	(1,295.4		)	(1,298.1		)
Premiums on traditional products with mortality or morbidity risk	2,429.2			2,416.5			2,448.8
Fees and surrender charges on interest-sensitive products	126.8			213.2			295.9
Insurance policy income	$	2,556.0		$	2,629.7		$	2,744.7

Schedule of other operating cost and expense

Other operating costs and expenses were as follows (dollars in millions):

	2015		2014		2013
Commission expense	$	103.8	$	99.4	$	103.8
Salaries and wages	205.2		242.4		234.0
Other	430.2		461.0		428.4
Total other operating costs and expenses	$	739.2	$	802.8	$	766.2

Schedule of changes in present value of future insurance profits

Changes in the present value of future profits were as follows (dollars in millions):

	2015			2014			2013
Balance, beginning of year	$	489.4		$	679.3		$	626.0
Amortization	(69.1		)	(76.2		)	(92.0		)
Effect of reinsurance transaction	—			5.0			—
Amounts related to CLIC prior to being sold	—			(15.5		)	—
Amounts related to changes in unrealized investment gains (losses) on fixed maturities, available for sale	28.7			(103.2		)	145.3
Balance, end of year	$	449.0		$	489.4		$	679.3

Schedule of changes in deferred acquisition costs

Changes in deferred acquisition costs were as follows (dollars in millions):

	2015			2014			2013
Balance, beginning of year	$	770.6		$	968.1		$	629.7
Additions	246.4			242.8			222.8
Amortization	(190.9		)	(171.2		)	(204.3		)
Effect of reinsurance transaction	—			24.0			—
Amounts related to CLIC prior to being sold	—			(37.6		)	—
Amounts related to changes in unrealized investment gains (losses) on fixed maturities, available for sale	257.2			(255.5		)	315.9
Other	—			—			4.0
Balance, end of year	$	1,083.3		$	770.6		$	968.1

XML

CONSOLIDATED STATEMENT CASH FLOWS (Tables)

12 Months Ended

Dec. 31, 2015

Supplemental Cash Flow Elements [Abstract]

Schedule of the reconciliation for net income provided by operating activities

The following reconciles net income to net cash provided by operating activities (dollars in millions):

	2015			2014				2013
Cash flows from operating activities:
Net income	$	270.7		$	51.4			$	478.0
Adjustments to reconcile net income to net cash from operating activities:
Amortization and depreciation	283.4			274.2				324.6
Income taxes	92.9			119.7				(181.2		)
Insurance liabilities	297.4			398.2				465.8
Accrual and amortization of investment income	(27.6		)	(148.3		)		(276.3		)
Deferral of policy acquisition costs	(246.4		)	(242.8		)		(222.8		)
Net realized investment (gains) losses	36.6			(36.7		)		(33.6		)
Payment to reinsurer pursuant to long-term care business reinsured	—			(590.3		)		—
Net loss on sale of subsidiary, (gain) loss on reinsurance transactions and transition expenses	9.0			239.8				98.4
Loss on extinguishment or modification of debt	32.8			.6				65.4
Other	(4.9		)	56.0				2.1
Net cash from operating activities	$	743.9		$	121.8		(a)	$	720.4

______________________

(a) Cash flows from operating activities reflect outflows in the 2014 period due to the payment to reinsurer to transfer certain long-term care business.

Effects of reinsurance

On July 1, 2014, Bankers Life recaptured the life business written by Bankers Life that was reinsured by Wilton Reassurance Company ("Wilton Re") in 2009. The following summarizes the impact of the recapture (dollars in millions):

Investments	$	139.4		(a) (b)
Cash	7.7
Present value of future profits and deferred acquisition costs	29.0			(b)
Reinsurance receivables	(155.9		)	(b)
Other liabilities	5.9			(b)
Gain on reinsurance transaction (classified as "Loss on sale of subsidiary, (gain) loss on reinsurance transactions and transition expenses")	26.1
Income tax expense	9.2
Gain on reinsurance transaction (net of income taxes)	$	16.9

___________________

(a)    Such amount has been reduced by a $28.0 million recapture fee.

(b)    Such non-cash amounts have been excluded from the consolidated statement of cash flows.

Schedule of other significant noncash transactions

Other non-cash items not reflected in the financing activities section of the consolidated statement of cash flows (dollars in millions):

	2015		2014		2013
Stock options, restricted stock and performance units	$	17.1	$	15.6	$	15.1

XML

STATUTORY INFORMATION (BASED ON NON-GAAP MEASURES) (Tables)

12 Months Ended

Dec. 31, 2015

Insurance [Abstract]

Schedule of statutory accounting practices

The Company's insurance subsidiaries reported the following amounts to regulatory agencies, after appropriate elimination of intercompany accounts among such subsidiaries (dollars in millions):

	2015		2014
Statutory capital and surplus	$	1,739.2	$	1,654.4
Asset valuation reserve	196.9		203.1
Interest maintenance reserve	476.0		504.1
Total	$	2,412.1	$	2,361.6

XML

SALE OF SUBSIDIARY (Tables)

12 Months Ended

Dec. 31, 2015

Discontinued Operations and Disposal Groups [Abstract]

Schedule of Carrying Amount of CLIC Business Being Sold

The loss on the sale of CLIC in 2014, is summarized below (dollars in millions):

Net cash proceeds	$	224.9
Net assets being sold:
Investments	3,863.8
Cash and cash equivalents	164.7
Accrued investment income	42.7
Present value of future profits	15.5
Deferred acquisition costs	37.6
Reinsurance receivables	307.4
Income tax assets, net	84.4
Other assets	2.8
Liabilities for insurance products	(3,201.3		)
Other liabilities	(199.1		)
Investment borrowings	(383.4		)
Accumulated other comprehensive income	(240.5		)
Net assets being sold	494.6
Loss before taxes	(269.7		)
Tax expense related to the sale	14.2
Valuation allowance release related to the tax on the sale	(14.2		)
Valuation allowance increase related to the decrease in projected future taxable income	19.4
Net loss	$	(289.1	)

XML

BUSINESS SEGMENTS (Tables)

12 Months Ended

Dec. 31, 2015

Segment Reporting [Abstract]

Schedule of segment reporting information by segment

Operating information by segment was as follows (dollars in millions):

	2015		2014		2013
Revenues:
Bankers Life:
Insurance policy income:
Annuities	$	22.4	$	26.0	$	28.9
Health	1,251.0		1,287.1		1,311.2
Life	375.3		338.6		308.6
Net investment income (a)	884.7		957.3		1,005.7
Fee revenue and other income (a)	27.7		29.3		19.0
Total Bankers Life revenues	2,561.1		2,638.3		2,673.4
Washington National:
Insurance policy income:
Annuities	3.0		4.0		11.4
Health	615.4		597.6		587.1
Life	25.4		24.4		23.0
Net investment income (a)	253.6		276.1		296.9
Fee revenue and other income (a)	1.3		1.1		.9
Total Washington National revenues	898.7		903.2		919.3
Colonial Penn:
Insurance policy income:
Health	3.0		3.6		4.3
Life	260.5		242.4		227.8
Net investment income (a)	43.0		41.7		40.0
Fee revenue and other income (a)	1.0		1.0		.8
Total Colonial Penn revenues	307.5		288.7		272.9
Other CNO Business:
Insurance policy income - health	—		—		24.1
Net investment income (a)	—		—		33.3
Total Other CNO Business revenues	—		—		57.4
Corporate operations:
Net investment income	11.3		14.9		39.8
Fee and other income	8.6		6.7		6.2
Total corporate revenues	19.9		21.6		46.0
Total revenues	3,787.2		3,851.8		3,969.0

(continued on next page)

(continued from previous page)

	2015			2014			2013
Expenses:
Bankers Life:
Insurance policy benefits	$	1,588.4		$	1,667.6		$	1,788.7
Amortization	187.1			174.7			187.5
Interest expense on investment borrowings	8.8			7.9			6.7
Other operating costs and expenses	407.2			401.2			380.0
Total Bankers Life expenses	2,191.5			2,251.4			2,362.9
Washington National:
Insurance policy benefits	546.6			536.2			541.4
Amortization	55.2			64.6			64.9
Interest expense on investment borrowings	2.0			1.7			1.9
Other operating costs and expenses	183.4			189.5			170.5
Total Washington National expenses	787.2			792.0			778.7
Colonial Penn:
Insurance policy benefits	189.0			173.2			165.7
Amortization	14.4			15.3			14.5
Interest expense on investment borrowings	.1			—			—
Other operating costs and expenses	98.4			99.4			105.2
Total Colonial Penn expenses	301.9			287.9			285.4
Other CNO Business:
Insurance policy benefits	—			—			59.2
Other operating costs and expenses	—			—			25.8
Total Other CNO Business expenses	—			—			85.0
Corporate operations:
Interest expense on corporate debt	45.0			43.9			51.3
Interest expense on borrowings of variable interest entities	—			—			.1
Interest expense on investment borrowings	.2			.1			—
Other operating costs and expenses	38.6			49.1			43.1
Total corporate expenses	83.8			93.1			94.5
Total expenses	3,364.4			3,424.4			3,606.5
Pre-tax operating earnings by segment:
Bankers Life	369.6			386.9			310.5
Washington National	111.5			111.2			140.6
Colonial Penn	5.6			.8			(12.5		)
Other CNO Business	—			—			(27.6		)
Corporate operations	(63.9		)	(71.5		)	(48.5		)
Pre-tax operating earnings	$	422.8		$	427.4		$	362.5

___________________

(a) It is not practicable to provide additional components of revenue by product or services.

Reconciliation of operating profit (loss) from segments to consolidated

A reconciliation of segment revenues and expenses to consolidated revenues and expenses and net income is as follows (dollars in millions):

	2015			2014			2013
Total segment revenues	$	3,787.2		$	3,851.8		$	3,969.0
Net realized investment gains (losses)	(47.9		)	33.9			33.4
Revenues related to certain non-strategic investments and earnings attributable to VIEs	47.6			33.2			32.2
Fee revenue related to transition and support services agreements	25.0			15.0			—
Revenues of CLIC prior to being sold	—			210.8			441.5
Consolidated revenues	3,811.9			4,144.7			4,476.1
Total segment expenses	3,364.4			3,424.4			3,606.5
Insurance policy benefits - fair value changes in embedded derivative liabilities	(15.7		)	48.5			(54.4		)
Amortization related to fair value changes in embedded derivative liabilities	3.8			(12.5		)	19.0
Amortization related to net realized investment gains	(.5		)	1.0			1.6
Expenses related to certain non-strategic investments and expenses (earnings) attributable to VIEs	43.0			41.2			42.4
Other operating costs and expenses - fair value changes related to agent deferred compensation plan	(15.1		)	26.8			(15.8		)
Loss on extinguishment or modification of debt	32.8			.6			65.4
Loss on sale of subsidiary, (gain) loss on reinsurance transactions and transition expenses	9.0			239.8			98.4
Expenses related to transition and support services agreements	22.5			12.4			—
Expenses of CLIC prior to being sold	—			187.4			408.2
Consolidated expenses	3,444.2			3,969.6			4,171.3
Income before tax	367.7			175.1			304.8
Income tax expense:
Tax expense on period income	129.5			159.2			128.3
Valuation allowance for deferred tax assets and other tax items	(32.5		)	(35.5		)	(301.5		)
Net income	$	270.7		$	51.4		$	478.0

Schedule of balance sheet information, by segment

Segment balance sheet information was as follows (dollars in millions):

	2015		2014
Assets:
Bankers Life	$	19,067.8	$	19,303.0
Washington National	7,948.5		8,207.9
Colonial Penn	985.4		945.3
Corporate operations	3,123.4		2,699.7
Total assets	$	31,125.1	$	31,155.9
Liabilities:
Bankers Life	$	16,612.0	$	16,697.5
Washington National	6,665.1		6,778.8
Colonial Penn	869.3		802.2
Corporate operations	2,840.2		2,189.2
Total liabilities	$	26,986.6	$	26,467.7

Schedule of selected financial information, by segment

The following table presents selected financial information of our segments (dollars in millions):

Segment	Present value of future profits		Deferred acquisition costs		Insurance liabilities
2015
Bankers Life	$	114.9	$	718.2	$	15,234.1
Washington National	290.2		280.0		6,126.2
Colonial Penn	43.9		85.1		782.9
Total	$	449.0	$	1,083.3	$	22,143.2
2014
Bankers Life	$	128.4	$	456.6	$	15,308.9
Washington National	314.2		240.2		6,228.8
Colonial Penn	46.8		73.8		771.0
Total	$	489.4	$	770.6	$	22,308.7

XML

QUARTERLY FINANCIAL DATA (UNAUDITED) (Tables)

12 Months Ended

Dec. 31, 2015

Quarterly Financial Data [Abstract]

Schedule of quarterly financial information

Quarterly financial data (unaudited) were as follows (dollars in millions, except per share data):

2015	1st Qtr.			2nd Qtr.		3rd Qtr.		4th Qtr.
Revenues	$	978.3		$	959.5	$	904.5	$	969.6
Income before income taxes	$	82.3		$	72.7	$	52.4	$	160.3
Income tax expense	29.5			25.9		18.6		23.0
Net income	$	52.8		$	46.8	$	33.8	$	137.3
Earnings per common share:
Basic:
Net income	$	.26		$	.24	$	.18	$	.74
Diluted:
Net income	$	.26		$	.24	$	.18	$	.73
2014	1st Qtr.			2nd Qtr.		3rd Qtr.		4th Qtr.
Revenues	$	1,084.7		$	1,093.0	$	967.0	$	1,000.0
Income (loss) before income taxes	$	(169.6	)	$	114.4	$	154.4	$	75.9
Income tax expense (benefit)	58.4			36.3		37.0		(8.0		)
Net income (loss)	$	(228.0	)	$	78.1	$	117.4	$	83.9
Earnings per common share:
Basic:
Net income (loss)	$	(1.03	)	$	.36	$	.56	$	.41
Diluted:
Net income (loss)	$	(1.03	)	$	.35	$	.54	$	.41

XML

INVESTMENTS IN VARIABLE INTEREST ENTITIES (Tables)

12 Months Ended

Dec. 31, 2015

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of impact on balance sheet of consolidating variable interest entities

The following table provides supplemental information about the assets and liabilities of the VIEs which have been consolidated (dollars in millions):

	December 31, 2015
	VIEs		Eliminations			Net effect on consolidated balance sheet
Assets:
Investments held by variable interest entities	$	1,633.6	$	—		$	1,633.6
Notes receivable of VIEs held by insurance subsidiaries	—		(204.3		)	(204.3		)
Cash and cash equivalents held by variable interest entities	364.4		—			364.4
Accrued investment income	3.3		—			3.3
Income tax assets, net	26.0		(1.9		)	24.1
Other assets	1.4		(1.5		)	(0.1		)
Total assets	$	2,028.7	$	(207.7	)	$	1,821.0
Liabilities:
Other liabilities	$	196.6	$	(7.2	)	$	189.4
Borrowings related to variable interest entities	1,676.4		—			1,676.4
Notes payable of VIEs held by insurance subsidiaries	204.0		(204.0		)	—
Total liabilities	$	2,077.0	$	(211.2	)	$	1,865.8

	December 31, 2014
	VIEs		Eliminations			Net effect on consolidated balance sheet
Assets:
Investments held by variable interest entities	$	1,367.1	$	—		$	1,367.1
Notes receivable of VIEs held by insurance subsidiaries	—		(153.3		)	(153.3		)
Cash and cash equivalents held by variable interest entities	68.3		—			68.3
Accrued investment income	3.2		—			3.2
Income tax assets, net	18.1		(2.9		)	15.2
Other assets	—		(1.7		)	(1.7		)
Total assets	$	1,456.7	$	(157.9	)	$	1,298.8
Liabilities:
Other liabilities	$	61.2	$	(6.1	)	$	55.1
Borrowings related to variable interest entities	1,271.9		—			1,271.9
Notes payable of VIEs held by insurance subsidiaries	157.3		(157.3		)	—
Total liabilities	$	1,490.4	$	(163.4	)	$	1,327.0

Supplemental information, revenues and expenses of variable interest entities

The following table provides supplemental information about the revenues and expenses of the VIEs which have been consolidated in accordance with authoritative guidance, after giving effect to the elimination of our investment in the VIEs and investment management fees earned by a subsidiary of the Company (dollars in millions):

	2015			2014			2013
Revenues:
Net investment income – policyholder and reinsurer accounts and other special-purpose portfolios	$	62.1		$	47.2		$	42.3
Fee revenue and other income	1.6			1.1			1.8
Total revenues	63.7			48.3			44.1
Expenses:
Interest expense	38.8			30.1			26.0
Other operating expenses	2.0			1.2			1.4
Total expenses	40.8			31.3			27.4
Income before net realized investment losses and income taxes	22.9			17.0			16.7
Net realized investment losses	(17.7		)	(2.2		)	(1.6		)
Income before income taxes	$	5.2		$	14.8		$	15.1

Summary of variable interest entities by contractual maturity

The following table sets forth the amortized cost and estimated fair value of the investments held by the VIEs at December 31, 2015, by contractual maturity.  Actual maturities will differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without penalties.

	Amortized cost		Estimated fair value
	(Dollars in millions)
Due in one year or less	$	12.5	$	12.1
Due after one year through five years	719.2		695.1
Due after five years through ten years	947.6		926.4
Total	$	1,679.3	$	1,633.6

The following table sets forth the amortized cost and estimated fair value of those investments held by the VIEs with unrealized losses at December 31, 2015, by contractual maturity.  Actual maturities will differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without penalties.

	Amortized cost		Estimated fair value
	(Dollars in millions)
Due in one year or less	$	12.5	$	12.1
Due after one year through five years	654.3		630.0
Due after five years through ten years	852.4		830.9
Total	$	1,519.2	$	1,473.0

XML

BUSINESS AND BASIS OF PRESENTATION (NARRATIVE) (Details)	12 Months Ended
	Dec. 31, 2015 distribution_channel
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of product distribution channels	3

XML

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (PRESENT VALUE OF FUTURE PROFITS) (Details)	12 Months Ended
	Dec. 31, 2015
Accounting Policies [Abstract]
Discount rate used to determine present value of future profits	12.00%

XML

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (ACCOUNTING FOR CERTAIN MARKETING AND REINSURANCE AGREEMENTS) (Details)	Jul. 31, 2013
Accounting Policies [Abstract]
Quota-share agreement, percent of net premium and related policy benefits	50.00%

XML

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (REINSURANCE) (NARRATIVE) (Details) $ in Millions	1 Months Ended	3 Months Ended	12 Months Ended
	Dec. 31, 2013 USD ($)	Jun. 30, 2014 USD ($)	Dec. 31, 2015 USD ($) subsidiary	Dec. 31, 2014 USD ($)	Dec. 31, 2013 USD ($) subsidiary
Liability for Claims and Claims Adjustment Expense [Line Items]
Company retains no more than this amount of mortality risk			$ 0.8
Ceded premiums written			133.6	$ 176.7	$ 212.1
Reinsurance benefits netted against insurance policy benefits			167.7	195.3	196.2
Assumed premiums written			$ 38.5	35.0	$ 37.4
Number of insurance subsidiaries | subsidiary			3		2
Percent of coinsurance agreements					100.00%
Ceded long-term reserves	$ 495.0
Additional premiums paid by subsidiaries to enter into coinsurance agreement	$ 96.9
Over-collateralization rate of market-value trusts	7.00%
Loss on sale of subsidiary, (gain) loss on reinsurance transactions and transition expenses			$ 9.0	239.8	$ 98.4
Gain related to other reinsurance transactions		$ 3.8
Coventry health care marketing and quota share agreements [Member]
Liability for Claims and Claims Adjustment Expense [Line Items]
Assumed premiums written				$ 6.8	$ 19.7

XML

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (INCOME TAXES) (NARRATIVE) (Details) - USD ($) $ in Millions	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Accounting Policies [Abstract]
Valuation allowance	$ 213.5	$ 246.0	$ 294.8	$ 766.9

XML

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (INVESTMENTS IN VARIABLE INTEREST ENTITIES) (Details) $ in Millions	Dec. 31, 2015 USD ($)
Accounting Policies [Abstract]
Investments held in limited partnerships	$ 76.9
Unfunded commitments to limited partnerships	$ 82.2

XML

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (INVESTMENT BORROWINGS) (Details)	12 Months Ended
	Dec. 31, 2015 USD ($) subsidiary	Dec. 31, 2014 USD ($)	Dec. 31, 2013 USD ($) subsidiary
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Number of insurance subsidiaries | subsidiary	3		2
Investment borrowings	$ 1,548,100,000	$ 1,519,200,000
Repurchase agreements, borrowings outstanding	0	20,400,000
Federal Home Loan Bank advances [Member]
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Federal home loan bank stock	74,200,000
Investment borrowings	1,548,100,000
Fair value of collateral for borrowings	1,800,000,000
Aggregate fee to prepay all fixed rate FHLB borrowings	1,700,000
Interest expense on FHLB borrowings	10,900,000	$ 18,700,000	$ 27,900,000
Borrowings due June 2017 [Member] | Federal Home Loan Bank advances [Member]
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Investment borrowings	$ 57,700,000
Maturity date	Jun. 30, 2017
Interest rate	0.699%
Borrowings due August 2017 [Member] | Federal Home Loan Bank advances [Member]
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Investment borrowings	$ 50,000,000
Maturity date	Aug. 31, 2017
Interest rate	0.562%
Borrowings due August 2017 rate two [Member] | Federal Home Loan Bank advances [Member]
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Investment borrowings	$ 75,000,000
Maturity date	Aug. 31, 2017
Interest rate	0.543%
Borrowings due October 2017 [Member] | Federal Home Loan Bank advances [Member]
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Investment borrowings	$ 100,000,000
Maturity date	Oct. 31, 2017
Interest rate	0.751%
Borrowings due November 2017 [Member] | Federal Home Loan Bank advances [Member]
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Investment borrowings	$ 50,000,000
Maturity date	Nov. 30, 2017
Interest rate	0.917%
Borrowings due January 2018 [Member] | Federal Home Loan Bank advances [Member]
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Investment borrowings	$ 50,000,000
Maturity date	Jan. 31, 2018
Interest rate	0.67%
Borrowings due January 2018 rate two [Member] | Federal Home Loan Bank advances [Member]
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Investment borrowings	$ 50,000,000
Maturity date	Jan. 31, 2018
Interest rate	0.656%
Borrowings due February 2018 [Member] | Federal Home Loan Bank advances [Member]
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Investment borrowings	$ 50,000,000
Maturity date	Feb. 28, 2018
Interest rate	0.654%
Borrowings due February 2018 rate two [Member] | Federal Home Loan Bank advances [Member]
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Investment borrowings	$ 50,000,000
Maturity date	Feb. 28, 2018
Interest rate	0.452%
Borrowings due February 2018 rate three [Member] | Federal Home Loan Bank advances [Member]
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Investment borrowings	$ 22,000,000
Maturity date	Feb. 28, 2018
Interest rate	0.742%
Borrowings due May 2018 [Member] | Federal Home Loan Bank advances [Member]
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Investment borrowings	$ 100,000,000
Maturity date	May 30, 2018
Interest rate	0.872%
Borrowings due July 2018 [Member] | Federal Home Loan Bank advances [Member]
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Investment borrowings	$ 50,000,000
Maturity date	Jul. 31, 2018
Interest rate	0.793%
Borrowings due August 2018 [Member] | Federal Home Loan Bank advances [Member]
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Investment borrowings	$ 50,000,000
Maturity date	Aug. 31, 2018
Interest rate	0.482%
Borrowings due December 2018 [Member] | Federal Home Loan Bank advances [Member]
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Investment borrowings	$ 10,000,000
Maturity date	Dec. 31, 2018
Interest rate	0.807%
Borrowings due January 2019 [Member] | Federal Home Loan Bank advances [Member]
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Investment borrowings	$ 50,000,000
Maturity date	Jan. 31, 2019
Interest rate	0.737%
Borrowings due February 2019 [Member] | Federal Home Loan Bank advances [Member]
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Investment borrowings	$ 50,000,000
Maturity date	Feb. 28, 2019
Interest rate	0.452%
Borrowings due March 2019 [Member] | Federal Home Loan Bank advances [Member]
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Investment borrowings	$ 100,000,000
Maturity date	Mar. 31, 2019
Interest rate	0.831%
Borrowings due July 2019 [Member] | Federal Home Loan Bank advances [Member]
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Investment borrowings	$ 21,800,000
Maturity date	Jul. 31, 2019
Interest rate	0.892%
Borrowings due October 2019 [Member] | Federal Home Loan Bank advances [Member]
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Investment borrowings	$ 15,000,000
Maturity date	Oct. 31, 2019
Interest rate	0.837%
Borrowing due May 2020 [Member] | Federal Home Loan Bank advances [Member]
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Investment borrowings	$ 50,000,000
Maturity date	May 31, 2020
Interest rate	0.851%
Borrowings due June 2020 [Member] | Federal Home Loan Bank advances [Member]
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Investment borrowings	$ 21,800,000
Maturity date	Jun. 30, 2020
Interest rate	1.96%
Borrowing due September 2020, rate one [Member] | Federal Home Loan Bank advances [Member]
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Investment borrowings	$ 25,000,000
Maturity date	Sep. 30, 2020
Interest rate	0.951%
Borrowings due September 2020, rate two [Member] | Federal Home Loan Bank advances [Member]
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Investment borrowings	$ 100,000,000
Maturity date	Sep. 30, 2020
Interest rate	1.082%
Borrowings due September 2020, rate three [Member] | Federal Home Loan Bank advances [Member]
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Investment borrowings	$ 50,000,000
Maturity date	Sep. 30, 2020
Interest rate	1.082%
Borrowings due September 2020, rate four [Member] | Federal Home Loan Bank advances [Member]
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Investment borrowings	$ 75,000,000
Maturity date	Sep. 30, 2020
Interest rate	0.723%
Borrowings due October 2020 [Member] | Federal Home Loan Bank advances [Member]
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Investment borrowings	$ 100,000,000
Maturity date	Oct. 31, 2020
Interest rate	0.723%
Borrowings due December 2020 [Member] | Federal Home Loan Bank advances [Member]
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Investment borrowings	$ 50,000,000
Maturity date	Dec. 31, 2020
Interest rate	0.951%
Borrowings due August 2021 [Member] | Federal Home Loan Bank advances [Member]
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Investment borrowings	$ 28,200,000
Maturity date	Aug. 31, 2021
Interest rate	2.55%
Borrowings due March 2023 [Member] | Federal Home Loan Bank advances [Member]
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Investment borrowings	$ 26,100,000
Maturity date	Mar. 31, 2023
Interest rate	2.16%
Borrowings due June 2025 [Member] | Federal Home Loan Bank advances [Member]
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Investment borrowings	$ 20,500,000
Maturity date	Jun. 30, 2025
Interest rate	2.94%

XML

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (ACCOUNTING FOR DERIVATIVES) (NARRATIVE) (Details) $ in Millions	3 Months Ended
	Jun. 30, 2014 USD ($)
Accounting Policies [Abstract]
Gain related to other reinsurance transactions	$ 3.8

XML

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (MULTIBUCKET ANNUITY PRODUCTS) (NARRATIVE) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Accounting Policies [Abstract]
Return of premium annual percentage, multibucket annuity	3.00%
Insurance liabilities held, related to multibucket annuity products	$ 37.5	$ 43.4

XML

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (SALE OF INDUCEMENTS) (NARRATIVE) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Accounting Policies [Abstract]
Deferred sales inducements	$ 3.8	$ 5.1	$ 5.0
Deferred sales inducements, amortization expense	13.8	12.4	$ 22.9
Unamortized deferred sales inducements	57.4	67.4
Insurance liabilities for persistency bonus benefits	$ 0.9	$ 1.5

XML

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (OUT-OF-PERIOD ADJUSTMENTS) (NARRATIVE) (Details) - Out of Period Adjustment [Member] - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Out of period adjustment, increase in other operating costs and expenses	$ 2.4	$ 1.5
Out of period adjustment, decrease in tax expense	0.8	0.7
Out of period adjustment, effect on net income	$ 1.6	$ 7.6
Adjustment to earnings per diluted share (in dollars per share)	$ 0.01	$ 0.03
Out of period adjustment, increase in insurance policy benefits		$ 4.7
Out of period adjustment, increase in amortization expense		$ 2.1

XML

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (RECENTLY ISSUED ACCOUNTING STANDARDS) (Details) - USD ($) $ in Millions	Dec. 31, 2015	Dec. 31, 2014
New Accounting Pronouncement, Early Adoption [Line Items]
Other assets	$ 309.2	$ 309.4
Total assets	31,125.1	31,155.9
Borrowings related to variable interest entities	1,676.4	1,271.9
Notes payable – direct corporate obligations	911.1	780.3
Total liabilities	$ 26,986.6	26,467.7
Effect of adoption [Member]
New Accounting Pronouncement, Early Adoption [Line Items]
Other assets		(28.3)
Total assets		(28.3)
Borrowings related to variable interest entities		(14.2)
Notes payable – direct corporate obligations		(14.1)
Total liabilities		(28.3)
As originally reported [Member]
New Accounting Pronouncement, Early Adoption [Line Items]
Other assets		337.7
Total assets		31,184.2
Borrowings related to variable interest entities		1,286.1
Notes payable – direct corporate obligations		794.4
Total liabilities		$ 26,496.0

XML

INVESTMENTS (NARRATIVE) (Details)	12 Months Ended
	Dec. 31, 2015 USD ($) state	Dec. 31, 2014 USD ($) investment	Dec. 31, 2013 USD ($)
Schedule of Available-for-sale Securities [Line Items]
Premium deficiencies adjustments to present value of future profits	$ (109,300,000)	$ (128,800,000)
Reduction to deferred acquisition costs due to unrealized gains that would result in premium deficiency if unrealized gains were realized	(33,200,000)	(142,200,000)
Adjustment to insurance liabilities	(14,600,000)	(381,400,000)
Increase to deferred tax assets due to unrealized gains that would result in premium deficiency if unrealized gains were realized	55,800,000	232,100,000
Fixed maturities, available for sale, amortized cost	18,947,000,000	18,408,100,000
Estimated fair value	19,882,900,000	20,634,900,000
Fair value of fixed maturity investments and mortgage loans not accruing investment income	0	0
Net realized investment gains (losses)	(36,600,000)	36,700,000	$ 33,400,000
Net realized investment gains (losses), excluding impairment losses	(8,000,000)	64,000,000	45,000,000
Gain on dissolution of a variable interest entity	11,300,000	0	0
Net impairment losses recognized	39,900,000
Total other-than-temporary impairment losses	42,900,000	$ 27,300,000	11,600,000
Number of legacy private company investments | investment		2
Other-than-temporary impairment losses recognized in accumulated other comprehensive income	(3,000,000)	$ 0	0
Sales of investments	2,177,600,000	2,090,000,000	2,315,800,000
Other-than-temporary impairments	(39,900,000)	(27,300,000)	(11,600,000)
Fixed maturities in default	0
Value of available for sale securities sold	724,400,000	233,700,000	477,500,000
Impairment losses related to writedown of mortgage loans which losses major tenants		6,800,000	5,000,000
Other than temporary impairment losses, losses on other investments following unforeseen events		1,400,000
Other-than-temporary impairments included in accumulated other comprehensive income	4,900,000	3,200,000
Estimated fair value	$ 4,695,000,000
Percent of fixed maturities	23.60%
Number of additional states greater than specified percentage of mortgage loan balance | state	0
Assets held by insurance regulators	$ 38,200,000	42,300,000
Minimum [Member]
Schedule of Available-for-sale Securities [Line Items]
Percentage of mortgage loan balance	5.00%
Maximum [Member]
Schedule of Available-for-sale Securities [Line Items]
Percentage of commercial loan balance that is noncurrent	0.00%
California [Member]
Schedule of Available-for-sale Securities [Line Items]
Percentage of mortgage loan balance	13.00%
Texas [Member]
Schedule of Available-for-sale Securities [Line Items]
Percentage of mortgage loan balance	9.00%
Maryland [Member]
Schedule of Available-for-sale Securities [Line Items]
Percentage of mortgage loan balance	8.00%
Florida [Member]
Schedule of Available-for-sale Securities [Line Items]
Percentage of mortgage loan balance	5.00%
Total fixed maturities, available for sale [Member]
Schedule of Available-for-sale Securities [Line Items]
Net realized investment gains (losses)	$ (7,600,000)	51,400,000	39,200,000
Net impairment losses recognized	14,900,000	0	7,100,000
Other-than-temporary impairment losses recognized in accumulated other comprehensive income	(3,000,000)	0	0
Other-than-temporary impairments	(17,900,000)	0	(7,100,000)
Gross realized losses on sale	88,400,000	13,000,000	11,400,000
States and political subdivisions [Member]
Schedule of Available-for-sale Securities [Line Items]
Gross realized losses on sale		700,000
Corporate securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Gross realized losses on sale		12,300,000	8,900,000
Mortgage-backed and Asset-backed Securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Realized losses on sale			2,500,000
Equity securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Net realized investment gains (losses)	3,700,000	10,100,000	4,800,000
Total other-than-temporary impairment losses			2,500,000
Embedded Derivative Financial Instruments [Member]
Schedule of Available-for-sale Securities [Line Items]
Decrease in fair value of embedded derivatives			(6,800,000)
Increase in fair value of embedded derivatives		7,600,000
Coinsurance [Member] | Embedded Derivative Financial Instruments [Member]
Schedule of Available-for-sale Securities [Line Items]
Decrease in fair value of embedded derivatives	(7,000,000)
Increase in fair value of embedded derivatives		2,000,000
Marketable Securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Net realized investment gains (losses), excluding impairment losses	1,000,000	54,400,000	51,800,000
Fixed income investments [Member] | Energy Sector [Member]
Schedule of Available-for-sale Securities [Line Items]
Total other-than-temporary impairment losses	10,200,000
Gross realized losses on sale	59,700,000
Commercial bank loans held by VIEs [Member]
Schedule of Available-for-sale Securities [Line Items]
Total other-than-temporary impairment losses	16,400,000
Available-for-sale securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Total other-than-temporary impairment losses	5,400,000		$ 4,100,000
Legacy private company investments [Member]
Schedule of Available-for-sale Securities [Line Items]
Total other-than-temporary impairment losses	7,900,000	19,100,000
Non Investment Grade [Member]
Schedule of Available-for-sale Securities [Line Items]
Fixed maturities, available for sale, amortized cost	$ 2,234,500,000	2,339,200,000
Percentage of available-for-sale debt securities	12.00%
Estimated fair value	$ 2,222,800,000	2,416,100,000
Available-for-sale securities, percentage of amortized cost	99.00%
Other-than-temporary impairments included in accumulated other comprehensive income	$ 4,900,000	$ 3,200,000
Continuous unrealized loss position	20.00%

XML

INVESTMENTS (SCHEDULE OF FIXED MATURITIES FOR AVAILABLE FOR SALE AND EQUITY SECURITIES) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Schedule of Available-for-sale Securities [Line Items]
Amortized cost	$ 18,947.0	$ 18,408.1
Gross unrealized gains	1,324.4	2,323.6
Gross unrealized losses	(388.5)	(96.8)
Estimated fair value	19,882.9	20,634.9
Other-than-temporary impairments included in accumulated other comprehensive income	(4.9)	(3.2)
Equity securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Amortized cost	447.4	400.5
Gross unrealized gains	18.4	19.1
Gross unrealized losses	(2.8)	(0.6)
Estimated fair value	463.0	419.0
Investment Grade [Member]
Schedule of Available-for-sale Securities [Line Items]
Amortized cost	16,712.5	16,068.9
Gross unrealized gains	1,241.4	2,198.9
Gross unrealized losses	(293.8)	(49.0)
Estimated fair value	17,660.1	18,218.8
Other-than-temporary impairments included in accumulated other comprehensive income	0.0	0.0
Investment Grade [Member] | Corporate securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Amortized cost	11,477.5	11,177.1
Gross unrealized gains	929.4	1,710.5
Gross unrealized losses	(262.9)	(42.1)
Estimated fair value	12,144.0	12,845.5
Other-than-temporary impairments included in accumulated other comprehensive income	0.0	0.0
Investment Grade [Member] | US treasury and government [Member]
Schedule of Available-for-sale Securities [Line Items]
Amortized cost	172.5	138.8
Gross unrealized gains	22.3	30.2
Gross unrealized losses	(0.3)	(0.1)
Estimated fair value	194.5	168.9
Other-than-temporary impairments included in accumulated other comprehensive income	0.0	0.0
Investment Grade [Member] | States and political subdivisions [Member]
Schedule of Available-for-sale Securities [Line Items]
Amortized cost	1,889.6	1,960.6
Gross unrealized gains	208.6	299.3
Gross unrealized losses	(3.7)	(0.7)
Estimated fair value	2,094.5	2,259.2
Other-than-temporary impairments included in accumulated other comprehensive income	0.0	0.0
Investment Grade [Member] | Debt securities issued by foreign governments [Member]
Schedule of Available-for-sale Securities [Line Items]
Amortized cost	18.9	1.8
Gross unrealized gains	0.0	0.1
Gross unrealized losses	(0.6)	0.0
Estimated fair value	18.3	1.9
Other-than-temporary impairments included in accumulated other comprehensive income	0.0	0.0
Investment Grade [Member] | Asset-backed securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Amortized cost	979.8	720.7
Gross unrealized gains	22.1	52.0
Gross unrealized losses	(7.2)	(1.6)
Estimated fair value	994.7	771.1
Other-than-temporary impairments included in accumulated other comprehensive income	0.0	0.0
Investment Grade [Member] | Collateralized debt obligations [Member]
Schedule of Available-for-sale Securities [Line Items]
Amortized cost	188.5	314.9
Gross unrealized gains	0.4	2.4
Gross unrealized losses	(2.2)	(3.4)
Estimated fair value	186.7	313.9
Other-than-temporary impairments included in accumulated other comprehensive income	0.0	0.0
Investment Grade [Member] | Commercial mortgage-backed securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Amortized cost	1,531.7	1,179.7
Gross unrealized gains	41.3	80.9
Gross unrealized losses	(16.3)	(0.5)
Estimated fair value	1,556.7	1,260.1
Other-than-temporary impairments included in accumulated other comprehensive income	0.0	0.0
Investment Grade [Member] | Mortgage pass-through securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Amortized cost	3.1	4.2
Gross unrealized gains	0.3	0.4
Gross unrealized losses	0.0	0.0
Estimated fair value	3.4	4.6
Other-than-temporary impairments included in accumulated other comprehensive income	0.0	0.0
Investment Grade [Member] | Collateralized mortgage obligations [Member]
Schedule of Available-for-sale Securities [Line Items]
Amortized cost	450.9	571.1
Gross unrealized gains	17.0	23.1
Gross unrealized losses	(0.6)	(0.6)
Estimated fair value	467.3	593.6
Other-than-temporary impairments included in accumulated other comprehensive income	0.0	0.0
Non Investment Grade [Member]
Schedule of Available-for-sale Securities [Line Items]
Amortized cost	2,234.5	2,339.2
Gross unrealized gains	83.0	124.7
Gross unrealized losses	(94.7)	(47.8)
Estimated fair value	2,222.8	2,416.1
Other-than-temporary impairments included in accumulated other comprehensive income	(4.9)	(3.2)
Non Investment Grade [Member] | Corporate securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Amortized cost	798.5	1,139.3
Gross unrealized gains	8.3	29.2
Gross unrealized losses	(82.3)	(43.0)
Estimated fair value	724.5	1,125.5
Other-than-temporary impairments included in accumulated other comprehensive income	0.0	0.0
Non Investment Grade [Member] | States and political subdivisions [Member]
Schedule of Available-for-sale Securities [Line Items]
Amortized cost	13.6	20.6
Gross unrealized gains	0.0	0.2
Gross unrealized losses	(3.9)	(2.3)
Estimated fair value	9.7	18.5
Other-than-temporary impairments included in accumulated other comprehensive income	(3.0)	0.0
Non Investment Grade [Member] | Debt securities issued by foreign governments [Member]
Schedule of Available-for-sale Securities [Line Items]
Amortized cost	2.4
Gross unrealized gains	0.0
Gross unrealized losses	0.0
Estimated fair value	2.4
Other-than-temporary impairments included in accumulated other comprehensive income	0.0
Non Investment Grade [Member] | Asset-backed securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Amortized cost	838.0	465.9
Gross unrealized gains	25.7	33.8
Gross unrealized losses	(6.2)	(1.8)
Estimated fair value	857.5	497.9
Other-than-temporary impairments included in accumulated other comprehensive income	0.0	0.0
Non Investment Grade [Member] | Collateralized debt obligations [Member]
Schedule of Available-for-sale Securities [Line Items]
Amortized cost		10.4
Gross unrealized gains		0.2
Gross unrealized losses		0.0
Estimated fair value		10.6
Other-than-temporary impairments included in accumulated other comprehensive income		0.0
Non Investment Grade [Member] | Commercial mortgage-backed securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Amortized cost	49.9	15.3
Gross unrealized gains	0.0	0.9
Gross unrealized losses	(1.3)	0.0
Estimated fair value	48.6	16.2
Other-than-temporary impairments included in accumulated other comprehensive income	0.0	0.0
Non Investment Grade [Member] | Collateralized mortgage obligations [Member]
Schedule of Available-for-sale Securities [Line Items]
Amortized cost	532.1	687.7
Gross unrealized gains	49.0	60.4
Gross unrealized losses	(1.0)	(0.7)
Estimated fair value	580.1	747.4
Other-than-temporary impairments included in accumulated other comprehensive income	$ (1.9)	$ (3.2)

XML

INVESTMENTS (SUMMARY OF FIXED MATURITY SECURITIES AVAILABLE FOR SALE) (Details) - USD ($) $ in Millions	Dec. 31, 2015	Dec. 31, 2014
Schedule of Available-for-sale Securities [Line Items]
Fixed maturities, available for sale, amortized cost	$ 18,947.0	$ 18,408.1
Estimated fair value	$ 19,882.9	$ 20,634.9
Percentage of total estimated fair value	100.00%
NAIC designation 1 [Member]
Schedule of Available-for-sale Securities [Line Items]
Fixed maturities, available for sale, amortized cost	$ 9,491.4
Estimated fair value	$ 10,238.7
Percentage of total estimated fair value	51.50%
NAIC designation 2 [Member]
Schedule of Available-for-sale Securities [Line Items]
Fixed maturities, available for sale, amortized cost	$ 8,609.3
Estimated fair value	$ 8,876.1
Percentage of total estimated fair value	44.60%
NAIC designation 3 [Member]
Schedule of Available-for-sale Securities [Line Items]
Fixed maturities, available for sale, amortized cost	$ 591.4
Estimated fair value	$ 547.4
Percentage of total estimated fair value	2.80%
NAIC designation 4 [Member]
Schedule of Available-for-sale Securities [Line Items]
Fixed maturities, available for sale, amortized cost	$ 187.4
Estimated fair value	$ 160.0
Percentage of total estimated fair value	0.80%
NAIC designation 5 [Member]
Schedule of Available-for-sale Securities [Line Items]
Fixed maturities, available for sale, amortized cost	$ 53.7
Estimated fair value	$ 50.8
Percentage of total estimated fair value	0.30%
NAIC designation 6 [Member]
Schedule of Available-for-sale Securities [Line Items]
Fixed maturities, available for sale, amortized cost	$ 13.8
Estimated fair value	$ 9.9
Percentage of total estimated fair value	0.00%

XML

INVESTMENTS (SCHEDULE OF ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)) (Details) - USD ($) $ in Millions	Dec. 31, 2015	Dec. 31, 2014
Investments, Debt and Equity Securities [Abstract]
Net unrealized appreciation (depreciation) on fixed maturity securities, available for sale, on which an other-than-temporary impairment loss has been recognized	$ 1.6	$ 5.3
Net unrealized gains on all other investments	903.4	2,207.7
Adjustment to present value of future profits	(121.2)	(149.9)
Adjustment to deferred acquisition costs	(133.3)	(390.5)
Adjustment to insurance liabilities	(14.6)	(381.4)
Unrecognized net loss related to deferred compensation plan	(8.6)	(8.5)
Deferred income tax liabilities	(224.5)	(457.4)
Accumulated other comprehensive income	$ 402.8	$ 825.3

XML

INVESTMENTS (SCHEDULE OF INVESTMENTS CLASSIFIED BY CONTRACTUAL MATURITY DATE) (Details) - USD ($) $ in Millions	Dec. 31, 2015	Dec. 31, 2014
Available-for-sale Securities, Debt Maturities, Single Maturity Date, Amortized Cost Basis [Abstract]
Due in one year or less	$ 265.0
Due after one year through five years	2,246.2
Due after five years through ten years	1,755.7
Due after ten years	10,106.1
Subtotal	14,373.0
Structured securities	4,574.0
Amortized cost	18,947.0	$ 18,408.1
Available-for-sale Securities, Debt Maturities, Single Maturity Date [Abstract]
Due in one year or less	268.9
Due after one year through five years	2,389.1
Due after five years through ten years	1,824.5
Due after ten years	10,705.4
Subtotal	15,187.9
Structured securities	4,695.0
Estimated fair value	$ 19,882.9	$ 20,634.9

XML

INVESTMENTS (SCHEDULE OF INVESTMENT INCOME) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Schedule of Trading Securities and Other Trading Assets [Line Items]
Fixed maturities	$ 1,090.1	$ 1,175.8	$ 1,290.3
Equity securities	18.3	13.9	7.0
Mortgage loans	91.4	104.2	96.3
Policy loans	7.3	11.0	17.3
Other invested assets	17.4	17.1	14.4
Cash and cash equivalents	0.8	0.6	0.5
Trading securities (a)	10.7	14.8	12.8
Option income	36.5	118.9	77.4
Change in value of options	(72.7)	(49.4)	100.1
Other special-purpose portfolios	55.5	42.1	67.9
Gross investment income	1,255.3	1,449.0	1,684.0
Less investment expenses	21.7	21.6	20.0
Net investment income	1,233.6	1,427.4	1,664.0
Investment Income [Member]
Schedule of Trading Securities and Other Trading Assets [Line Items]
Increase (decrease) in trading securities	$ 0.4	$ 3.4	$ 0.4

XML

INVESTMENTS (SCHEDULE OF REALIZED GAIN (LOSS) ON INVESTMENTS) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Investment [Line Items]
Total other-than-temporary impairment losses	$ (39.9)	$ (27.3)	$ (11.6)
Other-than-temporary impairment losses recognized in accumulated other comprehensive income	3.0	0.0	0.0
Net impairment losses recognized	(39.9)
Net realized investment gains (losses)	(36.6)	36.7	33.4
Gain on dissolution of a variable interest entity	11.3	0.0	0.0
Total fixed maturities, available for sale [Member]
Investment [Line Items]
Gross realized gains on sale	95.7	64.4	57.7
Gross realized losses on sale	(88.4)	(13.0)	(11.4)
Total other-than-temporary impairment losses	(17.9)	0.0	(7.1)
Other-than-temporary impairment losses recognized in accumulated other comprehensive income	3.0	0.0	0.0
Net impairment losses recognized	(14.9)	0.0	(7.1)
Net realized investment gains (losses)	(7.6)	51.4	39.2
Equity securities [Member]
Investment [Line Items]
Net realized investment gains (losses)	3.7	10.1	4.8
Commercial mortgage loans [Member]
Investment [Line Items]
Net realized investment gains (losses)	(2.3)	(0.1)	(1.1)
Impairments of mortgage loans and other investments [Member]
Investment [Line Items]
Net realized investment gains (losses)	(25.0)	(27.3)	(4.5)
Other [Member]
Investment [Line Items]
Net realized investment gains (losses)	(16.7)	2.6	(5.0)
Investments [Member]
Investment [Line Items]
Change in estimated fair value of trading securities	$ (9.2)	$ 7.8	$ (3.0)

XML

INVESTMENTS (SCHEDULE OF INVESTMENTS IN OUR PORTFOLIO RATED BELOW-INVESTMENT GRADE WHICH HAVE BEEN CONTINUOUSLY IN AN UNREALIZED LOSS POSITION 1) (Details) - Fixed Maturities [Member] $ in Millions	Dec. 31, 2015 USD ($) issuer
Schedule of Available-for-sale Securities [Line Items]
Less than 6 months prior to sale, Number of issuers | issuer	12
Greater than or equal to 6 months and less than 12 months prior to sale, Number of issuers | issuer	2
Number of issuers, Total | issuer	14
Less than 6 months prior to sale, Amortized cost	$ 38.7
Greater than or equal to 6 months and less than 12 months prior to sale, Amortized cost	16.9
Amortized cost, Total	55.6
Less than 6 months prior to sale, Fair value	24.5
Greater than or equal to 6 months and less than 12 months prior to sale, Fair value	9.5
Fair value, Total	$ 34.0

XML

INVESTMENTS (SCHEDULE OF CREDIT LOSSES RECOGNIZED IN EARNINGS) (Details) - Available-for-sale securities [Member] - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Other than Temporary Impairment, Credit Losses Recognized in Earnings [Roll Forward]
Credit losses on fixed maturity securities, available for sale, beginning of period	$ (1.0)	$ (1.3)	$ (1.6)
Add: credit losses on other-than-temporary impairments not previously recognized	(2.0)	0.0	0.0
Less: credit losses on securities sold	0.4	0.3	0.3
Less: credit losses on securities impaired due to intent to sell	0.0	0.0	0.0
Add: credit losses on previously impaired securities	0.0	0.0	0.0
Less: increases in cash flows expected on previously impaired securities	0.0	0.0	0.0
Credit losses on fixed maturity securities, available for sale, end of period	$ (2.6)	$ (1.0)	$ (1.3)

XML

INVESTMENTS (SCHEDULE OF INVESTMENTS WITH UNREALIZED LOSSES CLASSIFIED BY CONTRACTUAL MATURITY DATE) (Details) $ in Millions	Dec. 31, 2015 USD ($)
Amortized cost
Due in one year or less	$ 20.7
Due after one year through five years	358.7
Due after five years through ten years	464.3
Due after ten years	2,938.4
Subtotal	3,782.1
Structured securities	1,916.4
Total	5,698.5
Estimated fair value
Due in one year or less	20.7
Due after one year through five years	343.8
Due after five years through ten years	426.4
Due after ten years	2,637.5
Subtotal	3,428.4
Structured securities	1,881.6
Total	$ 5,310.0

XML

INVESTMENTS (SCHEDULE OF INVESTMENTS IN OUR PORTFOLIO RATED BELOW-INVESTMENT GRADE WHICH HAVE BEEN CONTINUOUSLY IN AN UNREALIZED LOSS POSITION 2) (Details) $ in Millions	Dec. 31, 2015 USD ($) issuer	Dec. 31, 2014 USD ($)
Schedule of Available-for-sale Securities [Line Items]
Greater than 12 months, Unrealized losses	$ (97.2)	$ (24.5)
Unrealized losses, total	(388.5)	(96.8)
Greater than 12 months, Estimated fair value	495.0	439.2
Fair value, total	$ 5,310.0	$ 1,851.1
Non Investment Grade [Member]
Schedule of Available-for-sale Securities [Line Items]
Less than 6 months, Number of issuers | issuer	22
Greater than or equal to 6 months and less than 12 months, Number of issuers | issuer	2
Greater than 12 months, Number of issuers | issuer	1
Less than 6 months, Cost basis	$ 172.8
Greater than or equal to 6 months and less than 12 months, Cost basis	23.0
Greater than 12 months, Cost basis	18.2
Amortized cost, Total	214.0
Less than 6 months, Unrealized loss	(50.3)
Greater than or equal to 6 months and less than 12 months, Unrealized loss	(9.8)
Greater than 12 months, Unrealized losses	(6.1)
Unrealized losses, total	(66.2)
Less than 6 months, Estimated fair value	122.5
Great than or equal to 6 months and less than 12 months, Estimated fair value	13.2
Greater than 12 months, Estimated fair value	12.1
Fair value, total	$ 147.8

XML

INVESTMENTS (SCHEDULE OF UNREALIZED LOSS ON INVESTMENTS) (Details) - USD ($) $ in Millions	Dec. 31, 2015	Dec. 31, 2014
Schedule of Available-for-sale Securities [Line Items]
Fair value, less than twelve months	$ 4,815.0	$ 1,411.9
Unrealized losses, less than 12 months	(291.3)	(72.3)
Fair value, twelve months or longer, Fair value	495.0	439.2
Unrealized losses, 12 months or longer	(97.2)	(24.5)
Fair value, total	5,310.0	1,851.1
Unrealized losses, total	(388.5)	(96.8)
US treasury and government [Member]
Schedule of Available-for-sale Securities [Line Items]
Fair value, less than twelve months	43.6	12.1
Unrealized losses, less than 12 months	(0.3)	(0.1)
Fair value, twelve months or longer, Fair value	0.0	4.6
Unrealized losses, 12 months or longer	0.0	0.0
Fair value, total	43.6	16.7
Unrealized losses, total	(0.3)	(0.1)
States and political subdivisions [Member]
Schedule of Available-for-sale Securities [Line Items]
Fair value, less than twelve months	156.8	13.2
Unrealized losses, less than 12 months	(4.1)	(0.3)
Fair value, twelve months or longer, Fair value	14.8	44.5
Unrealized losses, 12 months or longer	(3.5)	(2.7)
Fair value, total	171.6	57.7
Unrealized losses, total	(7.6)	(3.0)
Debt securities issued by foreign governments [Member]
Schedule of Available-for-sale Securities [Line Items]
Fair value, less than twelve months	20.7
Unrealized losses, less than 12 months	(0.6)
Fair value, twelve months or longer, Fair value	0.0
Unrealized losses, 12 months or longer	0.0
Fair value, total	20.7
Unrealized losses, total	(0.6)
Corporate securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Fair value, less than twelve months	2,913.6	985.0
Unrealized losses, less than 12 months	(255.7)	(65.9)
Fair value, twelve months or longer, Fair value	278.9	297.5
Unrealized losses, 12 months or longer	(89.5)	(19.2)
Fair value, total	3,192.5	1,282.5
Unrealized losses, total	(345.2)	(85.1)
Asset-backed securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Fair value, less than twelve months	930.3	91.2
Unrealized losses, less than 12 months	(11.7)	(1.3)
Fair value, twelve months or longer, Fair value	98.4	60.5
Unrealized losses, 12 months or longer	(1.7)	(2.1)
Fair value, total	1,028.7	151.7
Unrealized losses, total	(13.4)	(3.4)
Collateralized debt obligations [Member]
Schedule of Available-for-sale Securities [Line Items]
Fair value, less than twelve months	96.2	184.2
Unrealized losses, less than 12 months	(1.8)	(3.4)
Fair value, twelve months or longer, Fair value	36.3	0.0
Unrealized losses, 12 months or longer	(0.4)	0.0
Fair value, total	132.5	184.2
Unrealized losses, total	(2.2)	(3.4)
Commercial mortgage-backed securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Fair value, less than twelve months	556.0	46.7
Unrealized losses, less than 12 months	(16.1)	(0.5)
Fair value, twelve months or longer, Fair value	25.7	0.0
Unrealized losses, 12 months or longer	(1.5)	0.0
Fair value, total	581.7	46.7
Unrealized losses, total	(17.6)	(0.5)
Mortgage pass-through securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Fair value, less than twelve months	0.0	0.5
Unrealized losses, less than 12 months	0.0	0.0
Fair value, twelve months or longer, Fair value	0.1	0.1
Unrealized losses, 12 months or longer	0.0	0.0
Fair value, total	0.1	0.6
Unrealized losses, total	0.0	0.0
Collateralized mortgage obligations [Member]
Schedule of Available-for-sale Securities [Line Items]
Fair value, less than twelve months	97.8	79.0
Unrealized losses, less than 12 months	(1.0)	(0.8)
Fair value, twelve months or longer, Fair value	40.8	32.0
Unrealized losses, 12 months or longer	(0.6)	(0.5)
Fair value, total	138.6	111.0
Unrealized losses, total	(1.6)	(1.3)
Equity securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Fair value, less than twelve months	140.1	13.2
Unrealized losses, less than 12 months	(2.4)	(0.6)
Fair value, twelve months or longer, Fair value	2.4	0.5
Unrealized losses, 12 months or longer	(0.4)	0.0
Fair value, total	142.5	13.7
Unrealized losses, total	$ (2.8)	$ (0.6)

XML

INVESTMENTS (SCHEDULE OF STRUCTURED SECURITIES) (Details) $ in Millions	12 Months Ended
	Dec. 31, 2015 USD ($)
Financial Instruments Owned and Pledged as Collateral [Line Items]
Par value	$ 5,213.1
Amortized cost	4,574.0
Estimated fair value	$ 4,695.0
Percent of fixed maturities	23.60%
Pass-throughs, sequential and equivalent securities[Member]
Financial Instruments Owned and Pledged as Collateral [Line Items]
Amortized cost	$ 750.0
Estimated fair value	$ 799.8
Percent of fixed maturities	4.00%
Planned amortization classes, target amortization classes and accretion-directed bonds [Member]
Financial Instruments Owned and Pledged as Collateral [Line Items]
Amortized cost	$ 187.7
Estimated fair value	$ 202.4
Percent of fixed maturities	1.00%
Commercial mortgage-backed securities [Member]
Financial Instruments Owned and Pledged as Collateral [Line Items]
Amortized cost	$ 1,581.6
Estimated fair value	$ 1,605.3
Percent of fixed maturities	8.10%
Asset-backed securities [Member]
Financial Instruments Owned and Pledged as Collateral [Line Items]
Amortized cost	$ 1,817.8
Estimated fair value	$ 1,852.2
Percent of fixed maturities	9.30%
Collateralized debt obligations [Member]
Financial Instruments Owned and Pledged as Collateral [Line Items]
Amortized cost	$ 188.5
Estimated fair value	$ 186.7
Percent of fixed maturities	0.90%
Other [Member]
Financial Instruments Owned and Pledged as Collateral [Line Items]
Amortized cost	$ 48.4
Estimated fair value	$ 48.6
Percent of fixed maturities	0.30%
Below 4 Percent [Member]
Financial Instruments Owned and Pledged as Collateral [Line Items]
Par value	$ 1,387.4
Amortized cost	978.3
Estimated fair value	$ 982.3
Structured settlement, interest rate, high end	4.00%
4 Percent - 5 Percent [Member]
Financial Instruments Owned and Pledged as Collateral [Line Items]
Par value	$ 1,363.8
Amortized cost	1,289.7
Estimated fair value	$ 1,300.0
Structured settlement, interest rate, low end	4.00%
Structured settlement, interest rate, high end	5.00%
5 Percent - 6 Percent [Member]
Financial Instruments Owned and Pledged as Collateral [Line Items]
Par value	$ 1,868.3
Amortized cost	1,747.4
Estimated fair value	$ 1,822.2
Structured settlement, interest rate, low end	5.00%
Structured settlement, interest rate, high end	6.00%
6 Percent - 7 Percent [Member]
Financial Instruments Owned and Pledged as Collateral [Line Items]
Par value	$ 454.6
Amortized cost	419.4
Estimated fair value	$ 445.2
Structured settlement, interest rate, low end	6.00%
Structured settlement, interest rate, high end	7.00%
7 Percent - 8 Percent [Member]
Financial Instruments Owned and Pledged as Collateral [Line Items]
Par value	$ 75.0
Amortized cost	75.7
Estimated fair value	$ 82.5
Structured settlement, interest rate, low end	7.00%
Structured settlement, interest rate, high end	8.00%
8 Percent and Above [Member]
Financial Instruments Owned and Pledged as Collateral [Line Items]
Par value	$ 64.0
Amortized cost	63.5
Estimated fair value	$ 62.8
Structured settlement, interest rate, low end	8.00%

XML

INVESTMENTS (SUMMARY OF WEIGHTED AVERAGE LOAN-TO-VALUE RATIO FOR OUTSTANDING MORTGAGE LOANS) (Details) $ in Millions	Dec. 31, 2015 USD ($)	Dec. 31, 2014 USD ($)
Schedule of Available-for-sale Securities [Line Items]
Mortgage loans	$ 1,721.0	$ 1,691.9
Carrying value [Member]
Schedule of Available-for-sale Securities [Line Items]
Mortgage loans	1,721.0
Estimate of fair value [Member]
Schedule of Available-for-sale Securities [Line Items]
Mortgage loans	1,772.4
Collateral	3,249.7
Less than 60% [Member] | Carrying value [Member]
Schedule of Available-for-sale Securities [Line Items]
Mortgage loans	796.2
Less than 60% [Member] | Estimate of fair value [Member]
Schedule of Available-for-sale Securities [Line Items]
Mortgage loans	828.0
Collateral	$ 1,925.0
Less than 60% [Member] | Maximum [Member]
Schedule of Available-for-sale Securities [Line Items]
Loan-to-value ratio	0.6
60% to 70% [Member] | Carrying value [Member]
Schedule of Available-for-sale Securities [Line Items]
Mortgage loans	$ 503.8
60% to 70% [Member] | Estimate of fair value [Member]
Schedule of Available-for-sale Securities [Line Items]
Mortgage loans	509.6
Collateral	$ 771.8
60% to 70% [Member] | Minimum [Member]
Schedule of Available-for-sale Securities [Line Items]
Loan-to-value ratio	0.6
60% to 70% [Member] | Maximum [Member]
Schedule of Available-for-sale Securities [Line Items]
Loan-to-value ratio	0.7
Greater than 70% to 80% [Member] | Carrying value [Member]
Schedule of Available-for-sale Securities [Line Items]
Mortgage loans	$ 326.8
Greater than 70% to 80% [Member] | Estimate of fair value [Member]
Schedule of Available-for-sale Securities [Line Items]
Mortgage loans	336.9
Collateral	$ 440.0
Greater than 70% to 80% [Member] | Minimum [Member]
Schedule of Available-for-sale Securities [Line Items]
Loan-to-value ratio	0.7
Greater than 70% to 80% [Member] | Maximum [Member]
Schedule of Available-for-sale Securities [Line Items]
Loan-to-value ratio	0.8
Greater than 80% to 90% [Member] | Carrying value [Member]
Schedule of Available-for-sale Securities [Line Items]
Mortgage loans	$ 89.9
Greater than 80% to 90% [Member] | Estimate of fair value [Member]
Schedule of Available-for-sale Securities [Line Items]
Mortgage loans	93.0
Collateral	$ 108.6
Greater than 80% to 90% [Member] | Minimum [Member]
Schedule of Available-for-sale Securities [Line Items]
Loan-to-value ratio	0.8
Greater than 80% to 90% [Member] | Maximum [Member]
Schedule of Available-for-sale Securities [Line Items]
Loan-to-value ratio	0.9
Greater than 90% [Member] | Carrying value [Member]
Schedule of Available-for-sale Securities [Line Items]
Mortgage loans	$ 4.3
Greater than 90% [Member] | Estimate of fair value [Member]
Schedule of Available-for-sale Securities [Line Items]
Mortgage loans	4.9
Collateral	$ 4.3
Greater than 90% [Member] | Minimum [Member]
Schedule of Available-for-sale Securities [Line Items]
Loan-to-value ratio	0.9

XML

FAIR VALUE MEASUREMENTS (NARRATIVE) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of level 3 fixed maturity securities valued using broker quotes, percentage	45.00%
Available for sale fixed maturities classified as level 3, investment grade, percent	45.00%
Available for sale fixed maturities classified as level 3, corporate securities, percent	82.00%
Fair value, measurements, recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Alternative investment funds	$ 92.7	$ 102.8

XML

FAIR VALUE MEASUREMENTS (FAIR VALUE MEASUREMENTS OF FINANCIAL INSTRUMENTS MEASURED ON A RECURRING BASIS - SECURITIES) (Details) - USD ($) $ in Millions	Dec. 31, 2015	Dec. 31, 2014
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	$ 19,882.9	$ 20,634.9
Trading securities	262.1	244.9
Investments held by variable interest entities - corporate securities	1,633.6	1,367.1
Assets held in separate accounts	4.7	5.6
Fair value, measurements, recurring [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Trading securities	262.1	244.9
Investments held by variable interest entities - corporate securities	1,633.6	1,367.1
Assets held in separate accounts	4.7	5.6
Total assets carried at fair value by category	22,288.9	22,780.1
Fair value, measurements, recurring [Member] | Derivatives [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Other invested assets - derivatives	42.6	108.6
Fair value, measurements, recurring [Member] | Embedded derivatives associated with fixed index annuity products [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total liabilities for insurance products	1,057.1	1,081.5
Fair value, measurements, recurring [Member] | Corporate securities [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	12,868.5	13,971.0
Equity securities - corporate securities	463.0	419.0
Trading securities	21.5	24.3
Fair value, measurements, recurring [Member] | US treasury and government [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	194.5	168.9
Trading securities	1.9	3.7
Fair value, measurements, recurring [Member] | States and political subdivisions [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	2,104.2	2,277.7
Fair value, measurements, recurring [Member] | Debt securities issued by foreign governments [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	20.7	1.9
Fair value, measurements, recurring [Member] | Asset-backed securities [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	1,852.2	1,269.0
Trading securities	35.5	24.0
Fair value, measurements, recurring [Member] | Collateralized debt obligations [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	186.7	324.5
Trading securities	2.1
Fair value, measurements, recurring [Member] | Commercial mortgage-backed securities [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	1,605.3	1,276.3
Trading securities	158.0	159.6
Fair value, measurements, recurring [Member] | Mortgage pass-through securities [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	3.4	4.6
Trading securities		0.1
Fair value, measurements, recurring [Member] | Collateralized mortgage obligations [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	1,047.4	1,341.0
Trading securities	38.2	29.7
Fair value, measurements, recurring [Member] | Total fixed maturities, available for sale [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	19,882.9	20,634.9
Fair value, measurements, recurring [Member] | Equity securities [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Trading securities	4.9	3.5
Fair value, measurements, recurring [Member] | Level 1 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Trading securities	4.9	3.5
Investments held by variable interest entities - corporate securities	0.0	0.0
Assets held in separate accounts	0.0	0.0
Total assets carried at fair value by category	261.4	221.8
Fair value, measurements, recurring [Member] | Level 1 [Member] | Derivatives [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Other invested assets - derivatives	1.6	1.4
Fair value, measurements, recurring [Member] | Level 1 [Member] | Embedded derivatives associated with fixed index annuity products [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total liabilities for insurance products	0.0	0.0
Fair value, measurements, recurring [Member] | Level 1 [Member] | Corporate securities [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	0.0	0.0
Equity securities - corporate securities	254.9	216.9
Trading securities	0.0	0.0
Fair value, measurements, recurring [Member] | Level 1 [Member] | US treasury and government [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	0.0	0.0
Trading securities	0.0	0.0
Fair value, measurements, recurring [Member] | Level 1 [Member] | States and political subdivisions [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	0.0	0.0
Fair value, measurements, recurring [Member] | Level 1 [Member] | Debt securities issued by foreign governments [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	0.0	0.0
Fair value, measurements, recurring [Member] | Level 1 [Member] | Asset-backed securities [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	0.0	0.0
Trading securities	0.0	0.0
Fair value, measurements, recurring [Member] | Level 1 [Member] | Collateralized debt obligations [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	0.0	0.0
Trading securities	0.0
Fair value, measurements, recurring [Member] | Level 1 [Member] | Commercial mortgage-backed securities [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	0.0	0.0
Trading securities	0.0	0.0
Fair value, measurements, recurring [Member] | Level 1 [Member] | Mortgage pass-through securities [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	0.0	0.0
Trading securities		0.0
Fair value, measurements, recurring [Member] | Level 1 [Member] | Collateralized mortgage obligations [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	0.0	0.0
Trading securities	0.0	0.0
Fair value, measurements, recurring [Member] | Level 1 [Member] | Total fixed maturities, available for sale [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	0.0	0.0
Fair value, measurements, recurring [Member] | Level 1 [Member] | Equity securities [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Trading securities	4.9	3.5
Fair value, measurements, recurring [Member] | Level 2 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Trading securities	217.3	212.8
Investments held by variable interest entities - corporate securities	1,633.6	1,367.1
Assets held in separate accounts	4.7	5.6
Total assets carried at fair value by category	21,748.1	22,039.5
Fair value, measurements, recurring [Member] | Level 2 [Member] | Derivatives [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Other invested assets - derivatives	41.0	107.2
Fair value, measurements, recurring [Member] | Level 2 [Member] | Embedded derivatives associated with fixed index annuity products [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total liabilities for insurance products	0.0	0.0
Fair value, measurements, recurring [Member] | Level 2 [Member] | Corporate securities [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	12,698.1	13,605.1
Equity securities - corporate securities	176.1	174.1
Trading securities	21.5	24.3
Fair value, measurements, recurring [Member] | Level 2 [Member] | US treasury and government [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	194.5	168.9
Trading securities	1.9	3.7
Fair value, measurements, recurring [Member] | Level 2 [Member] | States and political subdivisions [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	2,104.2	2,242.2
Fair value, measurements, recurring [Member] | Level 2 [Member] | Debt securities issued by foreign governments [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	20.7	1.9
Fair value, measurements, recurring [Member] | Level 2 [Member] | Asset-backed securities [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	1,816.3	1,209.8
Trading securities	35.5	24.0
Fair value, measurements, recurring [Member] | Level 2 [Member] | Collateralized debt obligations [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	186.7	324.5
Trading securities	2.1
Fair value, measurements, recurring [Member] | Level 2 [Member] | Commercial mortgage-backed securities [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	1,604.2	1,275.1
Trading securities	118.1	131.0
Fair value, measurements, recurring [Member] | Level 2 [Member] | Mortgage pass-through securities [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	3.3	4.2
Trading securities		0.1
Fair value, measurements, recurring [Member] | Level 2 [Member] | Collateralized mortgage obligations [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	1,047.4	1,341.0
Trading securities	38.2	29.7
Fair value, measurements, recurring [Member] | Level 2 [Member] | Total fixed maturities, available for sale [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	19,675.4	20,172.7
Fair value, measurements, recurring [Member] | Level 2 [Member] | Equity securities [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Trading securities	0.0	0.0
Fair value, measurements, recurring [Member] | Level 3 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Trading securities	39.9	28.6
Investments held by variable interest entities - corporate securities	0.0	0.0
Assets held in separate accounts	0.0	0.0
Total assets carried at fair value by category	279.4	518.8
Fair value, measurements, recurring [Member] | Level 3 [Member] | Derivatives [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Other invested assets - derivatives	0.0	0.0
Fair value, measurements, recurring [Member] | Level 3 [Member] | Embedded derivatives associated with fixed index annuity products [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total liabilities for insurance products	1,057.1	1,081.5
Fair value, measurements, recurring [Member] | Level 3 [Member] | Corporate securities [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	170.4	365.9
Equity securities - corporate securities	32.0	28.0
Trading securities	0.0	0.0
Fair value, measurements, recurring [Member] | Level 3 [Member] | US treasury and government [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	0.0	0.0
Trading securities	0.0	0.0
Fair value, measurements, recurring [Member] | Level 3 [Member] | States and political subdivisions [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	0.0	35.5
Fair value, measurements, recurring [Member] | Level 3 [Member] | Debt securities issued by foreign governments [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	0.0	0.0
Fair value, measurements, recurring [Member] | Level 3 [Member] | Asset-backed securities [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	35.9	59.2
Trading securities	0.0	0.0
Fair value, measurements, recurring [Member] | Level 3 [Member] | Collateralized debt obligations [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	0.0	0.0
Trading securities	0.0
Fair value, measurements, recurring [Member] | Level 3 [Member] | Commercial mortgage-backed securities [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	1.1	1.2
Trading securities	39.9	28.6
Fair value, measurements, recurring [Member] | Level 3 [Member] | Mortgage pass-through securities [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	0.1	0.4
Trading securities		0.0
Fair value, measurements, recurring [Member] | Level 3 [Member] | Collateralized mortgage obligations [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	0.0	0.0
Trading securities	0.0	0.0
Fair value, measurements, recurring [Member] | Level 3 [Member] | Total fixed maturities, available for sale [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total fixed maturities, available for sale	207.5	462.2
Fair value, measurements, recurring [Member] | Level 3 [Member] | Equity securities [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Trading securities	$ 0.0	$ 0.0

XML

FAIR VALUE MEASUREMENTS (FAIR VALUE MEASUREMENTS OF FINANCIAL INSTRUMENTS MEASURED ON A RECURRING BASIS - FINANCIAL INSTRUMENTS) (Details) - USD ($) $ in Millions	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents - unrestricted	$ 432.3	$ 611.6	$ 699.0	$ 582.5
Cash and cash equivalents - held by variable interest entities	364.4	68.3
Fair value, measurements, recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Mortgage loans	1,721.0	1,691.9
Policy loans	109.4	106.9
Company-owned life insurance	158.1	157.6
Cash and cash equivalents - unrestricted	432.3	611.6
Cash and cash equivalents - held by variable interest entities	364.4	68.3
Policyholder account balances	10,762.3	10,707.2
Investment borrowings	1,548.1	1,519.2
Borrowings related to variable interest entities	1,676.4	1,271.9
Notes payable – direct corporate obligations	911.1	780.3
Fair value, measurements, recurring [Member] | Estimate of fair value measurement [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Mortgage loans	1,772.4	1,768.9
Policy loans	109.4	106.9
Company-owned life insurance	158.1	157.6
Cash and cash equivalents - unrestricted	432.3	611.6
Cash and cash equivalents - held by variable interest entities	364.4	68.3
Policyholder account balances	10,762.3	10,707.2
Investment borrowings	1,549.8	1,520.4
Borrowings related to variable interest entities	1,673.6	1,229.2
Notes payable – direct corporate obligations	937.8	807.4
Fair value, measurements, recurring [Member] | Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Mortgage loans	0.0	0.0
Policy loans	0.0	0.0
Company-owned life insurance	0.0	0.0
Cash and cash equivalents - unrestricted	432.3	549.6
Cash and cash equivalents - held by variable interest entities	364.4	68.3
Policyholder account balances	0.0	0.0
Investment borrowings	0.0	0.0
Borrowings related to variable interest entities	0.0	0.0
Notes payable – direct corporate obligations	0.0	0.0
Fair value, measurements, recurring [Member] | Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Mortgage loans	0.0	0.0
Policy loans	0.0	0.0
Company-owned life insurance	158.1	157.6
Cash and cash equivalents - unrestricted	0.0	62.0
Cash and cash equivalents - held by variable interest entities	0.0	0.0
Policyholder account balances	0.0	0.0
Investment borrowings	1,549.8	1,520.4
Borrowings related to variable interest entities	1,673.6	1,229.2
Notes payable – direct corporate obligations	937.8	807.4
Fair value, measurements, recurring [Member] | Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Mortgage loans	1,772.4	1,768.9
Policy loans	109.4	106.9
Company-owned life insurance	0.0	0.0
Cash and cash equivalents - unrestricted	0.0	0.0
Cash and cash equivalents - held by variable interest entities	0.0	0.0
Policyholder account balances	10,762.3	10,707.2
Investment borrowings	0.0	0.0
Borrowings related to variable interest entities	0.0	0.0
Notes payable – direct corporate obligations	$ 0.0	$ 0.0

XML

FAIR VALUE MEASUREMENTS (FAIR VALUE ASSETS AND LIABILITIES MEASURED ON A RECURRING BASIS, UNOBSERVABLE INPUT RECONCILIATION) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Liabilities:
Beginning balance	$ (1,081.5)	$ (905.5)
Purchases, sales, issuances and settlements, net		(102.5)
Total realized and unrealized gains (losses) included in net income		(73.5)
Total realized and unrealized gains (losses) included in accumulated other comprehensive income (loss)		0.0
Transfers into level 3		0.0
Transfers out of level 3		0.0
Assets of CLIC sold		0.0
Ending balance		(1,081.5)
Amount of total gains (losses) for the year included in our net income related to liabilities still held as of the reporting date		(73.5)
Future policy benefits - embedded derivatives associated with fixed index annuity products [Member]
Liabilities:
Beginning balance	(1,081.5)	(903.7)
Purchases, sales, issuances and settlements, net	(11.9)	(104.3)
Total realized and unrealized gains (losses) included in net income	36.3	(73.5)
Total realized and unrealized gains (losses) included in accumulated other comprehensive income (loss)	0.0	0.0
Transfers into level 3	0.0	0.0
Transfers out of level 3	0.0	0.0
Assets of CLIC sold		0.0
Ending balance	(1,057.1)	(1,081.5)
Amount of total gains (losses) for the year included in our net income related to liabilities still held as of the reporting date	36.3	(73.5)
Other liabilities - embedded derivatives associated with modified coinsurance agreement [Member]
Liabilities:
Beginning balance	0.0	(1.8)
Purchases, sales, issuances and settlements, net		1.8
Total realized and unrealized gains (losses) included in net income		0.0
Total realized and unrealized gains (losses) included in accumulated other comprehensive income (loss)		0.0
Transfers into level 3		0.0
Transfers out of level 3		0.0
Assets of CLIC sold		0.0
Ending balance		0.0
Amount of total gains (losses) for the year included in our net income related to liabilities still held as of the reporting date		0.0
Corporate securities [Member]
Assets:
Beginning balance	365.9	359.6
Purchases, sales, issuances and settlements, net	31.0	70.0
Total realized and unrealized gains (losses) included in net income	(2.2)	0.0
Total realized and unrealized gains (losses) included in accumulated other comprehensive income (loss)	(19.5)	20.1
Transfers into level 3	37.4	36.8
Transfers out of level 3	(242.2)	(69.4)
Assets of CLIC sold		(51.2)
Ending balance	170.4	365.9
Amount of total gains (losses) for the year included in our net income relating to assets still held as of the reporting date	0.0	0.0
States and political subdivisions [Member]
Assets:
Beginning balance	35.5	0.0
Purchases, sales, issuances and settlements, net	(35.5)	(1.8)
Total realized and unrealized gains (losses) included in net income	0.0	0.0
Total realized and unrealized gains (losses) included in accumulated other comprehensive income (loss)	0.0	3.0
Transfers into level 3	0.0	36.5
Transfers out of level 3	0.0	0.0
Assets of CLIC sold		(2.2)
Ending balance	0.0	35.5
Amount of total gains (losses) for the year included in our net income relating to assets still held as of the reporting date	0.0	0.0
Asset-backed securities [Member]
Assets:
Beginning balance	59.2	42.2
Purchases, sales, issuances and settlements, net	6.7	7.6
Total realized and unrealized gains (losses) included in net income	0.0	0.0
Total realized and unrealized gains (losses) included in accumulated other comprehensive income (loss)	(1.4)	5.1
Transfers into level 3	0.0	14.0
Transfers out of level 3	(28.6)	0.0
Assets of CLIC sold		(9.7)
Ending balance	35.9	59.2
Amount of total gains (losses) for the year included in our net income relating to assets still held as of the reporting date	0.0	0.0
Collateralized debt obligations [Member]
Assets:
Beginning balance	0.0	246.7
Purchases, sales, issuances and settlements, net		0.0
Total realized and unrealized gains (losses) included in net income		0.0
Total realized and unrealized gains (losses) included in accumulated other comprehensive income (loss)		0.0
Transfers into level 3		0.0
Transfers out of level 3		(246.7)
Assets of CLIC sold		0.0
Ending balance		0.0
Amount of total gains (losses) for the year included in our net income relating to assets still held as of the reporting date		0.0
Commercial mortgage-backed securities [Member]
Assets:
Beginning balance	1.2	0.0
Purchases, sales, issuances and settlements, net	(0.1)	1.1
Total realized and unrealized gains (losses) included in net income	0.0	0.0
Total realized and unrealized gains (losses) included in accumulated other comprehensive income (loss)	0.0	0.1
Transfers into level 3	0.0	0.0
Transfers out of level 3	0.0	0.0
Assets of CLIC sold		0.0
Ending balance	1.1	1.2
Amount of total gains (losses) for the year included in our net income relating to assets still held as of the reporting date	0.0	0.0
Mortgage pass-through securities [Member]
Assets:
Beginning balance	0.4	1.6
Purchases, sales, issuances and settlements, net	(0.3)	(1.2)
Total realized and unrealized gains (losses) included in net income	0.0	0.0
Total realized and unrealized gains (losses) included in accumulated other comprehensive income (loss)	0.0	0.0
Transfers into level 3	0.0	0.0
Transfers out of level 3	0.0	0.0
Assets of CLIC sold		0.0
Ending balance	0.1	0.4
Amount of total gains (losses) for the year included in our net income relating to assets still held as of the reporting date	0.0	0.0
Total fixed maturities, available for sale [Member]
Assets:
Beginning balance	462.2	650.1
Purchases, sales, issuances and settlements, net	1.8	75.7
Total realized and unrealized gains (losses) included in net income	(2.2)	0.0
Total realized and unrealized gains (losses) included in accumulated other comprehensive income (loss)	(20.9)	28.3
Transfers into level 3	37.4	87.3
Transfers out of level 3	(270.8)	(316.1)
Assets of CLIC sold		(63.1)
Ending balance	207.5	462.2
Amount of total gains (losses) for the year included in our net income relating to assets still held as of the reporting date	0.0	0.0
Equity securities - corporate securities [Member]
Assets:
Beginning balance	28.0	24.5
Purchases, sales, issuances and settlements, net	4.0	3.5
Total realized and unrealized gains (losses) included in net income	0.0	0.0
Total realized and unrealized gains (losses) included in accumulated other comprehensive income (loss)	0.0	0.0
Transfers into level 3	0.0	0.0
Transfers out of level 3	0.0	0.0
Assets of CLIC sold		0.0
Ending balance	32.0	28.0
Amount of total gains (losses) for the year included in our net income relating to assets still held as of the reporting date	0.0	0.0
Trading securities - commercial mortgage-backed securities [Member]
Assets:
Beginning balance	28.6	0.0
Purchases, sales, issuances and settlements, net	9.5	29.0
Total realized and unrealized gains (losses) included in net income	0.0	0.0
Total realized and unrealized gains (losses) included in accumulated other comprehensive income (loss)	1.8	(0.4)
Transfers into level 3	0.0	0.0
Transfers out of level 3	0.0	0.0
Assets of CLIC sold		0.0
Ending balance	39.9	28.6
Amount of total gains (losses) for the year included in our net income relating to assets still held as of the reporting date	$ 1.8	$ (0.4)

XML

FAIR VALUE MEASUREMENTS (FAIR VALUE ASSETS AND LIABILITIES MEASURED ON A RECURRING BASIS, UNOBSERVABLE INPUT RECONCILIATION - ACTIVITY) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Liabilities:
Purchases		$ (121.9)
Sales		10.9
Issuances		(47.5)
Settlements		56.0
Purchases, sales, issuances and settlements, net		(102.5)
Future policy benefits - embedded derivatives associated with fixed index annuity products [Member]
Liabilities:
Purchases	$ (137.8)	(121.9)
Sales	64.4	7.5
Issuances	(4.0)	(45.9)
Settlements	65.5	56.0
Purchases, sales, issuances and settlements, net	(11.9)	(104.3)
Other liabilities - embedded derivatives associated with modified coinsurance agreement [Member]
Liabilities:
Purchases		0.0
Sales		3.4
Issuances		(1.6)
Settlements		0.0
Purchases, sales, issuances and settlements, net		1.8
Corporate securities [Member]
Assets:
Purchases	62.2	71.7
Sales	(31.2)	(1.7)
Issuances	0.0	0.0
Settlements	0.0	0.0
Purchases, sales, issuances and settlements, net	31.0	70.0
States and political subdivisions [Member]
Assets:
Purchases	0.0	0.0
Sales	(35.5)	(1.8)
Issuances	0.0	0.0
Settlements	0.0	0.0
Purchases, sales, issuances and settlements, net	(35.5)	(1.8)
Asset-backed securities [Member]
Assets:
Purchases	13.7	9.9
Sales	(7.0)	(2.3)
Issuances	0.0	0.0
Settlements	0.0	0.0
Purchases, sales, issuances and settlements, net	6.7	7.6
Collateralized debt obligations [Member]
Assets:
Purchases, sales, issuances and settlements, net		0.0
Commercial mortgage-backed securities [Member]
Assets:
Purchases	0.0	1.1
Sales	(0.1)	0.0
Issuances	0.0	0.0
Settlements	0.0	0.0
Purchases, sales, issuances and settlements, net	(0.1)	1.1
Mortgage pass-through securities [Member]
Assets:
Purchases	0.0	1.1
Sales	(0.3)	(2.3)
Issuances	0.0	0.0
Settlements	0.0	0.0
Purchases, sales, issuances and settlements, net	(0.3)	(1.2)
Total fixed maturities, available for sale [Member]
Assets:
Purchases	75.9	83.8
Sales	(74.1)	(8.1)
Issuances	0.0	0.0
Settlements	0.0	0.0
Purchases, sales, issuances and settlements, net	1.8	75.7
Equity securities - corporate securities [Member]
Assets:
Purchases	4.0	3.5
Sales	0.0	0.0
Issuances	0.0	0.0
Settlements	0.0	0.0
Purchases, sales, issuances and settlements, net	4.0	3.5
Trading securities - commercial mortgage-backed securities [Member]
Assets:
Purchases	9.5	29.0
Sales	0.0	0.0
Issuances	0.0	0.0
Settlements	0.0	0.0
Purchases, sales, issuances and settlements, net	$ 9.5	$ 29.0

XML

FAIR VALUE MEASUREMENTS (FAIR VALUE INPUTS) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Investments	$ 24,487.1	$ 24,908.3
Other invested assets	415.1	443.6
Policyholder account balances	10,762.3	10,707.2
Level 3 [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Investments	279.4	518.8
Other invested assets	148.3	148.1
Policyholder account balances	$ 1,057.1	$ 1,081.5
Level 3 [Member] | Interest sensitive products [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Weighted average projected portfolio yields	5.42%	5.42%
Weighted average discount rates	1.94%	1.78%
Weighted average surrender rates	14.09%	14.16%
Level 3 [Member] | Interest sensitive products [Member] | Minimum [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Projected Portfolio Yields	5.15%	5.15%
Discount rates	0.00%	0.00%
Surrender rates	1.67%	1.98%
Level 3 [Member] | Interest sensitive products [Member] | Maximum [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Projected Portfolio Yields	5.61%	5.61%
Discount rates	3.18%	2.74%
Surrender rates	46.56%	47.88%
Level 3 [Member] | Corporate securities [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Investments	$ 76.9	$ 312.1
Weighted average discount rate	5.35%	2.58%
Level 3 [Member] | Corporate securities [Member] | Minimum [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Discount rate	1.65%	1.48%
Level 3 [Member] | Corporate securities [Member] | Maximum [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Discount rate	9.74%	5.83%
Level 3 [Member] | Asset-backed securities [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Investments	$ 22.2	$ 30.6
Weighted average discount rate	3.50%	2.95%
Level 3 [Member] | Asset-backed securities [Member] | Minimum [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Discount rate	2.83%	1.99%
Level 3 [Member] | Asset-backed securities [Member] | Maximum [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Discount rate	4.45%	4.15%
Level 3 [Member] | Equity securities [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Investments	$ 32.0	$ 28.0

XML

LIABILITIES FOR INSURANCE PRODUCTS (SCHEDULE OF INSURANCE LIABILITIES BY PRODUCT SEGMENT) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Liability for Future Policy Benefit, by Product Segment [Line Items]
Future policy benefits	$ 10,602.1	$ 10,835.4
Policyholder account balance	$ 10,762.3	10,707.2
Long-term Care [Member]
Liability for Future Policy Benefit, by Product Segment [Line Items]
Interest rate assumption	6.00%
Future policy benefits	$ 5,172.2	5,385.2
Traditional Life Insurance Contracts [Member]
Liability for Future Policy Benefit, by Product Segment [Line Items]
Interest rate assumption	5.00%
Future policy benefits	$ 2,248.7	2,175.8
Accident and Health Contract [Member]
Liability for Future Policy Benefit, by Product Segment [Line Items]
Interest rate assumption	5.00%
Future policy benefits	$ 2,589.9	2,519.1
Interest-sensitive Life Insurance Contract [Member]
Liability for Future Policy Benefit, by Product Segment [Line Items]
Interest rate assumption	4.00%
Future policy benefits	$ 44.7	47.6
Policyholder account balance	$ 992.8	929.5
Annuities and Supplemental Contract with Life Contingencies [Member]
Liability for Future Policy Benefit, by Product Segment [Line Items]
Interest rate assumption	4.00%
Future policy benefits	$ 546.6	707.7
Fixed Index Annuity [Member]
Liability for Future Policy Benefit, by Product Segment [Line Items]
Policyholder account balance	4,884.4	4,496.9
Other Annuity [Member]
Liability for Future Policy Benefit, by Product Segment [Line Items]
Policyholder account balance	$ 4,885.1	$ 5,280.8

XML

LIABILITIES FOR INSURANCE PRODUCTS (SUMMARY OF LIABILITIES FOR UNPAID CLAIMS ADJUSTMENT EXPENSE) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]
Less reinsurance receivables	$ (2,991.1)
Paid claims related to:
Add reinsurance receivables	2,859.3	$ 2,991.1
Accident and Health Insurance Product Line [Member]
Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]
Balance, beginning of year	1,679.5	1,710.1	$ 1,679.3
Less reinsurance receivables	(125.0)	(164.1)	(27.4)
Net balance, beginning of year	1,554.5	1,546.0	1,651.9
Incurred claims related to:
Current year	1,481.0	1,468.1	1,511.1
Prior years	(13.3)	(39.9)	(162.3)
Total incurred	1,467.7	1,428.2	1,348.8
Interest on claim reserves	71.0	70.5	75.2
Paid claims related to:
Current year	841.8	848.7	870.0
Prior years	649.6	641.5	659.9
Total paid	1,491.4	1,490.2	1,529.9
Net balance, end of year	1,601.8	1,554.5	1,546.0
Add reinsurance receivables	130.0	125.0	164.1
Balance, end of year	$ 1,731.8	$ 1,679.5	$ 1,710.1

XML

INCOME TAXES (NARRATIVE) (Details) - USD ($) $ in Millions		12 Months Ended
	May. 08, 2013	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2008	Dec. 31, 2012	May. 11, 2010	Jan. 20, 2009
Operating Loss Carryforwards [Line Items]
Deferred tax assets more likely than not to be realized through future taxable earnings		$ 946.6	$ 799.8
Deferred tax assets		1,160.1	1,045.8
Valuation allowance		$ 213.5	246.0	$ 294.8		$ 766.9
Period adjusted average annual taxable income to remain flat		2 years
Aggregate growth rate for the next five years		3.00%
Forecast period of model		5 years
Estimated normalized annual taxable income for current year		$ 345.0
Estimated normalized annual taxable income for current year, non-life taxable income		75.0
Estimated normalized annual taxable income for current year, life income		270.0
Increase (decrease) in valuation allowance		$ (32.5)	(48.8)	(472.1)
Loss limitation based on income of life insurance company, percent		35.00%
Loss limitation based on loss of non-life entities, percent		35.00%
Federal long-term tax exempt rate		2.61%
Ownership change threshold restricting NOL usage		50.00%
Ownership percentage threshold relating to company 382 securities								4.99%
Ownership percentage threshold relating to company 382 provision, ownership percentage at which transfers of common stock become void (less than)	4.99%						5.00%
Section 382 Charter amendment, extension term	3 years
Capital loss carryforward		$ 39.4
Unrecognized tax benefits that would impact effective tax rate		155.4	155.4
Unrecognized tax benefits, income tax penalties and interest accrued		3.2	2.4
Net state operating loss carryforwards		14.1	$ 15.2
Loss on investment in senior health					$ 878.0
Amount of capital loss carryforwards that will be expired if IRS position is correct				$ 473.0
Unrecognized tax benefit related to loss on investment in Senior Health		166.0
Increase in valuation allowance if unrecognized tax benefit is recognized		$ 34.0
Future cash tax payments as a percent of life insurance, taxable income due		65.00%
NOL carryforwards related to the deductions for stock options and restricted stock		$ 13.9
Internal Revenue Service (IRS) [Member]
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards		2,600.0
Life [Member]
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards		538.3
Loss on investment in senior health					742.0
Non-life [Member]
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards		$ 2,620.1
Loss on investment in senior health					$ 136.0

XML

INCOME TAXES (SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE) (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Income Tax Disclosure [Abstract]
Current tax expense									$ 10.7	$ 15.6	$ 8.2
Deferred tax expense									118.6	143.6	120.1
Tax expense on period income									129.3	159.2	128.3
Tax expense related to the sale									0.0	14.2	0.0
Deferred taxes on expired capital loss carryforwards									0.0	0.0	159.4
Change in valuation allowance									(32.5)	(48.8)	(472.1)
Other items									0.2	(0.9)	11.2
Total income tax expense (benefit)	$ 23.0	$ 18.6	$ 25.9	$ 29.5	$ (8.0)	$ 37.0	$ 36.3	$ 58.4	$ 97.0	$ 123.7	$ (173.2)

XML

INCOME TAXES (SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILLIATION) (Details)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Income Tax Disclosure [Abstract]
U.S. statutory corporate rate	35.00%	35.00%	35.00%
Valuation allowance	(8.80%)	(27.90%)	(154.90%)
Expired capital loss carryforwards (which were fully offset by a corresponding reduction in the valuation allowance)	0.00%	0.00%	52.30%
Non-taxable income and nondeductible benefits, net	(0.20%)	(0.90%)	5.00%
State taxes	2.10%	1.50%	1.90%
Impact of the sale of CLIC	0.00%	66.30%	0.00%
Other items	(1.70%)	(3.40%)	3.90%
Effective tax rate	26.40%	70.60%	(56.80%)

XML

INCOME TAXES (SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES) (Details) - USD ($) $ in Millions	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Deferred tax assets:
Net federal operating loss carryforwards	$ 916.3	$ 1,048.4
Net state operating loss carryforwards	14.1	15.2
Tax credits	55.3	47.2
Capital loss carryforwards	13.8	0.0
Investments	26.5	59.7
Insurance liabilities	600.3	585.9
Other	63.0	67.3
Gross deferred tax assets	1,689.3	1,823.7
Deferred tax liabilities:
Present value of future profits and deferred acquisition costs	(305.4)	(320.5)
Accumulated other comprehensive income	(223.8)	(457.4)
Gross deferred tax liabilities	(529.2)	(777.9)
Net deferred tax assets before valuation allowance	1,160.1	1,045.8
Valuation allowance	(213.5)	(246.0)	$ (294.8)	$ (766.9)
Net deferred tax assets	946.6	799.8
Current income taxes accrued	(47.8)	(41.1)
Income tax assets, net	$ 898.8	$ 758.7

XML

INCOME TAXES (SUMMARY OF VALUATION ALLOWANCE) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Increase (Decrease) in Valuation Allowance [Roll Forward]
Beginning valuation allowance	$ 246.0	$ 294.8	$ 766.9
Change in valuation allowance	(32.5)	(48.8)	(472.1)
Ending valuation allowance	$ 213.5	$ 246.0	$ 294.8

XML

INCOME TAXES (SUMMARY OF OPERATING LOSS CARRYFORWARDS) (Details) $ in Millions	12 Months Ended
	Dec. 31, 2015 USD ($)
Operating Loss Carryforwards [Line Items]
Total loss carryforwards	$ 3,158.4
Total loss carryforwards, unrecognized tax benefit	(540.3)
Total loss carryforwards, net of unrecognized tax benefits	2,618.1
Life [Member]
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	538.3
Net operating loss carryforward, unrecognized tax benefit	(342.9)
Net operating loss carryforwards, net of unrecognized tax benefits	195.4
Non-life [Member]
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	2,620.1
Net operating loss carryforward, unrecognized tax benefit	(197.4)
Net operating loss carryforwards, net of unrecognized tax benefits	$ 2,422.7
2023 [Member]
Operating Loss Carryforwards [Line Items]
Year of expiration	Dec. 31, 2023
Total loss carryforwards	$ 2,460.3
2023 [Member] | Life [Member]
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	538.3
2023 [Member] | Non-life [Member]
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	$ 1,922.0
2025 [Member]
Operating Loss Carryforwards [Line Items]
Year of expiration	Dec. 31, 2025
Total loss carryforwards	$ 91.5
2025 [Member] | Life [Member]
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	0.0
2025 [Member] | Non-life [Member]
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	$ 91.5
2026 [Member]
Operating Loss Carryforwards [Line Items]
Year of expiration	Dec. 31, 2026
Total loss carryforwards	$ 207.4
2026 [Member] | Life [Member]
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	0.0
2026 [Member] | Non-life [Member]
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	$ 207.4
2027 [Member]
Operating Loss Carryforwards [Line Items]
Year of expiration	Dec. 31, 2027
Total loss carryforwards	$ 4.9
2027 [Member] | Life [Member]
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	0.0
2027 [Member] | Non-life [Member]
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	$ 4.9
2028 [Member]
Operating Loss Carryforwards [Line Items]
Year of expiration	Dec. 31, 2028
Total loss carryforwards	$ 203.7
2028 [Member] | Life [Member]
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	0.0
2028 [Member] | Non-life [Member]
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	$ 203.7
2029 [Member]
Operating Loss Carryforwards [Line Items]
Year of expiration	Dec. 31, 2029
Total loss carryforwards	$ 146.6
2029 [Member] | Life [Member]
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	0.0
2029 [Member] | Non-life [Member]
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	$ 146.6
2032 [Member]
Operating Loss Carryforwards [Line Items]
Year of expiration	Dec. 31, 2032
Total loss carryforwards	$ 44.0
2032 [Member] | Life [Member]
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	0.0
2032 [Member] | Non-life [Member]
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	$ 44.0

XML

INCOME TAXES (RECONCILIATION OF UNRECOGNIZED TAX BENEFITS) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Balance at beginning of year	$ 228.7	$ 226.7
Increase based on tax positions taken in prior years	5.5	10.9
Decrease based on tax positions taken in prior years	0.0	0.0
Increase based on tax positions taken in the current year	0.0	0.0
Decrease in unrecognized tax benefits related to settlements with taxing authorities	0.0	(8.9)
Balance at end of year	$ 234.2	$ 228.7

XML

NOTES PAYABLE - DIRECT CORPORATE OBLIGATIONS (SCHEDULE OF LONG-TERM DEBT INSTRUMENTS) (Details) - USD ($) $ in Millions	Dec. 31, 2015	May. 19, 2015	Dec. 31, 2014	Sep. 28, 2012
Debt Instrument [Line Items]
Long-term debt	$ 911.1		$ 780.3
Unamortized debt issue costs	(13.9)		(14.1)
Senior Secured Credit Agreement [Member]
Debt Instrument [Line Items]
Long-term debt	0.0		522.1
Unamortized discount on Previous Senior Secured Credit Agreement	0.0		(2.7)
Senior Notes [Member] | Senior Note 4.500 Percent [Member]
Debt Instrument [Line Items]
Long-term debt	325.0		0.0
Interest rate		4.50%
Senior Notes [Member] | Senior Note 5.250 Percent [Member]
Debt Instrument [Line Items]
Long-term debt	500.0		0.0
Interest rate		5.25%
Senior Notes [Member] | Senior Secured Note 6.375 Percent [Member]
Debt Instrument [Line Items]
Long-term debt	0.0		275.0
Interest rate				6.375%
Line of Credit [Member] | Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Long-term debt	$ 100.0		$ 0.0

XML

NOTES PAYABLE - DIRECT CORPORATE OBLIGATIONS (NEW NOTES) (NARRATIVE) (Details) - USD ($)	May. 19, 2015	Sep. 28, 2012
Senior Notes [Member] | Senior Note 4.500 Percent [Member]
Debt Instrument [Line Items]
Aggregate principal amount	$ 325,000,000
Interest rate	4.50%
Senior Notes [Member] | Senior Note 5.250 Percent [Member]
Debt Instrument [Line Items]
Aggregate principal amount	$ 500,000,000
Interest rate	5.25%
Senior Notes [Member] | Senior Note 5.250 Percent [Member] | On and After February 28, 2025 [Member]
Debt Instrument [Line Items]
Redemption price, percent	100.00%
Senior Notes [Member] | Senior Note 5.250 Percent [Member] | Change of Control Repurchase Event [Member]
Debt Instrument [Line Items]
Redemption price, percent	101.00%
Senior Notes [Member] | Senior Secured Note 6.375 Percent [Member]
Debt Instrument [Line Items]
Interest rate		6.375%
Line of Credit [Member] | Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Maximum borrowing capacity	$ 150,000,000
Debt instrument, term	4 years

XML

NOTES PAYABLE - DIRECT CORPORATE OBLIGATIONS (NEW REVOLVING CREDIT AGREEMENT) (NARRATIVE) (Details) - Line of Credit [Member] - USD ($)	May. 19, 2015	Dec. 31, 2015
Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Initial drawing amount	$ 100,000,000
Remaining borrowing capacity	50,000,000
Maximum borrowing capacity	150,000,000
Potential additional borrowing capacity	$ 50,000,000.0
Interest rate on amounts outstanding at period end		2.42%
Fronting fee as a percent of aggregate face amount of letters of credit outstanding	0.125%
Debt covenant, required minimum debt to total capitalization ratio	30.00%
Debt covenant, actual debt to total capitalization ratio at period end		19.90%
Debt covenant, minimum required aggregate total adjusted capital to company action level risk-based capital ratio	250.00%
Debt covenant, actual aggregate total adjusted capital to company action level risk-based capital ratio at period end		449.00%
Debt covenant, minimum required consolidated net worth, component one, amount	$ 2,674,000,000
Debt covenant, minimum required consolidated net worth, component two, as a percent of net equity proceeds received from issuance and sale of equity interests	50.00%
Debt covenant, actual consolidated net worth at period end		$ 3,735,700,000
Debt covenant, required minimum consolidated net worth, amount		$ 2,677,000,000
Revolving Credit Facility [Member] | Federal Funds Rate [Member]
Debt Instrument [Line Items]
Basis spread on variable rate	0.50%
Revolving Credit Facility [Member] | One-Month Eurodollar [Member]
Debt Instrument [Line Items]
Basis spread on variable rate	1.00%
Revolving Credit Facility [Member] | Eurodollar [Member]
Debt Instrument [Line Items]
Basis spread on variable rate	2.00%
Bridge Loan [Member]
Debt Instrument [Line Items]
Maximum borrowing capacity	$ 5,000,000.0
Letter of Credit [Member]
Debt Instrument [Line Items]
Maximum borrowing capacity	$ 5,000,000.0

XML

NOTES PAYABLE - DIRECT CORPORATE OBLIGATIONS (PREVIOUS SENIOR SECURED CREDIT AGREEMENT) (NARRATIVE) (Details)				6 Months Ended		12 Months Ended
	May. 19, 2015 USD ($)	May. 30, 2014 USD ($)	Sep. 28, 2012 USD ($)	Dec. 31, 2013 USD ($)	Jun. 30, 2013 USD ($)	Dec. 31, 2015 USD ($) Rate	Dec. 31, 2014 USD ($)	Dec. 31, 2013 USD ($)
Debt Instrument [Line Items]
Amount outstanding prior to repayment						$ 925,000,000
Secured Debt [Member] | Conseco Life Insurance Company [Member]
Debt Instrument [Line Items]
Proceeds threshold before excess is used to prepay amounts outstanding under Previous Senior Secured Credit Agreement		$ 125,000,000
Line of Credit [Member] | Secured Debt [Member] | Term Loan Facility, Six-Year [Member]
Debt Instrument [Line Items]
Debt instrument, term			6 years
Amount outstanding prior to repayment							$ 389,800,000
Annual amortization percentage of loan on first and second year			1.00%
Line of Credit [Member] | Secured Debt [Member] | Term Loan Facility, Six-Year [Member] | Eurodollar [Member]
Debt Instrument [Line Items]
Interest rate on amounts outstanding at period end							3.75%
Line of Credit [Member] | Secured Debt [Member] | Term Loan Facility, Four-Year [Member]
Debt Instrument [Line Items]
Debt instrument, term			4 years
Amount outstanding prior to repayment							$ 112,500,000
Annual amortization percentage of loan on first and second year			20.00%
Annual amortization percentage of loan in third and fourth years			30.00%
Line of Credit [Member] | Secured Debt [Member] | Term Loan Facility, Four-Year [Member] | Eurodollar [Member]
Debt Instrument [Line Items]
Interest rate on amounts outstanding at period end							3.00%
Line of Credit [Member] | Secured Debt [Member] | Senior Secured Credit Agreement [Member]
Debt Instrument [Line Items]
Additional debt payment						$ 19,800,000	$ 59,400,000
Line of Credit [Member] | Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Debt instrument, term	4 years
Maximum borrowing capacity	$ 150,000,000
Interest rate on amounts outstanding at period end						2.42%
Debt covenant, debt to total capitalization ratio (less than) | Rate						19.90%
Line of Credit [Member] | Revolving Credit Facility [Member] | Revolving Credit Facility, Three Year [Member]
Debt Instrument [Line Items]
Debt instrument, term			3 years
Maximum borrowing capacity			$ 50,000,000
Notes Payable to Banks [Member] | Senior Secured Credit Agreement [Member]
Debt Instrument [Line Items]
Additional debt payment								$ 42,700,000
Mandatory prepayment amount				$ 0	$ 20,400,000
Debt covenant, debt to total capitalization ratio (less than)				0.2				0.2
Mandatory prepayment as a percent of share repurchases and common stock dividend payments					33.33%

XML

NOTES PAYABLE - DIRECT CORPORATE OBLIGATIONS (6.375% NOTES) (NARRATIVE) (Details) - USD ($)	Dec. 31, 2015	Dec. 31, 2014	Sep. 28, 2012
Debt Instrument [Line Items]
Notes payable – direct corporate obligations	$ 911,100,000	$ 780,300,000
Senior Notes [Member] | Senior Secured Note 6.375 Percent [Member]
Debt Instrument [Line Items]
Notes payable – direct corporate obligations			$ 275,000,000
Interest rate			6.375%

XML

NOTES PAYABLE - DIRECT CORPORATE OBLIGATIONS (SOURCES AND USES OF RECAPITALIZATION TRANSACTIONS) (Details) - USD ($) $ in Millions		12 Months Ended
	May. 19, 2015	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Debt Instrument [Line Items]
Sources of cash for debt refinancing	$ 925.0	$ 910.0	$ 0.0	$ 0.0
Repayments of notes payable		797.1	62.9	126.9
Accrued interest	4.3	$ 90.0	$ 81.7	$ 95.9
Debt issuance costs	16.0
General corporate purposes	109.6
Total uses	925.0
Senior Debt Obligations [Member]
Debt Instrument [Line Items]
Repayments of notes payable	502.3
Senior Secured Note 6.375 Percent [Member]
Debt Instrument [Line Items]
Repayments of notes payable	292.8
Senior Notes [Member]
Debt Instrument [Line Items]
Sources of cash for debt refinancing	825.0
Line of Credit [Member] | Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Sources of cash for debt refinancing	$ 100.0

XML

NOTES PAYABLE - DIRECT CORPORATE OBLIGATIONS (7.0% DEBENTURES) (NARRATIVE) (Details) shares in Thousands	3 Months Ended	12 Months Ended
	Sep. 30, 2012 USD ($)	Dec. 31, 2015 USD ($) shares	Dec. 31, 2014 USD ($) shares	Dec. 31, 2013 USD ($) shares	May. 30, 2014 USD ($)	Jul. 01, 2013 USD ($)	May. 31, 2013 USD ($)	Mar. 28, 2013 USD ($)	May. 31, 2010 USD ($)
Debt Instrument [Line Items]
Notes payable – direct corporate obligations		$ 911,100,000	$ 780,300,000
Convertible Subordinated Debt [Member]
Debt Instrument [Line Items]
Aggregate principal amount									$ 293,000,000.0
Interest rate		7.00%			7.00%				7.00%
Principle amount of debt repurchased					$ 3,500,000		$ 4,500,000
Debt repurchase price					$ 3,700,000		$ 9,400,000
Conversion rate for convertible senior debentures						184.3127
Par value of each convertible senior debenture						$ 1,000
Face amount of convertible debentures submitted for conversion						$ 25,700,000
Conversion of 7.0% debentures (in shares) | shares		0	0	4,739
Convertible Subordinated Debt [Member] | Notes Payable, Other Payables [Member]
Debt Instrument [Line Items]
Repayments of long-term debt	$ 355,100,000
Principle amount of debt repurchased				$ 63,800,000				$ 59,300,000
Debt repurchase price								$ 124,800,000
Convertible Subordinated Debt [Member] | Notes Payable, Other Payables [Member] | Paulson & Co. Inc. [Member]
Debt Instrument [Line Items]
Notes payable – direct corporate obligations	$ 200,000,000

XML

NOTES PAYABLE - DIRECT CORPORATE OBLIGATIONS (LOSS ON EXTINGUISHMENT OF DEBT) (NARRATIVE) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	May. 30, 2014	Sep. 28, 2012	May. 31, 2010
Debt Instrument [Line Items]
Loss on extinguishment or modification of debt	$ (32.8)	$ (0.6)	$ (65.4)
Extinguishment of beneficial conversion feature related to the repurchase of convertible debentures			(12.6)
Common stock and additional paid-in capital [Member]
Debt Instrument [Line Items]
Extinguishment of beneficial conversion feature related to the repurchase of convertible debentures			(12.6)
Senior Secured Credit Agreement [Member]
Debt Instrument [Line Items]
Loss on extinguishment or modification of debt			(2.9)
Convertible Subordinated Debt [Member]
Debt Instrument [Line Items]
Loss on extinguishment or modification of debt		(0.2)	$ (62.5)
Interest rate	7.00%			7.00%		7.00%
Secured Debt [Member] | Senior Secured Credit Agreement [Member]
Debt Instrument [Line Items]
Loss on extinguishment or modification of debt		$ (0.4)
Senior Notes [Member] | Senior Secured Note 6.375 Percent [Member]
Debt Instrument [Line Items]
Interest rate					6.375%

XML

NOTES PAYABLE - DIRECT CORPORATE OBLIGATIONS (SCHEDULE OF MATURITIES OF LONG-TERM DEBT) (Details) $ in Millions	Dec. 31, 2015 USD ($)
Debt Disclosure [Abstract]
2016	$ 0.0
2017	0.0
2018	0.0
2019	100.0
2020	325.0
Thereafter	500.0
Long-term Debt	$ 925.0

XML

LITIGATION AND OTHER LEGAL PROCEEDINGS (NARRATIVE) (Details) $ in Millions	12 Months Ended
	Dec. 31, 2015 USD ($) state individual	Dec. 31, 2014 USD ($)	Dec. 31, 2013 USD ($)
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Number of states participating in examination of compliance with unclaimed property laws | state	38
Amount of insurance-related assessment liability	$ 24.0	$ 23.7
Premium tax offset for loss contingency accruals	26.1	23.6
Insurance-related assessment, expense recognized	1.2	1.1	$ 2.7
Operating leases and sponsorship agreements, expense	$ 48.8	50.4	$ 44.3
Former Chief Executive Officers [Member]
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Number of Company's former chief executive officers' retirement benefits guaranteed by subsidiaries | individual	2
Deferred compensation arrangement with individual, recorded liability	$ 25.8	$ 27.2

XML

LITIGATION AND OTHER LEGAL PROCEEDINGS (SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS FOR OPERATING LEASES) (Details) $ in Millions	Dec. 31, 2015 USD ($)
Commitments and Contingencies Disclosure [Abstract]
2016	$ 54.3
2017	33.2
2018	28.3
2019	17.2
2020	5.2
Thereafter	8.9
Total	$ 147.1

XML

AGENT DEFERRED COMPENSATION PLAN (NARRATIVE) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Cost recognized for defined contribution plan	$ 5.0	$ 5.1	$ 4.6
Agent Deferred Compensation Plan [Member]
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Pension and other postretirement defined benefit plans, liabilities	170.8	175.1
Net periodic benefit cost	2.2	36.3	(2.9)
Actuarial net gains (losses)	15.2	(24.3)	17.2
Company-owned life insurance	158.1	157.6
Change in value of corporate or bank owned life insurance	$ 0.5	$ 5.7	$ 19.7
Rate of compensation increase	4.00%
Required service period minimum	5 years
Minimum [Member] | Agent Deferred Compensation Plan [Member]
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Retirement age	60 years
Maximum [Member] | Agent Deferred Compensation Plan [Member]
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Retirement age	65 years

XML

AGENT DEFERRED COMPENSATION PLAN (SCHEDULE OF ASSUMPTIONS USED) (Details) - Agent Deferred Compensation Plan [Member]	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Discount rate - Benefit Obligations	4.50%	4.15%
Discount rate - Net Period Costs	4.15%	4.75%

XML

AGENT DEFERRED COMPENSATION PLAN (SCHEDULE OF EXPECTED BENEFIT PAYMENTS) (Details) $ in Millions	Dec. 31, 2015 USD ($)
Compensation and Retirement Disclosure [Abstract]
2016	$ 6.6
2017	6.9
2018	7.3
2019	7.8
2020	8.1
2021 - 2025	$ 47.2

XML

DERIVATIVES (FAIR VALUE BY BALANCE SHEET LOCATION) (Details) - USD ($) $ in Millions	Dec. 31, 2015	Dec. 31, 2014
Equity Contract [Member]
Derivatives, Fair Value [Line Items]
Derivative Asset, Fair Value, Gross Asset	$ 41.0	$ 107.2
Interest Rate Contract [Member]
Derivatives, Fair Value [Line Items]
Derivative Asset, Fair Value, Gross Asset	0.1	(0.2)
Not Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative Asset, Fair Value, Gross Asset	36.1	109.0
Gross derivative liability	1,057.1	1,081.5
Not Designated as Hedging Instrument [Member] | Equity Contract [Member] | Other Invested Assets [Member]
Derivatives, Fair Value [Line Items]
Derivative Asset, Fair Value, Gross Asset	41.0	107.2
Not Designated as Hedging Instrument [Member] | Interest Rate Contract [Member] | Other Invested Assets [Member]
Derivatives, Fair Value [Line Items]
Derivative Asset, Fair Value, Gross Asset	0.1	(0.2)
Not Designated as Hedging Instrument [Member] | Reinsurance Receivables - Embedded Derivative [Member] | Other Invested Assets [Member]
Derivatives, Fair Value [Line Items]
Derivative Asset, Fair Value, Gross Asset	(5.0)	2.0
Not Designated as Hedging Instrument [Member] | Fixed Index Products [Member] | Future Policy Benefits [Member]
Derivatives, Fair Value [Line Items]
Gross derivative liability	1,057.1	$ 1,081.5
Embedded Derivative Associated With Modified Coinsurance Agreement [Member]
Derivatives, Fair Value [Line Items]
Gross derivative asset	$ 145.0

XML

DERIVATIVES (SCHEDULE OF DERIVATIVE INSTRUMENTS) (Details) $ in Millions	12 Months Ended
	Dec. 31, 2015 USD ($) policy Contract
Interest Rate Contract [Member]
Derivative Instrument [Roll Forward]
December 31, 2014 | Contract	402
Additions | Contract	2,643
Maturities/terminations | Contract	(2,781)
December 31, 2015 | Contract	264
Embedded Derivative Financial Instruments [Member]
Derivative Instrument [Roll Forward]
December 31, 2014 | policy	93,185
Additions | policy	10,256
Maturities/terminations | policy	(6,781)
December 31, 2015 | policy	96,660
Equity Contract [Member]
Derivative, Notional Amount [Roll Forward]
December 31, 2014 | $	$ 2,403.9
Additions | $	2,397.0
Maturities/terminations | $	(2,421.2)
December 31, 2015 | $	$ 2,379.7

XML

DERIVATIVES (SCHEDULE PRE-TAX GAINS (LOSSES) RECOGNIZED IN NET INCOME FOR DERIVATIVE INSTRUMENTS) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Derivative [Line Items]
Gains (losses) on derivative instruments not designated as hedging instruments	$ (9.6)	$ (10.4)	$ 230.1
Investment Income [Member]
Derivative [Line Items]
Gains (losses) on derivative instruments not designated as hedging instruments	(36.2)	68.1	181.2
Investment Income [Member] | Equity Swap [Member]
Derivative [Line Items]
Gains (losses) on derivative instruments not designated as hedging instruments	(36.2)	69.5	177.5
Investment Income [Member] | Embedded Derivative Financial Instruments [Member]
Derivative [Line Items]
Gains (losses) on derivative instruments not designated as hedging instruments	0.0	(1.4)	3.7
Gain (Loss) on Investments [Member]
Derivative [Line Items]
Gains (losses) on derivative instruments not designated as hedging instruments	(9.7)	(5.0)	(0.4)
Gain (Loss) on Investments [Member] | Interest Rate Contract [Member]
Derivative [Line Items]
Gains (losses) on derivative instruments not designated as hedging instruments	(2.7)	(7.0)	(0.4)
Gain (Loss) on Investments [Member] | Embedded Derivative Financial Instruments [Member] | Coinsurance [Member]
Derivative [Line Items]
Gains (losses) on derivative instruments not designated as hedging instruments	(7.0)	2.0	0.0
Insurance Policy Benefits [Member] | Embedded Derivative Financial Instruments [Member]
Derivative [Line Items]
Gains (losses) on derivative instruments not designated as hedging instruments	$ 36.3	$ (73.5)	$ 49.3

XML

DERIVATIVES (DERIVATIVES WITH MASTER NETTING ARRANGEMENTS) (Details) - USD ($) $ in Millions	Dec. 31, 2015	Dec. 31, 2014
Derivative [Line Items]
Gross amounts of recognized liabilities		$ 20.4
Gross amounts offset in the balance sheet		0.0
Net amounts of liabilities presented in the balance sheet		20.4
Financial instruments		20.4
Cash collateral pledged		0.0
Net amount		0.0
Fair value of collateralized investment securities		25.3
Equity Contract [Member]
Derivative [Line Items]
Gross amounts recognized	$ 41.0	107.2
Gross amounts offset in the balance sheet	0.0	0.0
Net amounts of assets presented in the balance sheet	41.0	107.2
Financial instruments	0.0	0.0
Cash collateral received	0.0	0.0
Net amount	41.0	107.2
Interest Rate Contract [Member]
Derivative [Line Items]
Gross amounts recognized	0.1	(0.2)
Gross amounts offset in the balance sheet	1.5	1.5
Net amounts of assets presented in the balance sheet	1.6	1.3
Financial instruments	0.0	0.0
Cash collateral received	0.0	0.0
Net amount	$ 1.6	$ 1.3

XML

SHAREHOLDERS' EQUITY (NARRATIVE) (Details)	1 Months Ended	4 Months Ended	8 Months Ended	12 Months Ended				36 Months Ended	46 Months Ended	60 Months Ended
	Sep. 30, 2014 USD ($)	Apr. 30, 2015 $ / shares	Dec. 31, 2015 USD ($) $ / shares shares	Dec. 31, 2015 USD ($) $ / shares shares	Dec. 31, 2014 USD ($) $ / shares shares	Dec. 31, 2013 USD ($) $ / shares shares	Dec. 31, 2006	Dec. 31, 2009	Nov. 30, 2015 USD ($)	Dec. 31, 2014 USD ($) shares	May. 30, 2014 USD ($)	May. 31, 2013 USD ($)	Mar. 28, 2013 USD ($)	May. 31, 2011 USD ($)	May. 31, 2010
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock repurchase program, increase in authorized amount									$ 1,600,000,000
Payments for repurchase of common stock				$ 365,200,000	$ 319,100,000	$ 118,400,000
Payments for repurchase of stock warrants	$ 57,400,000
Stock repurchase program, remaining repurchase authorized amount			$ 455,700,000	455,700,000
Common stock dividends paid				$ 52,000,000	$ 51,000,000	$ 24,400,000
Dividends (in dollars per share) | $ / shares		$ 0.06	$ 0.07	$ 0.27	$ 0.24	$ 0.11
Available for future grant (in shares) | shares			6,882,000	6,882,000	8,571,000	9,099,000				8,571,000
Proceeds from stock options exercised				$ 6,300,000	$ 5,000,000	$ 15,100,000
Price of junior preferred stock (per 1/1000 of a share) | $ / shares			$ 70.00	$ 70.00
Junior preferred stock right becomes exercisable when a person or group becomes owner of stated percentage (more than)				4.99%
Conversion rate per $1000 principal amount of 7.0% convertible debentures, shares (in shares)			182.1494	182.1494
Par value of each 7.0% convertible debenture			$ 1,000	$ 1,000
Conversion price (in dollars per share) | $ / shares			$ 5.49	$ 5.49
Series B Preferred Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Series B junior participating preferred stock par value (in dollars per share) | $ / shares			$ 0.01	$ 0.01
Junior preferred stock, purchase right to purchase fractional share (in shares) | shares				0.001
Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated share-based compensation expense				$ 9,600,000	7,900,000	7,200,000
Allocated share-based compensation expense, net of tax				$ 6,200,000	5,100,000	$ 4,700,000
Compensation expense related to stock options reduced both basic and diluted earnings per share (in dollars per share) | $ / shares				$ (0.03)		$ (0.02)
Unrecognized compensation expense			$ 11,200,000	$ 11,200,000
Weighted average recognition period				1 year 10 months 24 days
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period				3 years
Allocated share-based compensation expense				$ 2,200,000	3,000,000	$ 4,500,000
Unrecognized compensation expense			900,000	$ 900,000	$ 1,400,000					$ 1,400,000
Weighted average recognition period				1 year 7 months 24 days
Granted (in dollars per share) | $ / shares				$ 17.59	$ 17.15	$ 12.00
Grant date fair value of performance shares awarded			1,700,000	$ 1,700,000	$ 1,900,000	$ 2,100,000				1,900,000
Fair value of vested shares				$ 2,700,000	$ 3,700,000	$ 5,600,000
Restricted Stock [Member] | Directors, Officers, and Employees [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares) | shares				95,000	100,000	200,000
Performance Shares [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated share-based compensation expense				$ 5,300,000	$ 4,700,000	$ 3,400,000
Granted (in shares) | shares				516,660	283,630	424,400
Grant date fair value of performance shares awarded			$ 9,400,000	$ 9,400,000	$ 5,200,000					$ 5,200,000
Performance period				3 years
Performance unit payout				200.00%	150.00%
2006 and Prior Years [Member] | Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period							4 years
Expiration period							10 years
Years 2007 Through 2009 [Member] | Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period								3 years
Expiration period								5 years
Years 2010 and Thereafter [Member] | Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period										3 years
Expiration period										7 years
2015 [Member] | Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period				3 years
Expiration period				10 years
Convertible Subordinated Debt [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Principle amount of debt repurchased											$ 3,500,000	$ 4,500,000
Interest rate			7.00%	7.00%							7.00%				7.00%
Convertible Subordinated Debt [Member] | Notes Payable, Other Payables [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Principle amount of debt repurchased						$ 63,800,000							$ 59,300,000
Common Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
stock purchased and retired (in shares) | shares				20,582,000	18,489,000	8,949,000
Common Share Repurchase Program [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock repurchase program, authorized amount														$ 100,000,000.0

XML

SHAREHOLDERS' EQUITY (SCHEDULE OF COMMON STOCK OUTSTANDING) (Details) - shares	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Common Stock Outstanding [Roll Forward]
Balance, beginning of year (in shares)	203,324,458
Balance, end of year (in shares)	184,028,511	203,324,458
Number of stock tendered for payment of federal and state taxes owed	237,000	257,000	472,000
Convertible Subordinated Debt [Member]
Common Stock Outstanding [Roll Forward]
Conversion of 7.0% debentures (in shares)	0	0	4,739,000
Common Stock [Member]
Common Stock Outstanding [Roll Forward]
Balance, beginning of year (in shares)	203,324,000	220,324,000	221,502,000
Treasury stock purchased and retired (in shares)	(20,582,000)	(18,489,000)	(8,949,000)
Balance, end of year (in shares)	184,029,000	203,324,000	220,324,000
Common Stock [Member] | Employee Stock Option [Member]
Common Stock Outstanding [Roll Forward]
Shares issued under employee benefit compensation plans (in shares)	769,000	916,000	2,087,000
Common Stock [Member] | Restricted and Performance Stock [Member]
Common Stock Outstanding [Roll Forward]
Shares issued under employee benefit compensation plans (in shares)	518,000	573,000	945,000

XML

SHAREHOLDERS' EQUITY (SCHEDULE OF SHARE-BASED COMPENSATION) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Outstanding at the beginning of the year (in shares)	5,011	5,579	6,655
Options granted (in shares)	1,361	1,014	1,447
Exercised (in shares)	(769)	(917)	(2,087)
Forfeited or terminated (in shares)	(404)	(665)	(436)
Outstanding at the end of the year (in shares)	5,199	5,011	5,579
Options exercisable at the end of the year (in shares)	2,399	2,030	2,529
Available for future grant (in shares)	6,882	8,571	9,099
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]
Outstanding at the beginning of the year (in dollars per share)	$ 12.04	$ 10.64	$ 9.72
Options granted (in dollars per share)	16.45	19.10	11.01
Exercised (in dollars per share)	(8.20)	(5.47)	(7.27)
Forfeited or terminated (in dollars per share)	(17.70)	(20.07)	(13.95)
Outstanding at the end of the year (in dollars per share)	$ 13.32	$ 12.04	$ 10.64
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]
Options outstanding, weighted average remaining life	4 years 9 months 24 days	4 years 3 months 24 days	4 years
Options exercisable at the end of the year, weighted average remaining life	2 years 5 months 24 days	2 years 8 months 24 days	2 years 1 month 24 days
Options exercised, aggregate intrinsic value	$ 4.8	$ 3.8	$ 6.0
Options outstanding, aggregate intrinsic value	38.4	32.1	32.5
Options exercisable at the end of the year, aggregate intrinsic value	$ 15.3	$ 12.1	$ 13.9

XML

SHAREHOLDERS' EQUITY (SCHEDULE OF VALUATION ASSUMPTIONS ON PAYMENT AWARDS) (Details) - Employee Stock Option [Member] - $ / shares	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average risk-free interest rates	1.70%	1.60%	0.80%
Weighted average dividend yields	1.50%	1.30%	0.70%
Volatility factors	85.00%	51.00%	107.00%
Weighted average expected life (in years)	6 years 3 months 24 days	4 years 9 months 24 days	4 years 9 months 24 days
Weighted average fair value per share (in dollars per share)	$ 10.83	$ 7.65	$ 8.02

XML

SHAREHOLDERS' EQUITY (SCHEDULE OF SHARE-BASED COMPENSATION BY EXERCISE PRICE RANGE) (Details) shares in Thousands	12 Months Ended
	Dec. 31, 2015 $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number outstanding (in shares) | shares	5,199
Number exercisable (in shares) | shares	2,399
Range of exercise prices: $6.45 - $6.77
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise price range, lower range limit (in dollars per share)	$ 6.45
Exercise price range, upper range limit (in dollars per share)	$ 6.77
Number outstanding (in shares) | shares	427
Remaining life (in years)	1 year 2 months 24 days
Average exercise price (in dollars per share)	$ 6.45
Number exercisable (in shares) | shares	427
Average exercise price (in dollars per share)	$ 6.45
Range of exercise prices: $7.38 - $7.51
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise price range, lower range limit (in dollars per share)	7.38
Exercise price range, upper range limit (in dollars per share)	$ 7.51
Number outstanding (in shares) | shares	1,097
Remaining life (in years)	2 years 9 months 24 days
Average exercise price (in dollars per share)	$ 7.46
Number exercisable (in shares) | shares	1,097
Average exercise price (in dollars per share)	$ 7.46
Range of exercise prices: $8.29 - $12.34
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise price range, lower range limit (in dollars per share)	8.29
Exercise price range, upper range limit (in dollars per share)	$ 12.34
Number outstanding (in shares) | shares	1,146
Remaining life (in years)	4 years 1 month 24 days
Average exercise price (in dollars per share)	$ 10.76
Number exercisable (in shares) | shares	551
Average exercise price (in dollars per share)	$ 10.61
Range of exercise prices: $12.74 - $18.27
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise price range, lower range limit (in dollars per share)	12.74
Exercise price range, upper range limit (in dollars per share)	$ 18.27
Number outstanding (in shares) | shares	1,332
Remaining life (in years)	8 years 10 months 24 days
Average exercise price (in dollars per share)	$ 16.40
Number exercisable (in shares) | shares	18
Average exercise price (in dollars per share)	$ 14.49
Range of exercise prices: $19.15 - $25.45
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise price range, lower range limit (in dollars per share)	19.15
Exercise price range, upper range limit (in dollars per share)	$ 25.45
Number outstanding (in shares) | shares	1,197
Remaining life (in years)	4 years
Average exercise price (in dollars per share)	$ 20.18
Number exercisable (in shares) | shares	306
Average exercise price (in dollars per share)	$ 23.19

XML

SHAREHOLDERS' EQUITY (SCHEDULE OF NONVESTED SHARE ACTIVITY) (Details) - Restricted Stock [Member] - $ / shares shares in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Non-vested shares, beginning of year (in shares)	236
Vested (in shares)	(234)
Forfeited (in shares)	(2)
Non-vested shares, end of year (in shares)	95	236
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Non-vested shares, beginning of year (in dollars per share)	$ 10.95
Granted (in dollars per share)	17.59	$ 17.15	$ 12.00
Vested (in dollars per share)	11.73
Forfeited (in dollars per share)	11.31
Non-vested shares, end of year (in dollars per share)	$ 15.66	$ 10.95

XML

SHAREHOLDERS' EQUITY (SCHEDULE OF PERFORMANCE SHARE-BASED COMPENSATION) (Details) - shares shares in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Shareholder Return Awards [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]
Awards outstanding, beginning of period (in units)	519	382	193
Granted (in units)	258	142	212
Additional shares issued pursuant to achieving certain performance criteria (in units)	85	0	0
Vested (in units)	(260)	0	0
Forfeited (in units)	(53)	(5)	(23)
Awards outstanding, end of period (in units)	549	519	382
Performance unit payout	150.00%
Operating Return on Equity Awards [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]
Awards outstanding, beginning of period (in units)	343	204	0
Granted (in units)	258	142	212
Additional shares issued pursuant to achieving certain performance criteria (in units)	0	0	0
Vested (in units)	0	0	0
Forfeited (in units)	(52)	(3)	(8)
Awards outstanding, end of period (in units)	549	343	204
Pre-Tax Operating Income Awards [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]
Awards outstanding, beginning of period (in units)	176	470	977
Granted (in units)	0	0	0
Additional shares issued pursuant to achieving certain performance criteria (in units)	85	142	223
Vested (in units)	(260)	(434)	(668)
Forfeited (in units)	(1)	(2)	(62)
Awards outstanding, end of period (in units)	0	176	470

XML

SHAREHOLDERS' EQUITY (SCHEDULE OF EARNINGS PER SHARE RECONCILIATION) (Details) - USD ($) shares in Thousands, $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Net income for basic earnings per share	$ 137.3	$ 33.8	$ 46.8	$ 52.8	$ 83.9	$ 117.4	$ 78.1	$ (228.0)	$ 270.7	$ 51.4	$ 478.0
Add: interest expense on 7.0% Debentures, net of income taxes									0.0	0.0	1.6
Net income (loss) for diluted earnings per share									$ 270.7	$ 51.4	$ 479.6
Shares:
Weighted average shares outstanding for basic earnings per share (in dollars per share)									193,054	212,917	221,628
Effect of dilutive securities on weighted average shares:
7.0% Debentures (in shares)									0	0	5,780
Stock options, restricted stock and performance units (in shares)									2,112	2,505	2,776
Warrants (in shares)									0	2,233	2,518
Dilutive potential common shares (in shares)									2,112	4,738	11,074
Weighted average shares outstanding for diluted earnings per share (in shares)									195,166	217,655	232,702

XML

OTHER OPERATING STATEMENT DATA (SCHEDULE OF INSURANCE POLICY INCOME) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Insurance [Abstract]
Direct premiums collected	$ 3,769.6	$ 3,856.2	$ 3,966.0
Reinsurance assumed	38.4	34.5	38.0
Reinsurance ceded	(142.8)	(187.9)	(240.5)
Premiums collected, net of reinsurance	3,665.2	3,702.8	3,763.5
Change in unearned premiums	5.9	9.1	(16.6)
Less premiums on interest-sensitive life and products without mortality and morbidity risk which are recorded as additions to insurance liabilities	(1,241.9)	(1,295.4)	(1,298.1)
Premiums on traditional products with mortality or morbidity risk	2,429.2	2,416.5	2,448.8
Fees and surrender charges on interest-sensitive products	126.8	213.2	295.9
Insurance policy income	$ 2,556.0	$ 2,629.7	$ 2,744.7

XML

OTHER OPERATING STATEMENT DATA (SCHEDULE OF OTHER OPERATING COST AND EXPENSE) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Expenses:
Commission expense	$ 103.8	$ 99.4	$ 103.8
Salaries and wages	205.2	242.4	234.0
Other	430.2	461.0	428.4
Total other operating costs and expenses	$ 739.2	$ 802.8	$ 766.2

XML

OTHER OPERATING STATEMENT DATA (SCHEDULE OF CHANGES IN PRESENT VALUE OF FUTURE INSURANCE PROFITS) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Movement in Present Value of Future Insurance Profits [Roll Forward]
Balance, beginning of year	$ 489.4	$ 679.3	$ 626.0
Amortization	(69.1)	(76.2)	(92.0)
Effect of reinsurance transaction	0.0	5.0	0.0
Amounts related to CLIC prior to being sold	0.0	(15.5)	0.0
Amounts related to changes in unrealized investment gains (losses) on fixed maturities, available for sale	28.7	(103.2)	145.3
Balance, end of year	$ 449.0	$ 489.4	$ 679.3

XML

OTHER OPERATING STATEMENT DATA (SCHEDULE OF CHANGES IN DEFERRED ACQUISITION COSTS) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]
Balance, beginning of year	$ 770.6	$ 968.1	$ 629.7
Additions	246.4	242.8	222.8
Amortization	(190.9)	(171.2)	(204.3)
Effect of reinsurance transaction	0.0	24.0	0.0
Amounts related to CLIC prior to being sold	0.0	(37.6)	0.0
Amounts related to changes in unrealized investment gains (losses) on fixed maturities, available for sale	257.2	(255.5)	315.9
Other	0.0	0.0	4.0
Balance, end of year	$ 1,083.3	$ 770.6	$ 968.1

XML

OTHER OPERATING STATEMENT DATA (NARRATIVE) (Details) - state	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Supplementary Insurance Information, by Segment [Line Items]
Number of states with largest share of collected premiums	4
Percentage of total collected premiums (more than for 5%)	5.00%
Number of additional states greater than specified percentage of total collected premiums	0
Percentage of Amount Amortized During Next Five Years [Abstract]
2016	11.00%
2017	10.00%
2018	9.00%
2019	8.00%
2020	7.00%
Average interest accrual rate associated with amortization method of present value of future insurance profits	5.00%	5.00%	5.00%
Florida [Member]
Supplementary Insurance Information, by Segment [Line Items]
Percentage of total collected premiums (more than for 5%)	9.00%
Pennsylvania [Member]
Supplementary Insurance Information, by Segment [Line Items]
Percentage of total collected premiums (more than for 5%)	7.00%
California [Member]
Supplementary Insurance Information, by Segment [Line Items]
Percentage of total collected premiums (more than for 5%)	6.00%
Texas [Member]
Supplementary Insurance Information, by Segment [Line Items]
Percentage of total collected premiums (more than for 5%)	6.00%

XML

CONSOLIDATED STATEMENT CASH FLOWS (SCHEDULE OF THE RECONCILIATION FOR NET INCOME PROVIDED BY OPERATING ACTIVITIES) (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2015	Dec. 31, 2014		Dec. 31, 2013
Additional Cash Flow Elements, Operating Activities [Abstract]
Net income	$ 137.3	$ 33.8	$ 46.8	$ 52.8	$ 83.9	$ 117.4	$ 78.1	$ (228.0)	$ 270.7	$ 51.4		$ 478.0
Adjustments to reconcile net income to net cash from operating activities:
Amortization and depreciation									283.4	274.2		324.6
Income taxes									92.9	119.7		(181.2)
Insurance liabilities									297.4	398.2		465.8
Accrual and amortization of investment income									(27.6)	(148.3)		(276.3)
Deferral of policy acquisition costs									(246.4)	(242.8)		(222.8)
Net realized investment (gains) losses									36.6	(36.7)		(33.6)
Payment to reinsurer pursuant to long-term care business reinsured									0.0	(590.3)		0.0
Net loss on sale of subsidiary, (gain) loss on reinsurance transactions and transition expenses									9.0	239.8		98.4
Loss on extinguishment or modification of debt									32.8	0.6		65.4
Other									(4.9)	56.0		2.1
Net cash from operating activities									$ 743.9	$ 121.8	[1]	$ 720.4

[1] Cash flows from operating activities reflect outflows in 2014 due to the payment to reinsurer to transfer certain long-term care business.

XML

CONSOLIDATED STATEMENT CASH FLOWS (EFFECTS OF REINSURANCE) (Details) $ in Millions	Jul. 01, 2014 USD ($)
Ceded Credit Risk [Line Items]
Gain on reinsurance transaction (net of income taxes)	$ 16.9
Bankers Life [Member] | Wilton Reassurance Company [Member]
Ceded Credit Risk [Line Items]
Gain on reinsurance transaction (classified as Loss on sale of subsidiary, (gain) loss on reinsurance transactions and transition expenses)	26.1
Income tax expense	9.2
Gain on reinsurance transaction (net of income taxes)	16.9
Reinsurance recapture fee paid	28.0
Bankers Life [Member] | Wilton Reassurance Company [Member] | Investments [Member]
Ceded Credit Risk [Line Items]
Reinsurance recapture, gross	139.4
Bankers Life [Member] | Wilton Reassurance Company [Member] | Cash [Member]
Ceded Credit Risk [Line Items]
Reinsurance recapture, gross	7.7
Bankers Life [Member] | Wilton Reassurance Company [Member] | Present value of future profits and deferred acquisition costs [Member]
Ceded Credit Risk [Line Items]
Reinsurance recapture, gross	29.0
Bankers Life [Member] | Wilton Reassurance Company [Member] | Reinsurance receivables [Member]
Ceded Credit Risk [Line Items]
Reinsurance recapture, gross	(155.9)
Bankers Life [Member] | Wilton Reassurance Company [Member] | Other liabilities [Member]
Ceded Credit Risk [Line Items]
Reinsurance recapture, gross	$ 5.9

XML

CONSOLIDATED STATEMENT CASH FLOWS (SCHEDULE OF OTHER SIGNIFICANT NONCASH TRANSACTIONS) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Supplemental Cash Flow Elements [Abstract]
Stock options, restricted stock and performance units	$ 17.1	$ 15.6	$ 15.1

XML

STATUTORY INFORMATION (BASED ON NON-GAAP MEASURES) (SCHEDULE OF STATUTORY ACCOUNTING PRACTICES) (Details) - USD ($) $ in Millions	Dec. 31, 2015	Dec. 31, 2014
Insurance [Abstract]
Statutory capital and surplus	$ 1,739.2	$ 1,654.4
Asset valuation reserve	196.9	203.1
Interest maintenance reserve	476.0	504.1
Total	$ 2,412.1	$ 2,361.6

XML

STATUTORY INFORMATION (BASED ON NON-GAAP MEASURES) (NARRATIVE) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Statutory Accounting Practices [Line Items]
Statutory capital and surplus included investments in upstream affiliates	$ 42.6	$ 42.6
Statutory accounting practices, statutory net income, amount	332.6	364.3	$ 386.5
Statutory accounting practices, net realized capital gain (loss), net of income taxes	(18.0)	(18.2)	19.0
Statutory accounting practices, pre-tax amounts for fees and interest paid	$ 154.2	$ 157.5	$ 159.7
Percentage of statutory capital and surplus, available for dividend distribution without prior approval from regulatory agency	10.00%
Amount of extraordinary dividends paid by insurance subsidiaries	$ 265.7
Capital contributions to insurance subsidiaries from parent	$ 0.0
Adjusted Capital to Risk-based Capital Ratio (less than)	95.00%
Maximum [Member] | Company Plan for Improving Capital Position [Member]
Statutory Accounting Practices [Line Items]
Adjusted Capital to Risk-based Capital Ratio (less than)	100.00%
Maximum [Member] | Regulatory Authority Special Examination [Member]
Statutory Accounting Practices [Line Items]
Adjusted Capital to Risk-based Capital Ratio (less than)	75.00%
Maximum [Member] | Regulatory Authority, Any Action Deemed Necessary [Member]
Statutory Accounting Practices [Line Items]
Adjusted Capital to Risk-based Capital Ratio (less than)	50.00%
Maximum [Member] | Regulatory Authority Control [Member]
Statutory Accounting Practices [Line Items]
Adjusted Capital to Risk-based Capital Ratio (less than)	35.00%
Maximum [Member] | Trend Test [Member]
Statutory Accounting Practices [Line Items]
Adjusted Capital to Risk-based Capital Ratio (less than)	150.00%
Minimum [Member] | Company Plan for Improving Capital Position [Member]
Statutory Accounting Practices [Line Items]
Adjusted Capital to Risk-based Capital Ratio (less than)	75.00%
Minimum [Member] | Regulatory Authority Special Examination [Member]
Statutory Accounting Practices [Line Items]
Adjusted Capital to Risk-based Capital Ratio (less than)	50.00%
Minimum [Member] | Regulatory Authority, Any Action Deemed Necessary [Member]
Statutory Accounting Practices [Line Items]
Adjusted Capital to Risk-based Capital Ratio (less than)	35.00%
Minimum [Member] | Trend Test [Member]
Statutory Accounting Practices [Line Items]
Adjusted Capital to Risk-based Capital Ratio (less than)	100.00%

XML

SALE OF SUBSIDIARY (NARRATIVE) (Details) - USD ($) $ in Millions		3 Months Ended			12 Months Ended
	Jul. 01, 2014	Dec. 31, 2014	Sep. 30, 2014	Mar. 31, 2014	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Tax (expense) benefit related to tax gain on sale					$ 0.0	$ (14.2)	$ 0.0
Gain related to other reinsurance transaction	$ 16.9
Conseco Life Insurance Company [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Loss on the sale of CLIC		$ 2.9	$ 6.0	$ (298.0)
Bankers Life [Member] | Wilton Reassurance Company [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Reinsurance recapture fee paid	28.0
Gain related to other reinsurance transaction	16.9
Conseco Life Insurance Company [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Net cash proceeds	224.9
Tax (expense) benefit related to tax gain on sale	(14.2)
Valuation allowance release related to the gain	14.2
Valuation allowance increase related to the decrease in projected future taxable income	(19.4)
Conseco Life Insurance Company [Member] | Transition Services for the Year Ended June 30, 2015 [Member] | Wilton Reassurance Company [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Fees from transition and special Support Services Agreements	30.0
Conseco Life Insurance Company [Member] | Transition Services for the Year Ended June 30, 2016 [Member] | Wilton Reassurance Company [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Fees from transition and special Support Services Agreements	20.0
Conseco Life Insurance Company [Member] | Transition Services for the the Three Years Ended June 30, 2019 [Member] | Wilton Reassurance Company [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Fees from transition and special Support Services Agreements	$ 0.2

XML

SALE OF SUBSIDIARY (SCHEDULE OF CARRYING AMOUNT OF CLIC BUSINESS BEING SOLD) (Details) - USD ($) $ in Millions		12 Months Ended
	Jul. 01, 2014	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Net assets being sold:
Loss before taxes		$ (9.0)	$ (239.8)	$ (98.4)
Tax expense related to the sale		$ 0.0	$ 14.2	$ 0.0
Conseco Life Insurance Company [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Net cash proceeds	$ 224.9
Net assets being sold:
Investments	3,863.8
Cash and cash equivalents	164.7
Accrued investment income	42.7
Present value of future profits	15.5
Deferred acquisition costs	37.6
Reinsurance receivables	307.4
Income tax assets, net	84.4
Other assets	2.8
Liabilities for insurance products	(3,201.3)
Other liabilities	(199.1)
Investment borrowings	(383.4)
Accumulated other comprehensive income	(240.5)
Net assets being sold	494.6
Loss before taxes	(269.7)
Tax expense related to the sale	14.2
Valuation allowance release related to the tax on the sale	(14.2)
Valuation allowance increase related to the decrease in projected future taxable income	19.4
Net loss	$ (289.1)

XML

BUSINESS SEGMENTS (SCHEDULE OF SEGMENT REPORTING INFORMATION BY SEGMENT) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Revenues:
Net investment income	$ 1,233.6	$ 1,427.4	$ 1,664.0
Fee revenue and other income	58.9	50.9	34.0
Total	3,787.2	3,851.8	3,969.0
Benefits and expenses:
Insurance policy benefits	2,308.3	2,586.2	2,839.7
Other operating costs and expenses	739.2	802.8	766.2
Total expenses	3,364.4	3,424.4	3,606.5
Pre-tax operating earnings by segment	422.8	427.4	362.5
Bankers Life [Member]
Revenues:
Insurance policy income, Annuities	22.4	26.0	28.9
Insurance policy income, Health	1,251.0	1,287.1	1,311.2
Insurance policy income, Life	375.3	338.6	308.6
Net investment income	884.7	957.3	1,005.7
Fee revenue and other income	27.7	29.3	19.0
Total	2,561.1	2,638.3	2,673.4
Benefits and expenses:
Insurance policy benefits	1,588.4	1,667.6	1,788.7
Amortization	187.1	174.7	187.5
Interest expense on investment borrowings	8.8	7.9	6.7
Other operating costs and expenses	407.2	401.2	380.0
Total expenses	2,191.5	2,251.4	2,362.9
Pre-tax operating earnings by segment	369.6	386.9	310.5
Washington National [Member]
Revenues:
Insurance policy income, Annuities	3.0	4.0	11.4
Insurance policy income, Health	615.4	597.6	587.1
Insurance policy income, Life	25.4	24.4	23.0
Net investment income	253.6	276.1	296.9
Fee revenue and other income	1.3	1.1	0.9
Total	898.7	903.2	919.3
Benefits and expenses:
Insurance policy benefits	546.6	536.2	541.4
Amortization	55.2	64.6	64.9
Interest expense on investment borrowings	2.0	1.7	1.9
Other operating costs and expenses	183.4	189.5	170.5
Total expenses	787.2	792.0	778.7
Pre-tax operating earnings by segment	111.5	111.2	140.6
Colonial Penn [Member]
Revenues:
Insurance policy income, Health	3.0	3.6	4.3
Insurance policy income, Life	260.5	242.4	227.8
Net investment income	43.0	41.7	40.0
Fee revenue and other income	1.0	1.0	0.8
Total	307.5	288.7	272.9
Benefits and expenses:
Insurance policy benefits	189.0	173.2	165.7
Amortization	14.4	15.3	14.5
Interest expense on investment borrowings	0.1	0.0	0.0
Other operating costs and expenses	98.4	99.4	105.2
Total expenses	301.9	287.9	285.4
Pre-tax operating earnings by segment	5.6	0.8	(12.5)
Other CNO Business [Member]
Revenues:
Insurance policy income, Health	0.0	0.0	24.1
Net investment income	0.0	0.0	33.3
Total	0.0	0.0	57.4
Benefits and expenses:
Insurance policy benefits	0.0	0.0	59.2
Other operating costs and expenses	0.0	0.0	25.8
Total expenses	0.0	0.0	85.0
Pre-tax operating earnings by segment	0.0	0.0	(27.6)
Corporate operations [Member]
Revenues:
Net investment income	11.3	14.9	39.8
Fee revenue and other income	8.6	6.7	6.2
Total	19.9	21.6	46.0
Benefits and expenses:
Interest expense on investment borrowings	0.2	0.1	0.0
Other operating costs and expenses	38.6	49.1	43.1
Interest expense on corporate debt	45.0	43.9	51.3
Interest expense on borrowings of variable interest entities	0.0	0.0	0.1
Total expenses	83.8	93.1	94.5
Pre-tax operating earnings by segment	$ (63.9)	$ (71.5)	$ (48.5)

XML

BUSINESS SEGMENTS (RECONCILIATION OF OPERATING PROFIT (LOSS) FROM SEGMENTS TO CONSOLIDATED) (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Segment Reporting [Abstract]
Total segment revenues									$ 3,787.2	$ 3,851.8	$ 3,969.0
Net realized investment gains (losses)									(47.9)	33.9	33.4
Revenues related to certain non-strategic investments and earnings attributable to VIEs									47.6	33.2	32.2
Fee revenue related to transition and support services agreements									25.0	15.0	0.0
Revenues of CLIC prior to being sold									0.0	210.8	441.5
Total revenues	$ 969.6	$ 904.5	$ 959.5	$ 978.3	$ 1,000.0	$ 967.0	$ 1,093.0	$ 1,084.7	3,811.9	4,144.7	4,476.1
Total segment expenses									3,364.4	3,424.4	3,606.5
Insurance policy benefits - fair value changes in embedded derivative liabilities									(15.7)	48.5	(54.4)
Amortization related to fair value changes in embedded derivative liabilities									3.8	(12.5)	19.0
Amortization related to net realized investment gains									(0.5)	1.0	1.6
Expenses related to certain non-strategic investments and expenses (earnings) attributable to VIEs									43.0	41.2	42.4
Other operating costs and expenses - fair value changes related to agent deferred compensation plan									(15.1)	26.8	(15.8)
Loss on extinguishment or modification of debt									32.8	0.6	65.4
Loss on sale of subsidiary, (gain) loss on reinsurance transactions and transition expenses									9.0	239.8	98.4
Expenses related to transition and support services agreements									22.5	12.4	0.0
Expenses of CLIC prior to being sold									0.0	187.4	408.2
Total benefits and expenses									3,444.2	3,969.6	4,171.3
Income before income taxes	160.3	52.4	72.7	82.3	75.9	154.4	114.4	(169.6)	367.7	175.1	304.8
Tax expense on period income									129.5	159.2	128.3
Valuation allowance for deferred tax assets and other tax items									(32.5)	(35.5)	(301.5)
Net income	$ 137.3	$ 33.8	$ 46.8	$ 52.8	$ 83.9	$ 117.4	$ 78.1	$ (228.0)	$ 270.7	$ 51.4	$ 478.0

XML

BUSINESS SEGMENTS (SCHEDULE OF BALANCE SHEET INFORMATION, BY SEGMENT) (Details) - USD ($) $ in Millions	Dec. 31, 2015	Dec. 31, 2014
Segment Reporting Information [Line Items]
Total assets	$ 31,125.1	$ 31,155.9
Total liabilities	26,986.6	26,467.7
Bankers Life [Member]
Segment Reporting Information [Line Items]
Total assets	19,067.8	19,303.0
Total liabilities	16,612.0	16,697.5
Washington National [Member]
Segment Reporting Information [Line Items]
Total assets	7,948.5	8,207.9
Total liabilities	6,665.1	6,778.8
Colonial Penn [Member]
Segment Reporting Information [Line Items]
Total assets	985.4	945.3
Total liabilities	869.3	802.2
Corporate operations [Member]
Segment Reporting Information [Line Items]
Total assets	3,123.4	2,699.7
Total liabilities	$ 2,840.2	$ 2,189.2

XML

BUSINESS SEGMENTS (SCHEDULE OF SELECTED FINANCIAL INFORMATION, BY SEGMENT) (Details) - USD ($) $ in Millions	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Segment Reporting Information [Line Items]
Present value of future profits	$ 449.0	$ 489.4	$ 679.3	$ 626.0
Deferred acquisition costs	1,083.3	770.6
Insurance liabilities	22,143.2	22,308.7
Bankers Life [Member]
Segment Reporting Information [Line Items]
Present value of future profits	114.9	128.4
Deferred acquisition costs	718.2	456.6
Insurance liabilities	15,234.1	15,308.9
Washington National [Member]
Segment Reporting Information [Line Items]
Present value of future profits	290.2	314.2
Deferred acquisition costs	280.0	240.2
Insurance liabilities	6,126.2	6,228.8
Colonial Penn [Member]
Segment Reporting Information [Line Items]
Present value of future profits	43.9	46.8
Deferred acquisition costs	85.1	73.8
Insurance liabilities	$ 782.9	$ 771.0

XML

QUARTERLY FINANCIAL DATA (UNAUDITED) (SCHEDULE OF QUARTERLY FINANCIAL INFORMATION) (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Quarterly Financial Data [Abstract]
Revenues	$ 969.6	$ 904.5	$ 959.5	$ 978.3	$ 1,000.0	$ 967.0	$ 1,093.0	$ 1,084.7	$ 3,811.9	$ 4,144.7	$ 4,476.1
Income (loss) before income taxes	160.3	52.4	72.7	82.3	75.9	154.4	114.4	(169.6)	367.7	175.1	304.8
Income tax expense (benefit)	23.0	18.6	25.9	29.5	(8.0)	37.0	36.3	58.4	97.0	123.7	(173.2)
Net income (loss)	$ 137.3	$ 33.8	$ 46.8	$ 52.8	$ 83.9	$ 117.4	$ 78.1	$ (228.0)	$ 270.7	$ 51.4	$ 478.0
Basic:
Net income (loss) (in dollars per share)	$ 0.74	$ 0.18	$ 0.24	$ 0.26	$ 0.41	$ 0.56	$ 0.36	$ (1.03)	$ 1.40	$ 0.24	$ 2.16
Diluted:
Net income (loss) (in dollars per share)	$ 0.73	$ 0.18	$ 0.24	$ 0.26	$ 0.41	$ 0.54	$ 0.35	$ (1.03)	$ 1.39	$ 0.24	$ 2.06

XML

INVESTMENTS IN VARIABLE INTEREST ENTITIES (NARRATIVE) (Details) $ in Millions	12 Months Ended
	Dec. 31, 2015 USD ($) variable_interest_entity entity	Dec. 31, 2014 USD ($)	Dec. 31, 2013 USD ($)
Variable Interest Entity [Line Items]
Number of new VIEs consolidated in 2015 | variable_interest_entity	2
Number of new VIEs consolidated in 2014 | variable_interest_entity	2
Number of new VIEs consolidated in 2013 | variable_interest_entity	1
Gain on dissolution of a variable interest entity	$ 11.3	$ 0.0	$ 0.0
Repayments of investment borrowings related to variable interest entities, amounts due in 2022	450.2
Repayments of investment borrowings related to variable interest entities, amounts due in 2024	381.8
Repayments of investment borrowings related to variable interest entities, amounts due in 2026	326.9
Repayments of investment borrowings related to variable interest entities, amounts due in 2027	276.3
Repayments of investment borrowings related to variable interest entities, amounts due in 2028	274.8
Variable interest entity amortized cost securities held	1,679.3
Variable interest entity, gross unrealized gains fixed maturity securities	0.5
Variable interest entity gross unrealized losses fixed maturity securities	(46.2)
Variable interest entity, estimated fair value of securities held	1,633.6
Variable interest entities net realized gain (loss) on investments	(17.7)	(2.2)	(1.6)
Variable interest entities, net losses from the sales of fixed maturities	(1.3)
Writedowns of investments for other than temporary declines in fair value recognized through net income	$ (16.4)		(1.1)
Variable interest entities, net losses from the sales of fixed maturities			(0.5)
Number of VIEs in default | entity	0
Investments held by VIEs and sold	$ 46.1	38.7	11.1
Variable interest entity, gross investment losses from sale	1.8	2.4	$ 0.9
Less than twelve months [Member]
Variable Interest Entity [Line Items]
Fair value investments held by variable interest entity that had been in an unrealized loss position	1,178.7	1,053.2
Gross unrealized gain (loss) on investments held by VIEs	(23.9)	(27.3)
Greater than twelve months [Member]
Variable Interest Entity [Line Items]
Fair value investments held by variable interest entity that had been in an unrealized loss position	294.3	167.4
Gross unrealized gain (loss) on investments held by VIEs	$ (22.3)	$ (4.2)

XML

INVESTMENTS IN VARIABLE INTEREST ENTITIES (SCHEDULE OF IMPACT ON BALANCE SHEET OF CONSOLIDATING VARIABLE INTEREST ENTITIES) (Details) - USD ($) $ in Millions	Dec. 31, 2015	Dec. 31, 2014
Assets [Abstract]
Investments held by variable interest entities	$ 1,633.6	$ 1,367.1
Cash and cash equivalents held by variable interest entities	364.4	68.3
Liabilities:
Borrowings related to variable interest entities	1,676.4	1,271.9
VIEs [Member]
Assets [Abstract]
Investments held by variable interest entities	1,633.6	1,367.1
Notes receivable of VIEs held by insurance subsidiaries	0.0	0.0
Cash and cash equivalents held by variable interest entities	364.4	68.3
Accrued investment income	3.3	3.2
Income tax assets, net	26.0	18.1
Other assets	1.4	0.0
Total assets	2,028.7	1,456.7
Liabilities:
Other liabilities	196.6	61.2
Borrowings related to variable interest entities	1,676.4	1,271.9
Notes payable of VIEs held by insurance subsidiaries	204.0	157.3
Total liabilities	2,077.0	1,490.4
Eliminations [Member]
Assets [Abstract]
Investments held by variable interest entities	0.0	0.0
Notes receivable of VIEs held by insurance subsidiaries	(204.3)	(153.3)
Cash and cash equivalents held by variable interest entities	0.0	0.0
Accrued investment income	0.0	0.0
Income tax assets, net	(1.9)	(2.9)
Other assets	(1.5)	(1.7)
Total assets	(207.7)	(157.9)
Liabilities:
Other liabilities	(7.2)	(6.1)
Borrowings related to variable interest entities	0.0	0.0
Notes payable of VIEs held by insurance subsidiaries	(204.0)	(157.3)
Total liabilities	(211.2)	(163.4)
Variable Interest Entity, Primary Beneficiary [Member]
Assets [Abstract]
Investments held by variable interest entities	1,633.6	1,367.1
Notes receivable of VIEs held by insurance subsidiaries	(204.3)	(153.3)
Cash and cash equivalents held by variable interest entities	364.4	68.3
Accrued investment income	3.3	3.2
Income tax assets, net	24.1	15.2
Other assets	(0.1)	(1.7)
Total assets	1,821.0	1,298.8
Liabilities:
Other liabilities	189.4	55.1
Borrowings related to variable interest entities	1,676.4	1,271.9
Notes payable of VIEs held by insurance subsidiaries	0.0	0.0
Total liabilities	$ 1,865.8	$ 1,327.0

XML

INVESTMENTS IN VARIABLE INTEREST ENTITIES (SUPPLEMENTAL INFORMATION, REVENUES AND EXPENSES OF VARIABLE INTEREST ENTITIES) (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Revenues:
Policyholder and reinsurer accounts and other special-purpose portfolios									$ 30.0	$ 126.4	$ 258.2
Fee revenue and other income									58.9	50.9	34.0
Total revenues	$ 969.6	$ 904.5	$ 959.5	$ 978.3	$ 1,000.0	$ 967.0	$ 1,093.0	$ 1,084.7	3,811.9	4,144.7	4,476.1
Expenses:
Interest expense									94.9	92.8	105.3
Other operating costs and expenses									739.2	802.8	766.2
Total benefits and expenses									3,444.2	3,969.6	4,171.3
Net realized investment losses									(47.9)	33.9	33.4
Income before income taxes	$ 160.3	$ 52.4	$ 72.7	$ 82.3	$ 75.9	$ 154.4	$ 114.4	$ (169.6)	367.7	175.1	304.8
Variable Interest Entity, Primary Beneficiary [Member]
Revenues:
Policyholder and reinsurer accounts and other special-purpose portfolios									62.1	47.2	42.3
Fee revenue and other income									1.6	1.1	1.8
Total revenues									63.7	48.3	44.1
Expenses:
Interest expense									38.8	30.1	26.0
Other operating costs and expenses									2.0	1.2	1.4
Total benefits and expenses									40.8	31.3	27.4
Income before net realized investment losses and income taxes									22.9	17.0	16.7
Net realized investment losses									(17.7)	(2.2)	(1.6)
Income before income taxes									$ 5.2	$ 14.8	$ 15.1

XML

INVESTMENTS IN VARIABLE INTEREST ENTITIES (SUMMARY OF VARIABLE INTEREST ENTITIES BY CONTRACTUAL MATURITY) (Details) $ in Millions	Dec. 31, 2015 USD ($)
Variable Interest Entity [Line Items]
Total, Amortized Cost	$ 1,679.3
Total, Estimated Fair Value	1,633.6
Amortized Cost [Member]
Variable Interest Entity [Line Items]
Due in one year or less	12.5
Due after one year through five years	719.2
Due after five years through ten years	947.6
Total, Amortized Cost	1,679.3
Due in one year or less	12.5
Due after one year through five years	654.3
Due after five years through ten years	852.4
Total, Amortized Cost	1,519.2
Estimated Fair Value [Member]
Variable Interest Entity [Line Items]
Due in one year or less	12.1
Due after one year through five years	695.1
Due after five years through ten years	926.4
Total, Estimated Fair Value	1,633.6
Due in one year or less	12.1
Due after one year through five years	630.0
Due after five years through ten years	830.9
Total, Estimated Fair Value	$ 1,473.0

XML

SCHEDULE II - BALANCE SHEET (Details) - USD ($) $ in Millions	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Assets [Abstract]
Fixed maturities, available for sale, at fair value (amortized cost: 2015 - $5.0; 2014 - $35.0)	$ 19,882.9	$ 20,634.9
Cash and cash equivalents - unrestricted	432.3	611.6	$ 699.0	$ 582.5
Equity securities at fair value (cost: 2015 - $247.3; 2014 - $202.7)	463.0	419.0
Trading securities	262.1	244.9
Income tax assets, net	898.8	758.7
Other assets	309.2	309.4
Total assets	31,125.1	31,155.9
Liabilities:
Notes payable	911.1	780.3
Other liabilities	707.8	587.6
Total liabilities	$ 26,986.6	$ 26,467.7
Commitments and Contingencies
Shareholders' equity:
Accumulated other comprehensive income	$ 402.8	$ 825.3
Retained earnings	347.1	128.5
Total shareholders' equity	4,138.5	4,688.2	4,955.2	5,049.3
Total liabilities and shareholders' equity	31,125.1	31,155.9
Parent Company [Member]
Assets [Abstract]
Fixed maturities, available for sale, at fair value (amortized cost: 2015 - $5.0; 2014 - $35.0)	5.0	34.9
Cash and cash equivalents - unrestricted	128.9	86.6	$ 131.1	$ 165.7
Equity securities at fair value (cost: 2015 - $247.3; 2014 - $202.7)	254.9	216.9
Trading securities	1.0	2.1
Investment in wholly-owned subsidiaries (eliminated in consolidation)	4,809.2	5,263.3
Income tax assets, net	58.5	47.9
Other invested assets - affiliated (eliminated in consolidation)	0.0	27.0
Receivable from subsidiaries (eliminated in consolidation)	3.8	10.8
Other assets	3.1	3.1
Total assets	5,264.4	5,692.6
Liabilities:
Notes payable	911.1	780.3
Payable to subsidiaries (eliminated in consolidation)	135.9	114.3
Other liabilities	78.9	109.8
Total liabilities	$ 1,125.9	$ 1,004.4
Commitments and Contingencies
Shareholders' equity:
Common stock and additional paid-in capital ($0.01 par value, 8,000,000,000 shares authorized, shares issued and outstanding: 2015 - 184,028,511; 2014 – 203,324,458)	$ 3,388.6	$ 3,734.4
Accumulated other comprehensive income	402.8	825.3
Retained earnings	347.1	128.5
Total shareholders' equity	4,138.5	4,688.2
Total liabilities and shareholders' equity	$ 5,264.4	$ 5,692.6

XML

SCHEDULE II - BALANCE SHEET Parenthetical (Details) - USD ($) $ / shares in Units, $ in Millions	Dec. 31, 2015	Dec. 31, 2014
Condensed Financial Statements, Captions [Line Items]
Fixed maturities, available for sale, amortized cost	$ 18,947.0	$ 18,408.1
Equity securities cost	$ 447.4	$ 400.5
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	8,000,000,000	8,000,000,000
Common stock, shares issued (in shares)	184,028,511	203,324,458
Common stock, shares outstanding (in shares)	184,028,511	203,324,458
Parent Company [Member]
Condensed Financial Statements, Captions [Line Items]
Fixed maturities, available for sale, amortized cost	$ 5.0	$ 35.0
Equity securities cost	$ 247.3	$ 202.7
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	8,000,000,000	8,000,000,000
Common stock, shares issued (in shares)	184,028,511	203,324,458
Common stock, shares outstanding (in shares)	184,028,511	203,324,458

XML

SCHEDULE II - STATEMENT OF OPERATIONS (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Revenues:
Net investment income									$ 1,233.6	$ 1,427.4	$ 1,664.0
Net realized investment gains (losses)									(47.9)	33.9	33.4
Total revenues	$ 969.6	$ 904.5	$ 959.5	$ 978.3	$ 1,000.0	$ 967.0	$ 1,093.0	$ 1,084.7	3,811.9	4,144.7	4,476.1
Expenses:
Interest expense									94.9	92.8	105.3
Loss on extinguishment or modification of debt									32.8	0.6	65.4
Income before income taxes	160.3	52.4	72.7	82.3	75.9	154.4	114.4	(169.6)	367.7	175.1	304.8
Income tax expense (benefit)	23.0	18.6	25.9	29.5	(8.0)	37.0	36.3	58.4	97.0	123.7	(173.2)
Net income	$ 137.3	$ 33.8	$ 46.8	$ 52.8	$ 83.9	$ 117.4	$ 78.1	$ (228.0)	270.7	51.4	478.0
Parent Company [Member]
Revenues:
Net investment income									16.9	12.7	21.1
Net realized investment gains (losses)									3.5	11.1	0.4
Intercompany revenues (losses) (eliminated in consolidation)									(1.5)	(1.0)	1.6
Total revenues									18.9	22.8	23.1
Expenses:
Interest expense									45.2	44.0	51.4
Intercompany expenses (eliminated in consolidation)									0.4	0.3	0.3
Operating costs and expenses									21.0	66.6	26.1
Loss on extinguishment or modification of debt									32.8	0.6	65.4
Total expenses									99.4	111.5	143.2
Income before income taxes									(80.5)	(88.7)	(120.1)
Income tax expense (benefit)									(37.9)	(34.1)	(8.8)
Loss before equity in undistributed earnings of subsidiaries									(42.6)	(54.6)	(111.3)
Equity in undistributed earnings of subsidiaries (eliminated in consolidation)									313.3	106.0	589.3
Net income									$ 270.7	$ 51.4	$ 478.0

XML

SCHEDULE II - STATEMENT OF CASH FLOWS (Details) - USD ($) $ in Millions		12 Months Ended
	May. 19, 2015	Dec. 31, 2015	Dec. 31, 2014		Dec. 31, 2013
Condensed Financial Statements, Captions [Line Items]
Cash flows from operating activities		$ 743.9	$ 121.8	[1]	$ 720.4
Cash flows from investing activities:
Sales of investments		2,177.6	2,090.0		2,315.8
Purchases of investments		(4,767.2)	(3,731.6)		(5,367.1)
Net sales of trading securities		(12.3)	4.9		30.0
Net cash provided (used) by investing activities		(1,069.6)	56.3		(602.5)
Cash flows from financing activities:
Issuance of notes payable, net	$ 925.0	910.0	0.0		0.0
Payments on notes payable		(797.1)	(62.9)		(126.9)
Expenses related to extinguishment or modification of debt		(17.8)	(0.6)		(61.6)
Issuance of common stock		6.3	5.0		15.1
Payments to repurchase common stock and warrants		(365.2)	(319.1)		(118.4)
Amount paid to extinguish the beneficial conversion feature associated with repurchase of convertible debentures		0.0	0.0		(12.6)
Net cash provided (used) by financing activities		146.4	(265.5)		(1.4)
Net increase (decrease) in cash and cash equivalents		(179.3)	(87.4)		116.5
Cash and cash equivalents, beginning of year		611.6	699.0		582.5
Cash and cash equivalents, end of year		432.3	611.6		699.0
Parent Company [Member]
Condensed Financial Statements, Captions [Line Items]
Cash flows from operating activities		(55.1)	(66.7)		(65.9)
Cash flows from investing activities:
Sales of investments		66.5	229.8		95.8
Sales of investments - affiliated		16.0	18.3		0.0
Maturities and redemptions of investments - affiliated		8.3	0.0		0.0
Purchases of investments		(68.6)	(320.1)		(119.3)
Purchases of investments - affiliated		(3.4)	(30.7)		(10.0)
Net sales of trading securities		11.8	9.9		12.6
Dividends received from consolidated subsidiary, net of capital contributions of nil in 2015, $18.8 in 2014 and nil in 2013		269.7	423.5		242.8
Net cash provided (used) by investing activities		300.3	330.7		221.9
Cash flows from financing activities:
Issuance of notes payable, net		910.0	0.0		0.0
Payments on notes payable		(797.1)	(62.9)		(126.9)
Expenses related to extinguishment or modification of debt		(17.8)	(0.6)		(61.6)
Issuance of common stock		6.3	5.0		15.1
Payments to repurchase common stock and warrants		(361.5)	(376.5)		(118.4)
Common stock dividends paid		(52.0)	(51.0)		(24.4)
Amount paid to extinguish the beneficial conversion feature associated with repurchase of convertible debentures		0.0	0.0		(12.6)
Investment borrowings - repurchase agreements, net		(20.4)	20.4		0.0
Issuance of notes payable to affiliates		234.4	257.8		222.1
Payments on notes payable to affiliates		(104.8)	(100.7)		(83.9)
Net cash provided (used) by financing activities		(202.9)	(308.5)		(190.6)
Net increase (decrease) in cash and cash equivalents		42.3	(44.5)		(34.6)
Cash and cash equivalents, beginning of year		86.6	131.1		165.7
Cash and cash equivalents, end of year		$ 128.9	$ 86.6		$ 131.1

[1] Cash flows from operating activities reflect outflows in 2014 due to the payment to reinsurer to transfer certain long-term care business.

XML

SCHEDULE II - STATEMENT OF CASH FLOWS Parenthetical (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Condensed Financial Information of Parent Company Only Disclosure [Abstract]
Capital contributions	$ 0.0	$ 18.8	$ 0.0

XML

SCHEDULE IV (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Reinsurance Premiums for Insurance Companies, by Product Segment [Line Items]
Assumed premiums earned	$ 38.4	$ 34.5	$ 38.0
Reinsurance ceded	(142.8)	(187.9)	(240.5)
Insurance policy income	2,556.0	2,629.7	2,744.7
Life insurance inforce
Reinsurance Premiums for Insurance Companies, by Product Segment [Line Items]
Direct	25,807.0	25,029.0	53,304.9
Assumed	137.4	147.1	305.7
Ceded	(3,780.8)	(3,660.1)	(11,477.6)
Net insurance inforce	$ 22,163.6	$ 21,516.0	$ 42,133.0
Percentage of assumed to net	0.60%	0.70%	0.70%
Insurance policy income
Reinsurance Premiums for Insurance Companies, by Product Segment [Line Items]
Direct premiums earned	$ 2,524.3	$ 2,558.2	$ 2,623.5
Assumed premiums earned	38.5	35.0	37.4
Reinsurance ceded	(133.6)	(176.7)	(212.1)
Insurance policy income	$ 2,429.2	$ 2,416.5	$ 2,448.8
Premiums, percentage assumed	1.60%	1.40%	1.50%